data_2ggr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ggr _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 266' ' ' VAL . 4.3 Cg_endo . . . . . 0 N--CA 1.451 -0.978 0 N-CA-C 111.554 -0.21 . . . . 0.0 111.554 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . 0.949 HD13 ' HB ' ' A' ' 266' ' ' VAL . 0.2 OUTLIER -85.12 161.56 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 C-N-CA 119.219 -0.992 . . . . 0.0 109.852 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.828 ' HB3' HD22 ' A' ' 263' ' ' LEU . 44.4 m-85 -103.46 118.64 37.21 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 172.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.676 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -111.83 115.76 29.55 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.05 -174.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.499 ' HB3' ' O ' ' A' ' 292' ' ' ARG . 21.9 tpp180 -75.48 101.64 4.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 175.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . 0.74 HG22 ' HD3' ' A' ' 245' ' ' LYS . 5.2 p -81.29 119.88 31.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 C-N-CA 120.316 -0.554 . . . . 0.0 109.991 -175.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.409 HD11 ' C ' ' A' ' 243' ' ' ILE . 2.8 pp -102.23 9.15 8.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.629 -173.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.867 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 30.5 tt0 -176.9 95.44 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.192 -177.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.74 ' HD3' HG22 ' A' ' 242' ' ' VAL . 0.1 OUTLIER -146.48 164.22 33.22 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.839 0.828 . . . . 0.0 111.189 174.242 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.808 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 2.6 ptm180 -105.24 -175.88 2.92 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.637 -1.62 . . . . 0.0 108.767 -177.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 3.8 m -110.52 70.87 0.64 Allowed Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 121.42 0.628 . . . . 0.0 111.547 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.999 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 28.7 Cg_endo -95.29 123.08 0.32 Allowed 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 125.051 3.834 . . . . 0.0 111.913 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.464 ' C ' ' H ' ' A' ' 251' ' ' TYR . 40.7 m-80 -78.55 176.18 9.66 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.873 0.368 . . . . 0.0 111.038 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.685 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -62.9 -2.07 1.09 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.751 0.786 . . . . 0.0 111.349 175.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.464 ' H ' ' C ' ' A' ' 249' ' ' ASN . 12.0 m-85 -92.87 -1.93 56.32 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.998 178.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.38 47.81 1.14 Allowed 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt 59.99 30.22 19.73 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -167.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' THR . . . . . 0.685 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 29.4 p 63.79 86.22 0.12 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 113.825 -1.534 . . . . 0.0 111.048 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.644 ' HB1' ' HB2' ' A' ' 248' ' ' PRO . . . -120.6 163.78 17.5 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.951 178.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.495 ' HB3' ' CG ' ' A' ' 258' ' ' LEU . 4.5 mm? -83.15 120.59 25.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.203 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.999 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -88.84 91.19 8.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.65 0.738 . . . . 0.0 110.303 176.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.691 ' CD2' ' HB ' ' A' ' 264' ' ' VAL . 0.2 OUTLIER -148.34 176.28 10.4 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.561 -174.645 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.507 ' O ' HG11 ' A' ' 242' ' ' VAL . 15.4 tt0 -142.04 167.11 22.91 Favored 'General case' 0 C--N 1.313 -1.022 0 O-C-N 121.931 -0.481 . . . . 0.0 110.931 -162.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.488 ' N ' ' HG2' ' A' ' 259' ' ' GLU . 1.6 p -57.79 117.73 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 121.41 0.624 . . . . 0.0 111.236 174.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 107.52 -2.65 34.47 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.918 176.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -95.44 -173.33 2.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.941 0.4 . . . . 0.0 111.379 -173.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.828 HD22 ' HB3' ' A' ' 239' ' ' TYR . 3.4 tm? -133.73 122.27 23.11 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.711 -174.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.691 ' HB ' ' CD2' ' A' ' 258' ' ' LEU . 2.5 p -113.82 125.74 71.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.077 174.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.548 ' HG3' ' CE1' ' A' ' 239' ' ' TYR . 5.2 tmmm? -96.47 96.11 8.47 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.949 ' HB ' HD13 ' A' ' 238' ' ' ILE . 96.6 t -71.89 114.94 11.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.084 -177.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' THR . . . . . 0.437 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 4.7 t -93.36 -9.28 39.34 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 124.313 1.008 . . . . 0.0 111.266 -178.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.604 ' HA ' ' HE3' ' A' ' 268' ' ' LYS . 0.0 OUTLIER -127.32 103.28 7.31 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 175.399 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.471 HD11 ' O ' ' A' ' 269' ' ' ILE . 0.8 OUTLIER -98.98 160.12 3.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -170.426 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.589 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 3.6 p30 -146.69 -169.62 3.32 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.925 178.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 8.5 p -96.65 -37.0 6.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 5.0 m -73.27 -43.02 61.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.864 0.364 . . . . 0.0 111.767 -172.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . 0.846 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 124.27 -4.79 8.87 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.828 -175.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -90.59 82.19 5.83 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 176.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.589 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -116.87 175.51 5.54 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.246 0.546 . . . . 0.0 112.054 -174.244 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.495 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 36.0 mt-10 -102.62 124.66 48.57 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.831 177.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.595 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -108.41 153.38 16.83 Favored Glycine 0 N--CA 1.439 -1.128 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.418 -169.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.575 ' HG3' ' HG2' ' A' ' 283' ' ' ARG . 21.8 tt0 -130.74 119.8 22.87 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 173.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' CYS . . . . . 0.491 ' O ' ' HD2' ' A' ' 282' ' ' LYS . 53.7 t -116.56 96.22 5.41 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.958 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 24.38 61.31 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 O-C-N 124.914 1.384 . . . . 0.0 113.505 -177.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.79 -20.32 11.9 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.84 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . 0.491 ' HD2' ' O ' ' A' ' 279' ' ' CYS . 5.7 mptt -97.93 132.13 43.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.632 0.716 . . . . 0.0 109.749 174.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . 0.575 ' HG2' ' HG3' ' A' ' 278' ' ' GLU . 48.7 mtt180 -123.68 141.5 51.96 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 176.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 175.29 -148.79 9.73 Favored Glycine 0 C--O 1.223 -0.542 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.315 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' HIS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 12.8 p80 -149.17 145.92 27.4 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 117.37 0.585 . . . . 0.0 111.54 -177.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.611 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 4.4 m-85 -162.57 164.07 17.23 Favored Pre-proline 0 N--CA 1.47 0.546 0 C-N-CA 122.543 0.337 . . . . 0.0 111.119 -177.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.478 ' HD3' ' HD1' ' A' ' 286' ' ' PHE . 31.4 Cg_endo -95.39 168.11 1.45 Allowed 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 123.464 2.776 . . . . 0.0 114.144 -175.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.846 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 7.2 t80 -76.28 -17.71 59.33 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.748 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 35.8 p -45.61 -37.98 6.14 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -174.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . 0.867 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 0.8 OUTLIER -132.61 48.39 2.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.141 0.496 . . . . 0.0 112.32 -174.432 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 27.7 m -142.75 151.78 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.773 173.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.499 ' O ' ' HB3' ' A' ' 241' ' ' ARG . 21.2 mmt180 -128.83 109.39 11.24 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 176.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . 0.501 ' HB3' ' HA ' ' A' ' 240' ' ' ALA . 0.2 OUTLIER -116.7 144.07 44.88 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -162.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.541 ' O ' ' HB ' ' A' ' 238' ' ' ILE . 4.5 mp . . . . . 0 N--CA 1.438 -1.041 0 CA-C-N 113.461 -1.7 . . . . 0.0 108.8 169.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo . . . . . 0 N--CA 1.453 -0.889 0 CA-C-O 121.779 0.658 . . . . 0.0 111.612 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . 0.921 HG22 ' HB ' ' A' ' 266' ' ' VAL . 0.1 OUTLIER -105.92 142.55 18.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.971 -173.26 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.758 ' HB3' HD12 ' A' ' 263' ' ' LEU . 76.7 m-85 -96.81 117.04 30.21 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 174.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.509 ' HB2' HD21 ' A' ' 293' ' ' LEU . . . -114.68 117.19 30.13 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.424 -173.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.588 ' HB3' ' O ' ' A' ' 292' ' ' ARG . 23.8 tpp180 -83.12 103.18 12.35 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.316 -177.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . 1.008 HG22 ' HD3' ' A' ' 245' ' ' LYS . 3.7 p -81.86 128.79 38.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.258 -175.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.595 HD11 ' HB2' ' A' ' 244' ' ' GLN . 2.8 pp -107.33 7.43 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.344 -176.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.595 ' HB2' HD11 ' A' ' 243' ' ' ILE . 13.5 mt-30 -176.35 95.43 0.05 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.522 -173.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 1.008 ' HD3' HG22 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -146.09 163.32 35.68 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.118 0.485 . . . . 0.0 110.353 173.044 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.845 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 12.6 ptp180 -104.3 -177.08 3.26 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.344 -177.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 6.9 m -104.21 80.23 0.43 Allowed Pre-proline 0 CA--C 1.54 0.57 0 CA-C-O 121.522 0.677 . . . . 0.0 111.828 175.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.897 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 9.1 Cg_endo -92.93 176.67 1.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 125.167 3.911 . . . . 0.0 111.545 176.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -126.85 175.47 8.01 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.573 ' O ' HG21 ' A' ' 254' ' ' THR . . . -68.03 -0.99 5.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.4 175.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -114.93 14.83 17.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.431 0.634 . . . . 0.0 110.011 173.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -104.56 56.54 0.71 Allowed 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 173.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . 0.488 ' HA ' ' HE2' ' A' ' 253' ' ' LYS . 11.1 mmpt? 65.63 22.62 11.67 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.813 -169.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' THR . . . . . 0.573 HG21 ' O ' ' A' ' 250' ' ' ALA . 29.1 p 59.26 75.54 0.4 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.488 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.681 ' HB3' ' CE2' ' A' ' 286' ' ' PHE . . . -125.32 159.06 32.67 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.163 -176.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.583 HD23 ' O ' ' A' ' 277' ' ' GLY . 4.6 mm? -78.99 124.84 28.65 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.074 -0.967 . . . . 0.0 112.598 -176.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.897 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -83.03 93.17 7.52 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.338 0.589 . . . . 0.0 110.72 172.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.59 ' CD1' ' HE2' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -156.97 171.95 19.55 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.992 -1.003 . . . . 0.0 109.486 -177.508 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.474 ' O ' HG11 ' A' ' 242' ' ' VAL . 11.9 pt-20 -141.38 -163.87 1.65 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 118.488 0.586 . . . . 0.0 112.018 -167.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.42 HG21 ' HA ' ' A' ' 244' ' ' GLN . 75.3 t -67.08 118.27 10.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.024 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 105.69 -2.18 39.15 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.606 171.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.52 ' O ' ' HD3' ' A' ' 241' ' ' ARG . 7.9 mt-10 -91.85 -179.46 5.32 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.824 0.345 . . . . 0.0 110.92 -172.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.758 HD12 ' HB3' ' A' ' 239' ' ' TYR . 41.1 tp -129.22 161.06 31.03 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.981 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.536 ' N ' ' HG ' ' A' ' 263' ' ' LEU . 2.4 p -151.15 132.31 4.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.944 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -93.19 97.98 10.99 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 177.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.921 ' HB ' HG22 ' A' ' 238' ' ' ILE . 97.8 t -69.8 119.3 15.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.498 -178.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 73.7 p -102.2 -25.57 13.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.751 -175.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 2.4 tppp? -108.56 106.04 15.94 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 173.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.546 HD11 ' N ' ' A' ' 269' ' ' ILE . 0.1 OUTLIER -109.77 148.07 13.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -167.022 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.761 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 1.9 p30 -135.85 -170.76 2.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.688 176.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.07 -21.25 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 120.54 -0.464 . . . . 0.0 112.082 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.4 m -79.2 -44.26 22.23 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -174.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 126.02 -11.3 7.35 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.411 -177.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.504 HE21 ' C ' ' A' ' 274' ' ' GLN . 0.0 OUTLIER -91.33 107.79 19.45 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 174.196 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.761 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -147.72 -179.87 7.2 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -173.004 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.616 ' HG2' ' HB3' ' A' ' 285' ' ' HIS . 35.0 mt-10 -97.29 126.05 42.27 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.148 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.583 ' O ' HD23 ' A' ' 256' ' ' LEU . . . -110.68 156.42 15.57 Favored Glycine 0 N--CA 1.437 -1.242 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.717 -173.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 33.7 tt0 -135.21 119.69 18.03 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 172.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 45.6 t -109.72 97.1 6.71 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.922 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 34.4 56.52 0.67 Allowed 'General case' 0 N--CA 1.464 0.263 0 O-C-N 124.873 1.358 . . . . 0.0 112.479 176.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.36 -34.63 4.59 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.881 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 49.5 mttt -82.15 129.7 34.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.954 0.877 . . . . 0.0 110.874 178.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -113.07 148.29 35.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.026 0.441 . . . . 0.0 111.502 176.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 166.38 -150.42 17.59 Favored Glycine 0 C--O 1.225 -0.459 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.554 174.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' HIS . . . . . 0.616 ' HB3' ' HG2' ' A' ' 276' ' ' GLU . 30.1 p80 -149.74 157.22 43.01 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.59 0.695 . . . . 0.0 111.68 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.703 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 2.4 m-85 -163.3 158.78 18.0 Favored Pre-proline 0 C--N 1.331 -0.227 0 O-C-N 123.563 0.54 . . . . 0.0 110.479 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.479 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 10.7 Cg_endo -89.09 158.92 5.78 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.187 2.591 . . . . 0.0 111.938 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.4 ' HA ' HG22 ' A' ' 291' ' ' VAL . 3.0 p90 -83.97 -5.26 59.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.562 -176.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 11.1 t -54.83 -13.06 0.92 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . 0.535 ' NE2' ' HD2' ' A' ' 245' ' ' LYS . 0.6 OUTLIER -137.71 47.0 2.07 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.113 -0.367 . . . . 0.0 111.564 -179.635 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.752 HG11 ' HA ' ' A' ' 242' ' ' VAL . 35.6 m -147.36 170.26 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.39 0.614 . . . . 0.0 111.61 177.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.588 ' O ' ' HB3' ' A' ' 241' ' ' ARG . 16.3 tpp180 -129.35 110.16 11.69 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 171.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . 0.509 HD21 ' HB2' ' A' ' 240' ' ' ALA . 2.9 mt -91.31 140.64 29.59 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -163.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.44 HD11 ' N ' ' A' ' 294' ' ' LEU . 3.9 mp . . . . . 0 N--CA 1.445 -0.69 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 163.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.718 ' HB3' ' HA ' ' A' ' 267' ' ' THR . 4.2 Cg_exo . . . . . 0 CA--C 1.532 0.394 0 N-CA-C 113.271 0.45 . . . . 0.0 113.271 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . 0.726 HD11 ' HB ' ' A' ' 266' ' ' VAL . 0.1 OUTLIER -84.07 151.55 3.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 120.996 0.427 . . . . 0.0 111.095 -170.611 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.454 ' HB3' HD12 ' A' ' 263' ' ' LEU . 57.6 m-85 -103.96 119.62 39.32 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 175.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.642 ' HA ' ' HA ' ' A' ' 293' ' ' LEU . . . -113.46 118.33 34.21 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.336 0.589 . . . . 0.0 111.154 -171.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.412 ' HB3' ' O ' ' A' ' 292' ' ' ARG . 20.9 tpp180 -78.0 102.34 7.34 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.637 176.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . 0.632 HG22 ' HB2' ' A' ' 245' ' ' LYS . 3.2 p -80.94 124.96 39.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.609 -176.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' A' ' 244' ' ' GLN . 2.8 pp -105.44 8.58 9.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.588 -174.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.76 ' HA ' HG21 ' A' ' 260' ' ' VAL . 17.1 mt-30 -176.17 95.39 0.06 Allowed 'General case' 0 CA--C 1.515 -0.369 0 O-C-N 123.296 0.372 . . . . 0.0 110.347 -173.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.757 ' HG2' ' CD1' ' A' ' 258' ' ' LEU . 0.0 OUTLIER -146.72 163.56 35.55 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.603 0.716 . . . . 0.0 111.663 176.298 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.89 ' HG3' ' HG3' ' A' ' 248' ' ' PRO . 2.4 ptm180 -108.5 -173.3 2.24 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.175 -1.375 . . . . 0.0 109.303 -176.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 37.7 t -108.39 75.67 0.6 Allowed Pre-proline 0 CA--C 1.537 0.443 0 CA-C-O 121.523 0.678 . . . . 0.0 110.175 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.939 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 9.6 Cg_endo -95.0 132.45 0.57 Allowed 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 125.187 3.924 . . . . 0.0 111.768 178.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.414 ' C ' ' H ' ' A' ' 251' ' ' TYR . 3.6 m-20 -89.53 175.81 7.14 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.772 0.32 . . . . 0.0 110.423 -176.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -71.12 4.02 3.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.608 0.718 . . . . 0.0 110.669 177.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.414 ' H ' ' C ' ' A' ' 249' ' ' ASN . 26.5 m-85 -107.04 8.95 30.63 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.097 176.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 249' ' ' ASN . 0.7 OUTLIER -96.88 51.97 1.16 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.005 175.274 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.93 25.7 14.89 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -166.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 22.4 p 65.61 88.08 0.11 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.819 1.248 . . . . 0.0 110.0 -174.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.629 ' HB1' ' HB2' ' A' ' 248' ' ' PRO . . . -122.0 168.32 12.06 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.066 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.668 ' H ' ' HE2' ' A' ' 286' ' ' PHE . 4.3 mm? -94.86 118.44 31.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.526 -176.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.939 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -85.64 97.26 10.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.54 0.686 . . . . 0.0 110.115 176.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.757 ' CD1' ' HG2' ' A' ' 245' ' ' LYS . 0.2 OUTLIER -156.12 176.42 12.69 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.49 -174.471 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.547 ' HG2' ' N ' ' A' ' 260' ' ' VAL . 24.5 tt0 -142.67 173.79 11.23 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.584 -0.698 . . . . 0.0 111.705 -161.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' A' ' 244' ' ' GLN . 69.5 t -56.35 118.2 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 C-N-CA 123.241 0.616 . . . . 0.0 111.443 173.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 104.83 -2.38 41.64 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.805 173.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.427 ' OE2' ' HB3' ' A' ' 259' ' ' GLU . 14.4 mt-10 -97.14 -173.16 2.6 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.023 -174.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.454 HD12 ' HB3' ' A' ' 239' ' ' TYR . 12.4 tp -127.83 157.77 39.55 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.039 0.447 . . . . 0.0 110.685 -176.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.599 HG12 ' HB3' ' A' ' 240' ' ' ALA . 7.7 p -144.09 143.41 23.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 175.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -103.87 95.24 5.88 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.726 ' HB ' HD11 ' A' ' 238' ' ' ILE . 74.8 t -74.39 105.64 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-O 121.94 0.876 . . . . 0.0 110.566 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' THR . . . . . 0.718 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 5.3 t -93.93 -9.34 37.4 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 113.264 -1.789 . . . . 0.0 110.678 -174.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 14.8 tppt? -122.53 106.18 10.78 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 172.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.533 HD11 ' O ' ' A' ' 269' ' ' ILE . 0.7 OUTLIER -106.78 153.21 8.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -166.66 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.758 HD21 ' HB3' ' A' ' 275' ' ' TRP . 2.0 p30 -147.14 177.01 9.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.057 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 9.7 p -89.91 -23.39 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -176.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.63 -1.05 51.02 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -175.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . 0.783 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 78.31 8.7 87.43 Favored Glycine 0 C--O 1.223 -0.532 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.983 177.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.49 ' N ' HD22 ' A' ' 270' ' ' ASN . 19.3 mm-40 -93.29 73.25 4.56 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.758 ' HB3' HD21 ' A' ' 270' ' ' ASN . 0.0 OUTLIER -124.25 -179.41 4.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.507 0.67 . . . . 0.0 112.612 -166.554 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.701 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 32.0 mt-10 -104.32 125.74 50.82 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.584 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.584 ' O ' HD23 ' A' ' 256' ' ' LEU . . . -103.51 156.1 17.82 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.25 -173.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.528 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 20.0 tt0 -138.55 118.34 13.19 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 175.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' CYS . . . . . 0.617 ' SG ' ' HD3' ' A' ' 282' ' ' LYS . 26.6 p -102.48 97.12 7.4 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.419 -0.912 . . . . 0.0 109.635 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 12.0 m120 39.45 56.69 2.21 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.438 -1.256 . . . . 0.0 112.323 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 115.92 -39.87 2.6 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.646 -0.788 . . . . 0.0 114.136 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . 0.617 ' HD3' ' SG ' ' A' ' 279' ' ' CYS . 5.9 mptt -76.58 129.16 36.03 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 118.144 0.972 . . . . 0.0 110.414 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.39 131.06 54.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.606 -176.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -167.78 -151.18 6.88 Favored Glycine 0 C--O 1.224 -0.49 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.228 174.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' HIS . . . . . 0.701 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 16.8 p80 -150.56 147.91 28.03 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 117.122 0.461 . . . . 0.0 111.187 -177.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.668 ' HE2' ' H ' ' A' ' 256' ' ' LEU . 4.5 m-85 -157.84 160.18 30.12 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 120.728 0.299 . . . . 0.0 111.69 -177.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.547 ' HD2' ' HE2' ' A' ' 290' ' ' HIS . 94.2 Cg_endo -95.19 155.24 1.69 Allowed 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 123.342 2.694 . . . . 0.0 114.005 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.783 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 20.0 t80 -66.29 -21.39 66.27 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 114.221 -1.354 . . . . 0.0 112.514 -176.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 9.2 t -57.77 -20.73 37.33 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 -168.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . 0.547 ' HE2' ' HD2' ' A' ' 287' ' ' PRO . 1.0 OUTLIER -136.36 37.61 2.71 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.952 -0.468 . . . . 0.0 111.9 -175.181 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 32.8 m -141.05 151.0 19.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.253 175.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.412 ' O ' ' HB3' ' A' ' 241' ' ' ARG . 14.1 mmm180 -121.68 108.06 13.1 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 173.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 240' ' ' ALA . 0.0 OUTLIER -101.21 137.1 40.01 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -167.553 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.458 HD11 ' N ' ' A' ' 294' ' ' LEU . 4.3 mp . . . . . 0 N--CA 1.427 -1.597 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 162.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo . . . . . 0 N--CA 1.462 -0.377 0 CA-C-O 120.828 0.262 . . . . 0.0 111.856 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . 0.906 HG22 ' HB ' ' A' ' 266' ' ' VAL . 0.0 OUTLIER -91.79 131.04 39.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.951 -177.469 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -97.55 120.22 37.53 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 176.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.845 ' HB1' HD13 ' A' ' 238' ' ' ILE . . . -116.02 118.13 32.05 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.366 -174.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 292' ' ' ARG . 0.0 OUTLIER -78.88 100.94 7.43 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 174.601 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . 0.765 HG22 ' HB2' ' A' ' 245' ' ' LYS . 9.8 p -81.08 115.48 23.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 119.192 -1.003 . . . . 0.0 109.932 -176.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.486 HD11 ' HB2' ' A' ' 244' ' ' GLN . 2.8 pp -97.99 2.97 10.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.113 -174.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.774 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 56.1 tp60 -176.59 93.17 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.032 -174.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.765 ' HB2' HG22 ' A' ' 242' ' ' VAL . 0.5 OUTLIER -147.16 166.21 27.66 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.202 0.525 . . . . 0.0 110.026 173.114 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.781 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 6.2 ptm180 -102.25 -178.59 3.74 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.548 -174.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 43.5 t -107.73 80.6 1.0 Allowed Pre-proline 0 CA--C 1.536 0.415 0 CA-C-O 121.233 0.54 . . . . 0.0 111.011 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.843 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 9.9 Cg_endo -93.96 168.03 2.02 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 124.606 3.537 . . . . 0.0 111.339 174.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -123.3 178.24 5.22 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.02 0.438 . . . . 0.0 110.426 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.683 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -61.83 -2.23 0.81 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.571 174.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -100.99 -2.46 31.66 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.182 0.515 . . . . 0.0 110.543 176.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -105.6 65.45 0.71 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -177.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . 0.669 ' HA ' ' HE3' ' A' ' 253' ' ' LYS . 0.0 OUTLIER 61.2 19.7 10.31 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.587 -171.772 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' THR . . . . . 0.683 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 30.5 p 56.63 64.44 1.67 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.723 -175.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.504 ' HB3' ' CE2' ' A' ' 286' ' ' PHE . . . -109.55 154.65 22.44 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.272 -0.877 . . . . 0.0 111.006 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.706 ' HB3' HD21 ' A' ' 258' ' ' LEU . 0.2 OUTLIER -69.03 132.91 47.39 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.606 -175.643 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.843 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -85.52 93.25 8.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.346 0.593 . . . . 0.0 109.546 168.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.706 HD21 ' HB3' ' A' ' 256' ' ' LEU . 0.5 OUTLIER -142.14 160.92 39.26 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.292 -175.013 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.589 ' O ' HG11 ' A' ' 242' ' ' VAL . 37.4 tt0 -142.29 173.66 11.33 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.887 -165.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.546 HG23 ' HA ' ' A' ' 244' ' ' GLN . 47.3 t -56.15 117.79 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-O 121.267 0.556 . . . . 0.0 112.162 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 95.67 0.93 62.21 Favored Glycine 0 CA--C 1.505 -0.591 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.0 172.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -87.41 164.52 16.16 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.51 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.52 ' HG ' ' N ' ' A' ' 264' ' ' VAL . 16.6 tp -121.32 152.56 38.82 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.721 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.698 HG12 ' HB2' ' A' ' 279' ' ' CYS . 15.0 m -141.81 166.34 17.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -132.42 97.21 4.04 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.906 ' HB ' HG22 ' A' ' 238' ' ' ILE . 46.1 t -68.95 128.24 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.732 -176.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 11.6 p -100.03 -18.86 16.81 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 113.722 -1.581 . . . . 0.0 111.852 -173.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -127.73 106.4 9.11 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 121.459 0.647 . . . . 0.0 109.762 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.446 HD12 HG23 ' A' ' 238' ' ' ILE . 0.0 OUTLIER -98.21 154.48 3.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.604 -167.073 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.712 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 0.4 OUTLIER -146.43 -169.65 3.32 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.515 178.802 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 12.7 p -98.34 -35.04 4.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.961 -177.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 3.5 m -68.84 -44.61 73.06 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -174.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . 0.411 ' HA3' ' CD1' ' A' ' 288' ' ' PHE . . . 121.83 -5.98 10.47 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.316 -176.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.574 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.0 OUTLIER -96.01 70.73 2.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.791 0.805 . . . . 0.0 110.351 176.479 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.712 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -102.32 173.33 6.41 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.615 -172.265 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.733 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 33.3 tt0 -93.39 123.74 36.9 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.524 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -103.08 151.43 17.96 Favored Glycine 0 N--CA 1.437 -1.253 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.27 -171.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -129.12 119.51 24.26 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 173.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' CYS . . . . . 0.698 ' HB2' HG12 ' A' ' 264' ' ' VAL . 44.7 t -114.04 97.1 6.17 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.566 -177.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 28.84 61.31 0.13 Allowed 'General case' 0 N--CA 1.466 0.375 0 O-C-N 124.967 1.417 . . . . 0.0 112.564 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.58 -38.63 2.96 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 115.724 -0.671 . . . . 0.0 113.268 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -80.61 146.63 31.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.297 0.548 . . . . 0.0 110.52 177.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 39.8 mtt180 -132.4 129.78 39.78 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.012 0.434 . . . . 0.0 110.033 170.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . 0.631 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . -173.81 142.1 6.36 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.006 -177.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' HIS . . . . . 0.733 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 14.7 p80 -91.92 148.03 22.52 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 117.908 0.854 . . . . 0.0 111.681 -175.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.814 ' HD1' ' HD3' ' A' ' 287' ' ' PRO . 3.2 m-85 -165.03 170.12 6.73 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -174.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.814 ' HD3' ' HD1' ' A' ' 286' ' ' PHE . 58.1 Cg_endo -100.84 156.94 0.42 Allowed 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 123.306 2.67 . . . . 0.0 112.856 -174.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.411 ' CD1' ' HA3' ' A' ' 273' ' ' GLY . 0.7 OUTLIER -87.16 -8.85 56.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.076 -177.872 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' THR . . . . . 0.544 HG21 ' HB2' ' A' ' 287' ' ' PRO . 10.0 t -55.79 -32.65 63.68 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.84 -178.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . 0.774 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 0.5 OUTLIER -119.98 55.13 1.0 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.585 0.707 . . . . 0.0 111.365 175.363 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.446 HG13 ' HA ' ' A' ' 242' ' ' VAL . 10.6 m -147.17 171.96 3.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.811 170.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.472 ' O ' ' HB2' ' A' ' 241' ' ' ARG . 14.5 tpt180 -122.66 108.88 13.58 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 171.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . 0.45 HD23 ' CZ2' ' A' ' 275' ' ' TRP . 6.1 tp -84.62 123.55 30.46 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 115.231 -0.895 . . . . 0.0 113.37 -164.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 6.6 mt . . . . . 0 N--CA 1.44 -0.965 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 169.769 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.959 ' HB3' ' HA ' ' A' ' 267' ' ' THR . 4.5 Cg_exo . . . . . 0 C--O 1.238 0.487 0 CA-C-O 120.517 0.132 . . . . 0.0 111.92 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . 1.049 HG12 HG23 ' A' ' 266' ' ' VAL . 0.8 OUTLIER -78.73 160.77 4.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.016 -167.3 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.686 ' HB3' HD12 ' A' ' 263' ' ' LEU . 86.7 m-85 -108.5 118.75 37.58 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 174.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.582 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -113.77 118.49 34.42 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.165 0.507 . . . . 0.0 111.021 -174.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.403 ' HB3' ' O ' ' A' ' 292' ' ' ARG . 15.1 tpp180 -81.6 103.73 11.52 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . 1.0 HG22 ' HD2' ' A' ' 245' ' ' LYS . 5.6 p -86.01 130.74 36.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.986 -175.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.484 ' O ' HG13 ' A' ' 260' ' ' VAL . 2.8 pp -106.83 8.8 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.704 -174.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.749 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 63.3 tt0 -177.8 94.06 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -173.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 1.045 ' HD3' HD13 ' A' ' 258' ' ' LEU . 11.0 mttt -145.57 161.84 38.85 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 175.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.836 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 13.2 ptt180 -107.59 -176.31 3.03 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.875 -172.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 7.0 p -104.13 78.83 0.34 Allowed Pre-proline 0 CA--C 1.547 0.848 0 CA-C-O 121.812 0.815 . . . . 0.0 111.533 175.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.917 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 1.7 Cg_endo -88.99 177.95 2.81 Favored 'Trans proline' 0 N--CA 1.459 -0.537 1 C-N-CA 125.303 4.002 . . . . 0.0 110.654 174.436 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.458 ' C ' ' H ' ' A' ' 251' ' ' TYR . 27.7 m-80 -130.16 170.65 13.79 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.045 0.45 . . . . 0.0 109.913 177.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.69 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -76.4 14.87 0.68 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.568 0.699 . . . . 0.0 110.544 178.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.458 ' H ' ' C ' ' A' ' 249' ' ' ASN . 37.2 m-85 -110.92 1.89 17.83 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.844 175.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -95.6 49.19 1.17 Allowed 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.72 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt 60.42 33.99 20.63 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -166.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' THR . . . . . 0.69 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 71.5 p 59.55 77.63 0.3 Allowed 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 113.728 -1.578 . . . . 0.0 111.864 -178.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.404 ' C ' ' HA3' ' A' ' 284' ' ' GLY . . . -112.44 154.79 25.29 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.714 176.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 1.089 HD13 ' HG ' ' A' ' 258' ' ' LEU . 0.0 OUTLIER -83.73 133.64 34.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.255 -174.46 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.917 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -91.03 101.24 14.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.346 0.593 . . . . 0.0 109.591 171.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 1.089 ' HG ' HD13 ' A' ' 256' ' ' LEU . 0.1 OUTLIER -158.1 169.53 24.32 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.746 -174.864 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.446 ' HG2' ' N ' ' A' ' 260' ' ' VAL . 32.0 tt0 -142.16 173.21 11.73 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 121.902 -0.499 . . . . 0.0 112.048 -160.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.711 HG21 ' HA ' ' A' ' 244' ' ' GLN . 53.9 t -55.11 118.3 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 C-N-CA 123.364 0.665 . . . . 0.0 111.537 175.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 102.73 -1.69 48.84 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.644 -0.582 . . . . 0.0 111.644 172.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -95.94 173.23 7.54 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.711 -173.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.686 HD12 ' HB3' ' A' ' 239' ' ' TYR . 40.1 tp -117.27 157.62 25.75 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.326 0.584 . . . . 0.0 111.059 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.582 HG13 ' HB3' ' A' ' 240' ' ' ALA . 2.6 p -152.31 119.19 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.139 -177.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.436 ' HE3' ' HG2' ' A' ' 237' ' ' PRO . 54.7 tttp -86.9 97.34 10.62 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.572 177.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 1.049 HG23 HG12 ' A' ' 238' ' ' ILE . 7.0 m -77.23 114.4 17.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.892 0.853 . . . . 0.0 109.988 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' THR . . . . . 0.959 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 9.7 t -96.93 4.39 51.61 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.06 -174.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.539 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 0.0 OUTLIER -132.48 107.52 8.53 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 169.797 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.658 HG23 HG21 ' A' ' 238' ' ' ILE . 0.8 OUTLIER -111.12 156.37 12.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 114.961 -1.018 . . . . 0.0 113.355 -170.25 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.761 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 0.1 OUTLIER -146.13 -161.1 1.24 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.938 -1.483 . . . . 0.0 109.195 178.357 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.04 -23.3 4.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.888 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 3.0 m -65.62 -44.62 85.94 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -175.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . 0.621 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 124.03 -21.89 6.87 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.127 -177.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.601 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.3 OUTLIER -89.76 102.77 15.47 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 173.057 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.761 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -134.6 174.92 10.02 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.067 -177.071 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 44.4 tt0 -91.14 125.46 35.92 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.591 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -105.03 155.84 16.99 Favored Glycine 0 N--CA 1.437 -1.289 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.549 -175.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 30.8 tt0 -139.27 119.86 14.08 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 176.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 49.0 t -108.5 98.44 7.96 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 46.51 46.17 14.16 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.378 176.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 115.59 -39.34 2.78 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.385 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 55.3 mttt -69.96 130.87 43.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.237 0.518 . . . . 0.0 109.711 177.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 36.1 mtt180 -113.67 129.67 56.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.12 0.486 . . . . 0.0 110.969 176.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . 0.547 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . -170.18 142.82 7.44 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.995 -178.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' HIS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 25.3 p80 -99.56 148.73 23.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 117.265 0.533 . . . . 0.0 111.172 -171.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.638 ' CG ' ' HE2' ' A' ' 245' ' ' LYS . 5.8 m-85 -159.26 158.96 28.83 Favored Pre-proline 0 CA--C 1.533 0.289 0 O-C-N 123.469 0.48 . . . . 0.0 110.796 -176.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.601 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 97.2 Cg_endo -91.58 169.88 3.1 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.919 2.413 . . . . 0.0 113.909 -175.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.621 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 9.8 t80 -75.87 -13.18 60.27 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.554 -175.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 25.4 p -48.24 -29.36 3.72 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -174.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . 0.749 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 1.3 p-80 -136.9 39.84 2.55 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.779 0.323 . . . . 0.0 111.586 -171.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.493 HG21 ' HB2' ' A' ' 240' ' ' ALA . 3.1 p -141.78 150.81 19.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 119.454 -0.899 . . . . 0.0 112.53 -175.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.403 ' O ' ' HB3' ' A' ' 241' ' ' ARG . 30.0 mmm180 -130.39 108.89 10.32 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . 0.579 HD23 ' CE2' ' A' ' 288' ' ' PHE . 0.4 OUTLIER -120.09 145.34 46.98 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -163.799 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 N--CA 1.434 -1.26 0 CA-C-N 113.677 -1.601 . . . . 0.0 107.553 168.386 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.665 ' HB3' ' HA ' ' A' ' 267' ' ' THR . 7.6 Cg_exo . . . . . 0 N--CA 1.462 -0.337 0 N-CA-C 113.438 0.514 . . . . 0.0 113.438 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . 1.04 HG12 HG23 ' A' ' 266' ' ' VAL . 0.6 OUTLIER -80.59 160.17 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.987 -171.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.843 ' HD1' HD13 ' A' ' 263' ' ' LEU . 64.5 m-85 -104.23 120.48 41.25 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 173.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.764 ' HB3' HG12 ' A' ' 264' ' ' VAL . . . -113.65 116.97 30.3 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.309 -176.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 241' ' ' ARG . 0.0 OUTLIER -81.65 101.03 9.78 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.766 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . 0.736 ' CG2' ' HD3' ' A' ' 245' ' ' LYS . 3.4 p -78.33 122.3 33.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 119.931 -0.708 . . . . 0.0 110.116 -176.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.538 HG23 ' HG2' ' A' ' 292' ' ' ARG . 2.8 pp -110.12 6.46 8.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.516 -174.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.717 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 58.7 tt0 -176.3 94.55 0.05 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.081 -175.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.833 ' HE2' HD22 ' A' ' 258' ' ' LEU . 0.2 OUTLIER -147.07 168.0 22.67 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 122.008 0.909 . . . . 0.0 111.613 178.302 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.849 ' HG3' ' HG3' ' A' ' 248' ' ' PRO . 12.3 ptm180 -108.47 -176.4 3.04 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.787 -1.552 . . . . 0.0 109.717 -173.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 19.0 t -108.28 75.33 0.56 Allowed Pre-proline 0 CA--C 1.54 0.589 0 CA-C-O 121.029 0.442 . . . . 0.0 110.997 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.949 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 5.7 Cg_endo -91.11 177.41 2.03 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 124.861 3.707 . . . . 0.0 110.712 176.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.484 ' C ' ' H ' ' A' ' 251' ' ' TYR . 10.9 m120 -135.18 175.34 9.67 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.766 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -69.46 9.7 0.44 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.393 0.616 . . . . 0.0 111.269 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.484 ' H ' ' C ' ' A' ' 249' ' ' ASN . 18.9 m-85 -103.14 -4.01 25.05 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 176.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -105.28 67.96 0.79 Allowed 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.16 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . 0.46 ' HB2' ' HE2' ' A' ' 253' ' ' LYS . 2.6 mppt? 54.54 28.97 10.49 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -169.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' THR . . . . . 0.766 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 78.3 p 55.66 73.48 0.43 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.903 -174.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.571 ' C ' ' HA3' ' A' ' 284' ' ' GLY . . . -108.47 153.08 23.84 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.366 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.726 ' N ' ' HA3' ' A' ' 284' ' ' GLY . 0.2 OUTLIER -79.92 132.58 36.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.341 -173.083 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.949 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -92.22 100.98 13.49 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 173.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.833 HD22 ' HE2' ' A' ' 245' ' ' LYS . 0.6 OUTLIER -154.62 170.67 20.96 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.521 -174.658 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.439 ' O ' HG11 ' A' ' 242' ' ' VAL . 29.8 tt0 -142.98 169.55 17.36 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.704 0.288 . . . . 0.0 111.584 -165.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.407 ' N ' ' HG2' ' A' ' 259' ' ' GLU . 3.5 p -55.04 118.0 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.703 0.763 . . . . 0.0 112.351 176.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 105.23 -2.71 40.38 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 114.92 -1.037 . . . . 0.0 111.741 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -90.98 -179.9 5.58 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.832 -176.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.843 HD13 ' HD1' ' A' ' 239' ' ' TYR . 3.2 tm? -132.18 130.04 40.55 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.764 HG12 ' HB3' ' A' ' 240' ' ' ALA . 2.4 p -124.05 118.21 53.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.264 178.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 238' ' ' ILE . 78.8 tttt -87.27 97.06 10.58 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 1.04 HG23 HG12 ' A' ' 238' ' ' ILE . 5.0 m -77.11 122.93 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 121.87 0.843 . . . . 0.0 111.049 -175.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' THR . . . . . 0.665 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 49.5 p -91.8 -15.42 28.28 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.983 -174.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.562 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 0.0 OUTLIER -119.66 105.46 11.2 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.733 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.54 HG23 HG21 ' A' ' 238' ' ' ILE . 0.8 OUTLIER -106.46 159.54 6.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -170.235 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.722 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 3.5 p30 -145.59 -168.25 2.92 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.988 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 13.3 p -99.28 -32.27 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 120.616 -0.433 . . . . 0.0 112.004 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 11.7 m -78.62 -26.63 45.35 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -173.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . 0.62 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 105.35 4.25 40.8 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.364 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.778 ' N ' HE21 ' A' ' 274' ' ' GLN . 0.0 OUTLIER -97.07 81.14 3.03 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 176.82 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.722 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -122.93 168.42 12.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.19 -168.847 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.562 ' HB3' ' HB3' ' A' ' 268' ' ' LYS . 40.8 tt0 -90.42 126.06 35.77 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.111 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.652 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -108.7 159.05 14.36 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.303 -173.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 40.8 tt0 -140.94 120.15 12.94 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 172.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 34.6 t -114.62 96.89 5.97 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.349 -177.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 33.65 57.19 0.55 Allowed 'General case' 0 N--CA 1.465 0.28 0 O-C-N 124.615 1.197 . . . . 0.0 112.527 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.97 -39.27 2.72 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-N 115.705 -0.68 . . . . 0.0 113.351 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 0.2 OUTLIER -77.77 139.85 39.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.492 0.646 . . . . 0.0 109.943 178.621 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 12.4 mtm180 -124.25 129.2 50.35 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 175.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . 0.726 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . 177.72 145.97 6.11 Favored Glycine 0 C--O 1.225 -0.467 0 C-N-CA 120.09 -1.052 . . . . 0.0 113.58 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' HIS . . . . . 0.55 ' CB ' ' HA ' ' A' ' 276' ' ' GLU . 28.5 p80 -104.18 147.71 27.13 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.965 0.383 . . . . 0.0 111.423 -175.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.551 ' CZ ' ' HB3' ' A' ' 255' ' ' ALA . 12.4 m-85 -159.14 167.02 15.18 Favored Pre-proline 0 CA--C 1.535 0.397 0 O-C-N 123.271 0.357 . . . . 0.0 111.494 -175.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.455 ' HB2' HG22 ' A' ' 289' ' ' THR . 1.4 Cg_endo -86.25 153.99 9.46 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 123.514 2.809 . . . . 0.0 113.585 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.732 ' HE1' ' HG ' ' A' ' 293' ' ' LEU . 44.3 t80 -67.44 -23.28 65.51 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 114.374 -1.285 . . . . 0.0 112.477 -177.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' THR . . . . . 0.455 HG22 ' HB2' ' A' ' 287' ' ' PRO . 8.9 t -53.1 -29.36 30.27 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -168.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . 0.717 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 0.9 OUTLIER -122.16 53.43 1.23 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.612 0.72 . . . . 0.0 110.956 -179.684 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.515 ' O ' ' HD2' ' A' ' 292' ' ' ARG . 0.5 OUTLIER -147.24 158.74 9.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.129 176.912 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.538 ' HG2' HG23 ' A' ' 243' ' ' ILE . 21.1 mmm180 -121.69 109.49 14.8 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 173.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . 0.732 ' HG ' ' HE1' ' A' ' 288' ' ' PHE . 0.3 OUTLIER -91.07 127.19 36.4 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -161.396 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 239' ' ' TYR . 3.9 mt . . . . . 0 N--CA 1.438 -1.027 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 167.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo . . . . . 0 N--CA 1.462 -0.344 0 CA-C-O 121.211 0.421 . . . . 0.0 113.068 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . 0.689 HD13 ' HB1' ' A' ' 240' ' ' ALA . 0.0 OUTLIER -94.33 139.54 18.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 173.612 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.52 ' HB2' ' HB2' ' A' ' 294' ' ' LEU . 0.7 OUTLIER -99.28 143.94 28.96 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 172.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.726 ' HA ' ' HA ' ' A' ' 293' ' ' LEU . . . -136.03 116.97 14.22 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 118.781 -1.168 . . . . 0.0 110.548 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -85.9 102.0 13.35 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . 1.119 HG22 ' HD2' ' A' ' 245' ' ' LYS . 4.3 p -83.63 129.82 36.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.151 -173.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.9 pp -102.15 4.49 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.458 -175.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.549 ' HA ' HG21 ' A' ' 260' ' ' VAL . 10.1 tt0 -178.47 102.6 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.687 -175.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 1.119 ' HD2' HG22 ' A' ' 242' ' ' VAL . 8.1 mttt -145.72 162.33 37.84 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 175.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.884 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 7.9 ttt-85 -99.41 177.21 5.25 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 123.433 0.693 . . . . 0.0 109.462 -174.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.442 ' N ' ' CG ' ' A' ' 246' ' ' ARG . 9.4 m -100.85 75.94 0.14 Allowed Pre-proline 0 CA--C 1.548 0.883 0 CA-C-O 121.546 0.688 . . . . 0.0 111.787 172.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.884 ' HD3' ' O ' ' A' ' 246' ' ' ARG . 0.9 OUTLIER -90.52 175.49 2.69 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 125.212 3.941 . . . . 0.0 111.04 177.036 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.456 ' O ' ' HB2' ' A' ' 252' ' ' ASP . 11.5 m120 -128.22 175.73 8.22 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.949 0.404 . . . . 0.0 110.547 176.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.907 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -67.13 -11.22 56.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 122.127 0.965 . . . . 0.0 110.195 174.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -87.45 5.42 38.99 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.814 175.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 249' ' ' ASN . 3.0 m-20 -103.85 49.27 0.83 Allowed 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.168 177.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . 0.552 ' N ' ' HD2' ' A' ' 253' ' ' LYS . 0.0 OUTLIER 58.7 31.13 20.83 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -169.409 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' THR . . . . . 0.907 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 30.7 p 61.12 81.94 0.18 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 113.413 -1.721 . . . . 0.0 111.609 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.422 ' HB3' ' CE2' ' A' ' 286' ' ' PHE . . . -118.94 156.76 28.98 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.479 176.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.6 HD12 ' SG ' ' A' ' 279' ' ' CYS . 3.8 mm? -81.16 130.63 35.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.567 -175.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.823 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -89.99 97.76 11.38 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.438 0.637 . . . . 0.0 110.432 172.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.723 HD22 ' HD3' ' A' ' 245' ' ' LYS . 0.4 OUTLIER -159.79 171.89 18.67 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.275 -175.88 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.482 ' O ' HG11 ' A' ' 242' ' ' VAL . 12.4 pt-20 -143.53 -162.3 1.43 Allowed 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 119.822 -0.751 . . . . 0.0 112.865 -166.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.549 HG21 ' HA ' ' A' ' 244' ' ' GLN . 88.0 t -66.33 117.39 7.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.755 177.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 105.8 -1.27 38.9 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.85 171.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -91.58 -179.89 5.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.91 0.386 . . . . 0.0 111.399 -170.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.489 ' HG ' ' N ' ' A' ' 264' ' ' VAL . 38.2 tp -133.39 157.52 45.35 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.273 0.559 . . . . 0.0 111.314 -177.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.622 HG13 ' HB3' ' A' ' 240' ' ' ALA . 1.8 p -152.72 136.01 7.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.243 -177.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -98.49 96.8 8.24 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.67 ' HB ' HG22 ' A' ' 238' ' ' ILE . 52.0 t -68.63 117.92 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-O 121.205 0.526 . . . . 0.0 110.903 177.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 81.9 p -97.31 -19.2 18.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.422 -176.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.587 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 2.9 tppp? -116.97 107.08 14.13 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.537 HD11 ' O ' ' A' ' 269' ' ' ILE . 0.6 OUTLIER -102.67 155.48 5.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -167.631 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.833 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 3.5 p30 -143.41 -178.53 5.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.275 174.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 8.9 p -82.53 -35.94 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -176.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 5.9 m -82.19 -43.33 17.81 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -172.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . 0.538 ' HA3' ' CD2' ' A' ' 288' ' ' PHE . . . 123.41 2.42 8.99 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.518 -178.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 1.0 OUTLIER -93.35 85.17 4.9 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 173.272 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.833 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -131.12 -179.79 5.54 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.89 -168.022 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.684 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 39.2 mt-10 -94.48 124.81 38.73 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.018 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.551 ' O ' HD23 ' A' ' 256' ' ' LEU . . . -106.67 145.34 15.94 Favored Glycine 0 N--CA 1.437 -1.267 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.334 -175.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 0.4 OUTLIER -124.14 118.73 27.55 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.023 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' CYS . . . . . 0.6 ' SG ' HD12 ' A' ' 256' ' ' LEU . 29.7 p -111.01 98.76 7.78 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.449 -174.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 4.9 m120 49.09 45.65 22.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.491 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 114.14 -17.08 19.81 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.689 -0.767 . . . . 0.0 114.27 175.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . 0.553 ' HD2' ' N ' ' A' ' 282' ' ' LYS . 5.4 mptt -99.93 133.8 43.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.733 0.766 . . . . 0.0 110.352 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.94 134.48 54.43 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.793 0.33 . . . . 0.0 111.375 -174.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -176.22 -146.46 5.99 Favored Glycine 0 C--O 1.225 -0.407 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' HIS . . . . . 0.684 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 24.8 p80 -148.82 151.45 34.77 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 117.562 0.681 . . . . 0.0 111.134 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.642 ' CG ' ' HE2' ' A' ' 245' ' ' LYS . 1.8 m-85 -164.72 153.83 11.45 Favored Pre-proline 0 CA--C 1.535 0.395 0 O-C-N 123.452 0.47 . . . . 0.0 110.829 -177.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.501 ' HD2' ' HD1' ' A' ' 286' ' ' PHE . 95.3 Cg_endo -90.77 173.35 3.02 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.057 2.504 . . . . 0.0 114.029 -174.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.538 ' CD2' ' HA3' ' A' ' 273' ' ' GLY . 16.2 t80 -82.92 -20.86 34.55 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 114.369 -1.287 . . . . 0.0 111.926 -170.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 12.9 t -68.62 1.78 2.93 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -167.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . 0.585 ' HD2' HG11 ' A' ' 291' ' ' VAL . 1.2 p-80 -147.25 33.71 0.89 Allowed 'General case' 0 C--N 1.33 -0.239 0 O-C-N 121.706 -0.621 . . . . 0.0 111.682 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.585 HG11 ' HD2' ' A' ' 290' ' ' HIS . 31.8 m -140.25 151.76 21.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.73 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -122.03 108.37 13.3 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 173.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . 0.726 ' HA ' ' HA ' ' A' ' 240' ' ' ALA . 0.0 OUTLIER -94.42 139.54 30.99 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -163.687 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.52 ' HB2' ' HB2' ' A' ' 239' ' ' TYR . 5.0 mt . . . . . 0 N--CA 1.436 -1.153 0 CA-C-N 113.948 -1.478 . . . . 0.0 107.21 167.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.472 ' HG2' ' HE3' ' A' ' 265' ' ' LYS . 16.7 Cg_exo . . . . . 0 C--O 1.234 0.317 0 N-CA-C 112.536 0.168 . . . . 0.0 112.536 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . 0.722 HD11 ' CG2' ' A' ' 266' ' ' VAL . 0.0 OUTLIER -89.69 149.47 4.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.764 174.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.522 ' N ' HG12 ' A' ' 238' ' ' ILE . 20.2 m-85 -95.89 119.35 34.23 Favored 'General case' 0 C--O 1.208 -1.107 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.447 ' HB1' HD13 ' A' ' 238' ' ' ILE . . . -113.87 118.22 33.61 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.481 -171.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.31 101.38 8.89 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.067 178.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . 0.958 ' HA ' HG13 ' A' ' 291' ' ' VAL . 6.3 p -80.86 117.71 27.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.193 -176.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.559 ' O ' ' HG3' ' A' ' 244' ' ' GLN . 2.8 pp -105.15 0.61 10.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.013 -172.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.559 ' HG3' ' O ' ' A' ' 243' ' ' ILE . 57.5 mt-30 -172.25 94.08 0.14 Allowed 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -173.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.84 ' HG2' ' CD2' ' A' ' 258' ' ' LEU . 2.5 tptt -146.66 165.54 29.26 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.517 0.675 . . . . 0.0 111.453 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.764 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 2.7 ptm85 -102.23 -178.13 3.61 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.079 -1.418 . . . . 0.0 110.279 -173.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 21.9 t -110.48 72.46 0.72 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.333 0.587 . . . . 0.0 109.71 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 1.043 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 72.1 Cg_endo -95.54 175.82 0.92 Allowed 'Trans proline' 0 N--CA 1.441 -1.612 0 C-N-CA 124.135 3.223 . . . . 0.0 110.541 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -136.3 176.2 8.91 Favored 'General case' 0 C--N 1.314 -0.978 0 O-C-N 121.952 -0.467 . . . . 0.0 110.298 -177.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.751 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -61.55 -7.61 3.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.368 0.604 . . . . 0.0 111.001 172.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -95.51 -2.29 48.9 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.313 176.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -105.41 63.73 0.69 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? 56.94 30.75 18.59 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -169.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' THR . . . . . 0.751 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 44.5 p 52.49 62.94 2.44 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.323 -173.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.643 ' HB1' ' HB2' ' A' ' 248' ' ' PRO . . . -96.85 150.8 20.32 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.337 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.739 ' N ' ' HA3' ' A' ' 284' ' ' GLY . 0.4 OUTLIER -74.34 131.09 40.82 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.913 -179.016 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 1.043 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -90.56 104.5 17.07 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 175.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.84 ' CD2' ' HG2' ' A' ' 245' ' ' LYS . 0.6 OUTLIER -153.8 164.47 38.3 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.427 -175.144 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.574 ' O ' HG11 ' A' ' 242' ' ' VAL . 32.4 tt0 -142.3 174.66 10.42 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 120.578 0.228 . . . . 0.0 111.159 -165.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.47 HG21 ' HA ' ' A' ' 244' ' ' GLN . 88.3 t -57.12 117.7 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.373 0.606 . . . . 0.0 112.234 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 98.71 -2.1 58.5 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.507 170.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -84.38 175.88 9.07 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.33 -176.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.545 ' HG ' ' N ' ' A' ' 264' ' ' VAL . 17.0 tp -130.35 154.72 47.38 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.65 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.737 HG12 ' HB2' ' A' ' 279' ' ' CYS . 17.1 m -145.5 160.37 12.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.778 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.472 ' HE3' ' HG2' ' A' ' 237' ' ' PRO . 56.8 tttp -117.87 97.9 6.07 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 177.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.722 ' CG2' HD11 ' A' ' 238' ' ' ILE . 4.6 m -80.38 121.66 34.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.49 0.662 . . . . 0.0 110.345 -176.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 38.2 p -99.6 -5.09 29.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.853 -174.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.611 ' O ' ' HB3' ' A' ' 275' ' ' TRP . 1.3 tppp? -119.03 105.47 11.46 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 174.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.57 HD11 ' N ' ' A' ' 269' ' ' ILE . 0.2 OUTLIER -114.95 149.42 17.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.645 -166.736 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -144.14 -168.76 2.96 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.85 -174.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 28.7 m -100.88 -21.52 5.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.8 m -81.54 -45.39 15.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.776 0.322 . . . . 0.0 111.211 -175.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . 0.4 ' HA3' ' CD1' ' A' ' 288' ' ' PHE . . . 125.92 -8.37 7.66 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.655 -177.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.9 OUTLIER -90.56 105.04 17.55 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 173.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.611 ' HB3' ' O ' ' A' ' 268' ' ' LYS . 0.0 OUTLIER -115.57 173.46 6.52 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.706 0.765 . . . . 0.0 111.345 -175.464 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 268' ' ' LYS . 29.9 tt0 -96.65 124.28 40.59 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 165.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.415 ' O ' HD23 ' A' ' 256' ' ' LEU . . . -109.66 149.42 17.3 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.784 -167.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.626 ' HG3' ' HG2' ' A' ' 283' ' ' ARG . 31.9 tt0 -127.75 117.61 22.22 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 172.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' CYS . . . . . 0.737 ' HB2' HG12 ' A' ' 264' ' ' VAL . 53.7 t -101.65 94.84 6.06 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.314 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 36.38 55.13 1.08 Allowed 'General case' 0 CA--C 1.533 0.296 0 O-C-N 124.754 1.284 . . . . 0.0 111.843 175.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.51 -40.4 2.4 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 115.639 -0.71 . . . . 0.0 113.39 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . 0.494 ' HD2' ' HB3' ' A' ' 279' ' ' CYS . 35.3 mttt -76.42 138.83 40.62 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 117.513 0.656 . . . . 0.0 110.381 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . 0.626 ' HG2' ' HG3' ' A' ' 278' ' ' GLU . 23.2 mtt180 -122.33 129.93 52.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.365 0.602 . . . . 0.0 111.726 176.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . 0.739 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . -159.91 -171.09 25.32 Favored Glycine 0 C--O 1.221 -0.709 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.189 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -147.62 139.84 24.38 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 118.409 1.105 . . . . 0.0 111.053 175.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 255' ' ' ALA . 28.1 m-85 -159.17 168.89 11.46 Favored Pre-proline 0 N--CA 1.472 0.633 0 C-N-CA 122.627 0.371 . . . . 0.0 111.472 -174.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.418 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 17.7 Cg_endo -94.92 168.7 1.59 Allowed 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 123.611 2.874 . . . . 0.0 112.796 -177.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.667 ' HA ' ' CG2' ' A' ' 291' ' ' VAL . 29.4 p90 -87.12 -12.38 47.26 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.31 -174.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 5.2 t -49.91 -33.66 18.01 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . 0.531 ' HB2' ' HB2' ' A' ' 244' ' ' GLN . 1.5 p-80 -125.75 56.97 1.37 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.792 0.806 . . . . 0.0 111.686 177.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.958 HG13 ' HA ' ' A' ' 242' ' ' VAL . 0.9 OUTLIER -154.56 170.94 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.573 168.23 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -130.01 107.75 9.58 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 172.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . 0.62 ' H ' HD21 ' A' ' 293' ' ' LEU . 0.0 OUTLIER -94.86 127.05 40.6 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 119.41 -0.916 . . . . 0.0 112.063 -169.266 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 10.4 mt . . . . . 0 N--CA 1.438 -1.029 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 171.029 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.625 ' HA ' ' O ' ' A' ' 266' ' ' VAL . 4.3 Cg_endo . . . . . 0 N--CA 1.456 -0.717 0 CA-C-O 120.897 0.29 . . . . 0.0 112.51 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . 0.886 HD13 ' HB1' ' A' ' 240' ' ' ALA . 0.1 OUTLIER -86.38 152.46 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.345 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.709 ' HD1' HD12 ' A' ' 263' ' ' LEU . 59.4 m-85 -100.84 118.04 36.11 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 175.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.886 ' HB1' HD13 ' A' ' 238' ' ' ILE . . . -120.19 117.3 27.54 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.587 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.55 HH11 ' HA2' ' A' ' 261' ' ' GLY . 0.1 OUTLIER -85.76 103.48 14.58 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.7 -175.237 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . 0.712 ' HA ' HG12 ' A' ' 291' ' ' VAL . 2.2 t -66.17 131.79 31.84 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.104 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.081 -175.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.451 HD11 ' C ' ' A' ' 243' ' ' ILE . 2.9 pp -120.84 2.3 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 O-C-N 123.539 0.524 . . . . 0.0 110.421 176.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.537 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 8.2 tt0 -178.22 95.58 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.072 -172.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.781 ' HZ3' HD13 ' A' ' 258' ' ' LEU . 0.0 OUTLIER -145.75 164.84 30.59 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.37 0.605 . . . . 0.0 110.443 175.84 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.865 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 12.7 ttm180 -92.87 171.98 8.62 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.778 -176.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.422 ' N ' ' HG2' ' A' ' 246' ' ' ARG . 21.9 t -101.72 75.48 0.16 Allowed Pre-proline 0 CA--C 1.542 0.646 0 CA-C-O 121.02 0.438 . . . . 0.0 110.123 170.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.972 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 1.2 Cg_endo -89.02 178.89 2.53 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 125.226 3.951 . . . . 0.0 111.875 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -127.52 175.36 8.31 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.97 0.414 . . . . 0.0 109.959 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.497 ' O ' HG21 ' A' ' 254' ' ' THR . . . -68.98 -1.23 6.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.125 0.488 . . . . 0.0 110.796 174.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -106.17 1.18 25.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.124 176.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -93.34 55.02 2.19 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp 60.54 22.61 12.33 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.46 -168.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' THR . . . . . 0.497 HG21 ' O ' ' A' ' 250' ' ' ALA . 28.6 p 64.65 83.59 0.16 Allowed 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.553 -177.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.625 ' HB3' ' CE2' ' A' ' 286' ' ' PHE . . . -128.67 153.56 47.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.015 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.603 HD23 ' O ' ' A' ' 277' ' ' GLY . 4.2 mm? -72.83 120.48 18.51 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.85 -175.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.972 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -81.04 87.11 6.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.18 0.514 . . . . 0.0 111.007 174.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.781 HD13 ' HZ3' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -157.69 168.47 27.13 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.192 -176.046 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.463 ' O ' ' HB ' ' A' ' 242' ' ' VAL . 12.6 pt-20 -142.56 -164.91 1.92 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -168.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 4.3 p -60.25 122.46 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 121.593 0.711 . . . . 0.0 112.095 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.55 ' HA2' HH11 ' A' ' 241' ' ' ARG . . . 107.57 -1.44 34.41 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.851 172.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.567 ' HB2' HG23 ' A' ' 242' ' ' VAL . 13.7 mt-10 -89.68 -177.62 5.32 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -170.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.709 HD12 ' HD1' ' A' ' 239' ' ' TYR . 3.4 tm? -138.78 122.11 17.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.526 177.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.684 HG11 ' HB3' ' A' ' 240' ' ' ALA . 2.1 p -115.11 129.28 71.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.056 178.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 238' ' ' ILE . 75.9 tttt -98.54 95.17 7.11 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.749 ' HB ' HG21 ' A' ' 238' ' ' ILE . 21.0 t -66.14 123.17 18.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.243 -175.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 35.3 p -95.77 -24.46 16.49 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.855 -174.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 0.0 OUTLIER -119.12 107.34 13.36 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.534 -0.866 . . . . 0.0 109.509 177.007 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.559 HD11 ' O ' ' A' ' 269' ' ' ILE . 0.6 OUTLIER -97.04 155.08 3.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-N 114.334 -1.303 . . . . 0.0 114.166 -167.772 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.853 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 0.3 OUTLIER -146.48 -172.55 3.98 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.772 171.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 60.1 t -93.35 -41.31 12.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.949 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 2.6 p -58.95 -43.7 91.31 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -175.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . 0.434 ' H ' ' ND2' ' A' ' 270' ' ' ASN . . . 115.45 -4.34 21.6 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.319 -0.944 . . . . 0.0 112.673 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.61 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.0 OUTLIER -95.91 71.93 2.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.709 0.766 . . . . 0.0 109.725 176.667 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.853 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -111.98 179.01 4.12 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.633 -168.609 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.617 ' O ' HG11 ' A' ' 266' ' ' VAL . 6.1 tt0 -90.2 125.27 35.41 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.603 ' O ' HD23 ' A' ' 256' ' ' LEU . . . -110.26 141.9 16.41 Favored Glycine 0 N--CA 1.436 -1.304 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 -173.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 26.6 tt0 -127.14 118.48 24.44 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 170.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' CYS . . . . . 0.48 ' O ' ' HD3' ' A' ' 282' ' ' LYS . 13.8 t -106.28 96.88 6.78 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -178.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 28.69 60.33 0.13 Allowed 'General case' 0 N--CA 1.468 0.454 0 O-C-N 125.015 1.447 . . . . 0.0 112.991 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 115.63 -30.53 6.61 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.334 178.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . 0.556 ' HE3' ' O ' ' A' ' 257' ' ' ALA . 6.1 mppt? -85.94 131.59 34.25 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.096 0.448 . . . . 0.0 110.378 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . 0.416 ' HA ' ' HD2' ' A' ' 283' ' ' ARG . 40.1 mmm-85 -114.42 149.89 35.54 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.793 0.33 . . . . 0.0 111.698 -178.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . 0.615 ' O ' ' HG2' ' A' ' 276' ' ' GLU . . . 159.72 -162.41 32.97 Favored Glycine 0 C--O 1.216 -0.973 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 173.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' HIS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 31.3 p80 -136.94 148.48 46.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 118.087 0.943 . . . . 0.0 111.077 177.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.625 ' CE2' ' HB3' ' A' ' 255' ' ' ALA . 2.4 m-85 -161.24 159.06 24.11 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 120.718 0.294 . . . . 0.0 111.325 -174.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.61 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 73.4 Cg_endo -93.14 149.44 2.52 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.251 2.634 . . . . 0.0 112.867 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.606 ' HA ' HG22 ' A' ' 291' ' ' VAL . 0.5 OUTLIER -75.28 -9.1 58.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.251 -174.26 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 8.9 t -63.0 -24.93 68.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.231 -0.441 . . . . 0.0 112.017 -173.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . 0.537 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 1.4 p-80 -121.67 38.07 4.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.48 0.657 . . . . 0.0 111.343 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.712 HG12 ' HA ' ' A' ' 242' ' ' VAL . 27.6 m -144.26 161.56 15.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.423 170.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -117.0 106.85 13.85 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . 0.533 ' HA ' ' HA ' ' A' ' 240' ' ' ALA . 0.2 OUTLIER -102.93 129.04 49.51 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-O 121.753 0.787 . . . . 0.0 113.008 -165.598 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 3.8 mp . . . . . 0 N--CA 1.437 -1.087 0 CA-C-N 114.348 -1.296 . . . . 0.0 108.797 168.706 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 266' ' ' VAL . 3.2 Cg_exo . . . . . 0 N--CA 1.455 -0.753 0 N-CA-C 111.659 -0.17 . . . . 0.0 111.659 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . 0.807 HD11 ' HB ' ' A' ' 266' ' ' VAL . 0.1 OUTLIER -93.68 165.96 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.476 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.647 ' HB3' HD12 ' A' ' 263' ' ' LEU . 36.4 m-85 -102.66 123.86 47.14 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 172.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.62 ' HB3' HG22 ' A' ' 264' ' ' VAL . . . -111.72 117.73 33.66 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.287 -168.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 292' ' ' ARG . 0.0 OUTLIER -85.9 103.05 14.27 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.021 176.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . 0.629 HG22 ' HB2' ' A' ' 245' ' ' LYS . 3.5 p -91.57 121.4 42.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.737 -177.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.471 HD11 ' HB2' ' A' ' 244' ' ' GLN . 2.8 pp -100.33 4.7 10.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.864 -172.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.495 ' HB2' ' HB2' ' A' ' 290' ' ' HIS . 16.8 mt-30 -173.78 99.32 0.11 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.932 -174.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.978 ' HG2' HD13 ' A' ' 258' ' ' LEU . 0.1 OUTLIER -146.51 163.11 36.77 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.849 0.357 . . . . 0.0 110.057 176.316 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.82 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 10.5 ptp180 -103.32 -178.21 3.6 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.382 -178.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 2.9 m -105.81 77.45 0.41 Allowed Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.873 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 1.4 Cg_endo -88.82 173.78 4.13 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 124.934 3.756 . . . . 0.0 111.278 174.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.428 ' C ' ' H ' ' A' ' 251' ' ' TYR . 9.9 m120 -127.53 175.73 8.02 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 122.147 -0.346 . . . . 0.0 110.452 174.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.701 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -66.03 -1.69 3.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.587 0.708 . . . . 0.0 110.55 174.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.428 ' H ' ' C ' ' A' ' 249' ' ' ASN . 19.2 m-85 -100.18 3.97 44.08 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.674 177.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.44 ' C ' ' HD2' ' A' ' 253' ' ' LYS . 2.2 m-20 -102.73 49.58 0.84 Allowed 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . 0.447 ' N ' ' HD2' ' A' ' 253' ' ' LYS . 0.0 OUTLIER 60.36 30.88 20.17 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -169.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' THR . . . . . 0.701 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 32.0 p 59.37 74.65 0.43 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 113.388 -1.733 . . . . 0.0 112.16 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.425 ' HB3' ' CE2' ' A' ' 286' ' ' PHE . . . -115.77 150.46 36.88 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.008 174.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.759 ' HB3' HD12 ' A' ' 258' ' ' LEU . 0.0 OUTLIER -77.38 138.55 39.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.437 -174.497 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.873 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -90.55 94.45 9.71 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.336 0.588 . . . . 0.0 110.381 173.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.978 HD13 ' HG2' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -146.04 166.97 24.52 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.83 -175.467 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.442 ' O ' HG11 ' A' ' 242' ' ' VAL . 12.2 pt-20 -138.68 -166.48 2.02 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.08 0.467 . . . . 0.0 111.491 -169.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 2.3 p -67.09 116.82 6.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.199 175.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 103.2 -1.85 47.18 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 114.801 -1.09 . . . . 0.0 112.66 169.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.405 ' OE2' ' HA ' ' A' ' 258' ' ' LEU . 18.2 mt-10 -80.87 169.83 17.06 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.204 0.526 . . . . 0.0 111.123 -174.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.647 HD12 ' HB3' ' A' ' 239' ' ' TYR . 10.2 tp -132.6 151.0 52.07 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.317 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.685 HG11 HD22 ' A' ' 258' ' ' LEU . 18.4 m -148.12 173.71 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.088 -176.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.449 ' HG3' ' CE1' ' A' ' 239' ' ' TYR . 5.0 ttmm -119.72 95.55 4.82 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 175.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.807 ' HB ' HD11 ' A' ' 238' ' ' ILE . 53.8 t -69.19 115.05 6.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.136 0.493 . . . . 0.0 110.436 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 40.5 p -93.37 -7.97 43.2 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.261 -174.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.423 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 3.2 tppp? -129.5 104.82 7.69 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.591 HG23 HG21 ' A' ' 238' ' ' ILE . 0.8 OUTLIER -107.83 157.62 7.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.629 0.728 . . . . 0.0 112.82 -173.39 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.603 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 4.7 p30 -147.37 -176.81 5.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.359 -173.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 32.0 m -110.73 15.45 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.3 m -109.66 -43.33 4.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.073 0.463 . . . . 0.0 110.382 176.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . 0.779 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 123.73 -9.91 8.56 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.544 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.9 OUTLIER -95.37 90.13 5.7 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.659 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.603 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -115.87 171.36 7.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.112 -173.523 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.562 ' O ' HG13 ' A' ' 266' ' ' VAL . 36.0 mt-10 -96.05 122.81 39.28 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 174.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.49 ' O ' HD23 ' A' ' 256' ' ' LEU . . . -104.51 134.09 11.83 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.182 -171.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -120.47 119.37 32.8 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 117.542 0.671 . . . . 0.0 109.584 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' CYS . . . . . 0.556 ' HB2' HG13 ' A' ' 264' ' ' VAL . 36.2 t -111.11 98.21 7.36 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.677 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 43.0 57.32 3.71 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 124.141 0.9 . . . . 0.0 112.232 174.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 114.38 -34.3 4.99 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.9 174.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . 0.519 ' HD2' ' H ' ' A' ' 282' ' ' LYS . 4.1 mptt -98.87 138.89 35.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.332 0.566 . . . . 0.0 109.592 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . 0.457 ' HD2' ' N ' ' A' ' 283' ' ' ARG . 0.0 OUTLIER -121.54 129.11 52.68 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.454 0.645 . . . . 0.0 111.094 176.621 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . 0.571 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . -149.94 145.78 14.26 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.714 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -101.55 138.16 38.92 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 117.918 0.859 . . . . 0.0 111.953 -172.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.547 ' CG ' ' HE2' ' A' ' 245' ' ' LYS . 9.5 m-85 -154.44 163.54 23.87 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.635 -175.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.731 ' HD2' ' HE2' ' A' ' 290' ' ' HIS . 68.3 Cg_endo -96.79 174.67 0.73 Allowed 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 123.69 2.926 . . . . 0.0 115.203 -173.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.779 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 32.4 t80 -82.14 -21.76 36.46 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 113.978 -1.464 . . . . 0.0 112.716 -171.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 9.9 t -58.62 -13.15 5.11 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -171.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . 0.731 ' HE2' ' HD2' ' A' ' 287' ' ' PRO . 1.1 p-80 -141.64 44.28 1.72 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.962 0.41 . . . . 0.0 111.957 -177.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.418 ' O ' ' HD2' ' A' ' 292' ' ' ARG . 12.6 m -135.0 156.96 40.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.496 0.665 . . . . 0.0 112.022 177.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.418 ' HD2' ' O ' ' A' ' 291' ' ' VAL . 22.7 mmm180 -127.53 106.7 9.36 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 166.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . 0.426 HD12 ' CB ' ' A' ' 240' ' ' ALA . 1.8 mm? -92.21 143.46 26.4 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.63 -0.669 . . . . 0.0 112.242 -170.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.474 ' N ' HD21 ' A' ' 294' ' ' LEU . 4.1 mt . . . . . 0 C--N 1.318 -0.782 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 164.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.635 ' HB2' ' HD3' ' A' ' 265' ' ' LYS . 6.9 Cg_endo . . . . . 0 N--CA 1.448 -1.161 0 N-CA-C 110.788 -0.505 . . . . 0.0 110.788 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . 1.029 HG12 HG23 ' A' ' 266' ' ' VAL . 2.2 pt -82.38 158.67 3.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.642 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.697 ' HB3' HD22 ' A' ' 263' ' ' LEU . 36.1 m-85 -104.79 117.11 33.25 Favored 'General case' 0 C--O 1.21 -1.025 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 169.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.652 ' HB3' HG11 ' A' ' 264' ' ' VAL . . . -113.34 116.54 29.86 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.187 -172.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.413 ' HB3' ' O ' ' A' ' 292' ' ' ARG . 22.7 tpp180 -74.88 101.68 4.48 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.803 -1.09 . . . . 0.0 108.287 175.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . 0.6 HG22 ' HD3' ' A' ' 245' ' ' LYS . 7.6 p -83.59 124.57 39.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.153 -175.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.9 pp -102.36 1.66 10.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.109 -173.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.49 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 52.5 tt0 -177.37 98.51 0.05 OUTLIER 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.94 -176.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.643 ' HB3' ' O ' ' A' ' 258' ' ' LEU . 0.0 OUTLIER -146.09 163.29 35.76 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.272 0.558 . . . . 0.0 110.156 173.179 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.758 ' C ' ' HD3' ' A' ' 248' ' ' PRO . 5.7 ptp180 -94.82 -174.35 3.25 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.306 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 2.8 m -108.98 69.31 0.38 Allowed Pre-proline 0 CA--C 1.536 0.426 0 CA-C-O 121.246 0.546 . . . . 0.0 111.615 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.954 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 57.0 Cg_endo -95.86 122.25 0.27 Allowed 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 124.645 3.563 . . . . 0.0 111.442 178.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -79.35 175.66 10.4 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.989 0.423 . . . . 0.0 110.966 -176.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -65.02 -0.53 1.61 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.179 0.514 . . . . 0.0 111.375 177.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -103.67 8.61 37.43 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.087 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -98.12 53.47 1.08 Allowed 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . 0.538 ' HD3' ' N ' ' A' ' 253' ' ' LYS . 0.1 OUTLIER 61.42 28.99 18.26 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -167.399 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 26.5 p 62.09 87.01 0.1 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.197 -1.365 . . . . 0.0 110.942 -176.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.627 ' HB1' ' HB2' ' A' ' 248' ' ' PRO . . . -123.72 165.64 16.91 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.785 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.579 ' H ' ' HE2' ' A' ' 286' ' ' PHE . 4.3 mm? -89.07 114.96 26.24 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.009 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.954 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -85.31 87.14 7.35 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.59 0.709 . . . . 0.0 110.413 177.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.643 ' O ' ' HB3' ' A' ' 245' ' ' LYS . 0.4 OUTLIER -151.98 167.2 29.15 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.869 -173.247 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.574 ' O ' HG11 ' A' ' 242' ' ' VAL . 11.1 pt-20 -141.89 -161.89 1.31 Allowed 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.755 -0.591 . . . . 0.0 111.903 -170.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 2.7 p -65.06 119.13 8.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.494 0.664 . . . . 0.0 112.112 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 106.26 -2.67 37.51 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.927 171.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -90.99 -177.78 5.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.782 0.325 . . . . 0.0 111.434 -171.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.697 HD22 ' HB3' ' A' ' 239' ' ' TYR . 3.3 tm? -131.18 120.08 22.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.944 0.402 . . . . 0.0 110.458 -176.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.652 HG11 ' HB3' ' A' ' 240' ' ' ALA . 2.5 p -115.63 116.88 53.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.637 175.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.635 ' HD3' ' HB2' ' A' ' 237' ' ' PRO . 0.0 OUTLIER -89.41 98.64 11.88 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.006 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 1.029 HG23 HG12 ' A' ' 238' ' ' ILE . 6.1 m -79.12 122.89 35.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.533 0.682 . . . . 0.0 110.969 -176.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' THR . . . . . 0.505 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 36.4 p -86.47 -19.48 29.5 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.426 -174.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.885 ' HA ' ' HE3' ' A' ' 268' ' ' LYS . 0.1 OUTLIER -123.11 105.95 10.36 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -178.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.528 HD11 ' O ' ' A' ' 269' ' ' ILE . 0.7 OUTLIER -94.32 157.25 3.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -172.774 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.682 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 3.4 p30 -146.43 179.83 7.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.724 -179.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 10.2 p -93.36 -18.85 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -173.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 33.5 m -94.65 -34.91 12.41 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -176.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . 0.759 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 115.29 -2.81 22.25 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.929 -177.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 1.9 mp0 -89.93 76.79 7.03 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 175.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.682 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -115.1 173.02 6.71 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.532 0.682 . . . . 0.0 111.808 -171.636 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 36.1 mt-10 -96.85 125.55 41.38 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.132 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.624 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -111.25 155.02 16.37 Favored Glycine 0 N--CA 1.437 -1.265 0 CA-C-N 114.669 -1.151 . . . . 0.0 112.509 -169.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.556 ' HG2' ' HG3' ' A' ' 283' ' ' ARG . 6.1 tm-20 -139.47 119.7 13.74 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 174.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' CYS . . . . . 0.56 ' O ' ' HD3' ' A' ' 282' ' ' LYS . 12.4 t -124.46 99.85 6.39 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.829 -173.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . 0.427 ' N ' HD21 ' A' ' 280' ' ' ASN . 0.9 OUTLIER 51.66 38.01 21.57 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.808 0.693 . . . . 0.0 111.672 170.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 114.93 -26.42 9.35 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.187 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . 0.56 ' HD3' ' O ' ' A' ' 279' ' ' CYS . 0.1 OUTLIER -81.93 137.04 35.25 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 177.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . 0.556 ' HG3' ' HG2' ' A' ' 278' ' ' GLU . 0.1 OUTLIER -128.15 140.07 52.13 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.927 177.783 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 177.48 -145.51 7.2 Favored Glycine 0 C--O 1.222 -0.6 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.103 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' HIS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 13.7 p80 -150.54 140.2 21.66 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.665 0.233 . . . . 0.0 111.252 -178.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.579 ' HE2' ' H ' ' A' ' 256' ' ' LEU . 9.9 m-85 -157.44 159.31 30.9 Favored Pre-proline 0 N--CA 1.469 0.5 0 C-N-CA 122.249 0.22 . . . . 0.0 111.11 -177.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.515 ' HD2' ' HE2' ' A' ' 290' ' ' HIS . 63.7 Cg_endo -92.86 176.9 1.52 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.246 2.631 . . . . 0.0 114.435 -173.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.759 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 21.2 t80 -80.64 -33.62 35.55 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 113.816 -1.538 . . . . 0.0 112.657 -168.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 6.6 t -55.77 -33.72 64.6 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -168.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . 0.536 ' NE2' ' HD2' ' A' ' 245' ' ' LYS . 1.2 p-80 -115.05 49.27 1.07 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.605 0.717 . . . . 0.0 110.845 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -150.04 155.64 7.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.551 175.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.413 ' O ' ' HB3' ' A' ' 241' ' ' ARG . 29.2 mmm180 -130.83 107.42 9.12 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 175.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . 0.61 HD22 ' CZ ' ' A' ' 288' ' ' PHE . 0.3 OUTLIER -102.04 136.14 42.4 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -162.735 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.596 HD11 ' N ' ' A' ' 294' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.439 -1.02 0 CA-C-N 113.96 -1.473 . . . . 0.0 107.373 170.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.453 ' HB3' ' HA ' ' A' ' 267' ' ' THR . 7.1 Cg_exo . . . . . 0 N--CA 1.459 -0.501 0 CA-C-O 120.961 0.317 . . . . 0.0 112.003 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . 0.882 HG12 HG23 ' A' ' 266' ' ' VAL . 0.2 OUTLIER -92.8 167.47 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.545 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.667 ' HB3' HD12 ' A' ' 263' ' ' LEU . 72.4 m-85 -106.64 127.73 53.59 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 170.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.561 ' HB2' HG21 ' A' ' 291' ' ' VAL . . . -114.39 118.16 33.07 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.528 -176.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.595 ' NH1' ' HA2' ' A' ' 261' ' ' GLY . 0.1 OUTLIER -88.8 100.82 13.45 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.297 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . 1.007 HG22 ' HD2' ' A' ' 245' ' ' LYS . 7.2 p -86.56 127.15 40.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.071 -172.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.8 pp -100.29 3.28 10.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.4 -174.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.454 ' H ' HG21 ' A' ' 242' ' ' VAL . 7.2 tp-100 -177.33 106.91 0.06 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -176.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 1.042 ' HD3' ' HB2' ' A' ' 258' ' ' LEU . 14.7 tttt -144.63 157.15 44.33 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 177.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.787 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 16.4 ptt180 -103.92 -175.14 2.71 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 6.8 m -110.51 69.37 0.58 Allowed Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 121.177 0.513 . . . . 0.0 111.987 -174.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 1.007 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 17.8 Cg_endo -94.47 124.51 0.42 Allowed 'Trans proline' 0 N--CA 1.444 -1.433 0 C-N-CA 124.285 3.324 . . . . 0.0 111.175 176.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.457 ' C ' ' H ' ' A' ' 251' ' ' TYR . 7.0 m-20 -81.46 176.92 9.28 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.022 0.439 . . . . 0.0 111.043 -174.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.599 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -67.77 4.86 0.99 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.202 0.525 . . . . 0.0 111.281 177.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.457 ' H ' ' C ' ' A' ' 249' ' ' ASN . 44.8 m-85 -106.5 5.74 29.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.553 0.692 . . . . 0.0 109.572 176.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.408 ' C ' ' HD2' ' A' ' 253' ' ' LYS . 3.7 m-20 -101.17 55.73 0.84 Allowed 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . 0.408 ' HD2' ' C ' ' A' ' 252' ' ' ASP . 0.0 OUTLIER 59.0 27.01 15.78 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -169.568 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' THR . . . . . 0.599 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 30.2 p 61.42 85.19 0.12 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.63 -176.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.64 ' HB1' ' HB2' ' A' ' 248' ' ' PRO . . . -118.31 165.63 13.6 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.499 178.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.81 ' HB3' HD12 ' A' ' 258' ' ' LEU . 3.8 mm? -88.35 112.78 23.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.632 178.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 1.007 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -82.32 81.86 8.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.6 0.714 . . . . 0.0 110.234 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 1.042 ' HB2' ' HD3' ' A' ' 245' ' ' LYS . 6.1 mp -122.83 177.92 5.26 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.382 -171.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -143.71 -169.31 3.05 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.156 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 2.3 p -65.71 121.06 14.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.247 177.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.595 ' HA2' ' NH1' ' A' ' 241' ' ' ARG . . . 103.44 -2.22 46.39 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.486 171.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -88.76 174.99 7.68 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.991 0.424 . . . . 0.0 111.261 -171.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.667 HD12 ' HB3' ' A' ' 239' ' ' TYR . 21.5 tp -130.0 158.85 38.45 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.222 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.8 HG23 ' HB2' ' A' ' 279' ' ' CYS . 8.3 p -151.13 150.71 13.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.34 97.92 7.27 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.882 HG23 HG12 ' A' ' 238' ' ' ILE . 15.5 m -74.39 113.3 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 121.972 0.891 . . . . 0.0 110.43 -178.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' THR . . . . . 0.453 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 61.0 p -92.34 0.52 57.45 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.095 -174.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.65 107.14 6.48 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.375 172.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.599 HG23 HG22 ' A' ' 238' ' ' ILE . 0.8 OUTLIER -104.21 160.86 4.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 114.34 -1.3 . . . . 0.0 113.102 -170.25 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.673 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 3.8 p30 -146.87 171.62 14.92 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.815 -176.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 27.0 m -87.04 5.06 3.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -175.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 4.4 m -111.54 -43.42 3.67 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . 0.457 ' C ' HE21 ' A' ' 274' ' ' GLN . . . 120.24 -0.4 12.92 Favored Glycine 0 C--O 1.223 -0.543 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.021 -175.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.584 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.2 OUTLIER -98.04 77.64 2.47 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.813 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.673 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -117.87 169.88 9.27 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.461 -167.457 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.583 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 39.9 mt-10 -90.68 126.29 35.93 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.228 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.614 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -111.36 146.37 17.78 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.294 -170.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 4.3 tm-20 -133.7 116.51 15.87 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' CYS . . . . . 0.8 ' HB2' HG23 ' A' ' 264' ' ' VAL . 10.5 t -115.7 99.0 7.0 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.744 0.783 . . . . 0.0 110.009 -177.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 31.63 55.89 0.29 Allowed 'General case' 0 C--N 1.343 0.301 0 CA-C-N 112.918 -1.947 . . . . 0.0 113.525 175.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.82 -14.41 14.37 Favored Glycine 0 CA--C 1.522 0.495 0 CA-C-N 115.933 -0.576 . . . . 0.0 113.51 176.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 19.0 mttt -108.38 128.64 54.94 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 117.213 0.506 . . . . 0.0 109.699 177.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . 0.522 ' C ' ' HD3' ' A' ' 283' ' ' ARG . 0.2 OUTLIER -123.21 143.95 49.69 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.276 -0.569 . . . . 0.0 111.173 179.637 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 176.63 -145.1 7.24 Favored Glycine 0 C--O 1.224 -0.508 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.243 178.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' HIS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 13.6 p80 -150.15 147.65 28.0 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.852 0.326 . . . . 0.0 110.822 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.612 ' HD1' ' HD2' ' A' ' 287' ' ' PRO . 2.5 m-85 -161.68 153.93 16.57 Favored Pre-proline 0 N--CA 1.467 0.398 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -178.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.612 ' HD2' ' HD1' ' A' ' 286' ' ' PHE . 87.4 Cg_endo -88.32 165.1 6.8 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.399 2.733 . . . . 0.0 112.513 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.497 ' HA ' ' CG1' ' A' ' 291' ' ' VAL . 9.4 p90 -88.16 -4.77 58.69 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -172.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 5.6 t -56.76 -11.38 1.37 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -177.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -133.47 30.76 3.8 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 122.259 -0.276 . . . . 0.0 111.149 -175.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.609 HG22 ' HA ' ' A' ' 242' ' ' VAL . 9.5 p -147.35 157.6 9.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 C-N-CA 119.759 -0.776 . . . . 0.0 112.005 -170.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.418 ' HD2' ' HA ' ' A' ' 292' ' ' ARG . 25.3 tpt180 -125.98 109.74 12.79 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . 0.497 ' H ' HD21 ' A' ' 293' ' ' LEU . 0.4 OUTLIER -86.42 150.16 24.5 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 119.562 -0.855 . . . . 0.0 113.22 -165.522 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.56 ' HB2' ' HB2' ' A' ' 239' ' ' TYR . 11.3 mt . . . . . 0 N--CA 1.433 -1.283 0 N-CA-C 105.153 -2.165 . . . . 0.0 105.153 163.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo . . . . . 0 CA--C 1.52 -0.191 0 CA-C-O 121.661 0.609 . . . . 0.0 113.135 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . 0.967 HG22 ' HB ' ' A' ' 266' ' ' VAL . 0.1 OUTLIER -90.02 151.52 3.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.211 175.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.569 ' HD1' HD11 ' A' ' 263' ' ' LEU . 27.4 m-85 -109.64 117.37 33.76 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.629 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -115.15 117.17 29.78 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.413 0.625 . . . . 0.0 111.447 -171.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 4.2 tpp85 -74.89 104.79 5.64 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.847 174.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . 0.684 HG21 ' HD3' ' A' ' 245' ' ' LYS . 7.5 p -84.24 133.46 29.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.23 0.538 . . . . 0.0 110.852 -176.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.629 HD11 ' HB2' ' A' ' 244' ' ' GLN . 2.4 pp -115.19 3.99 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.919 -171.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.629 ' HB2' HD11 ' A' ' 243' ' ' ILE . 5.3 mt-30 -173.94 94.14 0.09 Allowed 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 123.202 0.314 . . . . 0.0 110.5 -175.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.684 ' HD3' HG21 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -147.1 162.99 37.71 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.238 0.542 . . . . 0.0 110.427 173.437 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.829 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 4.5 ptt180 -101.59 -176.42 3.13 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.978 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.4 77.96 0.23 Allowed Pre-proline 0 CA--C 1.542 0.644 0 O-C-N 122.156 -0.34 . . . . 0.0 111.382 175.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 1.009 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 12.7 Cg_endo -94.55 142.23 1.44 Allowed 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.54 3.494 . . . . 0.0 112.214 175.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.406 ' O ' ' HB2' ' A' ' 252' ' ' ASP . 15.1 m120 -96.78 177.06 5.76 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.731 -177.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.742 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -63.95 -7.63 8.93 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 121.823 0.821 . . . . 0.0 110.197 172.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -95.04 6.79 48.08 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.065 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 249' ' ' ASN . 1.1 m-20 -105.04 48.11 0.85 Allowed 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . 0.476 ' N ' ' HD2' ' A' ' 253' ' ' LYS . 0.1 OUTLIER 60.42 32.7 20.66 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -167.937 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' THR . . . . . 0.742 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 23.4 p 57.03 77.55 0.26 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.166 -1.379 . . . . 0.0 111.158 -179.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.411 ' HB3' ' CE2' ' A' ' 286' ' ' PHE . . . -117.77 167.14 11.65 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.024 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.506 ' H ' ' HE2' ' A' ' 286' ' ' PHE . 4.6 mm? -88.55 118.8 28.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.909 -175.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 1.009 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -83.54 90.64 7.27 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.768 0.794 . . . . 0.0 110.547 175.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.641 ' O ' ' HB3' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -150.72 167.52 27.14 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.04 -176.183 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.457 ' CG ' ' N ' ' A' ' 260' ' ' VAL . 24.7 tt0 -142.93 177.24 8.49 Favored 'General case' 0 C--N 1.313 -1.005 0 O-C-N 122.088 -0.383 . . . . 0.0 110.547 -164.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 243' ' ' ILE . 57.8 t -50.05 118.52 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 122.906 0.482 . . . . 0.0 111.479 174.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 106.1 -2.32 38.01 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.58 170.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -98.23 -173.59 2.62 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.875 0.369 . . . . 0.0 111.725 -172.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.569 HD11 ' HD1' ' A' ' 239' ' ' TYR . 3.3 tm? -129.47 131.14 46.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.525 -173.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.629 HG13 ' HB3' ' A' ' 240' ' ' ALA . 2.4 p -123.39 124.49 69.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.435 174.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -82.68 112.24 19.36 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 175.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.967 ' HB ' HG22 ' A' ' 238' ' ' ILE . 94.8 t -77.06 112.91 15.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 65.8 p -94.65 -32.89 13.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.962 -171.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.568 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 11.9 tppt? -116.16 107.56 15.05 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.548 HD11 ' O ' ' A' ' 269' ' ' ILE . 0.7 OUTLIER -96.74 140.25 17.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -168.134 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.865 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 0.3 OUTLIER -148.06 149.07 31.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.852 178.118 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 10.9 p -65.37 -17.4 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -173.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 3.9 p -78.26 -30.68 48.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.914 0.388 . . . . 0.0 111.995 -177.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . 0.606 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 94.96 -5.67 68.99 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.464 -177.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.646 ' HG3' ' HB3' ' A' ' 287' ' ' PRO . 1.7 mp0 -92.56 77.41 5.0 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 174.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.865 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -122.76 178.42 5.03 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.489 -0.778 . . . . 0.0 113.042 -167.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.568 ' HB2' ' HB3' ' A' ' 268' ' ' LYS . 40.2 mt-10 -83.33 127.47 33.69 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.525 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.44 ' O ' HD23 ' A' ' 256' ' ' LEU . . . -111.75 156.44 15.57 Favored Glycine 0 N--CA 1.433 -1.528 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.615 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 21.2 tt0 -141.88 119.43 11.68 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' CYS . . . . . 0.507 ' HB2' HD22 ' A' ' 258' ' ' LEU . 51.6 t -115.2 99.06 7.14 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.061 -176.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 45.18 45.12 9.23 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 124.065 0.853 . . . . 0.0 111.958 176.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 114.86 -33.51 5.31 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.202 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 12.2 mptt -73.32 139.69 46.22 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 117.178 0.489 . . . . 0.0 110.084 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -124.01 142.05 51.51 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.216 0.531 . . . . 0.0 111.921 -176.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 169.49 -145.54 9.41 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.391 175.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' HIS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 7.5 p80 -150.35 147.53 27.72 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.936 0.368 . . . . 0.0 111.191 -177.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.602 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 2.1 m-85 -158.18 150.74 17.93 Favored Pre-proline 0 N--CA 1.466 0.331 0 CA-C-O 120.936 0.398 . . . . 0.0 112.052 -178.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.646 ' HB3' ' HG3' ' A' ' 274' ' ' GLN . 2.4 Cg_endo -81.34 174.32 10.76 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.915 3.076 . . . . 0.0 114.152 -178.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.606 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 24.9 t80 -87.77 -35.67 17.74 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -167.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 4.1 t -65.41 -7.27 13.1 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -164.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . 0.531 ' NE2' ' HD2' ' A' ' 245' ' ' LYS . 1.1 p-80 -120.35 31.82 6.3 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.907 -0.496 . . . . 0.0 110.92 178.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 288' ' ' PHE . 4.0 p -147.23 154.19 11.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.296 0.569 . . . . 0.0 111.566 -175.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -131.95 110.25 10.63 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . 0.6 ' HA ' ' HA ' ' A' ' 240' ' ' ALA . 0.2 OUTLIER -118.02 135.68 54.01 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -162.18 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 N--CA 1.439 -0.981 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.864 168.712 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.509 ' HB3' ' HA ' ' A' ' 267' ' ' THR . 6.2 Cg_exo . . . . . 0 N--CA 1.455 -0.748 0 CA-C-O 120.285 0.035 . . . . 0.0 112.116 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . 0.889 HD11 ' HB ' ' A' ' 266' ' ' VAL . 0.2 OUTLIER -87.01 163.55 2.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.553 176.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.824 ' HB3' HD12 ' A' ' 263' ' ' LEU . 67.7 m-85 -104.92 123.49 47.84 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 171.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.677 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -112.52 118.62 35.62 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.861 -174.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 292' ' ' ARG . 0.0 OUTLIER -75.89 100.86 4.95 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . 0.707 HG22 ' HB2' ' A' ' 245' ' ' LYS . 3.3 p -82.63 121.01 35.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.111 -176.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.69 HD11 ' HB2' ' A' ' 244' ' ' GLN . 2.8 pp -105.85 10.55 9.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.708 -175.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.69 ' HB2' HD11 ' A' ' 243' ' ' ILE . 1.0 OUTLIER -177.0 94.95 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.272 -176.642 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.707 ' HB2' HG22 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -147.09 164.68 32.31 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.27 0.557 . . . . 0.0 111.202 174.335 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.806 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 3.2 ptm180 -101.06 -177.96 3.61 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.525 -177.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 46.2 t -104.67 81.91 0.6 Allowed Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 121.201 0.524 . . . . 0.0 110.918 174.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.926 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 4.6 Cg_endo -91.03 175.46 2.44 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 124.959 3.773 . . . . 0.0 111.881 174.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -138.55 179.91 6.19 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.146 176.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.721 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -57.25 -12.59 2.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.877 0.37 . . . . 0.0 111.89 176.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -91.34 -5.71 54.16 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 122.081 -0.387 . . . . 0.0 110.486 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -92.06 48.35 1.42 Allowed 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? 59.01 24.5 12.74 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -167.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' THR . . . . . 0.721 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 19.3 p 64.98 83.35 0.17 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.405 -1.271 . . . . 0.0 110.885 -177.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.603 ' HB3' ' CE2' ' A' ' 286' ' ' PHE . . . -122.33 159.25 27.84 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.466 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.52 HD23 ' C ' ' A' ' 277' ' ' GLY . 0.7 OUTLIER -78.27 123.91 27.48 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.251 -174.849 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.926 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -84.28 93.96 8.33 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.561 0.696 . . . . 0.0 111.171 172.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.63 ' O ' ' HB3' ' A' ' 245' ' ' LYS . 0.2 OUTLIER -155.6 167.98 28.64 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.623 -177.133 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.437 ' O ' HG11 ' A' ' 242' ' ' VAL . 12.3 pt-20 -141.78 -165.2 1.94 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.916 -0.49 . . . . 0.0 111.855 -172.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 43.0 t -59.63 118.38 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 96.71 0.18 60.76 Favored Glycine 0 CA--C 1.508 -0.396 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.165 170.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -89.74 -175.93 4.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.72 0.295 . . . . 0.0 110.396 -176.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.824 HD12 ' HB3' ' A' ' 239' ' ' TYR . 44.4 tp -130.0 159.84 35.46 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.01 0.433 . . . . 0.0 111.322 -176.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.677 HG13 ' HB3' ' A' ' 240' ' ' ALA . 2.4 p -152.24 133.82 5.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.019 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.434 ' HE2' ' HG2' ' A' ' 237' ' ' PRO . 86.1 tttt -96.16 96.36 8.77 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.246 0.546 . . . . 0.0 109.833 178.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.889 ' HB ' HD11 ' A' ' 238' ' ' ILE . 50.3 t -76.98 114.72 17.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.043 0.449 . . . . 0.0 111.473 -178.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' THR . . . . . 0.509 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 42.0 p -90.8 -10.45 42.79 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.49 -174.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.497 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 13.3 tppt? -127.21 105.94 8.9 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.814 HG23 HG21 ' A' ' 238' ' ' ILE . 0.8 OUTLIER -111.65 140.25 32.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -170.391 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.887 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 0.2 OUTLIER -148.6 140.44 23.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.634 177.766 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 10.6 p -58.68 -15.07 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -172.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.4 m -62.0 -36.11 80.54 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.297 0.481 . . . . 0.0 112.297 -177.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . 0.523 ' CA ' ' HB2' ' A' ' 288' ' ' PHE . . . 89.11 36.43 7.64 Favored Glycine 0 N--CA 1.437 -1.299 0 C-N-CA 119.908 -1.139 . . . . 0.0 110.797 -170.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 1.0 OUTLIER -148.7 96.92 2.65 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 171.163 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.887 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -134.15 173.07 12.0 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -168.959 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.613 ' O ' HG13 ' A' ' 266' ' ' VAL . 18.4 mm-40 -90.06 123.39 33.89 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.348 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -105.37 162.12 14.48 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -175.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.509 ' HG2' ' HG3' ' A' ' 283' ' ' ARG . 3.5 tm-20 -151.47 120.17 6.54 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 174.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 43.4 t -122.64 97.68 5.57 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.668 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 45.17 49.92 9.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.329 170.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.49 -27.31 8.08 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.684 -0.77 . . . . 0.0 113.4 177.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.85 128.58 41.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 117.311 0.556 . . . . 0.0 110.166 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . 0.509 ' HG3' ' HG2' ' A' ' 278' ' ' GLU . 0.4 OUTLIER -109.0 136.44 48.52 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.185 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . 0.485 ' N ' HD22 ' A' ' 256' ' ' LEU . . . -161.94 -171.98 28.74 Favored Glycine 0 C--O 1.226 -0.395 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.599 -176.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -147.02 135.79 22.17 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 172.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.682 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 4.4 m-85 -154.81 158.63 32.2 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -173.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.56 ' HD2' ' HE2' ' A' ' 290' ' ' HIS . 56.9 Cg_endo -94.93 164.68 1.69 Allowed 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.442 2.761 . . . . 0.0 113.938 -176.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.588 ' HA ' HG22 ' A' ' 291' ' ' VAL . 9.1 t80 -74.86 -18.47 60.43 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.131 -174.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 8.9 t -48.31 -24.91 1.35 Allowed 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 -175.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . 0.56 ' HE2' ' HD2' ' A' ' 287' ' ' PRO . 0.8 OUTLIER -137.51 48.19 2.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.807 0.337 . . . . 0.0 111.86 -177.839 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.588 HG22 ' HA ' ' A' ' 288' ' ' PHE . 30.1 m -143.22 155.09 16.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 121.102 0.477 . . . . 0.0 111.208 173.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.471 ' HD2' ' O ' ' A' ' 291' ' ' VAL . 15.9 mmm180 -121.79 110.43 15.9 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 173.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . 0.432 HD13 ' HZ2' ' A' ' 275' ' ' TRP . 2.6 tp -94.24 126.92 39.78 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -160.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.586 HD11 ' N ' ' A' ' 294' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.448 -0.573 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 163.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 266' ' ' VAL . 10.1 Cg_endo . . . . . 0 N--CA 1.446 -1.277 0 CA-C-O 120.971 0.321 . . . . 0.0 112.413 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . 1.064 HD13 ' HB1' ' A' ' 240' ' ' ALA . 0.1 OUTLIER -92.46 144.6 8.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 171.682 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.795 ' HD1' HD13 ' A' ' 263' ' ' LEU . 46.7 m-85 -96.96 119.53 35.6 Favored 'General case' 0 C--O 1.21 -1.01 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 173.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 1.064 ' HB1' HD13 ' A' ' 238' ' ' ILE . . . -113.94 115.9 28.4 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.107 -173.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.448 ' HB3' ' O ' ' A' ' 292' ' ' ARG . 17.8 tpp180 -84.76 103.4 13.82 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.189 -1.369 . . . . 0.0 108.375 177.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . 1.123 HG11 ' HD2' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -89.75 149.47 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.546 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.669 -177.245 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.485 HD11 ' C ' ' A' ' 243' ' ' ILE . 2.3 pp -124.88 11.23 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-N 113.544 -1.662 . . . . 0.0 110.654 -171.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.778 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 52.9 tt0 -177.23 94.6 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.63 -174.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 1.123 ' HD2' HG11 ' A' ' 242' ' ' VAL . 5.3 mttt -146.93 162.79 37.99 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.966 0.412 . . . . 0.0 110.11 177.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.84 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 10.7 ptm180 -113.37 -177.26 3.09 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.494 -174.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 9.3 m -102.57 81.83 0.4 Allowed Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 121.488 0.661 . . . . 0.0 112.091 174.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.94 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 1.1 Cg_endo -90.84 177.03 2.21 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 125.063 3.842 . . . . 0.0 110.573 171.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -131.36 175.43 9.14 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.105 0.478 . . . . 0.0 110.622 175.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.622 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -66.96 -2.97 5.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.316 0.579 . . . . 0.0 110.883 176.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -95.79 1.35 53.2 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.295 177.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -97.96 51.08 1.03 Allowed 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . 0.669 ' HA ' ' HE2' ' A' ' 253' ' ' LYS . 10.7 mmpt? 62.11 26.7 16.08 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -168.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' THR . . . . . 0.622 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 24.4 p 63.83 86.05 0.13 Allowed 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 125.107 1.504 . . . . 0.0 110.699 -175.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.404 ' HB3' ' CE2' ' A' ' 286' ' ' PHE . . . -121.66 156.55 32.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.186 178.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.589 HD23 ' O ' ' A' ' 277' ' ' GLY . 4.3 mm? -78.53 131.23 36.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.841 -178.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.94 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -92.03 99.05 11.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.361 0.6 . . . . 0.0 110.355 171.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.779 HD13 ' HD3' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -153.3 174.4 14.35 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.371 -175.332 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.431 ' CG ' ' N ' ' A' ' 260' ' ' VAL . 32.3 tt0 -142.84 175.73 9.61 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 122.128 -0.357 . . . . 0.0 111.073 -165.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 244' ' ' GLN . 56.0 t -57.07 118.71 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 123.083 0.553 . . . . 0.0 111.351 175.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 104.53 -1.19 42.71 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -97.79 -179.16 4.34 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.676 -169.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.795 HD13 ' HD1' ' A' ' 239' ' ' TYR . 2.3 tm? -134.16 134.29 41.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.07 0.462 . . . . 0.0 110.613 -170.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.662 HG12 ' HB3' ' A' ' 240' ' ' ALA . 5.4 p -125.54 145.3 33.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.453 173.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -99.79 99.65 10.49 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 175.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.921 ' HB ' HG21 ' A' ' 238' ' ' ILE . 76.0 t -70.06 114.14 7.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.324 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 33.2 p -92.6 -32.3 14.85 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.165 -171.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.36 107.65 15.08 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 121.598 0.713 . . . . 0.0 109.831 175.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.554 HD11 ' O ' ' A' ' 269' ' ' ILE . 0.6 OUTLIER -93.91 154.1 3.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 113.877 -1.511 . . . . 0.0 113.366 -170.024 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.712 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 2.4 p30 -145.89 -178.62 6.21 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.688 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 53.6 t -87.63 -38.81 12.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.5 m -73.33 -28.15 61.91 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -172.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . 0.868 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 102.99 0.66 48.42 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.582 -175.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.431 ' NE2' ' HB3' ' A' ' 287' ' ' PRO . 0.2 OUTLIER -89.96 76.14 7.1 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.9 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.712 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -122.33 175.66 6.29 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.619 0.723 . . . . 0.0 112.709 -170.033 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 284' ' ' GLY . 43.1 tt0 -98.52 127.31 44.4 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.081 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.589 ' O ' HD23 ' A' ' 256' ' ' LEU . . . -112.1 151.59 17.98 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.908 -174.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.616 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 17.2 tt0 -136.23 119.9 17.2 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 174.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 49.5 t -101.2 97.6 8.1 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.258 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 36.89 58.11 1.14 Allowed 'General case' 0 N--CA 1.465 0.282 0 O-C-N 124.542 1.151 . . . . 0.0 112.261 177.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.08 -37.51 3.39 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.661 177.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . 0.616 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 37.3 mttt -82.13 128.28 33.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 117.808 0.804 . . . . 0.0 110.587 -178.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -110.79 141.85 43.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.344 0.592 . . . . 0.0 112.002 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . 0.469 ' O ' ' HG3' ' A' ' 276' ' ' GLU . . . -176.07 -158.89 20.77 Favored Glycine 0 C--O 1.216 -1.021 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 174.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -149.66 146.67 27.4 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 118.848 1.324 . . . . 0.0 111.842 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.404 ' CE2' ' HB3' ' A' ' 255' ' ' ALA . 4.0 m-85 -154.18 162.74 26.15 Favored Pre-proline 0 C--O 1.238 0.471 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.571 -176.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.431 ' HB3' ' NE2' ' A' ' 274' ' ' GLN . 87.5 Cg_endo -92.92 171.67 2.18 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.151 2.567 . . . . 0.0 114.177 -176.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.868 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 17.9 t80 -79.65 -16.19 56.21 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 114.112 -1.404 . . . . 0.0 111.795 -174.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 67.3 p -55.63 -28.91 57.97 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -168.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . 0.778 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 1.5 p-80 -127.88 35.77 4.43 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.617 -172.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.619 HG22 HG12 ' A' ' 242' ' ' VAL . 5.4 p -139.36 148.27 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 C-N-CA 119.428 -0.909 . . . . 0.0 112.422 -174.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.448 ' O ' ' HB3' ' A' ' 241' ' ' ARG . 26.1 mmt180 -129.95 110.93 12.06 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.0 178.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . 0.651 HD23 ' H ' ' A' ' 293' ' ' LEU . 0.1 OUTLIER -89.89 138.5 31.44 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.588 0.709 . . . . 0.0 112.779 -163.695 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 239' ' ' TYR . 7.1 mt . . . . . 0 N--CA 1.433 -1.323 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 161.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.598 ' HA ' ' O ' ' A' ' 266' ' ' VAL . 11.7 Cg_exo . . . . . 0 N--CA 1.454 -0.807 0 N-CA-C 111.137 -0.37 . . . . 0.0 111.137 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . 0.859 HD11 ' HB ' ' A' ' 266' ' ' VAL . 0.2 OUTLIER -88.02 170.72 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.329 -177.634 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.95 ' HB3' HD22 ' A' ' 263' ' ' LEU . 81.9 m-85 -111.02 120.92 43.99 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 173.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.516 ' HB3' HG11 ' A' ' 264' ' ' VAL . . . -112.76 118.26 34.49 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.82 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.574 ' HD3' ' O ' ' A' ' 262' ' ' GLU . 0.0 OUTLIER -79.97 103.86 10.15 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.571 -177.737 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . 0.886 ' HA ' HG11 ' A' ' 291' ' ' VAL . 2.2 t -68.88 136.19 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.225 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.2 -177.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.444 HD11 ' C ' ' A' ' 243' ' ' ILE . 2.7 pp -123.01 -1.33 6.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.406 0.622 . . . . 0.0 110.227 172.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 1.048 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 33.4 tt0 -164.37 99.72 0.82 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.713 -178.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.958 ' HG2' ' HB2' ' A' ' 258' ' ' LEU . 5.3 tptt -145.76 165.12 29.74 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.419 0.628 . . . . 0.0 110.454 176.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.82 ' HG3' ' HG3' ' A' ' 248' ' ' PRO . 3.6 ptm180 -113.03 -178.78 3.46 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.466 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 5.9 m -105.67 75.76 0.33 Allowed Pre-proline 0 CA--C 1.537 0.481 0 CA-C-O 121.103 0.478 . . . . 0.0 111.826 176.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.968 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 1.0 OUTLIER -88.28 175.5 4.0 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 124.055 3.17 . . . . 0.0 111.527 175.002 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.422 ' HB3' ' HD1' ' A' ' 251' ' ' TYR . 66.3 m-20 -132.68 179.21 6.29 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.769 176.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.843 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -56.95 -10.92 1.23 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.304 0.573 . . . . 0.0 110.895 171.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.422 ' HD1' ' HB3' ' A' ' 249' ' ' ASN . 34.4 m-85 -83.21 -11.24 58.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.677 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -96.31 45.23 1.07 Allowed 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -175.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 4.1 mmpm? 60.74 28.76 18.48 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 -168.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' THR . . . . . 0.843 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 26.8 p 62.17 80.72 0.22 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.906 -178.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.515 ' HB3' ' CE2' ' A' ' 286' ' ' PHE . . . -117.03 156.99 26.57 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.619 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 1.008 ' HB3' HD11 ' A' ' 258' ' ' LEU . 4.5 mm? -79.1 120.32 23.47 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.389 -176.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.968 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -76.3 84.01 3.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.347 0.594 . . . . 0.0 110.867 172.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 1.008 HD11 ' HB3' ' A' ' 256' ' ' LEU . 2.4 mp -119.71 175.39 5.89 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.374 -176.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.538 ' O ' ' HB ' ' A' ' 242' ' ' VAL . 24.9 tt0 -146.17 174.61 11.17 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.403 ' N ' ' CG ' ' A' ' 259' ' ' GLU . 7.2 p -58.28 124.1 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.681 0.753 . . . . 0.0 111.825 173.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 97.9 1.5 58.54 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.192 175.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.574 ' O ' ' HD3' ' A' ' 241' ' ' ARG . 6.6 mt-10 -87.32 -174.21 4.74 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -171.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.95 HD22 ' HB3' ' A' ' 239' ' ' TYR . 3.4 tm? -140.62 131.18 25.47 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.563 -177.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.826 ' HB ' HD23 ' A' ' 258' ' ' LEU . 4.1 p -126.62 125.68 67.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.247 175.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -90.49 95.51 10.2 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.337 0.589 . . . . 0.0 109.45 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.859 ' HB ' HD11 ' A' ' 238' ' ' ILE . 48.4 t -77.84 118.21 24.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.476 -176.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 41.1 p -93.74 -12.72 28.55 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.856 -1.066 . . . . 0.0 111.593 -176.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.54 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 17.4 tppt? -119.65 104.37 10.21 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.356 174.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.477 HD11 ' O ' ' A' ' 269' ' ' ILE . 0.8 OUTLIER -105.99 159.64 5.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -172.31 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.543 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 3.9 p30 -145.2 -166.41 2.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.658 -177.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 9.8 p -103.82 -18.01 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.883 -177.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.4 m -83.62 -45.34 13.58 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.122 -0.361 . . . . 0.0 111.263 -177.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . 0.487 ' HA3' ' CD1' ' A' ' 288' ' ' PHE . . . 124.57 -7.84 8.36 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.249 -175.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -95.12 103.21 15.06 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 173.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.659 ' HZ2' HD13 ' A' ' 293' ' ' LEU . 0.0 OUTLIER -127.35 177.79 6.48 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.726 -174.213 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.71 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 46.5 mt-10 -99.08 125.12 44.52 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.567 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -108.8 154.0 16.63 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.448 -0.797 . . . . 0.0 112.636 -169.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.536 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 0.2 OUTLIER -133.3 117.43 17.34 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 172.044 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' CYS . . . . . 0.696 ' SG ' ' HD2' ' A' ' 282' ' ' LYS . 27.4 p -109.45 98.16 7.6 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.311 -176.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 9.9 m120 39.65 55.81 2.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.429 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 117.09 -39.94 2.52 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.78 -0.645 . . . . 0.0 114.054 176.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . 0.696 ' HD2' ' SG ' ' A' ' 279' ' ' CYS . 20.1 mttp -86.33 132.55 33.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 117.919 0.86 . . . . 0.0 111.287 -174.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -106.11 150.19 26.04 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.964 0.412 . . . . 0.0 111.833 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 175.52 -147.92 9.12 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.002 171.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' HIS . . . . . 0.71 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 10.2 p80 -147.62 151.38 36.12 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.698 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 0.9 OUTLIER -166.76 154.6 9.01 Favored Pre-proline 0 N--CA 1.469 0.478 0 CA-C-O 120.695 0.283 . . . . 0.0 111.492 -177.54 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.525 ' HD2' ' HE2' ' A' ' 290' ' ' HIS . 9.3 Cg_endo -90.19 163.03 4.7 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 124.049 3.166 . . . . 0.0 112.972 -177.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.509 ' HA ' HG22 ' A' ' 291' ' ' VAL . 18.4 p90 -87.8 -18.77 28.6 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -172.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 7.5 t -66.77 -4.23 8.62 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -169.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . 1.048 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 0.8 OUTLIER -130.59 33.86 4.21 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.245 173.143 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.886 HG11 ' HA ' ' A' ' 242' ' ' VAL . 26.8 m -145.03 167.34 10.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.483 173.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -123.05 109.12 13.68 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . 0.659 HD13 ' HZ2' ' A' ' 275' ' ' TRP . 0.1 OUTLIER -91.99 128.81 37.97 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.635 -0.826 . . . . 0.0 112.862 -165.6 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.465 ' N ' HD21 ' A' ' 294' ' ' LEU . 4.4 mt . . . . . 0 C--N 1.32 -0.708 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 169.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.532 ' HG2' ' HE2' ' A' ' 265' ' ' LYS . 1.2 Cg_endo . . . . . 0 N--CA 1.46 -0.445 0 N-CA-C 113.009 0.349 . . . . 0.0 113.009 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . 0.641 ' HB ' ' O ' ' A' ' 294' ' ' LEU . 0.2 OUTLIER -107.53 163.32 5.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 175.405 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.791 ' HB3' HD22 ' A' ' 263' ' ' LEU . 69.8 m-85 -101.86 120.75 40.89 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 174.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.736 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -113.93 117.18 30.64 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.461 0.648 . . . . 0.0 110.234 -177.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.499 ' NH1' ' HA2' ' A' ' 261' ' ' GLY . 0.6 OUTLIER -84.17 107.26 16.38 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.682 -176.046 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . 0.722 ' HA ' HG12 ' A' ' 291' ' ' VAL . 3.9 t -69.6 131.74 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.122 -177.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.471 ' O ' HG23 ' A' ' 260' ' ' VAL . 2.8 pp -121.94 -0.52 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.015 175.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.631 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 6.7 tp-100 -178.1 95.69 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.685 -175.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.627 ' HB3' ' O ' ' A' ' 258' ' ' LEU . 0.9 OUTLIER -146.29 162.88 37.14 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.158 0.504 . . . . 0.0 110.261 177.248 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.854 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 12.1 ttt180 -95.43 179.64 5.09 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.35 -174.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.453 ' N ' ' CG ' ' A' ' 246' ' ' ARG . 8.9 m -106.36 69.68 0.23 Allowed Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 121.893 0.854 . . . . 0.0 110.805 173.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.9 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 11.6 Cg_endo -95.62 131.71 0.49 Allowed 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 125.146 3.897 . . . . 0.0 111.376 -178.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -92.39 178.26 5.88 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.58 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.615 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -59.85 -8.13 2.03 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.388 0.613 . . . . 0.0 110.999 174.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -92.14 -8.08 46.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.198 0.523 . . . . 0.0 110.118 177.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -104.67 66.85 0.8 Allowed 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.645 -174.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . 0.404 ' HD3' ' N ' ' A' ' 253' ' ' LYS . 0.0 OUTLIER 60.97 23.66 13.78 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.179 -172.67 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' THR . . . . . 0.615 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 34.8 p 52.81 65.33 1.55 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.888 -177.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.722 ' HB3' ' CE2' ' A' ' 286' ' ' PHE . . . -109.53 158.32 18.12 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.429 -175.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.641 HD22 ' CA ' ' A' ' 284' ' ' GLY . 1.7 mm? -67.37 128.37 36.16 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.869 176.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.9 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -92.6 98.08 11.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.442 0.639 . . . . 0.0 110.311 173.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.627 ' O ' ' HB3' ' A' ' 245' ' ' LYS . 0.2 OUTLIER -160.06 164.48 33.09 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.881 -173.743 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.504 ' O ' ' HG3' ' A' ' 262' ' ' GLU . 12.0 pt-20 -143.47 -167.52 2.59 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.975 -0.453 . . . . 0.0 111.888 -172.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 243' ' ' ILE . 62.8 t -54.49 123.22 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.499 ' HA2' ' NH1' ' A' ' 241' ' ' ARG . . . 102.04 -1.04 51.24 Favored Glycine 0 CA--C 1.509 -0.331 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.699 170.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 259' ' ' GLU . 8.3 mt-10 -86.57 -174.83 5.19 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -168.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.791 HD22 ' HB3' ' A' ' 239' ' ' TYR . 3.4 tm? -140.0 128.28 22.55 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.634 177.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.736 HG13 ' HB3' ' A' ' 240' ' ' ALA . 2.6 p -127.17 115.54 41.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.297 177.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.532 ' HE2' ' HG2' ' A' ' 237' ' ' PRO . 86.9 tttt -89.61 100.75 13.49 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.63 ' HB ' ' HA2' ' A' ' 277' ' ' GLY . 0.8 OUTLIER -83.09 137.16 21.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.897 -175.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 23.2 p -99.34 -8.3 25.05 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.704 -176.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 268' ' ' LYS . 14.0 tppt? -126.51 107.44 10.24 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.052 173.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.636 HG23 HG22 ' A' ' 238' ' ' ILE . 0.9 OUTLIER -105.04 163.26 4.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -170.76 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.498 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 4.3 p30 -143.3 -172.53 3.72 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.225 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 26.0 m -103.03 -5.91 9.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -175.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 5.5 m -100.99 -44.85 5.6 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.481 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . 0.484 ' HA3' ' CD1' ' A' ' 288' ' ' PHE . . . 133.18 -1.81 4.6 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.289 -0.958 . . . . 0.0 113.513 -178.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -95.99 102.08 13.83 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 118.003 0.901 . . . . 0.0 109.274 174.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.851 ' HZ2' ' HG ' ' A' ' 293' ' ' LEU . 0.0 OUTLIER -128.24 173.27 10.28 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -173.582 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.502 ' O ' ' HB ' ' A' ' 266' ' ' VAL . 45.1 tt0 -96.34 125.16 40.65 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 171.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.63 ' HA2' ' HB ' ' A' ' 266' ' ' VAL . . . -114.97 165.47 12.07 Favored Glycine 0 N--CA 1.439 -1.132 0 CA-C-N 115.466 -0.788 . . . . 0.0 113.15 -166.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.629 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 22.4 tt0 -139.04 118.86 13.19 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 171.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' CYS . . . . . 0.606 ' SG ' ' HB2' ' A' ' 282' ' ' LYS . 21.8 p -99.93 96.3 7.46 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 119.474 -0.891 . . . . 0.0 108.904 176.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 11.4 m120 41.59 52.69 3.9 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.935 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 115.18 -28.62 7.84 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.548 -0.834 . . . . 0.0 114.691 175.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . 0.629 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 10.0 mptt -91.63 134.21 34.89 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.105 0.952 . . . . 0.0 110.428 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . 0.414 ' HD2' ' N ' ' A' ' 283' ' ' ARG . 3.5 mpt_? -106.27 157.76 17.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.953 0.406 . . . . 0.0 111.301 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . 0.641 ' CA ' HD22 ' A' ' 256' ' ' LEU . . . 175.37 -172.97 45.96 Favored Glycine 0 C--O 1.224 -0.499 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -177.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' HIS . . . . . 0.411 ' H ' ' HA ' ' A' ' 255' ' ' ALA . 12.3 p80 -146.85 143.6 28.69 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 118.674 1.237 . . . . 0.0 111.782 171.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.722 ' CE2' ' HB3' ' A' ' 255' ' ' ALA . 5.8 m-85 -156.3 163.04 26.22 Favored Pre-proline 0 N--CA 1.464 0.264 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.429 -174.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -92.57 167.09 2.76 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.178 2.585 . . . . 0.0 112.06 175.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.484 ' CD1' ' HA3' ' A' ' 273' ' ' GLY . 39.7 p90 -85.18 -8.02 58.78 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -172.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 6.3 t -56.33 -13.19 2.01 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -174.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . 0.631 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 0.9 OUTLIER -138.94 33.56 2.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.928 0.394 . . . . 0.0 111.89 -178.259 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.722 HG12 ' HA ' ' A' ' 242' ' ' VAL . 15.5 m -146.74 162.08 9.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.348 176.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -117.79 106.37 12.95 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 176.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . 0.851 ' HG ' ' HZ2' ' A' ' 275' ' ' TRP . 0.0 OUTLIER -104.55 128.66 52.57 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 119.622 -0.831 . . . . 0.0 113.223 -169.363 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.641 ' O ' ' HB ' ' A' ' 238' ' ' ILE . 4.8 mp . . . . . 0 N--CA 1.436 -1.15 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 168.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.429 ' HB3' ' HA ' ' A' ' 267' ' ' THR . 11.3 Cg_exo . . . . . 0 N--CA 1.454 -0.824 0 N-CA-C 110.171 -0.742 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . 0.753 HG22 HG22 ' A' ' 269' ' ' ILE . 0.2 OUTLIER -80.43 158.21 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.115 -171.045 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.709 ' HD1' HD11 ' A' ' 263' ' ' LEU . 83.1 m-85 -99.43 118.33 35.8 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 174.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -114.78 115.74 27.51 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -175.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -79.93 101.88 8.86 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 176.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . 0.847 HG22 ' HD3' ' A' ' 245' ' ' LYS . 7.6 p -81.95 119.11 30.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.324 -175.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.409 HD11 ' C ' ' A' ' 243' ' ' ILE . 2.8 pp -98.71 3.7 10.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.411 -174.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.526 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 8.3 tt0 -177.28 106.0 0.06 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.446 -175.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.847 ' HD3' HG22 ' A' ' 242' ' ' VAL . 0.2 OUTLIER -146.93 166.0 28.09 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.344 0.593 . . . . 0.0 110.903 174.446 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.794 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 5.7 ptt180 -104.7 -178.8 3.76 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.135 -0.938 . . . . 0.0 108.602 -177.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 4.7 m -104.22 76.95 0.28 Allowed Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 121.227 0.537 . . . . 0.0 112.357 176.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.982 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 3.3 Cg_exo -83.31 177.43 6.51 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.274 3.316 . . . . 0.0 110.6 174.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.408 ' C ' ' H ' ' A' ' 251' ' ' TYR . 4.0 m-80 -139.49 176.99 8.26 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.054 -178.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.932 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -63.6 -5.06 3.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.634 0.73 . . . . 0.0 110.567 170.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.408 ' H ' ' C ' ' A' ' 249' ' ' ASN . 14.2 m-85 -90.2 -11.01 42.32 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.772 176.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -105.95 60.21 0.66 Allowed 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.557 -173.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . 0.5 ' N ' ' HD2' ' A' ' 253' ' ' LYS . 7.2 mptt 56.28 31.56 18.74 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -170.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' THR . . . . . 0.932 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 74.3 p 53.14 53.06 12.5 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 114.174 -1.375 . . . . 0.0 112.547 -177.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.413 ' HA ' ' H ' ' A' ' 285' ' ' HIS . . . -90.07 161.4 15.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.046 0.45 . . . . 0.0 110.709 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.668 ' N ' ' HA3' ' A' ' 284' ' ' GLY . 0.2 OUTLIER -78.89 132.67 36.86 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.745 -173.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.982 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -91.27 100.75 13.5 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 172.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.782 HD23 ' HG2' ' A' ' 245' ' ' LYS . 0.7 OUTLIER -150.26 171.25 17.25 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.493 -174.59 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.444 ' O ' HG11 ' A' ' 242' ' ' VAL . 30.9 tt0 -143.59 170.31 16.08 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.188 -163.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 2.5 p -53.81 118.74 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 121.528 0.68 . . . . 0.0 111.724 173.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 106.45 -1.67 37.05 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.011 171.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -89.04 176.21 7.08 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.079 -174.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.709 HD11 ' HD1' ' A' ' 239' ' ' TYR . 3.0 tm? -126.7 130.47 50.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.227 0.536 . . . . 0.0 110.132 -178.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.459 HG23 HD12 ' A' ' 258' ' ' LEU . 2.2 t -111.44 145.09 18.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.604 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 238' ' ' ILE . 62.3 tttp -120.68 95.12 4.59 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 170.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.722 ' HB ' ' HA2' ' A' ' 277' ' ' GLY . 1.4 m -84.71 124.42 39.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.723 -173.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' THR . . . . . 0.429 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 40.4 p -88.36 -9.49 52.56 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.868 -174.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 4.4 tppp? -116.92 103.62 10.47 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.753 HG22 HG22 ' A' ' 238' ' ' ILE . 0.7 OUTLIER -102.61 154.41 5.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.85 -172.816 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.519 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 4.2 p30 -144.23 -170.81 3.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.774 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 12.0 p -95.67 -33.87 4.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.916 -178.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 10.8 m -74.07 -43.02 59.22 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -173.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 123.88 -5.7 9.03 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.163 -177.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.66 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.9 OUTLIER -94.53 104.71 16.66 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 173.535 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.545 ' HZ2' HD12 ' A' ' 293' ' ' LEU . 0.0 OUTLIER -129.71 -179.76 5.37 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.598 0.713 . . . . 0.0 112.055 -173.684 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.506 ' HG2' ' HD1' ' A' ' 285' ' ' HIS . 32.2 mt-10 -102.42 123.87 46.98 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 173.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.722 ' HA2' ' HB ' ' A' ' 266' ' ' VAL . . . -109.09 153.39 16.84 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.905 -165.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.572 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 29.7 tt0 -135.42 118.88 16.85 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 174.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 47.9 t -99.3 96.38 7.7 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 12.8 m120 38.4 55.93 1.8 Allowed 'General case' 0 CA--C 1.533 0.323 0 O-C-N 124.362 1.039 . . . . 0.0 112.023 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 115.91 -40.26 2.48 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 120.433 -0.889 . . . . 0.0 114.091 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . 0.572 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 0.8 OUTLIER -80.05 136.82 36.66 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.969 0.884 . . . . 0.0 110.241 179.788 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 283' ' ' ARG . 5.6 mpt_? -113.12 131.23 55.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.643 0.735 . . . . 0.0 112.031 178.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . 0.668 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . -147.51 -166.96 12.89 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 114.282 -1.326 . . . . 0.0 111.651 174.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' HIS . . . . . 0.506 ' HD1' ' HG2' ' A' ' 276' ' ' GLU . 5.6 m-70 -145.91 139.89 26.58 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 117.684 0.742 . . . . 0.0 109.427 178.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.709 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 10.4 m-85 -167.99 157.2 8.69 Favored Pre-proline 0 N--CA 1.471 0.603 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -172.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.66 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 58.7 Cg_endo -95.34 176.39 0.9 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.709 2.939 . . . . 0.0 113.457 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.433 ' HA ' HG22 ' A' ' 291' ' ' VAL . 24.1 p90 -86.07 -9.74 56.2 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.106 -173.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 11.1 t -70.26 8.26 0.82 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -168.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . 0.526 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 0.9 OUTLIER -155.77 38.21 0.37 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.091 0.472 . . . . 0.0 110.95 177.517 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.58 HG21 HD21 ' A' ' 293' ' ' LEU . 27.6 m -144.67 157.76 14.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.014 0.435 . . . . 0.0 111.112 178.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -115.88 108.84 16.8 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 170.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . 0.58 HD21 HG21 ' A' ' 291' ' ' VAL . 0.2 OUTLIER -102.98 123.65 46.98 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -165.727 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 4.6 mp . . . . . 0 N--CA 1.439 -1.002 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.092 167.414 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo . . . . . 0 C--O 1.235 0.342 0 CA-C-O 121.006 0.336 . . . . 0.0 112.593 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . 1.032 HG12 HG23 ' A' ' 266' ' ' VAL . 1.3 pt -91.75 167.98 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.727 173.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.754 ' HB3' HD12 ' A' ' 263' ' ' LEU . 61.5 m-85 -116.35 119.66 36.39 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 169.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.639 ' HA ' ' HA ' ' A' ' 293' ' ' LEU . . . -113.21 117.66 32.52 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.944 -175.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.476 ' HD3' ' O ' ' A' ' 262' ' ' GLU . 16.3 tpp180 -82.45 102.91 11.62 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.416 175.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . 0.935 HG22 ' HD2' ' A' ' 245' ' ' LYS . 2.6 p -87.26 135.15 25.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.512 -173.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.411 HD11 ' C ' ' A' ' 243' ' ' ILE . 2.8 pp -109.61 9.1 8.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.787 -175.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.797 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 58.2 tt0 -176.92 95.24 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.723 0.297 . . . . 0.0 110.26 -173.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.935 ' HD2' HG22 ' A' ' 242' ' ' VAL . 4.3 mttt -146.29 161.72 39.68 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 175.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.869 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 5.8 ptp180 -106.62 -178.07 3.54 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -177.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 32.0 t -103.3 80.37 0.36 Allowed Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 120.955 0.407 . . . . 0.0 111.262 176.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.939 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 3.1 Cg_endo -91.45 177.67 1.87 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 125.161 3.907 . . . . 0.0 111.184 175.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.425 ' C ' ' H ' ' A' ' 251' ' ' TYR . 90.5 m-20 -130.29 174.94 9.35 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 175.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.77 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -72.22 5.12 3.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.417 0.627 . . . . 0.0 110.332 175.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.425 ' H ' ' C ' ' A' ' 249' ' ' ASN . 28.7 m-85 -99.2 -2.62 36.28 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.216 174.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.404 ' C ' ' HD2' ' A' ' 253' ' ' LYS . 35.6 m-20 -105.15 63.72 0.7 Allowed 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.464 -177.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . 0.404 ' HD2' ' C ' ' A' ' 252' ' ' ASP . 7.0 mptt 57.58 25.62 11.83 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -171.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' THR . . . . . 0.77 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 44.9 p 56.06 75.86 0.32 Allowed 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.823 -174.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -113.77 150.3 33.62 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.253 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.467 ' O ' ' HE2' ' A' ' 286' ' ' PHE . 0.0 OUTLIER -72.84 132.92 44.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.611 -176.163 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.939 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -95.12 104.27 16.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.371 0.605 . . . . 0.0 111.479 174.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.729 ' HG ' ' HD3' ' A' ' 245' ' ' LYS . 0.4 OUTLIER -163.81 175.5 10.41 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.54 -176.344 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.441 ' O ' HG11 ' A' ' 242' ' ' VAL . 12.3 pt-20 -142.45 -166.42 2.26 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 121.591 -0.693 . . . . 0.0 112.383 -171.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 2.8 p -68.51 122.01 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.295 177.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 104.18 -0.75 43.96 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.284 174.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.476 ' O ' ' HD3' ' A' ' 241' ' ' ARG . 9.4 mt-10 -98.73 -174.72 2.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.842 0.353 . . . . 0.0 111.666 -170.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.754 HD12 ' HB3' ' A' ' 239' ' ' TYR . 50.7 tp -133.74 160.27 38.09 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.508 -177.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.486 ' N ' ' HG ' ' A' ' 263' ' ' LEU . 2.8 p -153.48 136.91 7.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.389 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.464 ' HE2' ' CE1' ' A' ' 239' ' ' TYR . 37.9 ttmt -99.98 102.1 13.38 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 175.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 1.032 HG23 HG12 ' A' ' 238' ' ' ILE . 4.0 m -86.79 115.68 28.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.97 0.89 . . . . 0.0 110.71 -178.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 9.9 t -99.95 4.08 44.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.596 -1.183 . . . . 0.0 110.394 -177.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.529 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 0.0 OUTLIER -124.94 107.19 10.6 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 168.128 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.55 HG21 HG22 ' A' ' 266' ' ' VAL . 0.8 OUTLIER -110.49 158.22 10.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 115.286 -0.87 . . . . 0.0 113.113 -172.098 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.721 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 2.6 p30 -146.34 -172.98 4.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.698 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 11.6 p -93.39 -31.92 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 45.7 m -74.99 -43.44 53.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -173.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . 0.771 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 125.04 -13.51 7.55 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.499 -178.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.6 OUTLIER -89.23 93.09 9.44 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 173.285 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.721 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -123.05 179.09 4.79 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.183 -176.204 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 53.4 tt0 -104.32 125.77 50.85 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.675 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -110.2 169.68 13.69 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.95 -172.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 3.1 tm-20 -152.32 119.45 5.87 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 171.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 44.6 t -115.63 99.55 7.42 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.084 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 43.3 54.33 5.16 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 124.252 0.97 . . . . 0.0 112.313 173.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 117.73 -40.45 2.33 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-N 115.828 -0.624 . . . . 0.0 114.102 176.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 0.0 OUTLIER -93.32 128.79 39.48 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 118.066 0.933 . . . . 0.0 109.934 -178.996 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . 0.544 ' H ' ' HD3' ' A' ' 283' ' ' ARG . 0.0 OUTLIER -121.2 145.47 47.8 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.266 176.28 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 173.05 157.75 15.61 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.072 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' HIS . . . . . 0.536 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 30.5 p80 -98.08 148.35 23.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.04 0.42 . . . . 0.0 112.117 -171.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.467 ' HE2' ' O ' ' A' ' 256' ' ' LEU . 5.3 m-85 -158.55 159.21 29.85 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.515 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.523 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 93.6 Cg_endo -89.36 168.28 5.14 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.206 2.604 . . . . 0.0 113.809 -177.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.771 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 19.0 t80 -76.62 -19.99 57.22 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 114.158 -1.383 . . . . 0.0 111.922 -172.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 8.9 t -61.8 -11.47 12.61 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -168.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . 0.797 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 1.0 OUTLIER -137.68 33.91 2.45 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.69 -0.631 . . . . 0.0 112.351 -176.359 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.566 HG11 ' HD2' ' A' ' 290' ' ' HIS . 34.1 m -139.93 153.11 22.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.882 0.372 . . . . 0.0 111.192 177.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -121.06 107.96 13.25 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 169.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . 0.723 HD23 ' CE2' ' A' ' 288' ' ' PHE . 0.2 OUTLIER -101.49 139.96 36.44 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -169.935 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.465 HD11 ' N ' ' A' ' 294' ' ' LEU . 4.5 mp . . . . . 0 N--CA 1.431 -1.424 0 CA-C-N 113.397 -1.729 . . . . 0.0 107.412 166.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo . . . . . 0 N--CA 1.45 -1.043 0 CA-C-O 120.679 0.2 . . . . 0.0 111.935 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . 0.669 HD11 ' HB ' ' A' ' 266' ' ' VAL . 0.1 OUTLIER -97.08 152.24 4.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.391 -178.641 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.694 ' HB3' HD22 ' A' ' 263' ' ' LEU . 67.3 m-85 -96.65 119.54 35.32 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 174.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 293' ' ' LEU . . . -114.42 116.72 29.35 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.24 0.543 . . . . 0.0 110.352 -174.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -86.19 102.29 13.78 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.592 178.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . 0.745 HG22 ' HD3' ' A' ' 245' ' ' LYS . 3.0 p -79.55 128.53 38.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.534 -175.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.689 HD11 ' HB2' ' A' ' 244' ' ' GLN . 2.8 pp -108.31 3.53 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.88 -175.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.689 ' HB2' HD11 ' A' ' 243' ' ' ILE . 4.0 mt-30 -176.29 95.67 0.05 Allowed 'General case' 0 N--CA 1.463 0.203 0 O-C-N 123.043 0.214 . . . . 0.0 111.061 -175.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.759 ' HE2' HD22 ' A' ' 258' ' ' LEU . 0.0 OUTLIER -146.5 163.17 36.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.183 0.516 . . . . 0.0 111.164 173.663 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.848 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 9.8 ptt180 -101.27 -176.92 3.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.679 -177.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 27.3 t -101.66 82.69 0.4 Allowed Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 120.856 0.36 . . . . 0.0 111.292 175.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.965 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 7.0 Cg_endo -93.02 177.14 1.44 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.656 3.571 . . . . 0.0 110.778 172.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' ASN . . . . . 0.455 ' C ' ' H ' ' A' ' 251' ' ' TYR . 51.8 m-80 -131.04 177.26 7.58 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.026 0.441 . . . . 0.0 110.678 176.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.789 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -64.2 0.25 1.02 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.356 0.598 . . . . 0.0 110.99 173.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.455 ' H ' ' C ' ' A' ' 249' ' ' ASN . 44.4 m-85 -103.81 8.57 37.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.454 0.645 . . . . 0.0 109.696 177.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.74 53.19 0.73 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.162 -0.927 . . . . 0.0 108.727 176.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt 58.01 30.45 19.24 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -167.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' THR . . . . . 0.789 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 43.4 p 59.1 71.3 0.59 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.826 -176.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -111.55 150.75 29.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.65 179.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.613 ' N ' ' HA3' ' A' ' 284' ' ' GLY . 0.2 OUTLIER -72.12 133.67 45.32 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.663 -174.543 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.965 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -90.57 98.92 12.06 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 172.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.759 HD22 ' HE2' ' A' ' 245' ' ' LYS . 0.9 OUTLIER -154.94 171.14 20.19 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.108 -173.735 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.5 ' O ' HG11 ' A' ' 242' ' ' VAL . 12.3 pt-20 -142.28 -166.59 2.28 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.177 0.513 . . . . 0.0 111.873 -171.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.565 HG22 ' HA ' ' A' ' 244' ' ' GLN . 48.2 t -68.12 117.61 10.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.124 176.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 107.13 0.86 35.74 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.132 172.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -93.15 179.78 5.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.188 0.518 . . . . 0.0 111.915 -173.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.694 HD22 ' HB3' ' A' ' 239' ' ' TYR . 3.0 tm? -136.89 133.57 35.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.251 -176.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.954 HG13 ' HB2' ' A' ' 279' ' ' CYS . 34.1 m -126.15 154.86 35.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.097 173.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -111.52 96.04 5.86 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.669 ' HB ' HD11 ' A' ' 238' ' ' ILE . 49.2 t -69.88 121.47 19.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.836 -174.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 40.8 p -103.51 -7.19 21.06 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.626 -176.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.574 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 0.0 OUTLIER -126.85 106.77 9.56 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 119.445 -0.902 . . . . 0.0 108.74 171.018 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' ILE . . . . . 0.489 HD11 ' O ' ' A' ' 269' ' ' ILE . 0.7 OUTLIER -107.65 148.66 11.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 114.451 -1.249 . . . . 0.0 113.72 -168.613 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.883 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 0.3 OUTLIER -147.12 154.04 40.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.463 -178.947 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 35.9 m -70.4 -9.71 12.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -174.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.5 m -89.75 -45.49 9.26 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.867 -178.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 119.68 -7.95 12.03 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.061 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.683 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.0 OUTLIER -93.94 70.75 4.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.484 0.659 . . . . 0.0 109.636 176.897 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.883 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -112.74 174.83 5.7 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.327 -168.814 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.679 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 32.9 tt0 -94.87 123.82 38.56 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.225 0.536 . . . . 0.0 109.796 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -100.96 150.21 18.64 Favored Glycine 0 N--CA 1.436 -1.326 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.299 -175.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.795 ' HG3' ' HG2' ' A' ' 283' ' ' ARG . 32.4 tt0 -127.8 116.85 20.81 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' CYS . . . . . 0.954 ' HB2' HG13 ' A' ' 264' ' ' VAL . 43.7 t -111.17 98.36 7.46 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 24.95 61.56 0.05 Allowed 'General case' 0 C--N 1.343 0.306 0 O-C-N 125.619 1.824 . . . . 0.0 113.301 174.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 118.53 -24.27 8.63 Favored Glycine 0 CA--C 1.523 0.55 0 CA-C-N 115.447 -0.797 . . . . 0.0 114.134 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.35 144.4 31.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 118.003 0.902 . . . . 0.0 110.38 175.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . 0.795 ' HG2' ' HG3' ' A' ' 278' ' ' GLU . 28.7 mtm180 -123.91 129.5 51.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.792 0.33 . . . . 0.0 110.188 171.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . 0.613 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . -165.52 140.57 6.46 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.112 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' HIS . . . . . 0.679 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 20.7 p80 -99.25 148.04 24.54 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 117.434 0.617 . . . . 0.0 111.696 -175.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.645 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 5.7 m-85 -161.2 164.05 19.34 Favored Pre-proline 0 C--O 1.235 0.324 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.041 -177.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.683 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 1.7 Cg_endo -85.72 158.76 10.54 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.518 2.812 . . . . 0.0 112.13 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.654 ' HB2' HD23 ' A' ' 293' ' ' LEU . 1.8 p90 -87.03 -5.95 58.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.891 -174.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' THR . . . . . 0.513 HG21 ' HB2' ' A' ' 287' ' ' PRO . 5.6 t -52.8 -32.73 45.48 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . 0.425 ' CD2' ' HD2' ' A' ' 245' ' ' LYS . 0.8 OUTLIER -121.38 43.77 2.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.35 0.595 . . . . 0.0 111.429 -177.322 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.698 HG13 ' HA ' ' A' ' 242' ' ' VAL . 19.8 m -147.46 170.11 3.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.158 173.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -131.71 109.06 9.9 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 173.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' LEU . . . . . 0.654 HD23 ' HB2' ' A' ' 288' ' ' PHE . 0.1 OUTLIER -113.88 133.13 55.62 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.742 0.782 . . . . 0.0 112.883 -166.379 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 4.5 mp . . . . . 0 N--CA 1.437 -1.076 0 CA-C-N 114.326 -1.307 . . . . 0.0 108.075 171.86 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . 0.471 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . . . . . . 0 N--CA 1.446 -0.665 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 266' ' ' VAL . 4.3 Cg_endo -88.05 121.62 1.47 Allowed 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.395 2.73 . . . . 0.0 111.554 176.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 0.949 HD13 ' HB ' ' A' ' 266' ' ' VAL . 0.2 OUTLIER -85.12 161.56 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 C-N-CA 119.219 -0.992 . . . . 0.0 109.852 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.828 ' HB3' HD22 ' A' ' 263' ' ' LEU . 44.4 m-85 -103.46 118.64 37.21 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 172.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.676 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -111.83 115.76 29.55 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.05 -174.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.499 ' HB3' ' O ' ' A' ' 292' ' ' ARG . 21.9 tpp180 -75.48 101.64 4.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 175.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . 0.74 HG22 ' HD3' ' A' ' 245' ' ' LYS . 5.2 p -81.29 119.88 31.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 C-N-CA 120.316 -0.554 . . . . 0.0 109.991 -175.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.409 HD11 ' C ' ' A' ' 243' ' ' ILE . 2.8 pp -102.23 9.15 8.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.629 -173.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.867 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 30.5 tt0 -176.9 95.44 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.192 -177.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.74 ' HD3' HG22 ' A' ' 242' ' ' VAL . 0.1 OUTLIER -146.48 164.22 33.22 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.839 0.828 . . . . 0.0 111.189 174.242 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.808 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 2.6 ptm180 -105.24 -175.88 2.92 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.637 -1.62 . . . . 0.0 108.767 -177.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 3.8 m -110.52 70.87 0.64 Allowed Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 121.42 0.628 . . . . 0.0 111.547 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.999 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 28.7 Cg_endo -95.29 123.08 0.32 Allowed 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 125.051 3.834 . . . . 0.0 111.913 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.464 ' C ' ' H ' ' A' ' 251' ' ' TYR . 40.7 m-80 -78.55 176.18 9.66 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.873 0.368 . . . . 0.0 111.038 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.685 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -62.9 -2.07 1.09 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.751 0.786 . . . . 0.0 111.349 175.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.464 ' H ' ' C ' ' A' ' 249' ' ' ASN . 12.0 m-85 -92.87 -1.93 56.32 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.998 178.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.38 47.81 1.14 Allowed 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt 59.99 30.22 19.73 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -167.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' THR . . . . . 0.685 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 29.4 p 63.79 86.22 0.12 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 113.825 -1.534 . . . . 0.0 111.048 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.644 ' HB1' ' HB2' ' A' ' 248' ' ' PRO . . . -120.6 163.78 17.5 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.951 178.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.495 ' HB3' ' CG ' ' A' ' 258' ' ' LEU . 4.5 mm? -83.15 120.59 25.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.203 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.999 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -88.84 91.19 8.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.65 0.738 . . . . 0.0 110.303 176.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.691 ' CD2' ' HB ' ' A' ' 264' ' ' VAL . 0.2 OUTLIER -148.34 176.28 10.4 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.561 -174.645 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.507 ' O ' HG11 ' A' ' 242' ' ' VAL . 15.4 tt0 -142.04 167.11 22.91 Favored 'General case' 0 C--N 1.313 -1.022 0 O-C-N 121.931 -0.481 . . . . 0.0 110.931 -162.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.488 ' N ' ' HG2' ' A' ' 259' ' ' GLU . 1.6 p -57.79 117.73 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 121.41 0.624 . . . . 0.0 111.236 174.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 107.52 -2.65 34.47 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.918 176.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -95.44 -173.33 2.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.941 0.4 . . . . 0.0 111.379 -173.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.828 HD22 ' HB3' ' A' ' 239' ' ' TYR . 3.4 tm? -133.73 122.27 23.11 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.711 -174.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.691 ' HB ' ' CD2' ' A' ' 258' ' ' LEU . 2.5 p -113.82 125.74 71.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.077 174.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.548 ' HG3' ' CE1' ' A' ' 239' ' ' TYR . 5.2 tmmm? -96.47 96.11 8.47 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.949 ' HB ' HD13 ' A' ' 238' ' ' ILE . 96.6 t -71.89 114.94 11.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.084 -177.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' THR . . . . . 0.437 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 4.7 t -93.36 -9.28 39.34 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 124.313 1.008 . . . . 0.0 111.266 -178.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.604 ' HA ' ' HE3' ' A' ' 268' ' ' LYS . 0.0 OUTLIER -127.32 103.28 7.31 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 175.399 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.471 HD11 ' O ' ' A' ' 269' ' ' ILE . 0.8 OUTLIER -98.98 160.12 3.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -170.426 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.589 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 3.6 p30 -146.69 -169.62 3.32 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.925 178.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 8.5 p -96.65 -37.0 6.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 5.0 m -73.27 -43.02 61.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.864 0.364 . . . . 0.0 111.767 -172.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . 0.846 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 124.27 -4.79 8.87 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.828 -175.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -90.59 82.19 5.83 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 176.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.589 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -116.87 175.51 5.54 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.246 0.546 . . . . 0.0 112.054 -174.244 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.495 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 36.0 mt-10 -102.62 124.66 48.57 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.831 177.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.595 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -108.41 153.38 16.83 Favored Glycine 0 N--CA 1.439 -1.128 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.418 -169.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.575 ' HG3' ' HG2' ' A' ' 283' ' ' ARG . 21.8 tt0 -130.74 119.8 22.87 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 173.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . 0.491 ' O ' ' HD2' ' A' ' 282' ' ' LYS . 53.7 t -116.56 96.22 5.41 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.958 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 24.38 61.31 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 O-C-N 124.914 1.384 . . . . 0.0 113.505 -177.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.79 -20.32 11.9 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.84 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . 0.491 ' HD2' ' O ' ' A' ' 279' ' ' CYS . 5.7 mptt -97.93 132.13 43.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.632 0.716 . . . . 0.0 109.749 174.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . 0.575 ' HG2' ' HG3' ' A' ' 278' ' ' GLU . 48.7 mtt180 -123.68 141.5 51.96 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 176.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 175.29 -148.79 9.73 Favored Glycine 0 C--O 1.223 -0.542 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.315 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' HIS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 12.8 p80 -149.17 145.92 27.4 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 117.37 0.585 . . . . 0.0 111.54 -177.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.611 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 4.4 m-85 -162.57 164.07 17.23 Favored Pre-proline 0 N--CA 1.47 0.546 0 C-N-CA 122.543 0.337 . . . . 0.0 111.119 -177.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.478 ' HD3' ' HD1' ' A' ' 286' ' ' PHE . 31.4 Cg_endo -95.39 168.11 1.45 Allowed 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 123.464 2.776 . . . . 0.0 114.144 -175.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.846 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 7.2 t80 -76.28 -17.71 59.33 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.748 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 35.8 p -45.61 -37.98 6.14 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -174.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . 0.867 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 0.8 OUTLIER -132.61 48.39 2.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.141 0.496 . . . . 0.0 112.32 -174.432 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 27.7 m -142.75 151.78 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.773 173.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.499 ' O ' ' HB3' ' A' ' 241' ' ' ARG . 21.2 mmt180 -128.83 109.39 11.24 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 176.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . 0.501 ' HB3' ' HA ' ' A' ' 240' ' ' ALA . 0.2 OUTLIER -116.7 144.07 44.88 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -162.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.541 ' O ' ' HB ' ' A' ' 238' ' ' ILE . 4.5 mp -86.97 171.11 11.02 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 113.461 -1.7 . . . . 0.0 108.8 169.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.414 ' OD1' ' HG2' ' A' ' 297' ' ' GLN . 4.3 t70 -76.35 168.27 20.36 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.778 0.799 . . . . 0.0 111.887 -163.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.641 ' HB3' HG23 ' A' ' 238' ' ' ILE . 6.0 pt20 -100.73 -5.72 26.04 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.594 -175.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.414 ' HG2' ' OD1' ' A' ' 295' ' ' ASP . 17.3 pt20 -89.18 -0.41 57.43 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 174.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 CA--C 1.531 0.224 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.221 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . 0.455 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . . . . . . 0 N--CA 1.443 -0.859 0 N-CA-C 112.088 -0.405 . . . . 0.0 112.088 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.455 ' HD3' ' HA2' ' A' ' 236' ' ' GLY . 5.1 Cg_exo -78.54 142.28 18.27 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.44 2.093 . . . . 0.0 111.612 175.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 0.921 HG22 ' HB ' ' A' ' 266' ' ' VAL . 0.1 OUTLIER -105.92 142.55 18.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.971 -173.26 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.758 ' HB3' HD12 ' A' ' 263' ' ' LEU . 76.7 m-85 -96.81 117.04 30.21 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 174.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.509 ' HB2' HD21 ' A' ' 293' ' ' LEU . . . -114.68 117.19 30.13 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.424 -173.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.588 ' HB3' ' O ' ' A' ' 292' ' ' ARG . 23.8 tpp180 -83.12 103.18 12.35 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.316 -177.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . 1.008 HG22 ' HD3' ' A' ' 245' ' ' LYS . 3.7 p -81.86 128.79 38.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.258 -175.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.595 HD11 ' HB2' ' A' ' 244' ' ' GLN . 2.8 pp -107.33 7.43 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.344 -176.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.595 ' HB2' HD11 ' A' ' 243' ' ' ILE . 13.5 mt-30 -176.35 95.43 0.05 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.522 -173.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 1.008 ' HD3' HG22 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -146.09 163.32 35.68 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.118 0.485 . . . . 0.0 110.353 173.044 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.845 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 12.6 ptp180 -104.3 -177.08 3.26 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.344 -177.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 6.9 m -104.21 80.23 0.43 Allowed Pre-proline 0 CA--C 1.54 0.57 0 CA-C-O 121.522 0.677 . . . . 0.0 111.828 175.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.897 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 9.1 Cg_endo -92.93 176.67 1.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 125.167 3.911 . . . . 0.0 111.545 176.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -126.85 175.47 8.01 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.573 ' O ' HG21 ' A' ' 254' ' ' THR . . . -68.03 -0.99 5.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.4 175.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -114.93 14.83 17.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.431 0.634 . . . . 0.0 110.011 173.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -104.56 56.54 0.71 Allowed 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 173.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . 0.488 ' HA ' ' HE2' ' A' ' 253' ' ' LYS . 11.1 mmpt? 65.63 22.62 11.67 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.813 -169.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' THR . . . . . 0.573 HG21 ' O ' ' A' ' 250' ' ' ALA . 29.1 p 59.26 75.54 0.4 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.488 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.681 ' HB3' ' CE2' ' A' ' 286' ' ' PHE . . . -125.32 159.06 32.67 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.163 -176.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.583 HD23 ' O ' ' A' ' 277' ' ' GLY . 4.6 mm? -78.99 124.84 28.65 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.074 -0.967 . . . . 0.0 112.598 -176.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.897 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -83.03 93.17 7.52 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.338 0.589 . . . . 0.0 110.72 172.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.59 ' CD1' ' HE2' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -156.97 171.95 19.55 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.992 -1.003 . . . . 0.0 109.486 -177.508 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.474 ' O ' HG11 ' A' ' 242' ' ' VAL . 11.9 pt-20 -141.38 -163.87 1.65 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 118.488 0.586 . . . . 0.0 112.018 -167.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.42 HG21 ' HA ' ' A' ' 244' ' ' GLN . 75.3 t -67.08 118.27 10.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.024 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 105.69 -2.18 39.15 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.606 171.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.52 ' O ' ' HD3' ' A' ' 241' ' ' ARG . 7.9 mt-10 -91.85 -179.46 5.32 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.824 0.345 . . . . 0.0 110.92 -172.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.758 HD12 ' HB3' ' A' ' 239' ' ' TYR . 41.1 tp -129.22 161.06 31.03 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.981 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.536 ' N ' ' HG ' ' A' ' 263' ' ' LEU . 2.4 p -151.15 132.31 4.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.944 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -93.19 97.98 10.99 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 177.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.921 ' HB ' HG22 ' A' ' 238' ' ' ILE . 97.8 t -69.8 119.3 15.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.498 -178.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 73.7 p -102.2 -25.57 13.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.751 -175.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 2.4 tppp? -108.56 106.04 15.94 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 173.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.546 HD11 ' N ' ' A' ' 269' ' ' ILE . 0.1 OUTLIER -109.77 148.07 13.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -167.022 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.761 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 1.9 p30 -135.85 -170.76 2.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.688 176.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.07 -21.25 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 120.54 -0.464 . . . . 0.0 112.082 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.4 m -79.2 -44.26 22.23 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -174.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 126.02 -11.3 7.35 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.411 -177.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.504 HE21 ' C ' ' A' ' 274' ' ' GLN . 0.0 OUTLIER -91.33 107.79 19.45 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 174.196 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.761 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -147.72 -179.87 7.2 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -173.004 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.616 ' HG2' ' HB3' ' A' ' 285' ' ' HIS . 35.0 mt-10 -97.29 126.05 42.27 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.148 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.583 ' O ' HD23 ' A' ' 256' ' ' LEU . . . -110.68 156.42 15.57 Favored Glycine 0 N--CA 1.437 -1.242 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.717 -173.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 33.7 tt0 -135.21 119.69 18.03 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 172.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 45.6 t -109.72 97.1 6.71 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.922 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 34.4 56.52 0.67 Allowed 'General case' 0 N--CA 1.464 0.263 0 O-C-N 124.873 1.358 . . . . 0.0 112.479 176.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.36 -34.63 4.59 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.881 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 49.5 mttt -82.15 129.7 34.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.954 0.877 . . . . 0.0 110.874 178.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -113.07 148.29 35.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.026 0.441 . . . . 0.0 111.502 176.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 166.38 -150.42 17.59 Favored Glycine 0 C--O 1.225 -0.459 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.554 174.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' HIS . . . . . 0.616 ' HB3' ' HG2' ' A' ' 276' ' ' GLU . 30.1 p80 -149.74 157.22 43.01 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.59 0.695 . . . . 0.0 111.68 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.703 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 2.4 m-85 -163.3 158.78 18.0 Favored Pre-proline 0 C--N 1.331 -0.227 0 O-C-N 123.563 0.54 . . . . 0.0 110.479 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.479 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 10.7 Cg_endo -89.09 158.92 5.78 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.187 2.591 . . . . 0.0 111.938 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.4 ' HA ' HG22 ' A' ' 291' ' ' VAL . 3.0 p90 -83.97 -5.26 59.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.562 -176.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 11.1 t -54.83 -13.06 0.92 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . 0.535 ' NE2' ' HD2' ' A' ' 245' ' ' LYS . 0.6 OUTLIER -137.71 47.0 2.07 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.113 -0.367 . . . . 0.0 111.564 -179.635 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.752 HG11 ' HA ' ' A' ' 242' ' ' VAL . 35.6 m -147.36 170.26 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.39 0.614 . . . . 0.0 111.61 177.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.588 ' O ' ' HB3' ' A' ' 241' ' ' ARG . 16.3 tpp180 -129.35 110.16 11.69 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 171.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . 0.509 HD21 ' HB2' ' A' ' 240' ' ' ALA . 2.9 mt -91.31 140.64 29.59 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -163.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.44 HD11 ' N ' ' A' ' 294' ' ' LEU . 3.9 mp -98.05 125.28 42.95 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 163.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -75.76 156.22 34.8 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 122.157 0.98 . . . . 0.0 111.373 -164.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.402 ' H ' ' HG2' ' A' ' 296' ' ' GLN . 6.4 pt20 -77.59 -18.04 57.23 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.617 -1.629 . . . . 0.0 111.116 -175.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -85.21 -10.24 56.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.21 0.528 . . . . 0.0 109.712 171.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 12.4 m120 . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.636 -179.591 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . 0.561 ' N ' ' HD2' ' A' ' 237' ' ' PRO . . . . . . . . 0 CA--C 1.521 0.451 0 CA-C-O 120.136 -0.258 . . . . 0.0 112.495 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.718 ' HB3' ' HA ' ' A' ' 267' ' ' THR . 4.2 Cg_exo -39.99 147.73 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 124.9 3.733 . . . . 0.0 113.271 173.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 0.726 HD11 ' HB ' ' A' ' 266' ' ' VAL . 0.1 OUTLIER -84.07 151.55 3.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 120.996 0.427 . . . . 0.0 111.095 -170.611 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.454 ' HB3' HD12 ' A' ' 263' ' ' LEU . 57.6 m-85 -103.96 119.62 39.32 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 175.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.642 ' HA ' ' HA ' ' A' ' 293' ' ' LEU . . . -113.46 118.33 34.21 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.336 0.589 . . . . 0.0 111.154 -171.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.412 ' HB3' ' O ' ' A' ' 292' ' ' ARG . 20.9 tpp180 -78.0 102.34 7.34 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.637 176.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . 0.632 HG22 ' HB2' ' A' ' 245' ' ' LYS . 3.2 p -80.94 124.96 39.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.609 -176.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' A' ' 244' ' ' GLN . 2.8 pp -105.44 8.58 9.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.588 -174.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.76 ' HA ' HG21 ' A' ' 260' ' ' VAL . 17.1 mt-30 -176.17 95.39 0.06 Allowed 'General case' 0 CA--C 1.515 -0.369 0 O-C-N 123.296 0.372 . . . . 0.0 110.347 -173.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.757 ' HG2' ' CD1' ' A' ' 258' ' ' LEU . 0.0 OUTLIER -146.72 163.56 35.55 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.603 0.716 . . . . 0.0 111.663 176.298 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.89 ' HG3' ' HG3' ' A' ' 248' ' ' PRO . 2.4 ptm180 -108.5 -173.3 2.24 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.175 -1.375 . . . . 0.0 109.303 -176.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 37.7 t -108.39 75.67 0.6 Allowed Pre-proline 0 CA--C 1.537 0.443 0 CA-C-O 121.523 0.678 . . . . 0.0 110.175 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.939 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 9.6 Cg_endo -95.0 132.45 0.57 Allowed 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 125.187 3.924 . . . . 0.0 111.768 178.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.414 ' C ' ' H ' ' A' ' 251' ' ' TYR . 3.6 m-20 -89.53 175.81 7.14 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.772 0.32 . . . . 0.0 110.423 -176.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -71.12 4.02 3.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.608 0.718 . . . . 0.0 110.669 177.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.414 ' H ' ' C ' ' A' ' 249' ' ' ASN . 26.5 m-85 -107.04 8.95 30.63 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.097 176.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 249' ' ' ASN . 0.7 OUTLIER -96.88 51.97 1.16 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.005 175.274 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.93 25.7 14.89 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -166.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 22.4 p 65.61 88.08 0.11 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.819 1.248 . . . . 0.0 110.0 -174.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.629 ' HB1' ' HB2' ' A' ' 248' ' ' PRO . . . -122.0 168.32 12.06 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.066 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.668 ' H ' ' HE2' ' A' ' 286' ' ' PHE . 4.3 mm? -94.86 118.44 31.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.526 -176.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.939 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -85.64 97.26 10.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.54 0.686 . . . . 0.0 110.115 176.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.757 ' CD1' ' HG2' ' A' ' 245' ' ' LYS . 0.2 OUTLIER -156.12 176.42 12.69 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.49 -174.471 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.547 ' HG2' ' N ' ' A' ' 260' ' ' VAL . 24.5 tt0 -142.67 173.79 11.23 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.584 -0.698 . . . . 0.0 111.705 -161.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' A' ' 244' ' ' GLN . 69.5 t -56.35 118.2 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 C-N-CA 123.241 0.616 . . . . 0.0 111.443 173.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 104.83 -2.38 41.64 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.805 173.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.427 ' OE2' ' HB3' ' A' ' 259' ' ' GLU . 14.4 mt-10 -97.14 -173.16 2.6 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.023 -174.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.454 HD12 ' HB3' ' A' ' 239' ' ' TYR . 12.4 tp -127.83 157.77 39.55 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.039 0.447 . . . . 0.0 110.685 -176.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.599 HG12 ' HB3' ' A' ' 240' ' ' ALA . 7.7 p -144.09 143.41 23.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 175.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -103.87 95.24 5.88 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.726 ' HB ' HD11 ' A' ' 238' ' ' ILE . 74.8 t -74.39 105.64 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-O 121.94 0.876 . . . . 0.0 110.566 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' THR . . . . . 0.718 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 5.3 t -93.93 -9.34 37.4 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 113.264 -1.789 . . . . 0.0 110.678 -174.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 14.8 tppt? -122.53 106.18 10.78 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 172.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.533 HD11 ' O ' ' A' ' 269' ' ' ILE . 0.7 OUTLIER -106.78 153.21 8.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -166.66 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.758 HD21 ' HB3' ' A' ' 275' ' ' TRP . 2.0 p30 -147.14 177.01 9.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.057 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 9.7 p -89.91 -23.39 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -176.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.63 -1.05 51.02 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -175.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . 0.783 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 78.31 8.7 87.43 Favored Glycine 0 C--O 1.223 -0.532 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.983 177.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.49 ' N ' HD22 ' A' ' 270' ' ' ASN . 19.3 mm-40 -93.29 73.25 4.56 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.758 ' HB3' HD21 ' A' ' 270' ' ' ASN . 0.0 OUTLIER -124.25 -179.41 4.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.507 0.67 . . . . 0.0 112.612 -166.554 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.701 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 32.0 mt-10 -104.32 125.74 50.82 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.584 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.584 ' O ' HD23 ' A' ' 256' ' ' LEU . . . -103.51 156.1 17.82 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.25 -173.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.528 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 20.0 tt0 -138.55 118.34 13.19 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 175.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . 0.617 ' SG ' ' HD3' ' A' ' 282' ' ' LYS . 26.6 p -102.48 97.12 7.4 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.419 -0.912 . . . . 0.0 109.635 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 12.0 m120 39.45 56.69 2.21 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.438 -1.256 . . . . 0.0 112.323 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 115.92 -39.87 2.6 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.646 -0.788 . . . . 0.0 114.136 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . 0.617 ' HD3' ' SG ' ' A' ' 279' ' ' CYS . 5.9 mptt -76.58 129.16 36.03 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 118.144 0.972 . . . . 0.0 110.414 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.39 131.06 54.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.606 -176.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -167.78 -151.18 6.88 Favored Glycine 0 C--O 1.224 -0.49 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.228 174.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' HIS . . . . . 0.701 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 16.8 p80 -150.56 147.91 28.03 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 117.122 0.461 . . . . 0.0 111.187 -177.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.668 ' HE2' ' H ' ' A' ' 256' ' ' LEU . 4.5 m-85 -157.84 160.18 30.12 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 120.728 0.299 . . . . 0.0 111.69 -177.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.547 ' HD2' ' HE2' ' A' ' 290' ' ' HIS . 94.2 Cg_endo -95.19 155.24 1.69 Allowed 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 123.342 2.694 . . . . 0.0 114.005 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.783 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 20.0 t80 -66.29 -21.39 66.27 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 114.221 -1.354 . . . . 0.0 112.514 -176.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 9.2 t -57.77 -20.73 37.33 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 -168.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . 0.547 ' HE2' ' HD2' ' A' ' 287' ' ' PRO . 1.0 OUTLIER -136.36 37.61 2.71 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.952 -0.468 . . . . 0.0 111.9 -175.181 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 32.8 m -141.05 151.0 19.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.253 175.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.412 ' O ' ' HB3' ' A' ' 241' ' ' ARG . 14.1 mmm180 -121.68 108.06 13.1 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 173.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 240' ' ' ALA . 0.0 OUTLIER -101.21 137.1 40.01 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -167.553 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.458 HD11 ' N ' ' A' ' 294' ' ' LEU . 4.3 mp -77.23 121.36 23.56 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 162.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.67 ' HB3' ' HG2' ' A' ' 297' ' ' GLN . 23.2 t70 -87.76 157.05 19.14 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.807 -161.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -75.58 5.83 5.52 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.99 -1.459 . . . . 0.0 111.214 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.67 ' HG2' ' HB3' ' A' ' 295' ' ' ASP . 0.0 OUTLIER -66.05 -42.14 89.9 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 168.223 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . 0.501 ' N ' ' HG3' ' A' ' 297' ' ' GLN . 55.5 t-20 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.76 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . 0.469 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . . . . . . 0 N--CA 1.448 -0.559 0 N-CA-C 111.864 -0.495 . . . . 0.0 111.864 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.469 ' HD3' ' HA2' ' A' ' 236' ' ' GLY . 9.1 Cg_exo -71.08 127.86 14.09 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 123.054 2.502 . . . . 0.0 111.856 -178.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 0.906 HG22 ' HB ' ' A' ' 266' ' ' VAL . 0.0 OUTLIER -91.79 131.04 39.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.951 -177.469 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -97.55 120.22 37.53 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 176.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.845 ' HB1' HD13 ' A' ' 238' ' ' ILE . . . -116.02 118.13 32.05 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.366 -174.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 292' ' ' ARG . 0.0 OUTLIER -78.88 100.94 7.43 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 174.601 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . 0.765 HG22 ' HB2' ' A' ' 245' ' ' LYS . 9.8 p -81.08 115.48 23.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 119.192 -1.003 . . . . 0.0 109.932 -176.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.486 HD11 ' HB2' ' A' ' 244' ' ' GLN . 2.8 pp -97.99 2.97 10.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.113 -174.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.774 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 56.1 tp60 -176.59 93.17 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.032 -174.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.765 ' HB2' HG22 ' A' ' 242' ' ' VAL . 0.5 OUTLIER -147.16 166.21 27.66 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.202 0.525 . . . . 0.0 110.026 173.114 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.781 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 6.2 ptm180 -102.25 -178.59 3.74 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.548 -174.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 43.5 t -107.73 80.6 1.0 Allowed Pre-proline 0 CA--C 1.536 0.415 0 CA-C-O 121.233 0.54 . . . . 0.0 111.011 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.843 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 9.9 Cg_endo -93.96 168.03 2.02 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 124.606 3.537 . . . . 0.0 111.339 174.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -123.3 178.24 5.22 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.02 0.438 . . . . 0.0 110.426 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.683 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -61.83 -2.23 0.81 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.571 174.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -100.99 -2.46 31.66 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.182 0.515 . . . . 0.0 110.543 176.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -105.6 65.45 0.71 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -177.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . 0.669 ' HA ' ' HE3' ' A' ' 253' ' ' LYS . 0.0 OUTLIER 61.2 19.7 10.31 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.587 -171.772 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' THR . . . . . 0.683 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 30.5 p 56.63 64.44 1.67 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.723 -175.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.504 ' HB3' ' CE2' ' A' ' 286' ' ' PHE . . . -109.55 154.65 22.44 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.272 -0.877 . . . . 0.0 111.006 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.706 ' HB3' HD21 ' A' ' 258' ' ' LEU . 0.2 OUTLIER -69.03 132.91 47.39 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.606 -175.643 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.843 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -85.52 93.25 8.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.346 0.593 . . . . 0.0 109.546 168.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.706 HD21 ' HB3' ' A' ' 256' ' ' LEU . 0.5 OUTLIER -142.14 160.92 39.26 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.292 -175.013 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.589 ' O ' HG11 ' A' ' 242' ' ' VAL . 37.4 tt0 -142.29 173.66 11.33 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.887 -165.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.546 HG23 ' HA ' ' A' ' 244' ' ' GLN . 47.3 t -56.15 117.79 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-O 121.267 0.556 . . . . 0.0 112.162 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 95.67 0.93 62.21 Favored Glycine 0 CA--C 1.505 -0.591 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.0 172.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -87.41 164.52 16.16 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.51 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.52 ' HG ' ' N ' ' A' ' 264' ' ' VAL . 16.6 tp -121.32 152.56 38.82 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.721 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.698 HG12 ' HB2' ' A' ' 279' ' ' CYS . 15.0 m -141.81 166.34 17.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -132.42 97.21 4.04 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.906 ' HB ' HG22 ' A' ' 238' ' ' ILE . 46.1 t -68.95 128.24 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.732 -176.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 11.6 p -100.03 -18.86 16.81 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 113.722 -1.581 . . . . 0.0 111.852 -173.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -127.73 106.4 9.11 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 121.459 0.647 . . . . 0.0 109.762 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 1.009 HG23 HE22 ' A' ' 296' ' ' GLN . 0.0 OUTLIER -98.21 154.48 3.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.604 -167.073 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.712 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 0.4 OUTLIER -146.43 -169.65 3.32 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.515 178.802 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 12.7 p -98.34 -35.04 4.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.961 -177.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 3.5 m -68.84 -44.61 73.06 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -174.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . 0.411 ' HA3' ' CD1' ' A' ' 288' ' ' PHE . . . 121.83 -5.98 10.47 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.316 -176.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.574 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.0 OUTLIER -96.01 70.73 2.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.791 0.805 . . . . 0.0 110.351 176.479 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.712 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -102.32 173.33 6.41 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.615 -172.265 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.733 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 33.3 tt0 -93.39 123.74 36.9 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.524 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -103.08 151.43 17.96 Favored Glycine 0 N--CA 1.437 -1.253 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.27 -171.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -129.12 119.51 24.26 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 173.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . 0.698 ' HB2' HG12 ' A' ' 264' ' ' VAL . 44.7 t -114.04 97.1 6.17 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.566 -177.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 28.84 61.31 0.13 Allowed 'General case' 0 N--CA 1.466 0.375 0 O-C-N 124.967 1.417 . . . . 0.0 112.564 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.58 -38.63 2.96 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 115.724 -0.671 . . . . 0.0 113.268 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -80.61 146.63 31.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.297 0.548 . . . . 0.0 110.52 177.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 39.8 mtt180 -132.4 129.78 39.78 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.012 0.434 . . . . 0.0 110.033 170.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . 0.631 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . -173.81 142.1 6.36 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.006 -177.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' HIS . . . . . 0.733 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 14.7 p80 -91.92 148.03 22.52 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 117.908 0.854 . . . . 0.0 111.681 -175.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.814 ' HD1' ' HD3' ' A' ' 287' ' ' PRO . 3.2 m-85 -165.03 170.12 6.73 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -174.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.814 ' HD3' ' HD1' ' A' ' 286' ' ' PHE . 58.1 Cg_endo -100.84 156.94 0.42 Allowed 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 123.306 2.67 . . . . 0.0 112.856 -174.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.411 ' CD1' ' HA3' ' A' ' 273' ' ' GLY . 0.7 OUTLIER -87.16 -8.85 56.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.076 -177.872 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.544 HG21 ' HB2' ' A' ' 287' ' ' PRO . 10.0 t -55.79 -32.65 63.68 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.84 -178.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . 0.774 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 0.5 OUTLIER -119.98 55.13 1.0 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.585 0.707 . . . . 0.0 111.365 175.363 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.446 HG13 ' HA ' ' A' ' 242' ' ' VAL . 10.6 m -147.17 171.96 3.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.811 170.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.472 ' O ' ' HB2' ' A' ' 241' ' ' ARG . 14.5 tpt180 -122.66 108.88 13.58 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 171.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . 0.45 HD23 ' CZ2' ' A' ' 275' ' ' TRP . 6.1 tp -84.62 123.55 30.46 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 115.231 -0.895 . . . . 0.0 113.37 -164.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 6.6 mt -88.31 132.96 34.2 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 169.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' A' ' 297' ' ' GLN . 31.1 t70 -74.72 136.27 41.79 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 122.097 0.951 . . . . 0.0 111.903 -163.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 1.009 HE22 HG23 ' A' ' 269' ' ' ILE . 9.3 pt20 -77.47 -1.95 32.97 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.569 -1.65 . . . . 0.0 112.366 -172.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.466 ' HB2' ' OD2' ' A' ' 295' ' ' ASP . 7.8 mt-30 -94.25 1.16 56.02 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 171.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 16.6 m120 . . . . . 0 CA--C 1.536 0.431 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.436 173.401 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.28 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.959 ' HB3' ' HA ' ' A' ' 267' ' ' THR . 4.5 Cg_exo -41.67 134.62 3.55 Favored 'Trans proline' 0 C--O 1.238 0.487 0 C-N-CA 124.112 3.208 . . . . 0.0 111.92 169.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 1.049 HG12 HG23 ' A' ' 266' ' ' VAL . 0.8 OUTLIER -78.73 160.77 4.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.016 -167.3 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.686 ' HB3' HD12 ' A' ' 263' ' ' LEU . 86.7 m-85 -108.5 118.75 37.58 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 174.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.582 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -113.77 118.49 34.42 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.165 0.507 . . . . 0.0 111.021 -174.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.403 ' HB3' ' O ' ' A' ' 292' ' ' ARG . 15.1 tpp180 -81.6 103.73 11.52 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . 1.0 HG22 ' HD2' ' A' ' 245' ' ' LYS . 5.6 p -86.01 130.74 36.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.986 -175.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.484 ' O ' HG13 ' A' ' 260' ' ' VAL . 2.8 pp -106.83 8.8 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.704 -174.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.749 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 63.3 tt0 -177.8 94.06 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -173.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 1.045 ' HD3' HD13 ' A' ' 258' ' ' LEU . 11.0 mttt -145.57 161.84 38.85 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 175.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.836 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 13.2 ptt180 -107.59 -176.31 3.03 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.875 -172.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 7.0 p -104.13 78.83 0.34 Allowed Pre-proline 0 CA--C 1.547 0.848 0 CA-C-O 121.812 0.815 . . . . 0.0 111.533 175.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.917 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 1.7 Cg_endo -88.99 177.95 2.81 Favored 'Trans proline' 0 N--CA 1.459 -0.537 1 C-N-CA 125.303 4.002 . . . . 0.0 110.654 174.436 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.458 ' C ' ' H ' ' A' ' 251' ' ' TYR . 27.7 m-80 -130.16 170.65 13.79 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.045 0.45 . . . . 0.0 109.913 177.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.69 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -76.4 14.87 0.68 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.568 0.699 . . . . 0.0 110.544 178.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.458 ' H ' ' C ' ' A' ' 249' ' ' ASN . 37.2 m-85 -110.92 1.89 17.83 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.844 175.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -95.6 49.19 1.17 Allowed 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.72 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt 60.42 33.99 20.63 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -166.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' THR . . . . . 0.69 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 71.5 p 59.55 77.63 0.3 Allowed 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 113.728 -1.578 . . . . 0.0 111.864 -178.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.404 ' C ' ' HA3' ' A' ' 284' ' ' GLY . . . -112.44 154.79 25.29 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.714 176.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 1.089 HD13 ' HG ' ' A' ' 258' ' ' LEU . 0.0 OUTLIER -83.73 133.64 34.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.255 -174.46 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.917 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -91.03 101.24 14.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.346 0.593 . . . . 0.0 109.591 171.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 1.089 ' HG ' HD13 ' A' ' 256' ' ' LEU . 0.1 OUTLIER -158.1 169.53 24.32 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.746 -174.864 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.446 ' HG2' ' N ' ' A' ' 260' ' ' VAL . 32.0 tt0 -142.16 173.21 11.73 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 121.902 -0.499 . . . . 0.0 112.048 -160.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.711 HG21 ' HA ' ' A' ' 244' ' ' GLN . 53.9 t -55.11 118.3 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 C-N-CA 123.364 0.665 . . . . 0.0 111.537 175.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 102.73 -1.69 48.84 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.644 -0.582 . . . . 0.0 111.644 172.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -95.94 173.23 7.54 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.711 -173.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.686 HD12 ' HB3' ' A' ' 239' ' ' TYR . 40.1 tp -117.27 157.62 25.75 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.326 0.584 . . . . 0.0 111.059 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.582 HG13 ' HB3' ' A' ' 240' ' ' ALA . 2.6 p -152.31 119.19 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.139 -177.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.436 ' HE3' ' HG2' ' A' ' 237' ' ' PRO . 54.7 tttp -86.9 97.34 10.62 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.572 177.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 1.049 HG23 HG12 ' A' ' 238' ' ' ILE . 7.0 m -77.23 114.4 17.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.892 0.853 . . . . 0.0 109.988 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' THR . . . . . 0.959 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 9.7 t -96.93 4.39 51.61 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.06 -174.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.539 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 0.0 OUTLIER -132.48 107.52 8.53 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 169.797 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.658 HG23 HG21 ' A' ' 238' ' ' ILE . 0.8 OUTLIER -111.12 156.37 12.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 114.961 -1.018 . . . . 0.0 113.355 -170.25 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.761 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 0.1 OUTLIER -146.13 -161.1 1.24 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.938 -1.483 . . . . 0.0 109.195 178.357 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.04 -23.3 4.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.888 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 3.0 m -65.62 -44.62 85.94 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -175.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . 0.621 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 124.03 -21.89 6.87 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.127 -177.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.601 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.3 OUTLIER -89.76 102.77 15.47 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 173.057 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.761 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -134.6 174.92 10.02 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.067 -177.071 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 44.4 tt0 -91.14 125.46 35.92 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.591 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -105.03 155.84 16.99 Favored Glycine 0 N--CA 1.437 -1.289 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.549 -175.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 30.8 tt0 -139.27 119.86 14.08 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 176.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 49.0 t -108.5 98.44 7.96 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 46.51 46.17 14.16 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.378 176.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 115.59 -39.34 2.78 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.385 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 55.3 mttt -69.96 130.87 43.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.237 0.518 . . . . 0.0 109.711 177.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 36.1 mtt180 -113.67 129.67 56.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.12 0.486 . . . . 0.0 110.969 176.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . 0.547 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . -170.18 142.82 7.44 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.995 -178.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' HIS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 25.3 p80 -99.56 148.73 23.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 117.265 0.533 . . . . 0.0 111.172 -171.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.638 ' CG ' ' HE2' ' A' ' 245' ' ' LYS . 5.8 m-85 -159.26 158.96 28.83 Favored Pre-proline 0 CA--C 1.533 0.289 0 O-C-N 123.469 0.48 . . . . 0.0 110.796 -176.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.601 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 97.2 Cg_endo -91.58 169.88 3.1 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.919 2.413 . . . . 0.0 113.909 -175.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.621 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 9.8 t80 -75.87 -13.18 60.27 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.554 -175.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 25.4 p -48.24 -29.36 3.72 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -174.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . 0.749 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 1.3 p-80 -136.9 39.84 2.55 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.779 0.323 . . . . 0.0 111.586 -171.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.493 HG21 ' HB2' ' A' ' 240' ' ' ALA . 3.1 p -141.78 150.81 19.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 119.454 -0.899 . . . . 0.0 112.53 -175.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.403 ' O ' ' HB3' ' A' ' 241' ' ' ARG . 30.0 mmm180 -130.39 108.89 10.32 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . 0.579 HD23 ' CE2' ' A' ' 288' ' ' PHE . 0.4 OUTLIER -120.09 145.34 46.98 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -163.799 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 4.7 mp -80.12 124.51 28.83 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 113.677 -1.601 . . . . 0.0 107.553 168.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.444 ' OD1' ' HG2' ' A' ' 297' ' ' GLN . 9.1 t70 -83.27 152.74 25.01 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.587 -165.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.61 ' HB3' HG22 ' A' ' 238' ' ' ILE . 7.7 pt20 -75.15 -8.27 56.11 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.266 -1.334 . . . . 0.0 112.047 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.46 HE21 ' HB2' ' A' ' 297' ' ' GLN . 1.6 pt20 -78.18 -22.98 47.82 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.16 172.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.233 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . 0.658 ' N ' ' HD2' ' A' ' 237' ' ' PRO . . . . . . . . 0 N--CA 1.46 0.297 0 N-CA-C 112.585 -0.206 . . . . 0.0 112.585 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.665 ' HB3' ' HA ' ' A' ' 267' ' ' THR . 7.6 Cg_exo -38.72 141.79 0.32 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 125.086 3.857 . . . . 0.0 113.438 171.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 1.04 HG12 HG23 ' A' ' 266' ' ' VAL . 0.6 OUTLIER -80.59 160.17 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.987 -171.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.843 ' HD1' HD13 ' A' ' 263' ' ' LEU . 64.5 m-85 -104.23 120.48 41.25 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 173.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.764 ' HB3' HG12 ' A' ' 264' ' ' VAL . . . -113.65 116.97 30.3 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.309 -176.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 241' ' ' ARG . 0.0 OUTLIER -81.65 101.03 9.78 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.766 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . 0.736 ' CG2' ' HD3' ' A' ' 245' ' ' LYS . 3.4 p -78.33 122.3 33.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 119.931 -0.708 . . . . 0.0 110.116 -176.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.538 HG23 ' HG2' ' A' ' 292' ' ' ARG . 2.8 pp -110.12 6.46 8.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.516 -174.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.717 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 58.7 tt0 -176.3 94.55 0.05 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.081 -175.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.833 ' HE2' HD22 ' A' ' 258' ' ' LEU . 0.2 OUTLIER -147.07 168.0 22.67 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 122.008 0.909 . . . . 0.0 111.613 178.302 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.849 ' HG3' ' HG3' ' A' ' 248' ' ' PRO . 12.3 ptm180 -108.47 -176.4 3.04 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.787 -1.552 . . . . 0.0 109.717 -173.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 19.0 t -108.28 75.33 0.56 Allowed Pre-proline 0 CA--C 1.54 0.589 0 CA-C-O 121.029 0.442 . . . . 0.0 110.997 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.949 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 5.7 Cg_endo -91.11 177.41 2.03 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 124.861 3.707 . . . . 0.0 110.712 176.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.484 ' C ' ' H ' ' A' ' 251' ' ' TYR . 10.9 m120 -135.18 175.34 9.67 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.766 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -69.46 9.7 0.44 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.393 0.616 . . . . 0.0 111.269 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.484 ' H ' ' C ' ' A' ' 249' ' ' ASN . 18.9 m-85 -103.14 -4.01 25.05 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 176.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -105.28 67.96 0.79 Allowed 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.16 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . 0.46 ' HB2' ' HE2' ' A' ' 253' ' ' LYS . 2.6 mppt? 54.54 28.97 10.49 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -169.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' THR . . . . . 0.766 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 78.3 p 55.66 73.48 0.43 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.903 -174.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.571 ' C ' ' HA3' ' A' ' 284' ' ' GLY . . . -108.47 153.08 23.84 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.366 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.726 ' N ' ' HA3' ' A' ' 284' ' ' GLY . 0.2 OUTLIER -79.92 132.58 36.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.341 -173.083 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.949 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -92.22 100.98 13.49 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 173.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.833 HD22 ' HE2' ' A' ' 245' ' ' LYS . 0.6 OUTLIER -154.62 170.67 20.96 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.521 -174.658 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.439 ' O ' HG11 ' A' ' 242' ' ' VAL . 29.8 tt0 -142.98 169.55 17.36 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.704 0.288 . . . . 0.0 111.584 -165.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.407 ' N ' ' HG2' ' A' ' 259' ' ' GLU . 3.5 p -55.04 118.0 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.703 0.763 . . . . 0.0 112.351 176.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 105.23 -2.71 40.38 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 114.92 -1.037 . . . . 0.0 111.741 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -90.98 -179.9 5.58 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.832 -176.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.843 HD13 ' HD1' ' A' ' 239' ' ' TYR . 3.2 tm? -132.18 130.04 40.55 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.764 HG12 ' HB3' ' A' ' 240' ' ' ALA . 2.4 p -124.05 118.21 53.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.264 178.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 238' ' ' ILE . 78.8 tttt -87.27 97.06 10.58 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 1.04 HG23 HG12 ' A' ' 238' ' ' ILE . 5.0 m -77.11 122.93 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 121.87 0.843 . . . . 0.0 111.049 -175.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' THR . . . . . 0.665 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 49.5 p -91.8 -15.42 28.28 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.983 -174.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.562 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 0.0 OUTLIER -119.66 105.46 11.2 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.733 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.54 HG23 HG21 ' A' ' 238' ' ' ILE . 0.8 OUTLIER -106.46 159.54 6.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -170.235 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.722 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 3.5 p30 -145.59 -168.25 2.92 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.988 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 13.3 p -99.28 -32.27 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 120.616 -0.433 . . . . 0.0 112.004 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 11.7 m -78.62 -26.63 45.35 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -173.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . 0.62 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 105.35 4.25 40.8 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.364 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.778 ' N ' HE21 ' A' ' 274' ' ' GLN . 0.0 OUTLIER -97.07 81.14 3.03 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 176.82 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.722 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -122.93 168.42 12.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.19 -168.847 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.562 ' HB3' ' HB3' ' A' ' 268' ' ' LYS . 40.8 tt0 -90.42 126.06 35.77 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.111 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.652 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -108.7 159.05 14.36 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.303 -173.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 40.8 tt0 -140.94 120.15 12.94 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 172.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 34.6 t -114.62 96.89 5.97 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.349 -177.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 33.65 57.19 0.55 Allowed 'General case' 0 N--CA 1.465 0.28 0 O-C-N 124.615 1.197 . . . . 0.0 112.527 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.97 -39.27 2.72 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-N 115.705 -0.68 . . . . 0.0 113.351 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 0.2 OUTLIER -77.77 139.85 39.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.492 0.646 . . . . 0.0 109.943 178.621 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 12.4 mtm180 -124.25 129.2 50.35 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 175.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . 0.726 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . 177.72 145.97 6.11 Favored Glycine 0 C--O 1.225 -0.467 0 C-N-CA 120.09 -1.052 . . . . 0.0 113.58 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' HIS . . . . . 0.55 ' CB ' ' HA ' ' A' ' 276' ' ' GLU . 28.5 p80 -104.18 147.71 27.13 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.965 0.383 . . . . 0.0 111.423 -175.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.551 ' CZ ' ' HB3' ' A' ' 255' ' ' ALA . 12.4 m-85 -159.14 167.02 15.18 Favored Pre-proline 0 CA--C 1.535 0.397 0 O-C-N 123.271 0.357 . . . . 0.0 111.494 -175.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.455 ' HB2' HG22 ' A' ' 289' ' ' THR . 1.4 Cg_endo -86.25 153.99 9.46 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 123.514 2.809 . . . . 0.0 113.585 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.732 ' HE1' ' HG ' ' A' ' 293' ' ' LEU . 44.3 t80 -67.44 -23.28 65.51 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 114.374 -1.285 . . . . 0.0 112.477 -177.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.455 HG22 ' HB2' ' A' ' 287' ' ' PRO . 8.9 t -53.1 -29.36 30.27 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -168.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . 0.717 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 0.9 OUTLIER -122.16 53.43 1.23 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.612 0.72 . . . . 0.0 110.956 -179.684 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.515 ' O ' ' HD2' ' A' ' 292' ' ' ARG . 0.5 OUTLIER -147.24 158.74 9.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.129 176.912 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.538 ' HG2' HG23 ' A' ' 243' ' ' ILE . 21.1 mmm180 -121.69 109.49 14.8 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 173.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . 0.732 ' HG ' ' HE1' ' A' ' 288' ' ' PHE . 0.3 OUTLIER -91.07 127.19 36.4 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -161.396 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 239' ' ' TYR . 3.9 mt -91.05 121.67 33.05 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 167.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -79.04 147.43 32.83 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.903 0.858 . . . . 0.0 112.415 -163.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.887 ' HB3' HG22 ' A' ' 238' ' ' ILE . 0.6 OUTLIER -76.72 -6.15 50.98 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.775 -177.603 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -72.43 -30.22 64.41 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 173.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 15.1 m120 . . . . . 0 C--N 1.332 -0.159 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.633 179.171 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . 0.439 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . . . . . . 0 N--CA 1.446 -0.68 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.503 ' HD2' ' HB3' ' A' ' 298' ' ' ASN . 12.4 Cg_exo -69.06 132.22 23.97 Favored 'Trans proline' 0 C--N 1.33 -0.399 0 C-N-CA 122.977 2.451 . . . . 0.0 113.068 -176.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 0.713 ' HB ' ' HG3' ' A' ' 296' ' ' GLN . 0.0 OUTLIER -94.33 139.54 18.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 173.612 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.52 ' HB2' ' HB2' ' A' ' 294' ' ' LEU . 0.7 OUTLIER -99.28 143.94 28.96 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 172.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.726 ' HA ' ' HA ' ' A' ' 293' ' ' LEU . . . -136.03 116.97 14.22 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 118.781 -1.168 . . . . 0.0 110.548 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -85.9 102.0 13.35 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . 1.119 HG22 ' HD2' ' A' ' 245' ' ' LYS . 4.3 p -83.63 129.82 36.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.151 -173.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.9 pp -102.15 4.49 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.458 -175.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.549 ' HA ' HG21 ' A' ' 260' ' ' VAL . 10.1 tt0 -178.47 102.6 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.687 -175.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 1.119 ' HD2' HG22 ' A' ' 242' ' ' VAL . 8.1 mttt -145.72 162.33 37.84 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 175.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.884 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 7.9 ttt-85 -99.41 177.21 5.25 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 123.433 0.693 . . . . 0.0 109.462 -174.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.442 ' N ' ' CG ' ' A' ' 246' ' ' ARG . 9.4 m -100.85 75.94 0.14 Allowed Pre-proline 0 CA--C 1.548 0.883 0 CA-C-O 121.546 0.688 . . . . 0.0 111.787 172.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.884 ' HD3' ' O ' ' A' ' 246' ' ' ARG . 0.9 OUTLIER -90.52 175.49 2.69 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 125.212 3.941 . . . . 0.0 111.04 177.036 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.456 ' O ' ' HB2' ' A' ' 252' ' ' ASP . 11.5 m120 -128.22 175.73 8.22 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.949 0.404 . . . . 0.0 110.547 176.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.907 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -67.13 -11.22 56.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 122.127 0.965 . . . . 0.0 110.195 174.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -87.45 5.42 38.99 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.814 175.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 249' ' ' ASN . 3.0 m-20 -103.85 49.27 0.83 Allowed 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.168 177.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . 0.552 ' N ' ' HD2' ' A' ' 253' ' ' LYS . 0.0 OUTLIER 58.7 31.13 20.83 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -169.409 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' THR . . . . . 0.907 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 30.7 p 61.12 81.94 0.18 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 113.413 -1.721 . . . . 0.0 111.609 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.422 ' HB3' ' CE2' ' A' ' 286' ' ' PHE . . . -118.94 156.76 28.98 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.479 176.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.6 HD12 ' SG ' ' A' ' 279' ' ' CYS . 3.8 mm? -81.16 130.63 35.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.567 -175.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.823 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -89.99 97.76 11.38 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.438 0.637 . . . . 0.0 110.432 172.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.723 HD22 ' HD3' ' A' ' 245' ' ' LYS . 0.4 OUTLIER -159.79 171.89 18.67 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.275 -175.88 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.482 ' O ' HG11 ' A' ' 242' ' ' VAL . 12.4 pt-20 -143.53 -162.3 1.43 Allowed 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 119.822 -0.751 . . . . 0.0 112.865 -166.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.549 HG21 ' HA ' ' A' ' 244' ' ' GLN . 88.0 t -66.33 117.39 7.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.755 177.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 105.8 -1.27 38.9 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.85 171.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -91.58 -179.89 5.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.91 0.386 . . . . 0.0 111.399 -170.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.489 ' HG ' ' N ' ' A' ' 264' ' ' VAL . 38.2 tp -133.39 157.52 45.35 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.273 0.559 . . . . 0.0 111.314 -177.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.622 HG13 ' HB3' ' A' ' 240' ' ' ALA . 1.8 p -152.72 136.01 7.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.243 -177.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -98.49 96.8 8.24 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.67 ' HB ' HG22 ' A' ' 238' ' ' ILE . 52.0 t -68.63 117.92 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-O 121.205 0.526 . . . . 0.0 110.903 177.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 81.9 p -97.31 -19.2 18.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.422 -176.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.587 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 2.9 tppp? -116.97 107.08 14.13 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.771 HG22 HE21 ' A' ' 296' ' ' GLN . 0.6 OUTLIER -102.67 155.48 5.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -167.631 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.833 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 3.5 p30 -143.41 -178.53 5.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.275 174.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 8.9 p -82.53 -35.94 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -176.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 5.9 m -82.19 -43.33 17.81 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -172.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . 0.538 ' HA3' ' CD2' ' A' ' 288' ' ' PHE . . . 123.41 2.42 8.99 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.518 -178.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 1.0 OUTLIER -93.35 85.17 4.9 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 173.272 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.833 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -131.12 -179.79 5.54 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.89 -168.022 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.684 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 39.2 mt-10 -94.48 124.81 38.73 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.018 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.551 ' O ' HD23 ' A' ' 256' ' ' LEU . . . -106.67 145.34 15.94 Favored Glycine 0 N--CA 1.437 -1.267 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.334 -175.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 0.4 OUTLIER -124.14 118.73 27.55 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.023 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . 0.6 ' SG ' HD12 ' A' ' 256' ' ' LEU . 29.7 p -111.01 98.76 7.78 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.449 -174.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 4.9 m120 49.09 45.65 22.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.491 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 114.14 -17.08 19.81 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.689 -0.767 . . . . 0.0 114.27 175.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . 0.553 ' HD2' ' N ' ' A' ' 282' ' ' LYS . 5.4 mptt -99.93 133.8 43.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.733 0.766 . . . . 0.0 110.352 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.94 134.48 54.43 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.793 0.33 . . . . 0.0 111.375 -174.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -176.22 -146.46 5.99 Favored Glycine 0 C--O 1.225 -0.407 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' HIS . . . . . 0.684 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 24.8 p80 -148.82 151.45 34.77 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 117.562 0.681 . . . . 0.0 111.134 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.642 ' CG ' ' HE2' ' A' ' 245' ' ' LYS . 1.8 m-85 -164.72 153.83 11.45 Favored Pre-proline 0 CA--C 1.535 0.395 0 O-C-N 123.452 0.47 . . . . 0.0 110.829 -177.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.501 ' HD2' ' HD1' ' A' ' 286' ' ' PHE . 95.3 Cg_endo -90.77 173.35 3.02 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.057 2.504 . . . . 0.0 114.029 -174.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.538 ' CD2' ' HA3' ' A' ' 273' ' ' GLY . 16.2 t80 -82.92 -20.86 34.55 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 114.369 -1.287 . . . . 0.0 111.926 -170.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 12.9 t -68.62 1.78 2.93 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -167.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . 0.585 ' HD2' HG11 ' A' ' 291' ' ' VAL . 1.2 p-80 -147.25 33.71 0.89 Allowed 'General case' 0 C--N 1.33 -0.239 0 O-C-N 121.706 -0.621 . . . . 0.0 111.682 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.585 HG11 ' HD2' ' A' ' 290' ' ' HIS . 31.8 m -140.25 151.76 21.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.73 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -122.03 108.37 13.3 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 173.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . 0.726 ' HA ' ' HA ' ' A' ' 240' ' ' ALA . 0.0 OUTLIER -94.42 139.54 30.99 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -163.687 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.52 ' HB2' ' HB2' ' A' ' 239' ' ' TYR . 5.0 mt -79.12 165.7 23.05 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 113.948 -1.478 . . . . 0.0 107.21 167.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -71.25 133.66 46.25 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 122.964 1.364 . . . . 0.0 113.125 -157.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.771 HE21 HG22 ' A' ' 269' ' ' ILE . 58.5 tt0 -72.82 88.11 1.31 Allowed 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 111.895 -2.411 . . . . 0.0 111.245 -176.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 175.33 -34.95 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.086 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . 0.503 ' HB3' ' HD2' ' A' ' 237' ' ' PRO . 2.7 t-20 . . . . . 0 N--CA 1.465 0.312 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . 0.422 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . . . . . . 0 N--CA 1.447 -0.593 0 N-CA-C 112.945 -0.062 . . . . 0.0 112.945 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.472 ' HG2' ' HE3' ' A' ' 265' ' ' LYS . 16.7 Cg_exo -72.23 129.53 15.15 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.449 2.766 . . . . 0.0 112.536 177.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 0.722 HD11 ' CG2' ' A' ' 266' ' ' VAL . 0.0 OUTLIER -89.69 149.47 4.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.764 174.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.522 ' N ' HG12 ' A' ' 238' ' ' ILE . 20.2 m-85 -95.89 119.35 34.23 Favored 'General case' 0 C--O 1.208 -1.107 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.447 ' HB1' HD13 ' A' ' 238' ' ' ILE . . . -113.87 118.22 33.61 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.481 -171.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.31 101.38 8.89 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.067 178.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . 0.958 ' HA ' HG13 ' A' ' 291' ' ' VAL . 6.3 p -80.86 117.71 27.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.193 -176.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.559 ' O ' ' HG3' ' A' ' 244' ' ' GLN . 2.8 pp -105.15 0.61 10.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.013 -172.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.559 ' HG3' ' O ' ' A' ' 243' ' ' ILE . 57.5 mt-30 -172.25 94.08 0.14 Allowed 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -173.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.84 ' HG2' ' CD2' ' A' ' 258' ' ' LEU . 2.5 tptt -146.66 165.54 29.26 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.517 0.675 . . . . 0.0 111.453 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.764 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 2.7 ptm85 -102.23 -178.13 3.61 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.079 -1.418 . . . . 0.0 110.279 -173.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 21.9 t -110.48 72.46 0.72 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.333 0.587 . . . . 0.0 109.71 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 1.043 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 72.1 Cg_endo -95.54 175.82 0.92 Allowed 'Trans proline' 0 N--CA 1.441 -1.612 0 C-N-CA 124.135 3.223 . . . . 0.0 110.541 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -136.3 176.2 8.91 Favored 'General case' 0 C--N 1.314 -0.978 0 O-C-N 121.952 -0.467 . . . . 0.0 110.298 -177.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.751 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -61.55 -7.61 3.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.368 0.604 . . . . 0.0 111.001 172.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -95.51 -2.29 48.9 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.313 176.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -105.41 63.73 0.69 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? 56.94 30.75 18.59 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -169.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' THR . . . . . 0.751 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 44.5 p 52.49 62.94 2.44 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.323 -173.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.643 ' HB1' ' HB2' ' A' ' 248' ' ' PRO . . . -96.85 150.8 20.32 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.337 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.739 ' N ' ' HA3' ' A' ' 284' ' ' GLY . 0.4 OUTLIER -74.34 131.09 40.82 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.913 -179.016 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 1.043 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -90.56 104.5 17.07 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 175.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.84 ' CD2' ' HG2' ' A' ' 245' ' ' LYS . 0.6 OUTLIER -153.8 164.47 38.3 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.427 -175.144 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.574 ' O ' HG11 ' A' ' 242' ' ' VAL . 32.4 tt0 -142.3 174.66 10.42 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 120.578 0.228 . . . . 0.0 111.159 -165.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.47 HG21 ' HA ' ' A' ' 244' ' ' GLN . 88.3 t -57.12 117.7 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.373 0.606 . . . . 0.0 112.234 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 98.71 -2.1 58.5 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.507 170.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -84.38 175.88 9.07 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.33 -176.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.545 ' HG ' ' N ' ' A' ' 264' ' ' VAL . 17.0 tp -130.35 154.72 47.38 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.65 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.737 HG12 ' HB2' ' A' ' 279' ' ' CYS . 17.1 m -145.5 160.37 12.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.778 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.472 ' HE3' ' HG2' ' A' ' 237' ' ' PRO . 56.8 tttp -117.87 97.9 6.07 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 177.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.722 ' CG2' HD11 ' A' ' 238' ' ' ILE . 4.6 m -80.38 121.66 34.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.49 0.662 . . . . 0.0 110.345 -176.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 38.2 p -99.6 -5.09 29.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.853 -174.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.611 ' O ' ' HB3' ' A' ' 275' ' ' TRP . 1.3 tppp? -119.03 105.47 11.46 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 174.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.57 HD11 ' N ' ' A' ' 269' ' ' ILE . 0.2 OUTLIER -114.95 149.42 17.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.645 -166.736 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -144.14 -168.76 2.96 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.85 -174.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 28.7 m -100.88 -21.52 5.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.8 m -81.54 -45.39 15.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.776 0.322 . . . . 0.0 111.211 -175.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . 0.4 ' HA3' ' CD1' ' A' ' 288' ' ' PHE . . . 125.92 -8.37 7.66 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.655 -177.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.9 OUTLIER -90.56 105.04 17.55 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 173.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.611 ' HB3' ' O ' ' A' ' 268' ' ' LYS . 0.0 OUTLIER -115.57 173.46 6.52 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.706 0.765 . . . . 0.0 111.345 -175.464 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 268' ' ' LYS . 29.9 tt0 -96.65 124.28 40.59 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 165.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.415 ' O ' HD23 ' A' ' 256' ' ' LEU . . . -109.66 149.42 17.3 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.784 -167.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.626 ' HG3' ' HG2' ' A' ' 283' ' ' ARG . 31.9 tt0 -127.75 117.61 22.22 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 172.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . 0.737 ' HB2' HG12 ' A' ' 264' ' ' VAL . 53.7 t -101.65 94.84 6.06 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.314 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 36.38 55.13 1.08 Allowed 'General case' 0 CA--C 1.533 0.296 0 O-C-N 124.754 1.284 . . . . 0.0 111.843 175.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.51 -40.4 2.4 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 115.639 -0.71 . . . . 0.0 113.39 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . 0.494 ' HD2' ' HB3' ' A' ' 279' ' ' CYS . 35.3 mttt -76.42 138.83 40.62 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 117.513 0.656 . . . . 0.0 110.381 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . 0.626 ' HG2' ' HG3' ' A' ' 278' ' ' GLU . 23.2 mtt180 -122.33 129.93 52.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.365 0.602 . . . . 0.0 111.726 176.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . 0.739 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . -159.91 -171.09 25.32 Favored Glycine 0 C--O 1.221 -0.709 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.189 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -147.62 139.84 24.38 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 118.409 1.105 . . . . 0.0 111.053 175.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 255' ' ' ALA . 28.1 m-85 -159.17 168.89 11.46 Favored Pre-proline 0 N--CA 1.472 0.633 0 C-N-CA 122.627 0.371 . . . . 0.0 111.472 -174.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.418 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 17.7 Cg_endo -94.92 168.7 1.59 Allowed 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 123.611 2.874 . . . . 0.0 112.796 -177.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.667 ' HA ' ' CG2' ' A' ' 291' ' ' VAL . 29.4 p90 -87.12 -12.38 47.26 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.31 -174.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 5.2 t -49.91 -33.66 18.01 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . 0.531 ' HB2' ' HB2' ' A' ' 244' ' ' GLN . 1.5 p-80 -125.75 56.97 1.37 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.792 0.806 . . . . 0.0 111.686 177.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.958 HG13 ' HA ' ' A' ' 242' ' ' VAL . 0.9 OUTLIER -154.56 170.94 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.573 168.23 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -130.01 107.75 9.58 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 172.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . 0.62 ' H ' HD21 ' A' ' 293' ' ' LEU . 0.0 OUTLIER -94.86 127.05 40.6 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 119.41 -0.916 . . . . 0.0 112.063 -169.266 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 10.4 mt -76.08 123.24 25.47 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 171.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -76.39 148.21 37.52 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.936 0.874 . . . . 0.0 111.834 -164.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -76.86 18.34 0.36 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.654 -1.612 . . . . 0.0 112.122 -176.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -73.64 -28.26 61.69 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 167.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 16.5 m120 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.957 -179.875 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . 0.45 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . . . . . . 0 N--CA 1.449 -0.463 0 N-CA-C 112.232 -0.347 . . . . 0.0 112.232 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.625 ' HA ' ' O ' ' A' ' 266' ' ' VAL . 4.3 Cg_endo -86.78 121.75 1.85 Allowed 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.206 2.604 . . . . 0.0 112.51 -178.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 0.886 HD13 ' HB1' ' A' ' 240' ' ' ALA . 0.1 OUTLIER -86.38 152.46 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.345 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.709 ' HD1' HD12 ' A' ' 263' ' ' LEU . 59.4 m-85 -100.84 118.04 36.11 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 175.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.886 ' HB1' HD13 ' A' ' 238' ' ' ILE . . . -120.19 117.3 27.54 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.587 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.55 HH11 ' HA2' ' A' ' 261' ' ' GLY . 0.1 OUTLIER -85.76 103.48 14.58 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.7 -175.237 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . 0.712 ' HA ' HG12 ' A' ' 291' ' ' VAL . 2.2 t -66.17 131.79 31.84 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.104 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.081 -175.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.451 HD11 ' C ' ' A' ' 243' ' ' ILE . 2.9 pp -120.84 2.3 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 O-C-N 123.539 0.524 . . . . 0.0 110.421 176.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.537 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 8.2 tt0 -178.22 95.58 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.072 -172.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.781 ' HZ3' HD13 ' A' ' 258' ' ' LEU . 0.0 OUTLIER -145.75 164.84 30.59 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.37 0.605 . . . . 0.0 110.443 175.84 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.865 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 12.7 ttm180 -92.87 171.98 8.62 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.778 -176.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.422 ' N ' ' HG2' ' A' ' 246' ' ' ARG . 21.9 t -101.72 75.48 0.16 Allowed Pre-proline 0 CA--C 1.542 0.646 0 CA-C-O 121.02 0.438 . . . . 0.0 110.123 170.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.972 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 1.2 Cg_endo -89.02 178.89 2.53 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 125.226 3.951 . . . . 0.0 111.875 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -127.52 175.36 8.31 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.97 0.414 . . . . 0.0 109.959 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.497 ' O ' HG21 ' A' ' 254' ' ' THR . . . -68.98 -1.23 6.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.125 0.488 . . . . 0.0 110.796 174.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -106.17 1.18 25.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.124 176.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -93.34 55.02 2.19 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp 60.54 22.61 12.33 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.46 -168.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' THR . . . . . 0.497 HG21 ' O ' ' A' ' 250' ' ' ALA . 28.6 p 64.65 83.59 0.16 Allowed 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.553 -177.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.625 ' HB3' ' CE2' ' A' ' 286' ' ' PHE . . . -128.67 153.56 47.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.015 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.603 HD23 ' O ' ' A' ' 277' ' ' GLY . 4.2 mm? -72.83 120.48 18.51 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.85 -175.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.972 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -81.04 87.11 6.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.18 0.514 . . . . 0.0 111.007 174.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.781 HD13 ' HZ3' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -157.69 168.47 27.13 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.192 -176.046 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.463 ' O ' ' HB ' ' A' ' 242' ' ' VAL . 12.6 pt-20 -142.56 -164.91 1.92 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -168.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 4.3 p -60.25 122.46 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 121.593 0.711 . . . . 0.0 112.095 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.55 ' HA2' HH11 ' A' ' 241' ' ' ARG . . . 107.57 -1.44 34.41 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.851 172.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.567 ' HB2' HG23 ' A' ' 242' ' ' VAL . 13.7 mt-10 -89.68 -177.62 5.32 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -170.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.709 HD12 ' HD1' ' A' ' 239' ' ' TYR . 3.4 tm? -138.78 122.11 17.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.526 177.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.684 HG11 ' HB3' ' A' ' 240' ' ' ALA . 2.1 p -115.11 129.28 71.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.056 178.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 238' ' ' ILE . 75.9 tttt -98.54 95.17 7.11 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.749 ' HB ' HG21 ' A' ' 238' ' ' ILE . 21.0 t -66.14 123.17 18.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.243 -175.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 35.3 p -95.77 -24.46 16.49 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.855 -174.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 0.0 OUTLIER -119.12 107.34 13.36 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.534 -0.866 . . . . 0.0 109.509 177.007 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.559 HD11 ' O ' ' A' ' 269' ' ' ILE . 0.6 OUTLIER -97.04 155.08 3.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-N 114.334 -1.303 . . . . 0.0 114.166 -167.772 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.853 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 0.3 OUTLIER -146.48 -172.55 3.98 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.772 171.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 60.1 t -93.35 -41.31 12.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.949 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 2.6 p -58.95 -43.7 91.31 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -175.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . 0.434 ' H ' ' ND2' ' A' ' 270' ' ' ASN . . . 115.45 -4.34 21.6 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.319 -0.944 . . . . 0.0 112.673 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.61 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.0 OUTLIER -95.91 71.93 2.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.709 0.766 . . . . 0.0 109.725 176.667 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.853 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -111.98 179.01 4.12 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.633 -168.609 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.617 ' O ' HG11 ' A' ' 266' ' ' VAL . 6.1 tt0 -90.2 125.27 35.41 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.603 ' O ' HD23 ' A' ' 256' ' ' LEU . . . -110.26 141.9 16.41 Favored Glycine 0 N--CA 1.436 -1.304 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 -173.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 26.6 tt0 -127.14 118.48 24.44 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 170.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . 0.48 ' O ' ' HD3' ' A' ' 282' ' ' LYS . 13.8 t -106.28 96.88 6.78 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -178.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 28.69 60.33 0.13 Allowed 'General case' 0 N--CA 1.468 0.454 0 O-C-N 125.015 1.447 . . . . 0.0 112.991 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 115.63 -30.53 6.61 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.334 178.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . 0.556 ' HE3' ' O ' ' A' ' 257' ' ' ALA . 6.1 mppt? -85.94 131.59 34.25 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.096 0.448 . . . . 0.0 110.378 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . 0.416 ' HA ' ' HD2' ' A' ' 283' ' ' ARG . 40.1 mmm-85 -114.42 149.89 35.54 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.793 0.33 . . . . 0.0 111.698 -178.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . 0.615 ' O ' ' HG2' ' A' ' 276' ' ' GLU . . . 159.72 -162.41 32.97 Favored Glycine 0 C--O 1.216 -0.973 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 173.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' HIS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 31.3 p80 -136.94 148.48 46.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 118.087 0.943 . . . . 0.0 111.077 177.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.625 ' CE2' ' HB3' ' A' ' 255' ' ' ALA . 2.4 m-85 -161.24 159.06 24.11 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 120.718 0.294 . . . . 0.0 111.325 -174.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.61 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 73.4 Cg_endo -93.14 149.44 2.52 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.251 2.634 . . . . 0.0 112.867 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.606 ' HA ' HG22 ' A' ' 291' ' ' VAL . 0.5 OUTLIER -75.28 -9.1 58.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.251 -174.26 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 8.9 t -63.0 -24.93 68.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.231 -0.441 . . . . 0.0 112.017 -173.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . 0.537 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 1.4 p-80 -121.67 38.07 4.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.48 0.657 . . . . 0.0 111.343 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.712 HG12 ' HA ' ' A' ' 242' ' ' VAL . 27.6 m -144.26 161.56 15.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.423 170.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -117.0 106.85 13.85 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . 0.533 ' HA ' ' HA ' ' A' ' 240' ' ' ALA . 0.2 OUTLIER -102.93 129.04 49.51 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-O 121.753 0.787 . . . . 0.0 113.008 -165.598 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 3.8 mp -93.51 174.08 7.37 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 114.348 -1.296 . . . . 0.0 108.797 168.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.636 ' OD2' ' HA ' ' A' ' 298' ' ' ASN . 12.7 t0 -76.76 156.86 32.07 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.194 -165.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.811 ' HG2' ' HB ' ' A' ' 238' ' ' ILE . 13.8 mt-30 -77.45 -36.41 52.97 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.396 -1.274 . . . . 0.0 109.203 -172.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? 178.76 20.06 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.023 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . 0.636 ' HA ' ' OD2' ' A' ' 295' ' ' ASP . 14.4 m120 . . . . . 0 CA--C 1.535 0.385 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.028 -169.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . 0.404 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . . . . . . 0 N--CA 1.442 -0.953 0 N-CA-C 111.504 -0.639 . . . . 0.0 111.504 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.404 ' HD3' ' HA2' ' A' ' 236' ' ' GLY . 3.2 Cg_exo -76.51 131.48 12.62 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.487 2.791 . . . . 0.0 111.659 -177.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 0.807 HD11 ' HB ' ' A' ' 266' ' ' VAL . 0.1 OUTLIER -93.68 165.96 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.476 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.647 ' HB3' HD12 ' A' ' 263' ' ' LEU . 36.4 m-85 -102.66 123.86 47.14 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 172.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.62 ' HB3' HG22 ' A' ' 264' ' ' VAL . . . -111.72 117.73 33.66 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.287 -168.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 292' ' ' ARG . 0.0 OUTLIER -85.9 103.05 14.27 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.021 176.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . 0.629 HG22 ' HB2' ' A' ' 245' ' ' LYS . 3.5 p -91.57 121.4 42.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.737 -177.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.471 HD11 ' HB2' ' A' ' 244' ' ' GLN . 2.8 pp -100.33 4.7 10.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.864 -172.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.495 ' HB2' ' HB2' ' A' ' 290' ' ' HIS . 16.8 mt-30 -173.78 99.32 0.11 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.932 -174.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.978 ' HG2' HD13 ' A' ' 258' ' ' LEU . 0.1 OUTLIER -146.51 163.11 36.77 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.849 0.357 . . . . 0.0 110.057 176.316 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.82 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 10.5 ptp180 -103.32 -178.21 3.6 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.382 -178.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 2.9 m -105.81 77.45 0.41 Allowed Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.873 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 1.4 Cg_endo -88.82 173.78 4.13 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 124.934 3.756 . . . . 0.0 111.278 174.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.428 ' C ' ' H ' ' A' ' 251' ' ' TYR . 9.9 m120 -127.53 175.73 8.02 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 122.147 -0.346 . . . . 0.0 110.452 174.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.701 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -66.03 -1.69 3.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.587 0.708 . . . . 0.0 110.55 174.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.428 ' H ' ' C ' ' A' ' 249' ' ' ASN . 19.2 m-85 -100.18 3.97 44.08 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.674 177.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.44 ' C ' ' HD2' ' A' ' 253' ' ' LYS . 2.2 m-20 -102.73 49.58 0.84 Allowed 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . 0.447 ' N ' ' HD2' ' A' ' 253' ' ' LYS . 0.0 OUTLIER 60.36 30.88 20.17 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -169.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' THR . . . . . 0.701 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 32.0 p 59.37 74.65 0.43 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 113.388 -1.733 . . . . 0.0 112.16 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.425 ' HB3' ' CE2' ' A' ' 286' ' ' PHE . . . -115.77 150.46 36.88 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.008 174.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.759 ' HB3' HD12 ' A' ' 258' ' ' LEU . 0.0 OUTLIER -77.38 138.55 39.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.437 -174.497 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.873 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -90.55 94.45 9.71 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.336 0.588 . . . . 0.0 110.381 173.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.978 HD13 ' HG2' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -146.04 166.97 24.52 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.83 -175.467 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.442 ' O ' HG11 ' A' ' 242' ' ' VAL . 12.2 pt-20 -138.68 -166.48 2.02 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.08 0.467 . . . . 0.0 111.491 -169.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 2.3 p -67.09 116.82 6.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.199 175.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 103.2 -1.85 47.18 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 114.801 -1.09 . . . . 0.0 112.66 169.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.405 ' OE2' ' HA ' ' A' ' 258' ' ' LEU . 18.2 mt-10 -80.87 169.83 17.06 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.204 0.526 . . . . 0.0 111.123 -174.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.647 HD12 ' HB3' ' A' ' 239' ' ' TYR . 10.2 tp -132.6 151.0 52.07 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.317 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.685 HG11 HD22 ' A' ' 258' ' ' LEU . 18.4 m -148.12 173.71 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.088 -176.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.449 ' HG3' ' CE1' ' A' ' 239' ' ' TYR . 5.0 ttmm -119.72 95.55 4.82 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 175.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.807 ' HB ' HD11 ' A' ' 238' ' ' ILE . 53.8 t -69.19 115.05 6.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.136 0.493 . . . . 0.0 110.436 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 40.5 p -93.37 -7.97 43.2 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.261 -174.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.423 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 3.2 tppp? -129.5 104.82 7.69 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.591 HG23 HG21 ' A' ' 238' ' ' ILE . 0.8 OUTLIER -107.83 157.62 7.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.629 0.728 . . . . 0.0 112.82 -173.39 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.603 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 4.7 p30 -147.37 -176.81 5.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.359 -173.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 32.0 m -110.73 15.45 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.3 m -109.66 -43.33 4.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.073 0.463 . . . . 0.0 110.382 176.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . 0.779 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 123.73 -9.91 8.56 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.544 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.9 OUTLIER -95.37 90.13 5.7 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.659 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.603 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -115.87 171.36 7.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.112 -173.523 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.562 ' O ' HG13 ' A' ' 266' ' ' VAL . 36.0 mt-10 -96.05 122.81 39.28 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 174.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.49 ' O ' HD23 ' A' ' 256' ' ' LEU . . . -104.51 134.09 11.83 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.182 -171.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -120.47 119.37 32.8 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 117.542 0.671 . . . . 0.0 109.584 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . 0.556 ' HB2' HG13 ' A' ' 264' ' ' VAL . 36.2 t -111.11 98.21 7.36 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.677 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 43.0 57.32 3.71 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 124.141 0.9 . . . . 0.0 112.232 174.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 114.38 -34.3 4.99 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.9 174.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . 0.519 ' HD2' ' H ' ' A' ' 282' ' ' LYS . 4.1 mptt -98.87 138.89 35.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.332 0.566 . . . . 0.0 109.592 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . 0.457 ' HD2' ' N ' ' A' ' 283' ' ' ARG . 0.0 OUTLIER -121.54 129.11 52.68 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.454 0.645 . . . . 0.0 111.094 176.621 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . 0.571 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . -149.94 145.78 14.26 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.714 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -101.55 138.16 38.92 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 117.918 0.859 . . . . 0.0 111.953 -172.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.547 ' CG ' ' HE2' ' A' ' 245' ' ' LYS . 9.5 m-85 -154.44 163.54 23.87 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.635 -175.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.731 ' HD2' ' HE2' ' A' ' 290' ' ' HIS . 68.3 Cg_endo -96.79 174.67 0.73 Allowed 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 123.69 2.926 . . . . 0.0 115.203 -173.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.779 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 32.4 t80 -82.14 -21.76 36.46 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 113.978 -1.464 . . . . 0.0 112.716 -171.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 9.9 t -58.62 -13.15 5.11 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -171.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . 0.731 ' HE2' ' HD2' ' A' ' 287' ' ' PRO . 1.1 p-80 -141.64 44.28 1.72 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.962 0.41 . . . . 0.0 111.957 -177.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.418 ' O ' ' HD2' ' A' ' 292' ' ' ARG . 12.6 m -135.0 156.96 40.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.496 0.665 . . . . 0.0 112.022 177.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.418 ' HD2' ' O ' ' A' ' 291' ' ' VAL . 22.7 mmm180 -127.53 106.7 9.36 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 166.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . 0.426 HD12 ' CB ' ' A' ' 240' ' ' ALA . 1.8 mm? -92.21 143.46 26.4 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.63 -0.669 . . . . 0.0 112.242 -170.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.474 ' N ' HD21 ' A' ' 294' ' ' LEU . 4.1 mt -94.81 123.58 38.35 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 164.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.58 ' OD2' ' HB2' ' A' ' 297' ' ' GLN . 4.5 p-10 -76.83 155.63 32.86 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.773 0.797 . . . . 0.0 112.215 -166.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.742 ' HB3' HG22 ' A' ' 238' ' ' ILE . 1.7 pm0 -77.58 12.34 1.67 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.273 -1.331 . . . . 0.0 111.579 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.58 ' HB2' ' OD2' ' A' ' 295' ' ' ASP . 29.0 mm-40 -91.36 -30.2 16.68 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 171.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 19.7 m120 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.15 176.07 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 113.721 0.249 . . . . 0.0 113.721 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.635 ' HB2' ' HD3' ' A' ' 265' ' ' LYS . 6.9 Cg_endo -90.82 131.56 1.56 Allowed 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 124.022 3.148 . . . . 0.0 110.788 172.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 1.029 HG12 HG23 ' A' ' 266' ' ' VAL . 2.2 pt -82.38 158.67 3.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.642 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.697 ' HB3' HD22 ' A' ' 263' ' ' LEU . 36.1 m-85 -104.79 117.11 33.25 Favored 'General case' 0 C--O 1.21 -1.025 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 169.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.652 ' HB3' HG11 ' A' ' 264' ' ' VAL . . . -113.34 116.54 29.86 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.187 -172.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.413 ' HB3' ' O ' ' A' ' 292' ' ' ARG . 22.7 tpp180 -74.88 101.68 4.48 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.803 -1.09 . . . . 0.0 108.287 175.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . 0.6 HG22 ' HD3' ' A' ' 245' ' ' LYS . 7.6 p -83.59 124.57 39.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.153 -175.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.9 pp -102.36 1.66 10.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.109 -173.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.49 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 52.5 tt0 -177.37 98.51 0.05 OUTLIER 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.94 -176.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.643 ' HB3' ' O ' ' A' ' 258' ' ' LEU . 0.0 OUTLIER -146.09 163.29 35.76 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.272 0.558 . . . . 0.0 110.156 173.179 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.758 ' C ' ' HD3' ' A' ' 248' ' ' PRO . 5.7 ptp180 -94.82 -174.35 3.25 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.306 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 2.8 m -108.98 69.31 0.38 Allowed Pre-proline 0 CA--C 1.536 0.426 0 CA-C-O 121.246 0.546 . . . . 0.0 111.615 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.954 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 57.0 Cg_endo -95.86 122.25 0.27 Allowed 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 124.645 3.563 . . . . 0.0 111.442 178.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -79.35 175.66 10.4 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.989 0.423 . . . . 0.0 110.966 -176.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -65.02 -0.53 1.61 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.179 0.514 . . . . 0.0 111.375 177.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -103.67 8.61 37.43 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.087 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -98.12 53.47 1.08 Allowed 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . 0.538 ' HD3' ' N ' ' A' ' 253' ' ' LYS . 0.1 OUTLIER 61.42 28.99 18.26 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -167.399 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 26.5 p 62.09 87.01 0.1 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.197 -1.365 . . . . 0.0 110.942 -176.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.627 ' HB1' ' HB2' ' A' ' 248' ' ' PRO . . . -123.72 165.64 16.91 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.785 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.579 ' H ' ' HE2' ' A' ' 286' ' ' PHE . 4.3 mm? -89.07 114.96 26.24 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.009 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.954 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -85.31 87.14 7.35 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.59 0.709 . . . . 0.0 110.413 177.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.643 ' O ' ' HB3' ' A' ' 245' ' ' LYS . 0.4 OUTLIER -151.98 167.2 29.15 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.869 -173.247 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.574 ' O ' HG11 ' A' ' 242' ' ' VAL . 11.1 pt-20 -141.89 -161.89 1.31 Allowed 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.755 -0.591 . . . . 0.0 111.903 -170.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 2.7 p -65.06 119.13 8.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.494 0.664 . . . . 0.0 112.112 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 106.26 -2.67 37.51 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.927 171.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -90.99 -177.78 5.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.782 0.325 . . . . 0.0 111.434 -171.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.697 HD22 ' HB3' ' A' ' 239' ' ' TYR . 3.3 tm? -131.18 120.08 22.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.944 0.402 . . . . 0.0 110.458 -176.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.652 HG11 ' HB3' ' A' ' 240' ' ' ALA . 2.5 p -115.63 116.88 53.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.637 175.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.635 ' HD3' ' HB2' ' A' ' 237' ' ' PRO . 0.0 OUTLIER -89.41 98.64 11.88 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.006 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 1.029 HG23 HG12 ' A' ' 238' ' ' ILE . 6.1 m -79.12 122.89 35.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.533 0.682 . . . . 0.0 110.969 -176.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' THR . . . . . 0.505 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 36.4 p -86.47 -19.48 29.5 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.426 -174.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.885 ' HA ' ' HE3' ' A' ' 268' ' ' LYS . 0.1 OUTLIER -123.11 105.95 10.36 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -178.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.537 HG22 ' NE2' ' A' ' 296' ' ' GLN . 0.7 OUTLIER -94.32 157.25 3.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -172.774 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.682 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 3.4 p30 -146.43 179.83 7.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.724 -179.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 10.2 p -93.36 -18.85 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -173.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 33.5 m -94.65 -34.91 12.41 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -176.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . 0.759 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 115.29 -2.81 22.25 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.929 -177.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 1.9 mp0 -89.93 76.79 7.03 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 175.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.682 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -115.1 173.02 6.71 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.532 0.682 . . . . 0.0 111.808 -171.636 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 36.1 mt-10 -96.85 125.55 41.38 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.132 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.624 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -111.25 155.02 16.37 Favored Glycine 0 N--CA 1.437 -1.265 0 CA-C-N 114.669 -1.151 . . . . 0.0 112.509 -169.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.556 ' HG2' ' HG3' ' A' ' 283' ' ' ARG . 6.1 tm-20 -139.47 119.7 13.74 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 174.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . 0.56 ' O ' ' HD3' ' A' ' 282' ' ' LYS . 12.4 t -124.46 99.85 6.39 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.829 -173.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . 0.427 ' N ' HD21 ' A' ' 280' ' ' ASN . 0.9 OUTLIER 51.66 38.01 21.57 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.808 0.693 . . . . 0.0 111.672 170.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 114.93 -26.42 9.35 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.187 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . 0.56 ' HD3' ' O ' ' A' ' 279' ' ' CYS . 0.1 OUTLIER -81.93 137.04 35.25 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 177.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . 0.556 ' HG3' ' HG2' ' A' ' 278' ' ' GLU . 0.1 OUTLIER -128.15 140.07 52.13 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.927 177.783 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 177.48 -145.51 7.2 Favored Glycine 0 C--O 1.222 -0.6 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.103 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' HIS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 13.7 p80 -150.54 140.2 21.66 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.665 0.233 . . . . 0.0 111.252 -178.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.579 ' HE2' ' H ' ' A' ' 256' ' ' LEU . 9.9 m-85 -157.44 159.31 30.9 Favored Pre-proline 0 N--CA 1.469 0.5 0 C-N-CA 122.249 0.22 . . . . 0.0 111.11 -177.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.515 ' HD2' ' HE2' ' A' ' 290' ' ' HIS . 63.7 Cg_endo -92.86 176.9 1.52 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.246 2.631 . . . . 0.0 114.435 -173.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.759 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 21.2 t80 -80.64 -33.62 35.55 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 113.816 -1.538 . . . . 0.0 112.657 -168.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 6.6 t -55.77 -33.72 64.6 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -168.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . 0.536 ' NE2' ' HD2' ' A' ' 245' ' ' LYS . 1.2 p-80 -115.05 49.27 1.07 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.605 0.717 . . . . 0.0 110.845 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -150.04 155.64 7.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.551 175.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.413 ' O ' ' HB3' ' A' ' 241' ' ' ARG . 29.2 mmm180 -130.83 107.42 9.12 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 175.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . 0.61 HD22 ' CZ ' ' A' ' 288' ' ' PHE . 0.3 OUTLIER -102.04 136.14 42.4 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -162.735 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.596 HD11 ' N ' ' A' ' 294' ' ' LEU . 0.0 OUTLIER -84.42 143.6 29.32 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 113.96 -1.473 . . . . 0.0 107.373 170.477 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -75.61 152.6 37.63 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.34 -163.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.822 ' HB3' HG22 ' A' ' 238' ' ' ILE . 12.5 pt20 -93.79 -22.8 18.46 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.066 -174.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.457 HE21 ' HB2' ' A' ' 297' ' ' GLN . 0.0 OUTLIER -91.95 -35.04 14.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.191 0.519 . . . . 0.0 109.606 -178.919 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 10.8 m120 . . . . . 0 C--N 1.323 -0.554 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.897 171.925 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . 0.483 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . . . . . . 0 N--CA 1.445 -0.741 0 N-CA-C 112.255 -0.338 . . . . 0.0 112.255 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.483 ' HD3' ' HA2' ' A' ' 236' ' ' GLY . 7.1 Cg_exo -73.17 133.72 19.98 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.072 2.515 . . . . 0.0 112.003 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 1.081 HG23 ' HB3' ' A' ' 296' ' ' GLN . 0.2 OUTLIER -92.8 167.47 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.545 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.667 ' HB3' HD12 ' A' ' 263' ' ' LEU . 72.4 m-85 -106.64 127.73 53.59 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 170.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.561 ' HB2' HG21 ' A' ' 291' ' ' VAL . . . -114.39 118.16 33.07 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.528 -176.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.595 ' NH1' ' HA2' ' A' ' 261' ' ' GLY . 0.1 OUTLIER -88.8 100.82 13.45 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.297 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . 1.007 HG22 ' HD2' ' A' ' 245' ' ' LYS . 7.2 p -86.56 127.15 40.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.071 -172.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.8 pp -100.29 3.28 10.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.4 -174.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.454 ' H ' HG21 ' A' ' 242' ' ' VAL . 7.2 tp-100 -177.33 106.91 0.06 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -176.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 1.042 ' HD3' ' HB2' ' A' ' 258' ' ' LEU . 14.7 tttt -144.63 157.15 44.33 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 177.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.787 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 16.4 ptt180 -103.92 -175.14 2.71 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 6.8 m -110.51 69.37 0.58 Allowed Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 121.177 0.513 . . . . 0.0 111.987 -174.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 1.007 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 17.8 Cg_endo -94.47 124.51 0.42 Allowed 'Trans proline' 0 N--CA 1.444 -1.433 0 C-N-CA 124.285 3.324 . . . . 0.0 111.175 176.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.457 ' C ' ' H ' ' A' ' 251' ' ' TYR . 7.0 m-20 -81.46 176.92 9.28 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.022 0.439 . . . . 0.0 111.043 -174.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.599 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -67.77 4.86 0.99 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.202 0.525 . . . . 0.0 111.281 177.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.457 ' H ' ' C ' ' A' ' 249' ' ' ASN . 44.8 m-85 -106.5 5.74 29.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.553 0.692 . . . . 0.0 109.572 176.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.408 ' C ' ' HD2' ' A' ' 253' ' ' LYS . 3.7 m-20 -101.17 55.73 0.84 Allowed 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . 0.408 ' HD2' ' C ' ' A' ' 252' ' ' ASP . 0.0 OUTLIER 59.0 27.01 15.78 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -169.568 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' THR . . . . . 0.599 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 30.2 p 61.42 85.19 0.12 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.63 -176.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.64 ' HB1' ' HB2' ' A' ' 248' ' ' PRO . . . -118.31 165.63 13.6 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.499 178.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.81 ' HB3' HD12 ' A' ' 258' ' ' LEU . 3.8 mm? -88.35 112.78 23.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.632 178.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 1.007 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -82.32 81.86 8.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.6 0.714 . . . . 0.0 110.234 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 1.042 ' HB2' ' HD3' ' A' ' 245' ' ' LYS . 6.1 mp -122.83 177.92 5.26 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.382 -171.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -143.71 -169.31 3.05 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.156 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 2.3 p -65.71 121.06 14.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.247 177.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.595 ' HA2' ' NH1' ' A' ' 241' ' ' ARG . . . 103.44 -2.22 46.39 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.486 171.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -88.76 174.99 7.68 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.991 0.424 . . . . 0.0 111.261 -171.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.667 HD12 ' HB3' ' A' ' 239' ' ' TYR . 21.5 tp -130.0 158.85 38.45 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.222 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.8 HG23 ' HB2' ' A' ' 279' ' ' CYS . 8.3 p -151.13 150.71 13.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.34 97.92 7.27 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.882 HG23 HG12 ' A' ' 238' ' ' ILE . 15.5 m -74.39 113.3 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 121.972 0.891 . . . . 0.0 110.43 -178.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' THR . . . . . 0.453 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 61.0 p -92.34 0.52 57.45 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.095 -174.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.65 107.14 6.48 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.375 172.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.599 HG23 HG22 ' A' ' 238' ' ' ILE . 0.8 OUTLIER -104.21 160.86 4.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 114.34 -1.3 . . . . 0.0 113.102 -170.25 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.673 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 3.8 p30 -146.87 171.62 14.92 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.815 -176.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 27.0 m -87.04 5.06 3.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -175.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 4.4 m -111.54 -43.42 3.67 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . 0.457 ' C ' HE21 ' A' ' 274' ' ' GLN . . . 120.24 -0.4 12.92 Favored Glycine 0 C--O 1.223 -0.543 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.021 -175.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.584 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.2 OUTLIER -98.04 77.64 2.47 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.813 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.673 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -117.87 169.88 9.27 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.461 -167.457 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.583 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 39.9 mt-10 -90.68 126.29 35.93 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.228 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.614 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -111.36 146.37 17.78 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.294 -170.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 4.3 tm-20 -133.7 116.51 15.87 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . 0.8 ' HB2' HG23 ' A' ' 264' ' ' VAL . 10.5 t -115.7 99.0 7.0 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.744 0.783 . . . . 0.0 110.009 -177.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 31.63 55.89 0.29 Allowed 'General case' 0 C--N 1.343 0.301 0 CA-C-N 112.918 -1.947 . . . . 0.0 113.525 175.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.82 -14.41 14.37 Favored Glycine 0 CA--C 1.522 0.495 0 CA-C-N 115.933 -0.576 . . . . 0.0 113.51 176.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 19.0 mttt -108.38 128.64 54.94 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 117.213 0.506 . . . . 0.0 109.699 177.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . 0.522 ' C ' ' HD3' ' A' ' 283' ' ' ARG . 0.2 OUTLIER -123.21 143.95 49.69 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.276 -0.569 . . . . 0.0 111.173 179.637 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 176.63 -145.1 7.24 Favored Glycine 0 C--O 1.224 -0.508 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.243 178.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' HIS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 13.6 p80 -150.15 147.65 28.0 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.852 0.326 . . . . 0.0 110.822 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.612 ' HD1' ' HD2' ' A' ' 287' ' ' PRO . 2.5 m-85 -161.68 153.93 16.57 Favored Pre-proline 0 N--CA 1.467 0.398 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -178.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.612 ' HD2' ' HD1' ' A' ' 286' ' ' PHE . 87.4 Cg_endo -88.32 165.1 6.8 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.399 2.733 . . . . 0.0 112.513 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.497 ' HA ' ' CG1' ' A' ' 291' ' ' VAL . 9.4 p90 -88.16 -4.77 58.69 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -172.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 5.6 t -56.76 -11.38 1.37 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -177.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -133.47 30.76 3.8 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 122.259 -0.276 . . . . 0.0 111.149 -175.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.609 HG22 ' HA ' ' A' ' 242' ' ' VAL . 9.5 p -147.35 157.6 9.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 C-N-CA 119.759 -0.776 . . . . 0.0 112.005 -170.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.418 ' HD2' ' HA ' ' A' ' 292' ' ' ARG . 25.3 tpt180 -125.98 109.74 12.79 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . 0.497 ' H ' HD21 ' A' ' 293' ' ' LEU . 0.4 OUTLIER -86.42 150.16 24.5 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 119.562 -0.855 . . . . 0.0 113.22 -165.522 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.56 ' HB2' ' HB2' ' A' ' 239' ' ' TYR . 11.3 mt -99.81 122.78 43.28 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 105.153 -2.165 . . . . 0.0 105.153 163.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.514 ' HB3' ' HG3' ' A' ' 297' ' ' GLN . 4.7 t70 -77.87 150.83 34.09 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 122.197 0.998 . . . . 0.0 112.713 -160.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 1.081 ' HB3' HG23 ' A' ' 238' ' ' ILE . 5.5 pt20 -73.95 -9.17 58.37 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 113.512 -1.677 . . . . 0.0 111.433 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.514 ' HG3' ' HB3' ' A' ' 295' ' ' ASP . 0.0 OUTLIER -71.14 -21.85 62.14 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.163 173.01 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . 0.435 ' C ' HD21 ' A' ' 298' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 121.23 0.538 . . . . 0.0 110.105 175.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . 0.508 ' O ' ' HB2' ' A' ' 296' ' ' GLN . . . . . . . . 0 N--CA 1.447 -0.569 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -67.48 136.12 38.61 Favored 'Trans proline' 0 CA--C 1.52 -0.191 0 C-N-CA 123.242 2.628 . . . . 0.0 113.135 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 0.967 HG22 ' HB ' ' A' ' 266' ' ' VAL . 0.1 OUTLIER -90.02 151.52 3.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.211 175.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.569 ' HD1' HD11 ' A' ' 263' ' ' LEU . 27.4 m-85 -109.64 117.37 33.76 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.629 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -115.15 117.17 29.78 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.413 0.625 . . . . 0.0 111.447 -171.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 4.2 tpp85 -74.89 104.79 5.64 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.847 174.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . 0.684 HG21 ' HD3' ' A' ' 245' ' ' LYS . 7.5 p -84.24 133.46 29.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.23 0.538 . . . . 0.0 110.852 -176.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.629 HD11 ' HB2' ' A' ' 244' ' ' GLN . 2.4 pp -115.19 3.99 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.919 -171.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.629 ' HB2' HD11 ' A' ' 243' ' ' ILE . 5.3 mt-30 -173.94 94.14 0.09 Allowed 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 123.202 0.314 . . . . 0.0 110.5 -175.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.684 ' HD3' HG21 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -147.1 162.99 37.71 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.238 0.542 . . . . 0.0 110.427 173.437 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.829 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 4.5 ptt180 -101.59 -176.42 3.13 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.978 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.4 77.96 0.23 Allowed Pre-proline 0 CA--C 1.542 0.644 0 O-C-N 122.156 -0.34 . . . . 0.0 111.382 175.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 1.009 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 12.7 Cg_endo -94.55 142.23 1.44 Allowed 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.54 3.494 . . . . 0.0 112.214 175.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.406 ' O ' ' HB2' ' A' ' 252' ' ' ASP . 15.1 m120 -96.78 177.06 5.76 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.731 -177.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.742 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -63.95 -7.63 8.93 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 121.823 0.821 . . . . 0.0 110.197 172.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -95.04 6.79 48.08 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.065 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 249' ' ' ASN . 1.1 m-20 -105.04 48.11 0.85 Allowed 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . 0.476 ' N ' ' HD2' ' A' ' 253' ' ' LYS . 0.1 OUTLIER 60.42 32.7 20.66 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -167.937 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' THR . . . . . 0.742 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 23.4 p 57.03 77.55 0.26 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.166 -1.379 . . . . 0.0 111.158 -179.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.411 ' HB3' ' CE2' ' A' ' 286' ' ' PHE . . . -117.77 167.14 11.65 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.024 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.506 ' H ' ' HE2' ' A' ' 286' ' ' PHE . 4.6 mm? -88.55 118.8 28.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.909 -175.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 1.009 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -83.54 90.64 7.27 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.768 0.794 . . . . 0.0 110.547 175.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.641 ' O ' ' HB3' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -150.72 167.52 27.14 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.04 -176.183 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.457 ' CG ' ' N ' ' A' ' 260' ' ' VAL . 24.7 tt0 -142.93 177.24 8.49 Favored 'General case' 0 C--N 1.313 -1.005 0 O-C-N 122.088 -0.383 . . . . 0.0 110.547 -164.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 243' ' ' ILE . 57.8 t -50.05 118.52 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 122.906 0.482 . . . . 0.0 111.479 174.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 106.1 -2.32 38.01 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.58 170.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -98.23 -173.59 2.62 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.875 0.369 . . . . 0.0 111.725 -172.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.569 HD11 ' HD1' ' A' ' 239' ' ' TYR . 3.3 tm? -129.47 131.14 46.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.525 -173.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.629 HG13 ' HB3' ' A' ' 240' ' ' ALA . 2.4 p -123.39 124.49 69.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.435 174.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -82.68 112.24 19.36 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 175.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.967 ' HB ' HG22 ' A' ' 238' ' ' ILE . 94.8 t -77.06 112.91 15.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 65.8 p -94.65 -32.89 13.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.962 -171.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.568 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 11.9 tppt? -116.16 107.56 15.05 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.697 HG22 ' NE2' ' A' ' 296' ' ' GLN . 0.7 OUTLIER -96.74 140.25 17.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -168.134 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.865 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 0.3 OUTLIER -148.06 149.07 31.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.852 178.118 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 10.9 p -65.37 -17.4 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -173.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 3.9 p -78.26 -30.68 48.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.914 0.388 . . . . 0.0 111.995 -177.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . 0.606 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 94.96 -5.67 68.99 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.464 -177.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.646 ' HG3' ' HB3' ' A' ' 287' ' ' PRO . 1.7 mp0 -92.56 77.41 5.0 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 174.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.865 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -122.76 178.42 5.03 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.489 -0.778 . . . . 0.0 113.042 -167.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.568 ' HB2' ' HB3' ' A' ' 268' ' ' LYS . 40.2 mt-10 -83.33 127.47 33.69 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.525 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.44 ' O ' HD23 ' A' ' 256' ' ' LEU . . . -111.75 156.44 15.57 Favored Glycine 0 N--CA 1.433 -1.528 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.615 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 21.2 tt0 -141.88 119.43 11.68 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . 0.507 ' HB2' HD22 ' A' ' 258' ' ' LEU . 51.6 t -115.2 99.06 7.14 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.061 -176.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 45.18 45.12 9.23 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 124.065 0.853 . . . . 0.0 111.958 176.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 114.86 -33.51 5.31 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.202 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 12.2 mptt -73.32 139.69 46.22 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 117.178 0.489 . . . . 0.0 110.084 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -124.01 142.05 51.51 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.216 0.531 . . . . 0.0 111.921 -176.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 169.49 -145.54 9.41 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.391 175.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' HIS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 7.5 p80 -150.35 147.53 27.72 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.936 0.368 . . . . 0.0 111.191 -177.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.602 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 2.1 m-85 -158.18 150.74 17.93 Favored Pre-proline 0 N--CA 1.466 0.331 0 CA-C-O 120.936 0.398 . . . . 0.0 112.052 -178.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.646 ' HB3' ' HG3' ' A' ' 274' ' ' GLN . 2.4 Cg_endo -81.34 174.32 10.76 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.915 3.076 . . . . 0.0 114.152 -178.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.606 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 24.9 t80 -87.77 -35.67 17.74 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -167.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 4.1 t -65.41 -7.27 13.1 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -164.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . 0.531 ' NE2' ' HD2' ' A' ' 245' ' ' LYS . 1.1 p-80 -120.35 31.82 6.3 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.907 -0.496 . . . . 0.0 110.92 178.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 288' ' ' PHE . 4.0 p -147.23 154.19 11.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.296 0.569 . . . . 0.0 111.566 -175.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -131.95 110.25 10.63 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . 0.6 ' HA ' ' HA ' ' A' ' 240' ' ' ALA . 0.2 OUTLIER -118.02 135.68 54.01 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -162.18 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 5.3 mp -77.93 153.42 32.55 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.864 168.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -76.34 150.49 36.86 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.756 -162.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.697 ' NE2' HG22 ' A' ' 269' ' ' ILE . 2.6 pt20 -77.86 5.41 9.67 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 113.618 -1.628 . . . . 0.0 112.086 -173.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -73.96 -31.78 63.16 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.11 174.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 120.795 0.331 . . . . 0.0 111.156 -175.059 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . 0.419 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . . . . . . 0 N--CA 1.447 -0.611 0 N-CA-C 112.145 -0.382 . . . . 0.0 112.145 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.509 ' HB3' ' HA ' ' A' ' 267' ' ' THR . 6.2 Cg_exo -78.68 131.73 10.49 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.149 2.566 . . . . 0.0 112.116 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 1.081 HG22 ' HB3' ' A' ' 296' ' ' GLN . 0.2 OUTLIER -87.01 163.55 2.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.553 176.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.824 ' HB3' HD12 ' A' ' 263' ' ' LEU . 67.7 m-85 -104.92 123.49 47.84 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 171.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.677 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -112.52 118.62 35.62 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.861 -174.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 292' ' ' ARG . 0.0 OUTLIER -75.89 100.86 4.95 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . 0.707 HG22 ' HB2' ' A' ' 245' ' ' LYS . 3.3 p -82.63 121.01 35.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.111 -176.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.69 HD11 ' HB2' ' A' ' 244' ' ' GLN . 2.8 pp -105.85 10.55 9.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.708 -175.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.69 ' HB2' HD11 ' A' ' 243' ' ' ILE . 1.0 OUTLIER -177.0 94.95 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.272 -176.642 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.707 ' HB2' HG22 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -147.09 164.68 32.31 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.27 0.557 . . . . 0.0 111.202 174.335 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.806 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 3.2 ptm180 -101.06 -177.96 3.61 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.525 -177.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 46.2 t -104.67 81.91 0.6 Allowed Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 121.201 0.524 . . . . 0.0 110.918 174.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.926 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 4.6 Cg_endo -91.03 175.46 2.44 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 124.959 3.773 . . . . 0.0 111.881 174.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -138.55 179.91 6.19 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.146 176.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.721 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -57.25 -12.59 2.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.877 0.37 . . . . 0.0 111.89 176.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -91.34 -5.71 54.16 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 122.081 -0.387 . . . . 0.0 110.486 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -92.06 48.35 1.42 Allowed 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? 59.01 24.5 12.74 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -167.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' THR . . . . . 0.721 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 19.3 p 64.98 83.35 0.17 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.405 -1.271 . . . . 0.0 110.885 -177.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.603 ' HB3' ' CE2' ' A' ' 286' ' ' PHE . . . -122.33 159.25 27.84 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.466 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.52 HD23 ' C ' ' A' ' 277' ' ' GLY . 0.7 OUTLIER -78.27 123.91 27.48 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.251 -174.849 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.926 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -84.28 93.96 8.33 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.561 0.696 . . . . 0.0 111.171 172.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.63 ' O ' ' HB3' ' A' ' 245' ' ' LYS . 0.2 OUTLIER -155.6 167.98 28.64 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.623 -177.133 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.437 ' O ' HG11 ' A' ' 242' ' ' VAL . 12.3 pt-20 -141.78 -165.2 1.94 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.916 -0.49 . . . . 0.0 111.855 -172.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 43.0 t -59.63 118.38 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 96.71 0.18 60.76 Favored Glycine 0 CA--C 1.508 -0.396 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.165 170.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -89.74 -175.93 4.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.72 0.295 . . . . 0.0 110.396 -176.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.824 HD12 ' HB3' ' A' ' 239' ' ' TYR . 44.4 tp -130.0 159.84 35.46 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.01 0.433 . . . . 0.0 111.322 -176.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.677 HG13 ' HB3' ' A' ' 240' ' ' ALA . 2.4 p -152.24 133.82 5.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.019 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.434 ' HE2' ' HG2' ' A' ' 237' ' ' PRO . 86.1 tttt -96.16 96.36 8.77 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.246 0.546 . . . . 0.0 109.833 178.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.889 ' HB ' HD11 ' A' ' 238' ' ' ILE . 50.3 t -76.98 114.72 17.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.043 0.449 . . . . 0.0 111.473 -178.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' THR . . . . . 0.509 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 42.0 p -90.8 -10.45 42.79 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.49 -174.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.497 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 13.3 tppt? -127.21 105.94 8.9 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.814 HG23 HG21 ' A' ' 238' ' ' ILE . 0.8 OUTLIER -111.65 140.25 32.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -170.391 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.887 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 0.2 OUTLIER -148.6 140.44 23.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.634 177.766 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 10.6 p -58.68 -15.07 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -172.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.4 m -62.0 -36.11 80.54 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.297 0.481 . . . . 0.0 112.297 -177.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . 0.523 ' CA ' ' HB2' ' A' ' 288' ' ' PHE . . . 89.11 36.43 7.64 Favored Glycine 0 N--CA 1.437 -1.299 0 C-N-CA 119.908 -1.139 . . . . 0.0 110.797 -170.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 1.0 OUTLIER -148.7 96.92 2.65 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 171.163 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.887 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -134.15 173.07 12.0 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -168.959 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.613 ' O ' HG13 ' A' ' 266' ' ' VAL . 18.4 mm-40 -90.06 123.39 33.89 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.348 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -105.37 162.12 14.48 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -175.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.509 ' HG2' ' HG3' ' A' ' 283' ' ' ARG . 3.5 tm-20 -151.47 120.17 6.54 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 174.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 43.4 t -122.64 97.68 5.57 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.668 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 45.17 49.92 9.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.329 170.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.49 -27.31 8.08 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.684 -0.77 . . . . 0.0 113.4 177.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.85 128.58 41.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 117.311 0.556 . . . . 0.0 110.166 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . 0.509 ' HG3' ' HG2' ' A' ' 278' ' ' GLU . 0.4 OUTLIER -109.0 136.44 48.52 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.185 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . 0.485 ' N ' HD22 ' A' ' 256' ' ' LEU . . . -161.94 -171.98 28.74 Favored Glycine 0 C--O 1.226 -0.395 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.599 -176.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -147.02 135.79 22.17 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 172.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.682 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 4.4 m-85 -154.81 158.63 32.2 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -173.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.56 ' HD2' ' HE2' ' A' ' 290' ' ' HIS . 56.9 Cg_endo -94.93 164.68 1.69 Allowed 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.442 2.761 . . . . 0.0 113.938 -176.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.588 ' HA ' HG22 ' A' ' 291' ' ' VAL . 9.1 t80 -74.86 -18.47 60.43 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.131 -174.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 8.9 t -48.31 -24.91 1.35 Allowed 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 -175.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . 0.56 ' HE2' ' HD2' ' A' ' 287' ' ' PRO . 0.8 OUTLIER -137.51 48.19 2.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.807 0.337 . . . . 0.0 111.86 -177.839 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.588 HG22 ' HA ' ' A' ' 288' ' ' PHE . 30.1 m -143.22 155.09 16.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 121.102 0.477 . . . . 0.0 111.208 173.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.471 ' HD2' ' O ' ' A' ' 291' ' ' VAL . 15.9 mmm180 -121.79 110.43 15.9 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 173.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . 0.432 HD13 ' HZ2' ' A' ' 275' ' ' TRP . 2.6 tp -94.24 126.92 39.78 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -160.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.586 HD11 ' N ' ' A' ' 294' ' ' LEU . 0.1 OUTLIER -83.41 124.4 30.63 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 163.886 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -82.76 152.9 25.52 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.932 0.872 . . . . 0.0 112.208 -162.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 1.081 ' HB3' HG22 ' A' ' 238' ' ' ILE . 9.0 pt20 -75.45 -7.98 55.51 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.753 -1.567 . . . . 0.0 111.716 -176.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.498 ' HG3' ' N ' ' A' ' 298' ' ' ASN . 0.2 OUTLIER -65.03 -38.28 90.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.971 0.415 . . . . 0.0 110.02 173.406 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . 0.498 ' N ' ' HG3' ' A' ' 297' ' ' GLN . 13.5 m120 . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.755 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.553 0 N-CA-C 112.774 -0.13 . . . . 0.0 112.774 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 266' ' ' VAL . 10.1 Cg_endo -91.29 120.01 0.61 Allowed 'Trans proline' 0 N--CA 1.446 -1.277 0 C-N-CA 123.515 2.81 . . . . 0.0 112.413 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 1.064 HD13 ' HB1' ' A' ' 240' ' ' ALA . 0.1 OUTLIER -92.46 144.6 8.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 171.682 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.795 ' HD1' HD13 ' A' ' 263' ' ' LEU . 46.7 m-85 -96.96 119.53 35.6 Favored 'General case' 0 C--O 1.21 -1.01 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 173.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 1.064 ' HB1' HD13 ' A' ' 238' ' ' ILE . . . -113.94 115.9 28.4 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.107 -173.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.448 ' HB3' ' O ' ' A' ' 292' ' ' ARG . 17.8 tpp180 -84.76 103.4 13.82 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.189 -1.369 . . . . 0.0 108.375 177.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . 1.123 HG11 ' HD2' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -89.75 149.47 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.546 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.669 -177.245 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.485 HD11 ' C ' ' A' ' 243' ' ' ILE . 2.3 pp -124.88 11.23 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-N 113.544 -1.662 . . . . 0.0 110.654 -171.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.778 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 52.9 tt0 -177.23 94.6 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.63 -174.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 1.123 ' HD2' HG11 ' A' ' 242' ' ' VAL . 5.3 mttt -146.93 162.79 37.99 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.966 0.412 . . . . 0.0 110.11 177.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.84 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 10.7 ptm180 -113.37 -177.26 3.09 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.494 -174.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 9.3 m -102.57 81.83 0.4 Allowed Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 121.488 0.661 . . . . 0.0 112.091 174.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.94 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 1.1 Cg_endo -90.84 177.03 2.21 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 125.063 3.842 . . . . 0.0 110.573 171.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -131.36 175.43 9.14 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.105 0.478 . . . . 0.0 110.622 175.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.622 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -66.96 -2.97 5.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.316 0.579 . . . . 0.0 110.883 176.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -95.79 1.35 53.2 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.295 177.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -97.96 51.08 1.03 Allowed 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . 0.669 ' HA ' ' HE2' ' A' ' 253' ' ' LYS . 10.7 mmpt? 62.11 26.7 16.08 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -168.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' THR . . . . . 0.622 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 24.4 p 63.83 86.05 0.13 Allowed 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 125.107 1.504 . . . . 0.0 110.699 -175.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.404 ' HB3' ' CE2' ' A' ' 286' ' ' PHE . . . -121.66 156.55 32.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.186 178.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.589 HD23 ' O ' ' A' ' 277' ' ' GLY . 4.3 mm? -78.53 131.23 36.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.841 -178.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.94 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -92.03 99.05 11.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.361 0.6 . . . . 0.0 110.355 171.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.779 HD13 ' HD3' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -153.3 174.4 14.35 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.371 -175.332 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.431 ' CG ' ' N ' ' A' ' 260' ' ' VAL . 32.3 tt0 -142.84 175.73 9.61 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 122.128 -0.357 . . . . 0.0 111.073 -165.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 244' ' ' GLN . 56.0 t -57.07 118.71 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 123.083 0.553 . . . . 0.0 111.351 175.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 104.53 -1.19 42.71 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -97.79 -179.16 4.34 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.676 -169.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.795 HD13 ' HD1' ' A' ' 239' ' ' TYR . 2.3 tm? -134.16 134.29 41.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.07 0.462 . . . . 0.0 110.613 -170.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.662 HG12 ' HB3' ' A' ' 240' ' ' ALA . 5.4 p -125.54 145.3 33.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.453 173.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -99.79 99.65 10.49 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 175.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.921 ' HB ' HG21 ' A' ' 238' ' ' ILE . 76.0 t -70.06 114.14 7.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.324 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 33.2 p -92.6 -32.3 14.85 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.165 -171.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.36 107.65 15.08 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 121.598 0.713 . . . . 0.0 109.831 175.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.554 HD11 ' O ' ' A' ' 269' ' ' ILE . 0.6 OUTLIER -93.91 154.1 3.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 113.877 -1.511 . . . . 0.0 113.366 -170.024 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.712 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 2.4 p30 -145.89 -178.62 6.21 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.688 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 53.6 t -87.63 -38.81 12.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.5 m -73.33 -28.15 61.91 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -172.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . 0.868 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 102.99 0.66 48.42 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.582 -175.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.431 ' NE2' ' HB3' ' A' ' 287' ' ' PRO . 0.2 OUTLIER -89.96 76.14 7.1 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.9 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.712 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -122.33 175.66 6.29 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.619 0.723 . . . . 0.0 112.709 -170.033 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 284' ' ' GLY . 43.1 tt0 -98.52 127.31 44.4 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.081 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.589 ' O ' HD23 ' A' ' 256' ' ' LEU . . . -112.1 151.59 17.98 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.908 -174.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.616 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 17.2 tt0 -136.23 119.9 17.2 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 174.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 49.5 t -101.2 97.6 8.1 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.258 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 36.89 58.11 1.14 Allowed 'General case' 0 N--CA 1.465 0.282 0 O-C-N 124.542 1.151 . . . . 0.0 112.261 177.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.08 -37.51 3.39 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.661 177.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . 0.616 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 37.3 mttt -82.13 128.28 33.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 117.808 0.804 . . . . 0.0 110.587 -178.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -110.79 141.85 43.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.344 0.592 . . . . 0.0 112.002 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . 0.469 ' O ' ' HG3' ' A' ' 276' ' ' GLU . . . -176.07 -158.89 20.77 Favored Glycine 0 C--O 1.216 -1.021 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 174.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -149.66 146.67 27.4 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 118.848 1.324 . . . . 0.0 111.842 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.404 ' CE2' ' HB3' ' A' ' 255' ' ' ALA . 4.0 m-85 -154.18 162.74 26.15 Favored Pre-proline 0 C--O 1.238 0.471 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.571 -176.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.431 ' HB3' ' NE2' ' A' ' 274' ' ' GLN . 87.5 Cg_endo -92.92 171.67 2.18 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.151 2.567 . . . . 0.0 114.177 -176.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.868 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 17.9 t80 -79.65 -16.19 56.21 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 114.112 -1.404 . . . . 0.0 111.795 -174.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 67.3 p -55.63 -28.91 57.97 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -168.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . 0.778 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 1.5 p-80 -127.88 35.77 4.43 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.617 -172.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.619 HG22 HG12 ' A' ' 242' ' ' VAL . 5.4 p -139.36 148.27 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 C-N-CA 119.428 -0.909 . . . . 0.0 112.422 -174.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.448 ' O ' ' HB3' ' A' ' 241' ' ' ARG . 26.1 mmt180 -129.95 110.93 12.06 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.0 178.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . 0.651 HD23 ' H ' ' A' ' 293' ' ' LEU . 0.1 OUTLIER -89.89 138.5 31.44 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.588 0.709 . . . . 0.0 112.779 -163.695 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 239' ' ' TYR . 7.1 mt -81.12 133.63 35.5 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 161.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -73.69 132.6 42.87 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 122.187 0.994 . . . . 0.0 112.952 -160.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.754 ' HB3' ' HA ' ' A' ' 238' ' ' ILE . 15.1 pt20 -80.71 -0.23 37.45 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.579 -1.646 . . . . 0.0 112.656 -176.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.05 10.75 34.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.628 0.728 . . . . 0.0 109.422 169.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 . . . . . 0 CA--C 1.532 0.277 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.789 167.709 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . 0.448 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . . . . . . 0 N--CA 1.445 -0.758 0 N-CA-C 112.556 -0.218 . . . . 0.0 112.556 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.598 ' HA ' ' O ' ' A' ' 266' ' ' VAL . 11.7 Cg_exo -73.09 119.38 6.0 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.124 1.882 . . . . 0.0 111.137 175.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 1.089 HG22 ' HB3' ' A' ' 296' ' ' GLN . 0.2 OUTLIER -88.02 170.72 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.329 -177.634 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.95 ' HB3' HD22 ' A' ' 263' ' ' LEU . 81.9 m-85 -111.02 120.92 43.99 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 173.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.516 ' HB3' HG11 ' A' ' 264' ' ' VAL . . . -112.76 118.26 34.49 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.82 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.574 ' HD3' ' O ' ' A' ' 262' ' ' GLU . 0.0 OUTLIER -79.97 103.86 10.15 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.571 -177.737 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . 0.886 ' HA ' HG11 ' A' ' 291' ' ' VAL . 2.2 t -68.88 136.19 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.225 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.2 -177.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.444 HD11 ' C ' ' A' ' 243' ' ' ILE . 2.7 pp -123.01 -1.33 6.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.406 0.622 . . . . 0.0 110.227 172.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 1.048 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 33.4 tt0 -164.37 99.72 0.82 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.713 -178.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.958 ' HG2' ' HB2' ' A' ' 258' ' ' LEU . 5.3 tptt -145.76 165.12 29.74 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.419 0.628 . . . . 0.0 110.454 176.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.82 ' HG3' ' HG3' ' A' ' 248' ' ' PRO . 3.6 ptm180 -113.03 -178.78 3.46 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.466 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 5.9 m -105.67 75.76 0.33 Allowed Pre-proline 0 CA--C 1.537 0.481 0 CA-C-O 121.103 0.478 . . . . 0.0 111.826 176.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.968 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 1.0 OUTLIER -88.28 175.5 4.0 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 124.055 3.17 . . . . 0.0 111.527 175.002 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.422 ' HB3' ' HD1' ' A' ' 251' ' ' TYR . 66.3 m-20 -132.68 179.21 6.29 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.769 176.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.843 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -56.95 -10.92 1.23 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.304 0.573 . . . . 0.0 110.895 171.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.422 ' HD1' ' HB3' ' A' ' 249' ' ' ASN . 34.4 m-85 -83.21 -11.24 58.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.677 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -96.31 45.23 1.07 Allowed 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -175.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 4.1 mmpm? 60.74 28.76 18.48 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 -168.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' THR . . . . . 0.843 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 26.8 p 62.17 80.72 0.22 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.906 -178.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.515 ' HB3' ' CE2' ' A' ' 286' ' ' PHE . . . -117.03 156.99 26.57 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.619 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 1.008 ' HB3' HD11 ' A' ' 258' ' ' LEU . 4.5 mm? -79.1 120.32 23.47 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.389 -176.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.968 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -76.3 84.01 3.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.347 0.594 . . . . 0.0 110.867 172.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 1.008 HD11 ' HB3' ' A' ' 256' ' ' LEU . 2.4 mp -119.71 175.39 5.89 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.374 -176.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.538 ' O ' ' HB ' ' A' ' 242' ' ' VAL . 24.9 tt0 -146.17 174.61 11.17 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.403 ' N ' ' CG ' ' A' ' 259' ' ' GLU . 7.2 p -58.28 124.1 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.681 0.753 . . . . 0.0 111.825 173.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 97.9 1.5 58.54 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.192 175.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.574 ' O ' ' HD3' ' A' ' 241' ' ' ARG . 6.6 mt-10 -87.32 -174.21 4.74 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -171.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.95 HD22 ' HB3' ' A' ' 239' ' ' TYR . 3.4 tm? -140.62 131.18 25.47 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.563 -177.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.826 ' HB ' HD23 ' A' ' 258' ' ' LEU . 4.1 p -126.62 125.68 67.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.247 175.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -90.49 95.51 10.2 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.337 0.589 . . . . 0.0 109.45 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.859 ' HB ' HD11 ' A' ' 238' ' ' ILE . 48.4 t -77.84 118.21 24.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.476 -176.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 41.1 p -93.74 -12.72 28.55 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.856 -1.066 . . . . 0.0 111.593 -176.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.54 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 17.4 tppt? -119.65 104.37 10.21 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.356 174.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.477 HD11 ' O ' ' A' ' 269' ' ' ILE . 0.8 OUTLIER -105.99 159.64 5.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -172.31 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.543 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 3.9 p30 -145.2 -166.41 2.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.658 -177.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 9.8 p -103.82 -18.01 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.883 -177.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.4 m -83.62 -45.34 13.58 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.122 -0.361 . . . . 0.0 111.263 -177.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . 0.487 ' HA3' ' CD1' ' A' ' 288' ' ' PHE . . . 124.57 -7.84 8.36 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.249 -175.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -95.12 103.21 15.06 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 173.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.659 ' HZ2' HD13 ' A' ' 293' ' ' LEU . 0.0 OUTLIER -127.35 177.79 6.48 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.726 -174.213 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.71 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 46.5 mt-10 -99.08 125.12 44.52 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.567 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -108.8 154.0 16.63 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.448 -0.797 . . . . 0.0 112.636 -169.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.536 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 0.2 OUTLIER -133.3 117.43 17.34 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 172.044 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . 0.696 ' SG ' ' HD2' ' A' ' 282' ' ' LYS . 27.4 p -109.45 98.16 7.6 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.311 -176.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 9.9 m120 39.65 55.81 2.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.429 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 117.09 -39.94 2.52 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.78 -0.645 . . . . 0.0 114.054 176.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . 0.696 ' HD2' ' SG ' ' A' ' 279' ' ' CYS . 20.1 mttp -86.33 132.55 33.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 117.919 0.86 . . . . 0.0 111.287 -174.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -106.11 150.19 26.04 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.964 0.412 . . . . 0.0 111.833 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 175.52 -147.92 9.12 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.002 171.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' HIS . . . . . 0.71 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 10.2 p80 -147.62 151.38 36.12 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.698 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 0.9 OUTLIER -166.76 154.6 9.01 Favored Pre-proline 0 N--CA 1.469 0.478 0 CA-C-O 120.695 0.283 . . . . 0.0 111.492 -177.54 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.525 ' HD2' ' HE2' ' A' ' 290' ' ' HIS . 9.3 Cg_endo -90.19 163.03 4.7 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 124.049 3.166 . . . . 0.0 112.972 -177.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.509 ' HA ' HG22 ' A' ' 291' ' ' VAL . 18.4 p90 -87.8 -18.77 28.6 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -172.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 7.5 t -66.77 -4.23 8.62 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -169.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . 1.048 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 0.8 OUTLIER -130.59 33.86 4.21 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.245 173.143 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.886 HG11 ' HA ' ' A' ' 242' ' ' VAL . 26.8 m -145.03 167.34 10.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.483 173.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -123.05 109.12 13.68 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . 0.659 HD13 ' HZ2' ' A' ' 275' ' ' TRP . 0.1 OUTLIER -91.99 128.81 37.97 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.635 -0.826 . . . . 0.0 112.862 -165.6 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.465 ' N ' HD21 ' A' ' 294' ' ' LEU . 4.4 mt -84.82 135.57 34.04 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 169.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.51 ' OD1' ' HG2' ' A' ' 297' ' ' GLN . 7.1 t70 -76.29 149.66 37.06 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.665 0.745 . . . . 0.0 111.447 -166.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 1.089 ' HB3' HG22 ' A' ' 238' ' ' ILE . 10.0 pt20 -75.46 2.03 12.55 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.371 -177.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.51 ' HG2' ' OD1' ' A' ' 295' ' ' ASP . 15.9 mm100 -64.07 -23.57 67.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.38 170.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 42.2 t30 . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.234 176.742 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . 0.463 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . . . . . . 0 N--CA 1.447 -0.594 0 N-CA-C 111.73 -0.548 . . . . 0.0 111.73 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.532 ' HG2' ' HE2' ' A' ' 265' ' ' LYS . 1.2 Cg_endo -84.96 148.13 10.64 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 123.383 2.722 . . . . 0.0 113.009 -177.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 0.949 HG23 ' HB3' ' A' ' 296' ' ' GLN . 0.2 OUTLIER -107.53 163.32 5.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 175.405 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.791 ' HB3' HD22 ' A' ' 263' ' ' LEU . 69.8 m-85 -101.86 120.75 40.89 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 174.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.736 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -113.93 117.18 30.64 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.461 0.648 . . . . 0.0 110.234 -177.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.499 ' NH1' ' HA2' ' A' ' 261' ' ' GLY . 0.6 OUTLIER -84.17 107.26 16.38 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.682 -176.046 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . 0.722 ' HA ' HG12 ' A' ' 291' ' ' VAL . 3.9 t -69.6 131.74 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.122 -177.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.471 ' O ' HG23 ' A' ' 260' ' ' VAL . 2.8 pp -121.94 -0.52 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.015 175.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.631 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 6.7 tp-100 -178.1 95.69 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.685 -175.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.627 ' HB3' ' O ' ' A' ' 258' ' ' LEU . 0.9 OUTLIER -146.29 162.88 37.14 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.158 0.504 . . . . 0.0 110.261 177.248 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.854 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 12.1 ttt180 -95.43 179.64 5.09 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.35 -174.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.453 ' N ' ' CG ' ' A' ' 246' ' ' ARG . 8.9 m -106.36 69.68 0.23 Allowed Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 121.893 0.854 . . . . 0.0 110.805 173.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.9 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 11.6 Cg_endo -95.62 131.71 0.49 Allowed 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 125.146 3.897 . . . . 0.0 111.376 -178.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -92.39 178.26 5.88 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.58 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.615 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -59.85 -8.13 2.03 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.388 0.613 . . . . 0.0 110.999 174.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -92.14 -8.08 46.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.198 0.523 . . . . 0.0 110.118 177.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -104.67 66.85 0.8 Allowed 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.645 -174.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . 0.404 ' HD3' ' N ' ' A' ' 253' ' ' LYS . 0.0 OUTLIER 60.97 23.66 13.78 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.179 -172.67 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' THR . . . . . 0.615 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 34.8 p 52.81 65.33 1.55 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.888 -177.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.722 ' HB3' ' CE2' ' A' ' 286' ' ' PHE . . . -109.53 158.32 18.12 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.429 -175.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.641 HD22 ' CA ' ' A' ' 284' ' ' GLY . 1.7 mm? -67.37 128.37 36.16 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.869 176.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.9 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -92.6 98.08 11.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.442 0.639 . . . . 0.0 110.311 173.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.627 ' O ' ' HB3' ' A' ' 245' ' ' LYS . 0.2 OUTLIER -160.06 164.48 33.09 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.881 -173.743 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.504 ' O ' ' HG3' ' A' ' 262' ' ' GLU . 12.0 pt-20 -143.47 -167.52 2.59 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.975 -0.453 . . . . 0.0 111.888 -172.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 243' ' ' ILE . 62.8 t -54.49 123.22 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.499 ' HA2' ' NH1' ' A' ' 241' ' ' ARG . . . 102.04 -1.04 51.24 Favored Glycine 0 CA--C 1.509 -0.331 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.699 170.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 259' ' ' GLU . 8.3 mt-10 -86.57 -174.83 5.19 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -168.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.791 HD22 ' HB3' ' A' ' 239' ' ' TYR . 3.4 tm? -140.0 128.28 22.55 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.634 177.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.736 HG13 ' HB3' ' A' ' 240' ' ' ALA . 2.6 p -127.17 115.54 41.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.297 177.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.532 ' HE2' ' HG2' ' A' ' 237' ' ' PRO . 86.9 tttt -89.61 100.75 13.49 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.63 ' HB ' ' HA2' ' A' ' 277' ' ' GLY . 0.8 OUTLIER -83.09 137.16 21.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.897 -175.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 23.2 p -99.34 -8.3 25.05 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.704 -176.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 268' ' ' LYS . 14.0 tppt? -126.51 107.44 10.24 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.052 173.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.636 HG23 HG22 ' A' ' 238' ' ' ILE . 0.9 OUTLIER -105.04 163.26 4.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -170.76 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.498 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 4.3 p30 -143.3 -172.53 3.72 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.225 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 26.0 m -103.03 -5.91 9.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -175.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 5.5 m -100.99 -44.85 5.6 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.481 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . 0.484 ' HA3' ' CD1' ' A' ' 288' ' ' PHE . . . 133.18 -1.81 4.6 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.289 -0.958 . . . . 0.0 113.513 -178.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -95.99 102.08 13.83 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 118.003 0.901 . . . . 0.0 109.274 174.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.851 ' HZ2' ' HG ' ' A' ' 293' ' ' LEU . 0.0 OUTLIER -128.24 173.27 10.28 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -173.582 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.502 ' O ' ' HB ' ' A' ' 266' ' ' VAL . 45.1 tt0 -96.34 125.16 40.65 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 171.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.63 ' HA2' ' HB ' ' A' ' 266' ' ' VAL . . . -114.97 165.47 12.07 Favored Glycine 0 N--CA 1.439 -1.132 0 CA-C-N 115.466 -0.788 . . . . 0.0 113.15 -166.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.629 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 22.4 tt0 -139.04 118.86 13.19 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 171.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . 0.606 ' SG ' ' HB2' ' A' ' 282' ' ' LYS . 21.8 p -99.93 96.3 7.46 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 119.474 -0.891 . . . . 0.0 108.904 176.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 11.4 m120 41.59 52.69 3.9 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.935 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 115.18 -28.62 7.84 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.548 -0.834 . . . . 0.0 114.691 175.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . 0.629 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 10.0 mptt -91.63 134.21 34.89 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.105 0.952 . . . . 0.0 110.428 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . 0.414 ' HD2' ' N ' ' A' ' 283' ' ' ARG . 3.5 mpt_? -106.27 157.76 17.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.953 0.406 . . . . 0.0 111.301 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . 0.641 ' CA ' HD22 ' A' ' 256' ' ' LEU . . . 175.37 -172.97 45.96 Favored Glycine 0 C--O 1.224 -0.499 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -177.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' HIS . . . . . 0.411 ' H ' ' HA ' ' A' ' 255' ' ' ALA . 12.3 p80 -146.85 143.6 28.69 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 118.674 1.237 . . . . 0.0 111.782 171.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.722 ' CE2' ' HB3' ' A' ' 255' ' ' ALA . 5.8 m-85 -156.3 163.04 26.22 Favored Pre-proline 0 N--CA 1.464 0.264 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.429 -174.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -92.57 167.09 2.76 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.178 2.585 . . . . 0.0 112.06 175.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.484 ' CD1' ' HA3' ' A' ' 273' ' ' GLY . 39.7 p90 -85.18 -8.02 58.78 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -172.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 6.3 t -56.33 -13.19 2.01 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -174.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . 0.631 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 0.9 OUTLIER -138.94 33.56 2.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.928 0.394 . . . . 0.0 111.89 -178.259 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.722 HG12 ' HA ' ' A' ' 242' ' ' VAL . 15.5 m -146.74 162.08 9.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.348 176.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -117.79 106.37 12.95 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 176.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . 0.851 ' HG ' ' HZ2' ' A' ' 275' ' ' TRP . 0.0 OUTLIER -104.55 128.66 52.57 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 119.622 -0.831 . . . . 0.0 113.223 -169.363 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.641 ' O ' ' HB ' ' A' ' 238' ' ' ILE . 4.8 mp -84.7 125.0 32.14 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 168.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.552 ' HB3' ' HG2' ' A' ' 297' ' ' GLN . 33.8 t70 -84.72 153.47 23.05 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.497 -164.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.949 ' HB3' HG23 ' A' ' 238' ' ' ILE . 0.0 OUTLIER -76.57 11.89 1.47 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.1 -176.27 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.552 ' HG2' ' HB3' ' A' ' 295' ' ' ASP . 9.3 pt20 -58.45 -35.52 72.26 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 163.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . 0.44 ' N ' ' HG3' ' A' ' 297' ' ' GLN . 7.8 t30 . . . . . 0 N--CA 1.451 -0.4 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.706 174.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.972 0 CA-C-O 120.904 0.169 . . . . 0.0 113.199 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.429 ' HB3' ' HA ' ' A' ' 267' ' ' THR . 11.3 Cg_exo -71.23 120.57 7.09 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.49 2.127 . . . . 0.0 110.171 171.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 1.001 HG23 ' HB3' ' A' ' 296' ' ' GLN . 0.2 OUTLIER -80.43 158.21 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.115 -171.045 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.709 ' HD1' HD11 ' A' ' 263' ' ' LEU . 83.1 m-85 -99.43 118.33 35.8 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 174.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -114.78 115.74 27.51 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -175.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -79.93 101.88 8.86 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 176.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . 0.847 HG22 ' HD3' ' A' ' 245' ' ' LYS . 7.6 p -81.95 119.11 30.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.324 -175.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.409 HD11 ' C ' ' A' ' 243' ' ' ILE . 2.8 pp -98.71 3.7 10.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.411 -174.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.526 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 8.3 tt0 -177.28 106.0 0.06 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.446 -175.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.847 ' HD3' HG22 ' A' ' 242' ' ' VAL . 0.2 OUTLIER -146.93 166.0 28.09 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.344 0.593 . . . . 0.0 110.903 174.446 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.794 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 5.7 ptt180 -104.7 -178.8 3.76 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.135 -0.938 . . . . 0.0 108.602 -177.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 4.7 m -104.22 76.95 0.28 Allowed Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 121.227 0.537 . . . . 0.0 112.357 176.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.982 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 3.3 Cg_exo -83.31 177.43 6.51 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.274 3.316 . . . . 0.0 110.6 174.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.408 ' C ' ' H ' ' A' ' 251' ' ' TYR . 4.0 m-80 -139.49 176.99 8.26 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.054 -178.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.932 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -63.6 -5.06 3.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.634 0.73 . . . . 0.0 110.567 170.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.408 ' H ' ' C ' ' A' ' 249' ' ' ASN . 14.2 m-85 -90.2 -11.01 42.32 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.772 176.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -105.95 60.21 0.66 Allowed 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.557 -173.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . 0.5 ' N ' ' HD2' ' A' ' 253' ' ' LYS . 7.2 mptt 56.28 31.56 18.74 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -170.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' THR . . . . . 0.932 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 74.3 p 53.14 53.06 12.5 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 114.174 -1.375 . . . . 0.0 112.547 -177.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.413 ' HA ' ' H ' ' A' ' 285' ' ' HIS . . . -90.07 161.4 15.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.046 0.45 . . . . 0.0 110.709 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.668 ' N ' ' HA3' ' A' ' 284' ' ' GLY . 0.2 OUTLIER -78.89 132.67 36.86 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.745 -173.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.982 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -91.27 100.75 13.5 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 172.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.782 HD23 ' HG2' ' A' ' 245' ' ' LYS . 0.7 OUTLIER -150.26 171.25 17.25 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.493 -174.59 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.444 ' O ' HG11 ' A' ' 242' ' ' VAL . 30.9 tt0 -143.59 170.31 16.08 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.188 -163.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 2.5 p -53.81 118.74 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 121.528 0.68 . . . . 0.0 111.724 173.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 106.45 -1.67 37.05 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.011 171.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -89.04 176.21 7.08 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.079 -174.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.709 HD11 ' HD1' ' A' ' 239' ' ' TYR . 3.0 tm? -126.7 130.47 50.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.227 0.536 . . . . 0.0 110.132 -178.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.459 HG23 HD12 ' A' ' 258' ' ' LEU . 2.2 t -111.44 145.09 18.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.604 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 238' ' ' ILE . 62.3 tttp -120.68 95.12 4.59 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 170.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.722 ' HB ' ' HA2' ' A' ' 277' ' ' GLY . 1.4 m -84.71 124.42 39.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.723 -173.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' THR . . . . . 0.429 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 40.4 p -88.36 -9.49 52.56 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.868 -174.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 4.4 tppp? -116.92 103.62 10.47 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.753 HG22 HG22 ' A' ' 238' ' ' ILE . 0.7 OUTLIER -102.61 154.41 5.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.85 -172.816 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.519 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 4.2 p30 -144.23 -170.81 3.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.774 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 12.0 p -95.67 -33.87 4.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.916 -178.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 10.8 m -74.07 -43.02 59.22 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -173.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 123.88 -5.7 9.03 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.163 -177.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.66 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.9 OUTLIER -94.53 104.71 16.66 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 173.535 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.545 ' HZ2' HD12 ' A' ' 293' ' ' LEU . 0.0 OUTLIER -129.71 -179.76 5.37 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.598 0.713 . . . . 0.0 112.055 -173.684 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.506 ' HG2' ' HD1' ' A' ' 285' ' ' HIS . 32.2 mt-10 -102.42 123.87 46.98 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 173.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.722 ' HA2' ' HB ' ' A' ' 266' ' ' VAL . . . -109.09 153.39 16.84 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.905 -165.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.572 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 29.7 tt0 -135.42 118.88 16.85 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 174.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 47.9 t -99.3 96.38 7.7 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 12.8 m120 38.4 55.93 1.8 Allowed 'General case' 0 CA--C 1.533 0.323 0 O-C-N 124.362 1.039 . . . . 0.0 112.023 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 115.91 -40.26 2.48 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 120.433 -0.889 . . . . 0.0 114.091 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . 0.572 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 0.8 OUTLIER -80.05 136.82 36.66 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.969 0.884 . . . . 0.0 110.241 179.788 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 283' ' ' ARG . 5.6 mpt_? -113.12 131.23 55.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.643 0.735 . . . . 0.0 112.031 178.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . 0.668 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . -147.51 -166.96 12.89 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 114.282 -1.326 . . . . 0.0 111.651 174.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' HIS . . . . . 0.506 ' HD1' ' HG2' ' A' ' 276' ' ' GLU . 5.6 m-70 -145.91 139.89 26.58 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 117.684 0.742 . . . . 0.0 109.427 178.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.709 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 10.4 m-85 -167.99 157.2 8.69 Favored Pre-proline 0 N--CA 1.471 0.603 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -172.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.66 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 58.7 Cg_endo -95.34 176.39 0.9 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.709 2.939 . . . . 0.0 113.457 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.433 ' HA ' HG22 ' A' ' 291' ' ' VAL . 24.1 p90 -86.07 -9.74 56.2 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.106 -173.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 11.1 t -70.26 8.26 0.82 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -168.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . 0.526 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 0.9 OUTLIER -155.77 38.21 0.37 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.091 0.472 . . . . 0.0 110.95 177.517 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.58 HG21 HD21 ' A' ' 293' ' ' LEU . 27.6 m -144.67 157.76 14.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.014 0.435 . . . . 0.0 111.112 178.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -115.88 108.84 16.8 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 170.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . 0.58 HD21 HG21 ' A' ' 291' ' ' VAL . 0.2 OUTLIER -102.98 123.65 46.98 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -165.727 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 4.6 mp -82.38 125.31 30.89 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.092 167.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -77.63 160.07 28.77 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.922 0.867 . . . . 0.0 111.728 -166.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 1.001 ' HB3' HG23 ' A' ' 238' ' ' ILE . 12.3 pt20 -75.5 -15.42 60.4 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.07 -1.423 . . . . 0.0 111.499 -176.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -84.1 -8.8 59.0 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.116 175.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . 0.41 HD21 ' HA ' ' A' ' 298' ' ' ASN . 1.6 m120 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.748 174.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . 0.461 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . . . . . . 0 N--CA 1.446 -0.687 0 N-CA-C 113.463 0.145 . . . . 0.0 113.463 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.461 ' HD3' ' HA2' ' A' ' 236' ' ' GLY . 26.4 Cg_exo -68.06 145.66 68.07 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.859 3.04 . . . . 0.0 112.593 174.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 1.032 HG12 HG23 ' A' ' 266' ' ' VAL . 1.3 pt -91.75 167.98 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.727 173.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.754 ' HB3' HD12 ' A' ' 263' ' ' LEU . 61.5 m-85 -116.35 119.66 36.39 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 169.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.639 ' HA ' ' HA ' ' A' ' 293' ' ' LEU . . . -113.21 117.66 32.52 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.944 -175.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.476 ' HD3' ' O ' ' A' ' 262' ' ' GLU . 16.3 tpp180 -82.45 102.91 11.62 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.416 175.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . 0.935 HG22 ' HD2' ' A' ' 245' ' ' LYS . 2.6 p -87.26 135.15 25.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.512 -173.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.411 HD11 ' C ' ' A' ' 243' ' ' ILE . 2.8 pp -109.61 9.1 8.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.787 -175.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.797 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 58.2 tt0 -176.92 95.24 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.723 0.297 . . . . 0.0 110.26 -173.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.935 ' HD2' HG22 ' A' ' 242' ' ' VAL . 4.3 mttt -146.29 161.72 39.68 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 175.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.869 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 5.8 ptp180 -106.62 -178.07 3.54 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -177.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 32.0 t -103.3 80.37 0.36 Allowed Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 120.955 0.407 . . . . 0.0 111.262 176.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.939 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 3.1 Cg_endo -91.45 177.67 1.87 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 125.161 3.907 . . . . 0.0 111.184 175.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.425 ' C ' ' H ' ' A' ' 251' ' ' TYR . 90.5 m-20 -130.29 174.94 9.35 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 175.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.77 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -72.22 5.12 3.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.417 0.627 . . . . 0.0 110.332 175.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.425 ' H ' ' C ' ' A' ' 249' ' ' ASN . 28.7 m-85 -99.2 -2.62 36.28 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.216 174.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.404 ' C ' ' HD2' ' A' ' 253' ' ' LYS . 35.6 m-20 -105.15 63.72 0.7 Allowed 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.464 -177.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . 0.404 ' HD2' ' C ' ' A' ' 252' ' ' ASP . 7.0 mptt 57.58 25.62 11.83 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -171.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' THR . . . . . 0.77 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 44.9 p 56.06 75.86 0.32 Allowed 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.823 -174.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -113.77 150.3 33.62 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.253 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.467 ' O ' ' HE2' ' A' ' 286' ' ' PHE . 0.0 OUTLIER -72.84 132.92 44.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.611 -176.163 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.939 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -95.12 104.27 16.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.371 0.605 . . . . 0.0 111.479 174.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.729 ' HG ' ' HD3' ' A' ' 245' ' ' LYS . 0.4 OUTLIER -163.81 175.5 10.41 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.54 -176.344 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.441 ' O ' HG11 ' A' ' 242' ' ' VAL . 12.3 pt-20 -142.45 -166.42 2.26 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 121.591 -0.693 . . . . 0.0 112.383 -171.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 2.8 p -68.51 122.01 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.295 177.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 104.18 -0.75 43.96 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.284 174.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.476 ' O ' ' HD3' ' A' ' 241' ' ' ARG . 9.4 mt-10 -98.73 -174.72 2.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.842 0.353 . . . . 0.0 111.666 -170.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.754 HD12 ' HB3' ' A' ' 239' ' ' TYR . 50.7 tp -133.74 160.27 38.09 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.508 -177.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.486 ' N ' ' HG ' ' A' ' 263' ' ' LEU . 2.8 p -153.48 136.91 7.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.389 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.464 ' HE2' ' CE1' ' A' ' 239' ' ' TYR . 37.9 ttmt -99.98 102.1 13.38 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 175.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 1.032 HG23 HG12 ' A' ' 238' ' ' ILE . 4.0 m -86.79 115.68 28.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.97 0.89 . . . . 0.0 110.71 -178.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 9.9 t -99.95 4.08 44.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.596 -1.183 . . . . 0.0 110.394 -177.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.529 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 0.0 OUTLIER -124.94 107.19 10.6 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 168.128 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.55 HG21 HG22 ' A' ' 266' ' ' VAL . 0.8 OUTLIER -110.49 158.22 10.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 115.286 -0.87 . . . . 0.0 113.113 -172.098 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.721 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 2.6 p30 -146.34 -172.98 4.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.698 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 11.6 p -93.39 -31.92 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 45.7 m -74.99 -43.44 53.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -173.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . 0.771 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 125.04 -13.51 7.55 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.499 -178.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.6 OUTLIER -89.23 93.09 9.44 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 173.285 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.721 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -123.05 179.09 4.79 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.183 -176.204 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 53.4 tt0 -104.32 125.77 50.85 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.675 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -110.2 169.68 13.69 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.95 -172.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 3.1 tm-20 -152.32 119.45 5.87 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 171.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 44.6 t -115.63 99.55 7.42 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.084 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 43.3 54.33 5.16 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 124.252 0.97 . . . . 0.0 112.313 173.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 117.73 -40.45 2.33 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-N 115.828 -0.624 . . . . 0.0 114.102 176.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 0.0 OUTLIER -93.32 128.79 39.48 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 118.066 0.933 . . . . 0.0 109.934 -178.996 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . 0.544 ' H ' ' HD3' ' A' ' 283' ' ' ARG . 0.0 OUTLIER -121.2 145.47 47.8 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.266 176.28 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 173.05 157.75 15.61 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.072 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' HIS . . . . . 0.536 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 30.5 p80 -98.08 148.35 23.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.04 0.42 . . . . 0.0 112.117 -171.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.467 ' HE2' ' O ' ' A' ' 256' ' ' LEU . 5.3 m-85 -158.55 159.21 29.85 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.515 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.523 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 93.6 Cg_endo -89.36 168.28 5.14 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.206 2.604 . . . . 0.0 113.809 -177.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.771 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 19.0 t80 -76.62 -19.99 57.22 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 114.158 -1.383 . . . . 0.0 111.922 -172.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 8.9 t -61.8 -11.47 12.61 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -168.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . 0.797 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 1.0 OUTLIER -137.68 33.91 2.45 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.69 -0.631 . . . . 0.0 112.351 -176.359 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.566 HG11 ' HD2' ' A' ' 290' ' ' HIS . 34.1 m -139.93 153.11 22.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.882 0.372 . . . . 0.0 111.192 177.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -121.06 107.96 13.25 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 169.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . 0.723 HD23 ' CE2' ' A' ' 288' ' ' PHE . 0.2 OUTLIER -101.49 139.96 36.44 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -169.935 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.465 HD11 ' N ' ' A' ' 294' ' ' LEU . 4.5 mp -77.0 130.23 37.19 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 113.397 -1.729 . . . . 0.0 107.412 166.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.417 ' HB3' ' HG3' ' A' ' 297' ' ' GLN . 13.7 m-20 -77.13 144.15 38.65 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.486 -164.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.954 ' HB3' HG22 ' A' ' 238' ' ' ILE . 3.1 pt20 -77.15 0.47 21.54 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 113.864 -1.516 . . . . 0.0 111.233 -177.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.417 ' HG3' ' HB3' ' A' ' 295' ' ' ASP . 0.0 OUTLIER -79.01 -16.06 57.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.062 0.458 . . . . 0.0 110.145 175.447 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 48.1 t30 . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.19 175.965 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . 0.413 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . . . . . . 0 N--CA 1.449 -0.458 0 N-CA-C 112.583 -0.207 . . . . 0.0 112.583 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.413 ' HD3' ' HA2' ' A' ' 236' ' ' GLY . 18.9 Cg_endo -89.03 136.45 2.97 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 123.156 2.57 . . . . 0.0 111.935 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 0.669 HD11 ' HB ' ' A' ' 266' ' ' VAL . 0.1 OUTLIER -97.08 152.24 4.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.391 -178.641 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.694 ' HB3' HD22 ' A' ' 263' ' ' LEU . 67.3 m-85 -96.65 119.54 35.32 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 174.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 293' ' ' LEU . . . -114.42 116.72 29.35 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.24 0.543 . . . . 0.0 110.352 -174.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -86.19 102.29 13.78 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.592 178.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . 0.745 HG22 ' HD3' ' A' ' 245' ' ' LYS . 3.0 p -79.55 128.53 38.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.534 -175.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.689 HD11 ' HB2' ' A' ' 244' ' ' GLN . 2.8 pp -108.31 3.53 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.88 -175.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.689 ' HB2' HD11 ' A' ' 243' ' ' ILE . 4.0 mt-30 -176.29 95.67 0.05 Allowed 'General case' 0 N--CA 1.463 0.203 0 O-C-N 123.043 0.214 . . . . 0.0 111.061 -175.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.759 ' HE2' HD22 ' A' ' 258' ' ' LEU . 0.0 OUTLIER -146.5 163.17 36.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.183 0.516 . . . . 0.0 111.164 173.663 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.848 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 9.8 ptt180 -101.27 -176.92 3.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.679 -177.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 27.3 t -101.66 82.69 0.4 Allowed Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 120.856 0.36 . . . . 0.0 111.292 175.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.965 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 7.0 Cg_endo -93.02 177.14 1.44 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.656 3.571 . . . . 0.0 110.778 172.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . 0.455 ' C ' ' H ' ' A' ' 251' ' ' TYR . 51.8 m-80 -131.04 177.26 7.58 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.026 0.441 . . . . 0.0 110.678 176.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.789 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -64.2 0.25 1.02 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.356 0.598 . . . . 0.0 110.99 173.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.455 ' H ' ' C ' ' A' ' 249' ' ' ASN . 44.4 m-85 -103.81 8.57 37.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.454 0.645 . . . . 0.0 109.696 177.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.74 53.19 0.73 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.162 -0.927 . . . . 0.0 108.727 176.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt 58.01 30.45 19.24 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -167.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' THR . . . . . 0.789 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 43.4 p 59.1 71.3 0.59 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.826 -176.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -111.55 150.75 29.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.65 179.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.613 ' N ' ' HA3' ' A' ' 284' ' ' GLY . 0.2 OUTLIER -72.12 133.67 45.32 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.663 -174.543 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.965 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -90.57 98.92 12.06 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 172.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.759 HD22 ' HE2' ' A' ' 245' ' ' LYS . 0.9 OUTLIER -154.94 171.14 20.19 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.108 -173.735 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.5 ' O ' HG11 ' A' ' 242' ' ' VAL . 12.3 pt-20 -142.28 -166.59 2.28 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.177 0.513 . . . . 0.0 111.873 -171.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.565 HG22 ' HA ' ' A' ' 244' ' ' GLN . 48.2 t -68.12 117.61 10.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.124 176.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 107.13 0.86 35.74 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.132 172.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -93.15 179.78 5.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.188 0.518 . . . . 0.0 111.915 -173.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.694 HD22 ' HB3' ' A' ' 239' ' ' TYR . 3.0 tm? -136.89 133.57 35.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.251 -176.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.954 HG13 ' HB2' ' A' ' 279' ' ' CYS . 34.1 m -126.15 154.86 35.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.097 173.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -111.52 96.04 5.86 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.669 ' HB ' HD11 ' A' ' 238' ' ' ILE . 49.2 t -69.88 121.47 19.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.836 -174.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 40.8 p -103.51 -7.19 21.06 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.626 -176.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.574 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 0.0 OUTLIER -126.85 106.77 9.56 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 119.445 -0.902 . . . . 0.0 108.74 171.018 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.489 HD11 ' O ' ' A' ' 269' ' ' ILE . 0.7 OUTLIER -107.65 148.66 11.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 114.451 -1.249 . . . . 0.0 113.72 -168.613 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.883 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 0.3 OUTLIER -147.12 154.04 40.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.463 -178.947 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 35.9 m -70.4 -9.71 12.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -174.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.5 m -89.75 -45.49 9.26 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.867 -178.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 119.68 -7.95 12.03 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.061 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.683 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.0 OUTLIER -93.94 70.75 4.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.484 0.659 . . . . 0.0 109.636 176.897 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.883 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -112.74 174.83 5.7 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.327 -168.814 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.679 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 32.9 tt0 -94.87 123.82 38.56 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.225 0.536 . . . . 0.0 109.796 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -100.96 150.21 18.64 Favored Glycine 0 N--CA 1.436 -1.326 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.299 -175.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.795 ' HG3' ' HG2' ' A' ' 283' ' ' ARG . 32.4 tt0 -127.8 116.85 20.81 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . 0.954 ' HB2' HG13 ' A' ' 264' ' ' VAL . 43.7 t -111.17 98.36 7.46 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 24.95 61.56 0.05 Allowed 'General case' 0 C--N 1.343 0.306 0 O-C-N 125.619 1.824 . . . . 0.0 113.301 174.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 118.53 -24.27 8.63 Favored Glycine 0 CA--C 1.523 0.55 0 CA-C-N 115.447 -0.797 . . . . 0.0 114.134 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.35 144.4 31.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 118.003 0.902 . . . . 0.0 110.38 175.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . 0.795 ' HG2' ' HG3' ' A' ' 278' ' ' GLU . 28.7 mtm180 -123.91 129.5 51.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.792 0.33 . . . . 0.0 110.188 171.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . 0.613 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . -165.52 140.57 6.46 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.112 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' HIS . . . . . 0.679 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 20.7 p80 -99.25 148.04 24.54 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 117.434 0.617 . . . . 0.0 111.696 -175.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.645 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 5.7 m-85 -161.2 164.05 19.34 Favored Pre-proline 0 C--O 1.235 0.324 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.041 -177.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.683 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 1.7 Cg_endo -85.72 158.76 10.54 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.518 2.812 . . . . 0.0 112.13 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.654 ' HB2' HD23 ' A' ' 293' ' ' LEU . 1.8 p90 -87.03 -5.95 58.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.891 -174.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.513 HG21 ' HB2' ' A' ' 287' ' ' PRO . 5.6 t -52.8 -32.73 45.48 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . 0.425 ' CD2' ' HD2' ' A' ' 245' ' ' LYS . 0.8 OUTLIER -121.38 43.77 2.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.35 0.595 . . . . 0.0 111.429 -177.322 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.698 HG13 ' HA ' ' A' ' 242' ' ' VAL . 19.8 m -147.46 170.11 3.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.158 173.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -131.71 109.06 9.9 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 173.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . 0.654 HD23 ' HB2' ' A' ' 288' ' ' PHE . 0.1 OUTLIER -113.88 133.13 55.62 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.742 0.782 . . . . 0.0 112.883 -166.379 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 4.5 mp -86.41 125.67 33.85 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.326 -1.307 . . . . 0.0 108.075 171.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -75.96 166.75 23.05 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.282 -167.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.427 ' HB3' HG22 ' A' ' 238' ' ' ILE . 1.5 pm0 -76.74 -0.49 23.92 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.731 -176.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.89 -16.21 30.5 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.88 174.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.16 179.349 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.545 ' HB2' ' HD3' ' A' ' 265' ' ' LYS . 4.3 Cg_endo . . . . . 0 N--CA 1.451 -0.978 0 N-CA-C 111.554 -0.21 . . . . 0.0 111.554 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.779 ' CD1' ' HB ' ' A' ' 266' ' ' VAL . 0.2 OUTLIER -85.12 161.56 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 C-N-CA 119.219 -0.992 . . . . 0.0 109.852 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.839 ' HB3' HD21 ' A' ' 263' ' ' LEU . 44.4 m-85 -103.46 118.64 37.21 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 172.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.702 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -111.83 115.76 29.55 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.05 -174.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.514 ' HB3' ' O ' ' A' ' 292' ' ' ARG . 21.9 tpp180 -75.48 101.64 4.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 175.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.751 HG21 ' HD3' ' A' ' 245' ' ' LYS . 5.2 p -81.29 119.88 31.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 C-N-CA 120.316 -0.554 . . . . 0.0 109.991 -175.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.8 pp -102.23 9.15 8.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.629 -173.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.88 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 17.5 tt0 -176.9 95.44 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.192 -177.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.751 ' HD3' HG21 ' A' ' 242' ' ' VAL . 0.1 OUTLIER -146.48 164.22 33.22 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.839 0.828 . . . . 0.0 111.189 174.242 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.83 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 2.6 ptm180 -105.24 -175.88 2.92 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.637 -1.62 . . . . 0.0 108.767 -177.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 3.8 m -110.52 70.87 0.64 Allowed Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 121.42 0.628 . . . . 0.0 111.547 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 1.016 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 28.7 Cg_endo -95.29 123.08 0.32 Allowed 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 125.051 3.834 . . . . 0.0 111.913 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.416 ' C ' ' H ' ' A' ' 251' ' ' TYR . 40.7 m-80 -78.55 176.18 9.66 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.873 0.368 . . . . 0.0 111.038 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.705 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -62.9 -2.07 1.09 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.751 0.786 . . . . 0.0 111.349 175.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.416 ' H ' ' C ' ' A' ' 249' ' ' ASN . 12.0 m-85 -92.87 -1.93 56.32 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.998 178.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.38 47.81 1.14 Allowed 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt 59.99 30.22 19.73 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -167.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' THR . . . . . 0.705 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 29.4 p 63.79 86.22 0.12 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 113.825 -1.534 . . . . 0.0 111.048 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.685 ' HB3' ' HB2' ' A' ' 248' ' ' PRO . . . -120.6 163.78 17.5 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.951 178.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.515 ' HB3' ' CG ' ' A' ' 258' ' ' LEU . 4.5 mm? -83.15 120.59 25.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.203 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.016 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -88.84 91.19 8.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.65 0.738 . . . . 0.0 110.303 176.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.699 ' CD2' ' HB ' ' A' ' 264' ' ' VAL . 0.2 OUTLIER -148.34 176.28 10.4 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.561 -174.645 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.501 ' HG2' ' N ' ' A' ' 260' ' ' VAL . 15.4 tt0 -142.04 167.11 22.91 Favored 'General case' 0 C--N 1.313 -1.022 0 O-C-N 121.931 -0.481 . . . . 0.0 110.931 -162.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.501 ' N ' ' HG2' ' A' ' 259' ' ' GLU . 1.6 p -57.79 117.73 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 121.41 0.624 . . . . 0.0 111.236 174.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 107.52 -2.65 34.47 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.918 176.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -95.44 -173.33 2.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.941 0.4 . . . . 0.0 111.379 -173.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.839 HD21 ' HB3' ' A' ' 239' ' ' TYR . 3.4 tm? -133.73 122.27 23.11 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.711 -174.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.702 HG13 ' HB3' ' A' ' 240' ' ' ALA . 2.5 p -113.82 125.74 71.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.077 174.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.563 ' HG3' ' CE1' ' A' ' 239' ' ' TYR . 5.2 tmmm? -96.47 96.11 8.47 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.779 ' HB ' ' CD1' ' A' ' 238' ' ' ILE . 96.6 t -71.89 114.94 11.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.084 -177.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' THR . . . . . 0.446 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 4.7 t -93.36 -9.28 39.34 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 124.313 1.008 . . . . 0.0 111.266 -178.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.631 ' HA ' ' HE3' ' A' ' 268' ' ' LYS . 0.0 OUTLIER -127.32 103.28 7.31 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 175.399 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.449 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.8 OUTLIER -98.98 160.12 3.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -170.426 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.622 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 3.6 p30 -146.69 -169.62 3.32 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.925 178.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 8.5 p -96.65 -37.0 6.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 5.0 m -73.27 -43.02 61.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.864 0.364 . . . . 0.0 111.767 -172.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' GLY . . . . . 0.866 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 124.27 -4.79 8.87 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.828 -175.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -90.59 82.19 5.83 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 176.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.622 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -116.87 175.51 5.54 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.246 0.546 . . . . 0.0 112.054 -174.244 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.558 ' O ' HG13 ' A' ' 266' ' ' VAL . 36.0 mt-10 -102.62 124.66 48.57 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.831 177.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.614 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -108.41 153.38 16.83 Favored Glycine 0 N--CA 1.439 -1.128 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.418 -169.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.599 ' HG3' ' HG2' ' A' ' 283' ' ' ARG . 21.8 tt0 -130.74 119.8 22.87 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 173.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 279' ' ' CYS . . . . . 0.507 ' O ' ' HD2' ' A' ' 282' ' ' LYS . 53.7 t -116.56 96.22 5.41 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.958 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 24.38 61.31 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 O-C-N 124.914 1.384 . . . . 0.0 113.505 -177.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.79 -20.32 11.9 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.84 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' LYS . . . . . 0.507 ' HD2' ' O ' ' A' ' 279' ' ' CYS . 5.7 mptt -97.93 132.13 43.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.632 0.716 . . . . 0.0 109.749 174.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 283' ' ' ARG . . . . . 0.599 ' HG2' ' HG3' ' A' ' 278' ' ' GLU . 48.7 mtt180 -123.68 141.5 51.96 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 176.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 175.29 -148.79 9.73 Favored Glycine 0 C--O 1.223 -0.542 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.315 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' HIS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 12.8 p80 -149.17 145.92 27.4 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 117.37 0.585 . . . . 0.0 111.54 -177.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.617 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 4.4 m-85 -162.57 164.07 17.23 Favored Pre-proline 0 N--CA 1.47 0.546 0 C-N-CA 122.543 0.337 . . . . 0.0 111.119 -177.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.511 ' HD3' ' HD1' ' A' ' 286' ' ' PHE . 31.4 Cg_endo -95.39 168.11 1.45 Allowed 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 123.464 2.776 . . . . 0.0 114.144 -175.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.866 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 7.2 t80 -76.28 -17.71 59.33 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.748 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 35.8 p -45.61 -37.98 6.14 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -174.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' HIS . . . . . 0.88 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 0.8 OUTLIER -132.61 48.39 2.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.141 0.496 . . . . 0.0 112.32 -174.432 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 27.7 m -142.75 151.78 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.773 173.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.514 ' O ' ' HB3' ' A' ' 241' ' ' ARG . 21.2 mmt180 -128.83 109.39 11.24 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 176.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 293' ' ' LEU . . . . . 0.512 ' HB3' ' HA ' ' A' ' 240' ' ' ALA . 0.2 OUTLIER -116.7 144.07 44.88 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -162.643 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.554 ' O ' ' HB ' ' A' ' 238' ' ' ILE . 4.5 mp . . . . . 0 N--CA 1.438 -1.041 0 CA-C-N 113.461 -1.7 . . . . 0.0 108.8 169.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo . . . . . 0 N--CA 1.453 -0.889 0 CA-C-O 121.779 0.658 . . . . 0.0 111.612 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.934 HG23 ' HB ' ' A' ' 266' ' ' VAL . 0.1 OUTLIER -105.92 142.55 18.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.971 -173.26 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.708 ' HB3' HD11 ' A' ' 263' ' ' LEU . 76.7 m-85 -96.81 117.04 30.21 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 174.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.485 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -114.68 117.19 30.13 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.424 -173.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.59 ' HB3' ' O ' ' A' ' 292' ' ' ARG . 23.8 tpp180 -83.12 103.18 12.35 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.316 -177.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.984 HG21 ' HD3' ' A' ' 245' ' ' LYS . 3.7 p -81.86 128.79 38.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.258 -175.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.601 HD12 ' HB2' ' A' ' 244' ' ' GLN . 2.8 pp -107.33 7.43 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.344 -176.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.601 ' HB2' HD12 ' A' ' 243' ' ' ILE . 13.5 mt-30 -176.35 95.43 0.05 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.522 -173.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.984 ' HD3' HG21 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -146.09 163.32 35.68 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.118 0.485 . . . . 0.0 110.353 173.044 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.857 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 12.6 ptp180 -104.3 -177.08 3.26 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.344 -177.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 6.9 m -104.21 80.23 0.43 Allowed Pre-proline 0 CA--C 1.54 0.57 0 CA-C-O 121.522 0.677 . . . . 0.0 111.828 175.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.922 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 9.1 Cg_endo -92.93 176.67 1.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 125.167 3.911 . . . . 0.0 111.545 176.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -126.85 175.47 8.01 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.602 ' O ' HG22 ' A' ' 254' ' ' THR . . . -68.03 -0.99 5.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.4 175.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -114.93 14.83 17.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.431 0.634 . . . . 0.0 110.011 173.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -104.56 56.54 0.71 Allowed 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 173.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' LYS . . . . . 0.504 ' HE2' ' HA ' ' A' ' 253' ' ' LYS . 11.1 mmpt? 65.63 22.62 11.67 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.813 -169.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' THR . . . . . 0.602 HG22 ' O ' ' A' ' 250' ' ' ALA . 29.1 p 59.26 75.54 0.4 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.488 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.679 ' HB1' ' CE2' ' A' ' 286' ' ' PHE . . . -125.32 159.06 32.67 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.163 -176.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.591 HD21 ' O ' ' A' ' 277' ' ' GLY . 4.6 mm? -78.99 124.84 28.65 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.074 -0.967 . . . . 0.0 112.598 -176.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.922 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -83.03 93.17 7.52 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.338 0.589 . . . . 0.0 110.72 172.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.609 HD11 ' HE2' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -156.97 171.95 19.55 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.992 -1.003 . . . . 0.0 109.486 -177.508 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.413 ' O ' HG13 ' A' ' 242' ' ' VAL . 11.9 pt-20 -141.38 -163.87 1.65 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 118.488 0.586 . . . . 0.0 112.018 -167.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 244' ' ' GLN . 75.3 t -67.08 118.27 10.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.024 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 105.69 -2.18 39.15 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.606 171.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.536 ' O ' ' HD3' ' A' ' 241' ' ' ARG . 7.9 mt-10 -91.85 -179.46 5.32 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.824 0.345 . . . . 0.0 110.92 -172.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.708 HD11 ' HB3' ' A' ' 239' ' ' TYR . 41.1 tp -129.22 161.06 31.03 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.981 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.542 ' N ' ' HG ' ' A' ' 263' ' ' LEU . 2.4 p -151.15 132.31 4.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.944 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -93.19 97.98 10.99 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 177.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.934 ' HB ' HG23 ' A' ' 238' ' ' ILE . 97.8 t -69.8 119.3 15.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.498 -178.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 73.7 p -102.2 -25.57 13.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.751 -175.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.523 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 2.4 tppp? -108.56 106.04 15.94 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 173.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.769 HD13 ' H ' ' A' ' 269' ' ' ILE . 0.1 OUTLIER -109.77 148.07 13.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -167.022 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.772 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 1.9 p30 -135.85 -170.76 2.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.688 176.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.07 -21.25 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 120.54 -0.464 . . . . 0.0 112.082 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.4 m -79.2 -44.26 22.23 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -174.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 126.02 -11.3 7.35 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.411 -177.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.529 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 1.5 tm0? -91.33 107.79 19.45 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 174.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.772 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -147.72 -179.87 7.2 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -173.004 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.631 ' HG2' ' HB3' ' A' ' 285' ' ' HIS . 35.0 mt-10 -97.29 126.05 42.27 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.148 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.591 ' O ' HD21 ' A' ' 256' ' ' LEU . . . -110.68 156.42 15.57 Favored Glycine 0 N--CA 1.437 -1.242 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.717 -173.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 33.7 tt0 -135.21 119.69 18.03 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 172.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 45.6 t -109.72 97.1 6.71 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.922 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 34.4 56.52 0.67 Allowed 'General case' 0 N--CA 1.464 0.263 0 O-C-N 124.873 1.358 . . . . 0.0 112.479 176.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.36 -34.63 4.59 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.881 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 49.5 mttt -82.15 129.7 34.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.954 0.877 . . . . 0.0 110.874 178.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -113.07 148.29 35.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.026 0.441 . . . . 0.0 111.502 176.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 166.38 -150.42 17.59 Favored Glycine 0 C--O 1.225 -0.459 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.554 174.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' HIS . . . . . 0.631 ' HB3' ' HG2' ' A' ' 276' ' ' GLU . 30.1 p80 -149.74 157.22 43.01 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.59 0.695 . . . . 0.0 111.68 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.711 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 2.4 m-85 -163.3 158.78 18.0 Favored Pre-proline 0 C--N 1.331 -0.227 0 O-C-N 123.563 0.54 . . . . 0.0 110.479 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.529 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 10.7 Cg_endo -89.09 158.92 5.78 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.187 2.591 . . . . 0.0 111.938 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -83.97 -5.26 59.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.562 -176.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 11.1 t -54.83 -13.06 0.92 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' HIS . . . . . 0.548 ' NE2' ' HD2' ' A' ' 245' ' ' LYS . 0.6 OUTLIER -137.71 47.0 2.07 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.113 -0.367 . . . . 0.0 111.564 -179.635 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.769 HG12 ' HA ' ' A' ' 242' ' ' VAL . 35.6 m -147.36 170.26 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.39 0.614 . . . . 0.0 111.61 177.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.59 ' O ' ' HB3' ' A' ' 241' ' ' ARG . 16.3 tpp180 -129.35 110.16 11.69 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 171.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 293' ' ' LEU . . . . . 0.505 ' HB3' HD11 ' A' ' 238' ' ' ILE . 2.9 mt -91.31 140.64 29.59 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -163.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.422 ' N ' HD12 ' A' ' 294' ' ' LEU . 3.9 mp . . . . . 0 N--CA 1.445 -0.69 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 163.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.751 ' HB3' ' HA ' ' A' ' 267' ' ' THR . 4.2 Cg_exo . . . . . 0 CA--C 1.532 0.394 0 N-CA-C 113.271 0.45 . . . . 0.0 113.271 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.726 HD13 ' HB ' ' A' ' 266' ' ' VAL . 0.1 OUTLIER -84.07 151.55 3.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 120.996 0.427 . . . . 0.0 111.095 -170.611 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.49 ' HB3' HD11 ' A' ' 263' ' ' LEU . 57.6 m-85 -103.96 119.62 39.32 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 175.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.643 ' HA ' ' HA ' ' A' ' 293' ' ' LEU . . . -113.46 118.33 34.21 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.336 0.589 . . . . 0.0 111.154 -171.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.42 ' HB3' ' O ' ' A' ' 292' ' ' ARG . 20.9 tpp180 -78.0 102.34 7.34 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.637 176.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.647 HG21 ' HB2' ' A' ' 245' ' ' LYS . 3.2 p -80.94 124.96 39.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.609 -176.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.567 HD12 ' HB2' ' A' ' 244' ' ' GLN . 2.8 pp -105.44 8.58 9.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.588 -174.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.797 ' HA ' HG22 ' A' ' 260' ' ' VAL . 17.1 mt-30 -176.17 95.39 0.06 Allowed 'General case' 0 CA--C 1.515 -0.369 0 O-C-N 123.296 0.372 . . . . 0.0 110.347 -173.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.762 ' HG2' ' CD1' ' A' ' 258' ' ' LEU . 0.0 OUTLIER -146.72 163.56 35.55 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.603 0.716 . . . . 0.0 111.663 176.298 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.905 ' HG3' ' HG3' ' A' ' 248' ' ' PRO . 2.4 ptm180 -108.5 -173.3 2.24 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.175 -1.375 . . . . 0.0 109.303 -176.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 37.7 t -108.39 75.67 0.6 Allowed Pre-proline 0 CA--C 1.537 0.443 0 CA-C-O 121.523 0.678 . . . . 0.0 110.175 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.955 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 9.6 Cg_endo -95.0 132.45 0.57 Allowed 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 125.187 3.924 . . . . 0.0 111.768 178.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.41 ' O ' ' HB2' ' A' ' 252' ' ' ASP . 3.6 m-20 -89.53 175.81 7.14 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.772 0.32 . . . . 0.0 110.423 -176.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -71.12 4.02 3.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.608 0.718 . . . . 0.0 110.669 177.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -107.04 8.95 30.63 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.097 176.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 249' ' ' ASN . 0.7 OUTLIER -96.88 51.97 1.16 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.005 175.274 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.93 25.7 14.89 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -166.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 22.4 p 65.61 88.08 0.11 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.819 1.248 . . . . 0.0 110.0 -174.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.748 ' HB3' ' HB2' ' A' ' 248' ' ' PRO . . . -122.0 168.32 12.06 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.066 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.747 ' H ' ' HE2' ' A' ' 286' ' ' PHE . 4.3 mm? -94.86 118.44 31.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.526 -176.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.955 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -85.64 97.26 10.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.54 0.686 . . . . 0.0 110.115 176.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.762 ' CD1' ' HG2' ' A' ' 245' ' ' LYS . 0.2 OUTLIER -156.12 176.42 12.69 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.49 -174.471 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.564 ' HG2' ' N ' ' A' ' 260' ' ' VAL . 24.5 tt0 -142.67 173.79 11.23 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.584 -0.698 . . . . 0.0 111.705 -161.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.797 HG22 ' HA ' ' A' ' 244' ' ' GLN . 69.5 t -56.35 118.2 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 C-N-CA 123.241 0.616 . . . . 0.0 111.443 173.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 104.83 -2.38 41.64 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.805 173.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.442 ' OE2' ' HB3' ' A' ' 259' ' ' GLU . 14.4 mt-10 -97.14 -173.16 2.6 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.023 -174.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.49 HD11 ' HB3' ' A' ' 239' ' ' TYR . 12.4 tp -127.83 157.77 39.55 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.039 0.447 . . . . 0.0 110.685 -176.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.563 HG12 ' HB3' ' A' ' 240' ' ' ALA . 7.7 p -144.09 143.41 23.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 175.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -103.87 95.24 5.88 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.726 ' HB ' HD13 ' A' ' 238' ' ' ILE . 74.8 t -74.39 105.64 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-O 121.94 0.876 . . . . 0.0 110.566 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' THR . . . . . 0.751 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 5.3 t -93.93 -9.34 37.4 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 113.264 -1.789 . . . . 0.0 110.678 -174.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.552 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 14.8 tppt? -122.53 106.18 10.78 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 172.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.531 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.7 OUTLIER -106.78 153.21 8.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -166.66 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.802 HD22 ' HB3' ' A' ' 275' ' ' TRP . 2.0 p30 -147.14 177.01 9.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.057 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 9.7 p -89.91 -23.39 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -176.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.63 -1.05 51.02 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -175.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' GLY . . . . . 0.773 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 78.31 8.7 87.43 Favored Glycine 0 C--O 1.223 -0.532 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.983 177.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.492 ' N ' HD21 ' A' ' 270' ' ' ASN . 9.7 mm100 -93.29 73.25 4.56 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.802 ' HB3' HD22 ' A' ' 270' ' ' ASN . 0.0 OUTLIER -124.25 -179.41 4.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.507 0.67 . . . . 0.0 112.612 -166.554 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.728 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 32.0 mt-10 -104.32 125.74 50.82 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.584 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.594 ' O ' HD21 ' A' ' 256' ' ' LEU . . . -103.51 156.1 17.82 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.25 -173.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 20.0 tt0 -138.55 118.34 13.19 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 175.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 279' ' ' CYS . . . . . 0.626 ' SG ' ' HD3' ' A' ' 282' ' ' LYS . 26.6 p -102.48 97.12 7.4 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.419 -0.912 . . . . 0.0 109.635 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 39.45 56.69 2.21 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.438 -1.256 . . . . 0.0 112.323 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 115.92 -39.87 2.6 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.646 -0.788 . . . . 0.0 114.136 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' LYS . . . . . 0.626 ' HD3' ' SG ' ' A' ' 279' ' ' CYS . 5.9 mptt -76.58 129.16 36.03 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 118.144 0.972 . . . . 0.0 110.414 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.39 131.06 54.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.606 -176.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -167.78 -151.18 6.88 Favored Glycine 0 C--O 1.224 -0.49 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.228 174.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' HIS . . . . . 0.728 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 16.8 p80 -150.56 147.91 28.03 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 117.122 0.461 . . . . 0.0 111.187 -177.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.747 ' HE2' ' H ' ' A' ' 256' ' ' LEU . 4.5 m-85 -157.84 160.18 30.12 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 120.728 0.299 . . . . 0.0 111.69 -177.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -95.19 155.24 1.69 Allowed 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 123.342 2.694 . . . . 0.0 114.005 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.773 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 20.0 t80 -66.29 -21.39 66.27 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 114.221 -1.354 . . . . 0.0 112.514 -176.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 9.2 t -57.77 -20.73 37.33 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 -168.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' HIS . . . . . 0.569 ' HB2' ' HB2' ' A' ' 244' ' ' GLN . 1.0 OUTLIER -136.36 37.61 2.71 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.952 -0.468 . . . . 0.0 111.9 -175.181 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.408 HG23 ' CD1' ' A' ' 293' ' ' LEU . 32.8 m -141.05 151.0 19.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.253 175.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.42 ' O ' ' HB3' ' A' ' 241' ' ' ARG . 14.1 mmm180 -121.68 108.06 13.1 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 173.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 293' ' ' LEU . . . . . 0.643 ' HA ' ' HA ' ' A' ' 240' ' ' ALA . 0.0 OUTLIER -101.21 137.1 40.01 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -167.553 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.538 ' H ' HD12 ' A' ' 294' ' ' LEU . 4.3 mp . . . . . 0 N--CA 1.427 -1.597 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 162.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo . . . . . 0 N--CA 1.462 -0.377 0 CA-C-O 120.828 0.262 . . . . 0.0 111.856 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 1.041 HG23 ' HB ' ' A' ' 266' ' ' VAL . 0.0 OUTLIER -91.79 131.04 39.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.951 -177.469 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.421 ' HB2' ' HB2' ' A' ' 294' ' ' LEU . 47.4 m-85 -97.55 120.22 37.53 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 176.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.732 ' HB2' HD11 ' A' ' 238' ' ' ILE . . . -116.02 118.13 32.05 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.366 -174.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 292' ' ' ARG . 0.0 OUTLIER -78.88 100.94 7.43 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 174.601 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.786 HG21 ' HB2' ' A' ' 245' ' ' LYS . 9.8 p -81.08 115.48 23.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 119.192 -1.003 . . . . 0.0 109.932 -176.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.5 HD12 ' HB2' ' A' ' 244' ' ' GLN . 2.8 pp -97.99 2.97 10.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.113 -174.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.794 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 56.1 tp60 -176.59 93.17 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.032 -174.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.876 ' HG2' HD21 ' A' ' 258' ' ' LEU . 0.5 OUTLIER -147.16 166.21 27.66 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.202 0.525 . . . . 0.0 110.026 173.114 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.807 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 6.2 ptm180 -102.25 -178.59 3.74 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.548 -174.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 43.5 t -107.73 80.6 1.0 Allowed Pre-proline 0 CA--C 1.536 0.415 0 CA-C-O 121.233 0.54 . . . . 0.0 111.011 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.88 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 9.9 Cg_endo -93.96 168.03 2.02 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 124.606 3.537 . . . . 0.0 111.339 174.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -123.3 178.24 5.22 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.02 0.438 . . . . 0.0 110.426 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.712 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -61.83 -2.23 0.81 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.571 174.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -100.99 -2.46 31.66 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.182 0.515 . . . . 0.0 110.543 176.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -105.6 65.45 0.71 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -177.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' LYS . . . . . 0.678 ' HA ' ' HE3' ' A' ' 253' ' ' LYS . 0.0 OUTLIER 61.2 19.7 10.31 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.587 -171.772 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 254' ' ' THR . . . . . 0.712 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 30.5 p 56.63 64.44 1.67 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.723 -175.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.519 ' HB1' ' CE2' ' A' ' 286' ' ' PHE . . . -109.55 154.65 22.44 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.272 -0.877 . . . . 0.0 111.006 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.874 ' HB3' HD22 ' A' ' 258' ' ' LEU . 0.2 OUTLIER -69.03 132.91 47.39 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.606 -175.643 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.88 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -85.52 93.25 8.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.346 0.593 . . . . 0.0 109.546 168.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.876 HD21 ' HG2' ' A' ' 245' ' ' LYS . 0.5 OUTLIER -142.14 160.92 39.26 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.292 -175.013 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.577 ' O ' HG13 ' A' ' 242' ' ' VAL . 37.4 tt0 -142.29 173.66 11.33 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.887 -165.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.551 HG22 ' HA ' ' A' ' 244' ' ' GLN . 47.3 t -56.15 117.79 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-O 121.267 0.556 . . . . 0.0 112.162 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 95.67 0.93 62.21 Favored Glycine 0 CA--C 1.505 -0.591 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.0 172.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -87.41 164.52 16.16 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.51 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.53 ' HG ' ' N ' ' A' ' 264' ' ' VAL . 16.6 tp -121.32 152.56 38.82 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.721 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.723 HG12 ' HB2' ' A' ' 279' ' ' CYS . 15.0 m -141.81 166.34 17.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.401 ' O ' ' HD3' ' A' ' 265' ' ' LYS . 8.2 tmtt? -132.42 97.21 4.04 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 1.041 ' HB ' HG23 ' A' ' 238' ' ' ILE . 46.1 t -68.95 128.24 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.732 -176.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 11.6 p -100.03 -18.86 16.81 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 113.722 -1.581 . . . . 0.0 111.852 -173.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -127.73 106.4 9.11 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 121.459 0.647 . . . . 0.0 109.762 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.592 HD12 HG22 ' A' ' 238' ' ' ILE . 0.0 OUTLIER -98.21 154.48 3.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.604 -167.073 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.784 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 15.3 p30 -146.43 -169.65 3.32 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.515 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 12.7 p -98.34 -35.04 4.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.961 -177.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 3.5 m -68.84 -44.61 73.06 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -174.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' GLY . . . . . 0.421 ' HA3' ' CD1' ' A' ' 288' ' ' PHE . . . 121.83 -5.98 10.47 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.316 -176.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.6 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.0 OUTLIER -96.01 70.73 2.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.791 0.805 . . . . 0.0 110.351 176.479 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.784 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -102.32 173.33 6.41 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.615 -172.265 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.744 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 33.3 tt0 -93.39 123.74 36.9 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.524 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -103.08 151.43 17.96 Favored Glycine 0 N--CA 1.437 -1.253 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.27 -171.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -129.12 119.51 24.26 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 173.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' CYS . . . . . 0.723 ' HB2' HG12 ' A' ' 264' ' ' VAL . 44.7 t -114.04 97.1 6.17 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.566 -177.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 28.84 61.31 0.13 Allowed 'General case' 0 N--CA 1.466 0.375 0 O-C-N 124.967 1.417 . . . . 0.0 112.564 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.58 -38.63 2.96 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 115.724 -0.671 . . . . 0.0 113.268 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -80.61 146.63 31.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.297 0.548 . . . . 0.0 110.52 177.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 39.8 mtt180 -132.4 129.78 39.78 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.012 0.434 . . . . 0.0 110.033 170.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' GLY . . . . . 0.636 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . -173.81 142.1 6.36 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.006 -177.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 285' ' ' HIS . . . . . 0.744 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 14.7 p80 -91.92 148.03 22.52 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 117.908 0.854 . . . . 0.0 111.681 -175.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.84 ' HD1' ' HD3' ' A' ' 287' ' ' PRO . 3.2 m-85 -165.03 170.12 6.73 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -174.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.84 ' HD3' ' HD1' ' A' ' 286' ' ' PHE . 58.1 Cg_endo -100.84 156.94 0.42 Allowed 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 123.306 2.67 . . . . 0.0 112.856 -174.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.469 ' HA ' HG22 ' A' ' 291' ' ' VAL . 0.7 OUTLIER -87.16 -8.85 56.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.076 -177.872 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.566 HG22 ' HB2' ' A' ' 287' ' ' PRO . 10.0 t -55.79 -32.65 63.68 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.84 -178.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 290' ' ' HIS . . . . . 0.794 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 0.5 OUTLIER -119.98 55.13 1.0 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.585 0.707 . . . . 0.0 111.365 175.363 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.469 HG22 ' HA ' ' A' ' 288' ' ' PHE . 10.6 m -147.17 171.96 3.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.811 170.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 241' ' ' ARG . 14.5 tpt180 -122.66 108.88 13.58 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 171.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 6.1 tp -84.62 123.55 30.46 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 115.231 -0.895 . . . . 0.0 113.37 -164.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 239' ' ' TYR . 6.6 mt . . . . . 0 N--CA 1.44 -0.965 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 169.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.987 ' HB3' ' HA ' ' A' ' 267' ' ' THR . 4.5 Cg_exo . . . . . 0 C--O 1.238 0.487 0 CA-C-O 120.517 0.132 . . . . 0.0 111.92 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 1.077 HG12 HG22 ' A' ' 266' ' ' VAL . 0.8 OUTLIER -78.73 160.77 4.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.016 -167.3 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.682 ' HB3' HD11 ' A' ' 263' ' ' LEU . 86.7 m-85 -108.5 118.75 37.58 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 174.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.596 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -113.77 118.49 34.42 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.165 0.507 . . . . 0.0 111.021 -174.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.415 ' HB3' ' O ' ' A' ' 292' ' ' ARG . 15.1 tpp180 -81.6 103.73 11.52 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 1.07 HG21 ' HD2' ' A' ' 245' ' ' LYS . 5.6 p -86.01 130.74 36.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.986 -175.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.45 HD12 ' HB2' ' A' ' 244' ' ' GLN . 2.8 pp -106.83 8.8 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.704 -174.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.77 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 63.3 tt0 -177.8 94.06 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -173.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 1.07 ' HD2' HG21 ' A' ' 242' ' ' VAL . 11.0 mttt -145.57 161.84 38.85 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 175.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.856 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 13.2 ptt180 -107.59 -176.31 3.03 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.875 -172.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 7.0 p -104.13 78.83 0.34 Allowed Pre-proline 0 CA--C 1.547 0.848 0 CA-C-O 121.812 0.815 . . . . 0.0 111.533 175.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.959 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 1.7 Cg_endo -88.99 177.95 2.81 Favored 'Trans proline' 0 N--CA 1.459 -0.537 1 C-N-CA 125.303 4.002 . . . . 0.0 110.654 174.436 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.422 ' C ' ' H ' ' A' ' 251' ' ' TYR . 27.7 m-80 -130.16 170.65 13.79 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.045 0.45 . . . . 0.0 109.913 177.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.699 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -76.4 14.87 0.68 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.568 0.699 . . . . 0.0 110.544 178.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.422 ' H ' ' C ' ' A' ' 249' ' ' ASN . 37.2 m-85 -110.92 1.89 17.83 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.844 175.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -95.6 49.19 1.17 Allowed 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.72 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt 60.42 33.99 20.63 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -166.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' THR . . . . . 0.699 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 71.5 p 59.55 77.63 0.3 Allowed 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 113.728 -1.578 . . . . 0.0 111.864 -178.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.425 ' C ' ' HA3' ' A' ' 284' ' ' GLY . . . -112.44 154.79 25.29 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.714 176.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 1.108 HD12 ' HG ' ' A' ' 258' ' ' LEU . 0.0 OUTLIER -83.73 133.64 34.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.255 -174.46 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.959 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -91.03 101.24 14.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.346 0.593 . . . . 0.0 109.591 171.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 1.108 ' HG ' HD12 ' A' ' 256' ' ' LEU . 0.1 OUTLIER -158.1 169.53 24.32 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.746 -174.864 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.457 ' HG2' ' N ' ' A' ' 260' ' ' VAL . 32.0 tt0 -142.16 173.21 11.73 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 121.902 -0.499 . . . . 0.0 112.048 -160.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.736 HG22 ' HA ' ' A' ' 244' ' ' GLN . 53.9 t -55.11 118.3 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 C-N-CA 123.364 0.665 . . . . 0.0 111.537 175.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 102.73 -1.69 48.84 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.644 -0.582 . . . . 0.0 111.644 172.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -95.94 173.23 7.54 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.711 -173.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.682 HD11 ' HB3' ' A' ' 239' ' ' TYR . 40.1 tp -117.27 157.62 25.75 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.326 0.584 . . . . 0.0 111.059 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.596 HG13 ' HB3' ' A' ' 240' ' ' ALA . 2.6 p -152.31 119.19 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.139 -177.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.453 ' HE3' ' HG2' ' A' ' 237' ' ' PRO . 54.7 tttp -86.9 97.34 10.62 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.572 177.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 1.077 HG22 HG12 ' A' ' 238' ' ' ILE . 7.0 m -77.23 114.4 17.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.892 0.853 . . . . 0.0 109.988 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' THR . . . . . 0.987 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 9.7 t -96.93 4.39 51.61 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.06 -174.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.563 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 0.0 OUTLIER -132.48 107.52 8.53 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 169.797 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.674 HG21 HG23 ' A' ' 238' ' ' ILE . 0.8 OUTLIER -111.12 156.37 12.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 114.961 -1.018 . . . . 0.0 113.355 -170.25 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.766 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 0.1 OUTLIER -146.13 -161.1 1.24 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.938 -1.483 . . . . 0.0 109.195 178.357 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.04 -23.3 4.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.888 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 3.0 m -65.62 -44.62 85.94 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -175.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 273' ' ' GLY . . . . . 0.64 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 124.03 -21.89 6.87 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.127 -177.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.647 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 10.1 tm0? -89.76 102.77 15.47 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 173.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.766 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -134.6 174.92 10.02 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.067 -177.071 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 44.4 tt0 -91.14 125.46 35.92 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.629 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -105.03 155.84 16.99 Favored Glycine 0 N--CA 1.437 -1.289 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.549 -175.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 30.8 tt0 -139.27 119.86 14.08 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 176.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' CYS . . . . . 0.438 ' HB3' HD11 ' A' ' 256' ' ' LEU . 49.0 t -108.5 98.44 7.96 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 46.51 46.17 14.16 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.378 176.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 115.59 -39.34 2.78 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.385 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 55.3 mttt -69.96 130.87 43.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.237 0.518 . . . . 0.0 109.711 177.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 36.1 mtt180 -113.67 129.67 56.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.12 0.486 . . . . 0.0 110.969 176.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' GLY . . . . . 0.55 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . -170.18 142.82 7.44 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.995 -178.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 285' ' ' HIS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 25.3 p80 -99.56 148.73 23.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 117.265 0.533 . . . . 0.0 111.172 -171.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.65 ' CG ' ' HE2' ' A' ' 245' ' ' LYS . 5.8 m-85 -159.26 158.96 28.83 Favored Pre-proline 0 CA--C 1.533 0.289 0 O-C-N 123.469 0.48 . . . . 0.0 110.796 -176.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.647 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 97.2 Cg_endo -91.58 169.88 3.1 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.919 2.413 . . . . 0.0 113.909 -175.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.64 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 9.8 t80 -75.87 -13.18 60.27 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.554 -175.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 25.4 p -48.24 -29.36 3.72 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -174.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' HIS . . . . . 0.77 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 1.3 p-80 -136.9 39.84 2.55 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.779 0.323 . . . . 0.0 111.586 -171.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.462 HG23 ' HA ' ' A' ' 242' ' ' VAL . 3.1 p -141.78 150.81 19.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 119.454 -0.899 . . . . 0.0 112.53 -175.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.415 ' O ' ' HB3' ' A' ' 241' ' ' ARG . 30.0 mmm180 -130.39 108.89 10.32 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 293' ' ' LEU . . . . . 0.59 HD21 ' CE2' ' A' ' 288' ' ' PHE . 0.4 OUTLIER -120.09 145.34 46.98 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -163.799 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.493 ' H ' HD12 ' A' ' 294' ' ' LEU . 4.7 mp . . . . . 0 N--CA 1.434 -1.26 0 CA-C-N 113.677 -1.601 . . . . 0.0 107.553 168.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.681 ' HB3' ' HA ' ' A' ' 267' ' ' THR . 7.6 Cg_exo . . . . . 0 N--CA 1.462 -0.337 0 N-CA-C 113.438 0.514 . . . . 0.0 113.438 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 1.092 HG12 HG22 ' A' ' 266' ' ' VAL . 0.6 OUTLIER -80.59 160.17 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.987 -171.917 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.883 ' HD1' HD11 ' A' ' 263' ' ' LEU . 64.5 m-85 -104.23 120.48 41.25 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 173.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.766 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -113.65 116.97 30.3 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.309 -176.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 241' ' ' ARG . 0.0 OUTLIER -81.65 101.03 9.78 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.766 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.75 ' CG2' ' HD3' ' A' ' 245' ' ' LYS . 3.4 p -78.33 122.3 33.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 119.931 -0.708 . . . . 0.0 110.116 -176.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.534 HG21 ' HG2' ' A' ' 292' ' ' ARG . 2.8 pp -110.12 6.46 8.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.516 -174.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.733 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 58.7 tt0 -176.3 94.55 0.05 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.081 -175.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.857 ' HE2' HD21 ' A' ' 258' ' ' LEU . 0.2 OUTLIER -147.07 168.0 22.67 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 122.008 0.909 . . . . 0.0 111.613 178.302 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.854 ' HG3' ' HG3' ' A' ' 248' ' ' PRO . 12.3 ptm180 -108.47 -176.4 3.04 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.787 -1.552 . . . . 0.0 109.717 -173.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 19.0 t -108.28 75.33 0.56 Allowed Pre-proline 0 CA--C 1.54 0.589 0 CA-C-O 121.029 0.442 . . . . 0.0 110.997 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.98 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 5.7 Cg_endo -91.11 177.41 2.03 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 124.861 3.707 . . . . 0.0 110.712 176.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.451 ' C ' ' H ' ' A' ' 251' ' ' TYR . 84.4 m-20 -135.18 175.34 9.67 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.781 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -69.46 9.7 0.44 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.393 0.616 . . . . 0.0 111.269 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.451 ' H ' ' C ' ' A' ' 249' ' ' ASN . 18.9 m-85 -103.14 -4.01 25.05 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 176.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -105.28 67.96 0.79 Allowed 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.16 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' LYS . . . . . 0.457 ' HE2' ' HB2' ' A' ' 253' ' ' LYS . 2.6 mppt? 54.54 28.97 10.49 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -169.121 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' THR . . . . . 0.781 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 78.3 p 55.66 73.48 0.43 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.903 -174.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.589 ' C ' ' HA3' ' A' ' 284' ' ' GLY . . . -108.47 153.08 23.84 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.366 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.727 ' N ' ' HA3' ' A' ' 284' ' ' GLY . 0.2 OUTLIER -79.92 132.58 36.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.341 -173.083 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.98 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -92.22 100.98 13.49 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 173.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.857 HD21 ' HE2' ' A' ' 245' ' ' LYS . 0.6 OUTLIER -154.62 170.67 20.96 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.521 -174.658 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.489 ' O ' HG13 ' A' ' 242' ' ' VAL . 29.8 tt0 -142.98 169.55 17.36 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.704 0.288 . . . . 0.0 111.584 -165.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.417 ' N ' ' HG2' ' A' ' 259' ' ' GLU . 3.5 p -55.04 118.0 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.703 0.763 . . . . 0.0 112.351 176.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 105.23 -2.71 40.38 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 114.92 -1.037 . . . . 0.0 111.741 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -90.98 -179.9 5.58 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.832 -176.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.883 HD11 ' HD1' ' A' ' 239' ' ' TYR . 3.2 tm? -132.18 130.04 40.55 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.766 HG13 ' HB3' ' A' ' 240' ' ' ALA . 2.4 p -124.05 118.21 53.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.264 178.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 238' ' ' ILE . 78.8 tttt -87.27 97.06 10.58 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 1.092 HG22 HG12 ' A' ' 238' ' ' ILE . 5.0 m -77.11 122.93 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 121.87 0.843 . . . . 0.0 111.049 -175.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 267' ' ' THR . . . . . 0.681 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 49.5 p -91.8 -15.42 28.28 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.983 -174.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.596 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 0.0 OUTLIER -119.66 105.46 11.2 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.733 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.579 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.8 OUTLIER -106.46 159.54 6.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -170.235 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.782 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 3.5 p30 -145.59 -168.25 2.92 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.988 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 13.3 p -99.28 -32.27 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 120.616 -0.433 . . . . 0.0 112.004 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 11.7 m -78.62 -26.63 45.35 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -173.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' GLY . . . . . 0.624 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 105.35 4.25 40.8 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.364 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -97.07 81.14 3.03 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.782 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -122.93 168.42 12.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.19 -168.847 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.596 ' HB3' ' HB3' ' A' ' 268' ' ' LYS . 40.8 tt0 -90.42 126.06 35.77 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.111 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.687 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -108.7 159.05 14.36 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.303 -173.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 40.8 tt0 -140.94 120.15 12.94 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 172.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' CYS . . . . . 0.412 ' HB3' HD11 ' A' ' 256' ' ' LEU . 34.6 t -114.62 96.89 5.97 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.349 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 33.65 57.19 0.55 Allowed 'General case' 0 N--CA 1.465 0.28 0 O-C-N 124.615 1.197 . . . . 0.0 112.527 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.97 -39.27 2.72 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-N 115.705 -0.68 . . . . 0.0 113.351 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 0.2 OUTLIER -77.77 139.85 39.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.492 0.646 . . . . 0.0 109.943 178.621 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 12.4 mtm180 -124.25 129.2 50.35 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 175.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' GLY . . . . . 0.727 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . 177.72 145.97 6.11 Favored Glycine 0 C--O 1.225 -0.467 0 C-N-CA 120.09 -1.052 . . . . 0.0 113.58 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 285' ' ' HIS . . . . . 0.554 ' CB ' ' HA ' ' A' ' 276' ' ' GLU . 28.5 p80 -104.18 147.71 27.13 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.965 0.383 . . . . 0.0 111.423 -175.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.56 ' CZ ' ' HB1' ' A' ' 255' ' ' ALA . 12.4 m-85 -159.14 167.02 15.18 Favored Pre-proline 0 CA--C 1.535 0.397 0 O-C-N 123.271 0.357 . . . . 0.0 111.494 -175.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.456 ' HD3' ' HD1' ' A' ' 286' ' ' PHE . 1.4 Cg_endo -86.25 153.99 9.46 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 123.514 2.809 . . . . 0.0 113.585 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.738 ' HE1' ' HG ' ' A' ' 293' ' ' LEU . 44.3 t80 -67.44 -23.28 65.51 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 114.374 -1.285 . . . . 0.0 112.477 -177.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.441 HG22 ' HB2' ' A' ' 287' ' ' PRO . 8.9 t -53.1 -29.36 30.27 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -168.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' HIS . . . . . 0.733 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 0.9 OUTLIER -122.16 53.43 1.23 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.612 0.72 . . . . 0.0 110.956 -179.684 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.518 ' O ' ' HD2' ' A' ' 292' ' ' ARG . 0.5 OUTLIER -147.24 158.74 9.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.129 176.912 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.534 ' HG2' HG21 ' A' ' 243' ' ' ILE . 21.1 mmm180 -121.69 109.49 14.8 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 173.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 293' ' ' LEU . . . . . 0.954 HD11 HD12 ' A' ' 238' ' ' ILE . 0.3 OUTLIER -91.07 127.19 36.4 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -161.396 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 239' ' ' TYR . 3.9 mt . . . . . 0 N--CA 1.438 -1.027 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 167.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo . . . . . 0 N--CA 1.462 -0.344 0 CA-C-O 121.211 0.421 . . . . 0.0 113.068 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.836 HG23 ' HB ' ' A' ' 266' ' ' VAL . 0.0 OUTLIER -94.33 139.54 18.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 173.612 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.567 ' HB2' ' HB2' ' A' ' 294' ' ' LEU . 0.7 OUTLIER -99.28 143.94 28.96 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 172.837 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.746 ' HA ' ' HA ' ' A' ' 293' ' ' LEU . . . -136.03 116.97 14.22 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 118.781 -1.168 . . . . 0.0 110.548 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -85.9 102.0 13.35 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 1.051 HG21 ' HD2' ' A' ' 245' ' ' LYS . 4.3 p -83.63 129.82 36.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.151 -173.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.9 pp -102.15 4.49 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.458 -175.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.621 ' H ' HG22 ' A' ' 242' ' ' VAL . 64.1 tt0 -178.47 102.6 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.687 -175.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 1.051 ' HD2' HG21 ' A' ' 242' ' ' VAL . 8.1 mttt -145.72 162.33 37.84 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 175.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.897 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 7.9 ttt-85 -99.41 177.21 5.25 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 123.433 0.693 . . . . 0.0 109.462 -174.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.442 ' N ' ' CG ' ' A' ' 246' ' ' ARG . 9.4 m -100.85 75.94 0.14 Allowed Pre-proline 0 CA--C 1.548 0.883 0 CA-C-O 121.546 0.688 . . . . 0.0 111.787 172.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.897 ' HD3' ' O ' ' A' ' 246' ' ' ARG . 0.9 OUTLIER -90.52 175.49 2.69 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 125.212 3.941 . . . . 0.0 111.04 177.036 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 252' ' ' ASP . 94.7 m-20 -128.22 175.73 8.22 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.949 0.404 . . . . 0.0 110.547 176.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.927 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -67.13 -11.22 56.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 122.127 0.965 . . . . 0.0 110.195 174.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -87.45 5.42 38.99 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.814 175.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 249' ' ' ASN . 3.0 m-20 -103.85 49.27 0.83 Allowed 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.168 177.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 253' ' ' LYS . . . . . 0.551 ' N ' ' HD2' ' A' ' 253' ' ' LYS . 0.0 OUTLIER 58.7 31.13 20.83 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -169.409 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 254' ' ' THR . . . . . 0.927 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 30.7 p 61.12 81.94 0.18 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 113.413 -1.721 . . . . 0.0 111.609 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.435 ' HB1' ' CE2' ' A' ' 286' ' ' PHE . . . -118.94 156.76 28.98 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.479 176.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.802 HD12 ' SG ' ' A' ' 279' ' ' CYS . 3.8 mm? -81.16 130.63 35.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.567 -175.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.854 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -89.99 97.76 11.38 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.438 0.637 . . . . 0.0 110.432 172.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.73 HD21 ' HD3' ' A' ' 245' ' ' LYS . 0.4 OUTLIER -159.79 171.89 18.67 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.275 -175.88 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.446 ' O ' HG13 ' A' ' 242' ' ' VAL . 12.4 pt-20 -143.53 -162.3 1.43 Allowed 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 119.822 -0.751 . . . . 0.0 112.865 -166.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.551 HG22 ' HA ' ' A' ' 244' ' ' GLN . 88.0 t -66.33 117.39 7.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.755 177.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 105.8 -1.27 38.9 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.85 171.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -91.58 -179.89 5.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.91 0.386 . . . . 0.0 111.399 -170.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.501 ' HG ' ' N ' ' A' ' 264' ' ' VAL . 38.2 tp -133.39 157.52 45.35 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.273 0.559 . . . . 0.0 111.314 -177.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.68 HG13 ' HB3' ' A' ' 240' ' ' ALA . 1.8 p -152.72 136.01 7.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.243 -177.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -98.49 96.8 8.24 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.836 ' HB ' HG23 ' A' ' 238' ' ' ILE . 52.0 t -68.63 117.92 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-O 121.205 0.526 . . . . 0.0 110.903 177.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 81.9 p -97.31 -19.2 18.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.422 -176.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.608 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 2.9 tppp? -116.97 107.08 14.13 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.469 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.6 OUTLIER -102.67 155.48 5.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -167.631 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.818 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 3.5 p30 -143.41 -178.53 5.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.275 174.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 8.9 p -82.53 -35.94 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -176.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 5.9 m -82.19 -43.33 17.81 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -172.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' GLY . . . . . 0.555 ' HA3' ' CD2' ' A' ' 288' ' ' PHE . . . 123.41 2.42 8.99 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.518 -178.002 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 1.0 OUTLIER -93.35 85.17 4.9 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 173.272 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.818 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -131.12 -179.79 5.54 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.89 -168.022 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.696 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 39.2 mt-10 -94.48 124.81 38.73 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.018 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.563 ' O ' HD21 ' A' ' 256' ' ' LEU . . . -106.67 145.34 15.94 Favored Glycine 0 N--CA 1.437 -1.267 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.334 -175.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.579 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 0.4 OUTLIER -124.14 118.73 27.55 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.023 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 279' ' ' CYS . . . . . 0.802 ' SG ' HD12 ' A' ' 256' ' ' LEU . 29.7 p -111.01 98.76 7.78 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.449 -174.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 15.7 m-20 49.09 45.65 22.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.491 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 114.14 -17.08 19.81 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.689 -0.767 . . . . 0.0 114.27 175.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 282' ' ' LYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 5.4 mptt -99.93 133.8 43.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.733 0.766 . . . . 0.0 110.352 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.94 134.48 54.43 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.793 0.33 . . . . 0.0 111.375 -174.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -176.22 -146.46 5.99 Favored Glycine 0 C--O 1.225 -0.407 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' HIS . . . . . 0.696 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 24.8 p80 -148.82 151.45 34.77 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 117.562 0.681 . . . . 0.0 111.134 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.656 ' CG ' ' HE2' ' A' ' 245' ' ' LYS . 1.8 m-85 -164.72 153.83 11.45 Favored Pre-proline 0 CA--C 1.535 0.395 0 O-C-N 123.452 0.47 . . . . 0.0 110.829 -177.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.534 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 95.3 Cg_endo -90.77 173.35 3.02 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.057 2.504 . . . . 0.0 114.029 -174.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.555 ' CD2' ' HA3' ' A' ' 273' ' ' GLY . 16.2 t80 -82.92 -20.86 34.55 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 114.369 -1.287 . . . . 0.0 111.926 -170.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 12.9 t -68.62 1.78 2.93 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -167.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' HIS . . . . . 0.452 ' CE1' ' HD2' ' A' ' 287' ' ' PRO . 0.2 OUTLIER -147.25 33.71 0.89 Allowed 'General case' 0 C--N 1.33 -0.239 0 O-C-N 121.706 -0.621 . . . . 0.0 111.682 178.78 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.431 HG23 ' CD1' ' A' ' 293' ' ' LEU . 31.8 m -140.25 151.76 21.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.73 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.415 ' HA ' ' HD2' ' A' ' 292' ' ' ARG . 20.8 tpt180 -122.03 108.37 13.3 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 173.128 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 293' ' ' LEU . . . . . 0.746 ' HA ' ' HA ' ' A' ' 240' ' ' ALA . 0.0 OUTLIER -94.42 139.54 30.99 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -163.687 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.567 ' HB2' ' HB2' ' A' ' 239' ' ' TYR . 5.0 mt . . . . . 0 N--CA 1.436 -1.153 0 CA-C-N 113.948 -1.478 . . . . 0.0 107.21 167.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.477 ' HG2' ' HE3' ' A' ' 265' ' ' LYS . 16.7 Cg_exo . . . . . 0 C--O 1.234 0.317 0 N-CA-C 112.536 0.168 . . . . 0.0 112.536 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.729 HD13 HG22 ' A' ' 266' ' ' VAL . 0.0 OUTLIER -89.69 149.47 4.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.764 174.965 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.543 ' N ' HG12 ' A' ' 238' ' ' ILE . 20.2 m-85 -95.89 119.35 34.23 Favored 'General case' 0 C--O 1.208 -1.107 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.46 ' HB3' ' CG2' ' A' ' 264' ' ' VAL . . . -113.87 118.22 33.61 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.481 -171.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.31 101.38 8.89 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.067 178.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 1.079 ' HA ' HG12 ' A' ' 291' ' ' VAL . 6.3 p -80.86 117.71 27.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.193 -176.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.568 ' O ' ' HG3' ' A' ' 244' ' ' GLN . 2.8 pp -105.15 0.61 10.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.013 -172.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.574 ' HB2' ' HB2' ' A' ' 290' ' ' HIS . 57.5 mt-30 -172.25 94.08 0.14 Allowed 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -173.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.848 ' HG2' ' CD2' ' A' ' 258' ' ' LEU . 2.5 tptt -146.66 165.54 29.26 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.517 0.675 . . . . 0.0 111.453 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.788 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 2.7 ptm85 -102.23 -178.13 3.61 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.079 -1.418 . . . . 0.0 110.279 -173.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 21.9 t -110.48 72.46 0.72 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.333 0.587 . . . . 0.0 109.71 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 1.071 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 72.1 Cg_endo -95.54 175.82 0.92 Allowed 'Trans proline' 0 N--CA 1.441 -1.612 0 C-N-CA 124.135 3.223 . . . . 0.0 110.541 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -136.3 176.2 8.91 Favored 'General case' 0 C--N 1.314 -0.978 0 O-C-N 121.952 -0.467 . . . . 0.0 110.298 -177.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.775 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -61.55 -7.61 3.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.368 0.604 . . . . 0.0 111.001 172.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -95.51 -2.29 48.9 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.313 176.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -105.41 63.73 0.69 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? 56.94 30.75 18.59 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -169.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' THR . . . . . 0.775 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 44.5 p 52.49 62.94 2.44 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.323 -173.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.605 ' HB3' ' HB2' ' A' ' 248' ' ' PRO . . . -96.85 150.8 20.32 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.337 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.755 ' N ' ' HA3' ' A' ' 284' ' ' GLY . 0.4 OUTLIER -74.34 131.09 40.82 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.913 -179.016 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.071 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -90.56 104.5 17.07 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 175.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.848 ' CD2' ' HG2' ' A' ' 245' ' ' LYS . 0.6 OUTLIER -153.8 164.47 38.3 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.427 -175.144 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.558 ' O ' HG13 ' A' ' 242' ' ' VAL . 32.4 tt0 -142.3 174.66 10.42 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 120.578 0.228 . . . . 0.0 111.159 -165.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.505 HG22 ' HA ' ' A' ' 244' ' ' GLN . 88.3 t -57.12 117.7 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.373 0.606 . . . . 0.0 112.234 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 98.71 -2.1 58.5 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.507 170.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -84.38 175.88 9.07 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.33 -176.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.558 ' HG ' ' N ' ' A' ' 264' ' ' VAL . 17.0 tp -130.35 154.72 47.38 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.65 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.7 HG12 ' HB2' ' A' ' 279' ' ' CYS . 17.1 m -145.5 160.37 12.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.778 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.477 ' HE3' ' HG2' ' A' ' 237' ' ' PRO . 56.8 tttp -117.87 97.9 6.07 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 177.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.729 HG22 HD13 ' A' ' 238' ' ' ILE . 4.6 m -80.38 121.66 34.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.49 0.662 . . . . 0.0 110.345 -176.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 38.2 p -99.6 -5.09 29.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.853 -174.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.63 ' O ' ' HB3' ' A' ' 275' ' ' TRP . 1.3 tppp? -119.03 105.47 11.46 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 174.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.78 HD13 ' H ' ' A' ' 269' ' ' ILE . 0.2 OUTLIER -114.95 149.42 17.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.645 -166.736 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -144.14 -168.76 2.96 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.85 -174.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 28.7 m -100.88 -21.52 5.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.8 m -81.54 -45.39 15.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.776 0.322 . . . . 0.0 111.211 -175.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 125.92 -8.37 7.66 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.655 -177.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.6 OUTLIER -90.56 105.04 17.55 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 173.604 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.63 ' HB3' ' O ' ' A' ' 268' ' ' LYS . 0.0 OUTLIER -115.57 173.46 6.52 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.706 0.765 . . . . 0.0 111.345 -175.464 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 268' ' ' LYS . 29.9 tt0 -96.65 124.28 40.59 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 165.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.517 ' O ' HD23 ' A' ' 256' ' ' LEU . . . -109.66 149.42 17.3 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.784 -167.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.643 ' HG3' ' HG2' ' A' ' 283' ' ' ARG . 31.9 tt0 -127.75 117.61 22.22 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 172.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 279' ' ' CYS . . . . . 0.7 ' HB2' HG12 ' A' ' 264' ' ' VAL . 53.7 t -101.65 94.84 6.06 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.314 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 36.38 55.13 1.08 Allowed 'General case' 0 CA--C 1.533 0.296 0 O-C-N 124.754 1.284 . . . . 0.0 111.843 175.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.51 -40.4 2.4 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 115.639 -0.71 . . . . 0.0 113.39 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' LYS . . . . . 0.503 ' HD2' ' HB3' ' A' ' 279' ' ' CYS . 35.3 mttt -76.42 138.83 40.62 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 117.513 0.656 . . . . 0.0 110.381 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 283' ' ' ARG . . . . . 0.643 ' HG2' ' HG3' ' A' ' 278' ' ' GLU . 23.2 mtt180 -122.33 129.93 52.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.365 0.602 . . . . 0.0 111.726 176.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 284' ' ' GLY . . . . . 0.755 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . -159.91 -171.09 25.32 Favored Glycine 0 C--O 1.221 -0.709 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.189 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 285' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -147.62 139.84 24.38 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 118.409 1.105 . . . . 0.0 111.053 175.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.589 ' CZ ' ' HB1' ' A' ' 255' ' ' ALA . 28.1 m-85 -159.17 168.89 11.46 Favored Pre-proline 0 N--CA 1.472 0.633 0 C-N-CA 122.627 0.371 . . . . 0.0 111.472 -174.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.481 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 17.7 Cg_endo -94.92 168.7 1.59 Allowed 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 123.611 2.874 . . . . 0.0 112.796 -177.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.679 ' HA ' ' CG2' ' A' ' 291' ' ' VAL . 29.4 p90 -87.12 -12.38 47.26 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.31 -174.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 5.2 t -49.91 -33.66 18.01 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' HIS . . . . . 0.574 ' HB2' ' HB2' ' A' ' 244' ' ' GLN . 2.2 p80 -125.75 56.97 1.37 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.792 0.806 . . . . 0.0 111.686 177.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 1.079 HG12 ' HA ' ' A' ' 242' ' ' VAL . 0.9 OUTLIER -154.56 170.94 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.573 168.23 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -130.01 107.75 9.58 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 172.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' LEU . . . . . 0.702 HD22 ' H ' ' A' ' 293' ' ' LEU . 0.0 OUTLIER -94.86 127.05 40.6 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 119.41 -0.916 . . . . 0.0 112.063 -169.266 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 10.4 mt . . . . . 0 N--CA 1.438 -1.029 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 171.029 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.625 ' HA ' ' O ' ' A' ' 266' ' ' VAL . 4.3 Cg_endo . . . . . 0 N--CA 1.456 -0.717 0 CA-C-O 120.897 0.29 . . . . 0.0 112.51 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.897 HD11 ' HB2' ' A' ' 240' ' ' ALA . 0.1 OUTLIER -86.38 152.46 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.345 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.795 ' HD1' HD11 ' A' ' 263' ' ' LEU . 59.4 m-85 -100.84 118.04 36.11 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 175.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.897 ' HB2' HD11 ' A' ' 238' ' ' ILE . . . -120.19 117.3 27.54 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.587 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.555 HH11 ' HA2' ' A' ' 261' ' ' GLY . 0.1 OUTLIER -85.76 103.48 14.58 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.7 -175.237 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.737 ' HA ' HG12 ' A' ' 291' ' ' VAL . 2.2 t -66.17 131.79 31.84 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.104 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.081 -175.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.417 HD12 ' CB ' ' A' ' 244' ' ' GLN . 2.9 pp -120.84 2.3 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 O-C-N 123.539 0.524 . . . . 0.0 110.421 176.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.547 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 53.1 tt0 -178.22 95.58 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.072 -172.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.722 ' HB3' ' O ' ' A' ' 258' ' ' LEU . 0.0 OUTLIER -145.75 164.84 30.59 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.37 0.605 . . . . 0.0 110.443 175.84 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.881 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 12.7 ttm180 -92.87 171.98 8.62 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.778 -176.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.443 ' N ' ' HG2' ' A' ' 246' ' ' ARG . 21.9 t -101.72 75.48 0.16 Allowed Pre-proline 0 CA--C 1.542 0.646 0 CA-C-O 121.02 0.438 . . . . 0.0 110.123 170.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.996 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 1.2 Cg_endo -89.02 178.89 2.53 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 125.226 3.951 . . . . 0.0 111.875 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -127.52 175.36 8.31 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.97 0.414 . . . . 0.0 109.959 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.518 ' O ' HG22 ' A' ' 254' ' ' THR . . . -68.98 -1.23 6.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.125 0.488 . . . . 0.0 110.796 174.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -106.17 1.18 25.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.124 176.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -93.34 55.02 2.19 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp 60.54 22.61 12.33 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.46 -168.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' THR . . . . . 0.518 HG22 ' O ' ' A' ' 250' ' ' ALA . 28.6 p 64.65 83.59 0.16 Allowed 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.553 -177.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.64 ' HB1' ' CE2' ' A' ' 286' ' ' PHE . . . -128.67 153.56 47.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.015 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.59 HD21 ' O ' ' A' ' 277' ' ' GLY . 4.2 mm? -72.83 120.48 18.51 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.85 -175.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.996 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -81.04 87.11 6.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.18 0.514 . . . . 0.0 111.007 174.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.722 ' O ' ' HB3' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -157.69 168.47 27.13 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.192 -176.046 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.477 ' O ' ' HB ' ' A' ' 242' ' ' VAL . 12.6 pt-20 -142.56 -164.91 1.92 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -168.05 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 4.3 p -60.25 122.46 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 121.593 0.711 . . . . 0.0 112.095 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.555 ' HA2' HH11 ' A' ' 241' ' ' ARG . . . 107.57 -1.44 34.41 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.851 172.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -89.68 -177.62 5.32 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -170.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.795 HD11 ' HD1' ' A' ' 239' ' ' TYR . 3.4 tm? -138.78 122.11 17.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.526 177.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.7 HG13 ' HB3' ' A' ' 240' ' ' ALA . 2.1 p -115.11 129.28 71.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.056 178.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 238' ' ' ILE . 75.9 tttt -98.54 95.17 7.11 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.768 ' HB ' HG23 ' A' ' 238' ' ' ILE . 21.0 t -66.14 123.17 18.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.243 -175.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 35.3 p -95.77 -24.46 16.49 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.855 -174.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.568 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 0.0 OUTLIER -119.12 107.34 13.36 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.534 -0.866 . . . . 0.0 109.509 177.007 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.471 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.6 OUTLIER -97.04 155.08 3.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-N 114.334 -1.303 . . . . 0.0 114.166 -167.772 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.893 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 9.9 p30 -146.48 -172.55 3.98 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.772 171.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 60.1 t -93.35 -41.31 12.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.949 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 2.6 p -58.95 -43.7 91.31 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -175.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 115.45 -4.34 21.6 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.319 -0.944 . . . . 0.0 112.673 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.587 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.0 OUTLIER -95.91 71.93 2.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.709 0.766 . . . . 0.0 109.725 176.667 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.893 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -111.98 179.01 4.12 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.633 -168.609 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.63 ' HG2' ' O ' ' A' ' 284' ' ' GLY . 6.1 tt0 -90.2 125.27 35.41 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.59 ' O ' HD21 ' A' ' 256' ' ' LEU . . . -110.26 141.9 16.41 Favored Glycine 0 N--CA 1.436 -1.304 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 -173.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 26.6 tt0 -127.14 118.48 24.44 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 170.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' CYS . . . . . 0.48 ' O ' ' HD3' ' A' ' 282' ' ' LYS . 13.8 t -106.28 96.88 6.78 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -178.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 28.69 60.33 0.13 Allowed 'General case' 0 N--CA 1.468 0.454 0 O-C-N 125.015 1.447 . . . . 0.0 112.991 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 115.63 -30.53 6.61 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.334 178.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' LYS . . . . . 0.569 ' HE3' ' O ' ' A' ' 257' ' ' ALA . 6.1 mppt? -85.94 131.59 34.25 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.096 0.448 . . . . 0.0 110.378 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 40.1 mmm-85 -114.42 149.89 35.54 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.793 0.33 . . . . 0.0 111.698 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 284' ' ' GLY . . . . . 0.63 ' O ' ' HG2' ' A' ' 276' ' ' GLU . . . 159.72 -162.41 32.97 Favored Glycine 0 C--O 1.216 -0.973 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 173.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 285' ' ' HIS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 31.3 p80 -136.94 148.48 46.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 118.087 0.943 . . . . 0.0 111.077 177.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.64 ' CE2' ' HB1' ' A' ' 255' ' ' ALA . 2.4 m-85 -161.24 159.06 24.11 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 120.718 0.294 . . . . 0.0 111.325 -174.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 73.4 Cg_endo -93.14 149.44 2.52 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.251 2.634 . . . . 0.0 112.867 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.636 ' HA ' HG22 ' A' ' 291' ' ' VAL . 0.5 OUTLIER -75.28 -9.1 58.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.251 -174.26 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 8.9 t -63.0 -24.93 68.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.231 -0.441 . . . . 0.0 112.017 -173.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' HIS . . . . . 0.547 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 1.4 p-80 -121.67 38.07 4.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.48 0.657 . . . . 0.0 111.343 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.737 HG12 ' HA ' ' A' ' 242' ' ' VAL . 27.6 m -144.26 161.56 15.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.423 170.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -117.0 106.85 13.85 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' LEU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 240' ' ' ALA . 0.2 OUTLIER -102.93 129.04 49.51 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-O 121.753 0.787 . . . . 0.0 113.008 -165.598 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 3.8 mp . . . . . 0 N--CA 1.437 -1.087 0 CA-C-N 114.348 -1.296 . . . . 0.0 108.797 168.706 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 266' ' ' VAL . 3.2 Cg_exo . . . . . 0 N--CA 1.455 -0.753 0 N-CA-C 111.659 -0.17 . . . . 0.0 111.659 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.814 HD13 ' HB ' ' A' ' 266' ' ' VAL . 0.1 OUTLIER -93.68 165.96 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.476 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.694 ' HB3' HD11 ' A' ' 263' ' ' LEU . 36.4 m-85 -102.66 123.86 47.14 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 172.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.605 ' HB3' HG22 ' A' ' 264' ' ' VAL . . . -111.72 117.73 33.66 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.287 -168.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 292' ' ' ARG . 0.0 OUTLIER -85.9 103.05 14.27 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.021 176.91 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.611 HG21 ' HB2' ' A' ' 245' ' ' LYS . 3.5 p -91.57 121.4 42.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.737 -177.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.505 HD12 ' HB2' ' A' ' 244' ' ' GLN . 2.8 pp -100.33 4.7 10.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.864 -172.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.534 ' HB2' ' HB2' ' A' ' 290' ' ' HIS . 16.8 mt-30 -173.78 99.32 0.11 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.932 -174.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.966 ' HG2' HD13 ' A' ' 258' ' ' LEU . 0.1 OUTLIER -146.51 163.11 36.77 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.849 0.357 . . . . 0.0 110.057 176.316 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.848 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 10.5 ptp180 -103.32 -178.21 3.6 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.382 -178.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 2.9 m -105.81 77.45 0.41 Allowed Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.909 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 1.4 Cg_endo -88.82 173.78 4.13 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 124.934 3.756 . . . . 0.0 111.278 174.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -127.53 175.73 8.02 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 122.147 -0.346 . . . . 0.0 110.452 174.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.721 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -66.03 -1.69 3.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.587 0.708 . . . . 0.0 110.55 174.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -100.18 3.97 44.08 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.674 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.453 ' C ' ' HD2' ' A' ' 253' ' ' LYS . 2.2 m-20 -102.73 49.58 0.84 Allowed 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 253' ' ' LYS . . . . . 0.453 ' HD2' ' C ' ' A' ' 252' ' ' ASP . 0.0 OUTLIER 60.36 30.88 20.17 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -169.895 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 254' ' ' THR . . . . . 0.721 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 32.0 p 59.37 74.65 0.43 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 113.388 -1.733 . . . . 0.0 112.16 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.435 ' HB1' ' CE2' ' A' ' 286' ' ' PHE . . . -115.77 150.46 36.88 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.008 174.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.775 ' HB3' HD11 ' A' ' 258' ' ' LEU . 0.0 OUTLIER -77.38 138.55 39.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.437 -174.497 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.909 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -90.55 94.45 9.71 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.336 0.588 . . . . 0.0 110.381 173.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.966 HD13 ' HG2' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -146.04 166.97 24.52 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.83 -175.467 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.443 ' O ' HG13 ' A' ' 242' ' ' VAL . 12.2 pt-20 -138.68 -166.48 2.02 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.08 0.467 . . . . 0.0 111.491 -169.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 2.3 p -67.09 116.82 6.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.199 175.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 103.2 -1.85 47.18 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 114.801 -1.09 . . . . 0.0 112.66 169.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.433 ' HG3' ' HG2' ' A' ' 259' ' ' GLU . 18.2 mt-10 -80.87 169.83 17.06 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.204 0.526 . . . . 0.0 111.123 -174.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.694 HD11 ' HB3' ' A' ' 239' ' ' TYR . 10.2 tp -132.6 151.0 52.07 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.317 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.706 HG11 HD23 ' A' ' 258' ' ' LEU . 18.4 m -148.12 173.71 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.088 -176.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.452 ' HG3' ' CE1' ' A' ' 239' ' ' TYR . 5.0 ttmm -119.72 95.55 4.82 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 175.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.814 ' HB ' HD13 ' A' ' 238' ' ' ILE . 53.8 t -69.19 115.05 6.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.136 0.493 . . . . 0.0 110.436 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 40.5 p -93.37 -7.97 43.2 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.261 -174.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 3.2 tppp? -129.5 104.82 7.69 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.59 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.8 OUTLIER -107.83 157.62 7.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.629 0.728 . . . . 0.0 112.82 -173.39 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.632 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 4.7 p30 -147.37 -176.81 5.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.359 -173.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 32.0 m -110.73 15.45 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.3 m -109.66 -43.33 4.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.073 0.463 . . . . 0.0 110.382 176.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' GLY . . . . . 0.785 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 123.73 -9.91 8.56 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.544 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.9 OUTLIER -95.37 90.13 5.7 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.659 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.632 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -115.87 171.36 7.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.112 -173.523 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.664 ' O ' HG13 ' A' ' 266' ' ' VAL . 36.0 mt-10 -96.05 122.81 39.28 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 174.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.598 ' HA2' HG22 ' A' ' 266' ' ' VAL . . . -104.51 134.09 11.83 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.182 -171.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 34.0 tt0 -120.47 119.37 32.8 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 117.542 0.671 . . . . 0.0 109.584 178.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 279' ' ' CYS . . . . . 0.535 ' HB2' HG12 ' A' ' 264' ' ' VAL . 36.2 t -111.11 98.21 7.36 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.677 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 43.0 57.32 3.71 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 124.141 0.9 . . . . 0.0 112.232 174.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 114.38 -34.3 4.99 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.9 174.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' LYS . . . . . 0.567 ' HD2' ' H ' ' A' ' 282' ' ' LYS . 4.1 mptt -98.87 138.89 35.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.332 0.566 . . . . 0.0 109.592 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 283' ' ' ARG . . . . . 0.45 ' H ' ' HD2' ' A' ' 283' ' ' ARG . 0.0 OUTLIER -121.54 129.11 52.68 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.454 0.645 . . . . 0.0 111.094 176.621 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 284' ' ' GLY . . . . . 0.574 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . -149.94 145.78 14.26 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.714 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 285' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -101.55 138.16 38.92 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 117.918 0.859 . . . . 0.0 111.953 -172.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.562 ' CG ' ' HE2' ' A' ' 245' ' ' LYS . 9.5 m-85 -154.44 163.54 23.87 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.635 -175.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 68.3 Cg_endo -96.79 174.67 0.73 Allowed 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 123.69 2.926 . . . . 0.0 115.203 -173.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.785 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 32.4 t80 -82.14 -21.76 36.46 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 113.978 -1.464 . . . . 0.0 112.716 -171.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 9.9 t -58.62 -13.15 5.11 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -171.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' HIS . . . . . 0.534 ' HB2' ' HB2' ' A' ' 244' ' ' GLN . 1.1 p-80 -141.64 44.28 1.72 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.962 0.41 . . . . 0.0 111.957 -177.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.419 ' O ' ' HD2' ' A' ' 292' ' ' ARG . 12.6 m -135.0 156.96 40.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.496 0.665 . . . . 0.0 112.022 177.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.419 ' HD2' ' O ' ' A' ' 291' ' ' VAL . 22.7 mmm180 -127.53 106.7 9.36 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 166.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 293' ' ' LEU . . . . . 0.431 HD12 ' CB ' ' A' ' 240' ' ' ALA . 1.8 mm? -92.21 143.46 26.4 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.63 -0.669 . . . . 0.0 112.242 -170.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.459 HD23 ' N ' ' A' ' 294' ' ' LEU . 4.1 mt . . . . . 0 C--N 1.318 -0.782 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 164.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.676 ' HB2' ' HD3' ' A' ' 265' ' ' LYS . 6.9 Cg_endo . . . . . 0 N--CA 1.448 -1.161 0 N-CA-C 110.788 -0.505 . . . . 0.0 110.788 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 1.034 HG12 HG22 ' A' ' 266' ' ' VAL . 2.2 pt -82.38 158.67 3.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.642 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.709 ' HB3' HD21 ' A' ' 263' ' ' LEU . 36.1 m-85 -104.79 117.11 33.25 Favored 'General case' 0 C--O 1.21 -1.025 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 169.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.654 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -113.34 116.54 29.86 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.187 -172.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.417 ' HB3' ' O ' ' A' ' 292' ' ' ARG . 22.7 tpp180 -74.88 101.68 4.48 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.803 -1.09 . . . . 0.0 108.287 175.202 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.601 HG21 ' HD3' ' A' ' 245' ' ' LYS . 7.6 p -83.59 124.57 39.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.153 -175.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.9 pp -102.36 1.66 10.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.109 -173.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.507 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 52.5 tt0 -177.37 98.51 0.05 OUTLIER 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.94 -176.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.659 ' HE2' HD11 ' A' ' 258' ' ' LEU . 0.0 OUTLIER -146.09 163.29 35.76 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.272 0.558 . . . . 0.0 110.156 173.179 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.771 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 5.7 ptp180 -94.82 -174.35 3.25 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.306 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 2.8 m -108.98 69.31 0.38 Allowed Pre-proline 0 CA--C 1.536 0.426 0 CA-C-O 121.246 0.546 . . . . 0.0 111.615 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.976 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 57.0 Cg_endo -95.86 122.25 0.27 Allowed 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 124.645 3.563 . . . . 0.0 111.442 178.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -79.35 175.66 10.4 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.989 0.423 . . . . 0.0 110.966 -176.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -65.02 -0.53 1.61 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.179 0.514 . . . . 0.0 111.375 177.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -103.67 8.61 37.43 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.087 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -98.12 53.47 1.08 Allowed 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' LYS . . . . . 0.535 ' N ' ' HD3' ' A' ' 253' ' ' LYS . 0.1 OUTLIER 61.42 28.99 18.26 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -167.399 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 254' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 26.5 p 62.09 87.01 0.1 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.197 -1.365 . . . . 0.0 110.942 -176.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.648 ' HB3' ' HB2' ' A' ' 248' ' ' PRO . . . -123.72 165.64 16.91 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.785 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.602 ' H ' ' HE2' ' A' ' 286' ' ' PHE . 4.3 mm? -89.07 114.96 26.24 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.009 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.976 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -85.31 87.14 7.35 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.59 0.709 . . . . 0.0 110.413 177.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.659 HD11 ' HE2' ' A' ' 245' ' ' LYS . 0.4 OUTLIER -151.98 167.2 29.15 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.869 -173.247 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.543 ' O ' HG13 ' A' ' 242' ' ' VAL . 11.1 pt-20 -141.89 -161.89 1.31 Allowed 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.755 -0.591 . . . . 0.0 111.903 -170.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 2.7 p -65.06 119.13 8.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.494 0.664 . . . . 0.0 112.112 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 106.26 -2.67 37.51 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.927 171.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -90.99 -177.78 5.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.782 0.325 . . . . 0.0 111.434 -171.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.709 HD21 ' HB3' ' A' ' 239' ' ' TYR . 3.3 tm? -131.18 120.08 22.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.944 0.402 . . . . 0.0 110.458 -176.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.654 HG13 ' HB3' ' A' ' 240' ' ' ALA . 2.5 p -115.63 116.88 53.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.637 175.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.676 ' HD3' ' HB2' ' A' ' 237' ' ' PRO . 0.0 OUTLIER -89.41 98.64 11.88 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.006 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 1.034 HG22 HG12 ' A' ' 238' ' ' ILE . 6.1 m -79.12 122.89 35.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.533 0.682 . . . . 0.0 110.969 -176.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 267' ' ' THR . . . . . 0.516 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 36.4 p -86.47 -19.48 29.5 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.426 -174.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.902 ' HA ' ' HE3' ' A' ' 268' ' ' LYS . 0.1 OUTLIER -123.11 105.95 10.36 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -178.812 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.42 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.7 OUTLIER -94.32 157.25 3.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -172.774 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.722 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 3.4 p30 -146.43 179.83 7.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.724 -179.112 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 10.2 p -93.36 -18.85 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -173.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 33.5 m -94.65 -34.91 12.41 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -176.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 273' ' ' GLY . . . . . 0.767 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 115.29 -2.81 22.25 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.929 -177.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 1.9 mp0 -89.93 76.79 7.03 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 175.088 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.722 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -115.1 173.02 6.71 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.532 0.682 . . . . 0.0 111.808 -171.636 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 36.1 mt-10 -96.85 125.55 41.38 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.132 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.658 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -111.25 155.02 16.37 Favored Glycine 0 N--CA 1.437 -1.265 0 CA-C-N 114.669 -1.151 . . . . 0.0 112.509 -169.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.597 ' HG2' ' HG3' ' A' ' 283' ' ' ARG . 6.1 tm-20 -139.47 119.7 13.74 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 174.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 279' ' ' CYS . . . . . 0.576 ' O ' ' HD3' ' A' ' 282' ' ' LYS . 12.4 t -124.46 99.85 6.39 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.829 -173.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 51.66 38.01 21.57 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.808 0.693 . . . . 0.0 111.672 170.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 114.93 -26.42 9.35 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.187 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 282' ' ' LYS . . . . . 0.576 ' HD3' ' O ' ' A' ' 279' ' ' CYS . 0.1 OUTLIER -81.93 137.04 35.25 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 177.992 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 283' ' ' ARG . . . . . 0.597 ' HG3' ' HG2' ' A' ' 278' ' ' GLU . 0.1 OUTLIER -128.15 140.07 52.13 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.927 177.783 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 177.48 -145.51 7.2 Favored Glycine 0 C--O 1.222 -0.6 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.103 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 285' ' ' HIS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 13.7 p80 -150.54 140.2 21.66 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.665 0.233 . . . . 0.0 111.252 -178.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.602 ' HE2' ' H ' ' A' ' 256' ' ' LEU . 9.9 m-85 -157.44 159.31 30.9 Favored Pre-proline 0 N--CA 1.469 0.5 0 C-N-CA 122.249 0.22 . . . . 0.0 111.11 -177.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 63.7 Cg_endo -92.86 176.9 1.52 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.246 2.631 . . . . 0.0 114.435 -173.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.767 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 21.2 t80 -80.64 -33.62 35.55 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 113.816 -1.538 . . . . 0.0 112.657 -168.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 6.6 t -55.77 -33.72 64.6 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -168.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 290' ' ' HIS . . . . . 0.555 ' CD2' ' HD2' ' A' ' 245' ' ' LYS . 1.2 p-80 -115.05 49.27 1.07 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.605 0.717 . . . . 0.0 110.845 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -150.04 155.64 7.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.551 175.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.417 ' O ' ' HB3' ' A' ' 241' ' ' ARG . 29.2 mmm180 -130.83 107.42 9.12 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 175.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 293' ' ' LEU . . . . . 0.612 ' H ' HD23 ' A' ' 293' ' ' LEU . 0.3 OUTLIER -102.04 136.14 42.4 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -162.735 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 239' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.439 -1.02 0 CA-C-N 113.96 -1.473 . . . . 0.0 107.373 170.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.464 ' HB3' ' HA ' ' A' ' 267' ' ' THR . 7.1 Cg_exo . . . . . 0 N--CA 1.459 -0.501 0 CA-C-O 120.961 0.317 . . . . 0.0 112.003 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.965 HG12 HG22 ' A' ' 266' ' ' VAL . 0.2 OUTLIER -92.8 167.47 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.545 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.7 ' HB3' HD11 ' A' ' 263' ' ' LEU . 72.4 m-85 -106.64 127.73 53.59 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 170.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.513 ' HB3' ' CG1' ' A' ' 264' ' ' VAL . . . -114.39 118.16 33.07 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.528 -176.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.608 ' NH1' ' HA2' ' A' ' 261' ' ' GLY . 0.1 OUTLIER -88.8 100.82 13.45 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.297 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 1.016 HG21 ' HD2' ' A' ' 245' ' ' LYS . 7.2 p -86.56 127.15 40.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.071 -172.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.8 pp -100.29 3.28 10.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.4 -174.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.532 ' H ' HG22 ' A' ' 242' ' ' VAL . 56.1 tp60 -177.33 106.91 0.06 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -176.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 1.061 ' HD3' ' HB2' ' A' ' 258' ' ' LEU . 14.7 tttt -144.63 157.15 44.33 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 177.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.81 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 16.4 ptt180 -103.92 -175.14 2.71 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 6.8 m -110.51 69.37 0.58 Allowed Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 121.177 0.513 . . . . 0.0 111.987 -174.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 1.017 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 17.8 Cg_endo -94.47 124.51 0.42 Allowed 'Trans proline' 0 N--CA 1.444 -1.433 0 C-N-CA 124.285 3.324 . . . . 0.0 111.175 176.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.417 ' C ' ' H ' ' A' ' 251' ' ' TYR . 7.0 m-20 -81.46 176.92 9.28 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.022 0.439 . . . . 0.0 111.043 -174.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.607 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -67.77 4.86 0.99 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.202 0.525 . . . . 0.0 111.281 177.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.417 ' H ' ' C ' ' A' ' 249' ' ' ASN . 44.8 m-85 -106.5 5.74 29.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.553 0.692 . . . . 0.0 109.572 176.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.423 ' C ' ' HD2' ' A' ' 253' ' ' LYS . 3.7 m-20 -101.17 55.73 0.84 Allowed 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 253' ' ' LYS . . . . . 0.423 ' HD2' ' C ' ' A' ' 252' ' ' ASP . 0.0 OUTLIER 59.0 27.01 15.78 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -169.568 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 254' ' ' THR . . . . . 0.607 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 30.2 p 61.42 85.19 0.12 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.63 -176.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.685 ' HB3' ' HB2' ' A' ' 248' ' ' PRO . . . -118.31 165.63 13.6 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.499 178.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.961 ' HB3' HD13 ' A' ' 258' ' ' LEU . 3.8 mm? -88.35 112.78 23.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.632 178.187 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.017 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -82.32 81.86 8.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.6 0.714 . . . . 0.0 110.234 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 1.061 ' HB2' ' HD3' ' A' ' 245' ' ' LYS . 6.1 mp -122.83 177.92 5.26 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.382 -171.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -143.71 -169.31 3.05 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.156 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 2.3 p -65.71 121.06 14.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.247 177.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.608 ' HA2' ' NH1' ' A' ' 241' ' ' ARG . . . 103.44 -2.22 46.39 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.486 171.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -88.76 174.99 7.68 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.991 0.424 . . . . 0.0 111.261 -171.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.7 HD11 ' HB3' ' A' ' 239' ' ' TYR . 21.5 tp -130.0 158.85 38.45 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.222 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.823 HG23 ' HB2' ' A' ' 279' ' ' CYS . 8.3 p -151.13 150.71 13.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.427 ' HD3' ' HB2' ' A' ' 237' ' ' PRO . 0.0 OUTLIER -110.34 97.92 7.27 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.22 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.965 HG22 HG12 ' A' ' 238' ' ' ILE . 15.5 m -74.39 113.3 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 121.972 0.891 . . . . 0.0 110.43 -178.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 267' ' ' THR . . . . . 0.464 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 61.0 p -92.34 0.52 57.45 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.095 -174.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.65 107.14 6.48 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.375 172.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.605 HG21 HG23 ' A' ' 238' ' ' ILE . 0.8 OUTLIER -104.21 160.86 4.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 114.34 -1.3 . . . . 0.0 113.102 -170.25 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.717 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 3.8 p30 -146.87 171.62 14.92 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.815 -176.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 27.0 m -87.04 5.06 3.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -175.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 4.4 m -111.54 -43.42 3.67 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 273' ' ' GLY . . . . . 0.439 ' HA2' ' CZ2' ' A' ' 275' ' ' TRP . . . 120.24 -0.4 12.92 Favored Glycine 0 C--O 1.223 -0.543 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.021 -175.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.592 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 2.1 mp0 -98.04 77.64 2.47 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.717 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -117.87 169.88 9.27 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.461 -167.457 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.595 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 39.9 mt-10 -90.68 126.29 35.93 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.228 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.654 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -111.36 146.37 17.78 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.294 -170.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 4.3 tm-20 -133.7 116.51 15.87 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 279' ' ' CYS . . . . . 0.823 ' HB2' HG23 ' A' ' 264' ' ' VAL . 10.5 t -115.7 99.0 7.0 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.744 0.783 . . . . 0.0 110.009 -177.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 31.63 55.89 0.29 Allowed 'General case' 0 C--N 1.343 0.301 0 CA-C-N 112.918 -1.947 . . . . 0.0 113.525 175.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.82 -14.41 14.37 Favored Glycine 0 CA--C 1.522 0.495 0 CA-C-N 115.933 -0.576 . . . . 0.0 113.51 176.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 282' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 19.0 mttt -108.38 128.64 54.94 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 117.213 0.506 . . . . 0.0 109.699 177.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 283' ' ' ARG . . . . . 0.491 ' C ' ' HD3' ' A' ' 283' ' ' ARG . 0.2 OUTLIER -123.21 143.95 49.69 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.276 -0.569 . . . . 0.0 111.173 179.637 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 176.63 -145.1 7.24 Favored Glycine 0 C--O 1.224 -0.508 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.243 178.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 285' ' ' HIS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 13.6 p80 -150.15 147.65 28.0 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.852 0.326 . . . . 0.0 110.822 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.64 ' HD1' ' HD2' ' A' ' 287' ' ' PRO . 2.5 m-85 -161.68 153.93 16.57 Favored Pre-proline 0 N--CA 1.467 0.398 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -178.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.64 ' HD2' ' HD1' ' A' ' 286' ' ' PHE . 87.4 Cg_endo -88.32 165.1 6.8 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.399 2.733 . . . . 0.0 112.513 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.608 ' HA ' HG12 ' A' ' 291' ' ' VAL . 9.4 p90 -88.16 -4.77 58.69 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -172.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 5.6 t -56.76 -11.38 1.37 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -177.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -133.47 30.76 3.8 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 122.259 -0.276 . . . . 0.0 111.149 -175.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.709 HG23 ' HA ' ' A' ' 242' ' ' VAL . 9.5 p -147.35 157.6 9.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 C-N-CA 119.759 -0.776 . . . . 0.0 112.005 -170.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.447 ' HA ' ' HD2' ' A' ' 292' ' ' ARG . 25.3 tpt180 -125.98 109.74 12.79 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 293' ' ' LEU . . . . . 0.561 HD22 ' H ' ' A' ' 293' ' ' LEU . 0.4 OUTLIER -86.42 150.16 24.5 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 119.562 -0.855 . . . . 0.0 113.22 -165.522 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 239' ' ' TYR . 11.3 mt . . . . . 0 N--CA 1.433 -1.283 0 N-CA-C 105.153 -2.165 . . . . 0.0 105.153 163.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo . . . . . 0 CA--C 1.52 -0.191 0 CA-C-O 121.661 0.609 . . . . 0.0 113.135 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.942 HG23 ' HB ' ' A' ' 266' ' ' VAL . 0.1 OUTLIER -90.02 151.52 3.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.211 175.899 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.584 ' HD1' HD11 ' A' ' 263' ' ' LEU . 27.4 m-85 -109.64 117.37 33.76 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.616 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -115.15 117.17 29.78 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.413 0.625 . . . . 0.0 111.447 -171.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 241' ' ' ARG . 4.2 tpp85 -74.89 104.79 5.64 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.847 174.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.787 HG21 ' HD3' ' A' ' 245' ' ' LYS . 7.5 p -84.24 133.46 29.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.23 0.538 . . . . 0.0 110.852 -176.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.636 HD12 ' HB2' ' A' ' 244' ' ' GLN . 2.4 pp -115.19 3.99 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.919 -171.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.636 ' HB2' HD12 ' A' ' 243' ' ' ILE . 5.3 mt-30 -173.94 94.14 0.09 Allowed 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 123.202 0.314 . . . . 0.0 110.5 -175.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.787 ' HD3' HG21 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -147.1 162.99 37.71 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.238 0.542 . . . . 0.0 110.427 173.437 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.855 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 4.5 ptt180 -101.59 -176.42 3.13 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.978 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.4 77.96 0.23 Allowed Pre-proline 0 CA--C 1.542 0.644 0 O-C-N 122.156 -0.34 . . . . 0.0 111.382 175.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 1.032 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 12.7 Cg_endo -94.55 142.23 1.44 Allowed 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.54 3.494 . . . . 0.0 112.214 175.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.406 ' O ' ' HB2' ' A' ' 252' ' ' ASP . 15.1 m120 -96.78 177.06 5.76 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.731 -177.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.764 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -63.95 -7.63 8.93 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 121.823 0.821 . . . . 0.0 110.197 172.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -95.04 6.79 48.08 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.065 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 249' ' ' ASN . 1.1 m-20 -105.04 48.11 0.85 Allowed 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 253' ' ' LYS . . . . . 0.478 ' N ' ' HD2' ' A' ' 253' ' ' LYS . 0.1 OUTLIER 60.42 32.7 20.66 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -167.937 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 254' ' ' THR . . . . . 0.764 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 23.4 p 57.03 77.55 0.26 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.166 -1.379 . . . . 0.0 111.158 -179.152 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.62 ' HB3' ' HB2' ' A' ' 248' ' ' PRO . . . -117.77 167.14 11.65 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.024 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.537 ' H ' ' HE2' ' A' ' 286' ' ' PHE . 4.6 mm? -88.55 118.8 28.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.909 -175.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.032 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -83.54 90.64 7.27 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.768 0.794 . . . . 0.0 110.547 175.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.658 ' O ' ' HB3' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -150.72 167.52 27.14 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.04 -176.183 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.457 ' CG ' ' N ' ' A' ' 260' ' ' VAL . 24.7 tt0 -142.93 177.24 8.49 Favored 'General case' 0 C--N 1.313 -1.005 0 O-C-N 122.088 -0.383 . . . . 0.0 110.547 -164.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 243' ' ' ILE . 57.8 t -50.05 118.52 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 122.906 0.482 . . . . 0.0 111.479 174.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 106.1 -2.32 38.01 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.58 170.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -98.23 -173.59 2.62 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.875 0.369 . . . . 0.0 111.725 -172.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.584 HD11 ' HD1' ' A' ' 239' ' ' TYR . 3.3 tm? -129.47 131.14 46.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.525 -173.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.616 HG13 ' HB3' ' A' ' 240' ' ' ALA . 2.4 p -123.39 124.49 69.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.435 174.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -82.68 112.24 19.36 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 175.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.942 ' HB ' HG23 ' A' ' 238' ' ' ILE . 94.8 t -77.06 112.91 15.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 65.8 p -94.65 -32.89 13.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.962 -171.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.579 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 11.9 tppt? -116.16 107.56 15.05 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.052 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.477 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.7 OUTLIER -96.74 140.25 17.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -168.134 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.904 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 9.8 p30 -148.06 149.07 31.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.852 178.118 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 10.9 p -65.37 -17.4 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -173.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 3.9 p -78.26 -30.68 48.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.914 0.388 . . . . 0.0 111.995 -177.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 273' ' ' GLY . . . . . 0.605 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 94.96 -5.67 68.99 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.464 -177.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.64 ' HG3' ' HB3' ' A' ' 287' ' ' PRO . 1.7 mp0 -92.56 77.41 5.0 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 174.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.904 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -122.76 178.42 5.03 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.489 -0.778 . . . . 0.0 113.042 -167.964 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 268' ' ' LYS . 40.2 mt-10 -83.33 127.47 33.69 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.525 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.448 ' O ' HD21 ' A' ' 256' ' ' LEU . . . -111.75 156.44 15.57 Favored Glycine 0 N--CA 1.433 -1.528 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.615 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 21.2 tt0 -141.88 119.43 11.68 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 279' ' ' CYS . . . . . 0.479 ' HB2' HD23 ' A' ' 258' ' ' LEU . 51.6 t -115.2 99.06 7.14 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.061 -176.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 45.18 45.12 9.23 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 124.065 0.853 . . . . 0.0 111.958 176.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 114.86 -33.51 5.31 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.202 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 282' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 12.2 mptt -73.32 139.69 46.22 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 117.178 0.489 . . . . 0.0 110.084 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -124.01 142.05 51.51 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.216 0.531 . . . . 0.0 111.921 -176.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 169.49 -145.54 9.41 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.391 175.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 285' ' ' HIS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 7.5 p80 -150.35 147.53 27.72 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.936 0.368 . . . . 0.0 111.191 -177.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.61 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 2.1 m-85 -158.18 150.74 17.93 Favored Pre-proline 0 N--CA 1.466 0.331 0 CA-C-O 120.936 0.398 . . . . 0.0 112.052 -178.471 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.64 ' HB3' ' HG3' ' A' ' 274' ' ' GLN . 2.4 Cg_endo -81.34 174.32 10.76 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.915 3.076 . . . . 0.0 114.152 -178.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.605 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 24.9 t80 -87.77 -35.67 17.74 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -167.102 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 4.1 t -65.41 -7.27 13.1 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -164.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 290' ' ' HIS . . . . . 0.534 ' NE2' ' HD2' ' A' ' 245' ' ' LYS . 1.1 p-80 -120.35 31.82 6.3 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.907 -0.496 . . . . 0.0 110.92 178.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.673 HG23 ' HA ' ' A' ' 242' ' ' VAL . 4.0 p -147.23 154.19 11.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.296 0.569 . . . . 0.0 111.566 -175.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -131.95 110.25 10.63 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 293' ' ' LEU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 240' ' ' ALA . 0.2 OUTLIER -118.02 135.68 54.01 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -162.18 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.443 ' H ' HD12 ' A' ' 294' ' ' LEU . 5.3 mp . . . . . 0 N--CA 1.439 -0.981 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.864 168.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.503 ' HB3' ' HA ' ' A' ' 267' ' ' THR . 6.2 Cg_exo . . . . . 0 N--CA 1.455 -0.748 0 CA-C-O 120.285 0.035 . . . . 0.0 112.116 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.869 HD13 ' HB ' ' A' ' 266' ' ' VAL . 0.2 OUTLIER -87.01 163.55 2.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.553 176.934 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.819 ' HB3' HD11 ' A' ' 263' ' ' LEU . 67.7 m-85 -104.92 123.49 47.84 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 171.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.694 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -112.52 118.62 35.62 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.861 -174.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 292' ' ' ARG . 0.0 OUTLIER -75.89 100.86 4.95 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.969 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.7 HG21 ' HB2' ' A' ' 245' ' ' LYS . 3.3 p -82.63 121.01 35.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.111 -176.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.708 HD12 ' HB2' ' A' ' 244' ' ' GLN . 2.8 pp -105.85 10.55 9.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.708 -175.155 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.708 ' HB2' HD12 ' A' ' 243' ' ' ILE . 1.0 OUTLIER -177.0 94.95 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.272 -176.642 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.7 ' HB2' HG21 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -147.09 164.68 32.31 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.27 0.557 . . . . 0.0 111.202 174.335 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.818 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 3.2 ptm180 -101.06 -177.96 3.61 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.525 -177.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 46.2 t -104.67 81.91 0.6 Allowed Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 121.201 0.524 . . . . 0.0 110.918 174.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.95 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 4.6 Cg_endo -91.03 175.46 2.44 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 124.959 3.773 . . . . 0.0 111.881 174.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -138.55 179.91 6.19 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.146 176.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.751 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -57.25 -12.59 2.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.877 0.37 . . . . 0.0 111.89 176.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -91.34 -5.71 54.16 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 122.081 -0.387 . . . . 0.0 110.486 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -92.06 48.35 1.42 Allowed 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? 59.01 24.5 12.74 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -167.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 254' ' ' THR . . . . . 0.751 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 19.3 p 64.98 83.35 0.17 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.405 -1.271 . . . . 0.0 110.885 -177.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.634 ' HB1' ' CE2' ' A' ' 286' ' ' PHE . . . -122.33 159.25 27.84 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.466 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.568 HD22 ' HA3' ' A' ' 284' ' ' GLY . 0.7 OUTLIER -78.27 123.91 27.48 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.251 -174.849 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.95 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -84.28 93.96 8.33 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.561 0.696 . . . . 0.0 111.171 172.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.644 ' O ' ' HB3' ' A' ' 245' ' ' LYS . 0.2 OUTLIER -155.6 167.98 28.64 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.623 -177.133 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.436 ' O ' HG13 ' A' ' 242' ' ' VAL . 12.3 pt-20 -141.78 -165.2 1.94 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.916 -0.49 . . . . 0.0 111.855 -172.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 43.0 t -59.63 118.38 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 96.71 0.18 60.76 Favored Glycine 0 CA--C 1.508 -0.396 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.165 170.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -89.74 -175.93 4.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.72 0.295 . . . . 0.0 110.396 -176.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.819 HD11 ' HB3' ' A' ' 239' ' ' TYR . 44.4 tp -130.0 159.84 35.46 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.01 0.433 . . . . 0.0 111.322 -176.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.694 HG13 ' HB3' ' A' ' 240' ' ' ALA . 2.4 p -152.24 133.82 5.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.019 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.464 ' HE2' ' HG2' ' A' ' 237' ' ' PRO . 86.1 tttt -96.16 96.36 8.77 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.246 0.546 . . . . 0.0 109.833 178.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.869 ' HB ' HD13 ' A' ' 238' ' ' ILE . 50.3 t -76.98 114.72 17.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.043 0.449 . . . . 0.0 111.473 -178.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 267' ' ' THR . . . . . 0.503 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 42.0 p -90.8 -10.45 42.79 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.49 -174.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.52 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 13.3 tppt? -127.21 105.94 8.9 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.818 HG21 HG23 ' A' ' 238' ' ' ILE . 0.8 OUTLIER -111.65 140.25 32.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -170.391 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.866 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 6.5 p30 -148.6 140.44 23.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.634 177.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 10.6 p -58.68 -15.07 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -172.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.4 m -62.0 -36.11 80.54 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.297 0.481 . . . . 0.0 112.297 -177.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 273' ' ' GLY . . . . . 0.536 ' CA ' ' HB2' ' A' ' 288' ' ' PHE . . . 89.11 36.43 7.64 Favored Glycine 0 N--CA 1.437 -1.299 0 C-N-CA 119.908 -1.139 . . . . 0.0 110.797 -170.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 1.0 OUTLIER -148.7 96.92 2.65 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 171.163 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.866 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -134.15 173.07 12.0 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -168.959 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.728 ' O ' HG13 ' A' ' 266' ' ' VAL . 18.4 mm-40 -90.06 123.39 33.89 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.348 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -105.37 162.12 14.48 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -175.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.537 ' HG2' ' HG3' ' A' ' 283' ' ' ARG . 3.5 tm-20 -151.47 120.17 6.54 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 174.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 43.4 t -122.64 97.68 5.57 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.668 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 45.17 49.92 9.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.329 170.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.49 -27.31 8.08 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.684 -0.77 . . . . 0.0 113.4 177.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.85 128.58 41.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 117.311 0.556 . . . . 0.0 110.166 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 283' ' ' ARG . . . . . 0.537 ' HG3' ' HG2' ' A' ' 278' ' ' GLU . 0.4 OUTLIER -109.0 136.44 48.52 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.185 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 284' ' ' GLY . . . . . 0.568 ' HA3' HD22 ' A' ' 256' ' ' LEU . . . -161.94 -171.98 28.74 Favored Glycine 0 C--O 1.226 -0.395 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.599 -176.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 285' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -147.02 135.79 22.17 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 172.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.688 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 4.4 m-85 -154.81 158.63 32.2 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -173.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 56.9 Cg_endo -94.93 164.68 1.69 Allowed 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.442 2.761 . . . . 0.0 113.938 -176.328 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.662 ' HA ' HG22 ' A' ' 291' ' ' VAL . 9.1 t80 -74.86 -18.47 60.43 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.131 -174.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 8.9 t -48.31 -24.91 1.35 Allowed 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 -175.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 290' ' ' HIS . . . . . 0.499 ' NE2' ' HD2' ' A' ' 245' ' ' LYS . 0.8 OUTLIER -137.51 48.19 2.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.807 0.337 . . . . 0.0 111.86 -177.839 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.662 HG22 ' HA ' ' A' ' 288' ' ' PHE . 30.1 m -143.22 155.09 16.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 121.102 0.477 . . . . 0.0 111.208 173.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.478 ' HD2' ' O ' ' A' ' 291' ' ' VAL . 15.9 mmm180 -121.79 110.43 15.9 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 173.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 293' ' ' LEU . . . . . 0.518 HD22 ' HE2' ' A' ' 288' ' ' PHE . 2.6 tp -94.24 126.92 39.78 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -160.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.535 HD13 ' N ' ' A' ' 294' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.448 -0.573 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 163.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.536 ' HA ' ' O ' ' A' ' 266' ' ' VAL . 10.1 Cg_endo . . . . . 0 N--CA 1.446 -1.277 0 CA-C-O 120.971 0.321 . . . . 0.0 112.413 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 1.089 HD11 ' HB2' ' A' ' 240' ' ' ALA . 0.1 OUTLIER -92.46 144.6 8.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 171.682 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.798 ' HD1' HD11 ' A' ' 263' ' ' LEU . 46.7 m-85 -96.96 119.53 35.6 Favored 'General case' 0 C--O 1.21 -1.01 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 173.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 1.089 ' HB2' HD11 ' A' ' 238' ' ' ILE . . . -113.94 115.9 28.4 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.107 -173.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.45 ' HB3' ' O ' ' A' ' 292' ' ' ARG . 17.8 tpp180 -84.76 103.4 13.82 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.189 -1.369 . . . . 0.0 108.375 177.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 1.049 HG11 ' HD2' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -89.75 149.47 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.546 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.669 -177.245 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.503 HD12 ' HB2' ' A' ' 244' ' ' GLN . 2.3 pp -124.88 11.23 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-N 113.544 -1.662 . . . . 0.0 110.654 -171.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.808 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 52.9 tt0 -177.23 94.6 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.63 -174.095 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 1.049 ' HD2' HG11 ' A' ' 242' ' ' VAL . 5.3 mttt -146.93 162.79 37.99 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.966 0.412 . . . . 0.0 110.11 177.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.868 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 10.7 ptm180 -113.37 -177.26 3.09 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.494 -174.05 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 9.3 m -102.57 81.83 0.4 Allowed Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 121.488 0.661 . . . . 0.0 112.091 174.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.97 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 1.1 Cg_endo -90.84 177.03 2.21 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 125.063 3.842 . . . . 0.0 110.573 171.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -131.36 175.43 9.14 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.105 0.478 . . . . 0.0 110.622 175.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.635 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -66.96 -2.97 5.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.316 0.579 . . . . 0.0 110.883 176.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -95.79 1.35 53.2 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.295 177.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -97.96 51.08 1.03 Allowed 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' LYS . . . . . 0.709 ' HE2' ' HA ' ' A' ' 253' ' ' LYS . 10.7 mmpt? 62.11 26.7 16.08 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -168.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 254' ' ' THR . . . . . 0.635 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 24.4 p 63.83 86.05 0.13 Allowed 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 125.107 1.504 . . . . 0.0 110.699 -175.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.418 ' HB1' ' CE2' ' A' ' 286' ' ' PHE . . . -121.66 156.55 32.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.186 178.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.596 HD21 ' O ' ' A' ' 277' ' ' GLY . 4.3 mm? -78.53 131.23 36.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.841 -178.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.97 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -92.03 99.05 11.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.361 0.6 . . . . 0.0 110.355 171.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.793 HD13 ' CD ' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -153.3 174.4 14.35 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.371 -175.332 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.431 ' CG ' ' N ' ' A' ' 260' ' ' VAL . 32.3 tt0 -142.84 175.73 9.61 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 122.128 -0.357 . . . . 0.0 111.073 -165.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.574 HG22 ' HA ' ' A' ' 244' ' ' GLN . 56.0 t -57.07 118.71 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 123.083 0.553 . . . . 0.0 111.351 175.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 104.53 -1.19 42.71 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -97.79 -179.16 4.34 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.676 -169.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.798 HD11 ' HD1' ' A' ' 239' ' ' TYR . 2.3 tm? -134.16 134.29 41.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.07 0.462 . . . . 0.0 110.613 -170.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.606 HG12 ' HB3' ' A' ' 240' ' ' ALA . 5.4 p -125.54 145.3 33.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.453 173.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -99.79 99.65 10.49 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 175.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.941 ' HB ' HG23 ' A' ' 238' ' ' ILE . 76.0 t -70.06 114.14 7.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.324 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 33.2 p -92.6 -32.3 14.85 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.165 -171.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.36 107.65 15.08 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 121.598 0.713 . . . . 0.0 109.831 175.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.434 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.6 OUTLIER -93.91 154.1 3.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 113.877 -1.511 . . . . 0.0 113.366 -170.024 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.754 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 2.4 p30 -145.89 -178.62 6.21 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.688 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 53.6 t -87.63 -38.81 12.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.5 m -73.33 -28.15 61.91 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -172.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 273' ' ' GLY . . . . . 0.853 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 102.99 0.66 48.42 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.582 -175.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -89.96 76.14 7.1 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.754 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -122.33 175.66 6.29 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.619 0.723 . . . . 0.0 112.709 -170.033 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 284' ' ' GLY . 43.1 tt0 -98.52 127.31 44.4 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.081 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.596 ' O ' HD21 ' A' ' 256' ' ' LEU . . . -112.1 151.59 17.98 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.908 -174.175 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.624 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 17.2 tt0 -136.23 119.9 17.2 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 174.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 49.5 t -101.2 97.6 8.1 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.258 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 36.89 58.11 1.14 Allowed 'General case' 0 N--CA 1.465 0.282 0 O-C-N 124.542 1.151 . . . . 0.0 112.261 177.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.08 -37.51 3.39 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.661 177.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 282' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 37.3 mttt -82.13 128.28 33.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 117.808 0.804 . . . . 0.0 110.587 -178.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -110.79 141.85 43.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.344 0.592 . . . . 0.0 112.002 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 284' ' ' GLY . . . . . 0.492 ' O ' ' HG3' ' A' ' 276' ' ' GLU . . . -176.07 -158.89 20.77 Favored Glycine 0 C--O 1.216 -1.021 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 174.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 285' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -149.66 146.67 27.4 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 118.848 1.324 . . . . 0.0 111.842 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.418 ' CE2' ' HB1' ' A' ' 255' ' ' ALA . 4.0 m-85 -154.18 162.74 26.15 Favored Pre-proline 0 C--O 1.238 0.471 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.571 -176.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -92.92 171.67 2.18 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.151 2.567 . . . . 0.0 114.177 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.853 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 17.9 t80 -79.65 -16.19 56.21 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 114.112 -1.404 . . . . 0.0 111.795 -174.016 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 67.3 p -55.63 -28.91 57.97 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -168.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 290' ' ' HIS . . . . . 0.808 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 1.5 p-80 -127.88 35.77 4.43 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.617 -172.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.788 HG23 HG13 ' A' ' 242' ' ' VAL . 5.4 p -139.36 148.27 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 C-N-CA 119.428 -0.909 . . . . 0.0 112.422 -174.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 241' ' ' ARG . 26.1 mmt180 -129.95 110.93 12.06 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.0 178.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 293' ' ' LEU . . . . . 0.722 HD22 ' H ' ' A' ' 293' ' ' LEU . 0.1 OUTLIER -89.89 138.5 31.44 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.588 0.709 . . . . 0.0 112.779 -163.695 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 239' ' ' TYR . 7.1 mt . . . . . 0 N--CA 1.433 -1.323 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 161.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.596 ' HA ' ' O ' ' A' ' 266' ' ' VAL . 11.7 Cg_exo . . . . . 0 N--CA 1.454 -0.807 0 N-CA-C 111.137 -0.37 . . . . 0.0 111.137 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.864 HD13 ' HB ' ' A' ' 266' ' ' VAL . 0.2 OUTLIER -88.02 170.72 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.329 -177.634 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.958 ' HB3' HD21 ' A' ' 263' ' ' LEU . 81.9 m-85 -111.02 120.92 43.99 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 173.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.557 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -112.76 118.26 34.49 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.82 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.572 ' HD3' ' O ' ' A' ' 262' ' ' GLU . 0.0 OUTLIER -79.97 103.86 10.15 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.571 -177.737 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.918 ' HA ' HG12 ' A' ' 291' ' ' VAL . 2.2 t -68.88 136.19 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.225 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.2 -177.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.415 ' C ' HD12 ' A' ' 243' ' ' ILE . 2.7 pp -123.01 -1.33 6.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.406 0.622 . . . . 0.0 110.227 172.244 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 1.07 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 33.4 tt0 -164.37 99.72 0.82 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.713 -178.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.975 ' HG2' ' HB2' ' A' ' 258' ' ' LEU . 5.3 tptt -145.76 165.12 29.74 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.419 0.628 . . . . 0.0 110.454 176.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.835 ' HG3' ' HG3' ' A' ' 248' ' ' PRO . 3.6 ptm180 -113.03 -178.78 3.46 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.466 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 5.9 m -105.67 75.76 0.33 Allowed Pre-proline 0 CA--C 1.537 0.481 0 CA-C-O 121.103 0.478 . . . . 0.0 111.826 176.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.993 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 1.0 OUTLIER -88.28 175.5 4.0 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 124.055 3.17 . . . . 0.0 111.527 175.002 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.454 ' HB3' ' HD1' ' A' ' 251' ' ' TYR . 66.3 m-20 -132.68 179.21 6.29 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.769 176.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.87 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -56.95 -10.92 1.23 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.304 0.573 . . . . 0.0 110.895 171.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.454 ' HD1' ' HB3' ' A' ' 249' ' ' ASN . 34.4 m-85 -83.21 -11.24 58.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.677 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -96.31 45.23 1.07 Allowed 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -175.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 4.1 mmpm? 60.74 28.76 18.48 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 -168.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 254' ' ' THR . . . . . 0.87 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 26.8 p 62.17 80.72 0.22 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.906 -178.084 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.513 ' HB1' ' CE2' ' A' ' 286' ' ' PHE . . . -117.03 156.99 26.57 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.619 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 1.024 ' HB3' HD13 ' A' ' 258' ' ' LEU . 4.5 mm? -79.1 120.32 23.47 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.389 -176.056 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.993 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -76.3 84.01 3.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.347 0.594 . . . . 0.0 110.867 172.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 1.024 HD13 ' HB3' ' A' ' 256' ' ' LEU . 2.4 mp -119.71 175.39 5.89 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.374 -176.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.554 ' O ' ' HB ' ' A' ' 242' ' ' VAL . 24.9 tt0 -146.17 174.61 11.17 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.403 ' N ' ' CG ' ' A' ' 259' ' ' GLU . 7.2 p -58.28 124.1 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.681 0.753 . . . . 0.0 111.825 173.338 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 97.9 1.5 58.54 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.192 175.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.572 ' O ' ' HD3' ' A' ' 241' ' ' ARG . 6.6 mt-10 -87.32 -174.21 4.74 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -171.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.958 HD21 ' HB3' ' A' ' 239' ' ' TYR . 3.4 tm? -140.62 131.18 25.47 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.563 -177.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.79 ' HB ' HD21 ' A' ' 258' ' ' LEU . 4.1 p -126.62 125.68 67.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.247 175.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -90.49 95.51 10.2 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.337 0.589 . . . . 0.0 109.45 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.864 ' HB ' HD13 ' A' ' 238' ' ' ILE . 48.4 t -77.84 118.21 24.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.476 -176.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 41.1 p -93.74 -12.72 28.55 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.856 -1.066 . . . . 0.0 111.593 -176.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.562 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 17.4 tppt? -119.65 104.37 10.21 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.356 174.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.534 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.8 OUTLIER -105.99 159.64 5.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -172.31 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.594 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 3.9 p30 -145.2 -166.41 2.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.658 -177.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 9.8 p -103.82 -18.01 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.883 -177.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.4 m -83.62 -45.34 13.58 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.122 -0.361 . . . . 0.0 111.263 -177.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 273' ' ' GLY . . . . . 0.483 ' HA3' ' CD1' ' A' ' 288' ' ' PHE . . . 124.57 -7.84 8.36 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.249 -175.086 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.445 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.6 OUTLIER -95.12 103.21 15.06 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 173.849 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.691 ' HZ2' HD13 ' A' ' 293' ' ' LEU . 0.0 OUTLIER -127.35 177.79 6.48 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.726 -174.213 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.736 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 46.5 mt-10 -99.08 125.12 44.52 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.142 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.576 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -108.8 154.0 16.63 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.448 -0.797 . . . . 0.0 112.636 -169.093 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.566 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 0.2 OUTLIER -133.3 117.43 17.34 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 172.044 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 279' ' ' CYS . . . . . 0.711 ' SG ' ' HD2' ' A' ' 282' ' ' LYS . 27.4 p -109.45 98.16 7.6 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.311 -176.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 39.65 55.81 2.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.429 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 117.09 -39.94 2.52 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.78 -0.645 . . . . 0.0 114.054 176.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 282' ' ' LYS . . . . . 0.711 ' HD2' ' SG ' ' A' ' 279' ' ' CYS . 20.1 mttp -86.33 132.55 33.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 117.919 0.86 . . . . 0.0 111.287 -174.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -106.11 150.19 26.04 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.964 0.412 . . . . 0.0 111.833 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 175.52 -147.92 9.12 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.002 171.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 285' ' ' HIS . . . . . 0.736 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 42.8 p-80 -147.62 151.38 36.12 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.705 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 0.9 OUTLIER -166.76 154.6 9.01 Favored Pre-proline 0 N--CA 1.469 0.478 0 CA-C-O 120.695 0.283 . . . . 0.0 111.492 -177.54 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.491 ' HD2' ' HD1' ' A' ' 286' ' ' PHE . 9.3 Cg_endo -90.19 163.03 4.7 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 124.049 3.166 . . . . 0.0 112.972 -177.164 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.542 ' HA ' HG22 ' A' ' 291' ' ' VAL . 18.4 p90 -87.8 -18.77 28.6 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -172.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 7.5 t -66.77 -4.23 8.62 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -169.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 290' ' ' HIS . . . . . 1.07 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 0.8 OUTLIER -130.59 33.86 4.21 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.245 173.143 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.918 HG12 ' HA ' ' A' ' 242' ' ' VAL . 26.8 m -145.03 167.34 10.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.483 173.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -123.05 109.12 13.68 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 293' ' ' LEU . . . . . 0.691 HD13 ' HZ2' ' A' ' 275' ' ' TRP . 0.1 OUTLIER -91.99 128.81 37.97 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.635 -0.826 . . . . 0.0 112.862 -165.6 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.451 HD23 ' N ' ' A' ' 294' ' ' LEU . 4.4 mt . . . . . 0 C--N 1.32 -0.708 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 169.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.554 ' HG2' ' HE2' ' A' ' 265' ' ' LYS . 1.2 Cg_endo . . . . . 0 N--CA 1.46 -0.445 0 N-CA-C 113.009 0.349 . . . . 0.0 113.009 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.728 HG23 HG21 ' A' ' 269' ' ' ILE . 0.2 OUTLIER -107.53 163.32 5.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 175.405 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.799 ' HB3' HD21 ' A' ' 263' ' ' LEU . 69.8 m-85 -101.86 120.75 40.89 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 174.149 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.76 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -113.93 117.18 30.64 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.461 0.648 . . . . 0.0 110.234 -177.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.508 ' NH1' ' HA2' ' A' ' 261' ' ' GLY . 0.6 OUTLIER -84.17 107.26 16.38 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.682 -176.046 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.76 ' HA ' HG12 ' A' ' 291' ' ' VAL . 3.9 t -69.6 131.74 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.122 -177.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.48 ' O ' HG22 ' A' ' 260' ' ' VAL . 2.8 pp -121.94 -0.52 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.015 175.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.649 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 6.7 tp-100 -178.1 95.69 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.685 -175.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.646 ' HB3' ' O ' ' A' ' 258' ' ' LEU . 0.9 OUTLIER -146.29 162.88 37.14 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.158 0.504 . . . . 0.0 110.261 177.248 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.877 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 12.1 ttt180 -95.43 179.64 5.09 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.35 -174.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.453 ' N ' ' CG ' ' A' ' 246' ' ' ARG . 8.9 m -106.36 69.68 0.23 Allowed Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 121.893 0.854 . . . . 0.0 110.805 173.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.923 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 11.6 Cg_endo -95.62 131.71 0.49 Allowed 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 125.146 3.897 . . . . 0.0 111.376 -178.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -92.39 178.26 5.88 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.58 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.641 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -59.85 -8.13 2.03 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.388 0.613 . . . . 0.0 110.999 174.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -92.14 -8.08 46.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.198 0.523 . . . . 0.0 110.118 177.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -104.67 66.85 0.8 Allowed 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.645 -174.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.97 23.66 13.78 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.179 -172.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' THR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 34.8 p 52.81 65.33 1.55 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.888 -177.144 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.732 ' HB1' ' CE2' ' A' ' 286' ' ' PHE . . . -109.53 158.32 18.12 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.429 -175.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.688 HD22 ' CA ' ' A' ' 284' ' ' GLY . 1.7 mm? -67.37 128.37 36.16 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.869 176.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.923 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -92.6 98.08 11.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.442 0.639 . . . . 0.0 110.311 173.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.646 ' O ' ' HB3' ' A' ' 245' ' ' LYS . 0.2 OUTLIER -160.06 164.48 33.09 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.881 -173.743 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.504 ' O ' ' HG3' ' A' ' 262' ' ' GLU . 12.0 pt-20 -143.47 -167.52 2.59 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.975 -0.453 . . . . 0.0 111.888 -172.024 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 243' ' ' ILE . 62.8 t -54.49 123.22 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.508 ' HA2' ' NH1' ' A' ' 241' ' ' ARG . . . 102.04 -1.04 51.24 Favored Glycine 0 CA--C 1.509 -0.331 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.699 170.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 259' ' ' GLU . 8.3 mt-10 -86.57 -174.83 5.19 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -168.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.799 HD21 ' HB3' ' A' ' 239' ' ' TYR . 3.4 tm? -140.0 128.28 22.55 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.634 177.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.76 HG13 ' HB3' ' A' ' 240' ' ' ALA . 2.6 p -127.17 115.54 41.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.297 177.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.554 ' HE2' ' HG2' ' A' ' 237' ' ' PRO . 86.9 tttt -89.61 100.75 13.49 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.658 ' HA ' ' HA2' ' A' ' 277' ' ' GLY . 0.8 OUTLIER -83.09 137.16 21.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.897 -175.968 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 23.2 p -99.34 -8.3 25.05 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.704 -176.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.442 ' HA ' ' HD3' ' A' ' 268' ' ' LYS . 14.0 tppt? -126.51 107.44 10.24 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.052 173.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.728 HG21 HG23 ' A' ' 238' ' ' ILE . 0.9 OUTLIER -105.04 163.26 4.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -170.76 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.514 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 4.3 p30 -143.3 -172.53 3.72 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.225 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 26.0 m -103.03 -5.91 9.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -175.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 5.5 m -100.99 -44.85 5.6 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.481 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 273' ' ' GLY . . . . . 0.482 ' HA3' ' CD1' ' A' ' 288' ' ' PHE . . . 133.18 -1.81 4.6 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.289 -0.958 . . . . 0.0 113.513 -178.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.7 OUTLIER -95.99 102.08 13.83 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 118.003 0.901 . . . . 0.0 109.274 174.463 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.87 ' HZ2' ' HG ' ' A' ' 293' ' ' LEU . 0.0 OUTLIER -128.24 173.27 10.28 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -173.582 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.517 ' O ' ' HB ' ' A' ' 266' ' ' VAL . 45.1 tt0 -96.34 125.16 40.65 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 171.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.658 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -114.97 165.47 12.07 Favored Glycine 0 N--CA 1.439 -1.132 0 CA-C-N 115.466 -0.788 . . . . 0.0 113.15 -166.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 22.4 tt0 -139.04 118.86 13.19 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 171.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 279' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 282' ' ' LYS . 21.8 p -99.93 96.3 7.46 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 119.474 -0.891 . . . . 0.0 108.904 176.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 62.6 m-20 41.59 52.69 3.9 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.935 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 115.18 -28.62 7.84 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.548 -0.834 . . . . 0.0 114.691 175.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 282' ' ' LYS . . . . . 0.641 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 10.0 mptt -91.63 134.21 34.89 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.105 0.952 . . . . 0.0 110.428 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 283' ' ' ARG . . . . . 0.411 ' N ' ' HD2' ' A' ' 283' ' ' ARG . 3.5 mpt_? -106.27 157.76 17.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.953 0.406 . . . . 0.0 111.301 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 284' ' ' GLY . . . . . 0.688 ' CA ' HD22 ' A' ' 256' ' ' LEU . . . 175.37 -172.97 45.96 Favored Glycine 0 C--O 1.224 -0.499 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -177.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 285' ' ' HIS . . . . . 0.463 ' H ' ' HA ' ' A' ' 255' ' ' ALA . 12.3 p80 -146.85 143.6 28.69 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 118.674 1.237 . . . . 0.0 111.782 171.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.732 ' CE2' ' HB1' ' A' ' 255' ' ' ALA . 5.8 m-85 -156.3 163.04 26.22 Favored Pre-proline 0 N--CA 1.464 0.264 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.429 -174.166 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 24.1 Cg_endo -92.57 167.09 2.76 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.178 2.585 . . . . 0.0 112.06 175.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.482 ' CD1' ' HA3' ' A' ' 273' ' ' GLY . 39.7 p90 -85.18 -8.02 58.78 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -172.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 6.3 t -56.33 -13.19 2.01 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -174.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 290' ' ' HIS . . . . . 0.649 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 0.1 OUTLIER -138.94 33.56 2.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.928 0.394 . . . . 0.0 111.89 -178.259 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.76 HG12 ' HA ' ' A' ' 242' ' ' VAL . 15.5 m -146.74 162.08 9.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.348 176.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -117.79 106.37 12.95 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 176.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 293' ' ' LEU . . . . . 0.87 ' HG ' ' HZ2' ' A' ' 275' ' ' TRP . 0.0 OUTLIER -104.55 128.66 52.57 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 119.622 -0.831 . . . . 0.0 113.223 -169.363 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.663 ' O ' ' HB ' ' A' ' 238' ' ' ILE . 4.8 mp . . . . . 0 N--CA 1.436 -1.15 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 168.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.43 ' HB3' ' HA ' ' A' ' 267' ' ' THR . 11.3 Cg_exo . . . . . 0 N--CA 1.454 -0.824 0 N-CA-C 110.171 -0.742 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.586 HG23 HG21 ' A' ' 269' ' ' ILE . 0.2 OUTLIER -80.43 158.21 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.115 -171.045 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.711 ' HD1' HD11 ' A' ' 263' ' ' LEU . 83.1 m-85 -99.43 118.33 35.8 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 174.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 293' ' ' LEU . . . -114.78 115.74 27.51 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -175.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -79.93 101.88 8.86 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 176.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.852 HG21 ' HD3' ' A' ' 245' ' ' LYS . 7.6 p -81.95 119.11 30.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.324 -175.09 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.8 pp -98.71 3.7 10.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.411 -174.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.543 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 51.4 tt0 -177.28 106.0 0.06 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.446 -175.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.852 ' HD3' HG21 ' A' ' 242' ' ' VAL . 0.2 OUTLIER -146.93 166.0 28.09 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.344 0.593 . . . . 0.0 110.903 174.446 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.822 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 5.7 ptt180 -104.7 -178.8 3.76 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.135 -0.938 . . . . 0.0 108.602 -177.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 4.7 m -104.22 76.95 0.28 Allowed Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 121.227 0.537 . . . . 0.0 112.357 176.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 1.012 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 3.3 Cg_exo -83.31 177.43 6.51 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.274 3.316 . . . . 0.0 110.6 174.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -139.49 176.99 8.26 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.054 -178.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.937 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -63.6 -5.06 3.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.634 0.73 . . . . 0.0 110.567 170.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -90.2 -11.01 42.32 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.772 176.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -105.95 60.21 0.66 Allowed 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.557 -173.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 253' ' ' LYS . . . . . 0.5 ' N ' ' HD2' ' A' ' 253' ' ' LYS . 7.2 mptt 56.28 31.56 18.74 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -170.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 254' ' ' THR . . . . . 0.937 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 74.3 p 53.14 53.06 12.5 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 114.174 -1.375 . . . . 0.0 112.547 -177.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.436 ' HA ' ' H ' ' A' ' 285' ' ' HIS . . . -90.07 161.4 15.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.046 0.45 . . . . 0.0 110.709 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.687 ' N ' ' HA3' ' A' ' 284' ' ' GLY . 0.2 OUTLIER -78.89 132.67 36.86 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.745 -173.99 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.012 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -91.27 100.75 13.5 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 172.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.802 HD11 ' HE2' ' A' ' 245' ' ' LYS . 0.7 OUTLIER -150.26 171.25 17.25 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.493 -174.59 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -143.59 170.31 16.08 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.188 -163.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 2.5 p -53.81 118.74 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 121.528 0.68 . . . . 0.0 111.724 173.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 106.45 -1.67 37.05 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.011 171.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -89.04 176.21 7.08 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.079 -174.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.711 HD11 ' HD1' ' A' ' 239' ' ' TYR . 3.0 tm? -126.7 130.47 50.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.227 0.536 . . . . 0.0 110.132 -178.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.437 HG22 HD12 ' A' ' 258' ' ' LEU . 2.2 t -111.44 145.09 18.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.604 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 238' ' ' ILE . 62.3 tttp -120.68 95.12 4.59 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 170.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.735 ' HB ' ' HA2' ' A' ' 277' ' ' GLY . 1.4 m -84.71 124.42 39.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.723 -173.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 267' ' ' THR . . . . . 0.43 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 40.4 p -88.36 -9.49 52.56 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.868 -174.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.503 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 4.4 tppp? -116.92 103.62 10.47 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.586 HG21 HG23 ' A' ' 238' ' ' ILE . 0.7 OUTLIER -102.61 154.41 5.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.85 -172.816 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.536 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 4.2 p30 -144.23 -170.81 3.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.774 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 12.0 p -95.67 -33.87 4.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.916 -178.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 10.8 m -74.07 -43.02 59.22 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -173.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 123.88 -5.7 9.03 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.163 -177.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.705 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.6 OUTLIER -94.53 104.71 16.66 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 173.535 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.588 ' HZ2' HD13 ' A' ' 293' ' ' LEU . 0.0 OUTLIER -129.71 -179.76 5.37 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.598 0.713 . . . . 0.0 112.055 -173.684 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.503 ' HB2' ' HB3' ' A' ' 268' ' ' LYS . 32.2 mt-10 -102.42 123.87 46.98 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 173.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.735 ' HA2' ' HB ' ' A' ' 266' ' ' VAL . . . -109.09 153.39 16.84 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.905 -165.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.589 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 29.7 tt0 -135.42 118.88 16.85 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 174.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 47.9 t -99.3 96.38 7.7 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 38.4 55.93 1.8 Allowed 'General case' 0 CA--C 1.533 0.323 0 O-C-N 124.362 1.039 . . . . 0.0 112.023 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 115.91 -40.26 2.48 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 120.433 -0.889 . . . . 0.0 114.091 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 282' ' ' LYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 0.8 OUTLIER -80.05 136.82 36.66 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.969 0.884 . . . . 0.0 110.241 179.788 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 283' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 283' ' ' ARG . 5.6 mpt_? -113.12 131.23 55.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.643 0.735 . . . . 0.0 112.031 178.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 284' ' ' GLY . . . . . 0.687 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . -147.51 -166.96 12.89 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 114.282 -1.326 . . . . 0.0 111.651 174.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 285' ' ' HIS . . . . . 0.436 ' H ' ' HA ' ' A' ' 255' ' ' ALA . 5.6 m-70 -145.91 139.89 26.58 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 117.684 0.742 . . . . 0.0 109.427 178.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.724 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 10.4 m-85 -167.99 157.2 8.69 Favored Pre-proline 0 N--CA 1.471 0.603 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -172.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.705 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 58.7 Cg_endo -95.34 176.39 0.9 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.709 2.939 . . . . 0.0 113.457 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.494 ' HA ' HG22 ' A' ' 291' ' ' VAL . 24.1 p90 -86.07 -9.74 56.2 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.106 -173.019 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 11.1 t -70.26 8.26 0.82 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -168.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 290' ' ' HIS . . . . . 0.543 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 0.9 OUTLIER -155.77 38.21 0.37 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.091 0.472 . . . . 0.0 110.95 177.517 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 242' ' ' VAL . 27.6 m -144.67 157.76 14.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.014 0.435 . . . . 0.0 111.112 178.255 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -115.88 108.84 16.8 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 170.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 293' ' ' LEU . . . . . 0.588 HD13 ' HZ2' ' A' ' 275' ' ' TRP . 0.2 OUTLIER -102.98 123.65 46.98 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -165.727 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.468 ' H ' HD12 ' A' ' 294' ' ' LEU . 4.6 mp . . . . . 0 N--CA 1.439 -1.002 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.092 167.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo . . . . . 0 C--O 1.235 0.342 0 CA-C-O 121.006 0.336 . . . . 0.0 112.593 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 1.044 HG12 HG22 ' A' ' 266' ' ' VAL . 1.3 pt -91.75 167.98 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.727 173.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.776 ' HB3' HD11 ' A' ' 263' ' ' LEU . 61.5 m-85 -116.35 119.66 36.39 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 169.082 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.626 ' HA ' ' HA ' ' A' ' 293' ' ' LEU . . . -113.21 117.66 32.52 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.944 -175.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.495 ' HD3' ' O ' ' A' ' 262' ' ' GLU . 16.3 tpp180 -82.45 102.91 11.62 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.416 175.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.906 HG21 ' HD2' ' A' ' 245' ' ' LYS . 2.6 p -87.26 135.15 25.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.512 -173.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.8 pp -109.61 9.1 8.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.787 -175.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.823 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 58.2 tt0 -176.92 95.24 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.723 0.297 . . . . 0.0 110.26 -173.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.906 ' HD2' HG21 ' A' ' 242' ' ' VAL . 4.3 mttt -146.29 161.72 39.68 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 175.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.878 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 5.8 ptp180 -106.62 -178.07 3.54 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -177.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 32.0 t -103.3 80.37 0.36 Allowed Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 120.955 0.407 . . . . 0.0 111.262 176.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.962 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 3.1 Cg_endo -91.45 177.67 1.87 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 125.161 3.907 . . . . 0.0 111.184 175.007 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -130.29 174.94 9.35 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 175.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.788 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -72.22 5.12 3.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.417 0.627 . . . . 0.0 110.332 175.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -99.2 -2.62 36.28 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.216 174.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.422 ' C ' ' HD2' ' A' ' 253' ' ' LYS . 35.6 m-20 -105.15 63.72 0.7 Allowed 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.464 -177.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 253' ' ' LYS . . . . . 0.422 ' HD2' ' C ' ' A' ' 252' ' ' ASP . 7.0 mptt 57.58 25.62 11.83 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -171.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 254' ' ' THR . . . . . 0.788 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 44.9 p 56.06 75.86 0.32 Allowed 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.823 -174.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -113.77 150.3 33.62 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.253 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.463 ' O ' ' HE2' ' A' ' 286' ' ' PHE . 0.0 OUTLIER -72.84 132.92 44.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.611 -176.163 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.962 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -95.12 104.27 16.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.371 0.605 . . . . 0.0 111.479 174.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.692 ' HG ' ' HD3' ' A' ' 245' ' ' LYS . 0.4 OUTLIER -163.81 175.5 10.41 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.54 -176.344 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -142.45 -166.42 2.26 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 121.591 -0.693 . . . . 0.0 112.383 -171.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 2.8 p -68.51 122.01 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.295 177.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 104.18 -0.75 43.96 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.284 174.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.495 ' O ' ' HD3' ' A' ' 241' ' ' ARG . 9.4 mt-10 -98.73 -174.72 2.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.842 0.353 . . . . 0.0 111.666 -170.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.776 HD11 ' HB3' ' A' ' 239' ' ' TYR . 50.7 tp -133.74 160.27 38.09 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.508 -177.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.498 ' N ' ' HG ' ' A' ' 263' ' ' LEU . 2.8 p -153.48 136.91 7.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.389 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.485 ' HE2' ' CE1' ' A' ' 239' ' ' TYR . 37.9 ttmt -99.98 102.1 13.38 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 175.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 1.044 HG22 HG12 ' A' ' 238' ' ' ILE . 4.0 m -86.79 115.68 28.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.97 0.89 . . . . 0.0 110.71 -178.195 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 9.9 t -99.95 4.08 44.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.596 -1.183 . . . . 0.0 110.394 -177.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 0.0 OUTLIER -124.94 107.19 10.6 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 168.128 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.579 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.8 OUTLIER -110.49 158.22 10.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 115.286 -0.87 . . . . 0.0 113.113 -172.098 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.769 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 2.6 p30 -146.34 -172.98 4.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.698 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 11.6 p -93.39 -31.92 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 45.7 m -74.99 -43.44 53.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -173.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 273' ' ' GLY . . . . . 0.777 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 125.04 -13.51 7.55 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.499 -178.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.569 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.6 OUTLIER -89.23 93.09 9.44 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 173.285 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.769 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -123.05 179.09 4.79 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.183 -176.204 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 268' ' ' LYS . 53.4 tt0 -104.32 125.77 50.85 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.723 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -110.2 169.68 13.69 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.95 -172.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 3.1 tm-20 -152.32 119.45 5.87 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 171.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 44.6 t -115.63 99.55 7.42 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.084 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 43.3 54.33 5.16 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 124.252 0.97 . . . . 0.0 112.313 173.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 117.73 -40.45 2.33 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-N 115.828 -0.624 . . . . 0.0 114.102 176.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 282' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 0.0 OUTLIER -93.32 128.79 39.48 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 118.066 0.933 . . . . 0.0 109.934 -178.996 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 283' ' ' ARG . . . . . 0.622 ' HD3' ' H ' ' A' ' 283' ' ' ARG . 0.0 OUTLIER -121.2 145.47 47.8 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.266 176.28 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 173.05 157.75 15.61 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.072 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 285' ' ' HIS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 30.5 p80 -98.08 148.35 23.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.04 0.42 . . . . 0.0 112.117 -171.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.463 ' HE2' ' O ' ' A' ' 256' ' ' LEU . 5.3 m-85 -158.55 159.21 29.85 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.515 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 93.6 Cg_endo -89.36 168.28 5.14 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.206 2.604 . . . . 0.0 113.809 -177.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.777 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 19.0 t80 -76.62 -19.99 57.22 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 114.158 -1.383 . . . . 0.0 111.922 -172.126 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 8.9 t -61.8 -11.47 12.61 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -168.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 290' ' ' HIS . . . . . 0.823 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 0.1 OUTLIER -137.68 33.91 2.45 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.69 -0.631 . . . . 0.0 112.351 -176.359 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.5 HG23 HD23 ' A' ' 293' ' ' LEU . 34.1 m -139.93 153.11 22.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.882 0.372 . . . . 0.0 111.192 177.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -121.06 107.96 13.25 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 169.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 293' ' ' LEU . . . . . 0.744 HD21 ' CE2' ' A' ' 288' ' ' PHE . 0.2 OUTLIER -101.49 139.96 36.44 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -169.935 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.512 ' N ' HD12 ' A' ' 294' ' ' LEU . 4.5 mp . . . . . 0 N--CA 1.431 -1.424 0 CA-C-N 113.397 -1.729 . . . . 0.0 107.412 166.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo . . . . . 0 N--CA 1.45 -1.043 0 CA-C-O 120.679 0.2 . . . . 0.0 111.935 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.662 HD13 ' HB ' ' A' ' 266' ' ' VAL . 0.1 OUTLIER -97.08 152.24 4.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.391 -178.641 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.7 ' HB3' HD21 ' A' ' 263' ' ' LEU . 67.3 m-85 -96.65 119.54 35.32 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 174.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 293' ' ' LEU . . . -114.42 116.72 29.35 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.24 0.543 . . . . 0.0 110.352 -174.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -86.19 102.29 13.78 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.592 178.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.74 HG21 ' HD3' ' A' ' 245' ' ' LYS . 3.0 p -79.55 128.53 38.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.534 -175.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.721 HD12 ' HB2' ' A' ' 244' ' ' GLN . 2.8 pp -108.31 3.53 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.88 -175.033 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.721 ' HB2' HD12 ' A' ' 243' ' ' ILE . 4.0 mt-30 -176.29 95.67 0.05 Allowed 'General case' 0 N--CA 1.463 0.203 0 O-C-N 123.043 0.214 . . . . 0.0 111.061 -175.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.74 ' HD3' HG21 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -146.5 163.17 36.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.183 0.516 . . . . 0.0 111.164 173.663 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.869 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 9.8 ptt180 -101.27 -176.92 3.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.679 -177.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 27.3 t -101.66 82.69 0.4 Allowed Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 120.856 0.36 . . . . 0.0 111.292 175.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.98 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 7.0 Cg_endo -93.02 177.14 1.44 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.656 3.571 . . . . 0.0 110.778 172.125 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 249' ' ' ASN . . . . . 0.409 ' C ' ' H ' ' A' ' 251' ' ' TYR . 51.8 m-80 -131.04 177.26 7.58 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.026 0.441 . . . . 0.0 110.678 176.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.812 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -64.2 0.25 1.02 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.356 0.598 . . . . 0.0 110.99 173.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.409 ' H ' ' C ' ' A' ' 249' ' ' ASN . 44.4 m-85 -103.81 8.57 37.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.454 0.645 . . . . 0.0 109.696 177.097 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.74 53.19 0.73 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.162 -0.927 . . . . 0.0 108.727 176.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt 58.01 30.45 19.24 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -167.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 254' ' ' THR . . . . . 0.812 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 43.4 p 59.1 71.3 0.59 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.826 -176.228 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.417 ' HB1' ' CE2' ' A' ' 286' ' ' PHE . . . -111.55 150.75 29.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.65 179.026 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.667 ' HB3' HD22 ' A' ' 258' ' ' LEU . 0.2 OUTLIER -72.12 133.67 45.32 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.663 -174.543 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.98 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -90.57 98.92 12.06 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 172.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.73 HD21 ' HE2' ' A' ' 245' ' ' LYS . 0.9 OUTLIER -154.94 171.14 20.19 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.108 -173.735 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.454 ' O ' HG13 ' A' ' 242' ' ' VAL . 12.3 pt-20 -142.28 -166.59 2.28 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.177 0.513 . . . . 0.0 111.873 -171.159 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.575 HG22 ' HA ' ' A' ' 244' ' ' GLN . 48.2 t -68.12 117.61 10.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.124 176.623 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 107.13 0.86 35.74 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.132 172.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.405 ' HB2' ' CG1' ' A' ' 242' ' ' VAL . 13.4 mt-10 -93.15 179.78 5.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.188 0.518 . . . . 0.0 111.915 -173.236 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.7 HD21 ' HB3' ' A' ' 239' ' ' TYR . 3.0 tm? -136.89 133.57 35.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.251 -176.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.95 HG12 ' HB2' ' A' ' 279' ' ' CYS . 34.1 m -126.15 154.86 35.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.097 173.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -111.52 96.04 5.86 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.662 ' HB ' HD13 ' A' ' 238' ' ' ILE . 49.2 t -69.88 121.47 19.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.836 -174.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 40.8 p -103.51 -7.19 21.06 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.626 -176.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.596 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 0.0 OUTLIER -126.85 106.77 9.56 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 119.445 -0.902 . . . . 0.0 108.74 171.018 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 269' ' ' ILE . . . . . 0.586 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.7 OUTLIER -107.65 148.66 11.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 114.451 -1.249 . . . . 0.0 113.72 -168.613 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.848 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 10.1 p30 -147.12 154.04 40.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.463 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 35.9 m -70.4 -9.71 12.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -174.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.5 m -89.75 -45.49 9.26 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.867 -178.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 119.68 -7.95 12.03 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.061 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.724 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.0 OUTLIER -93.94 70.75 4.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.484 0.659 . . . . 0.0 109.636 176.897 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.848 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -112.74 174.83 5.7 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.327 -168.814 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.691 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 32.9 tt0 -94.87 123.82 38.56 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.225 0.536 . . . . 0.0 109.796 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.6 ' HA2' HG22 ' A' ' 266' ' ' VAL . . . -100.96 150.21 18.64 Favored Glycine 0 N--CA 1.436 -1.326 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.299 -175.175 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.808 ' HG3' ' HG2' ' A' ' 283' ' ' ARG . 32.4 tt0 -127.8 116.85 20.81 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 279' ' ' CYS . . . . . 0.95 ' HB2' HG12 ' A' ' 264' ' ' VAL . 43.7 t -111.17 98.36 7.46 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 24.95 61.56 0.05 Allowed 'General case' 0 C--N 1.343 0.306 0 O-C-N 125.619 1.824 . . . . 0.0 113.301 174.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 118.53 -24.27 8.63 Favored Glycine 0 CA--C 1.523 0.55 0 CA-C-N 115.447 -0.797 . . . . 0.0 114.134 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.35 144.4 31.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 118.003 0.902 . . . . 0.0 110.38 175.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 283' ' ' ARG . . . . . 0.808 ' HG2' ' HG3' ' A' ' 278' ' ' GLU . 28.7 mtm180 -123.91 129.5 51.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.792 0.33 . . . . 0.0 110.188 171.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 284' ' ' GLY . . . . . 0.614 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . -165.52 140.57 6.46 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.112 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 285' ' ' HIS . . . . . 0.691 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 20.7 p80 -99.25 148.04 24.54 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 117.434 0.617 . . . . 0.0 111.696 -175.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.654 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 5.7 m-85 -161.2 164.05 19.34 Favored Pre-proline 0 C--O 1.235 0.324 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.041 -177.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.724 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 1.7 Cg_endo -85.72 158.76 10.54 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.518 2.812 . . . . 0.0 112.13 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.709 ' HB2' HD21 ' A' ' 293' ' ' LEU . 1.8 p90 -87.03 -5.95 58.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.891 -174.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.541 HG22 ' HB2' ' A' ' 287' ' ' PRO . 5.6 t -52.8 -32.73 45.48 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 290' ' ' HIS . . . . . 0.438 ' CD2' ' HD2' ' A' ' 245' ' ' LYS . 0.8 OUTLIER -121.38 43.77 2.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.35 0.595 . . . . 0.0 111.429 -177.322 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.692 HG12 ' HA ' ' A' ' 242' ' ' VAL . 19.8 m -147.46 170.11 3.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.158 173.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -131.71 109.06 9.9 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 173.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 293' ' ' LEU . . . . . 0.709 HD21 ' HB2' ' A' ' 288' ' ' PHE . 0.1 OUTLIER -113.88 133.13 55.62 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.742 0.782 . . . . 0.0 112.883 -166.379 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.456 ' H ' HD12 ' A' ' 294' ' ' LEU . 4.5 mp . . . . . 0 N--CA 1.437 -1.076 0 CA-C-N 114.326 -1.307 . . . . 0.0 108.075 171.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' GLY . . . . . 0.465 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . . . . . . 0 N--CA 1.446 -0.665 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.545 ' HB2' ' HD3' ' A' ' 265' ' ' LYS . 4.3 Cg_endo -88.05 121.62 1.47 Allowed 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.395 2.73 . . . . 0.0 111.554 176.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.779 ' CD1' ' HB ' ' A' ' 266' ' ' VAL . 0.2 OUTLIER -85.12 161.56 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 C-N-CA 119.219 -0.992 . . . . 0.0 109.852 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.839 ' HB3' HD21 ' A' ' 263' ' ' LEU . 44.4 m-85 -103.46 118.64 37.21 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 172.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.702 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -111.83 115.76 29.55 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.05 -174.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.514 ' HB3' ' O ' ' A' ' 292' ' ' ARG . 21.9 tpp180 -75.48 101.64 4.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 175.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.751 HG21 ' HD3' ' A' ' 245' ' ' LYS . 5.2 p -81.29 119.88 31.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 C-N-CA 120.316 -0.554 . . . . 0.0 109.991 -175.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.8 pp -102.23 9.15 8.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.629 -173.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.88 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 17.5 tt0 -176.9 95.44 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.192 -177.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.751 ' HD3' HG21 ' A' ' 242' ' ' VAL . 0.1 OUTLIER -146.48 164.22 33.22 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.839 0.828 . . . . 0.0 111.189 174.242 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.83 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 2.6 ptm180 -105.24 -175.88 2.92 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.637 -1.62 . . . . 0.0 108.767 -177.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 3.8 m -110.52 70.87 0.64 Allowed Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 121.42 0.628 . . . . 0.0 111.547 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 1.016 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 28.7 Cg_endo -95.29 123.08 0.32 Allowed 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 125.051 3.834 . . . . 0.0 111.913 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.416 ' C ' ' H ' ' A' ' 251' ' ' TYR . 40.7 m-80 -78.55 176.18 9.66 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.873 0.368 . . . . 0.0 111.038 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.705 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -62.9 -2.07 1.09 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.751 0.786 . . . . 0.0 111.349 175.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.416 ' H ' ' C ' ' A' ' 249' ' ' ASN . 12.0 m-85 -92.87 -1.93 56.32 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.998 178.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.38 47.81 1.14 Allowed 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt 59.99 30.22 19.73 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -167.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' THR . . . . . 0.705 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 29.4 p 63.79 86.22 0.12 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 113.825 -1.534 . . . . 0.0 111.048 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.685 ' HB3' ' HB2' ' A' ' 248' ' ' PRO . . . -120.6 163.78 17.5 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.951 178.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.515 ' HB3' ' CG ' ' A' ' 258' ' ' LEU . 4.5 mm? -83.15 120.59 25.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.203 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.016 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -88.84 91.19 8.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.65 0.738 . . . . 0.0 110.303 176.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.699 ' CD2' ' HB ' ' A' ' 264' ' ' VAL . 0.2 OUTLIER -148.34 176.28 10.4 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.561 -174.645 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.501 ' HG2' ' N ' ' A' ' 260' ' ' VAL . 15.4 tt0 -142.04 167.11 22.91 Favored 'General case' 0 C--N 1.313 -1.022 0 O-C-N 121.931 -0.481 . . . . 0.0 110.931 -162.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.501 ' N ' ' HG2' ' A' ' 259' ' ' GLU . 1.6 p -57.79 117.73 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 121.41 0.624 . . . . 0.0 111.236 174.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 107.52 -2.65 34.47 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.918 176.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -95.44 -173.33 2.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.941 0.4 . . . . 0.0 111.379 -173.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.839 HD21 ' HB3' ' A' ' 239' ' ' TYR . 3.4 tm? -133.73 122.27 23.11 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.711 -174.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.702 HG13 ' HB3' ' A' ' 240' ' ' ALA . 2.5 p -113.82 125.74 71.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.077 174.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.563 ' HG3' ' CE1' ' A' ' 239' ' ' TYR . 5.2 tmmm? -96.47 96.11 8.47 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.779 ' HB ' ' CD1' ' A' ' 238' ' ' ILE . 96.6 t -71.89 114.94 11.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.084 -177.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' THR . . . . . 0.446 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 4.7 t -93.36 -9.28 39.34 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 124.313 1.008 . . . . 0.0 111.266 -178.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.631 ' HA ' ' HE3' ' A' ' 268' ' ' LYS . 0.0 OUTLIER -127.32 103.28 7.31 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 175.399 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.449 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.8 OUTLIER -98.98 160.12 3.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -170.426 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.622 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 3.6 p30 -146.69 -169.62 3.32 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.925 178.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 8.5 p -96.65 -37.0 6.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 5.0 m -73.27 -43.02 61.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.864 0.364 . . . . 0.0 111.767 -172.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' GLY . . . . . 0.866 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 124.27 -4.79 8.87 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.828 -175.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -90.59 82.19 5.83 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 176.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.622 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -116.87 175.51 5.54 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.246 0.546 . . . . 0.0 112.054 -174.244 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.558 ' O ' HG13 ' A' ' 266' ' ' VAL . 36.0 mt-10 -102.62 124.66 48.57 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.831 177.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.614 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -108.41 153.38 16.83 Favored Glycine 0 N--CA 1.439 -1.128 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.418 -169.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.599 ' HG3' ' HG2' ' A' ' 283' ' ' ARG . 21.8 tt0 -130.74 119.8 22.87 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 173.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' CYS . . . . . 0.507 ' O ' ' HD2' ' A' ' 282' ' ' LYS . 53.7 t -116.56 96.22 5.41 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.958 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 24.38 61.31 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 O-C-N 124.914 1.384 . . . . 0.0 113.505 -177.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.79 -20.32 11.9 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.84 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' LYS . . . . . 0.507 ' HD2' ' O ' ' A' ' 279' ' ' CYS . 5.7 mptt -97.93 132.13 43.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.632 0.716 . . . . 0.0 109.749 174.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ARG . . . . . 0.599 ' HG2' ' HG3' ' A' ' 278' ' ' GLU . 48.7 mtt180 -123.68 141.5 51.96 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 176.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 175.29 -148.79 9.73 Favored Glycine 0 C--O 1.223 -0.542 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.315 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' HIS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 12.8 p80 -149.17 145.92 27.4 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 117.37 0.585 . . . . 0.0 111.54 -177.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.617 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 4.4 m-85 -162.57 164.07 17.23 Favored Pre-proline 0 N--CA 1.47 0.546 0 C-N-CA 122.543 0.337 . . . . 0.0 111.119 -177.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.511 ' HD3' ' HD1' ' A' ' 286' ' ' PHE . 31.4 Cg_endo -95.39 168.11 1.45 Allowed 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 123.464 2.776 . . . . 0.0 114.144 -175.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.866 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 7.2 t80 -76.28 -17.71 59.33 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.748 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 35.8 p -45.61 -37.98 6.14 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -174.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' HIS . . . . . 0.88 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 0.8 OUTLIER -132.61 48.39 2.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.141 0.496 . . . . 0.0 112.32 -174.432 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 27.7 m -142.75 151.78 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.773 173.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.514 ' O ' ' HB3' ' A' ' 241' ' ' ARG . 21.2 mmt180 -128.83 109.39 11.24 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 176.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' LEU . . . . . 0.512 ' HB3' ' HA ' ' A' ' 240' ' ' ALA . 0.2 OUTLIER -116.7 144.07 44.88 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -162.643 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.554 ' O ' ' HB ' ' A' ' 238' ' ' ILE . 4.5 mp -86.97 171.11 11.02 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 113.461 -1.7 . . . . 0.0 108.8 169.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.415 ' OD1' ' HG2' ' A' ' 297' ' ' GLN . 4.3 t70 -76.35 168.27 20.36 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.778 0.799 . . . . 0.0 111.887 -163.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.638 ' HB3' HG22 ' A' ' 238' ' ' ILE . 8.5 pt20 -100.73 -5.72 26.04 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.594 -175.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' GLN . . . . . 0.415 ' HG2' ' OD1' ' A' ' 295' ' ' ASP . 17.3 pt20 -89.18 -0.41 57.43 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 174.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 CA--C 1.531 0.224 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.221 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 236' ' ' GLY . . . . . 0.463 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . . . . . . 0 N--CA 1.443 -0.859 0 N-CA-C 112.088 -0.405 . . . . 0.0 112.088 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.463 ' HD3' ' HA2' ' A' ' 236' ' ' GLY . 5.1 Cg_exo -78.54 142.28 18.27 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.44 2.093 . . . . 0.0 111.612 175.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.934 HG23 ' HB ' ' A' ' 266' ' ' VAL . 0.1 OUTLIER -105.92 142.55 18.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.971 -173.26 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.708 ' HB3' HD11 ' A' ' 263' ' ' LEU . 76.7 m-85 -96.81 117.04 30.21 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 174.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.485 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -114.68 117.19 30.13 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.424 -173.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.59 ' HB3' ' O ' ' A' ' 292' ' ' ARG . 23.8 tpp180 -83.12 103.18 12.35 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.316 -177.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.984 HG21 ' HD3' ' A' ' 245' ' ' LYS . 3.7 p -81.86 128.79 38.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.258 -175.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.601 HD12 ' HB2' ' A' ' 244' ' ' GLN . 2.8 pp -107.33 7.43 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.344 -176.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.601 ' HB2' HD12 ' A' ' 243' ' ' ILE . 13.5 mt-30 -176.35 95.43 0.05 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.522 -173.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.984 ' HD3' HG21 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -146.09 163.32 35.68 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.118 0.485 . . . . 0.0 110.353 173.044 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.857 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 12.6 ptp180 -104.3 -177.08 3.26 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.344 -177.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 6.9 m -104.21 80.23 0.43 Allowed Pre-proline 0 CA--C 1.54 0.57 0 CA-C-O 121.522 0.677 . . . . 0.0 111.828 175.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.922 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 9.1 Cg_endo -92.93 176.67 1.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 125.167 3.911 . . . . 0.0 111.545 176.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -126.85 175.47 8.01 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.602 ' O ' HG22 ' A' ' 254' ' ' THR . . . -68.03 -0.99 5.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.4 175.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -114.93 14.83 17.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.431 0.634 . . . . 0.0 110.011 173.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -104.56 56.54 0.71 Allowed 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 173.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' LYS . . . . . 0.504 ' HE2' ' HA ' ' A' ' 253' ' ' LYS . 11.1 mmpt? 65.63 22.62 11.67 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.813 -169.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' THR . . . . . 0.602 HG22 ' O ' ' A' ' 250' ' ' ALA . 29.1 p 59.26 75.54 0.4 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.488 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.679 ' HB1' ' CE2' ' A' ' 286' ' ' PHE . . . -125.32 159.06 32.67 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.163 -176.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.591 HD21 ' O ' ' A' ' 277' ' ' GLY . 4.6 mm? -78.99 124.84 28.65 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.074 -0.967 . . . . 0.0 112.598 -176.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.922 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -83.03 93.17 7.52 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.338 0.589 . . . . 0.0 110.72 172.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.609 HD11 ' HE2' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -156.97 171.95 19.55 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.992 -1.003 . . . . 0.0 109.486 -177.508 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.413 ' O ' HG13 ' A' ' 242' ' ' VAL . 11.9 pt-20 -141.38 -163.87 1.65 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 118.488 0.586 . . . . 0.0 112.018 -167.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 244' ' ' GLN . 75.3 t -67.08 118.27 10.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.024 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 105.69 -2.18 39.15 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.606 171.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.536 ' O ' ' HD3' ' A' ' 241' ' ' ARG . 7.9 mt-10 -91.85 -179.46 5.32 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.824 0.345 . . . . 0.0 110.92 -172.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.708 HD11 ' HB3' ' A' ' 239' ' ' TYR . 41.1 tp -129.22 161.06 31.03 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.981 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.542 ' N ' ' HG ' ' A' ' 263' ' ' LEU . 2.4 p -151.15 132.31 4.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.944 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -93.19 97.98 10.99 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 177.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.934 ' HB ' HG23 ' A' ' 238' ' ' ILE . 97.8 t -69.8 119.3 15.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.498 -178.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 73.7 p -102.2 -25.57 13.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.751 -175.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.523 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 2.4 tppp? -108.56 106.04 15.94 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 173.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.769 HD13 ' H ' ' A' ' 269' ' ' ILE . 0.1 OUTLIER -109.77 148.07 13.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -167.022 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.772 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 1.9 p30 -135.85 -170.76 2.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.688 176.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.07 -21.25 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 120.54 -0.464 . . . . 0.0 112.082 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.4 m -79.2 -44.26 22.23 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -174.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 126.02 -11.3 7.35 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.411 -177.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.529 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 1.5 tm0? -91.33 107.79 19.45 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 174.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.772 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -147.72 -179.87 7.2 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -173.004 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.631 ' HG2' ' HB3' ' A' ' 285' ' ' HIS . 35.0 mt-10 -97.29 126.05 42.27 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.148 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.591 ' O ' HD21 ' A' ' 256' ' ' LEU . . . -110.68 156.42 15.57 Favored Glycine 0 N--CA 1.437 -1.242 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.717 -173.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 33.7 tt0 -135.21 119.69 18.03 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 172.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 45.6 t -109.72 97.1 6.71 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.922 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 34.4 56.52 0.67 Allowed 'General case' 0 N--CA 1.464 0.263 0 O-C-N 124.873 1.358 . . . . 0.0 112.479 176.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.36 -34.63 4.59 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.881 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 49.5 mttt -82.15 129.7 34.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.954 0.877 . . . . 0.0 110.874 178.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -113.07 148.29 35.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.026 0.441 . . . . 0.0 111.502 176.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 166.38 -150.42 17.59 Favored Glycine 0 C--O 1.225 -0.459 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.554 174.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' HIS . . . . . 0.631 ' HB3' ' HG2' ' A' ' 276' ' ' GLU . 30.1 p80 -149.74 157.22 43.01 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.59 0.695 . . . . 0.0 111.68 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.711 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 2.4 m-85 -163.3 158.78 18.0 Favored Pre-proline 0 C--N 1.331 -0.227 0 O-C-N 123.563 0.54 . . . . 0.0 110.479 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.529 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 10.7 Cg_endo -89.09 158.92 5.78 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.187 2.591 . . . . 0.0 111.938 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -83.97 -5.26 59.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.562 -176.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 11.1 t -54.83 -13.06 0.92 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' HIS . . . . . 0.548 ' NE2' ' HD2' ' A' ' 245' ' ' LYS . 0.6 OUTLIER -137.71 47.0 2.07 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.113 -0.367 . . . . 0.0 111.564 -179.635 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.769 HG12 ' HA ' ' A' ' 242' ' ' VAL . 35.6 m -147.36 170.26 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.39 0.614 . . . . 0.0 111.61 177.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.59 ' O ' ' HB3' ' A' ' 241' ' ' ARG . 16.3 tpp180 -129.35 110.16 11.69 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 171.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 293' ' ' LEU . . . . . 0.505 ' HB3' HD11 ' A' ' 238' ' ' ILE . 2.9 mt -91.31 140.64 29.59 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -163.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.422 ' N ' HD12 ' A' ' 294' ' ' LEU . 3.9 mp -98.05 125.28 42.95 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 163.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -75.76 156.22 34.8 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 122.157 0.98 . . . . 0.0 111.373 -164.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.45 ' H ' ' HG2' ' A' ' 296' ' ' GLN . 6.4 pt20 -77.59 -18.04 57.23 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.617 -1.629 . . . . 0.0 111.116 -175.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -85.21 -10.24 56.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.21 0.528 . . . . 0.0 109.712 171.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.636 -179.591 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 236' ' ' GLY . . . . . 0.545 ' N ' ' HD2' ' A' ' 237' ' ' PRO . . . . . . . . 0 CA--C 1.521 0.451 0 CA-C-O 120.136 -0.258 . . . . 0.0 112.495 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.751 ' HB3' ' HA ' ' A' ' 267' ' ' THR . 4.2 Cg_exo -39.99 147.73 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 124.9 3.733 . . . . 0.0 113.271 173.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.726 HD13 ' HB ' ' A' ' 266' ' ' VAL . 0.1 OUTLIER -84.07 151.55 3.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 120.996 0.427 . . . . 0.0 111.095 -170.611 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.49 ' HB3' HD11 ' A' ' 263' ' ' LEU . 57.6 m-85 -103.96 119.62 39.32 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 175.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.643 ' HA ' ' HA ' ' A' ' 293' ' ' LEU . . . -113.46 118.33 34.21 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.336 0.589 . . . . 0.0 111.154 -171.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.42 ' HB3' ' O ' ' A' ' 292' ' ' ARG . 20.9 tpp180 -78.0 102.34 7.34 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.637 176.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.647 HG21 ' HB2' ' A' ' 245' ' ' LYS . 3.2 p -80.94 124.96 39.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.609 -176.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.567 HD12 ' HB2' ' A' ' 244' ' ' GLN . 2.8 pp -105.44 8.58 9.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.588 -174.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.797 ' HA ' HG22 ' A' ' 260' ' ' VAL . 17.1 mt-30 -176.17 95.39 0.06 Allowed 'General case' 0 CA--C 1.515 -0.369 0 O-C-N 123.296 0.372 . . . . 0.0 110.347 -173.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.762 ' HG2' ' CD1' ' A' ' 258' ' ' LEU . 0.0 OUTLIER -146.72 163.56 35.55 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.603 0.716 . . . . 0.0 111.663 176.298 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.905 ' HG3' ' HG3' ' A' ' 248' ' ' PRO . 2.4 ptm180 -108.5 -173.3 2.24 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.175 -1.375 . . . . 0.0 109.303 -176.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 37.7 t -108.39 75.67 0.6 Allowed Pre-proline 0 CA--C 1.537 0.443 0 CA-C-O 121.523 0.678 . . . . 0.0 110.175 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.955 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 9.6 Cg_endo -95.0 132.45 0.57 Allowed 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 125.187 3.924 . . . . 0.0 111.768 178.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.41 ' O ' ' HB2' ' A' ' 252' ' ' ASP . 3.6 m-20 -89.53 175.81 7.14 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.772 0.32 . . . . 0.0 110.423 -176.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -71.12 4.02 3.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.608 0.718 . . . . 0.0 110.669 177.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -107.04 8.95 30.63 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.097 176.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 249' ' ' ASN . 0.7 OUTLIER -96.88 51.97 1.16 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.005 175.274 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.93 25.7 14.89 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -166.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 22.4 p 65.61 88.08 0.11 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.819 1.248 . . . . 0.0 110.0 -174.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.748 ' HB3' ' HB2' ' A' ' 248' ' ' PRO . . . -122.0 168.32 12.06 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.066 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.747 ' H ' ' HE2' ' A' ' 286' ' ' PHE . 4.3 mm? -94.86 118.44 31.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.526 -176.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.955 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -85.64 97.26 10.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.54 0.686 . . . . 0.0 110.115 176.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.762 ' CD1' ' HG2' ' A' ' 245' ' ' LYS . 0.2 OUTLIER -156.12 176.42 12.69 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.49 -174.471 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.564 ' HG2' ' N ' ' A' ' 260' ' ' VAL . 24.5 tt0 -142.67 173.79 11.23 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.584 -0.698 . . . . 0.0 111.705 -161.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.797 HG22 ' HA ' ' A' ' 244' ' ' GLN . 69.5 t -56.35 118.2 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 C-N-CA 123.241 0.616 . . . . 0.0 111.443 173.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 104.83 -2.38 41.64 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.805 173.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.442 ' OE2' ' HB3' ' A' ' 259' ' ' GLU . 14.4 mt-10 -97.14 -173.16 2.6 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.023 -174.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.49 HD11 ' HB3' ' A' ' 239' ' ' TYR . 12.4 tp -127.83 157.77 39.55 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.039 0.447 . . . . 0.0 110.685 -176.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.563 HG12 ' HB3' ' A' ' 240' ' ' ALA . 7.7 p -144.09 143.41 23.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 175.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -103.87 95.24 5.88 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.726 ' HB ' HD13 ' A' ' 238' ' ' ILE . 74.8 t -74.39 105.64 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-O 121.94 0.876 . . . . 0.0 110.566 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' THR . . . . . 0.751 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 5.3 t -93.93 -9.34 37.4 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 113.264 -1.789 . . . . 0.0 110.678 -174.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.552 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 14.8 tppt? -122.53 106.18 10.78 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 172.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.531 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.7 OUTLIER -106.78 153.21 8.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -166.66 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.802 HD22 ' HB3' ' A' ' 275' ' ' TRP . 2.0 p30 -147.14 177.01 9.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.057 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 9.7 p -89.91 -23.39 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -176.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.63 -1.05 51.02 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -175.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' GLY . . . . . 0.773 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 78.31 8.7 87.43 Favored Glycine 0 C--O 1.223 -0.532 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.983 177.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.492 ' N ' HD21 ' A' ' 270' ' ' ASN . 9.7 mm100 -93.29 73.25 4.56 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.802 ' HB3' HD22 ' A' ' 270' ' ' ASN . 0.0 OUTLIER -124.25 -179.41 4.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.507 0.67 . . . . 0.0 112.612 -166.554 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.728 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 32.0 mt-10 -104.32 125.74 50.82 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.584 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.594 ' O ' HD21 ' A' ' 256' ' ' LEU . . . -103.51 156.1 17.82 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.25 -173.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 20.0 tt0 -138.55 118.34 13.19 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 175.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' CYS . . . . . 0.626 ' SG ' ' HD3' ' A' ' 282' ' ' LYS . 26.6 p -102.48 97.12 7.4 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.419 -0.912 . . . . 0.0 109.635 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 39.45 56.69 2.21 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.438 -1.256 . . . . 0.0 112.323 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 115.92 -39.87 2.6 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.646 -0.788 . . . . 0.0 114.136 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' LYS . . . . . 0.626 ' HD3' ' SG ' ' A' ' 279' ' ' CYS . 5.9 mptt -76.58 129.16 36.03 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 118.144 0.972 . . . . 0.0 110.414 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.39 131.06 54.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.606 -176.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -167.78 -151.18 6.88 Favored Glycine 0 C--O 1.224 -0.49 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.228 174.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' HIS . . . . . 0.728 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 16.8 p80 -150.56 147.91 28.03 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 117.122 0.461 . . . . 0.0 111.187 -177.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.747 ' HE2' ' H ' ' A' ' 256' ' ' LEU . 4.5 m-85 -157.84 160.18 30.12 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 120.728 0.299 . . . . 0.0 111.69 -177.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -95.19 155.24 1.69 Allowed 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 123.342 2.694 . . . . 0.0 114.005 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.773 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 20.0 t80 -66.29 -21.39 66.27 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 114.221 -1.354 . . . . 0.0 112.514 -176.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 9.2 t -57.77 -20.73 37.33 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 -168.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' HIS . . . . . 0.569 ' HB2' ' HB2' ' A' ' 244' ' ' GLN . 1.0 OUTLIER -136.36 37.61 2.71 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.952 -0.468 . . . . 0.0 111.9 -175.181 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.408 HG23 ' CD1' ' A' ' 293' ' ' LEU . 32.8 m -141.05 151.0 19.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.253 175.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.42 ' O ' ' HB3' ' A' ' 241' ' ' ARG . 14.1 mmm180 -121.68 108.06 13.1 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 173.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' LEU . . . . . 0.643 ' HA ' ' HA ' ' A' ' 240' ' ' ALA . 0.0 OUTLIER -101.21 137.1 40.01 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -167.553 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.538 ' H ' HD12 ' A' ' 294' ' ' LEU . 4.3 mp -77.23 121.36 23.56 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 162.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.687 ' HB3' ' HG2' ' A' ' 297' ' ' GLN . 23.2 t70 -87.76 157.05 19.14 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.807 -161.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -75.58 5.83 5.52 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.99 -1.459 . . . . 0.0 111.214 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' GLN . . . . . 0.687 ' HG2' ' HB3' ' A' ' 295' ' ' ASP . 4.6 pt20 -66.05 -42.14 89.9 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 168.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 298' ' ' ASN . . . . . 0.498 ' N ' ' HG3' ' A' ' 297' ' ' GLN . 55.5 t-20 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.76 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' GLY . . . . . 0.469 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . . . . . . 0 N--CA 1.448 -0.559 0 N-CA-C 111.864 -0.495 . . . . 0.0 111.864 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.469 ' HD3' ' HA2' ' A' ' 236' ' ' GLY . 9.1 Cg_exo -71.08 127.86 14.09 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 123.054 2.502 . . . . 0.0 111.856 -178.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 1.041 HG23 ' HB ' ' A' ' 266' ' ' VAL . 0.0 OUTLIER -91.79 131.04 39.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.951 -177.469 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.421 ' HB2' ' HB2' ' A' ' 294' ' ' LEU . 47.4 m-85 -97.55 120.22 37.53 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 176.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.732 ' HB2' HD11 ' A' ' 238' ' ' ILE . . . -116.02 118.13 32.05 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.366 -174.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 292' ' ' ARG . 0.0 OUTLIER -78.88 100.94 7.43 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 174.601 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.786 HG21 ' HB2' ' A' ' 245' ' ' LYS . 9.8 p -81.08 115.48 23.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 119.192 -1.003 . . . . 0.0 109.932 -176.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.5 HD12 ' HB2' ' A' ' 244' ' ' GLN . 2.8 pp -97.99 2.97 10.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.113 -174.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.794 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 56.1 tp60 -176.59 93.17 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.032 -174.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.876 ' HG2' HD21 ' A' ' 258' ' ' LEU . 0.5 OUTLIER -147.16 166.21 27.66 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.202 0.525 . . . . 0.0 110.026 173.114 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.807 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 6.2 ptm180 -102.25 -178.59 3.74 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.548 -174.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 43.5 t -107.73 80.6 1.0 Allowed Pre-proline 0 CA--C 1.536 0.415 0 CA-C-O 121.233 0.54 . . . . 0.0 111.011 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.88 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 9.9 Cg_endo -93.96 168.03 2.02 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 124.606 3.537 . . . . 0.0 111.339 174.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -123.3 178.24 5.22 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.02 0.438 . . . . 0.0 110.426 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.712 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -61.83 -2.23 0.81 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.571 174.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -100.99 -2.46 31.66 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.182 0.515 . . . . 0.0 110.543 176.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -105.6 65.45 0.71 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -177.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' LYS . . . . . 0.678 ' HA ' ' HE3' ' A' ' 253' ' ' LYS . 0.0 OUTLIER 61.2 19.7 10.31 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.587 -171.772 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 254' ' ' THR . . . . . 0.712 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 30.5 p 56.63 64.44 1.67 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.723 -175.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.519 ' HB1' ' CE2' ' A' ' 286' ' ' PHE . . . -109.55 154.65 22.44 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.272 -0.877 . . . . 0.0 111.006 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.874 ' HB3' HD22 ' A' ' 258' ' ' LEU . 0.2 OUTLIER -69.03 132.91 47.39 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.606 -175.643 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.88 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -85.52 93.25 8.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.346 0.593 . . . . 0.0 109.546 168.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.876 HD21 ' HG2' ' A' ' 245' ' ' LYS . 0.5 OUTLIER -142.14 160.92 39.26 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.292 -175.013 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.577 ' O ' HG13 ' A' ' 242' ' ' VAL . 37.4 tt0 -142.29 173.66 11.33 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.887 -165.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.551 HG22 ' HA ' ' A' ' 244' ' ' GLN . 47.3 t -56.15 117.79 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-O 121.267 0.556 . . . . 0.0 112.162 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 95.67 0.93 62.21 Favored Glycine 0 CA--C 1.505 -0.591 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.0 172.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -87.41 164.52 16.16 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.51 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.53 ' HG ' ' N ' ' A' ' 264' ' ' VAL . 16.6 tp -121.32 152.56 38.82 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.721 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.723 HG12 ' HB2' ' A' ' 279' ' ' CYS . 15.0 m -141.81 166.34 17.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.401 ' O ' ' HD3' ' A' ' 265' ' ' LYS . 8.2 tmtt? -132.42 97.21 4.04 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 1.041 ' HB ' HG23 ' A' ' 238' ' ' ILE . 46.1 t -68.95 128.24 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.732 -176.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 11.6 p -100.03 -18.86 16.81 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 113.722 -1.581 . . . . 0.0 111.852 -173.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -127.73 106.4 9.11 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 121.459 0.647 . . . . 0.0 109.762 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.624 HG21 ' OE1' ' A' ' 296' ' ' GLN . 0.0 OUTLIER -98.21 154.48 3.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.604 -167.073 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.784 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 15.3 p30 -146.43 -169.65 3.32 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.515 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 12.7 p -98.34 -35.04 4.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.961 -177.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 3.5 m -68.84 -44.61 73.06 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -174.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' GLY . . . . . 0.421 ' HA3' ' CD1' ' A' ' 288' ' ' PHE . . . 121.83 -5.98 10.47 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.316 -176.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.6 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.0 OUTLIER -96.01 70.73 2.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.791 0.805 . . . . 0.0 110.351 176.479 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.784 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -102.32 173.33 6.41 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.615 -172.265 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.744 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 33.3 tt0 -93.39 123.74 36.9 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.524 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -103.08 151.43 17.96 Favored Glycine 0 N--CA 1.437 -1.253 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.27 -171.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -129.12 119.51 24.26 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 173.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' CYS . . . . . 0.723 ' HB2' HG12 ' A' ' 264' ' ' VAL . 44.7 t -114.04 97.1 6.17 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.566 -177.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 28.84 61.31 0.13 Allowed 'General case' 0 N--CA 1.466 0.375 0 O-C-N 124.967 1.417 . . . . 0.0 112.564 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.58 -38.63 2.96 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 115.724 -0.671 . . . . 0.0 113.268 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -80.61 146.63 31.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.297 0.548 . . . . 0.0 110.52 177.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 39.8 mtt180 -132.4 129.78 39.78 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.012 0.434 . . . . 0.0 110.033 170.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' GLY . . . . . 0.636 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . -173.81 142.1 6.36 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.006 -177.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 285' ' ' HIS . . . . . 0.744 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 14.7 p80 -91.92 148.03 22.52 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 117.908 0.854 . . . . 0.0 111.681 -175.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.84 ' HD1' ' HD3' ' A' ' 287' ' ' PRO . 3.2 m-85 -165.03 170.12 6.73 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -174.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.84 ' HD3' ' HD1' ' A' ' 286' ' ' PHE . 58.1 Cg_endo -100.84 156.94 0.42 Allowed 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 123.306 2.67 . . . . 0.0 112.856 -174.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.469 ' HA ' HG22 ' A' ' 291' ' ' VAL . 0.7 OUTLIER -87.16 -8.85 56.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.076 -177.872 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.566 HG22 ' HB2' ' A' ' 287' ' ' PRO . 10.0 t -55.79 -32.65 63.68 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.84 -178.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 290' ' ' HIS . . . . . 0.794 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 0.5 OUTLIER -119.98 55.13 1.0 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.585 0.707 . . . . 0.0 111.365 175.363 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.469 HG22 ' HA ' ' A' ' 288' ' ' PHE . 10.6 m -147.17 171.96 3.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.811 170.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 241' ' ' ARG . 14.5 tpt180 -122.66 108.88 13.58 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 171.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 6.1 tp -84.62 123.55 30.46 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 115.231 -0.895 . . . . 0.0 113.37 -164.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 239' ' ' TYR . 6.6 mt -88.31 132.96 34.2 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 169.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.464 ' OD2' ' HB2' ' A' ' 297' ' ' GLN . 31.1 t70 -74.72 136.27 41.79 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 122.097 0.951 . . . . 0.0 111.903 -163.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.624 ' OE1' HG21 ' A' ' 269' ' ' ILE . 5.6 pt20 -77.47 -1.95 32.97 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.569 -1.65 . . . . 0.0 112.366 -172.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 297' ' ' GLN . . . . . 0.464 ' HB2' ' OD2' ' A' ' 295' ' ' ASP . 61.0 mt-30 -94.25 1.16 56.02 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 171.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 16.6 m120 . . . . . 0 CA--C 1.536 0.431 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.436 173.401 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.28 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.987 ' HB3' ' HA ' ' A' ' 267' ' ' THR . 4.5 Cg_exo -41.67 134.62 3.55 Favored 'Trans proline' 0 C--O 1.238 0.487 0 C-N-CA 124.112 3.208 . . . . 0.0 111.92 169.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 1.077 HG12 HG22 ' A' ' 266' ' ' VAL . 0.8 OUTLIER -78.73 160.77 4.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.016 -167.3 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.682 ' HB3' HD11 ' A' ' 263' ' ' LEU . 86.7 m-85 -108.5 118.75 37.58 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 174.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.596 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -113.77 118.49 34.42 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.165 0.507 . . . . 0.0 111.021 -174.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.415 ' HB3' ' O ' ' A' ' 292' ' ' ARG . 15.1 tpp180 -81.6 103.73 11.52 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 1.07 HG21 ' HD2' ' A' ' 245' ' ' LYS . 5.6 p -86.01 130.74 36.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.986 -175.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.45 HD12 ' HB2' ' A' ' 244' ' ' GLN . 2.8 pp -106.83 8.8 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.704 -174.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.77 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 63.3 tt0 -177.8 94.06 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -173.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 1.07 ' HD2' HG21 ' A' ' 242' ' ' VAL . 11.0 mttt -145.57 161.84 38.85 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 175.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.856 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 13.2 ptt180 -107.59 -176.31 3.03 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.875 -172.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 7.0 p -104.13 78.83 0.34 Allowed Pre-proline 0 CA--C 1.547 0.848 0 CA-C-O 121.812 0.815 . . . . 0.0 111.533 175.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.959 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 1.7 Cg_endo -88.99 177.95 2.81 Favored 'Trans proline' 0 N--CA 1.459 -0.537 1 C-N-CA 125.303 4.002 . . . . 0.0 110.654 174.436 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.422 ' C ' ' H ' ' A' ' 251' ' ' TYR . 27.7 m-80 -130.16 170.65 13.79 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.045 0.45 . . . . 0.0 109.913 177.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.699 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -76.4 14.87 0.68 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.568 0.699 . . . . 0.0 110.544 178.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.422 ' H ' ' C ' ' A' ' 249' ' ' ASN . 37.2 m-85 -110.92 1.89 17.83 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.844 175.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -95.6 49.19 1.17 Allowed 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.72 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt 60.42 33.99 20.63 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -166.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' THR . . . . . 0.699 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 71.5 p 59.55 77.63 0.3 Allowed 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 113.728 -1.578 . . . . 0.0 111.864 -178.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.425 ' C ' ' HA3' ' A' ' 284' ' ' GLY . . . -112.44 154.79 25.29 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.714 176.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 1.108 HD12 ' HG ' ' A' ' 258' ' ' LEU . 0.0 OUTLIER -83.73 133.64 34.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.255 -174.46 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.959 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -91.03 101.24 14.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.346 0.593 . . . . 0.0 109.591 171.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 1.108 ' HG ' HD12 ' A' ' 256' ' ' LEU . 0.1 OUTLIER -158.1 169.53 24.32 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.746 -174.864 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.457 ' HG2' ' N ' ' A' ' 260' ' ' VAL . 32.0 tt0 -142.16 173.21 11.73 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 121.902 -0.499 . . . . 0.0 112.048 -160.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.736 HG22 ' HA ' ' A' ' 244' ' ' GLN . 53.9 t -55.11 118.3 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 C-N-CA 123.364 0.665 . . . . 0.0 111.537 175.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 102.73 -1.69 48.84 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.644 -0.582 . . . . 0.0 111.644 172.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -95.94 173.23 7.54 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.711 -173.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.682 HD11 ' HB3' ' A' ' 239' ' ' TYR . 40.1 tp -117.27 157.62 25.75 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.326 0.584 . . . . 0.0 111.059 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.596 HG13 ' HB3' ' A' ' 240' ' ' ALA . 2.6 p -152.31 119.19 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.139 -177.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.453 ' HE3' ' HG2' ' A' ' 237' ' ' PRO . 54.7 tttp -86.9 97.34 10.62 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.572 177.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 1.077 HG22 HG12 ' A' ' 238' ' ' ILE . 7.0 m -77.23 114.4 17.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.892 0.853 . . . . 0.0 109.988 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' THR . . . . . 0.987 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 9.7 t -96.93 4.39 51.61 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.06 -174.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.563 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 0.0 OUTLIER -132.48 107.52 8.53 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 169.797 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.674 HG21 HG23 ' A' ' 238' ' ' ILE . 0.8 OUTLIER -111.12 156.37 12.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 114.961 -1.018 . . . . 0.0 113.355 -170.25 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.766 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 0.1 OUTLIER -146.13 -161.1 1.24 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.938 -1.483 . . . . 0.0 109.195 178.357 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.04 -23.3 4.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.888 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 3.0 m -65.62 -44.62 85.94 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -175.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' GLY . . . . . 0.64 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 124.03 -21.89 6.87 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.127 -177.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.647 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 10.1 tm0? -89.76 102.77 15.47 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 173.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.766 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -134.6 174.92 10.02 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.067 -177.071 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 44.4 tt0 -91.14 125.46 35.92 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.629 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -105.03 155.84 16.99 Favored Glycine 0 N--CA 1.437 -1.289 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.549 -175.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 30.8 tt0 -139.27 119.86 14.08 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 176.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' CYS . . . . . 0.438 ' HB3' HD11 ' A' ' 256' ' ' LEU . 49.0 t -108.5 98.44 7.96 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 46.51 46.17 14.16 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.378 176.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 115.59 -39.34 2.78 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.385 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 55.3 mttt -69.96 130.87 43.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.237 0.518 . . . . 0.0 109.711 177.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 36.1 mtt180 -113.67 129.67 56.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.12 0.486 . . . . 0.0 110.969 176.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' GLY . . . . . 0.55 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . -170.18 142.82 7.44 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.995 -178.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 285' ' ' HIS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 25.3 p80 -99.56 148.73 23.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 117.265 0.533 . . . . 0.0 111.172 -171.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.65 ' CG ' ' HE2' ' A' ' 245' ' ' LYS . 5.8 m-85 -159.26 158.96 28.83 Favored Pre-proline 0 CA--C 1.533 0.289 0 O-C-N 123.469 0.48 . . . . 0.0 110.796 -176.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.647 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 97.2 Cg_endo -91.58 169.88 3.1 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.919 2.413 . . . . 0.0 113.909 -175.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.64 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 9.8 t80 -75.87 -13.18 60.27 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.554 -175.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 25.4 p -48.24 -29.36 3.72 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -174.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' HIS . . . . . 0.77 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 1.3 p-80 -136.9 39.84 2.55 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.779 0.323 . . . . 0.0 111.586 -171.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.462 HG23 ' HA ' ' A' ' 242' ' ' VAL . 3.1 p -141.78 150.81 19.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 119.454 -0.899 . . . . 0.0 112.53 -175.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.415 ' O ' ' HB3' ' A' ' 241' ' ' ARG . 30.0 mmm180 -130.39 108.89 10.32 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 293' ' ' LEU . . . . . 0.59 HD21 ' CE2' ' A' ' 288' ' ' PHE . 0.4 OUTLIER -120.09 145.34 46.98 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -163.799 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.493 ' H ' HD12 ' A' ' 294' ' ' LEU . 4.7 mp -80.12 124.51 28.83 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 113.677 -1.601 . . . . 0.0 107.553 168.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.449 ' OD1' ' HG2' ' A' ' 297' ' ' GLN . 9.1 t70 -83.27 152.74 25.01 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.587 -165.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.586 ' HB3' HG22 ' A' ' 238' ' ' ILE . 7.7 pt20 -75.15 -8.27 56.11 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.266 -1.334 . . . . 0.0 112.047 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 297' ' ' GLN . . . . . 0.449 ' HG2' ' OD1' ' A' ' 295' ' ' ASP . 15.8 pt20 -78.18 -22.98 47.82 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.16 172.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.233 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' GLY . . . . . 0.636 ' N ' ' HD2' ' A' ' 237' ' ' PRO . . . . . . . . 0 N--CA 1.46 0.297 0 N-CA-C 112.585 -0.206 . . . . 0.0 112.585 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.681 ' HB3' ' HA ' ' A' ' 267' ' ' THR . 7.6 Cg_exo -38.72 141.79 0.32 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 125.086 3.857 . . . . 0.0 113.438 171.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 1.092 HG12 HG22 ' A' ' 266' ' ' VAL . 0.6 OUTLIER -80.59 160.17 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.987 -171.917 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.883 ' HD1' HD11 ' A' ' 263' ' ' LEU . 64.5 m-85 -104.23 120.48 41.25 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 173.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.766 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -113.65 116.97 30.3 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.309 -176.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 241' ' ' ARG . 0.0 OUTLIER -81.65 101.03 9.78 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.766 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.75 ' CG2' ' HD3' ' A' ' 245' ' ' LYS . 3.4 p -78.33 122.3 33.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 119.931 -0.708 . . . . 0.0 110.116 -176.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.534 HG21 ' HG2' ' A' ' 292' ' ' ARG . 2.8 pp -110.12 6.46 8.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.516 -174.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.733 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 58.7 tt0 -176.3 94.55 0.05 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.081 -175.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.857 ' HE2' HD21 ' A' ' 258' ' ' LEU . 0.2 OUTLIER -147.07 168.0 22.67 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 122.008 0.909 . . . . 0.0 111.613 178.302 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.854 ' HG3' ' HG3' ' A' ' 248' ' ' PRO . 12.3 ptm180 -108.47 -176.4 3.04 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.787 -1.552 . . . . 0.0 109.717 -173.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 19.0 t -108.28 75.33 0.56 Allowed Pre-proline 0 CA--C 1.54 0.589 0 CA-C-O 121.029 0.442 . . . . 0.0 110.997 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.98 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 5.7 Cg_endo -91.11 177.41 2.03 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 124.861 3.707 . . . . 0.0 110.712 176.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.451 ' C ' ' H ' ' A' ' 251' ' ' TYR . 84.4 m-20 -135.18 175.34 9.67 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.781 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -69.46 9.7 0.44 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.393 0.616 . . . . 0.0 111.269 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.451 ' H ' ' C ' ' A' ' 249' ' ' ASN . 18.9 m-85 -103.14 -4.01 25.05 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 176.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -105.28 67.96 0.79 Allowed 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.16 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' LYS . . . . . 0.457 ' HE2' ' HB2' ' A' ' 253' ' ' LYS . 2.6 mppt? 54.54 28.97 10.49 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -169.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' THR . . . . . 0.781 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 78.3 p 55.66 73.48 0.43 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.903 -174.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.589 ' C ' ' HA3' ' A' ' 284' ' ' GLY . . . -108.47 153.08 23.84 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.366 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.727 ' N ' ' HA3' ' A' ' 284' ' ' GLY . 0.2 OUTLIER -79.92 132.58 36.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.341 -173.083 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.98 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -92.22 100.98 13.49 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 173.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.857 HD21 ' HE2' ' A' ' 245' ' ' LYS . 0.6 OUTLIER -154.62 170.67 20.96 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.521 -174.658 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.489 ' O ' HG13 ' A' ' 242' ' ' VAL . 29.8 tt0 -142.98 169.55 17.36 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.704 0.288 . . . . 0.0 111.584 -165.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.417 ' N ' ' HG2' ' A' ' 259' ' ' GLU . 3.5 p -55.04 118.0 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.703 0.763 . . . . 0.0 112.351 176.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 105.23 -2.71 40.38 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 114.92 -1.037 . . . . 0.0 111.741 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -90.98 -179.9 5.58 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.832 -176.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.883 HD11 ' HD1' ' A' ' 239' ' ' TYR . 3.2 tm? -132.18 130.04 40.55 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.766 HG13 ' HB3' ' A' ' 240' ' ' ALA . 2.4 p -124.05 118.21 53.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.264 178.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 238' ' ' ILE . 78.8 tttt -87.27 97.06 10.58 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 1.092 HG22 HG12 ' A' ' 238' ' ' ILE . 5.0 m -77.11 122.93 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 121.87 0.843 . . . . 0.0 111.049 -175.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' THR . . . . . 0.681 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 49.5 p -91.8 -15.42 28.28 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.983 -174.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.596 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 0.0 OUTLIER -119.66 105.46 11.2 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.733 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.579 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.8 OUTLIER -106.46 159.54 6.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -170.235 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.782 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 3.5 p30 -145.59 -168.25 2.92 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.988 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 13.3 p -99.28 -32.27 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 120.616 -0.433 . . . . 0.0 112.004 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 11.7 m -78.62 -26.63 45.35 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -173.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' GLY . . . . . 0.624 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 105.35 4.25 40.8 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.364 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -97.07 81.14 3.03 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.782 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -122.93 168.42 12.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.19 -168.847 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.596 ' HB3' ' HB3' ' A' ' 268' ' ' LYS . 40.8 tt0 -90.42 126.06 35.77 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.111 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.687 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -108.7 159.05 14.36 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.303 -173.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 40.8 tt0 -140.94 120.15 12.94 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 172.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' CYS . . . . . 0.412 ' HB3' HD11 ' A' ' 256' ' ' LEU . 34.6 t -114.62 96.89 5.97 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.349 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 33.65 57.19 0.55 Allowed 'General case' 0 N--CA 1.465 0.28 0 O-C-N 124.615 1.197 . . . . 0.0 112.527 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.97 -39.27 2.72 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-N 115.705 -0.68 . . . . 0.0 113.351 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 0.2 OUTLIER -77.77 139.85 39.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.492 0.646 . . . . 0.0 109.943 178.621 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 12.4 mtm180 -124.25 129.2 50.35 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 175.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' GLY . . . . . 0.727 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . 177.72 145.97 6.11 Favored Glycine 0 C--O 1.225 -0.467 0 C-N-CA 120.09 -1.052 . . . . 0.0 113.58 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 285' ' ' HIS . . . . . 0.554 ' CB ' ' HA ' ' A' ' 276' ' ' GLU . 28.5 p80 -104.18 147.71 27.13 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.965 0.383 . . . . 0.0 111.423 -175.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.56 ' CZ ' ' HB1' ' A' ' 255' ' ' ALA . 12.4 m-85 -159.14 167.02 15.18 Favored Pre-proline 0 CA--C 1.535 0.397 0 O-C-N 123.271 0.357 . . . . 0.0 111.494 -175.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.456 ' HD3' ' HD1' ' A' ' 286' ' ' PHE . 1.4 Cg_endo -86.25 153.99 9.46 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 123.514 2.809 . . . . 0.0 113.585 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.738 ' HE1' ' HG ' ' A' ' 293' ' ' LEU . 44.3 t80 -67.44 -23.28 65.51 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 114.374 -1.285 . . . . 0.0 112.477 -177.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.441 HG22 ' HB2' ' A' ' 287' ' ' PRO . 8.9 t -53.1 -29.36 30.27 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -168.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' HIS . . . . . 0.733 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 0.9 OUTLIER -122.16 53.43 1.23 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.612 0.72 . . . . 0.0 110.956 -179.684 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.518 ' O ' ' HD2' ' A' ' 292' ' ' ARG . 0.5 OUTLIER -147.24 158.74 9.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.129 176.912 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.534 ' HG2' HG21 ' A' ' 243' ' ' ILE . 21.1 mmm180 -121.69 109.49 14.8 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 173.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 293' ' ' LEU . . . . . 0.954 HD11 HD12 ' A' ' 238' ' ' ILE . 0.3 OUTLIER -91.07 127.19 36.4 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -161.396 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 239' ' ' TYR . 3.9 mt -91.05 121.67 33.05 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 167.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -79.04 147.43 32.83 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.903 0.858 . . . . 0.0 112.415 -163.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.984 ' HB3' HG22 ' A' ' 238' ' ' ILE . 0.6 OUTLIER -76.72 -6.15 50.98 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.775 -177.603 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -72.43 -30.22 64.41 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 173.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 . . . . . 0 C--N 1.332 -0.159 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.633 179.171 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 236' ' ' GLY . . . . . 0.444 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . . . . . . 0 N--CA 1.446 -0.68 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.506 ' HD2' ' HB3' ' A' ' 298' ' ' ASN . 12.4 Cg_exo -69.06 132.22 23.97 Favored 'Trans proline' 0 C--N 1.33 -0.399 0 C-N-CA 122.977 2.451 . . . . 0.0 113.068 -176.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.836 HG23 ' HB ' ' A' ' 266' ' ' VAL . 0.0 OUTLIER -94.33 139.54 18.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 173.612 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.567 ' HB2' ' HB2' ' A' ' 294' ' ' LEU . 0.7 OUTLIER -99.28 143.94 28.96 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 172.837 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.746 ' HA ' ' HA ' ' A' ' 293' ' ' LEU . . . -136.03 116.97 14.22 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 118.781 -1.168 . . . . 0.0 110.548 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -85.9 102.0 13.35 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 1.051 HG21 ' HD2' ' A' ' 245' ' ' LYS . 4.3 p -83.63 129.82 36.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.151 -173.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.9 pp -102.15 4.49 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.458 -175.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.621 ' H ' HG22 ' A' ' 242' ' ' VAL . 64.1 tt0 -178.47 102.6 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.687 -175.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 1.051 ' HD2' HG21 ' A' ' 242' ' ' VAL . 8.1 mttt -145.72 162.33 37.84 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 175.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.897 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 7.9 ttt-85 -99.41 177.21 5.25 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 123.433 0.693 . . . . 0.0 109.462 -174.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.442 ' N ' ' CG ' ' A' ' 246' ' ' ARG . 9.4 m -100.85 75.94 0.14 Allowed Pre-proline 0 CA--C 1.548 0.883 0 CA-C-O 121.546 0.688 . . . . 0.0 111.787 172.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.897 ' HD3' ' O ' ' A' ' 246' ' ' ARG . 0.9 OUTLIER -90.52 175.49 2.69 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 125.212 3.941 . . . . 0.0 111.04 177.036 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 252' ' ' ASP . 94.7 m-20 -128.22 175.73 8.22 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.949 0.404 . . . . 0.0 110.547 176.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.927 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -67.13 -11.22 56.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 122.127 0.965 . . . . 0.0 110.195 174.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -87.45 5.42 38.99 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.814 175.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 249' ' ' ASN . 3.0 m-20 -103.85 49.27 0.83 Allowed 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.168 177.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 253' ' ' LYS . . . . . 0.551 ' N ' ' HD2' ' A' ' 253' ' ' LYS . 0.0 OUTLIER 58.7 31.13 20.83 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -169.409 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 254' ' ' THR . . . . . 0.927 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 30.7 p 61.12 81.94 0.18 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 113.413 -1.721 . . . . 0.0 111.609 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.435 ' HB1' ' CE2' ' A' ' 286' ' ' PHE . . . -118.94 156.76 28.98 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.479 176.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.802 HD12 ' SG ' ' A' ' 279' ' ' CYS . 3.8 mm? -81.16 130.63 35.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.567 -175.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.854 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -89.99 97.76 11.38 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.438 0.637 . . . . 0.0 110.432 172.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.73 HD21 ' HD3' ' A' ' 245' ' ' LYS . 0.4 OUTLIER -159.79 171.89 18.67 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.275 -175.88 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.446 ' O ' HG13 ' A' ' 242' ' ' VAL . 12.4 pt-20 -143.53 -162.3 1.43 Allowed 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 119.822 -0.751 . . . . 0.0 112.865 -166.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.551 HG22 ' HA ' ' A' ' 244' ' ' GLN . 88.0 t -66.33 117.39 7.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.755 177.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 105.8 -1.27 38.9 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.85 171.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -91.58 -179.89 5.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.91 0.386 . . . . 0.0 111.399 -170.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.501 ' HG ' ' N ' ' A' ' 264' ' ' VAL . 38.2 tp -133.39 157.52 45.35 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.273 0.559 . . . . 0.0 111.314 -177.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.68 HG13 ' HB3' ' A' ' 240' ' ' ALA . 1.8 p -152.72 136.01 7.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.243 -177.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -98.49 96.8 8.24 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.836 ' HB ' HG23 ' A' ' 238' ' ' ILE . 52.0 t -68.63 117.92 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-O 121.205 0.526 . . . . 0.0 110.903 177.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 81.9 p -97.31 -19.2 18.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.422 -176.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.608 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 2.9 tppp? -116.97 107.08 14.13 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.469 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.6 OUTLIER -102.67 155.48 5.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -167.631 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.818 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 3.5 p30 -143.41 -178.53 5.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.275 174.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 8.9 p -82.53 -35.94 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -176.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 5.9 m -82.19 -43.33 17.81 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -172.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' GLY . . . . . 0.555 ' HA3' ' CD2' ' A' ' 288' ' ' PHE . . . 123.41 2.42 8.99 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.518 -178.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 1.0 OUTLIER -93.35 85.17 4.9 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 173.272 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.818 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -131.12 -179.79 5.54 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.89 -168.022 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.696 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 39.2 mt-10 -94.48 124.81 38.73 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.018 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.563 ' O ' HD21 ' A' ' 256' ' ' LEU . . . -106.67 145.34 15.94 Favored Glycine 0 N--CA 1.437 -1.267 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.334 -175.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.579 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 0.4 OUTLIER -124.14 118.73 27.55 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.023 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 279' ' ' CYS . . . . . 0.802 ' SG ' HD12 ' A' ' 256' ' ' LEU . 29.7 p -111.01 98.76 7.78 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.449 -174.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 15.7 m-20 49.09 45.65 22.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.491 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 114.14 -17.08 19.81 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.689 -0.767 . . . . 0.0 114.27 175.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' LYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 5.4 mptt -99.93 133.8 43.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.733 0.766 . . . . 0.0 110.352 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.94 134.48 54.43 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.793 0.33 . . . . 0.0 111.375 -174.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -176.22 -146.46 5.99 Favored Glycine 0 C--O 1.225 -0.407 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' HIS . . . . . 0.696 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 24.8 p80 -148.82 151.45 34.77 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 117.562 0.681 . . . . 0.0 111.134 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.656 ' CG ' ' HE2' ' A' ' 245' ' ' LYS . 1.8 m-85 -164.72 153.83 11.45 Favored Pre-proline 0 CA--C 1.535 0.395 0 O-C-N 123.452 0.47 . . . . 0.0 110.829 -177.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.534 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 95.3 Cg_endo -90.77 173.35 3.02 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.057 2.504 . . . . 0.0 114.029 -174.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.555 ' CD2' ' HA3' ' A' ' 273' ' ' GLY . 16.2 t80 -82.92 -20.86 34.55 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 114.369 -1.287 . . . . 0.0 111.926 -170.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 12.9 t -68.62 1.78 2.93 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -167.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' HIS . . . . . 0.452 ' CE1' ' HD2' ' A' ' 287' ' ' PRO . 0.2 OUTLIER -147.25 33.71 0.89 Allowed 'General case' 0 C--N 1.33 -0.239 0 O-C-N 121.706 -0.621 . . . . 0.0 111.682 178.78 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.431 HG23 ' CD1' ' A' ' 293' ' ' LEU . 31.8 m -140.25 151.76 21.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.73 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.415 ' HA ' ' HD2' ' A' ' 292' ' ' ARG . 20.8 tpt180 -122.03 108.37 13.3 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 173.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 293' ' ' LEU . . . . . 0.746 ' HA ' ' HA ' ' A' ' 240' ' ' ALA . 0.0 OUTLIER -94.42 139.54 30.99 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -163.687 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.567 ' HB2' ' HB2' ' A' ' 239' ' ' TYR . 5.0 mt -79.12 165.7 23.05 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 113.948 -1.478 . . . . 0.0 107.21 167.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -71.25 133.66 46.25 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 122.964 1.364 . . . . 0.0 113.125 -157.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.7 ' HA ' ' HA ' ' A' ' 238' ' ' ILE . 8.4 tt0 -72.82 88.11 1.31 Allowed 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 111.895 -2.411 . . . . 0.0 111.245 -176.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 175.33 -34.95 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.086 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' ASN . . . . . 0.506 ' HB3' ' HD2' ' A' ' 237' ' ' PRO . 2.7 t-20 . . . . . 0 N--CA 1.465 0.312 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' GLY . . . . . 0.419 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . . . . . . 0 N--CA 1.447 -0.593 0 N-CA-C 112.945 -0.062 . . . . 0.0 112.945 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.477 ' HG2' ' HE3' ' A' ' 265' ' ' LYS . 16.7 Cg_exo -72.23 129.53 15.15 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.449 2.766 . . . . 0.0 112.536 177.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.729 HD13 HG22 ' A' ' 266' ' ' VAL . 0.0 OUTLIER -89.69 149.47 4.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.764 174.965 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.543 ' N ' HG12 ' A' ' 238' ' ' ILE . 20.2 m-85 -95.89 119.35 34.23 Favored 'General case' 0 C--O 1.208 -1.107 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.46 ' HB3' ' CG2' ' A' ' 264' ' ' VAL . . . -113.87 118.22 33.61 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.481 -171.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.31 101.38 8.89 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.067 178.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 1.079 ' HA ' HG12 ' A' ' 291' ' ' VAL . 6.3 p -80.86 117.71 27.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.193 -176.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.568 ' O ' ' HG3' ' A' ' 244' ' ' GLN . 2.8 pp -105.15 0.61 10.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.013 -172.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.574 ' HB2' ' HB2' ' A' ' 290' ' ' HIS . 57.5 mt-30 -172.25 94.08 0.14 Allowed 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -173.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.848 ' HG2' ' CD2' ' A' ' 258' ' ' LEU . 2.5 tptt -146.66 165.54 29.26 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.517 0.675 . . . . 0.0 111.453 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.788 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 2.7 ptm85 -102.23 -178.13 3.61 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.079 -1.418 . . . . 0.0 110.279 -173.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 21.9 t -110.48 72.46 0.72 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.333 0.587 . . . . 0.0 109.71 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 1.071 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 72.1 Cg_endo -95.54 175.82 0.92 Allowed 'Trans proline' 0 N--CA 1.441 -1.612 0 C-N-CA 124.135 3.223 . . . . 0.0 110.541 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -136.3 176.2 8.91 Favored 'General case' 0 C--N 1.314 -0.978 0 O-C-N 121.952 -0.467 . . . . 0.0 110.298 -177.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.775 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -61.55 -7.61 3.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.368 0.604 . . . . 0.0 111.001 172.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -95.51 -2.29 48.9 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.313 176.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -105.41 63.73 0.69 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? 56.94 30.75 18.59 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -169.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' THR . . . . . 0.775 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 44.5 p 52.49 62.94 2.44 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.323 -173.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.605 ' HB3' ' HB2' ' A' ' 248' ' ' PRO . . . -96.85 150.8 20.32 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.337 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.755 ' N ' ' HA3' ' A' ' 284' ' ' GLY . 0.4 OUTLIER -74.34 131.09 40.82 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.913 -179.016 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.071 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -90.56 104.5 17.07 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 175.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.848 ' CD2' ' HG2' ' A' ' 245' ' ' LYS . 0.6 OUTLIER -153.8 164.47 38.3 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.427 -175.144 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.558 ' O ' HG13 ' A' ' 242' ' ' VAL . 32.4 tt0 -142.3 174.66 10.42 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 120.578 0.228 . . . . 0.0 111.159 -165.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.505 HG22 ' HA ' ' A' ' 244' ' ' GLN . 88.3 t -57.12 117.7 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.373 0.606 . . . . 0.0 112.234 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 98.71 -2.1 58.5 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.507 170.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -84.38 175.88 9.07 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.33 -176.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.558 ' HG ' ' N ' ' A' ' 264' ' ' VAL . 17.0 tp -130.35 154.72 47.38 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.65 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.7 HG12 ' HB2' ' A' ' 279' ' ' CYS . 17.1 m -145.5 160.37 12.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.778 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.477 ' HE3' ' HG2' ' A' ' 237' ' ' PRO . 56.8 tttp -117.87 97.9 6.07 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 177.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.729 HG22 HD13 ' A' ' 238' ' ' ILE . 4.6 m -80.38 121.66 34.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.49 0.662 . . . . 0.0 110.345 -176.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 38.2 p -99.6 -5.09 29.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.853 -174.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.63 ' O ' ' HB3' ' A' ' 275' ' ' TRP . 1.3 tppp? -119.03 105.47 11.46 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 174.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.78 HD13 ' H ' ' A' ' 269' ' ' ILE . 0.2 OUTLIER -114.95 149.42 17.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.645 -166.736 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -144.14 -168.76 2.96 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.85 -174.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 28.7 m -100.88 -21.52 5.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.8 m -81.54 -45.39 15.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.776 0.322 . . . . 0.0 111.211 -175.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 125.92 -8.37 7.66 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.655 -177.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.6 OUTLIER -90.56 105.04 17.55 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 173.604 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.63 ' HB3' ' O ' ' A' ' 268' ' ' LYS . 0.0 OUTLIER -115.57 173.46 6.52 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.706 0.765 . . . . 0.0 111.345 -175.464 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 268' ' ' LYS . 29.9 tt0 -96.65 124.28 40.59 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 165.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.517 ' O ' HD23 ' A' ' 256' ' ' LEU . . . -109.66 149.42 17.3 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.784 -167.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.643 ' HG3' ' HG2' ' A' ' 283' ' ' ARG . 31.9 tt0 -127.75 117.61 22.22 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 172.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' CYS . . . . . 0.7 ' HB2' HG12 ' A' ' 264' ' ' VAL . 53.7 t -101.65 94.84 6.06 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.314 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 36.38 55.13 1.08 Allowed 'General case' 0 CA--C 1.533 0.296 0 O-C-N 124.754 1.284 . . . . 0.0 111.843 175.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.51 -40.4 2.4 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 115.639 -0.71 . . . . 0.0 113.39 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' LYS . . . . . 0.503 ' HD2' ' HB3' ' A' ' 279' ' ' CYS . 35.3 mttt -76.42 138.83 40.62 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 117.513 0.656 . . . . 0.0 110.381 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' ARG . . . . . 0.643 ' HG2' ' HG3' ' A' ' 278' ' ' GLU . 23.2 mtt180 -122.33 129.93 52.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.365 0.602 . . . . 0.0 111.726 176.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' GLY . . . . . 0.755 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . -159.91 -171.09 25.32 Favored Glycine 0 C--O 1.221 -0.709 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.189 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 285' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -147.62 139.84 24.38 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 118.409 1.105 . . . . 0.0 111.053 175.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.589 ' CZ ' ' HB1' ' A' ' 255' ' ' ALA . 28.1 m-85 -159.17 168.89 11.46 Favored Pre-proline 0 N--CA 1.472 0.633 0 C-N-CA 122.627 0.371 . . . . 0.0 111.472 -174.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.481 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 17.7 Cg_endo -94.92 168.7 1.59 Allowed 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 123.611 2.874 . . . . 0.0 112.796 -177.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.679 ' HA ' ' CG2' ' A' ' 291' ' ' VAL . 29.4 p90 -87.12 -12.38 47.26 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.31 -174.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 5.2 t -49.91 -33.66 18.01 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' HIS . . . . . 0.574 ' HB2' ' HB2' ' A' ' 244' ' ' GLN . 2.2 p80 -125.75 56.97 1.37 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.792 0.806 . . . . 0.0 111.686 177.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 1.079 HG12 ' HA ' ' A' ' 242' ' ' VAL . 0.9 OUTLIER -154.56 170.94 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.573 168.23 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -130.01 107.75 9.58 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 172.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' LEU . . . . . 0.702 HD22 ' H ' ' A' ' 293' ' ' LEU . 0.0 OUTLIER -94.86 127.05 40.6 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 119.41 -0.916 . . . . 0.0 112.063 -169.266 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 10.4 mt -76.08 123.24 25.47 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 171.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -76.39 148.21 37.52 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.936 0.874 . . . . 0.0 111.834 -164.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -76.86 18.34 0.36 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.654 -1.612 . . . . 0.0 112.122 -176.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -73.64 -28.26 61.69 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 167.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 16.5 m120 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.957 -179.875 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 236' ' ' GLY . . . . . 0.447 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . . . . . . 0 N--CA 1.449 -0.463 0 N-CA-C 112.232 -0.347 . . . . 0.0 112.232 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.625 ' HA ' ' O ' ' A' ' 266' ' ' VAL . 4.3 Cg_endo -86.78 121.75 1.85 Allowed 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.206 2.604 . . . . 0.0 112.51 -178.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.897 HD11 ' HB2' ' A' ' 240' ' ' ALA . 0.1 OUTLIER -86.38 152.46 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.345 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.795 ' HD1' HD11 ' A' ' 263' ' ' LEU . 59.4 m-85 -100.84 118.04 36.11 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 175.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.897 ' HB2' HD11 ' A' ' 238' ' ' ILE . . . -120.19 117.3 27.54 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.587 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.555 HH11 ' HA2' ' A' ' 261' ' ' GLY . 0.1 OUTLIER -85.76 103.48 14.58 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.7 -175.237 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.737 ' HA ' HG12 ' A' ' 291' ' ' VAL . 2.2 t -66.17 131.79 31.84 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.104 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.081 -175.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.417 HD12 ' CB ' ' A' ' 244' ' ' GLN . 2.9 pp -120.84 2.3 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 O-C-N 123.539 0.524 . . . . 0.0 110.421 176.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.547 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 53.1 tt0 -178.22 95.58 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.072 -172.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.722 ' HB3' ' O ' ' A' ' 258' ' ' LEU . 0.0 OUTLIER -145.75 164.84 30.59 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.37 0.605 . . . . 0.0 110.443 175.84 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.881 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 12.7 ttm180 -92.87 171.98 8.62 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.778 -176.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.443 ' N ' ' HG2' ' A' ' 246' ' ' ARG . 21.9 t -101.72 75.48 0.16 Allowed Pre-proline 0 CA--C 1.542 0.646 0 CA-C-O 121.02 0.438 . . . . 0.0 110.123 170.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.996 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 1.2 Cg_endo -89.02 178.89 2.53 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 125.226 3.951 . . . . 0.0 111.875 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -127.52 175.36 8.31 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.97 0.414 . . . . 0.0 109.959 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.518 ' O ' HG22 ' A' ' 254' ' ' THR . . . -68.98 -1.23 6.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.125 0.488 . . . . 0.0 110.796 174.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -106.17 1.18 25.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.124 176.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -93.34 55.02 2.19 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp 60.54 22.61 12.33 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.46 -168.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' THR . . . . . 0.518 HG22 ' O ' ' A' ' 250' ' ' ALA . 28.6 p 64.65 83.59 0.16 Allowed 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.553 -177.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.64 ' HB1' ' CE2' ' A' ' 286' ' ' PHE . . . -128.67 153.56 47.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.015 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.59 HD21 ' O ' ' A' ' 277' ' ' GLY . 4.2 mm? -72.83 120.48 18.51 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.85 -175.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.996 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -81.04 87.11 6.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.18 0.514 . . . . 0.0 111.007 174.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.722 ' O ' ' HB3' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -157.69 168.47 27.13 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.192 -176.046 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.477 ' O ' ' HB ' ' A' ' 242' ' ' VAL . 12.6 pt-20 -142.56 -164.91 1.92 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -168.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 4.3 p -60.25 122.46 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 121.593 0.711 . . . . 0.0 112.095 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.555 ' HA2' HH11 ' A' ' 241' ' ' ARG . . . 107.57 -1.44 34.41 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.851 172.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -89.68 -177.62 5.32 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -170.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.795 HD11 ' HD1' ' A' ' 239' ' ' TYR . 3.4 tm? -138.78 122.11 17.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.526 177.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.7 HG13 ' HB3' ' A' ' 240' ' ' ALA . 2.1 p -115.11 129.28 71.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.056 178.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 238' ' ' ILE . 75.9 tttt -98.54 95.17 7.11 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.768 ' HB ' HG23 ' A' ' 238' ' ' ILE . 21.0 t -66.14 123.17 18.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.243 -175.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 35.3 p -95.77 -24.46 16.49 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.855 -174.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.568 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 0.0 OUTLIER -119.12 107.34 13.36 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.534 -0.866 . . . . 0.0 109.509 177.007 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.471 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.6 OUTLIER -97.04 155.08 3.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-N 114.334 -1.303 . . . . 0.0 114.166 -167.772 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.893 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 9.9 p30 -146.48 -172.55 3.98 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.772 171.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 60.1 t -93.35 -41.31 12.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.949 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 2.6 p -58.95 -43.7 91.31 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -175.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 115.45 -4.34 21.6 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.319 -0.944 . . . . 0.0 112.673 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.587 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.0 OUTLIER -95.91 71.93 2.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.709 0.766 . . . . 0.0 109.725 176.667 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.893 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -111.98 179.01 4.12 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.633 -168.609 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.63 ' HG2' ' O ' ' A' ' 284' ' ' GLY . 6.1 tt0 -90.2 125.27 35.41 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.59 ' O ' HD21 ' A' ' 256' ' ' LEU . . . -110.26 141.9 16.41 Favored Glycine 0 N--CA 1.436 -1.304 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 -173.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 26.6 tt0 -127.14 118.48 24.44 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 170.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' CYS . . . . . 0.48 ' O ' ' HD3' ' A' ' 282' ' ' LYS . 13.8 t -106.28 96.88 6.78 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -178.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 28.69 60.33 0.13 Allowed 'General case' 0 N--CA 1.468 0.454 0 O-C-N 125.015 1.447 . . . . 0.0 112.991 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 115.63 -30.53 6.61 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.334 178.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' LYS . . . . . 0.569 ' HE3' ' O ' ' A' ' 257' ' ' ALA . 6.1 mppt? -85.94 131.59 34.25 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.096 0.448 . . . . 0.0 110.378 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 40.1 mmm-85 -114.42 149.89 35.54 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.793 0.33 . . . . 0.0 111.698 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' GLY . . . . . 0.63 ' O ' ' HG2' ' A' ' 276' ' ' GLU . . . 159.72 -162.41 32.97 Favored Glycine 0 C--O 1.216 -0.973 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 173.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 285' ' ' HIS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 31.3 p80 -136.94 148.48 46.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 118.087 0.943 . . . . 0.0 111.077 177.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.64 ' CE2' ' HB1' ' A' ' 255' ' ' ALA . 2.4 m-85 -161.24 159.06 24.11 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 120.718 0.294 . . . . 0.0 111.325 -174.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 73.4 Cg_endo -93.14 149.44 2.52 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.251 2.634 . . . . 0.0 112.867 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.636 ' HA ' HG22 ' A' ' 291' ' ' VAL . 0.5 OUTLIER -75.28 -9.1 58.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.251 -174.26 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 8.9 t -63.0 -24.93 68.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.231 -0.441 . . . . 0.0 112.017 -173.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' HIS . . . . . 0.547 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 1.4 p-80 -121.67 38.07 4.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.48 0.657 . . . . 0.0 111.343 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.737 HG12 ' HA ' ' A' ' 242' ' ' VAL . 27.6 m -144.26 161.56 15.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.423 170.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -117.0 106.85 13.85 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' LEU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 240' ' ' ALA . 0.2 OUTLIER -102.93 129.04 49.51 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-O 121.753 0.787 . . . . 0.0 113.008 -165.598 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 3.8 mp -93.51 174.08 7.37 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 114.348 -1.296 . . . . 0.0 108.797 168.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.646 ' OD2' ' HA ' ' A' ' 298' ' ' ASN . 12.7 t0 -76.76 156.86 32.07 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.194 -165.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.822 ' HG2' ' HB ' ' A' ' 238' ' ' ILE . 2.4 mt-30 -77.45 -36.41 52.97 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.396 -1.274 . . . . 0.0 109.203 -172.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? 178.76 20.06 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.023 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' ASN . . . . . 0.646 ' HA ' ' OD2' ' A' ' 295' ' ' ASP . 14.4 m120 . . . . . 0 CA--C 1.535 0.385 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.028 -169.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.953 0 N-CA-C 111.504 -0.639 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 266' ' ' VAL . 3.2 Cg_exo -76.51 131.48 12.62 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.487 2.791 . . . . 0.0 111.659 -177.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.814 HD13 ' HB ' ' A' ' 266' ' ' VAL . 0.1 OUTLIER -93.68 165.96 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.476 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.694 ' HB3' HD11 ' A' ' 263' ' ' LEU . 36.4 m-85 -102.66 123.86 47.14 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 172.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.605 ' HB3' HG22 ' A' ' 264' ' ' VAL . . . -111.72 117.73 33.66 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.287 -168.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 292' ' ' ARG . 0.0 OUTLIER -85.9 103.05 14.27 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.021 176.91 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.611 HG21 ' HB2' ' A' ' 245' ' ' LYS . 3.5 p -91.57 121.4 42.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.737 -177.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.505 HD12 ' HB2' ' A' ' 244' ' ' GLN . 2.8 pp -100.33 4.7 10.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.864 -172.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.534 ' HB2' ' HB2' ' A' ' 290' ' ' HIS . 16.8 mt-30 -173.78 99.32 0.11 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.932 -174.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.966 ' HG2' HD13 ' A' ' 258' ' ' LEU . 0.1 OUTLIER -146.51 163.11 36.77 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.849 0.357 . . . . 0.0 110.057 176.316 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.848 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 10.5 ptp180 -103.32 -178.21 3.6 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.382 -178.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 2.9 m -105.81 77.45 0.41 Allowed Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.909 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 1.4 Cg_endo -88.82 173.78 4.13 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 124.934 3.756 . . . . 0.0 111.278 174.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -127.53 175.73 8.02 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 122.147 -0.346 . . . . 0.0 110.452 174.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.721 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -66.03 -1.69 3.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.587 0.708 . . . . 0.0 110.55 174.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -100.18 3.97 44.08 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.674 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.453 ' C ' ' HD2' ' A' ' 253' ' ' LYS . 2.2 m-20 -102.73 49.58 0.84 Allowed 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' LYS . . . . . 0.453 ' HD2' ' C ' ' A' ' 252' ' ' ASP . 0.0 OUTLIER 60.36 30.88 20.17 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -169.895 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 254' ' ' THR . . . . . 0.721 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 32.0 p 59.37 74.65 0.43 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 113.388 -1.733 . . . . 0.0 112.16 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.435 ' HB1' ' CE2' ' A' ' 286' ' ' PHE . . . -115.77 150.46 36.88 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.008 174.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.775 ' HB3' HD11 ' A' ' 258' ' ' LEU . 0.0 OUTLIER -77.38 138.55 39.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.437 -174.497 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.909 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -90.55 94.45 9.71 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.336 0.588 . . . . 0.0 110.381 173.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.966 HD13 ' HG2' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -146.04 166.97 24.52 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.83 -175.467 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.443 ' O ' HG13 ' A' ' 242' ' ' VAL . 12.2 pt-20 -138.68 -166.48 2.02 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.08 0.467 . . . . 0.0 111.491 -169.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 2.3 p -67.09 116.82 6.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.199 175.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 103.2 -1.85 47.18 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 114.801 -1.09 . . . . 0.0 112.66 169.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.433 ' HG3' ' HG2' ' A' ' 259' ' ' GLU . 18.2 mt-10 -80.87 169.83 17.06 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.204 0.526 . . . . 0.0 111.123 -174.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.694 HD11 ' HB3' ' A' ' 239' ' ' TYR . 10.2 tp -132.6 151.0 52.07 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.317 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.706 HG11 HD23 ' A' ' 258' ' ' LEU . 18.4 m -148.12 173.71 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.088 -176.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.452 ' HG3' ' CE1' ' A' ' 239' ' ' TYR . 5.0 ttmm -119.72 95.55 4.82 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 175.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.814 ' HB ' HD13 ' A' ' 238' ' ' ILE . 53.8 t -69.19 115.05 6.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.136 0.493 . . . . 0.0 110.436 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 40.5 p -93.37 -7.97 43.2 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.261 -174.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 3.2 tppp? -129.5 104.82 7.69 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.59 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.8 OUTLIER -107.83 157.62 7.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.629 0.728 . . . . 0.0 112.82 -173.39 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.632 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 4.7 p30 -147.37 -176.81 5.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.359 -173.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 32.0 m -110.73 15.45 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.3 m -109.66 -43.33 4.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.073 0.463 . . . . 0.0 110.382 176.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' GLY . . . . . 0.785 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 123.73 -9.91 8.56 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.544 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.9 OUTLIER -95.37 90.13 5.7 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.659 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.632 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -115.87 171.36 7.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.112 -173.523 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.664 ' O ' HG13 ' A' ' 266' ' ' VAL . 36.0 mt-10 -96.05 122.81 39.28 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 174.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.598 ' HA2' HG22 ' A' ' 266' ' ' VAL . . . -104.51 134.09 11.83 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.182 -171.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 34.0 tt0 -120.47 119.37 32.8 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 117.542 0.671 . . . . 0.0 109.584 178.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 279' ' ' CYS . . . . . 0.535 ' HB2' HG12 ' A' ' 264' ' ' VAL . 36.2 t -111.11 98.21 7.36 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.677 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 43.0 57.32 3.71 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 124.141 0.9 . . . . 0.0 112.232 174.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 114.38 -34.3 4.99 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.9 174.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' LYS . . . . . 0.567 ' HD2' ' H ' ' A' ' 282' ' ' LYS . 4.1 mptt -98.87 138.89 35.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.332 0.566 . . . . 0.0 109.592 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 283' ' ' ARG . . . . . 0.45 ' H ' ' HD2' ' A' ' 283' ' ' ARG . 0.0 OUTLIER -121.54 129.11 52.68 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.454 0.645 . . . . 0.0 111.094 176.621 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 284' ' ' GLY . . . . . 0.574 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . -149.94 145.78 14.26 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.714 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 285' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -101.55 138.16 38.92 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 117.918 0.859 . . . . 0.0 111.953 -172.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.562 ' CG ' ' HE2' ' A' ' 245' ' ' LYS . 9.5 m-85 -154.44 163.54 23.87 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.635 -175.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 68.3 Cg_endo -96.79 174.67 0.73 Allowed 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 123.69 2.926 . . . . 0.0 115.203 -173.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.785 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 32.4 t80 -82.14 -21.76 36.46 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 113.978 -1.464 . . . . 0.0 112.716 -171.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 9.9 t -58.62 -13.15 5.11 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -171.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' HIS . . . . . 0.534 ' HB2' ' HB2' ' A' ' 244' ' ' GLN . 1.1 p-80 -141.64 44.28 1.72 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.962 0.41 . . . . 0.0 111.957 -177.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.419 ' O ' ' HD2' ' A' ' 292' ' ' ARG . 12.6 m -135.0 156.96 40.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.496 0.665 . . . . 0.0 112.022 177.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.419 ' HD2' ' O ' ' A' ' 291' ' ' VAL . 22.7 mmm180 -127.53 106.7 9.36 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 166.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 293' ' ' LEU . . . . . 0.431 HD12 ' CB ' ' A' ' 240' ' ' ALA . 1.8 mm? -92.21 143.46 26.4 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.63 -0.669 . . . . 0.0 112.242 -170.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.459 HD23 ' N ' ' A' ' 294' ' ' LEU . 4.1 mt -94.81 123.58 38.35 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 164.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.586 ' OD2' ' HB2' ' A' ' 297' ' ' GLN . 4.5 p-10 -76.83 155.63 32.86 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.773 0.797 . . . . 0.0 112.215 -166.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.755 ' HB3' HG22 ' A' ' 238' ' ' ILE . 1.7 pm0 -77.58 12.34 1.67 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.273 -1.331 . . . . 0.0 111.579 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 297' ' ' GLN . . . . . 0.586 ' HB2' ' OD2' ' A' ' 295' ' ' ASP . 29.0 mm-40 -91.36 -30.2 16.68 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 171.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 19.7 m120 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.15 176.07 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 113.721 0.249 . . . . 0.0 113.721 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.676 ' HB2' ' HD3' ' A' ' 265' ' ' LYS . 6.9 Cg_endo -90.82 131.56 1.56 Allowed 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 124.022 3.148 . . . . 0.0 110.788 172.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 1.034 HG12 HG22 ' A' ' 266' ' ' VAL . 2.2 pt -82.38 158.67 3.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.642 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.709 ' HB3' HD21 ' A' ' 263' ' ' LEU . 36.1 m-85 -104.79 117.11 33.25 Favored 'General case' 0 C--O 1.21 -1.025 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 169.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.654 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -113.34 116.54 29.86 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.187 -172.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.417 ' HB3' ' O ' ' A' ' 292' ' ' ARG . 22.7 tpp180 -74.88 101.68 4.48 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.803 -1.09 . . . . 0.0 108.287 175.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.601 HG21 ' HD3' ' A' ' 245' ' ' LYS . 7.6 p -83.59 124.57 39.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.153 -175.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.9 pp -102.36 1.66 10.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.109 -173.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.507 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 52.5 tt0 -177.37 98.51 0.05 OUTLIER 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.94 -176.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.659 ' HE2' HD11 ' A' ' 258' ' ' LEU . 0.0 OUTLIER -146.09 163.29 35.76 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.272 0.558 . . . . 0.0 110.156 173.179 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.771 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 5.7 ptp180 -94.82 -174.35 3.25 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.306 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 2.8 m -108.98 69.31 0.38 Allowed Pre-proline 0 CA--C 1.536 0.426 0 CA-C-O 121.246 0.546 . . . . 0.0 111.615 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.976 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 57.0 Cg_endo -95.86 122.25 0.27 Allowed 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 124.645 3.563 . . . . 0.0 111.442 178.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -79.35 175.66 10.4 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.989 0.423 . . . . 0.0 110.966 -176.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -65.02 -0.53 1.61 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.179 0.514 . . . . 0.0 111.375 177.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -103.67 8.61 37.43 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.087 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -98.12 53.47 1.08 Allowed 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' LYS . . . . . 0.535 ' N ' ' HD3' ' A' ' 253' ' ' LYS . 0.1 OUTLIER 61.42 28.99 18.26 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -167.399 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 254' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 26.5 p 62.09 87.01 0.1 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.197 -1.365 . . . . 0.0 110.942 -176.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.648 ' HB3' ' HB2' ' A' ' 248' ' ' PRO . . . -123.72 165.64 16.91 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.785 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.602 ' H ' ' HE2' ' A' ' 286' ' ' PHE . 4.3 mm? -89.07 114.96 26.24 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.009 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.976 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -85.31 87.14 7.35 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.59 0.709 . . . . 0.0 110.413 177.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.659 HD11 ' HE2' ' A' ' 245' ' ' LYS . 0.4 OUTLIER -151.98 167.2 29.15 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.869 -173.247 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.543 ' O ' HG13 ' A' ' 242' ' ' VAL . 11.1 pt-20 -141.89 -161.89 1.31 Allowed 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.755 -0.591 . . . . 0.0 111.903 -170.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 2.7 p -65.06 119.13 8.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.494 0.664 . . . . 0.0 112.112 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 106.26 -2.67 37.51 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.927 171.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -90.99 -177.78 5.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.782 0.325 . . . . 0.0 111.434 -171.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.709 HD21 ' HB3' ' A' ' 239' ' ' TYR . 3.3 tm? -131.18 120.08 22.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.944 0.402 . . . . 0.0 110.458 -176.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.654 HG13 ' HB3' ' A' ' 240' ' ' ALA . 2.5 p -115.63 116.88 53.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.637 175.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.676 ' HD3' ' HB2' ' A' ' 237' ' ' PRO . 0.0 OUTLIER -89.41 98.64 11.88 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.006 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 1.034 HG22 HG12 ' A' ' 238' ' ' ILE . 6.1 m -79.12 122.89 35.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.533 0.682 . . . . 0.0 110.969 -176.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 267' ' ' THR . . . . . 0.516 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 36.4 p -86.47 -19.48 29.5 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.426 -174.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.902 ' HA ' ' HE3' ' A' ' 268' ' ' LYS . 0.1 OUTLIER -123.11 105.95 10.36 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -178.812 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.42 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.7 OUTLIER -94.32 157.25 3.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -172.774 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.722 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 3.4 p30 -146.43 179.83 7.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.724 -179.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 10.2 p -93.36 -18.85 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -173.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 33.5 m -94.65 -34.91 12.41 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -176.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 273' ' ' GLY . . . . . 0.767 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 115.29 -2.81 22.25 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.929 -177.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 1.9 mp0 -89.93 76.79 7.03 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 175.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.722 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -115.1 173.02 6.71 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.532 0.682 . . . . 0.0 111.808 -171.636 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 36.1 mt-10 -96.85 125.55 41.38 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.132 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.658 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -111.25 155.02 16.37 Favored Glycine 0 N--CA 1.437 -1.265 0 CA-C-N 114.669 -1.151 . . . . 0.0 112.509 -169.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.597 ' HG2' ' HG3' ' A' ' 283' ' ' ARG . 6.1 tm-20 -139.47 119.7 13.74 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 174.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 279' ' ' CYS . . . . . 0.576 ' O ' ' HD3' ' A' ' 282' ' ' LYS . 12.4 t -124.46 99.85 6.39 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.829 -173.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 51.66 38.01 21.57 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.808 0.693 . . . . 0.0 111.672 170.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 114.93 -26.42 9.35 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.187 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' LYS . . . . . 0.576 ' HD3' ' O ' ' A' ' 279' ' ' CYS . 0.1 OUTLIER -81.93 137.04 35.25 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 177.992 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 283' ' ' ARG . . . . . 0.597 ' HG3' ' HG2' ' A' ' 278' ' ' GLU . 0.1 OUTLIER -128.15 140.07 52.13 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.927 177.783 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 177.48 -145.51 7.2 Favored Glycine 0 C--O 1.222 -0.6 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.103 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 285' ' ' HIS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 13.7 p80 -150.54 140.2 21.66 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.665 0.233 . . . . 0.0 111.252 -178.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.602 ' HE2' ' H ' ' A' ' 256' ' ' LEU . 9.9 m-85 -157.44 159.31 30.9 Favored Pre-proline 0 N--CA 1.469 0.5 0 C-N-CA 122.249 0.22 . . . . 0.0 111.11 -177.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 63.7 Cg_endo -92.86 176.9 1.52 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.246 2.631 . . . . 0.0 114.435 -173.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.767 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 21.2 t80 -80.64 -33.62 35.55 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 113.816 -1.538 . . . . 0.0 112.657 -168.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 6.6 t -55.77 -33.72 64.6 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -168.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 290' ' ' HIS . . . . . 0.555 ' CD2' ' HD2' ' A' ' 245' ' ' LYS . 1.2 p-80 -115.05 49.27 1.07 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.605 0.717 . . . . 0.0 110.845 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -150.04 155.64 7.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.551 175.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.417 ' O ' ' HB3' ' A' ' 241' ' ' ARG . 29.2 mmm180 -130.83 107.42 9.12 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 175.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 293' ' ' LEU . . . . . 0.612 ' H ' HD23 ' A' ' 293' ' ' LEU . 0.3 OUTLIER -102.04 136.14 42.4 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -162.735 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 239' ' ' TYR . 0.0 OUTLIER -84.42 143.6 29.32 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 113.96 -1.473 . . . . 0.0 107.373 170.477 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -75.61 152.6 37.63 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.34 -163.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.847 ' HB3' HG22 ' A' ' 238' ' ' ILE . 19.8 pt20 -93.79 -22.8 18.46 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.066 -174.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -91.95 -35.04 14.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.191 0.519 . . . . 0.0 109.606 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 . . . . . 0 C--N 1.323 -0.554 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.897 171.925 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 236' ' ' GLY . . . . . 0.486 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . . . . . . 0 N--CA 1.445 -0.741 0 N-CA-C 112.255 -0.338 . . . . 0.0 112.255 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.486 ' HD3' ' HA2' ' A' ' 236' ' ' GLY . 7.1 Cg_exo -73.17 133.72 19.98 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.072 2.515 . . . . 0.0 112.003 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 1.062 HG22 ' HB3' ' A' ' 296' ' ' GLN . 0.2 OUTLIER -92.8 167.47 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.545 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.7 ' HB3' HD11 ' A' ' 263' ' ' LEU . 72.4 m-85 -106.64 127.73 53.59 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 170.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.513 ' HB3' ' CG1' ' A' ' 264' ' ' VAL . . . -114.39 118.16 33.07 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.528 -176.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.608 ' NH1' ' HA2' ' A' ' 261' ' ' GLY . 0.1 OUTLIER -88.8 100.82 13.45 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.297 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 1.016 HG21 ' HD2' ' A' ' 245' ' ' LYS . 7.2 p -86.56 127.15 40.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.071 -172.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.8 pp -100.29 3.28 10.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.4 -174.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.532 ' H ' HG22 ' A' ' 242' ' ' VAL . 56.1 tp60 -177.33 106.91 0.06 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -176.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 1.061 ' HD3' ' HB2' ' A' ' 258' ' ' LEU . 14.7 tttt -144.63 157.15 44.33 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 177.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.81 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 16.4 ptt180 -103.92 -175.14 2.71 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 6.8 m -110.51 69.37 0.58 Allowed Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 121.177 0.513 . . . . 0.0 111.987 -174.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 1.017 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 17.8 Cg_endo -94.47 124.51 0.42 Allowed 'Trans proline' 0 N--CA 1.444 -1.433 0 C-N-CA 124.285 3.324 . . . . 0.0 111.175 176.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.417 ' C ' ' H ' ' A' ' 251' ' ' TYR . 7.0 m-20 -81.46 176.92 9.28 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.022 0.439 . . . . 0.0 111.043 -174.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.607 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -67.77 4.86 0.99 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.202 0.525 . . . . 0.0 111.281 177.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.417 ' H ' ' C ' ' A' ' 249' ' ' ASN . 44.8 m-85 -106.5 5.74 29.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.553 0.692 . . . . 0.0 109.572 176.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.423 ' C ' ' HD2' ' A' ' 253' ' ' LYS . 3.7 m-20 -101.17 55.73 0.84 Allowed 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 253' ' ' LYS . . . . . 0.423 ' HD2' ' C ' ' A' ' 252' ' ' ASP . 0.0 OUTLIER 59.0 27.01 15.78 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -169.568 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 254' ' ' THR . . . . . 0.607 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 30.2 p 61.42 85.19 0.12 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.63 -176.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.685 ' HB3' ' HB2' ' A' ' 248' ' ' PRO . . . -118.31 165.63 13.6 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.499 178.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.961 ' HB3' HD13 ' A' ' 258' ' ' LEU . 3.8 mm? -88.35 112.78 23.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.632 178.187 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.017 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -82.32 81.86 8.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.6 0.714 . . . . 0.0 110.234 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 1.061 ' HB2' ' HD3' ' A' ' 245' ' ' LYS . 6.1 mp -122.83 177.92 5.26 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.382 -171.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -143.71 -169.31 3.05 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.156 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 2.3 p -65.71 121.06 14.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.247 177.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.608 ' HA2' ' NH1' ' A' ' 241' ' ' ARG . . . 103.44 -2.22 46.39 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.486 171.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -88.76 174.99 7.68 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.991 0.424 . . . . 0.0 111.261 -171.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.7 HD11 ' HB3' ' A' ' 239' ' ' TYR . 21.5 tp -130.0 158.85 38.45 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.222 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.823 HG23 ' HB2' ' A' ' 279' ' ' CYS . 8.3 p -151.13 150.71 13.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.427 ' HD3' ' HB2' ' A' ' 237' ' ' PRO . 0.0 OUTLIER -110.34 97.92 7.27 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.22 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.965 HG22 HG12 ' A' ' 238' ' ' ILE . 15.5 m -74.39 113.3 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 121.972 0.891 . . . . 0.0 110.43 -178.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 267' ' ' THR . . . . . 0.464 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 61.0 p -92.34 0.52 57.45 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.095 -174.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.65 107.14 6.48 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.375 172.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.605 HG21 HG23 ' A' ' 238' ' ' ILE . 0.8 OUTLIER -104.21 160.86 4.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 114.34 -1.3 . . . . 0.0 113.102 -170.25 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.717 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 3.8 p30 -146.87 171.62 14.92 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.815 -176.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 27.0 m -87.04 5.06 3.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -175.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 4.4 m -111.54 -43.42 3.67 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 273' ' ' GLY . . . . . 0.439 ' HA2' ' CZ2' ' A' ' 275' ' ' TRP . . . 120.24 -0.4 12.92 Favored Glycine 0 C--O 1.223 -0.543 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.021 -175.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.592 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 2.1 mp0 -98.04 77.64 2.47 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.717 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -117.87 169.88 9.27 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.461 -167.457 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.595 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 39.9 mt-10 -90.68 126.29 35.93 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.228 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.654 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -111.36 146.37 17.78 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.294 -170.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 4.3 tm-20 -133.7 116.51 15.87 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 279' ' ' CYS . . . . . 0.823 ' HB2' HG23 ' A' ' 264' ' ' VAL . 10.5 t -115.7 99.0 7.0 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.744 0.783 . . . . 0.0 110.009 -177.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 31.63 55.89 0.29 Allowed 'General case' 0 C--N 1.343 0.301 0 CA-C-N 112.918 -1.947 . . . . 0.0 113.525 175.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.82 -14.41 14.37 Favored Glycine 0 CA--C 1.522 0.495 0 CA-C-N 115.933 -0.576 . . . . 0.0 113.51 176.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 282' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 19.0 mttt -108.38 128.64 54.94 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 117.213 0.506 . . . . 0.0 109.699 177.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 283' ' ' ARG . . . . . 0.491 ' C ' ' HD3' ' A' ' 283' ' ' ARG . 0.2 OUTLIER -123.21 143.95 49.69 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.276 -0.569 . . . . 0.0 111.173 179.637 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 176.63 -145.1 7.24 Favored Glycine 0 C--O 1.224 -0.508 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.243 178.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' HIS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 13.6 p80 -150.15 147.65 28.0 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.852 0.326 . . . . 0.0 110.822 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.64 ' HD1' ' HD2' ' A' ' 287' ' ' PRO . 2.5 m-85 -161.68 153.93 16.57 Favored Pre-proline 0 N--CA 1.467 0.398 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -178.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.64 ' HD2' ' HD1' ' A' ' 286' ' ' PHE . 87.4 Cg_endo -88.32 165.1 6.8 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.399 2.733 . . . . 0.0 112.513 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.608 ' HA ' HG12 ' A' ' 291' ' ' VAL . 9.4 p90 -88.16 -4.77 58.69 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -172.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 5.6 t -56.76 -11.38 1.37 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -177.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -133.47 30.76 3.8 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 122.259 -0.276 . . . . 0.0 111.149 -175.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.709 HG23 ' HA ' ' A' ' 242' ' ' VAL . 9.5 p -147.35 157.6 9.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 C-N-CA 119.759 -0.776 . . . . 0.0 112.005 -170.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.447 ' HA ' ' HD2' ' A' ' 292' ' ' ARG . 25.3 tpt180 -125.98 109.74 12.79 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 293' ' ' LEU . . . . . 0.561 HD22 ' H ' ' A' ' 293' ' ' LEU . 0.4 OUTLIER -86.42 150.16 24.5 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 119.562 -0.855 . . . . 0.0 113.22 -165.522 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 239' ' ' TYR . 11.3 mt -99.81 122.78 43.28 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 105.153 -2.165 . . . . 0.0 105.153 163.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.522 ' HB3' ' HG3' ' A' ' 297' ' ' GLN . 4.7 t70 -77.87 150.83 34.09 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 122.197 0.998 . . . . 0.0 112.713 -160.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 1.062 ' HB3' HG22 ' A' ' 238' ' ' ILE . 5.5 pt20 -73.95 -9.17 58.37 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 113.512 -1.677 . . . . 0.0 111.433 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 297' ' ' GLN . . . . . 0.522 ' HG3' ' HB3' ' A' ' 295' ' ' ASP . 4.9 pp0? -71.14 -21.85 62.14 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.163 173.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 121.23 0.538 . . . . 0.0 110.105 175.786 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 236' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' A' ' 296' ' ' GLN . . . . . . . . 0 N--CA 1.447 -0.569 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.474 ' HD3' ' HA2' ' A' ' 236' ' ' GLY . 19.7 Cg_exo -67.48 136.12 38.61 Favored 'Trans proline' 0 CA--C 1.52 -0.191 0 C-N-CA 123.242 2.628 . . . . 0.0 113.135 -179.028 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.942 HG23 ' HB ' ' A' ' 266' ' ' VAL . 0.1 OUTLIER -90.02 151.52 3.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.211 175.899 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.584 ' HD1' HD11 ' A' ' 263' ' ' LEU . 27.4 m-85 -109.64 117.37 33.76 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.616 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -115.15 117.17 29.78 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.413 0.625 . . . . 0.0 111.447 -171.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 241' ' ' ARG . 4.2 tpp85 -74.89 104.79 5.64 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.847 174.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.787 HG21 ' HD3' ' A' ' 245' ' ' LYS . 7.5 p -84.24 133.46 29.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.23 0.538 . . . . 0.0 110.852 -176.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.636 HD12 ' HB2' ' A' ' 244' ' ' GLN . 2.4 pp -115.19 3.99 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.919 -171.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.636 ' HB2' HD12 ' A' ' 243' ' ' ILE . 5.3 mt-30 -173.94 94.14 0.09 Allowed 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 123.202 0.314 . . . . 0.0 110.5 -175.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.787 ' HD3' HG21 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -147.1 162.99 37.71 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.238 0.542 . . . . 0.0 110.427 173.437 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.855 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 4.5 ptt180 -101.59 -176.42 3.13 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.978 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.4 77.96 0.23 Allowed Pre-proline 0 CA--C 1.542 0.644 0 O-C-N 122.156 -0.34 . . . . 0.0 111.382 175.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 1.032 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 12.7 Cg_endo -94.55 142.23 1.44 Allowed 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.54 3.494 . . . . 0.0 112.214 175.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.406 ' O ' ' HB2' ' A' ' 252' ' ' ASP . 15.1 m120 -96.78 177.06 5.76 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.731 -177.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.764 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -63.95 -7.63 8.93 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 121.823 0.821 . . . . 0.0 110.197 172.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -95.04 6.79 48.08 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.065 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 249' ' ' ASN . 1.1 m-20 -105.04 48.11 0.85 Allowed 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 253' ' ' LYS . . . . . 0.478 ' N ' ' HD2' ' A' ' 253' ' ' LYS . 0.1 OUTLIER 60.42 32.7 20.66 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -167.937 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 254' ' ' THR . . . . . 0.764 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 23.4 p 57.03 77.55 0.26 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.166 -1.379 . . . . 0.0 111.158 -179.152 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.62 ' HB3' ' HB2' ' A' ' 248' ' ' PRO . . . -117.77 167.14 11.65 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.024 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.537 ' H ' ' HE2' ' A' ' 286' ' ' PHE . 4.6 mm? -88.55 118.8 28.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.909 -175.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.032 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -83.54 90.64 7.27 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.768 0.794 . . . . 0.0 110.547 175.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.658 ' O ' ' HB3' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -150.72 167.52 27.14 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.04 -176.183 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.457 ' CG ' ' N ' ' A' ' 260' ' ' VAL . 24.7 tt0 -142.93 177.24 8.49 Favored 'General case' 0 C--N 1.313 -1.005 0 O-C-N 122.088 -0.383 . . . . 0.0 110.547 -164.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 243' ' ' ILE . 57.8 t -50.05 118.52 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 122.906 0.482 . . . . 0.0 111.479 174.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 106.1 -2.32 38.01 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.58 170.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -98.23 -173.59 2.62 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.875 0.369 . . . . 0.0 111.725 -172.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.584 HD11 ' HD1' ' A' ' 239' ' ' TYR . 3.3 tm? -129.47 131.14 46.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.525 -173.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.616 HG13 ' HB3' ' A' ' 240' ' ' ALA . 2.4 p -123.39 124.49 69.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.435 174.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -82.68 112.24 19.36 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 175.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.942 ' HB ' HG23 ' A' ' 238' ' ' ILE . 94.8 t -77.06 112.91 15.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 65.8 p -94.65 -32.89 13.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.962 -171.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.579 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 11.9 tppt? -116.16 107.56 15.05 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.477 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.7 OUTLIER -96.74 140.25 17.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -168.134 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.904 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 9.8 p30 -148.06 149.07 31.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.852 178.118 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 10.9 p -65.37 -17.4 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -173.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 3.9 p -78.26 -30.68 48.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.914 0.388 . . . . 0.0 111.995 -177.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 273' ' ' GLY . . . . . 0.605 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 94.96 -5.67 68.99 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.464 -177.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.64 ' HG3' ' HB3' ' A' ' 287' ' ' PRO . 1.7 mp0 -92.56 77.41 5.0 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 174.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.904 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -122.76 178.42 5.03 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.489 -0.778 . . . . 0.0 113.042 -167.964 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 268' ' ' LYS . 40.2 mt-10 -83.33 127.47 33.69 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.525 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.448 ' O ' HD21 ' A' ' 256' ' ' LEU . . . -111.75 156.44 15.57 Favored Glycine 0 N--CA 1.433 -1.528 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.615 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 21.2 tt0 -141.88 119.43 11.68 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 279' ' ' CYS . . . . . 0.479 ' HB2' HD23 ' A' ' 258' ' ' LEU . 51.6 t -115.2 99.06 7.14 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.061 -176.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 45.18 45.12 9.23 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 124.065 0.853 . . . . 0.0 111.958 176.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 114.86 -33.51 5.31 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.202 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 282' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 12.2 mptt -73.32 139.69 46.22 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 117.178 0.489 . . . . 0.0 110.084 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -124.01 142.05 51.51 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.216 0.531 . . . . 0.0 111.921 -176.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 169.49 -145.54 9.41 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.391 175.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' HIS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 7.5 p80 -150.35 147.53 27.72 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.936 0.368 . . . . 0.0 111.191 -177.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.61 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 2.1 m-85 -158.18 150.74 17.93 Favored Pre-proline 0 N--CA 1.466 0.331 0 CA-C-O 120.936 0.398 . . . . 0.0 112.052 -178.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.64 ' HB3' ' HG3' ' A' ' 274' ' ' GLN . 2.4 Cg_endo -81.34 174.32 10.76 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.915 3.076 . . . . 0.0 114.152 -178.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.605 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 24.9 t80 -87.77 -35.67 17.74 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -167.102 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 4.1 t -65.41 -7.27 13.1 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -164.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 290' ' ' HIS . . . . . 0.534 ' NE2' ' HD2' ' A' ' 245' ' ' LYS . 1.1 p-80 -120.35 31.82 6.3 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.907 -0.496 . . . . 0.0 110.92 178.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.673 HG23 ' HA ' ' A' ' 242' ' ' VAL . 4.0 p -147.23 154.19 11.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.296 0.569 . . . . 0.0 111.566 -175.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -131.95 110.25 10.63 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' LEU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 240' ' ' ALA . 0.2 OUTLIER -118.02 135.68 54.01 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -162.18 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.443 ' H ' HD12 ' A' ' 294' ' ' LEU . 5.3 mp -77.93 153.42 32.55 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.864 168.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -76.34 150.49 36.86 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.756 -162.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.563 ' HA ' ' HA ' ' A' ' 238' ' ' ILE . 12.2 pt20 -77.86 5.41 9.67 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 113.618 -1.628 . . . . 0.0 112.086 -173.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -73.96 -31.78 63.16 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.11 174.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 120.795 0.331 . . . . 0.0 111.156 -175.059 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 236' ' ' GLY . . . . . 0.412 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . . . . . . 0 N--CA 1.447 -0.611 0 N-CA-C 112.145 -0.382 . . . . 0.0 112.145 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.503 ' HB3' ' HA ' ' A' ' 267' ' ' THR . 6.2 Cg_exo -78.68 131.73 10.49 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.149 2.566 . . . . 0.0 112.116 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 1.069 HG22 ' HB3' ' A' ' 296' ' ' GLN . 0.2 OUTLIER -87.01 163.55 2.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.553 176.934 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.819 ' HB3' HD11 ' A' ' 263' ' ' LEU . 67.7 m-85 -104.92 123.49 47.84 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 171.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.694 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -112.52 118.62 35.62 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.861 -174.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 292' ' ' ARG . 0.0 OUTLIER -75.89 100.86 4.95 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.969 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.7 HG21 ' HB2' ' A' ' 245' ' ' LYS . 3.3 p -82.63 121.01 35.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.111 -176.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.708 HD12 ' HB2' ' A' ' 244' ' ' GLN . 2.8 pp -105.85 10.55 9.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.708 -175.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.708 ' HB2' HD12 ' A' ' 243' ' ' ILE . 1.0 OUTLIER -177.0 94.95 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.272 -176.642 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.7 ' HB2' HG21 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -147.09 164.68 32.31 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.27 0.557 . . . . 0.0 111.202 174.335 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.818 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 3.2 ptm180 -101.06 -177.96 3.61 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.525 -177.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 46.2 t -104.67 81.91 0.6 Allowed Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 121.201 0.524 . . . . 0.0 110.918 174.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.95 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 4.6 Cg_endo -91.03 175.46 2.44 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 124.959 3.773 . . . . 0.0 111.881 174.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -138.55 179.91 6.19 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.146 176.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.751 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -57.25 -12.59 2.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.877 0.37 . . . . 0.0 111.89 176.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -91.34 -5.71 54.16 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 122.081 -0.387 . . . . 0.0 110.486 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -92.06 48.35 1.42 Allowed 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? 59.01 24.5 12.74 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -167.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' THR . . . . . 0.751 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 19.3 p 64.98 83.35 0.17 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.405 -1.271 . . . . 0.0 110.885 -177.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.634 ' HB1' ' CE2' ' A' ' 286' ' ' PHE . . . -122.33 159.25 27.84 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.466 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.568 HD22 ' HA3' ' A' ' 284' ' ' GLY . 0.7 OUTLIER -78.27 123.91 27.48 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.251 -174.849 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.95 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -84.28 93.96 8.33 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.561 0.696 . . . . 0.0 111.171 172.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.644 ' O ' ' HB3' ' A' ' 245' ' ' LYS . 0.2 OUTLIER -155.6 167.98 28.64 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.623 -177.133 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.436 ' O ' HG13 ' A' ' 242' ' ' VAL . 12.3 pt-20 -141.78 -165.2 1.94 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.916 -0.49 . . . . 0.0 111.855 -172.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 43.0 t -59.63 118.38 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 96.71 0.18 60.76 Favored Glycine 0 CA--C 1.508 -0.396 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.165 170.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -89.74 -175.93 4.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.72 0.295 . . . . 0.0 110.396 -176.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.819 HD11 ' HB3' ' A' ' 239' ' ' TYR . 44.4 tp -130.0 159.84 35.46 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.01 0.433 . . . . 0.0 111.322 -176.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.694 HG13 ' HB3' ' A' ' 240' ' ' ALA . 2.4 p -152.24 133.82 5.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.019 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.464 ' HE2' ' HG2' ' A' ' 237' ' ' PRO . 86.1 tttt -96.16 96.36 8.77 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.246 0.546 . . . . 0.0 109.833 178.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.869 ' HB ' HD13 ' A' ' 238' ' ' ILE . 50.3 t -76.98 114.72 17.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.043 0.449 . . . . 0.0 111.473 -178.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 267' ' ' THR . . . . . 0.503 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 42.0 p -90.8 -10.45 42.79 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.49 -174.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.52 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 13.3 tppt? -127.21 105.94 8.9 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.818 HG21 HG23 ' A' ' 238' ' ' ILE . 0.8 OUTLIER -111.65 140.25 32.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -170.391 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.866 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 6.5 p30 -148.6 140.44 23.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.634 177.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 10.6 p -58.68 -15.07 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -172.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.4 m -62.0 -36.11 80.54 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.297 0.481 . . . . 0.0 112.297 -177.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' GLY . . . . . 0.536 ' CA ' ' HB2' ' A' ' 288' ' ' PHE . . . 89.11 36.43 7.64 Favored Glycine 0 N--CA 1.437 -1.299 0 C-N-CA 119.908 -1.139 . . . . 0.0 110.797 -170.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 1.0 OUTLIER -148.7 96.92 2.65 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 171.163 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.866 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -134.15 173.07 12.0 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -168.959 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.728 ' O ' HG13 ' A' ' 266' ' ' VAL . 18.4 mm-40 -90.06 123.39 33.89 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.348 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -105.37 162.12 14.48 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -175.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.537 ' HG2' ' HG3' ' A' ' 283' ' ' ARG . 3.5 tm-20 -151.47 120.17 6.54 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 174.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 43.4 t -122.64 97.68 5.57 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.668 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 45.17 49.92 9.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.329 170.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.49 -27.31 8.08 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.684 -0.77 . . . . 0.0 113.4 177.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.85 128.58 41.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 117.311 0.556 . . . . 0.0 110.166 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 283' ' ' ARG . . . . . 0.537 ' HG3' ' HG2' ' A' ' 278' ' ' GLU . 0.4 OUTLIER -109.0 136.44 48.52 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.185 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 284' ' ' GLY . . . . . 0.568 ' HA3' HD22 ' A' ' 256' ' ' LEU . . . -161.94 -171.98 28.74 Favored Glycine 0 C--O 1.226 -0.395 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.599 -176.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 285' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -147.02 135.79 22.17 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 172.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.688 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 4.4 m-85 -154.81 158.63 32.2 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -173.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 56.9 Cg_endo -94.93 164.68 1.69 Allowed 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.442 2.761 . . . . 0.0 113.938 -176.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.662 ' HA ' HG22 ' A' ' 291' ' ' VAL . 9.1 t80 -74.86 -18.47 60.43 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.131 -174.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 8.9 t -48.31 -24.91 1.35 Allowed 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 -175.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' HIS . . . . . 0.499 ' NE2' ' HD2' ' A' ' 245' ' ' LYS . 0.8 OUTLIER -137.51 48.19 2.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.807 0.337 . . . . 0.0 111.86 -177.839 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.662 HG22 ' HA ' ' A' ' 288' ' ' PHE . 30.1 m -143.22 155.09 16.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 121.102 0.477 . . . . 0.0 111.208 173.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.478 ' HD2' ' O ' ' A' ' 291' ' ' VAL . 15.9 mmm180 -121.79 110.43 15.9 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 173.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 293' ' ' LEU . . . . . 0.518 HD22 ' HE2' ' A' ' 288' ' ' PHE . 2.6 tp -94.24 126.92 39.78 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -160.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.535 HD13 ' N ' ' A' ' 294' ' ' LEU . 0.1 OUTLIER -83.41 124.4 30.63 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 163.886 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -82.76 152.9 25.52 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.932 0.872 . . . . 0.0 112.208 -162.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 1.069 ' HB3' HG22 ' A' ' 238' ' ' ILE . 16.1 pt20 -75.45 -7.98 55.51 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.753 -1.567 . . . . 0.0 111.716 -176.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 297' ' ' GLN . . . . . 0.495 ' HG3' ' N ' ' A' ' 298' ' ' ASN . 6.5 pt20 -65.03 -38.28 90.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.971 0.415 . . . . 0.0 110.02 173.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 298' ' ' ASN . . . . . 0.495 ' N ' ' HG3' ' A' ' 297' ' ' GLN . 92.5 m-20 . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.755 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.553 0 N-CA-C 112.774 -0.13 . . . . 0.0 112.774 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.536 ' HA ' ' O ' ' A' ' 266' ' ' VAL . 10.1 Cg_endo -91.29 120.01 0.61 Allowed 'Trans proline' 0 N--CA 1.446 -1.277 0 C-N-CA 123.515 2.81 . . . . 0.0 112.413 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 1.089 HD11 ' HB2' ' A' ' 240' ' ' ALA . 0.1 OUTLIER -92.46 144.6 8.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 171.682 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.798 ' HD1' HD11 ' A' ' 263' ' ' LEU . 46.7 m-85 -96.96 119.53 35.6 Favored 'General case' 0 C--O 1.21 -1.01 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 173.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 1.089 ' HB2' HD11 ' A' ' 238' ' ' ILE . . . -113.94 115.9 28.4 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.107 -173.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.45 ' HB3' ' O ' ' A' ' 292' ' ' ARG . 17.8 tpp180 -84.76 103.4 13.82 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.189 -1.369 . . . . 0.0 108.375 177.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 1.049 HG11 ' HD2' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -89.75 149.47 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.546 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.669 -177.245 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.503 HD12 ' HB2' ' A' ' 244' ' ' GLN . 2.3 pp -124.88 11.23 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-N 113.544 -1.662 . . . . 0.0 110.654 -171.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.808 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 52.9 tt0 -177.23 94.6 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.63 -174.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 1.049 ' HD2' HG11 ' A' ' 242' ' ' VAL . 5.3 mttt -146.93 162.79 37.99 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.966 0.412 . . . . 0.0 110.11 177.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.868 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 10.7 ptm180 -113.37 -177.26 3.09 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.494 -174.05 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 9.3 m -102.57 81.83 0.4 Allowed Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 121.488 0.661 . . . . 0.0 112.091 174.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.97 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 1.1 Cg_endo -90.84 177.03 2.21 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 125.063 3.842 . . . . 0.0 110.573 171.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -131.36 175.43 9.14 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.105 0.478 . . . . 0.0 110.622 175.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.635 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -66.96 -2.97 5.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.316 0.579 . . . . 0.0 110.883 176.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -95.79 1.35 53.2 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.295 177.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -97.96 51.08 1.03 Allowed 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' LYS . . . . . 0.709 ' HE2' ' HA ' ' A' ' 253' ' ' LYS . 10.7 mmpt? 62.11 26.7 16.08 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -168.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 254' ' ' THR . . . . . 0.635 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 24.4 p 63.83 86.05 0.13 Allowed 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 125.107 1.504 . . . . 0.0 110.699 -175.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.418 ' HB1' ' CE2' ' A' ' 286' ' ' PHE . . . -121.66 156.55 32.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.186 178.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.596 HD21 ' O ' ' A' ' 277' ' ' GLY . 4.3 mm? -78.53 131.23 36.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.841 -178.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.97 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -92.03 99.05 11.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.361 0.6 . . . . 0.0 110.355 171.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.793 HD13 ' CD ' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -153.3 174.4 14.35 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.371 -175.332 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.431 ' CG ' ' N ' ' A' ' 260' ' ' VAL . 32.3 tt0 -142.84 175.73 9.61 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 122.128 -0.357 . . . . 0.0 111.073 -165.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.574 HG22 ' HA ' ' A' ' 244' ' ' GLN . 56.0 t -57.07 118.71 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 123.083 0.553 . . . . 0.0 111.351 175.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 104.53 -1.19 42.71 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -97.79 -179.16 4.34 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.676 -169.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.798 HD11 ' HD1' ' A' ' 239' ' ' TYR . 2.3 tm? -134.16 134.29 41.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.07 0.462 . . . . 0.0 110.613 -170.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.606 HG12 ' HB3' ' A' ' 240' ' ' ALA . 5.4 p -125.54 145.3 33.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.453 173.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -99.79 99.65 10.49 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 175.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.941 ' HB ' HG23 ' A' ' 238' ' ' ILE . 76.0 t -70.06 114.14 7.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.324 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 33.2 p -92.6 -32.3 14.85 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.165 -171.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.36 107.65 15.08 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 121.598 0.713 . . . . 0.0 109.831 175.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.434 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.6 OUTLIER -93.91 154.1 3.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 113.877 -1.511 . . . . 0.0 113.366 -170.024 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.754 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 2.4 p30 -145.89 -178.62 6.21 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.688 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 53.6 t -87.63 -38.81 12.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.5 m -73.33 -28.15 61.91 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -172.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 273' ' ' GLY . . . . . 0.853 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 102.99 0.66 48.42 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.582 -175.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -89.96 76.14 7.1 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.754 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -122.33 175.66 6.29 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.619 0.723 . . . . 0.0 112.709 -170.033 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 284' ' ' GLY . 43.1 tt0 -98.52 127.31 44.4 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.081 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.596 ' O ' HD21 ' A' ' 256' ' ' LEU . . . -112.1 151.59 17.98 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.908 -174.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.624 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 17.2 tt0 -136.23 119.9 17.2 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 174.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 49.5 t -101.2 97.6 8.1 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.258 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 36.89 58.11 1.14 Allowed 'General case' 0 N--CA 1.465 0.282 0 O-C-N 124.542 1.151 . . . . 0.0 112.261 177.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.08 -37.51 3.39 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.661 177.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 37.3 mttt -82.13 128.28 33.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 117.808 0.804 . . . . 0.0 110.587 -178.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -110.79 141.85 43.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.344 0.592 . . . . 0.0 112.002 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 284' ' ' GLY . . . . . 0.492 ' O ' ' HG3' ' A' ' 276' ' ' GLU . . . -176.07 -158.89 20.77 Favored Glycine 0 C--O 1.216 -1.021 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 174.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 285' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -149.66 146.67 27.4 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 118.848 1.324 . . . . 0.0 111.842 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.418 ' CE2' ' HB1' ' A' ' 255' ' ' ALA . 4.0 m-85 -154.18 162.74 26.15 Favored Pre-proline 0 C--O 1.238 0.471 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.571 -176.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -92.92 171.67 2.18 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.151 2.567 . . . . 0.0 114.177 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.853 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 17.9 t80 -79.65 -16.19 56.21 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 114.112 -1.404 . . . . 0.0 111.795 -174.016 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 67.3 p -55.63 -28.91 57.97 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -168.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 290' ' ' HIS . . . . . 0.808 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 1.5 p-80 -127.88 35.77 4.43 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.617 -172.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.788 HG23 HG13 ' A' ' 242' ' ' VAL . 5.4 p -139.36 148.27 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 C-N-CA 119.428 -0.909 . . . . 0.0 112.422 -174.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 241' ' ' ARG . 26.1 mmt180 -129.95 110.93 12.06 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.0 178.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 293' ' ' LEU . . . . . 0.722 HD22 ' H ' ' A' ' 293' ' ' LEU . 0.1 OUTLIER -89.89 138.5 31.44 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.588 0.709 . . . . 0.0 112.779 -163.695 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 239' ' ' TYR . 7.1 mt -81.12 133.63 35.5 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 161.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -73.69 132.6 42.87 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 122.187 0.994 . . . . 0.0 112.952 -160.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.784 ' HB3' ' HA ' ' A' ' 238' ' ' ILE . 15.1 pt20 -80.71 -0.23 37.45 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.579 -1.646 . . . . 0.0 112.656 -176.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.05 10.75 34.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.628 0.728 . . . . 0.0 109.422 169.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 . . . . . 0 CA--C 1.532 0.277 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.789 167.709 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 236' ' ' GLY . . . . . 0.458 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . . . . . . 0 N--CA 1.445 -0.758 0 N-CA-C 112.556 -0.218 . . . . 0.0 112.556 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.596 ' HA ' ' O ' ' A' ' 266' ' ' VAL . 11.7 Cg_exo -73.09 119.38 6.0 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.124 1.882 . . . . 0.0 111.137 175.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 1.013 HG22 ' HB3' ' A' ' 296' ' ' GLN . 0.2 OUTLIER -88.02 170.72 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.329 -177.634 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.958 ' HB3' HD21 ' A' ' 263' ' ' LEU . 81.9 m-85 -111.02 120.92 43.99 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 173.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.557 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -112.76 118.26 34.49 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.82 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.572 ' HD3' ' O ' ' A' ' 262' ' ' GLU . 0.0 OUTLIER -79.97 103.86 10.15 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.571 -177.737 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.918 ' HA ' HG12 ' A' ' 291' ' ' VAL . 2.2 t -68.88 136.19 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.225 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.2 -177.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.415 ' C ' HD12 ' A' ' 243' ' ' ILE . 2.7 pp -123.01 -1.33 6.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.406 0.622 . . . . 0.0 110.227 172.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 1.07 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 33.4 tt0 -164.37 99.72 0.82 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.713 -178.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.975 ' HG2' ' HB2' ' A' ' 258' ' ' LEU . 5.3 tptt -145.76 165.12 29.74 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.419 0.628 . . . . 0.0 110.454 176.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.835 ' HG3' ' HG3' ' A' ' 248' ' ' PRO . 3.6 ptm180 -113.03 -178.78 3.46 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.466 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 5.9 m -105.67 75.76 0.33 Allowed Pre-proline 0 CA--C 1.537 0.481 0 CA-C-O 121.103 0.478 . . . . 0.0 111.826 176.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.993 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 1.0 OUTLIER -88.28 175.5 4.0 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 124.055 3.17 . . . . 0.0 111.527 175.002 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.454 ' HB3' ' HD1' ' A' ' 251' ' ' TYR . 66.3 m-20 -132.68 179.21 6.29 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.769 176.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.87 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -56.95 -10.92 1.23 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.304 0.573 . . . . 0.0 110.895 171.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.454 ' HD1' ' HB3' ' A' ' 249' ' ' ASN . 34.4 m-85 -83.21 -11.24 58.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.677 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -96.31 45.23 1.07 Allowed 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -175.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 4.1 mmpm? 60.74 28.76 18.48 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 -168.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' THR . . . . . 0.87 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 26.8 p 62.17 80.72 0.22 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.906 -178.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.513 ' HB1' ' CE2' ' A' ' 286' ' ' PHE . . . -117.03 156.99 26.57 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.619 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 1.024 ' HB3' HD13 ' A' ' 258' ' ' LEU . 4.5 mm? -79.1 120.32 23.47 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.389 -176.056 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.993 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -76.3 84.01 3.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.347 0.594 . . . . 0.0 110.867 172.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 1.024 HD13 ' HB3' ' A' ' 256' ' ' LEU . 2.4 mp -119.71 175.39 5.89 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.374 -176.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.554 ' O ' ' HB ' ' A' ' 242' ' ' VAL . 24.9 tt0 -146.17 174.61 11.17 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.403 ' N ' ' CG ' ' A' ' 259' ' ' GLU . 7.2 p -58.28 124.1 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.681 0.753 . . . . 0.0 111.825 173.338 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 97.9 1.5 58.54 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.192 175.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.572 ' O ' ' HD3' ' A' ' 241' ' ' ARG . 6.6 mt-10 -87.32 -174.21 4.74 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -171.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.958 HD21 ' HB3' ' A' ' 239' ' ' TYR . 3.4 tm? -140.62 131.18 25.47 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.563 -177.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.79 ' HB ' HD21 ' A' ' 258' ' ' LEU . 4.1 p -126.62 125.68 67.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.247 175.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -90.49 95.51 10.2 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.337 0.589 . . . . 0.0 109.45 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.864 ' HB ' HD13 ' A' ' 238' ' ' ILE . 48.4 t -77.84 118.21 24.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.476 -176.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 41.1 p -93.74 -12.72 28.55 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.856 -1.066 . . . . 0.0 111.593 -176.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.562 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 17.4 tppt? -119.65 104.37 10.21 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.356 174.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.534 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.8 OUTLIER -105.99 159.64 5.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -172.31 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.594 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 3.9 p30 -145.2 -166.41 2.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.658 -177.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 9.8 p -103.82 -18.01 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.883 -177.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.4 m -83.62 -45.34 13.58 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.122 -0.361 . . . . 0.0 111.263 -177.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' GLY . . . . . 0.483 ' HA3' ' CD1' ' A' ' 288' ' ' PHE . . . 124.57 -7.84 8.36 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.249 -175.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.445 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.6 OUTLIER -95.12 103.21 15.06 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 173.849 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.691 ' HZ2' HD13 ' A' ' 293' ' ' LEU . 0.0 OUTLIER -127.35 177.79 6.48 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.726 -174.213 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.736 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 46.5 mt-10 -99.08 125.12 44.52 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.142 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.576 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -108.8 154.0 16.63 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.448 -0.797 . . . . 0.0 112.636 -169.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.566 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 0.2 OUTLIER -133.3 117.43 17.34 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 172.044 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 279' ' ' CYS . . . . . 0.711 ' SG ' ' HD2' ' A' ' 282' ' ' LYS . 27.4 p -109.45 98.16 7.6 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.311 -176.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 39.65 55.81 2.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.429 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 117.09 -39.94 2.52 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.78 -0.645 . . . . 0.0 114.054 176.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 282' ' ' LYS . . . . . 0.711 ' HD2' ' SG ' ' A' ' 279' ' ' CYS . 20.1 mttp -86.33 132.55 33.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 117.919 0.86 . . . . 0.0 111.287 -174.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -106.11 150.19 26.04 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.964 0.412 . . . . 0.0 111.833 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 175.52 -147.92 9.12 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.002 171.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 285' ' ' HIS . . . . . 0.736 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 42.8 p-80 -147.62 151.38 36.12 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.705 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 0.9 OUTLIER -166.76 154.6 9.01 Favored Pre-proline 0 N--CA 1.469 0.478 0 CA-C-O 120.695 0.283 . . . . 0.0 111.492 -177.54 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.491 ' HD2' ' HD1' ' A' ' 286' ' ' PHE . 9.3 Cg_endo -90.19 163.03 4.7 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 124.049 3.166 . . . . 0.0 112.972 -177.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.542 ' HA ' HG22 ' A' ' 291' ' ' VAL . 18.4 p90 -87.8 -18.77 28.6 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -172.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 7.5 t -66.77 -4.23 8.62 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -169.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 290' ' ' HIS . . . . . 1.07 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 0.8 OUTLIER -130.59 33.86 4.21 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.245 173.143 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.918 HG12 ' HA ' ' A' ' 242' ' ' VAL . 26.8 m -145.03 167.34 10.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.483 173.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -123.05 109.12 13.68 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' LEU . . . . . 0.691 HD13 ' HZ2' ' A' ' 275' ' ' TRP . 0.1 OUTLIER -91.99 128.81 37.97 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.635 -0.826 . . . . 0.0 112.862 -165.6 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.451 HD23 ' N ' ' A' ' 294' ' ' LEU . 4.4 mt -84.82 135.57 34.04 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 169.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.527 ' OD1' ' HG2' ' A' ' 297' ' ' GLN . 7.1 t70 -76.29 149.66 37.06 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.665 0.745 . . . . 0.0 111.447 -166.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 1.013 ' HB3' HG22 ' A' ' 238' ' ' ILE . 10.0 pt20 -75.46 2.03 12.55 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.371 -177.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 297' ' ' GLN . . . . . 0.527 ' HG2' ' OD1' ' A' ' 295' ' ' ASP . 88.9 mm-40 -64.07 -23.57 67.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.38 170.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 42.2 t30 . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.234 176.742 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 236' ' ' GLY . . . . . 0.462 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . . . . . . 0 N--CA 1.447 -0.594 0 N-CA-C 111.73 -0.548 . . . . 0.0 111.73 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.554 ' HG2' ' HE2' ' A' ' 265' ' ' LYS . 1.2 Cg_endo -84.96 148.13 10.64 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 123.383 2.722 . . . . 0.0 113.009 -177.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.991 HG22 ' HB3' ' A' ' 296' ' ' GLN . 0.2 OUTLIER -107.53 163.32 5.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 175.405 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.799 ' HB3' HD21 ' A' ' 263' ' ' LEU . 69.8 m-85 -101.86 120.75 40.89 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 174.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.76 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -113.93 117.18 30.64 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.461 0.648 . . . . 0.0 110.234 -177.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.508 ' NH1' ' HA2' ' A' ' 261' ' ' GLY . 0.6 OUTLIER -84.17 107.26 16.38 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.682 -176.046 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.76 ' HA ' HG12 ' A' ' 291' ' ' VAL . 3.9 t -69.6 131.74 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.122 -177.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.48 ' O ' HG22 ' A' ' 260' ' ' VAL . 2.8 pp -121.94 -0.52 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.015 175.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.649 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 6.7 tp-100 -178.1 95.69 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.685 -175.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.646 ' HB3' ' O ' ' A' ' 258' ' ' LEU . 0.9 OUTLIER -146.29 162.88 37.14 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.158 0.504 . . . . 0.0 110.261 177.248 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.877 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 12.1 ttt180 -95.43 179.64 5.09 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.35 -174.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.453 ' N ' ' CG ' ' A' ' 246' ' ' ARG . 8.9 m -106.36 69.68 0.23 Allowed Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 121.893 0.854 . . . . 0.0 110.805 173.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.923 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 11.6 Cg_endo -95.62 131.71 0.49 Allowed 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 125.146 3.897 . . . . 0.0 111.376 -178.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -92.39 178.26 5.88 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.58 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.641 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -59.85 -8.13 2.03 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.388 0.613 . . . . 0.0 110.999 174.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -92.14 -8.08 46.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.198 0.523 . . . . 0.0 110.118 177.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -104.67 66.85 0.8 Allowed 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.645 -174.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.97 23.66 13.78 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.179 -172.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' THR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 34.8 p 52.81 65.33 1.55 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.888 -177.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.732 ' HB1' ' CE2' ' A' ' 286' ' ' PHE . . . -109.53 158.32 18.12 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.429 -175.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.688 HD22 ' CA ' ' A' ' 284' ' ' GLY . 1.7 mm? -67.37 128.37 36.16 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.869 176.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.923 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -92.6 98.08 11.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.442 0.639 . . . . 0.0 110.311 173.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.646 ' O ' ' HB3' ' A' ' 245' ' ' LYS . 0.2 OUTLIER -160.06 164.48 33.09 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.881 -173.743 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.504 ' O ' ' HG3' ' A' ' 262' ' ' GLU . 12.0 pt-20 -143.47 -167.52 2.59 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.975 -0.453 . . . . 0.0 111.888 -172.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 243' ' ' ILE . 62.8 t -54.49 123.22 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.508 ' HA2' ' NH1' ' A' ' 241' ' ' ARG . . . 102.04 -1.04 51.24 Favored Glycine 0 CA--C 1.509 -0.331 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.699 170.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 259' ' ' GLU . 8.3 mt-10 -86.57 -174.83 5.19 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -168.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.799 HD21 ' HB3' ' A' ' 239' ' ' TYR . 3.4 tm? -140.0 128.28 22.55 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.634 177.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.76 HG13 ' HB3' ' A' ' 240' ' ' ALA . 2.6 p -127.17 115.54 41.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.297 177.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.554 ' HE2' ' HG2' ' A' ' 237' ' ' PRO . 86.9 tttt -89.61 100.75 13.49 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.658 ' HA ' ' HA2' ' A' ' 277' ' ' GLY . 0.8 OUTLIER -83.09 137.16 21.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.897 -175.968 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 23.2 p -99.34 -8.3 25.05 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.704 -176.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.442 ' HA ' ' HD3' ' A' ' 268' ' ' LYS . 14.0 tppt? -126.51 107.44 10.24 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.052 173.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.728 HG21 HG23 ' A' ' 238' ' ' ILE . 0.9 OUTLIER -105.04 163.26 4.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -170.76 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.514 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 4.3 p30 -143.3 -172.53 3.72 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.225 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 26.0 m -103.03 -5.91 9.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -175.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 5.5 m -100.99 -44.85 5.6 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.481 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' GLY . . . . . 0.482 ' HA3' ' CD1' ' A' ' 288' ' ' PHE . . . 133.18 -1.81 4.6 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.289 -0.958 . . . . 0.0 113.513 -178.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.7 OUTLIER -95.99 102.08 13.83 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 118.003 0.901 . . . . 0.0 109.274 174.463 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.87 ' HZ2' ' HG ' ' A' ' 293' ' ' LEU . 0.0 OUTLIER -128.24 173.27 10.28 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -173.582 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.517 ' O ' ' HB ' ' A' ' 266' ' ' VAL . 45.1 tt0 -96.34 125.16 40.65 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 171.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.658 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -114.97 165.47 12.07 Favored Glycine 0 N--CA 1.439 -1.132 0 CA-C-N 115.466 -0.788 . . . . 0.0 113.15 -166.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 22.4 tt0 -139.04 118.86 13.19 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 171.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 279' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 282' ' ' LYS . 21.8 p -99.93 96.3 7.46 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 119.474 -0.891 . . . . 0.0 108.904 176.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 62.6 m-20 41.59 52.69 3.9 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.935 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 115.18 -28.62 7.84 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.548 -0.834 . . . . 0.0 114.691 175.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' LYS . . . . . 0.641 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 10.0 mptt -91.63 134.21 34.89 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.105 0.952 . . . . 0.0 110.428 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 283' ' ' ARG . . . . . 0.411 ' N ' ' HD2' ' A' ' 283' ' ' ARG . 3.5 mpt_? -106.27 157.76 17.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.953 0.406 . . . . 0.0 111.301 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 284' ' ' GLY . . . . . 0.688 ' CA ' HD22 ' A' ' 256' ' ' LEU . . . 175.37 -172.97 45.96 Favored Glycine 0 C--O 1.224 -0.499 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -177.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 285' ' ' HIS . . . . . 0.463 ' H ' ' HA ' ' A' ' 255' ' ' ALA . 12.3 p80 -146.85 143.6 28.69 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 118.674 1.237 . . . . 0.0 111.782 171.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.732 ' CE2' ' HB1' ' A' ' 255' ' ' ALA . 5.8 m-85 -156.3 163.04 26.22 Favored Pre-proline 0 N--CA 1.464 0.264 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.429 -174.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 24.1 Cg_endo -92.57 167.09 2.76 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.178 2.585 . . . . 0.0 112.06 175.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.482 ' CD1' ' HA3' ' A' ' 273' ' ' GLY . 39.7 p90 -85.18 -8.02 58.78 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -172.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 6.3 t -56.33 -13.19 2.01 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -174.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 290' ' ' HIS . . . . . 0.649 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 0.1 OUTLIER -138.94 33.56 2.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.928 0.394 . . . . 0.0 111.89 -178.259 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.76 HG12 ' HA ' ' A' ' 242' ' ' VAL . 15.5 m -146.74 162.08 9.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.348 176.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -117.79 106.37 12.95 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 176.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' LEU . . . . . 0.87 ' HG ' ' HZ2' ' A' ' 275' ' ' TRP . 0.0 OUTLIER -104.55 128.66 52.57 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 119.622 -0.831 . . . . 0.0 113.223 -169.363 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.663 ' O ' ' HB ' ' A' ' 238' ' ' ILE . 4.8 mp -84.7 125.0 32.14 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 168.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.553 ' HB3' ' HG2' ' A' ' 297' ' ' GLN . 33.8 t70 -84.72 153.47 23.05 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.497 -164.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.991 ' HB3' HG22 ' A' ' 238' ' ' ILE . 0.0 OUTLIER -76.57 11.89 1.47 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.1 -176.27 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 297' ' ' GLN . . . . . 0.553 ' HG2' ' HB3' ' A' ' 295' ' ' ASP . 9.3 pt20 -58.45 -35.52 72.26 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 163.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 298' ' ' ASN . . . . . 0.448 ' N ' ' HG3' ' A' ' 297' ' ' GLN . 7.8 t30 . . . . . 0 N--CA 1.451 -0.4 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.706 174.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.972 0 CA-C-O 120.904 0.169 . . . . 0.0 113.199 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.43 ' HB3' ' HA ' ' A' ' 267' ' ' THR . 11.3 Cg_exo -71.23 120.57 7.09 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.49 2.127 . . . . 0.0 110.171 171.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 1.011 HG22 ' HB3' ' A' ' 296' ' ' GLN . 0.2 OUTLIER -80.43 158.21 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.115 -171.045 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.711 ' HD1' HD11 ' A' ' 263' ' ' LEU . 83.1 m-85 -99.43 118.33 35.8 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 174.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 293' ' ' LEU . . . -114.78 115.74 27.51 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -175.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -79.93 101.88 8.86 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 176.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.852 HG21 ' HD3' ' A' ' 245' ' ' LYS . 7.6 p -81.95 119.11 30.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.324 -175.09 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.8 pp -98.71 3.7 10.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.411 -174.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.543 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 51.4 tt0 -177.28 106.0 0.06 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.446 -175.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.852 ' HD3' HG21 ' A' ' 242' ' ' VAL . 0.2 OUTLIER -146.93 166.0 28.09 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.344 0.593 . . . . 0.0 110.903 174.446 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.822 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 5.7 ptt180 -104.7 -178.8 3.76 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.135 -0.938 . . . . 0.0 108.602 -177.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 4.7 m -104.22 76.95 0.28 Allowed Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 121.227 0.537 . . . . 0.0 112.357 176.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 1.012 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 3.3 Cg_exo -83.31 177.43 6.51 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.274 3.316 . . . . 0.0 110.6 174.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -139.49 176.99 8.26 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.054 -178.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.937 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -63.6 -5.06 3.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.634 0.73 . . . . 0.0 110.567 170.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -90.2 -11.01 42.32 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.772 176.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -105.95 60.21 0.66 Allowed 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.557 -173.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' LYS . . . . . 0.5 ' N ' ' HD2' ' A' ' 253' ' ' LYS . 7.2 mptt 56.28 31.56 18.74 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -170.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' THR . . . . . 0.937 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 74.3 p 53.14 53.06 12.5 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 114.174 -1.375 . . . . 0.0 112.547 -177.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.436 ' HA ' ' H ' ' A' ' 285' ' ' HIS . . . -90.07 161.4 15.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.046 0.45 . . . . 0.0 110.709 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.687 ' N ' ' HA3' ' A' ' 284' ' ' GLY . 0.2 OUTLIER -78.89 132.67 36.86 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.745 -173.99 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.012 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -91.27 100.75 13.5 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 172.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.802 HD11 ' HE2' ' A' ' 245' ' ' LYS . 0.7 OUTLIER -150.26 171.25 17.25 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.493 -174.59 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -143.59 170.31 16.08 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.188 -163.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 2.5 p -53.81 118.74 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 121.528 0.68 . . . . 0.0 111.724 173.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 106.45 -1.67 37.05 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.011 171.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -89.04 176.21 7.08 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.079 -174.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.711 HD11 ' HD1' ' A' ' 239' ' ' TYR . 3.0 tm? -126.7 130.47 50.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.227 0.536 . . . . 0.0 110.132 -178.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.437 HG22 HD12 ' A' ' 258' ' ' LEU . 2.2 t -111.44 145.09 18.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.604 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 238' ' ' ILE . 62.3 tttp -120.68 95.12 4.59 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 170.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.735 ' HB ' ' HA2' ' A' ' 277' ' ' GLY . 1.4 m -84.71 124.42 39.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.723 -173.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 267' ' ' THR . . . . . 0.43 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 40.4 p -88.36 -9.49 52.56 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.868 -174.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.503 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 4.4 tppp? -116.92 103.62 10.47 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.586 HG21 HG23 ' A' ' 238' ' ' ILE . 0.7 OUTLIER -102.61 154.41 5.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.85 -172.816 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.536 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 4.2 p30 -144.23 -170.81 3.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.774 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 12.0 p -95.67 -33.87 4.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.916 -178.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 10.8 m -74.07 -43.02 59.22 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -173.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 123.88 -5.7 9.03 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.163 -177.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.705 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.6 OUTLIER -94.53 104.71 16.66 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 173.535 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.588 ' HZ2' HD13 ' A' ' 293' ' ' LEU . 0.0 OUTLIER -129.71 -179.76 5.37 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.598 0.713 . . . . 0.0 112.055 -173.684 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.503 ' HB2' ' HB3' ' A' ' 268' ' ' LYS . 32.2 mt-10 -102.42 123.87 46.98 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 173.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.735 ' HA2' ' HB ' ' A' ' 266' ' ' VAL . . . -109.09 153.39 16.84 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.905 -165.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.589 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 29.7 tt0 -135.42 118.88 16.85 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 174.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 47.9 t -99.3 96.38 7.7 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 38.4 55.93 1.8 Allowed 'General case' 0 CA--C 1.533 0.323 0 O-C-N 124.362 1.039 . . . . 0.0 112.023 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 115.91 -40.26 2.48 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 120.433 -0.889 . . . . 0.0 114.091 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' LYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 0.8 OUTLIER -80.05 136.82 36.66 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.969 0.884 . . . . 0.0 110.241 179.788 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 283' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 283' ' ' ARG . 5.6 mpt_? -113.12 131.23 55.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.643 0.735 . . . . 0.0 112.031 178.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 284' ' ' GLY . . . . . 0.687 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . -147.51 -166.96 12.89 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 114.282 -1.326 . . . . 0.0 111.651 174.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 285' ' ' HIS . . . . . 0.436 ' H ' ' HA ' ' A' ' 255' ' ' ALA . 5.6 m-70 -145.91 139.89 26.58 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 117.684 0.742 . . . . 0.0 109.427 178.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.724 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 10.4 m-85 -167.99 157.2 8.69 Favored Pre-proline 0 N--CA 1.471 0.603 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -172.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.705 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 58.7 Cg_endo -95.34 176.39 0.9 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.709 2.939 . . . . 0.0 113.457 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.494 ' HA ' HG22 ' A' ' 291' ' ' VAL . 24.1 p90 -86.07 -9.74 56.2 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.106 -173.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 11.1 t -70.26 8.26 0.82 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -168.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 290' ' ' HIS . . . . . 0.543 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 0.9 OUTLIER -155.77 38.21 0.37 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.091 0.472 . . . . 0.0 110.95 177.517 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 242' ' ' VAL . 27.6 m -144.67 157.76 14.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.014 0.435 . . . . 0.0 111.112 178.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -115.88 108.84 16.8 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 170.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' LEU . . . . . 0.588 HD13 ' HZ2' ' A' ' 275' ' ' TRP . 0.2 OUTLIER -102.98 123.65 46.98 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -165.727 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.468 ' H ' HD12 ' A' ' 294' ' ' LEU . 4.6 mp -82.38 125.31 30.89 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.092 167.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -77.63 160.07 28.77 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.922 0.867 . . . . 0.0 111.728 -166.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 1.011 ' HB3' HG22 ' A' ' 238' ' ' ILE . 19.5 pt20 -75.5 -15.42 60.4 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.07 -1.423 . . . . 0.0 111.499 -176.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -84.1 -8.8 59.0 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.116 175.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 37.8 m-20 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.748 174.084 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 236' ' ' GLY . . . . . 0.459 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . . . . . . 0 N--CA 1.446 -0.687 0 N-CA-C 113.463 0.145 . . . . 0.0 113.463 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.459 ' HD3' ' HA2' ' A' ' 236' ' ' GLY . 26.4 Cg_exo -68.06 145.66 68.07 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.859 3.04 . . . . 0.0 112.593 174.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 1.044 HG12 HG22 ' A' ' 266' ' ' VAL . 1.3 pt -91.75 167.98 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.727 173.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.776 ' HB3' HD11 ' A' ' 263' ' ' LEU . 61.5 m-85 -116.35 119.66 36.39 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 169.082 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.626 ' HA ' ' HA ' ' A' ' 293' ' ' LEU . . . -113.21 117.66 32.52 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.944 -175.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.495 ' HD3' ' O ' ' A' ' 262' ' ' GLU . 16.3 tpp180 -82.45 102.91 11.62 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.416 175.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.906 HG21 ' HD2' ' A' ' 245' ' ' LYS . 2.6 p -87.26 135.15 25.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.512 -173.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.8 pp -109.61 9.1 8.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.787 -175.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.823 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 58.2 tt0 -176.92 95.24 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.723 0.297 . . . . 0.0 110.26 -173.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.906 ' HD2' HG21 ' A' ' 242' ' ' VAL . 4.3 mttt -146.29 161.72 39.68 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 175.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.878 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 5.8 ptp180 -106.62 -178.07 3.54 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -177.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 32.0 t -103.3 80.37 0.36 Allowed Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 120.955 0.407 . . . . 0.0 111.262 176.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.962 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 3.1 Cg_endo -91.45 177.67 1.87 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 125.161 3.907 . . . . 0.0 111.184 175.007 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -130.29 174.94 9.35 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 175.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.788 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -72.22 5.12 3.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.417 0.627 . . . . 0.0 110.332 175.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -99.2 -2.62 36.28 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.216 174.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.422 ' C ' ' HD2' ' A' ' 253' ' ' LYS . 35.6 m-20 -105.15 63.72 0.7 Allowed 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.464 -177.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 253' ' ' LYS . . . . . 0.422 ' HD2' ' C ' ' A' ' 252' ' ' ASP . 7.0 mptt 57.58 25.62 11.83 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -171.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 254' ' ' THR . . . . . 0.788 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 44.9 p 56.06 75.86 0.32 Allowed 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.823 -174.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -113.77 150.3 33.62 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.253 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.463 ' O ' ' HE2' ' A' ' 286' ' ' PHE . 0.0 OUTLIER -72.84 132.92 44.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.611 -176.163 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.962 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -95.12 104.27 16.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.371 0.605 . . . . 0.0 111.479 174.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.692 ' HG ' ' HD3' ' A' ' 245' ' ' LYS . 0.4 OUTLIER -163.81 175.5 10.41 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.54 -176.344 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -142.45 -166.42 2.26 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 121.591 -0.693 . . . . 0.0 112.383 -171.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 2.8 p -68.51 122.01 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.295 177.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 104.18 -0.75 43.96 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.284 174.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.495 ' O ' ' HD3' ' A' ' 241' ' ' ARG . 9.4 mt-10 -98.73 -174.72 2.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.842 0.353 . . . . 0.0 111.666 -170.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.776 HD11 ' HB3' ' A' ' 239' ' ' TYR . 50.7 tp -133.74 160.27 38.09 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.508 -177.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.498 ' N ' ' HG ' ' A' ' 263' ' ' LEU . 2.8 p -153.48 136.91 7.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.389 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.485 ' HE2' ' CE1' ' A' ' 239' ' ' TYR . 37.9 ttmt -99.98 102.1 13.38 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 175.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 1.044 HG22 HG12 ' A' ' 238' ' ' ILE . 4.0 m -86.79 115.68 28.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.97 0.89 . . . . 0.0 110.71 -178.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 9.9 t -99.95 4.08 44.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.596 -1.183 . . . . 0.0 110.394 -177.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 0.0 OUTLIER -124.94 107.19 10.6 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 168.128 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.579 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.8 OUTLIER -110.49 158.22 10.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 115.286 -0.87 . . . . 0.0 113.113 -172.098 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.769 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 2.6 p30 -146.34 -172.98 4.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.698 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 11.6 p -93.39 -31.92 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 45.7 m -74.99 -43.44 53.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -173.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 273' ' ' GLY . . . . . 0.777 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 125.04 -13.51 7.55 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.499 -178.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.569 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.6 OUTLIER -89.23 93.09 9.44 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 173.285 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.769 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -123.05 179.09 4.79 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.183 -176.204 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 268' ' ' LYS . 53.4 tt0 -104.32 125.77 50.85 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.723 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -110.2 169.68 13.69 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.95 -172.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 3.1 tm-20 -152.32 119.45 5.87 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 171.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 44.6 t -115.63 99.55 7.42 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.084 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 43.3 54.33 5.16 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 124.252 0.97 . . . . 0.0 112.313 173.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 117.73 -40.45 2.33 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-N 115.828 -0.624 . . . . 0.0 114.102 176.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 282' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 0.0 OUTLIER -93.32 128.79 39.48 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 118.066 0.933 . . . . 0.0 109.934 -178.996 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 283' ' ' ARG . . . . . 0.622 ' HD3' ' H ' ' A' ' 283' ' ' ARG . 0.0 OUTLIER -121.2 145.47 47.8 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.266 176.28 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 173.05 157.75 15.61 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.072 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 285' ' ' HIS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 30.5 p80 -98.08 148.35 23.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.04 0.42 . . . . 0.0 112.117 -171.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.463 ' HE2' ' O ' ' A' ' 256' ' ' LEU . 5.3 m-85 -158.55 159.21 29.85 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.515 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 93.6 Cg_endo -89.36 168.28 5.14 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.206 2.604 . . . . 0.0 113.809 -177.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.777 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 19.0 t80 -76.62 -19.99 57.22 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 114.158 -1.383 . . . . 0.0 111.922 -172.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 8.9 t -61.8 -11.47 12.61 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -168.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 290' ' ' HIS . . . . . 0.823 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 0.1 OUTLIER -137.68 33.91 2.45 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.69 -0.631 . . . . 0.0 112.351 -176.359 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.5 HG23 HD23 ' A' ' 293' ' ' LEU . 34.1 m -139.93 153.11 22.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.882 0.372 . . . . 0.0 111.192 177.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -121.06 107.96 13.25 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 169.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' LEU . . . . . 0.744 HD21 ' CE2' ' A' ' 288' ' ' PHE . 0.2 OUTLIER -101.49 139.96 36.44 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -169.935 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.512 ' N ' HD12 ' A' ' 294' ' ' LEU . 4.5 mp -77.0 130.23 37.19 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 113.397 -1.729 . . . . 0.0 107.412 166.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.451 ' HB3' ' HG3' ' A' ' 297' ' ' GLN . 13.7 m-20 -77.13 144.15 38.65 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.486 -164.362 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.951 ' HB3' HG22 ' A' ' 238' ' ' ILE . 1.8 pt20 -77.15 0.47 21.54 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 113.864 -1.516 . . . . 0.0 111.233 -177.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 297' ' ' GLN . . . . . 0.451 ' HG3' ' HB3' ' A' ' 295' ' ' ASP . 0.0 OUTLIER -79.01 -16.06 57.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.062 0.458 . . . . 0.0 110.145 175.447 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 48.1 t30 . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.19 175.965 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 236' ' ' GLY . . . . . 0.417 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . . . . . . 0 N--CA 1.449 -0.458 0 N-CA-C 112.583 -0.207 . . . . 0.0 112.583 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.417 ' HD3' ' HA2' ' A' ' 236' ' ' GLY . 18.9 Cg_endo -89.03 136.45 2.97 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 123.156 2.57 . . . . 0.0 111.935 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.662 HD13 ' HB ' ' A' ' 266' ' ' VAL . 0.1 OUTLIER -97.08 152.24 4.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.391 -178.641 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.7 ' HB3' HD21 ' A' ' 263' ' ' LEU . 67.3 m-85 -96.65 119.54 35.32 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 174.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 293' ' ' LEU . . . -114.42 116.72 29.35 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.24 0.543 . . . . 0.0 110.352 -174.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -86.19 102.29 13.78 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.592 178.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.74 HG21 ' HD3' ' A' ' 245' ' ' LYS . 3.0 p -79.55 128.53 38.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.534 -175.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.721 HD12 ' HB2' ' A' ' 244' ' ' GLN . 2.8 pp -108.31 3.53 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.88 -175.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.721 ' HB2' HD12 ' A' ' 243' ' ' ILE . 4.0 mt-30 -176.29 95.67 0.05 Allowed 'General case' 0 N--CA 1.463 0.203 0 O-C-N 123.043 0.214 . . . . 0.0 111.061 -175.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.74 ' HD3' HG21 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -146.5 163.17 36.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.183 0.516 . . . . 0.0 111.164 173.663 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.869 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 9.8 ptt180 -101.27 -176.92 3.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.679 -177.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 27.3 t -101.66 82.69 0.4 Allowed Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 120.856 0.36 . . . . 0.0 111.292 175.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.98 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 7.0 Cg_endo -93.02 177.14 1.44 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.656 3.571 . . . . 0.0 110.778 172.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' ASN . . . . . 0.409 ' C ' ' H ' ' A' ' 251' ' ' TYR . 51.8 m-80 -131.04 177.26 7.58 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.026 0.441 . . . . 0.0 110.678 176.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.812 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -64.2 0.25 1.02 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.356 0.598 . . . . 0.0 110.99 173.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.409 ' H ' ' C ' ' A' ' 249' ' ' ASN . 44.4 m-85 -103.81 8.57 37.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.454 0.645 . . . . 0.0 109.696 177.097 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.74 53.19 0.73 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.162 -0.927 . . . . 0.0 108.727 176.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt 58.01 30.45 19.24 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -167.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' THR . . . . . 0.812 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 43.4 p 59.1 71.3 0.59 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.826 -176.228 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.417 ' HB1' ' CE2' ' A' ' 286' ' ' PHE . . . -111.55 150.75 29.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.65 179.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.667 ' HB3' HD22 ' A' ' 258' ' ' LEU . 0.2 OUTLIER -72.12 133.67 45.32 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.663 -174.543 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.98 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -90.57 98.92 12.06 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 172.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.73 HD21 ' HE2' ' A' ' 245' ' ' LYS . 0.9 OUTLIER -154.94 171.14 20.19 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.108 -173.735 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.454 ' O ' HG13 ' A' ' 242' ' ' VAL . 12.3 pt-20 -142.28 -166.59 2.28 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.177 0.513 . . . . 0.0 111.873 -171.159 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.575 HG22 ' HA ' ' A' ' 244' ' ' GLN . 48.2 t -68.12 117.61 10.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.124 176.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 107.13 0.86 35.74 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.132 172.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.405 ' HB2' ' CG1' ' A' ' 242' ' ' VAL . 13.4 mt-10 -93.15 179.78 5.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.188 0.518 . . . . 0.0 111.915 -173.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.7 HD21 ' HB3' ' A' ' 239' ' ' TYR . 3.0 tm? -136.89 133.57 35.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.251 -176.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.95 HG12 ' HB2' ' A' ' 279' ' ' CYS . 34.1 m -126.15 154.86 35.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.097 173.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -111.52 96.04 5.86 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.662 ' HB ' HD13 ' A' ' 238' ' ' ILE . 49.2 t -69.88 121.47 19.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.836 -174.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 40.8 p -103.51 -7.19 21.06 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.626 -176.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.596 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 0.0 OUTLIER -126.85 106.77 9.56 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 119.445 -0.902 . . . . 0.0 108.74 171.018 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.586 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.7 OUTLIER -107.65 148.66 11.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 114.451 -1.249 . . . . 0.0 113.72 -168.613 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.848 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 10.1 p30 -147.12 154.04 40.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.463 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 35.9 m -70.4 -9.71 12.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -174.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.5 m -89.75 -45.49 9.26 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.867 -178.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 119.68 -7.95 12.03 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.061 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.724 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.0 OUTLIER -93.94 70.75 4.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.484 0.659 . . . . 0.0 109.636 176.897 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.848 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -112.74 174.83 5.7 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.327 -168.814 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.691 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 32.9 tt0 -94.87 123.82 38.56 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.225 0.536 . . . . 0.0 109.796 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.6 ' HA2' HG22 ' A' ' 266' ' ' VAL . . . -100.96 150.21 18.64 Favored Glycine 0 N--CA 1.436 -1.326 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.299 -175.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.808 ' HG3' ' HG2' ' A' ' 283' ' ' ARG . 32.4 tt0 -127.8 116.85 20.81 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 279' ' ' CYS . . . . . 0.95 ' HB2' HG12 ' A' ' 264' ' ' VAL . 43.7 t -111.17 98.36 7.46 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 24.95 61.56 0.05 Allowed 'General case' 0 C--N 1.343 0.306 0 O-C-N 125.619 1.824 . . . . 0.0 113.301 174.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 118.53 -24.27 8.63 Favored Glycine 0 CA--C 1.523 0.55 0 CA-C-N 115.447 -0.797 . . . . 0.0 114.134 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.35 144.4 31.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 118.003 0.902 . . . . 0.0 110.38 175.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 283' ' ' ARG . . . . . 0.808 ' HG2' ' HG3' ' A' ' 278' ' ' GLU . 28.7 mtm180 -123.91 129.5 51.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.792 0.33 . . . . 0.0 110.188 171.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 284' ' ' GLY . . . . . 0.614 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . -165.52 140.57 6.46 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.112 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 285' ' ' HIS . . . . . 0.691 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 20.7 p80 -99.25 148.04 24.54 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 117.434 0.617 . . . . 0.0 111.696 -175.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.654 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 5.7 m-85 -161.2 164.05 19.34 Favored Pre-proline 0 C--O 1.235 0.324 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.041 -177.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.724 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 1.7 Cg_endo -85.72 158.76 10.54 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.518 2.812 . . . . 0.0 112.13 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.709 ' HB2' HD21 ' A' ' 293' ' ' LEU . 1.8 p90 -87.03 -5.95 58.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.891 -174.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.541 HG22 ' HB2' ' A' ' 287' ' ' PRO . 5.6 t -52.8 -32.73 45.48 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 290' ' ' HIS . . . . . 0.438 ' CD2' ' HD2' ' A' ' 245' ' ' LYS . 0.8 OUTLIER -121.38 43.77 2.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.35 0.595 . . . . 0.0 111.429 -177.322 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.692 HG12 ' HA ' ' A' ' 242' ' ' VAL . 19.8 m -147.46 170.11 3.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.158 173.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -131.71 109.06 9.9 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 173.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 293' ' ' LEU . . . . . 0.709 HD21 ' HB2' ' A' ' 288' ' ' PHE . 0.1 OUTLIER -113.88 133.13 55.62 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.742 0.782 . . . . 0.0 112.883 -166.379 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.456 ' H ' HD12 ' A' ' 294' ' ' LEU . 4.5 mp -86.41 125.67 33.85 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.326 -1.307 . . . . 0.0 108.075 171.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -75.96 166.75 23.05 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.282 -167.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.428 ' HB3' HG22 ' A' ' 238' ' ' ILE . 1.5 pm0 -76.74 -0.49 23.92 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.731 -176.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -89.89 -16.21 30.5 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.88 174.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.16 179.349 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.545 ' HB2' ' HD3' ' A' ' 265' ' ' LYS . 4.3 Cg_endo . . . . . 0 N--CA 1.451 -0.978 0 N-CA-C 111.554 -0.21 . . . . 0.0 111.554 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.779 ' CD1' ' HB ' ' A' ' 266' ' ' VAL . 0.2 OUTLIER -85.12 161.56 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 C-N-CA 119.219 -0.992 . . . . 0.0 109.852 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.839 ' HB3' HD21 ' A' ' 263' ' ' LEU . 44.4 m-85 -103.46 118.64 37.21 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 172.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.702 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -111.83 115.76 29.55 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.05 -174.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.514 ' HB3' ' O ' ' A' ' 292' ' ' ARG . 21.9 tpp180 -75.48 101.64 4.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 175.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.751 HG21 ' HD3' ' A' ' 245' ' ' LYS . 5.2 p -81.29 119.88 31.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 C-N-CA 120.316 -0.554 . . . . 0.0 109.991 -175.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.8 pp -102.23 9.15 8.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.629 -173.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.88 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 30.5 tt0 -176.9 95.44 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.192 -177.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.751 ' HD3' HG21 ' A' ' 242' ' ' VAL . 0.1 OUTLIER -146.48 164.22 33.22 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.839 0.828 . . . . 0.0 111.189 174.242 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.83 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 2.6 ptm180 -105.24 -175.88 2.92 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.637 -1.62 . . . . 0.0 108.767 -177.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 3.8 m -110.52 70.87 0.64 Allowed Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 121.42 0.628 . . . . 0.0 111.547 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 1.016 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 28.7 Cg_endo -95.29 123.08 0.32 Allowed 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 125.051 3.834 . . . . 0.0 111.913 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.416 ' C ' ' H ' ' A' ' 251' ' ' TYR . 40.7 m-80 -78.55 176.18 9.66 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.873 0.368 . . . . 0.0 111.038 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.705 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -62.9 -2.07 1.09 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.751 0.786 . . . . 0.0 111.349 175.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.416 ' H ' ' C ' ' A' ' 249' ' ' ASN . 12.0 m-85 -92.87 -1.93 56.32 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.998 178.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.38 47.81 1.14 Allowed 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt 59.99 30.22 19.73 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -167.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . 0.705 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 29.4 p 63.79 86.22 0.12 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 113.825 -1.534 . . . . 0.0 111.048 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.685 ' HB3' ' HB2' ' A' ' 248' ' ' PRO . . . -120.6 163.78 17.5 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.951 178.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.515 ' HB3' ' CG ' ' A' ' 258' ' ' LEU . 4.5 mm? -83.15 120.59 25.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.203 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.016 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -88.84 91.19 8.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.65 0.738 . . . . 0.0 110.303 176.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.699 ' CD2' ' HB ' ' A' ' 264' ' ' VAL . 0.2 OUTLIER -148.34 176.28 10.4 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.561 -174.645 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.501 ' HG2' ' N ' ' A' ' 260' ' ' VAL . 15.4 tt0 -142.04 167.11 22.91 Favored 'General case' 0 C--N 1.313 -1.022 0 O-C-N 121.931 -0.481 . . . . 0.0 110.931 -162.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.501 ' N ' ' HG2' ' A' ' 259' ' ' GLU . 1.6 p -57.79 117.73 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 121.41 0.624 . . . . 0.0 111.236 174.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 107.52 -2.65 34.47 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.918 176.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -95.44 -173.33 2.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.941 0.4 . . . . 0.0 111.379 -173.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.839 HD21 ' HB3' ' A' ' 239' ' ' TYR . 3.4 tm? -133.73 122.27 23.11 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.711 -174.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.702 HG13 ' HB3' ' A' ' 240' ' ' ALA . 2.5 p -113.82 125.74 71.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.077 174.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.563 ' HG3' ' CE1' ' A' ' 239' ' ' TYR . 5.2 tmmm? -96.47 96.11 8.47 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.779 ' HB ' ' CD1' ' A' ' 238' ' ' ILE . 96.6 t -71.89 114.94 11.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.084 -177.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . 0.446 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 4.7 t -93.36 -9.28 39.34 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 124.313 1.008 . . . . 0.0 111.266 -178.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.631 ' HA ' ' HE3' ' A' ' 268' ' ' LYS . 0.0 OUTLIER -127.32 103.28 7.31 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 175.399 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.449 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.8 OUTLIER -98.98 160.12 3.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -170.426 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.622 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 3.6 p30 -146.69 -169.62 3.32 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.925 178.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 8.5 p -96.65 -37.0 6.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 5.0 m -73.27 -43.02 61.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.864 0.364 . . . . 0.0 111.767 -172.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . 0.866 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 124.27 -4.79 8.87 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.828 -175.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -90.59 82.19 5.83 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 176.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.622 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -116.87 175.51 5.54 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.246 0.546 . . . . 0.0 112.054 -174.244 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.558 ' O ' HG13 ' A' ' 266' ' ' VAL . 36.0 mt-10 -102.62 124.66 48.57 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.831 177.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.614 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -108.41 153.38 16.83 Favored Glycine 0 N--CA 1.439 -1.128 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.418 -169.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.599 ' HG3' ' HG2' ' A' ' 283' ' ' ARG . 21.8 tt0 -130.74 119.8 22.87 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 173.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' CYS . . . . . 0.507 ' O ' ' HD2' ' A' ' 282' ' ' LYS . 53.7 t -116.56 96.22 5.41 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.958 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 24.38 61.31 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 O-C-N 124.914 1.384 . . . . 0.0 113.505 -177.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.79 -20.32 11.9 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.84 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . 0.507 ' HD2' ' O ' ' A' ' 279' ' ' CYS . 5.7 mptt -97.93 132.13 43.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.632 0.716 . . . . 0.0 109.749 174.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . 0.599 ' HG2' ' HG3' ' A' ' 278' ' ' GLU . 48.7 mtt180 -123.68 141.5 51.96 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 176.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 175.29 -148.79 9.73 Favored Glycine 0 C--O 1.223 -0.542 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.315 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' HIS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 12.8 p80 -149.17 145.92 27.4 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 117.37 0.585 . . . . 0.0 111.54 -177.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.617 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 4.4 m-85 -162.57 164.07 17.23 Favored Pre-proline 0 N--CA 1.47 0.546 0 C-N-CA 122.543 0.337 . . . . 0.0 111.119 -177.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.511 ' HD3' ' HD1' ' A' ' 286' ' ' PHE . 31.4 Cg_endo -95.39 168.11 1.45 Allowed 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 123.464 2.776 . . . . 0.0 114.144 -175.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.866 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 7.2 t80 -76.28 -17.71 59.33 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.748 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 35.8 p -45.61 -37.98 6.14 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -174.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . 0.88 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 0.8 OUTLIER -132.61 48.39 2.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.141 0.496 . . . . 0.0 112.32 -174.432 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 27.7 m -142.75 151.78 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.773 173.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.514 ' O ' ' HB3' ' A' ' 241' ' ' ARG . 21.2 mmt180 -128.83 109.39 11.24 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 176.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . 0.512 ' HB3' ' HA ' ' A' ' 240' ' ' ALA . 0.2 OUTLIER -116.7 144.07 44.88 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -162.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.554 ' O ' ' HB ' ' A' ' 238' ' ' ILE . 4.5 mp . . . . . 0 N--CA 1.438 -1.041 0 CA-C-N 113.461 -1.7 . . . . 0.0 108.8 169.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo . . . . . 0 N--CA 1.453 -0.889 0 CA-C-O 121.779 0.658 . . . . 0.0 111.612 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.934 HG23 ' HB ' ' A' ' 266' ' ' VAL . 0.1 OUTLIER -105.92 142.55 18.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.971 -173.26 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.708 ' HB3' HD11 ' A' ' 263' ' ' LEU . 76.7 m-85 -96.81 117.04 30.21 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 174.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.485 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -114.68 117.19 30.13 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.424 -173.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.59 ' HB3' ' O ' ' A' ' 292' ' ' ARG . 23.8 tpp180 -83.12 103.18 12.35 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.316 -177.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.984 HG21 ' HD3' ' A' ' 245' ' ' LYS . 3.7 p -81.86 128.79 38.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.258 -175.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.601 HD12 ' HB2' ' A' ' 244' ' ' GLN . 2.8 pp -107.33 7.43 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.344 -176.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.601 ' HB2' HD12 ' A' ' 243' ' ' ILE . 13.5 mt-30 -176.35 95.43 0.05 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.522 -173.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.984 ' HD3' HG21 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -146.09 163.32 35.68 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.118 0.485 . . . . 0.0 110.353 173.044 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.857 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 12.6 ptp180 -104.3 -177.08 3.26 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.344 -177.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 6.9 m -104.21 80.23 0.43 Allowed Pre-proline 0 CA--C 1.54 0.57 0 CA-C-O 121.522 0.677 . . . . 0.0 111.828 175.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.922 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 9.1 Cg_endo -92.93 176.67 1.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 125.167 3.911 . . . . 0.0 111.545 176.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -126.85 175.47 8.01 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.602 ' O ' HG22 ' A' ' 254' ' ' THR . . . -68.03 -0.99 5.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.4 175.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -114.93 14.83 17.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.431 0.634 . . . . 0.0 110.011 173.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -104.56 56.54 0.71 Allowed 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 173.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . 0.504 ' HE2' ' HA ' ' A' ' 253' ' ' LYS . 11.1 mmpt? 65.63 22.62 11.67 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.813 -169.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . 0.602 HG22 ' O ' ' A' ' 250' ' ' ALA . 29.1 p 59.26 75.54 0.4 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.488 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.679 ' HB1' ' CE2' ' A' ' 286' ' ' PHE . . . -125.32 159.06 32.67 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.163 -176.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.591 HD21 ' O ' ' A' ' 277' ' ' GLY . 4.6 mm? -78.99 124.84 28.65 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.074 -0.967 . . . . 0.0 112.598 -176.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.922 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -83.03 93.17 7.52 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.338 0.589 . . . . 0.0 110.72 172.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.609 HD11 ' HE2' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -156.97 171.95 19.55 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.992 -1.003 . . . . 0.0 109.486 -177.508 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.413 ' O ' HG13 ' A' ' 242' ' ' VAL . 11.9 pt-20 -141.38 -163.87 1.65 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 118.488 0.586 . . . . 0.0 112.018 -167.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 244' ' ' GLN . 75.3 t -67.08 118.27 10.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.024 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 105.69 -2.18 39.15 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.606 171.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.536 ' O ' ' HD3' ' A' ' 241' ' ' ARG . 7.9 mt-10 -91.85 -179.46 5.32 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.824 0.345 . . . . 0.0 110.92 -172.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.708 HD11 ' HB3' ' A' ' 239' ' ' TYR . 41.1 tp -129.22 161.06 31.03 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.981 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.542 ' N ' ' HG ' ' A' ' 263' ' ' LEU . 2.4 p -151.15 132.31 4.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.944 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -93.19 97.98 10.99 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 177.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.934 ' HB ' HG23 ' A' ' 238' ' ' ILE . 97.8 t -69.8 119.3 15.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.498 -178.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 73.7 p -102.2 -25.57 13.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.751 -175.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.523 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 2.4 tppp? -108.56 106.04 15.94 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 173.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.769 HD13 ' H ' ' A' ' 269' ' ' ILE . 0.1 OUTLIER -109.77 148.07 13.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -167.022 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.772 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 1.9 p30 -135.85 -170.76 2.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.688 176.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.07 -21.25 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 120.54 -0.464 . . . . 0.0 112.082 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.4 m -79.2 -44.26 22.23 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -174.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 126.02 -11.3 7.35 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.411 -177.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.529 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.0 OUTLIER -91.33 107.79 19.45 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 174.196 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.772 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -147.72 -179.87 7.2 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -173.004 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.631 ' HG2' ' HB3' ' A' ' 285' ' ' HIS . 35.0 mt-10 -97.29 126.05 42.27 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.148 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.591 ' O ' HD21 ' A' ' 256' ' ' LEU . . . -110.68 156.42 15.57 Favored Glycine 0 N--CA 1.437 -1.242 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.717 -173.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 33.7 tt0 -135.21 119.69 18.03 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 172.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 45.6 t -109.72 97.1 6.71 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.922 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 34.4 56.52 0.67 Allowed 'General case' 0 N--CA 1.464 0.263 0 O-C-N 124.873 1.358 . . . . 0.0 112.479 176.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.36 -34.63 4.59 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.881 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 49.5 mttt -82.15 129.7 34.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.954 0.877 . . . . 0.0 110.874 178.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -113.07 148.29 35.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.026 0.441 . . . . 0.0 111.502 176.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 166.38 -150.42 17.59 Favored Glycine 0 C--O 1.225 -0.459 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.554 174.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' HIS . . . . . 0.631 ' HB3' ' HG2' ' A' ' 276' ' ' GLU . 30.1 p80 -149.74 157.22 43.01 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.59 0.695 . . . . 0.0 111.68 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.711 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 2.4 m-85 -163.3 158.78 18.0 Favored Pre-proline 0 C--N 1.331 -0.227 0 O-C-N 123.563 0.54 . . . . 0.0 110.479 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.529 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 10.7 Cg_endo -89.09 158.92 5.78 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.187 2.591 . . . . 0.0 111.938 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -83.97 -5.26 59.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.562 -176.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 11.1 t -54.83 -13.06 0.92 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . 0.548 ' NE2' ' HD2' ' A' ' 245' ' ' LYS . 0.6 OUTLIER -137.71 47.0 2.07 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.113 -0.367 . . . . 0.0 111.564 -179.635 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.769 HG12 ' HA ' ' A' ' 242' ' ' VAL . 35.6 m -147.36 170.26 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.39 0.614 . . . . 0.0 111.61 177.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.59 ' O ' ' HB3' ' A' ' 241' ' ' ARG . 16.3 tpp180 -129.35 110.16 11.69 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 171.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . 0.505 ' HB3' HD11 ' A' ' 238' ' ' ILE . 2.9 mt -91.31 140.64 29.59 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -163.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.422 ' N ' HD12 ' A' ' 294' ' ' LEU . 3.9 mp . . . . . 0 N--CA 1.445 -0.69 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 163.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.751 ' HB3' ' HA ' ' A' ' 267' ' ' THR . 4.2 Cg_exo . . . . . 0 CA--C 1.532 0.394 0 N-CA-C 113.271 0.45 . . . . 0.0 113.271 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.726 HD13 ' HB ' ' A' ' 266' ' ' VAL . 0.1 OUTLIER -84.07 151.55 3.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 120.996 0.427 . . . . 0.0 111.095 -170.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.49 ' HB3' HD11 ' A' ' 263' ' ' LEU . 57.6 m-85 -103.96 119.62 39.32 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 175.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.643 ' HA ' ' HA ' ' A' ' 293' ' ' LEU . . . -113.46 118.33 34.21 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.336 0.589 . . . . 0.0 111.154 -171.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.42 ' HB3' ' O ' ' A' ' 292' ' ' ARG . 20.9 tpp180 -78.0 102.34 7.34 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.637 176.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.647 HG21 ' HB2' ' A' ' 245' ' ' LYS . 3.2 p -80.94 124.96 39.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.609 -176.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.567 HD12 ' HB2' ' A' ' 244' ' ' GLN . 2.8 pp -105.44 8.58 9.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.588 -174.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.797 ' HA ' HG22 ' A' ' 260' ' ' VAL . 17.1 mt-30 -176.17 95.39 0.06 Allowed 'General case' 0 CA--C 1.515 -0.369 0 O-C-N 123.296 0.372 . . . . 0.0 110.347 -173.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.762 ' HG2' ' CD1' ' A' ' 258' ' ' LEU . 0.0 OUTLIER -146.72 163.56 35.55 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.603 0.716 . . . . 0.0 111.663 176.298 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.905 ' HG3' ' HG3' ' A' ' 248' ' ' PRO . 2.4 ptm180 -108.5 -173.3 2.24 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.175 -1.375 . . . . 0.0 109.303 -176.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 37.7 t -108.39 75.67 0.6 Allowed Pre-proline 0 CA--C 1.537 0.443 0 CA-C-O 121.523 0.678 . . . . 0.0 110.175 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.955 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 9.6 Cg_endo -95.0 132.45 0.57 Allowed 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 125.187 3.924 . . . . 0.0 111.768 178.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.41 ' O ' ' HB2' ' A' ' 252' ' ' ASP . 3.6 m-20 -89.53 175.81 7.14 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.772 0.32 . . . . 0.0 110.423 -176.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -71.12 4.02 3.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.608 0.718 . . . . 0.0 110.669 177.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -107.04 8.95 30.63 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.097 176.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 249' ' ' ASN . 0.7 OUTLIER -96.88 51.97 1.16 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.005 175.274 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.93 25.7 14.89 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -166.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 22.4 p 65.61 88.08 0.11 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.819 1.248 . . . . 0.0 110.0 -174.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.748 ' HB3' ' HB2' ' A' ' 248' ' ' PRO . . . -122.0 168.32 12.06 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.066 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.747 ' H ' ' HE2' ' A' ' 286' ' ' PHE . 4.3 mm? -94.86 118.44 31.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.526 -176.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.955 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -85.64 97.26 10.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.54 0.686 . . . . 0.0 110.115 176.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.762 ' CD1' ' HG2' ' A' ' 245' ' ' LYS . 0.2 OUTLIER -156.12 176.42 12.69 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.49 -174.471 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.564 ' HG2' ' N ' ' A' ' 260' ' ' VAL . 24.5 tt0 -142.67 173.79 11.23 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.584 -0.698 . . . . 0.0 111.705 -161.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.797 HG22 ' HA ' ' A' ' 244' ' ' GLN . 69.5 t -56.35 118.2 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 C-N-CA 123.241 0.616 . . . . 0.0 111.443 173.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 104.83 -2.38 41.64 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.805 173.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.442 ' OE2' ' HB3' ' A' ' 259' ' ' GLU . 14.4 mt-10 -97.14 -173.16 2.6 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.023 -174.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.49 HD11 ' HB3' ' A' ' 239' ' ' TYR . 12.4 tp -127.83 157.77 39.55 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.039 0.447 . . . . 0.0 110.685 -176.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.563 HG12 ' HB3' ' A' ' 240' ' ' ALA . 7.7 p -144.09 143.41 23.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 175.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -103.87 95.24 5.88 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.726 ' HB ' HD13 ' A' ' 238' ' ' ILE . 74.8 t -74.39 105.64 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-O 121.94 0.876 . . . . 0.0 110.566 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . 0.751 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 5.3 t -93.93 -9.34 37.4 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 113.264 -1.789 . . . . 0.0 110.678 -174.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.552 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 14.8 tppt? -122.53 106.18 10.78 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 172.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.531 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.7 OUTLIER -106.78 153.21 8.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -166.66 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.802 HD22 ' HB3' ' A' ' 275' ' ' TRP . 2.0 p30 -147.14 177.01 9.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.057 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 9.7 p -89.91 -23.39 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -176.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.63 -1.05 51.02 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -175.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . 0.773 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 78.31 8.7 87.43 Favored Glycine 0 C--O 1.223 -0.532 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.983 177.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.492 ' N ' HD21 ' A' ' 270' ' ' ASN . 19.3 mm-40 -93.29 73.25 4.56 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.802 ' HB3' HD22 ' A' ' 270' ' ' ASN . 0.0 OUTLIER -124.25 -179.41 4.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.507 0.67 . . . . 0.0 112.612 -166.554 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.728 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 32.0 mt-10 -104.32 125.74 50.82 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.584 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.594 ' O ' HD21 ' A' ' 256' ' ' LEU . . . -103.51 156.1 17.82 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.25 -173.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 20.0 tt0 -138.55 118.34 13.19 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 175.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' CYS . . . . . 0.626 ' SG ' ' HD3' ' A' ' 282' ' ' LYS . 26.6 p -102.48 97.12 7.4 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.419 -0.912 . . . . 0.0 109.635 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 12.0 m120 39.45 56.69 2.21 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.438 -1.256 . . . . 0.0 112.323 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 115.92 -39.87 2.6 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.646 -0.788 . . . . 0.0 114.136 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . 0.626 ' HD3' ' SG ' ' A' ' 279' ' ' CYS . 5.9 mptt -76.58 129.16 36.03 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 118.144 0.972 . . . . 0.0 110.414 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.39 131.06 54.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.606 -176.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -167.78 -151.18 6.88 Favored Glycine 0 C--O 1.224 -0.49 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.228 174.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' HIS . . . . . 0.728 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 16.8 p80 -150.56 147.91 28.03 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 117.122 0.461 . . . . 0.0 111.187 -177.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.747 ' HE2' ' H ' ' A' ' 256' ' ' LEU . 4.5 m-85 -157.84 160.18 30.12 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 120.728 0.299 . . . . 0.0 111.69 -177.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -95.19 155.24 1.69 Allowed 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 123.342 2.694 . . . . 0.0 114.005 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.773 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 20.0 t80 -66.29 -21.39 66.27 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 114.221 -1.354 . . . . 0.0 112.514 -176.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 9.2 t -57.77 -20.73 37.33 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 -168.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . 0.569 ' HB2' ' HB2' ' A' ' 244' ' ' GLN . 1.0 OUTLIER -136.36 37.61 2.71 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.952 -0.468 . . . . 0.0 111.9 -175.181 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.408 HG23 ' CD1' ' A' ' 293' ' ' LEU . 32.8 m -141.05 151.0 19.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.253 175.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.42 ' O ' ' HB3' ' A' ' 241' ' ' ARG . 14.1 mmm180 -121.68 108.06 13.1 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 173.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . 0.643 ' HA ' ' HA ' ' A' ' 240' ' ' ALA . 0.0 OUTLIER -101.21 137.1 40.01 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -167.553 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.538 ' H ' HD12 ' A' ' 294' ' ' LEU . 4.3 mp . . . . . 0 N--CA 1.427 -1.597 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 162.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo . . . . . 0 N--CA 1.462 -0.377 0 CA-C-O 120.828 0.262 . . . . 0.0 111.856 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 1.041 HG23 ' HB ' ' A' ' 266' ' ' VAL . 0.0 OUTLIER -91.79 131.04 39.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.951 -177.469 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.421 ' HB2' ' HB2' ' A' ' 294' ' ' LEU . 47.4 m-85 -97.55 120.22 37.53 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 176.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.732 ' HB2' HD11 ' A' ' 238' ' ' ILE . . . -116.02 118.13 32.05 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.366 -174.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 292' ' ' ARG . 0.0 OUTLIER -78.88 100.94 7.43 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 174.601 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.786 HG21 ' HB2' ' A' ' 245' ' ' LYS . 9.8 p -81.08 115.48 23.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 119.192 -1.003 . . . . 0.0 109.932 -176.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.5 HD12 ' HB2' ' A' ' 244' ' ' GLN . 2.8 pp -97.99 2.97 10.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.113 -174.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.794 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 56.1 tp60 -176.59 93.17 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.032 -174.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.876 ' HG2' HD21 ' A' ' 258' ' ' LEU . 0.5 OUTLIER -147.16 166.21 27.66 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.202 0.525 . . . . 0.0 110.026 173.114 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.807 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 6.2 ptm180 -102.25 -178.59 3.74 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.548 -174.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 43.5 t -107.73 80.6 1.0 Allowed Pre-proline 0 CA--C 1.536 0.415 0 CA-C-O 121.233 0.54 . . . . 0.0 111.011 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.88 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 9.9 Cg_endo -93.96 168.03 2.02 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 124.606 3.537 . . . . 0.0 111.339 174.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -123.3 178.24 5.22 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.02 0.438 . . . . 0.0 110.426 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.712 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -61.83 -2.23 0.81 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.571 174.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -100.99 -2.46 31.66 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.182 0.515 . . . . 0.0 110.543 176.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -105.6 65.45 0.71 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -177.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . 0.678 ' HA ' ' HE3' ' A' ' 253' ' ' LYS . 0.0 OUTLIER 61.2 19.7 10.31 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.587 -171.772 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . 0.712 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 30.5 p 56.63 64.44 1.67 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.723 -175.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.519 ' HB1' ' CE2' ' A' ' 286' ' ' PHE . . . -109.55 154.65 22.44 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.272 -0.877 . . . . 0.0 111.006 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.874 ' HB3' HD22 ' A' ' 258' ' ' LEU . 0.2 OUTLIER -69.03 132.91 47.39 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.606 -175.643 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.88 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -85.52 93.25 8.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.346 0.593 . . . . 0.0 109.546 168.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.876 HD21 ' HG2' ' A' ' 245' ' ' LYS . 0.5 OUTLIER -142.14 160.92 39.26 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.292 -175.013 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.577 ' O ' HG13 ' A' ' 242' ' ' VAL . 37.4 tt0 -142.29 173.66 11.33 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.887 -165.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.551 HG22 ' HA ' ' A' ' 244' ' ' GLN . 47.3 t -56.15 117.79 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-O 121.267 0.556 . . . . 0.0 112.162 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 95.67 0.93 62.21 Favored Glycine 0 CA--C 1.505 -0.591 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.0 172.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -87.41 164.52 16.16 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.51 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.53 ' HG ' ' N ' ' A' ' 264' ' ' VAL . 16.6 tp -121.32 152.56 38.82 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.721 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.723 HG12 ' HB2' ' A' ' 279' ' ' CYS . 15.0 m -141.81 166.34 17.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.401 ' O ' ' HD3' ' A' ' 265' ' ' LYS . 8.2 tmtt? -132.42 97.21 4.04 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 1.041 ' HB ' HG23 ' A' ' 238' ' ' ILE . 46.1 t -68.95 128.24 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.732 -176.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 11.6 p -100.03 -18.86 16.81 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 113.722 -1.581 . . . . 0.0 111.852 -173.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -127.73 106.4 9.11 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 121.459 0.647 . . . . 0.0 109.762 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.592 HD12 HG22 ' A' ' 238' ' ' ILE . 0.0 OUTLIER -98.21 154.48 3.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.604 -167.073 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.784 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 0.4 OUTLIER -146.43 -169.65 3.32 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.515 178.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 12.7 p -98.34 -35.04 4.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.961 -177.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 3.5 m -68.84 -44.61 73.06 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -174.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . 0.421 ' HA3' ' CD1' ' A' ' 288' ' ' PHE . . . 121.83 -5.98 10.47 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.316 -176.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.6 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.0 OUTLIER -96.01 70.73 2.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.791 0.805 . . . . 0.0 110.351 176.479 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.784 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -102.32 173.33 6.41 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.615 -172.265 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.744 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 33.3 tt0 -93.39 123.74 36.9 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.524 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -103.08 151.43 17.96 Favored Glycine 0 N--CA 1.437 -1.253 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.27 -171.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -129.12 119.51 24.26 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 173.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' CYS . . . . . 0.723 ' HB2' HG12 ' A' ' 264' ' ' VAL . 44.7 t -114.04 97.1 6.17 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.566 -177.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 28.84 61.31 0.13 Allowed 'General case' 0 N--CA 1.466 0.375 0 O-C-N 124.967 1.417 . . . . 0.0 112.564 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.58 -38.63 2.96 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 115.724 -0.671 . . . . 0.0 113.268 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -80.61 146.63 31.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.297 0.548 . . . . 0.0 110.52 177.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 39.8 mtt180 -132.4 129.78 39.78 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.012 0.434 . . . . 0.0 110.033 170.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . 0.636 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . -173.81 142.1 6.36 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.006 -177.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' HIS . . . . . 0.744 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 14.7 p80 -91.92 148.03 22.52 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 117.908 0.854 . . . . 0.0 111.681 -175.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.84 ' HD1' ' HD3' ' A' ' 287' ' ' PRO . 3.2 m-85 -165.03 170.12 6.73 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -174.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.84 ' HD3' ' HD1' ' A' ' 286' ' ' PHE . 58.1 Cg_endo -100.84 156.94 0.42 Allowed 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 123.306 2.67 . . . . 0.0 112.856 -174.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.469 ' HA ' HG22 ' A' ' 291' ' ' VAL . 0.7 OUTLIER -87.16 -8.85 56.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.076 -177.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.566 HG22 ' HB2' ' A' ' 287' ' ' PRO . 10.0 t -55.79 -32.65 63.68 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.84 -178.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . 0.794 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 0.5 OUTLIER -119.98 55.13 1.0 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.585 0.707 . . . . 0.0 111.365 175.363 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.469 HG22 ' HA ' ' A' ' 288' ' ' PHE . 10.6 m -147.17 171.96 3.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.811 170.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 241' ' ' ARG . 14.5 tpt180 -122.66 108.88 13.58 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 171.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 6.1 tp -84.62 123.55 30.46 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 115.231 -0.895 . . . . 0.0 113.37 -164.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 239' ' ' TYR . 6.6 mt . . . . . 0 N--CA 1.44 -0.965 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 169.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.987 ' HB3' ' HA ' ' A' ' 267' ' ' THR . 4.5 Cg_exo . . . . . 0 C--O 1.238 0.487 0 CA-C-O 120.517 0.132 . . . . 0.0 111.92 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 1.077 HG12 HG22 ' A' ' 266' ' ' VAL . 0.8 OUTLIER -78.73 160.77 4.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.016 -167.3 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.682 ' HB3' HD11 ' A' ' 263' ' ' LEU . 86.7 m-85 -108.5 118.75 37.58 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 174.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.596 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -113.77 118.49 34.42 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.165 0.507 . . . . 0.0 111.021 -174.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.415 ' HB3' ' O ' ' A' ' 292' ' ' ARG . 15.1 tpp180 -81.6 103.73 11.52 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 1.07 HG21 ' HD2' ' A' ' 245' ' ' LYS . 5.6 p -86.01 130.74 36.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.986 -175.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.45 HD12 ' HB2' ' A' ' 244' ' ' GLN . 2.8 pp -106.83 8.8 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.704 -174.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.77 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 63.3 tt0 -177.8 94.06 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -173.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 1.07 ' HD2' HG21 ' A' ' 242' ' ' VAL . 11.0 mttt -145.57 161.84 38.85 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 175.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.856 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 13.2 ptt180 -107.59 -176.31 3.03 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.875 -172.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 7.0 p -104.13 78.83 0.34 Allowed Pre-proline 0 CA--C 1.547 0.848 0 CA-C-O 121.812 0.815 . . . . 0.0 111.533 175.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.959 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 1.7 Cg_endo -88.99 177.95 2.81 Favored 'Trans proline' 0 N--CA 1.459 -0.537 1 C-N-CA 125.303 4.002 . . . . 0.0 110.654 174.436 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.422 ' C ' ' H ' ' A' ' 251' ' ' TYR . 27.7 m-80 -130.16 170.65 13.79 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.045 0.45 . . . . 0.0 109.913 177.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.699 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -76.4 14.87 0.68 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.568 0.699 . . . . 0.0 110.544 178.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.422 ' H ' ' C ' ' A' ' 249' ' ' ASN . 37.2 m-85 -110.92 1.89 17.83 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.844 175.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -95.6 49.19 1.17 Allowed 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.72 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt 60.42 33.99 20.63 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -166.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . 0.699 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 71.5 p 59.55 77.63 0.3 Allowed 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 113.728 -1.578 . . . . 0.0 111.864 -178.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.425 ' C ' ' HA3' ' A' ' 284' ' ' GLY . . . -112.44 154.79 25.29 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.714 176.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 1.108 HD12 ' HG ' ' A' ' 258' ' ' LEU . 0.0 OUTLIER -83.73 133.64 34.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.255 -174.46 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.959 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -91.03 101.24 14.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.346 0.593 . . . . 0.0 109.591 171.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 1.108 ' HG ' HD12 ' A' ' 256' ' ' LEU . 0.1 OUTLIER -158.1 169.53 24.32 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.746 -174.864 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.457 ' HG2' ' N ' ' A' ' 260' ' ' VAL . 32.0 tt0 -142.16 173.21 11.73 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 121.902 -0.499 . . . . 0.0 112.048 -160.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.736 HG22 ' HA ' ' A' ' 244' ' ' GLN . 53.9 t -55.11 118.3 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 C-N-CA 123.364 0.665 . . . . 0.0 111.537 175.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 102.73 -1.69 48.84 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.644 -0.582 . . . . 0.0 111.644 172.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -95.94 173.23 7.54 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.711 -173.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.682 HD11 ' HB3' ' A' ' 239' ' ' TYR . 40.1 tp -117.27 157.62 25.75 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.326 0.584 . . . . 0.0 111.059 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.596 HG13 ' HB3' ' A' ' 240' ' ' ALA . 2.6 p -152.31 119.19 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.139 -177.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.453 ' HE3' ' HG2' ' A' ' 237' ' ' PRO . 54.7 tttp -86.9 97.34 10.62 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.572 177.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 1.077 HG22 HG12 ' A' ' 238' ' ' ILE . 7.0 m -77.23 114.4 17.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.892 0.853 . . . . 0.0 109.988 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . 0.987 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 9.7 t -96.93 4.39 51.61 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.06 -174.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.563 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 0.0 OUTLIER -132.48 107.52 8.53 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 169.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.674 HG21 HG23 ' A' ' 238' ' ' ILE . 0.8 OUTLIER -111.12 156.37 12.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 114.961 -1.018 . . . . 0.0 113.355 -170.25 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.766 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 0.1 OUTLIER -146.13 -161.1 1.24 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.938 -1.483 . . . . 0.0 109.195 178.357 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.04 -23.3 4.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.888 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 3.0 m -65.62 -44.62 85.94 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -175.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . 0.64 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 124.03 -21.89 6.87 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.127 -177.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.647 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.3 OUTLIER -89.76 102.77 15.47 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 173.057 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.766 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -134.6 174.92 10.02 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.067 -177.071 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 44.4 tt0 -91.14 125.46 35.92 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.629 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -105.03 155.84 16.99 Favored Glycine 0 N--CA 1.437 -1.289 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.549 -175.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 30.8 tt0 -139.27 119.86 14.08 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 176.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' CYS . . . . . 0.438 ' HB3' HD11 ' A' ' 256' ' ' LEU . 49.0 t -108.5 98.44 7.96 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 46.51 46.17 14.16 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.378 176.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 115.59 -39.34 2.78 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.385 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 55.3 mttt -69.96 130.87 43.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.237 0.518 . . . . 0.0 109.711 177.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 36.1 mtt180 -113.67 129.67 56.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.12 0.486 . . . . 0.0 110.969 176.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . 0.55 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . -170.18 142.82 7.44 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.995 -178.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' HIS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 25.3 p80 -99.56 148.73 23.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 117.265 0.533 . . . . 0.0 111.172 -171.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.65 ' CG ' ' HE2' ' A' ' 245' ' ' LYS . 5.8 m-85 -159.26 158.96 28.83 Favored Pre-proline 0 CA--C 1.533 0.289 0 O-C-N 123.469 0.48 . . . . 0.0 110.796 -176.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.647 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 97.2 Cg_endo -91.58 169.88 3.1 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.919 2.413 . . . . 0.0 113.909 -175.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.64 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 9.8 t80 -75.87 -13.18 60.27 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.554 -175.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 25.4 p -48.24 -29.36 3.72 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -174.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . 0.77 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 1.3 p-80 -136.9 39.84 2.55 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.779 0.323 . . . . 0.0 111.586 -171.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.462 HG23 ' HA ' ' A' ' 242' ' ' VAL . 3.1 p -141.78 150.81 19.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 119.454 -0.899 . . . . 0.0 112.53 -175.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.415 ' O ' ' HB3' ' A' ' 241' ' ' ARG . 30.0 mmm180 -130.39 108.89 10.32 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . 0.59 HD21 ' CE2' ' A' ' 288' ' ' PHE . 0.4 OUTLIER -120.09 145.34 46.98 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -163.799 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.493 ' H ' HD12 ' A' ' 294' ' ' LEU . 4.7 mp . . . . . 0 N--CA 1.434 -1.26 0 CA-C-N 113.677 -1.601 . . . . 0.0 107.553 168.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.681 ' HB3' ' HA ' ' A' ' 267' ' ' THR . 7.6 Cg_exo . . . . . 0 N--CA 1.462 -0.337 0 N-CA-C 113.438 0.514 . . . . 0.0 113.438 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 1.092 HG12 HG22 ' A' ' 266' ' ' VAL . 0.6 OUTLIER -80.59 160.17 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.987 -171.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.883 ' HD1' HD11 ' A' ' 263' ' ' LEU . 64.5 m-85 -104.23 120.48 41.25 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 173.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.766 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -113.65 116.97 30.3 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.309 -176.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 241' ' ' ARG . 0.0 OUTLIER -81.65 101.03 9.78 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.766 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.75 ' CG2' ' HD3' ' A' ' 245' ' ' LYS . 3.4 p -78.33 122.3 33.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 119.931 -0.708 . . . . 0.0 110.116 -176.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.534 HG21 ' HG2' ' A' ' 292' ' ' ARG . 2.8 pp -110.12 6.46 8.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.516 -174.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.733 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 58.7 tt0 -176.3 94.55 0.05 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.081 -175.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.857 ' HE2' HD21 ' A' ' 258' ' ' LEU . 0.2 OUTLIER -147.07 168.0 22.67 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 122.008 0.909 . . . . 0.0 111.613 178.302 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.854 ' HG3' ' HG3' ' A' ' 248' ' ' PRO . 12.3 ptm180 -108.47 -176.4 3.04 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.787 -1.552 . . . . 0.0 109.717 -173.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 19.0 t -108.28 75.33 0.56 Allowed Pre-proline 0 CA--C 1.54 0.589 0 CA-C-O 121.029 0.442 . . . . 0.0 110.997 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.98 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 5.7 Cg_endo -91.11 177.41 2.03 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 124.861 3.707 . . . . 0.0 110.712 176.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.451 ' C ' ' H ' ' A' ' 251' ' ' TYR . 10.9 m120 -135.18 175.34 9.67 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.781 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -69.46 9.7 0.44 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.393 0.616 . . . . 0.0 111.269 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.451 ' H ' ' C ' ' A' ' 249' ' ' ASN . 18.9 m-85 -103.14 -4.01 25.05 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 176.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -105.28 67.96 0.79 Allowed 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.16 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . 0.457 ' HE2' ' HB2' ' A' ' 253' ' ' LYS . 2.6 mppt? 54.54 28.97 10.49 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -169.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . 0.781 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 78.3 p 55.66 73.48 0.43 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.903 -174.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.589 ' C ' ' HA3' ' A' ' 284' ' ' GLY . . . -108.47 153.08 23.84 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.366 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.727 ' N ' ' HA3' ' A' ' 284' ' ' GLY . 0.2 OUTLIER -79.92 132.58 36.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.341 -173.083 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.98 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -92.22 100.98 13.49 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 173.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.857 HD21 ' HE2' ' A' ' 245' ' ' LYS . 0.6 OUTLIER -154.62 170.67 20.96 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.521 -174.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.489 ' O ' HG13 ' A' ' 242' ' ' VAL . 29.8 tt0 -142.98 169.55 17.36 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.704 0.288 . . . . 0.0 111.584 -165.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.417 ' N ' ' HG2' ' A' ' 259' ' ' GLU . 3.5 p -55.04 118.0 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.703 0.763 . . . . 0.0 112.351 176.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 105.23 -2.71 40.38 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 114.92 -1.037 . . . . 0.0 111.741 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -90.98 -179.9 5.58 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.832 -176.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.883 HD11 ' HD1' ' A' ' 239' ' ' TYR . 3.2 tm? -132.18 130.04 40.55 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.766 HG13 ' HB3' ' A' ' 240' ' ' ALA . 2.4 p -124.05 118.21 53.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.264 178.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 238' ' ' ILE . 78.8 tttt -87.27 97.06 10.58 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 1.092 HG22 HG12 ' A' ' 238' ' ' ILE . 5.0 m -77.11 122.93 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 121.87 0.843 . . . . 0.0 111.049 -175.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . 0.681 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 49.5 p -91.8 -15.42 28.28 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.983 -174.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.596 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 0.0 OUTLIER -119.66 105.46 11.2 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.733 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.579 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.8 OUTLIER -106.46 159.54 6.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -170.235 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.782 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 3.5 p30 -145.59 -168.25 2.92 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.988 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 13.3 p -99.28 -32.27 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 120.616 -0.433 . . . . 0.0 112.004 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 11.7 m -78.62 -26.63 45.35 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -173.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . 0.624 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 105.35 4.25 40.8 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.364 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.804 ' N ' HE21 ' A' ' 274' ' ' GLN . 0.0 OUTLIER -97.07 81.14 3.03 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 176.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.782 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -122.93 168.42 12.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.19 -168.847 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.596 ' HB3' ' HB3' ' A' ' 268' ' ' LYS . 40.8 tt0 -90.42 126.06 35.77 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.111 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.687 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -108.7 159.05 14.36 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.303 -173.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 40.8 tt0 -140.94 120.15 12.94 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 172.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' CYS . . . . . 0.412 ' HB3' HD11 ' A' ' 256' ' ' LEU . 34.6 t -114.62 96.89 5.97 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.349 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 33.65 57.19 0.55 Allowed 'General case' 0 N--CA 1.465 0.28 0 O-C-N 124.615 1.197 . . . . 0.0 112.527 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.97 -39.27 2.72 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-N 115.705 -0.68 . . . . 0.0 113.351 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 0.2 OUTLIER -77.77 139.85 39.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.492 0.646 . . . . 0.0 109.943 178.621 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 12.4 mtm180 -124.25 129.2 50.35 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 175.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . 0.727 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . 177.72 145.97 6.11 Favored Glycine 0 C--O 1.225 -0.467 0 C-N-CA 120.09 -1.052 . . . . 0.0 113.58 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' HIS . . . . . 0.554 ' CB ' ' HA ' ' A' ' 276' ' ' GLU . 28.5 p80 -104.18 147.71 27.13 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.965 0.383 . . . . 0.0 111.423 -175.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.56 ' CZ ' ' HB1' ' A' ' 255' ' ' ALA . 12.4 m-85 -159.14 167.02 15.18 Favored Pre-proline 0 CA--C 1.535 0.397 0 O-C-N 123.271 0.357 . . . . 0.0 111.494 -175.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.456 ' HD3' ' HD1' ' A' ' 286' ' ' PHE . 1.4 Cg_endo -86.25 153.99 9.46 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 123.514 2.809 . . . . 0.0 113.585 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.738 ' HE1' ' HG ' ' A' ' 293' ' ' LEU . 44.3 t80 -67.44 -23.28 65.51 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 114.374 -1.285 . . . . 0.0 112.477 -177.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.441 HG22 ' HB2' ' A' ' 287' ' ' PRO . 8.9 t -53.1 -29.36 30.27 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -168.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . 0.733 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 0.9 OUTLIER -122.16 53.43 1.23 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.612 0.72 . . . . 0.0 110.956 -179.684 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.518 ' O ' ' HD2' ' A' ' 292' ' ' ARG . 0.5 OUTLIER -147.24 158.74 9.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.129 176.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.534 ' HG2' HG21 ' A' ' 243' ' ' ILE . 21.1 mmm180 -121.69 109.49 14.8 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 173.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . 0.954 HD11 HD12 ' A' ' 238' ' ' ILE . 0.3 OUTLIER -91.07 127.19 36.4 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -161.396 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 239' ' ' TYR . 3.9 mt . . . . . 0 N--CA 1.438 -1.027 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 167.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo . . . . . 0 N--CA 1.462 -0.344 0 CA-C-O 121.211 0.421 . . . . 0.0 113.068 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.836 HG23 ' HB ' ' A' ' 266' ' ' VAL . 0.0 OUTLIER -94.33 139.54 18.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 173.612 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.567 ' HB2' ' HB2' ' A' ' 294' ' ' LEU . 0.7 OUTLIER -99.28 143.94 28.96 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 172.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.746 ' HA ' ' HA ' ' A' ' 293' ' ' LEU . . . -136.03 116.97 14.22 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 118.781 -1.168 . . . . 0.0 110.548 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -85.9 102.0 13.35 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 1.051 HG21 ' HD2' ' A' ' 245' ' ' LYS . 4.3 p -83.63 129.82 36.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.151 -173.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.9 pp -102.15 4.49 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.458 -175.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.621 ' H ' HG22 ' A' ' 242' ' ' VAL . 10.1 tt0 -178.47 102.6 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.687 -175.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 1.051 ' HD2' HG21 ' A' ' 242' ' ' VAL . 8.1 mttt -145.72 162.33 37.84 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 175.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.897 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 7.9 ttt-85 -99.41 177.21 5.25 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 123.433 0.693 . . . . 0.0 109.462 -174.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.442 ' N ' ' CG ' ' A' ' 246' ' ' ARG . 9.4 m -100.85 75.94 0.14 Allowed Pre-proline 0 CA--C 1.548 0.883 0 CA-C-O 121.546 0.688 . . . . 0.0 111.787 172.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.897 ' HD3' ' O ' ' A' ' 246' ' ' ARG . 0.9 OUTLIER -90.52 175.49 2.69 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 125.212 3.941 . . . . 0.0 111.04 177.036 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 252' ' ' ASP . 11.5 m120 -128.22 175.73 8.22 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.949 0.404 . . . . 0.0 110.547 176.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.927 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -67.13 -11.22 56.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 122.127 0.965 . . . . 0.0 110.195 174.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -87.45 5.42 38.99 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.814 175.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 249' ' ' ASN . 3.0 m-20 -103.85 49.27 0.83 Allowed 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.168 177.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . 0.551 ' N ' ' HD2' ' A' ' 253' ' ' LYS . 0.0 OUTLIER 58.7 31.13 20.83 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -169.409 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . 0.927 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 30.7 p 61.12 81.94 0.18 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 113.413 -1.721 . . . . 0.0 111.609 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.435 ' HB1' ' CE2' ' A' ' 286' ' ' PHE . . . -118.94 156.76 28.98 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.479 176.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.802 HD12 ' SG ' ' A' ' 279' ' ' CYS . 3.8 mm? -81.16 130.63 35.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.567 -175.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.854 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -89.99 97.76 11.38 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.438 0.637 . . . . 0.0 110.432 172.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.73 HD21 ' HD3' ' A' ' 245' ' ' LYS . 0.4 OUTLIER -159.79 171.89 18.67 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.275 -175.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.446 ' O ' HG13 ' A' ' 242' ' ' VAL . 12.4 pt-20 -143.53 -162.3 1.43 Allowed 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 119.822 -0.751 . . . . 0.0 112.865 -166.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.551 HG22 ' HA ' ' A' ' 244' ' ' GLN . 88.0 t -66.33 117.39 7.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.755 177.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 105.8 -1.27 38.9 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.85 171.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -91.58 -179.89 5.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.91 0.386 . . . . 0.0 111.399 -170.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.501 ' HG ' ' N ' ' A' ' 264' ' ' VAL . 38.2 tp -133.39 157.52 45.35 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.273 0.559 . . . . 0.0 111.314 -177.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.68 HG13 ' HB3' ' A' ' 240' ' ' ALA . 1.8 p -152.72 136.01 7.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.243 -177.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -98.49 96.8 8.24 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.836 ' HB ' HG23 ' A' ' 238' ' ' ILE . 52.0 t -68.63 117.92 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-O 121.205 0.526 . . . . 0.0 110.903 177.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 81.9 p -97.31 -19.2 18.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.422 -176.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.608 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 2.9 tppp? -116.97 107.08 14.13 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.469 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.6 OUTLIER -102.67 155.48 5.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -167.631 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.818 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 3.5 p30 -143.41 -178.53 5.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.275 174.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 8.9 p -82.53 -35.94 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -176.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 5.9 m -82.19 -43.33 17.81 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -172.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . 0.555 ' HA3' ' CD2' ' A' ' 288' ' ' PHE . . . 123.41 2.42 8.99 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.518 -178.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 1.0 OUTLIER -93.35 85.17 4.9 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 173.272 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.818 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -131.12 -179.79 5.54 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.89 -168.022 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.696 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 39.2 mt-10 -94.48 124.81 38.73 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.018 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.563 ' O ' HD21 ' A' ' 256' ' ' LEU . . . -106.67 145.34 15.94 Favored Glycine 0 N--CA 1.437 -1.267 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.334 -175.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.579 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 0.4 OUTLIER -124.14 118.73 27.55 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.023 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' CYS . . . . . 0.802 ' SG ' HD12 ' A' ' 256' ' ' LEU . 29.7 p -111.01 98.76 7.78 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.449 -174.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 4.9 m120 49.09 45.65 22.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.491 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 114.14 -17.08 19.81 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.689 -0.767 . . . . 0.0 114.27 175.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 5.4 mptt -99.93 133.8 43.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.733 0.766 . . . . 0.0 110.352 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.94 134.48 54.43 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.793 0.33 . . . . 0.0 111.375 -174.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -176.22 -146.46 5.99 Favored Glycine 0 C--O 1.225 -0.407 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' HIS . . . . . 0.696 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 24.8 p80 -148.82 151.45 34.77 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 117.562 0.681 . . . . 0.0 111.134 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.656 ' CG ' ' HE2' ' A' ' 245' ' ' LYS . 1.8 m-85 -164.72 153.83 11.45 Favored Pre-proline 0 CA--C 1.535 0.395 0 O-C-N 123.452 0.47 . . . . 0.0 110.829 -177.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.534 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 95.3 Cg_endo -90.77 173.35 3.02 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.057 2.504 . . . . 0.0 114.029 -174.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.555 ' CD2' ' HA3' ' A' ' 273' ' ' GLY . 16.2 t80 -82.92 -20.86 34.55 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 114.369 -1.287 . . . . 0.0 111.926 -170.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 12.9 t -68.62 1.78 2.93 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -167.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . 0.593 ' HD2' HG13 ' A' ' 291' ' ' VAL . 1.2 p-80 -147.25 33.71 0.89 Allowed 'General case' 0 C--N 1.33 -0.239 0 O-C-N 121.706 -0.621 . . . . 0.0 111.682 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.593 HG13 ' HD2' ' A' ' 290' ' ' HIS . 31.8 m -140.25 151.76 21.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.73 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.415 ' HA ' ' HD2' ' A' ' 292' ' ' ARG . 20.8 tpt180 -122.03 108.37 13.3 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 173.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . 0.746 ' HA ' ' HA ' ' A' ' 240' ' ' ALA . 0.0 OUTLIER -94.42 139.54 30.99 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -163.687 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.567 ' HB2' ' HB2' ' A' ' 239' ' ' TYR . 5.0 mt . . . . . 0 N--CA 1.436 -1.153 0 CA-C-N 113.948 -1.478 . . . . 0.0 107.21 167.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.477 ' HG2' ' HE3' ' A' ' 265' ' ' LYS . 16.7 Cg_exo . . . . . 0 C--O 1.234 0.317 0 N-CA-C 112.536 0.168 . . . . 0.0 112.536 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.729 HD13 HG22 ' A' ' 266' ' ' VAL . 0.0 OUTLIER -89.69 149.47 4.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.764 174.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.543 ' N ' HG12 ' A' ' 238' ' ' ILE . 20.2 m-85 -95.89 119.35 34.23 Favored 'General case' 0 C--O 1.208 -1.107 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.46 ' HB3' ' CG2' ' A' ' 264' ' ' VAL . . . -113.87 118.22 33.61 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.481 -171.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.31 101.38 8.89 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.067 178.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 1.079 ' HA ' HG12 ' A' ' 291' ' ' VAL . 6.3 p -80.86 117.71 27.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.193 -176.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.568 ' O ' ' HG3' ' A' ' 244' ' ' GLN . 2.8 pp -105.15 0.61 10.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.013 -172.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.574 ' HB2' ' HB2' ' A' ' 290' ' ' HIS . 57.5 mt-30 -172.25 94.08 0.14 Allowed 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -173.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.848 ' HG2' ' CD2' ' A' ' 258' ' ' LEU . 2.5 tptt -146.66 165.54 29.26 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.517 0.675 . . . . 0.0 111.453 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.788 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 2.7 ptm85 -102.23 -178.13 3.61 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.079 -1.418 . . . . 0.0 110.279 -173.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 21.9 t -110.48 72.46 0.72 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.333 0.587 . . . . 0.0 109.71 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 1.071 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 72.1 Cg_endo -95.54 175.82 0.92 Allowed 'Trans proline' 0 N--CA 1.441 -1.612 0 C-N-CA 124.135 3.223 . . . . 0.0 110.541 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -136.3 176.2 8.91 Favored 'General case' 0 C--N 1.314 -0.978 0 O-C-N 121.952 -0.467 . . . . 0.0 110.298 -177.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.775 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -61.55 -7.61 3.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.368 0.604 . . . . 0.0 111.001 172.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -95.51 -2.29 48.9 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.313 176.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -105.41 63.73 0.69 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? 56.94 30.75 18.59 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -169.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . 0.775 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 44.5 p 52.49 62.94 2.44 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.323 -173.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.605 ' HB3' ' HB2' ' A' ' 248' ' ' PRO . . . -96.85 150.8 20.32 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.337 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.755 ' N ' ' HA3' ' A' ' 284' ' ' GLY . 0.4 OUTLIER -74.34 131.09 40.82 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.913 -179.016 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.071 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -90.56 104.5 17.07 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 175.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.848 ' CD2' ' HG2' ' A' ' 245' ' ' LYS . 0.6 OUTLIER -153.8 164.47 38.3 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.427 -175.144 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.558 ' O ' HG13 ' A' ' 242' ' ' VAL . 32.4 tt0 -142.3 174.66 10.42 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 120.578 0.228 . . . . 0.0 111.159 -165.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.505 HG22 ' HA ' ' A' ' 244' ' ' GLN . 88.3 t -57.12 117.7 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.373 0.606 . . . . 0.0 112.234 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 98.71 -2.1 58.5 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.507 170.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -84.38 175.88 9.07 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.33 -176.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.558 ' HG ' ' N ' ' A' ' 264' ' ' VAL . 17.0 tp -130.35 154.72 47.38 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.65 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.7 HG12 ' HB2' ' A' ' 279' ' ' CYS . 17.1 m -145.5 160.37 12.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.778 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.477 ' HE3' ' HG2' ' A' ' 237' ' ' PRO . 56.8 tttp -117.87 97.9 6.07 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 177.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.729 HG22 HD13 ' A' ' 238' ' ' ILE . 4.6 m -80.38 121.66 34.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.49 0.662 . . . . 0.0 110.345 -176.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 38.2 p -99.6 -5.09 29.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.853 -174.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.63 ' O ' ' HB3' ' A' ' 275' ' ' TRP . 1.3 tppp? -119.03 105.47 11.46 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 174.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.78 HD13 ' H ' ' A' ' 269' ' ' ILE . 0.2 OUTLIER -114.95 149.42 17.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.645 -166.736 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -144.14 -168.76 2.96 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.85 -174.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 28.7 m -100.88 -21.52 5.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.8 m -81.54 -45.39 15.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.776 0.322 . . . . 0.0 111.211 -175.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 125.92 -8.37 7.66 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.655 -177.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.9 OUTLIER -90.56 105.04 17.55 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 173.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.63 ' HB3' ' O ' ' A' ' 268' ' ' LYS . 0.0 OUTLIER -115.57 173.46 6.52 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.706 0.765 . . . . 0.0 111.345 -175.464 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 268' ' ' LYS . 29.9 tt0 -96.65 124.28 40.59 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 165.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.517 ' O ' HD23 ' A' ' 256' ' ' LEU . . . -109.66 149.42 17.3 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.784 -167.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.643 ' HG3' ' HG2' ' A' ' 283' ' ' ARG . 31.9 tt0 -127.75 117.61 22.22 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 172.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' CYS . . . . . 0.7 ' HB2' HG12 ' A' ' 264' ' ' VAL . 53.7 t -101.65 94.84 6.06 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.314 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 36.38 55.13 1.08 Allowed 'General case' 0 CA--C 1.533 0.296 0 O-C-N 124.754 1.284 . . . . 0.0 111.843 175.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.51 -40.4 2.4 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 115.639 -0.71 . . . . 0.0 113.39 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . 0.503 ' HD2' ' HB3' ' A' ' 279' ' ' CYS . 35.3 mttt -76.42 138.83 40.62 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 117.513 0.656 . . . . 0.0 110.381 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . 0.643 ' HG2' ' HG3' ' A' ' 278' ' ' GLU . 23.2 mtt180 -122.33 129.93 52.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.365 0.602 . . . . 0.0 111.726 176.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . 0.755 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . -159.91 -171.09 25.32 Favored Glycine 0 C--O 1.221 -0.709 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.189 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -147.62 139.84 24.38 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 118.409 1.105 . . . . 0.0 111.053 175.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.589 ' CZ ' ' HB1' ' A' ' 255' ' ' ALA . 28.1 m-85 -159.17 168.89 11.46 Favored Pre-proline 0 N--CA 1.472 0.633 0 C-N-CA 122.627 0.371 . . . . 0.0 111.472 -174.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.481 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 17.7 Cg_endo -94.92 168.7 1.59 Allowed 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 123.611 2.874 . . . . 0.0 112.796 -177.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.679 ' HA ' ' CG2' ' A' ' 291' ' ' VAL . 29.4 p90 -87.12 -12.38 47.26 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.31 -174.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 5.2 t -49.91 -33.66 18.01 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . 0.574 ' HB2' ' HB2' ' A' ' 244' ' ' GLN . 1.5 p-80 -125.75 56.97 1.37 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.792 0.806 . . . . 0.0 111.686 177.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 1.079 HG12 ' HA ' ' A' ' 242' ' ' VAL . 0.9 OUTLIER -154.56 170.94 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.573 168.23 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -130.01 107.75 9.58 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 172.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . 0.702 HD22 ' H ' ' A' ' 293' ' ' LEU . 0.0 OUTLIER -94.86 127.05 40.6 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 119.41 -0.916 . . . . 0.0 112.063 -169.266 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 10.4 mt . . . . . 0 N--CA 1.438 -1.029 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 171.029 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.625 ' HA ' ' O ' ' A' ' 266' ' ' VAL . 4.3 Cg_endo . . . . . 0 N--CA 1.456 -0.717 0 CA-C-O 120.897 0.29 . . . . 0.0 112.51 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.897 HD11 ' HB2' ' A' ' 240' ' ' ALA . 0.1 OUTLIER -86.38 152.46 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.345 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.795 ' HD1' HD11 ' A' ' 263' ' ' LEU . 59.4 m-85 -100.84 118.04 36.11 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 175.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.897 ' HB2' HD11 ' A' ' 238' ' ' ILE . . . -120.19 117.3 27.54 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.587 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.555 HH11 ' HA2' ' A' ' 261' ' ' GLY . 0.1 OUTLIER -85.76 103.48 14.58 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.7 -175.237 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.737 ' HA ' HG12 ' A' ' 291' ' ' VAL . 2.2 t -66.17 131.79 31.84 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.104 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.081 -175.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.417 HD12 ' CB ' ' A' ' 244' ' ' GLN . 2.9 pp -120.84 2.3 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 O-C-N 123.539 0.524 . . . . 0.0 110.421 176.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.547 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 8.2 tt0 -178.22 95.58 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.072 -172.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.722 ' HB3' ' O ' ' A' ' 258' ' ' LEU . 0.0 OUTLIER -145.75 164.84 30.59 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.37 0.605 . . . . 0.0 110.443 175.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.881 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 12.7 ttm180 -92.87 171.98 8.62 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.778 -176.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.443 ' N ' ' HG2' ' A' ' 246' ' ' ARG . 21.9 t -101.72 75.48 0.16 Allowed Pre-proline 0 CA--C 1.542 0.646 0 CA-C-O 121.02 0.438 . . . . 0.0 110.123 170.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.996 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 1.2 Cg_endo -89.02 178.89 2.53 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 125.226 3.951 . . . . 0.0 111.875 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -127.52 175.36 8.31 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.97 0.414 . . . . 0.0 109.959 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.518 ' O ' HG22 ' A' ' 254' ' ' THR . . . -68.98 -1.23 6.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.125 0.488 . . . . 0.0 110.796 174.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -106.17 1.18 25.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.124 176.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -93.34 55.02 2.19 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp 60.54 22.61 12.33 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.46 -168.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . 0.518 HG22 ' O ' ' A' ' 250' ' ' ALA . 28.6 p 64.65 83.59 0.16 Allowed 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.553 -177.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.64 ' HB1' ' CE2' ' A' ' 286' ' ' PHE . . . -128.67 153.56 47.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.015 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.59 HD21 ' O ' ' A' ' 277' ' ' GLY . 4.2 mm? -72.83 120.48 18.51 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.85 -175.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.996 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -81.04 87.11 6.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.18 0.514 . . . . 0.0 111.007 174.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.722 ' O ' ' HB3' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -157.69 168.47 27.13 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.192 -176.046 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.477 ' O ' ' HB ' ' A' ' 242' ' ' VAL . 12.6 pt-20 -142.56 -164.91 1.92 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -168.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 4.3 p -60.25 122.46 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 121.593 0.711 . . . . 0.0 112.095 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.555 ' HA2' HH11 ' A' ' 241' ' ' ARG . . . 107.57 -1.44 34.41 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.851 172.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -89.68 -177.62 5.32 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -170.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.795 HD11 ' HD1' ' A' ' 239' ' ' TYR . 3.4 tm? -138.78 122.11 17.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.526 177.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.7 HG13 ' HB3' ' A' ' 240' ' ' ALA . 2.1 p -115.11 129.28 71.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.056 178.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 238' ' ' ILE . 75.9 tttt -98.54 95.17 7.11 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.768 ' HB ' HG23 ' A' ' 238' ' ' ILE . 21.0 t -66.14 123.17 18.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.243 -175.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 35.3 p -95.77 -24.46 16.49 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.855 -174.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.568 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 0.0 OUTLIER -119.12 107.34 13.36 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.534 -0.866 . . . . 0.0 109.509 177.007 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.471 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.6 OUTLIER -97.04 155.08 3.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-N 114.334 -1.303 . . . . 0.0 114.166 -167.772 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.893 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 0.3 OUTLIER -146.48 -172.55 3.98 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.772 171.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 60.1 t -93.35 -41.31 12.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.949 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 2.6 p -58.95 -43.7 91.31 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -175.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . 0.517 ' H ' ' ND2' ' A' ' 270' ' ' ASN . . . 115.45 -4.34 21.6 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.319 -0.944 . . . . 0.0 112.673 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.587 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.0 OUTLIER -95.91 71.93 2.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.709 0.766 . . . . 0.0 109.725 176.667 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.893 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -111.98 179.01 4.12 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.633 -168.609 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.63 ' HG2' ' O ' ' A' ' 284' ' ' GLY . 6.1 tt0 -90.2 125.27 35.41 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.59 ' O ' HD21 ' A' ' 256' ' ' LEU . . . -110.26 141.9 16.41 Favored Glycine 0 N--CA 1.436 -1.304 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 -173.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 26.6 tt0 -127.14 118.48 24.44 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 170.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' CYS . . . . . 0.48 ' O ' ' HD3' ' A' ' 282' ' ' LYS . 13.8 t -106.28 96.88 6.78 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -178.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 28.69 60.33 0.13 Allowed 'General case' 0 N--CA 1.468 0.454 0 O-C-N 125.015 1.447 . . . . 0.0 112.991 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 115.63 -30.53 6.61 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.334 178.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . 0.569 ' HE3' ' O ' ' A' ' 257' ' ' ALA . 6.1 mppt? -85.94 131.59 34.25 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.096 0.448 . . . . 0.0 110.378 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 40.1 mmm-85 -114.42 149.89 35.54 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.793 0.33 . . . . 0.0 111.698 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . 0.63 ' O ' ' HG2' ' A' ' 276' ' ' GLU . . . 159.72 -162.41 32.97 Favored Glycine 0 C--O 1.216 -0.973 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 173.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' HIS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 31.3 p80 -136.94 148.48 46.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 118.087 0.943 . . . . 0.0 111.077 177.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.64 ' CE2' ' HB1' ' A' ' 255' ' ' ALA . 2.4 m-85 -161.24 159.06 24.11 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 120.718 0.294 . . . . 0.0 111.325 -174.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 73.4 Cg_endo -93.14 149.44 2.52 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.251 2.634 . . . . 0.0 112.867 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.636 ' HA ' HG22 ' A' ' 291' ' ' VAL . 0.5 OUTLIER -75.28 -9.1 58.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.251 -174.26 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 8.9 t -63.0 -24.93 68.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.231 -0.441 . . . . 0.0 112.017 -173.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . 0.547 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 1.4 p-80 -121.67 38.07 4.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.48 0.657 . . . . 0.0 111.343 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.737 HG12 ' HA ' ' A' ' 242' ' ' VAL . 27.6 m -144.26 161.56 15.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.423 170.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -117.0 106.85 13.85 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 240' ' ' ALA . 0.2 OUTLIER -102.93 129.04 49.51 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-O 121.753 0.787 . . . . 0.0 113.008 -165.598 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 3.8 mp . . . . . 0 N--CA 1.437 -1.087 0 CA-C-N 114.348 -1.296 . . . . 0.0 108.797 168.706 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 266' ' ' VAL . 3.2 Cg_exo . . . . . 0 N--CA 1.455 -0.753 0 N-CA-C 111.659 -0.17 . . . . 0.0 111.659 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.814 HD13 ' HB ' ' A' ' 266' ' ' VAL . 0.1 OUTLIER -93.68 165.96 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.476 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.694 ' HB3' HD11 ' A' ' 263' ' ' LEU . 36.4 m-85 -102.66 123.86 47.14 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 172.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.605 ' HB3' HG22 ' A' ' 264' ' ' VAL . . . -111.72 117.73 33.66 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.287 -168.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 292' ' ' ARG . 0.0 OUTLIER -85.9 103.05 14.27 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.021 176.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.611 HG21 ' HB2' ' A' ' 245' ' ' LYS . 3.5 p -91.57 121.4 42.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.737 -177.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.505 HD12 ' HB2' ' A' ' 244' ' ' GLN . 2.8 pp -100.33 4.7 10.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.864 -172.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.534 ' HB2' ' HB2' ' A' ' 290' ' ' HIS . 16.8 mt-30 -173.78 99.32 0.11 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.932 -174.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.966 ' HG2' HD13 ' A' ' 258' ' ' LEU . 0.1 OUTLIER -146.51 163.11 36.77 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.849 0.357 . . . . 0.0 110.057 176.316 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.848 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 10.5 ptp180 -103.32 -178.21 3.6 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.382 -178.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 2.9 m -105.81 77.45 0.41 Allowed Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.909 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 1.4 Cg_endo -88.82 173.78 4.13 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 124.934 3.756 . . . . 0.0 111.278 174.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -127.53 175.73 8.02 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 122.147 -0.346 . . . . 0.0 110.452 174.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.721 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -66.03 -1.69 3.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.587 0.708 . . . . 0.0 110.55 174.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -100.18 3.97 44.08 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.674 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.453 ' C ' ' HD2' ' A' ' 253' ' ' LYS . 2.2 m-20 -102.73 49.58 0.84 Allowed 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . 0.453 ' HD2' ' C ' ' A' ' 252' ' ' ASP . 0.0 OUTLIER 60.36 30.88 20.17 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -169.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . 0.721 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 32.0 p 59.37 74.65 0.43 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 113.388 -1.733 . . . . 0.0 112.16 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.435 ' HB1' ' CE2' ' A' ' 286' ' ' PHE . . . -115.77 150.46 36.88 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.008 174.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.775 ' HB3' HD11 ' A' ' 258' ' ' LEU . 0.0 OUTLIER -77.38 138.55 39.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.437 -174.497 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.909 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -90.55 94.45 9.71 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.336 0.588 . . . . 0.0 110.381 173.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.966 HD13 ' HG2' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -146.04 166.97 24.52 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.83 -175.467 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.443 ' O ' HG13 ' A' ' 242' ' ' VAL . 12.2 pt-20 -138.68 -166.48 2.02 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.08 0.467 . . . . 0.0 111.491 -169.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 2.3 p -67.09 116.82 6.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.199 175.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 103.2 -1.85 47.18 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 114.801 -1.09 . . . . 0.0 112.66 169.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.433 ' HG3' ' HG2' ' A' ' 259' ' ' GLU . 18.2 mt-10 -80.87 169.83 17.06 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.204 0.526 . . . . 0.0 111.123 -174.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.694 HD11 ' HB3' ' A' ' 239' ' ' TYR . 10.2 tp -132.6 151.0 52.07 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.317 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.706 HG11 HD23 ' A' ' 258' ' ' LEU . 18.4 m -148.12 173.71 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.088 -176.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.452 ' HG3' ' CE1' ' A' ' 239' ' ' TYR . 5.0 ttmm -119.72 95.55 4.82 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 175.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.814 ' HB ' HD13 ' A' ' 238' ' ' ILE . 53.8 t -69.19 115.05 6.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.136 0.493 . . . . 0.0 110.436 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 40.5 p -93.37 -7.97 43.2 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.261 -174.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 3.2 tppp? -129.5 104.82 7.69 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.59 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.8 OUTLIER -107.83 157.62 7.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.629 0.728 . . . . 0.0 112.82 -173.39 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.632 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 4.7 p30 -147.37 -176.81 5.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.359 -173.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 32.0 m -110.73 15.45 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.3 m -109.66 -43.33 4.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.073 0.463 . . . . 0.0 110.382 176.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . 0.785 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 123.73 -9.91 8.56 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.544 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.9 OUTLIER -95.37 90.13 5.7 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.659 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.632 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -115.87 171.36 7.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.112 -173.523 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.664 ' O ' HG13 ' A' ' 266' ' ' VAL . 36.0 mt-10 -96.05 122.81 39.28 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 174.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.598 ' HA2' HG22 ' A' ' 266' ' ' VAL . . . -104.51 134.09 11.83 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.182 -171.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 34.0 tt0 -120.47 119.37 32.8 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 117.542 0.671 . . . . 0.0 109.584 178.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' CYS . . . . . 0.535 ' HB2' HG12 ' A' ' 264' ' ' VAL . 36.2 t -111.11 98.21 7.36 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.677 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 43.0 57.32 3.71 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 124.141 0.9 . . . . 0.0 112.232 174.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 114.38 -34.3 4.99 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.9 174.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . 0.567 ' HD2' ' H ' ' A' ' 282' ' ' LYS . 4.1 mptt -98.87 138.89 35.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.332 0.566 . . . . 0.0 109.592 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . 0.45 ' H ' ' HD2' ' A' ' 283' ' ' ARG . 0.0 OUTLIER -121.54 129.11 52.68 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.454 0.645 . . . . 0.0 111.094 176.621 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . 0.574 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . -149.94 145.78 14.26 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.714 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -101.55 138.16 38.92 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 117.918 0.859 . . . . 0.0 111.953 -172.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.562 ' CG ' ' HE2' ' A' ' 245' ' ' LYS . 9.5 m-85 -154.44 163.54 23.87 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.635 -175.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 68.3 Cg_endo -96.79 174.67 0.73 Allowed 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 123.69 2.926 . . . . 0.0 115.203 -173.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.785 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 32.4 t80 -82.14 -21.76 36.46 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 113.978 -1.464 . . . . 0.0 112.716 -171.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 9.9 t -58.62 -13.15 5.11 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -171.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . 0.534 ' HB2' ' HB2' ' A' ' 244' ' ' GLN . 1.1 p-80 -141.64 44.28 1.72 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.962 0.41 . . . . 0.0 111.957 -177.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.419 ' O ' ' HD2' ' A' ' 292' ' ' ARG . 12.6 m -135.0 156.96 40.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.496 0.665 . . . . 0.0 112.022 177.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.419 ' HD2' ' O ' ' A' ' 291' ' ' VAL . 22.7 mmm180 -127.53 106.7 9.36 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 166.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . 0.431 HD12 ' CB ' ' A' ' 240' ' ' ALA . 1.8 mm? -92.21 143.46 26.4 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.63 -0.669 . . . . 0.0 112.242 -170.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.459 HD23 ' N ' ' A' ' 294' ' ' LEU . 4.1 mt . . . . . 0 C--N 1.318 -0.782 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 164.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.676 ' HB2' ' HD3' ' A' ' 265' ' ' LYS . 6.9 Cg_endo . . . . . 0 N--CA 1.448 -1.161 0 N-CA-C 110.788 -0.505 . . . . 0.0 110.788 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 1.034 HG12 HG22 ' A' ' 266' ' ' VAL . 2.2 pt -82.38 158.67 3.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.642 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.709 ' HB3' HD21 ' A' ' 263' ' ' LEU . 36.1 m-85 -104.79 117.11 33.25 Favored 'General case' 0 C--O 1.21 -1.025 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 169.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.654 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -113.34 116.54 29.86 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.187 -172.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.417 ' HB3' ' O ' ' A' ' 292' ' ' ARG . 22.7 tpp180 -74.88 101.68 4.48 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.803 -1.09 . . . . 0.0 108.287 175.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.601 HG21 ' HD3' ' A' ' 245' ' ' LYS . 7.6 p -83.59 124.57 39.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.153 -175.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.9 pp -102.36 1.66 10.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.109 -173.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.507 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 52.5 tt0 -177.37 98.51 0.05 OUTLIER 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.94 -176.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.659 ' HE2' HD11 ' A' ' 258' ' ' LEU . 0.0 OUTLIER -146.09 163.29 35.76 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.272 0.558 . . . . 0.0 110.156 173.179 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.771 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 5.7 ptp180 -94.82 -174.35 3.25 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.306 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 2.8 m -108.98 69.31 0.38 Allowed Pre-proline 0 CA--C 1.536 0.426 0 CA-C-O 121.246 0.546 . . . . 0.0 111.615 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.976 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 57.0 Cg_endo -95.86 122.25 0.27 Allowed 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 124.645 3.563 . . . . 0.0 111.442 178.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -79.35 175.66 10.4 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.989 0.423 . . . . 0.0 110.966 -176.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -65.02 -0.53 1.61 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.179 0.514 . . . . 0.0 111.375 177.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -103.67 8.61 37.43 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.087 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -98.12 53.47 1.08 Allowed 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . 0.535 ' N ' ' HD3' ' A' ' 253' ' ' LYS . 0.1 OUTLIER 61.42 28.99 18.26 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -167.399 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 26.5 p 62.09 87.01 0.1 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.197 -1.365 . . . . 0.0 110.942 -176.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.648 ' HB3' ' HB2' ' A' ' 248' ' ' PRO . . . -123.72 165.64 16.91 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.785 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.602 ' H ' ' HE2' ' A' ' 286' ' ' PHE . 4.3 mm? -89.07 114.96 26.24 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.009 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.976 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -85.31 87.14 7.35 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.59 0.709 . . . . 0.0 110.413 177.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.659 HD11 ' HE2' ' A' ' 245' ' ' LYS . 0.4 OUTLIER -151.98 167.2 29.15 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.869 -173.247 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.543 ' O ' HG13 ' A' ' 242' ' ' VAL . 11.1 pt-20 -141.89 -161.89 1.31 Allowed 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.755 -0.591 . . . . 0.0 111.903 -170.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 2.7 p -65.06 119.13 8.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.494 0.664 . . . . 0.0 112.112 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 106.26 -2.67 37.51 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.927 171.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -90.99 -177.78 5.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.782 0.325 . . . . 0.0 111.434 -171.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.709 HD21 ' HB3' ' A' ' 239' ' ' TYR . 3.3 tm? -131.18 120.08 22.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.944 0.402 . . . . 0.0 110.458 -176.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.654 HG13 ' HB3' ' A' ' 240' ' ' ALA . 2.5 p -115.63 116.88 53.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.637 175.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.676 ' HD3' ' HB2' ' A' ' 237' ' ' PRO . 0.0 OUTLIER -89.41 98.64 11.88 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.006 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 1.034 HG22 HG12 ' A' ' 238' ' ' ILE . 6.1 m -79.12 122.89 35.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.533 0.682 . . . . 0.0 110.969 -176.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . 0.516 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 36.4 p -86.47 -19.48 29.5 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.426 -174.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.902 ' HA ' ' HE3' ' A' ' 268' ' ' LYS . 0.1 OUTLIER -123.11 105.95 10.36 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -178.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.42 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.7 OUTLIER -94.32 157.25 3.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -172.774 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.722 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 3.4 p30 -146.43 179.83 7.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.724 -179.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 10.2 p -93.36 -18.85 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -173.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 33.5 m -94.65 -34.91 12.41 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -176.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . 0.767 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 115.29 -2.81 22.25 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.929 -177.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 1.9 mp0 -89.93 76.79 7.03 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 175.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.722 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -115.1 173.02 6.71 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.532 0.682 . . . . 0.0 111.808 -171.636 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 36.1 mt-10 -96.85 125.55 41.38 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.132 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.658 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -111.25 155.02 16.37 Favored Glycine 0 N--CA 1.437 -1.265 0 CA-C-N 114.669 -1.151 . . . . 0.0 112.509 -169.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.597 ' HG2' ' HG3' ' A' ' 283' ' ' ARG . 6.1 tm-20 -139.47 119.7 13.74 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 174.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' CYS . . . . . 0.576 ' O ' ' HD3' ' A' ' 282' ' ' LYS . 12.4 t -124.46 99.85 6.39 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.829 -173.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.443 HD22 ' N ' ' A' ' 280' ' ' ASN . 0.9 OUTLIER 51.66 38.01 21.57 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.808 0.693 . . . . 0.0 111.672 170.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 114.93 -26.42 9.35 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.187 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . 0.576 ' HD3' ' O ' ' A' ' 279' ' ' CYS . 0.1 OUTLIER -81.93 137.04 35.25 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 177.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . 0.597 ' HG3' ' HG2' ' A' ' 278' ' ' GLU . 0.1 OUTLIER -128.15 140.07 52.13 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.927 177.783 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 177.48 -145.51 7.2 Favored Glycine 0 C--O 1.222 -0.6 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.103 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' HIS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 13.7 p80 -150.54 140.2 21.66 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.665 0.233 . . . . 0.0 111.252 -178.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.602 ' HE2' ' H ' ' A' ' 256' ' ' LEU . 9.9 m-85 -157.44 159.31 30.9 Favored Pre-proline 0 N--CA 1.469 0.5 0 C-N-CA 122.249 0.22 . . . . 0.0 111.11 -177.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 63.7 Cg_endo -92.86 176.9 1.52 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.246 2.631 . . . . 0.0 114.435 -173.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.767 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 21.2 t80 -80.64 -33.62 35.55 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 113.816 -1.538 . . . . 0.0 112.657 -168.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 6.6 t -55.77 -33.72 64.6 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -168.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . 0.555 ' CD2' ' HD2' ' A' ' 245' ' ' LYS . 1.2 p-80 -115.05 49.27 1.07 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.605 0.717 . . . . 0.0 110.845 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -150.04 155.64 7.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.551 175.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.417 ' O ' ' HB3' ' A' ' 241' ' ' ARG . 29.2 mmm180 -130.83 107.42 9.12 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 175.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . 0.612 ' H ' HD23 ' A' ' 293' ' ' LEU . 0.3 OUTLIER -102.04 136.14 42.4 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -162.735 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 239' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.439 -1.02 0 CA-C-N 113.96 -1.473 . . . . 0.0 107.373 170.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.464 ' HB3' ' HA ' ' A' ' 267' ' ' THR . 7.1 Cg_exo . . . . . 0 N--CA 1.459 -0.501 0 CA-C-O 120.961 0.317 . . . . 0.0 112.003 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.965 HG12 HG22 ' A' ' 266' ' ' VAL . 0.2 OUTLIER -92.8 167.47 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.545 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.7 ' HB3' HD11 ' A' ' 263' ' ' LEU . 72.4 m-85 -106.64 127.73 53.59 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 170.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.513 ' HB3' ' CG1' ' A' ' 264' ' ' VAL . . . -114.39 118.16 33.07 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.528 -176.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.608 ' NH1' ' HA2' ' A' ' 261' ' ' GLY . 0.1 OUTLIER -88.8 100.82 13.45 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.297 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 1.016 HG21 ' HD2' ' A' ' 245' ' ' LYS . 7.2 p -86.56 127.15 40.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.071 -172.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.8 pp -100.29 3.28 10.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.4 -174.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.532 ' H ' HG22 ' A' ' 242' ' ' VAL . 7.2 tp-100 -177.33 106.91 0.06 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -176.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 1.061 ' HD3' ' HB2' ' A' ' 258' ' ' LEU . 14.7 tttt -144.63 157.15 44.33 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 177.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.81 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 16.4 ptt180 -103.92 -175.14 2.71 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 6.8 m -110.51 69.37 0.58 Allowed Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 121.177 0.513 . . . . 0.0 111.987 -174.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 1.017 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 17.8 Cg_endo -94.47 124.51 0.42 Allowed 'Trans proline' 0 N--CA 1.444 -1.433 0 C-N-CA 124.285 3.324 . . . . 0.0 111.175 176.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.417 ' C ' ' H ' ' A' ' 251' ' ' TYR . 7.0 m-20 -81.46 176.92 9.28 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.022 0.439 . . . . 0.0 111.043 -174.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.607 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -67.77 4.86 0.99 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.202 0.525 . . . . 0.0 111.281 177.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.417 ' H ' ' C ' ' A' ' 249' ' ' ASN . 44.8 m-85 -106.5 5.74 29.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.553 0.692 . . . . 0.0 109.572 176.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.423 ' C ' ' HD2' ' A' ' 253' ' ' LYS . 3.7 m-20 -101.17 55.73 0.84 Allowed 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . 0.423 ' HD2' ' C ' ' A' ' 252' ' ' ASP . 0.0 OUTLIER 59.0 27.01 15.78 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -169.568 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . 0.607 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 30.2 p 61.42 85.19 0.12 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.63 -176.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.685 ' HB3' ' HB2' ' A' ' 248' ' ' PRO . . . -118.31 165.63 13.6 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.499 178.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.961 ' HB3' HD13 ' A' ' 258' ' ' LEU . 3.8 mm? -88.35 112.78 23.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.632 178.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.017 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -82.32 81.86 8.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.6 0.714 . . . . 0.0 110.234 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 1.061 ' HB2' ' HD3' ' A' ' 245' ' ' LYS . 6.1 mp -122.83 177.92 5.26 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.382 -171.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -143.71 -169.31 3.05 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.156 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 2.3 p -65.71 121.06 14.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.247 177.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.608 ' HA2' ' NH1' ' A' ' 241' ' ' ARG . . . 103.44 -2.22 46.39 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.486 171.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -88.76 174.99 7.68 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.991 0.424 . . . . 0.0 111.261 -171.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.7 HD11 ' HB3' ' A' ' 239' ' ' TYR . 21.5 tp -130.0 158.85 38.45 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.222 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.823 HG23 ' HB2' ' A' ' 279' ' ' CYS . 8.3 p -151.13 150.71 13.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.427 ' HD3' ' HB2' ' A' ' 237' ' ' PRO . 0.0 OUTLIER -110.34 97.92 7.27 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.22 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.965 HG22 HG12 ' A' ' 238' ' ' ILE . 15.5 m -74.39 113.3 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 121.972 0.891 . . . . 0.0 110.43 -178.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . 0.464 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 61.0 p -92.34 0.52 57.45 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.095 -174.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.65 107.14 6.48 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.375 172.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.605 HG21 HG23 ' A' ' 238' ' ' ILE . 0.8 OUTLIER -104.21 160.86 4.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 114.34 -1.3 . . . . 0.0 113.102 -170.25 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.717 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 3.8 p30 -146.87 171.62 14.92 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.815 -176.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 27.0 m -87.04 5.06 3.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -175.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 4.4 m -111.54 -43.42 3.67 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . 0.439 ' HA2' ' CZ2' ' A' ' 275' ' ' TRP . . . 120.24 -0.4 12.92 Favored Glycine 0 C--O 1.223 -0.543 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.021 -175.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.592 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.2 OUTLIER -98.04 77.64 2.47 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.813 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.717 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -117.87 169.88 9.27 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.461 -167.457 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.595 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 39.9 mt-10 -90.68 126.29 35.93 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.228 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.654 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -111.36 146.37 17.78 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.294 -170.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 4.3 tm-20 -133.7 116.51 15.87 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' CYS . . . . . 0.823 ' HB2' HG23 ' A' ' 264' ' ' VAL . 10.5 t -115.7 99.0 7.0 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.744 0.783 . . . . 0.0 110.009 -177.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 31.63 55.89 0.29 Allowed 'General case' 0 C--N 1.343 0.301 0 CA-C-N 112.918 -1.947 . . . . 0.0 113.525 175.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.82 -14.41 14.37 Favored Glycine 0 CA--C 1.522 0.495 0 CA-C-N 115.933 -0.576 . . . . 0.0 113.51 176.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 19.0 mttt -108.38 128.64 54.94 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 117.213 0.506 . . . . 0.0 109.699 177.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . 0.491 ' C ' ' HD3' ' A' ' 283' ' ' ARG . 0.2 OUTLIER -123.21 143.95 49.69 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.276 -0.569 . . . . 0.0 111.173 179.637 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 176.63 -145.1 7.24 Favored Glycine 0 C--O 1.224 -0.508 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.243 178.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' HIS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 13.6 p80 -150.15 147.65 28.0 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.852 0.326 . . . . 0.0 110.822 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.64 ' HD1' ' HD2' ' A' ' 287' ' ' PRO . 2.5 m-85 -161.68 153.93 16.57 Favored Pre-proline 0 N--CA 1.467 0.398 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -178.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.64 ' HD2' ' HD1' ' A' ' 286' ' ' PHE . 87.4 Cg_endo -88.32 165.1 6.8 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.399 2.733 . . . . 0.0 112.513 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.608 ' HA ' HG12 ' A' ' 291' ' ' VAL . 9.4 p90 -88.16 -4.77 58.69 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -172.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 5.6 t -56.76 -11.38 1.37 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -177.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -133.47 30.76 3.8 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 122.259 -0.276 . . . . 0.0 111.149 -175.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.709 HG23 ' HA ' ' A' ' 242' ' ' VAL . 9.5 p -147.35 157.6 9.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 C-N-CA 119.759 -0.776 . . . . 0.0 112.005 -170.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.447 ' HA ' ' HD2' ' A' ' 292' ' ' ARG . 25.3 tpt180 -125.98 109.74 12.79 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . 0.561 HD22 ' H ' ' A' ' 293' ' ' LEU . 0.4 OUTLIER -86.42 150.16 24.5 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 119.562 -0.855 . . . . 0.0 113.22 -165.522 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 239' ' ' TYR . 11.3 mt . . . . . 0 N--CA 1.433 -1.283 0 N-CA-C 105.153 -2.165 . . . . 0.0 105.153 163.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo . . . . . 0 CA--C 1.52 -0.191 0 CA-C-O 121.661 0.609 . . . . 0.0 113.135 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.942 HG23 ' HB ' ' A' ' 266' ' ' VAL . 0.1 OUTLIER -90.02 151.52 3.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.211 175.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.584 ' HD1' HD11 ' A' ' 263' ' ' LEU . 27.4 m-85 -109.64 117.37 33.76 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.616 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -115.15 117.17 29.78 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.413 0.625 . . . . 0.0 111.447 -171.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 241' ' ' ARG . 4.2 tpp85 -74.89 104.79 5.64 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.847 174.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.787 HG21 ' HD3' ' A' ' 245' ' ' LYS . 7.5 p -84.24 133.46 29.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.23 0.538 . . . . 0.0 110.852 -176.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.636 HD12 ' HB2' ' A' ' 244' ' ' GLN . 2.4 pp -115.19 3.99 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.919 -171.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.636 ' HB2' HD12 ' A' ' 243' ' ' ILE . 5.3 mt-30 -173.94 94.14 0.09 Allowed 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 123.202 0.314 . . . . 0.0 110.5 -175.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.787 ' HD3' HG21 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -147.1 162.99 37.71 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.238 0.542 . . . . 0.0 110.427 173.437 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.855 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 4.5 ptt180 -101.59 -176.42 3.13 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.978 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.4 77.96 0.23 Allowed Pre-proline 0 CA--C 1.542 0.644 0 O-C-N 122.156 -0.34 . . . . 0.0 111.382 175.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 1.032 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 12.7 Cg_endo -94.55 142.23 1.44 Allowed 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.54 3.494 . . . . 0.0 112.214 175.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.406 ' O ' ' HB2' ' A' ' 252' ' ' ASP . 15.1 m120 -96.78 177.06 5.76 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.731 -177.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.764 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -63.95 -7.63 8.93 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 121.823 0.821 . . . . 0.0 110.197 172.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -95.04 6.79 48.08 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.065 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 249' ' ' ASN . 1.1 m-20 -105.04 48.11 0.85 Allowed 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . 0.478 ' N ' ' HD2' ' A' ' 253' ' ' LYS . 0.1 OUTLIER 60.42 32.7 20.66 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -167.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . 0.764 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 23.4 p 57.03 77.55 0.26 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.166 -1.379 . . . . 0.0 111.158 -179.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.62 ' HB3' ' HB2' ' A' ' 248' ' ' PRO . . . -117.77 167.14 11.65 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.024 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.537 ' H ' ' HE2' ' A' ' 286' ' ' PHE . 4.6 mm? -88.55 118.8 28.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.909 -175.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.032 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -83.54 90.64 7.27 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.768 0.794 . . . . 0.0 110.547 175.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.658 ' O ' ' HB3' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -150.72 167.52 27.14 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.04 -176.183 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.457 ' CG ' ' N ' ' A' ' 260' ' ' VAL . 24.7 tt0 -142.93 177.24 8.49 Favored 'General case' 0 C--N 1.313 -1.005 0 O-C-N 122.088 -0.383 . . . . 0.0 110.547 -164.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 243' ' ' ILE . 57.8 t -50.05 118.52 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 122.906 0.482 . . . . 0.0 111.479 174.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 106.1 -2.32 38.01 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.58 170.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -98.23 -173.59 2.62 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.875 0.369 . . . . 0.0 111.725 -172.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.584 HD11 ' HD1' ' A' ' 239' ' ' TYR . 3.3 tm? -129.47 131.14 46.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.525 -173.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.616 HG13 ' HB3' ' A' ' 240' ' ' ALA . 2.4 p -123.39 124.49 69.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.435 174.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -82.68 112.24 19.36 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 175.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.942 ' HB ' HG23 ' A' ' 238' ' ' ILE . 94.8 t -77.06 112.91 15.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 65.8 p -94.65 -32.89 13.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.962 -171.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.579 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 11.9 tppt? -116.16 107.56 15.05 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.477 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.7 OUTLIER -96.74 140.25 17.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -168.134 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.904 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 0.3 OUTLIER -148.06 149.07 31.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.852 178.118 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 10.9 p -65.37 -17.4 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -173.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 3.9 p -78.26 -30.68 48.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.914 0.388 . . . . 0.0 111.995 -177.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . 0.605 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 94.96 -5.67 68.99 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.464 -177.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.64 ' HG3' ' HB3' ' A' ' 287' ' ' PRO . 1.7 mp0 -92.56 77.41 5.0 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 174.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.904 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -122.76 178.42 5.03 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.489 -0.778 . . . . 0.0 113.042 -167.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 268' ' ' LYS . 40.2 mt-10 -83.33 127.47 33.69 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.525 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.448 ' O ' HD21 ' A' ' 256' ' ' LEU . . . -111.75 156.44 15.57 Favored Glycine 0 N--CA 1.433 -1.528 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.615 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 21.2 tt0 -141.88 119.43 11.68 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' CYS . . . . . 0.479 ' HB2' HD23 ' A' ' 258' ' ' LEU . 51.6 t -115.2 99.06 7.14 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.061 -176.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 45.18 45.12 9.23 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 124.065 0.853 . . . . 0.0 111.958 176.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 114.86 -33.51 5.31 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.202 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 12.2 mptt -73.32 139.69 46.22 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 117.178 0.489 . . . . 0.0 110.084 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -124.01 142.05 51.51 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.216 0.531 . . . . 0.0 111.921 -176.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 169.49 -145.54 9.41 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.391 175.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' HIS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 7.5 p80 -150.35 147.53 27.72 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.936 0.368 . . . . 0.0 111.191 -177.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.61 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 2.1 m-85 -158.18 150.74 17.93 Favored Pre-proline 0 N--CA 1.466 0.331 0 CA-C-O 120.936 0.398 . . . . 0.0 112.052 -178.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.64 ' HB3' ' HG3' ' A' ' 274' ' ' GLN . 2.4 Cg_endo -81.34 174.32 10.76 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.915 3.076 . . . . 0.0 114.152 -178.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.605 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 24.9 t80 -87.77 -35.67 17.74 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -167.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 4.1 t -65.41 -7.27 13.1 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -164.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . 0.534 ' NE2' ' HD2' ' A' ' 245' ' ' LYS . 1.1 p-80 -120.35 31.82 6.3 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.907 -0.496 . . . . 0.0 110.92 178.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.673 HG23 ' HA ' ' A' ' 242' ' ' VAL . 4.0 p -147.23 154.19 11.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.296 0.569 . . . . 0.0 111.566 -175.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -131.95 110.25 10.63 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 240' ' ' ALA . 0.2 OUTLIER -118.02 135.68 54.01 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -162.18 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.443 ' H ' HD12 ' A' ' 294' ' ' LEU . 5.3 mp . . . . . 0 N--CA 1.439 -0.981 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.864 168.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.503 ' HB3' ' HA ' ' A' ' 267' ' ' THR . 6.2 Cg_exo . . . . . 0 N--CA 1.455 -0.748 0 CA-C-O 120.285 0.035 . . . . 0.0 112.116 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.869 HD13 ' HB ' ' A' ' 266' ' ' VAL . 0.2 OUTLIER -87.01 163.55 2.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.553 176.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.819 ' HB3' HD11 ' A' ' 263' ' ' LEU . 67.7 m-85 -104.92 123.49 47.84 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 171.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.694 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -112.52 118.62 35.62 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.861 -174.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 292' ' ' ARG . 0.0 OUTLIER -75.89 100.86 4.95 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.7 HG21 ' HB2' ' A' ' 245' ' ' LYS . 3.3 p -82.63 121.01 35.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.111 -176.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.708 HD12 ' HB2' ' A' ' 244' ' ' GLN . 2.8 pp -105.85 10.55 9.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.708 -175.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.708 ' HB2' HD12 ' A' ' 243' ' ' ILE . 1.0 OUTLIER -177.0 94.95 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.272 -176.642 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.7 ' HB2' HG21 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -147.09 164.68 32.31 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.27 0.557 . . . . 0.0 111.202 174.335 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.818 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 3.2 ptm180 -101.06 -177.96 3.61 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.525 -177.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 46.2 t -104.67 81.91 0.6 Allowed Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 121.201 0.524 . . . . 0.0 110.918 174.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.95 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 4.6 Cg_endo -91.03 175.46 2.44 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 124.959 3.773 . . . . 0.0 111.881 174.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -138.55 179.91 6.19 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.146 176.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.751 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -57.25 -12.59 2.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.877 0.37 . . . . 0.0 111.89 176.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -91.34 -5.71 54.16 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 122.081 -0.387 . . . . 0.0 110.486 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -92.06 48.35 1.42 Allowed 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? 59.01 24.5 12.74 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -167.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . 0.751 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 19.3 p 64.98 83.35 0.17 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.405 -1.271 . . . . 0.0 110.885 -177.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.634 ' HB1' ' CE2' ' A' ' 286' ' ' PHE . . . -122.33 159.25 27.84 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.466 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.568 HD22 ' HA3' ' A' ' 284' ' ' GLY . 0.7 OUTLIER -78.27 123.91 27.48 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.251 -174.849 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.95 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -84.28 93.96 8.33 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.561 0.696 . . . . 0.0 111.171 172.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.644 ' O ' ' HB3' ' A' ' 245' ' ' LYS . 0.2 OUTLIER -155.6 167.98 28.64 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.623 -177.133 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.436 ' O ' HG13 ' A' ' 242' ' ' VAL . 12.3 pt-20 -141.78 -165.2 1.94 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.916 -0.49 . . . . 0.0 111.855 -172.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 43.0 t -59.63 118.38 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 96.71 0.18 60.76 Favored Glycine 0 CA--C 1.508 -0.396 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.165 170.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -89.74 -175.93 4.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.72 0.295 . . . . 0.0 110.396 -176.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.819 HD11 ' HB3' ' A' ' 239' ' ' TYR . 44.4 tp -130.0 159.84 35.46 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.01 0.433 . . . . 0.0 111.322 -176.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.694 HG13 ' HB3' ' A' ' 240' ' ' ALA . 2.4 p -152.24 133.82 5.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.019 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.464 ' HE2' ' HG2' ' A' ' 237' ' ' PRO . 86.1 tttt -96.16 96.36 8.77 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.246 0.546 . . . . 0.0 109.833 178.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.869 ' HB ' HD13 ' A' ' 238' ' ' ILE . 50.3 t -76.98 114.72 17.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.043 0.449 . . . . 0.0 111.473 -178.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . 0.503 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 42.0 p -90.8 -10.45 42.79 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.49 -174.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.52 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 13.3 tppt? -127.21 105.94 8.9 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.818 HG21 HG23 ' A' ' 238' ' ' ILE . 0.8 OUTLIER -111.65 140.25 32.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -170.391 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.866 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 0.2 OUTLIER -148.6 140.44 23.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.634 177.766 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 10.6 p -58.68 -15.07 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -172.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.4 m -62.0 -36.11 80.54 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.297 0.481 . . . . 0.0 112.297 -177.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . 0.536 ' CA ' ' HB2' ' A' ' 288' ' ' PHE . . . 89.11 36.43 7.64 Favored Glycine 0 N--CA 1.437 -1.299 0 C-N-CA 119.908 -1.139 . . . . 0.0 110.797 -170.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 1.0 OUTLIER -148.7 96.92 2.65 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 171.163 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.866 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -134.15 173.07 12.0 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -168.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.728 ' O ' HG13 ' A' ' 266' ' ' VAL . 18.4 mm-40 -90.06 123.39 33.89 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.348 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -105.37 162.12 14.48 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -175.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.537 ' HG2' ' HG3' ' A' ' 283' ' ' ARG . 3.5 tm-20 -151.47 120.17 6.54 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 174.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 43.4 t -122.64 97.68 5.57 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.668 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 45.17 49.92 9.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.329 170.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.49 -27.31 8.08 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.684 -0.77 . . . . 0.0 113.4 177.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.85 128.58 41.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 117.311 0.556 . . . . 0.0 110.166 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . 0.537 ' HG3' ' HG2' ' A' ' 278' ' ' GLU . 0.4 OUTLIER -109.0 136.44 48.52 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.185 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . 0.568 ' HA3' HD22 ' A' ' 256' ' ' LEU . . . -161.94 -171.98 28.74 Favored Glycine 0 C--O 1.226 -0.395 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.599 -176.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -147.02 135.79 22.17 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 172.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.688 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 4.4 m-85 -154.81 158.63 32.2 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -173.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 56.9 Cg_endo -94.93 164.68 1.69 Allowed 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.442 2.761 . . . . 0.0 113.938 -176.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.662 ' HA ' HG22 ' A' ' 291' ' ' VAL . 9.1 t80 -74.86 -18.47 60.43 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.131 -174.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 8.9 t -48.31 -24.91 1.35 Allowed 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 -175.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . 0.499 ' NE2' ' HD2' ' A' ' 245' ' ' LYS . 0.8 OUTLIER -137.51 48.19 2.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.807 0.337 . . . . 0.0 111.86 -177.839 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.662 HG22 ' HA ' ' A' ' 288' ' ' PHE . 30.1 m -143.22 155.09 16.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 121.102 0.477 . . . . 0.0 111.208 173.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.478 ' HD2' ' O ' ' A' ' 291' ' ' VAL . 15.9 mmm180 -121.79 110.43 15.9 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 173.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . 0.518 HD22 ' HE2' ' A' ' 288' ' ' PHE . 2.6 tp -94.24 126.92 39.78 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -160.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.535 HD13 ' N ' ' A' ' 294' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.448 -0.573 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 163.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.536 ' HA ' ' O ' ' A' ' 266' ' ' VAL . 10.1 Cg_endo . . . . . 0 N--CA 1.446 -1.277 0 CA-C-O 120.971 0.321 . . . . 0.0 112.413 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 1.089 HD11 ' HB2' ' A' ' 240' ' ' ALA . 0.1 OUTLIER -92.46 144.6 8.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 171.682 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.798 ' HD1' HD11 ' A' ' 263' ' ' LEU . 46.7 m-85 -96.96 119.53 35.6 Favored 'General case' 0 C--O 1.21 -1.01 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 173.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 1.089 ' HB2' HD11 ' A' ' 238' ' ' ILE . . . -113.94 115.9 28.4 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.107 -173.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.45 ' HB3' ' O ' ' A' ' 292' ' ' ARG . 17.8 tpp180 -84.76 103.4 13.82 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.189 -1.369 . . . . 0.0 108.375 177.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 1.049 HG11 ' HD2' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -89.75 149.47 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.546 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.669 -177.245 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.503 HD12 ' HB2' ' A' ' 244' ' ' GLN . 2.3 pp -124.88 11.23 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-N 113.544 -1.662 . . . . 0.0 110.654 -171.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.808 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 52.9 tt0 -177.23 94.6 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.63 -174.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 1.049 ' HD2' HG11 ' A' ' 242' ' ' VAL . 5.3 mttt -146.93 162.79 37.99 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.966 0.412 . . . . 0.0 110.11 177.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.868 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 10.7 ptm180 -113.37 -177.26 3.09 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.494 -174.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 9.3 m -102.57 81.83 0.4 Allowed Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 121.488 0.661 . . . . 0.0 112.091 174.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.97 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 1.1 Cg_endo -90.84 177.03 2.21 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 125.063 3.842 . . . . 0.0 110.573 171.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -131.36 175.43 9.14 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.105 0.478 . . . . 0.0 110.622 175.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.635 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -66.96 -2.97 5.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.316 0.579 . . . . 0.0 110.883 176.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -95.79 1.35 53.2 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.295 177.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -97.96 51.08 1.03 Allowed 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . 0.709 ' HE2' ' HA ' ' A' ' 253' ' ' LYS . 10.7 mmpt? 62.11 26.7 16.08 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -168.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . 0.635 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 24.4 p 63.83 86.05 0.13 Allowed 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 125.107 1.504 . . . . 0.0 110.699 -175.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.418 ' HB1' ' CE2' ' A' ' 286' ' ' PHE . . . -121.66 156.55 32.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.186 178.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.596 HD21 ' O ' ' A' ' 277' ' ' GLY . 4.3 mm? -78.53 131.23 36.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.841 -178.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.97 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -92.03 99.05 11.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.361 0.6 . . . . 0.0 110.355 171.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.793 HD13 ' CD ' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -153.3 174.4 14.35 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.371 -175.332 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.431 ' CG ' ' N ' ' A' ' 260' ' ' VAL . 32.3 tt0 -142.84 175.73 9.61 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 122.128 -0.357 . . . . 0.0 111.073 -165.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.574 HG22 ' HA ' ' A' ' 244' ' ' GLN . 56.0 t -57.07 118.71 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 123.083 0.553 . . . . 0.0 111.351 175.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 104.53 -1.19 42.71 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -97.79 -179.16 4.34 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.676 -169.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.798 HD11 ' HD1' ' A' ' 239' ' ' TYR . 2.3 tm? -134.16 134.29 41.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.07 0.462 . . . . 0.0 110.613 -170.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.606 HG12 ' HB3' ' A' ' 240' ' ' ALA . 5.4 p -125.54 145.3 33.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.453 173.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -99.79 99.65 10.49 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 175.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.941 ' HB ' HG23 ' A' ' 238' ' ' ILE . 76.0 t -70.06 114.14 7.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.324 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 33.2 p -92.6 -32.3 14.85 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.165 -171.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.36 107.65 15.08 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 121.598 0.713 . . . . 0.0 109.831 175.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.434 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.6 OUTLIER -93.91 154.1 3.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 113.877 -1.511 . . . . 0.0 113.366 -170.024 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.754 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 2.4 p30 -145.89 -178.62 6.21 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.688 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 53.6 t -87.63 -38.81 12.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.5 m -73.33 -28.15 61.91 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -172.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . 0.853 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 102.99 0.66 48.42 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.582 -175.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.426 ' NE2' ' HB3' ' A' ' 287' ' ' PRO . 0.2 OUTLIER -89.96 76.14 7.1 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.9 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.754 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -122.33 175.66 6.29 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.619 0.723 . . . . 0.0 112.709 -170.033 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 284' ' ' GLY . 43.1 tt0 -98.52 127.31 44.4 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.081 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.596 ' O ' HD21 ' A' ' 256' ' ' LEU . . . -112.1 151.59 17.98 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.908 -174.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.624 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 17.2 tt0 -136.23 119.9 17.2 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 174.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 49.5 t -101.2 97.6 8.1 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.258 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 36.89 58.11 1.14 Allowed 'General case' 0 N--CA 1.465 0.282 0 O-C-N 124.542 1.151 . . . . 0.0 112.261 177.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.08 -37.51 3.39 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.661 177.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 37.3 mttt -82.13 128.28 33.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 117.808 0.804 . . . . 0.0 110.587 -178.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -110.79 141.85 43.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.344 0.592 . . . . 0.0 112.002 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . 0.492 ' O ' ' HG3' ' A' ' 276' ' ' GLU . . . -176.07 -158.89 20.77 Favored Glycine 0 C--O 1.216 -1.021 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 174.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -149.66 146.67 27.4 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 118.848 1.324 . . . . 0.0 111.842 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.418 ' CE2' ' HB1' ' A' ' 255' ' ' ALA . 4.0 m-85 -154.18 162.74 26.15 Favored Pre-proline 0 C--O 1.238 0.471 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.571 -176.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.426 ' HB3' ' NE2' ' A' ' 274' ' ' GLN . 87.5 Cg_endo -92.92 171.67 2.18 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.151 2.567 . . . . 0.0 114.177 -176.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.853 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 17.9 t80 -79.65 -16.19 56.21 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 114.112 -1.404 . . . . 0.0 111.795 -174.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 67.3 p -55.63 -28.91 57.97 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -168.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . 0.808 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 1.5 p-80 -127.88 35.77 4.43 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.617 -172.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.788 HG23 HG13 ' A' ' 242' ' ' VAL . 5.4 p -139.36 148.27 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 C-N-CA 119.428 -0.909 . . . . 0.0 112.422 -174.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 241' ' ' ARG . 26.1 mmt180 -129.95 110.93 12.06 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.0 178.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . 0.722 HD22 ' H ' ' A' ' 293' ' ' LEU . 0.1 OUTLIER -89.89 138.5 31.44 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.588 0.709 . . . . 0.0 112.779 -163.695 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 239' ' ' TYR . 7.1 mt . . . . . 0 N--CA 1.433 -1.323 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 161.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.596 ' HA ' ' O ' ' A' ' 266' ' ' VAL . 11.7 Cg_exo . . . . . 0 N--CA 1.454 -0.807 0 N-CA-C 111.137 -0.37 . . . . 0.0 111.137 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.864 HD13 ' HB ' ' A' ' 266' ' ' VAL . 0.2 OUTLIER -88.02 170.72 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.329 -177.634 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.958 ' HB3' HD21 ' A' ' 263' ' ' LEU . 81.9 m-85 -111.02 120.92 43.99 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 173.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.557 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -112.76 118.26 34.49 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.82 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.572 ' HD3' ' O ' ' A' ' 262' ' ' GLU . 0.0 OUTLIER -79.97 103.86 10.15 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.571 -177.737 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.918 ' HA ' HG12 ' A' ' 291' ' ' VAL . 2.2 t -68.88 136.19 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.225 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.2 -177.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.415 ' C ' HD12 ' A' ' 243' ' ' ILE . 2.7 pp -123.01 -1.33 6.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.406 0.622 . . . . 0.0 110.227 172.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 1.07 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 33.4 tt0 -164.37 99.72 0.82 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.713 -178.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.975 ' HG2' ' HB2' ' A' ' 258' ' ' LEU . 5.3 tptt -145.76 165.12 29.74 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.419 0.628 . . . . 0.0 110.454 176.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.835 ' HG3' ' HG3' ' A' ' 248' ' ' PRO . 3.6 ptm180 -113.03 -178.78 3.46 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.466 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 5.9 m -105.67 75.76 0.33 Allowed Pre-proline 0 CA--C 1.537 0.481 0 CA-C-O 121.103 0.478 . . . . 0.0 111.826 176.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.993 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 1.0 OUTLIER -88.28 175.5 4.0 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 124.055 3.17 . . . . 0.0 111.527 175.002 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.454 ' HB3' ' HD1' ' A' ' 251' ' ' TYR . 66.3 m-20 -132.68 179.21 6.29 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.769 176.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.87 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -56.95 -10.92 1.23 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.304 0.573 . . . . 0.0 110.895 171.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.454 ' HD1' ' HB3' ' A' ' 249' ' ' ASN . 34.4 m-85 -83.21 -11.24 58.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.677 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -96.31 45.23 1.07 Allowed 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -175.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 4.1 mmpm? 60.74 28.76 18.48 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 -168.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . 0.87 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 26.8 p 62.17 80.72 0.22 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.906 -178.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.513 ' HB1' ' CE2' ' A' ' 286' ' ' PHE . . . -117.03 156.99 26.57 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.619 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 1.024 ' HB3' HD13 ' A' ' 258' ' ' LEU . 4.5 mm? -79.1 120.32 23.47 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.389 -176.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.993 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -76.3 84.01 3.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.347 0.594 . . . . 0.0 110.867 172.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 1.024 HD13 ' HB3' ' A' ' 256' ' ' LEU . 2.4 mp -119.71 175.39 5.89 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.374 -176.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.554 ' O ' ' HB ' ' A' ' 242' ' ' VAL . 24.9 tt0 -146.17 174.61 11.17 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.403 ' N ' ' CG ' ' A' ' 259' ' ' GLU . 7.2 p -58.28 124.1 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.681 0.753 . . . . 0.0 111.825 173.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 97.9 1.5 58.54 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.192 175.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.572 ' O ' ' HD3' ' A' ' 241' ' ' ARG . 6.6 mt-10 -87.32 -174.21 4.74 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -171.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.958 HD21 ' HB3' ' A' ' 239' ' ' TYR . 3.4 tm? -140.62 131.18 25.47 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.563 -177.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.79 ' HB ' HD21 ' A' ' 258' ' ' LEU . 4.1 p -126.62 125.68 67.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.247 175.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -90.49 95.51 10.2 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.337 0.589 . . . . 0.0 109.45 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.864 ' HB ' HD13 ' A' ' 238' ' ' ILE . 48.4 t -77.84 118.21 24.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.476 -176.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 41.1 p -93.74 -12.72 28.55 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.856 -1.066 . . . . 0.0 111.593 -176.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.562 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 17.4 tppt? -119.65 104.37 10.21 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.356 174.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.534 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.8 OUTLIER -105.99 159.64 5.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -172.31 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.594 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 3.9 p30 -145.2 -166.41 2.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.658 -177.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 9.8 p -103.82 -18.01 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.883 -177.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.4 m -83.62 -45.34 13.58 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.122 -0.361 . . . . 0.0 111.263 -177.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . 0.483 ' HA3' ' CD1' ' A' ' 288' ' ' PHE . . . 124.57 -7.84 8.36 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.249 -175.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.445 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.9 OUTLIER -95.12 103.21 15.06 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 173.849 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.691 ' HZ2' HD13 ' A' ' 293' ' ' LEU . 0.0 OUTLIER -127.35 177.79 6.48 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.726 -174.213 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.736 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 46.5 mt-10 -99.08 125.12 44.52 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.576 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -108.8 154.0 16.63 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.448 -0.797 . . . . 0.0 112.636 -169.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.566 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 0.2 OUTLIER -133.3 117.43 17.34 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 172.044 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' CYS . . . . . 0.711 ' SG ' ' HD2' ' A' ' 282' ' ' LYS . 27.4 p -109.45 98.16 7.6 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.311 -176.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 9.9 m120 39.65 55.81 2.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.429 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 117.09 -39.94 2.52 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.78 -0.645 . . . . 0.0 114.054 176.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . 0.711 ' HD2' ' SG ' ' A' ' 279' ' ' CYS . 20.1 mttp -86.33 132.55 33.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 117.919 0.86 . . . . 0.0 111.287 -174.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -106.11 150.19 26.04 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.964 0.412 . . . . 0.0 111.833 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 175.52 -147.92 9.12 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.002 171.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' HIS . . . . . 0.736 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 10.2 p80 -147.62 151.38 36.12 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.705 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 0.9 OUTLIER -166.76 154.6 9.01 Favored Pre-proline 0 N--CA 1.469 0.478 0 CA-C-O 120.695 0.283 . . . . 0.0 111.492 -177.54 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.491 ' HD2' ' HD1' ' A' ' 286' ' ' PHE . 9.3 Cg_endo -90.19 163.03 4.7 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 124.049 3.166 . . . . 0.0 112.972 -177.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.542 ' HA ' HG22 ' A' ' 291' ' ' VAL . 18.4 p90 -87.8 -18.77 28.6 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -172.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 7.5 t -66.77 -4.23 8.62 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -169.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . 1.07 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 0.8 OUTLIER -130.59 33.86 4.21 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.245 173.143 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.918 HG12 ' HA ' ' A' ' 242' ' ' VAL . 26.8 m -145.03 167.34 10.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.483 173.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -123.05 109.12 13.68 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . 0.691 HD13 ' HZ2' ' A' ' 275' ' ' TRP . 0.1 OUTLIER -91.99 128.81 37.97 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.635 -0.826 . . . . 0.0 112.862 -165.6 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.451 HD23 ' N ' ' A' ' 294' ' ' LEU . 4.4 mt . . . . . 0 C--N 1.32 -0.708 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 169.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.554 ' HG2' ' HE2' ' A' ' 265' ' ' LYS . 1.2 Cg_endo . . . . . 0 N--CA 1.46 -0.445 0 N-CA-C 113.009 0.349 . . . . 0.0 113.009 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.728 HG23 HG21 ' A' ' 269' ' ' ILE . 0.2 OUTLIER -107.53 163.32 5.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 175.405 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.799 ' HB3' HD21 ' A' ' 263' ' ' LEU . 69.8 m-85 -101.86 120.75 40.89 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 174.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.76 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -113.93 117.18 30.64 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.461 0.648 . . . . 0.0 110.234 -177.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.508 ' NH1' ' HA2' ' A' ' 261' ' ' GLY . 0.6 OUTLIER -84.17 107.26 16.38 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.682 -176.046 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.76 ' HA ' HG12 ' A' ' 291' ' ' VAL . 3.9 t -69.6 131.74 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.122 -177.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.48 ' O ' HG22 ' A' ' 260' ' ' VAL . 2.8 pp -121.94 -0.52 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.015 175.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.649 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 6.7 tp-100 -178.1 95.69 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.685 -175.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.646 ' HB3' ' O ' ' A' ' 258' ' ' LEU . 0.9 OUTLIER -146.29 162.88 37.14 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.158 0.504 . . . . 0.0 110.261 177.248 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.877 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 12.1 ttt180 -95.43 179.64 5.09 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.35 -174.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.453 ' N ' ' CG ' ' A' ' 246' ' ' ARG . 8.9 m -106.36 69.68 0.23 Allowed Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 121.893 0.854 . . . . 0.0 110.805 173.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.923 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 11.6 Cg_endo -95.62 131.71 0.49 Allowed 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 125.146 3.897 . . . . 0.0 111.376 -178.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -92.39 178.26 5.88 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.58 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.641 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -59.85 -8.13 2.03 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.388 0.613 . . . . 0.0 110.999 174.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -92.14 -8.08 46.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.198 0.523 . . . . 0.0 110.118 177.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -104.67 66.85 0.8 Allowed 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.645 -174.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.97 23.66 13.78 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.179 -172.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 34.8 p 52.81 65.33 1.55 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.888 -177.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.732 ' HB1' ' CE2' ' A' ' 286' ' ' PHE . . . -109.53 158.32 18.12 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.429 -175.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.688 HD22 ' CA ' ' A' ' 284' ' ' GLY . 1.7 mm? -67.37 128.37 36.16 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.869 176.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.923 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -92.6 98.08 11.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.442 0.639 . . . . 0.0 110.311 173.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.646 ' O ' ' HB3' ' A' ' 245' ' ' LYS . 0.2 OUTLIER -160.06 164.48 33.09 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.881 -173.743 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.504 ' O ' ' HG3' ' A' ' 262' ' ' GLU . 12.0 pt-20 -143.47 -167.52 2.59 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.975 -0.453 . . . . 0.0 111.888 -172.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 243' ' ' ILE . 62.8 t -54.49 123.22 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.508 ' HA2' ' NH1' ' A' ' 241' ' ' ARG . . . 102.04 -1.04 51.24 Favored Glycine 0 CA--C 1.509 -0.331 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.699 170.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 259' ' ' GLU . 8.3 mt-10 -86.57 -174.83 5.19 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -168.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.799 HD21 ' HB3' ' A' ' 239' ' ' TYR . 3.4 tm? -140.0 128.28 22.55 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.634 177.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.76 HG13 ' HB3' ' A' ' 240' ' ' ALA . 2.6 p -127.17 115.54 41.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.297 177.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.554 ' HE2' ' HG2' ' A' ' 237' ' ' PRO . 86.9 tttt -89.61 100.75 13.49 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.658 ' HA ' ' HA2' ' A' ' 277' ' ' GLY . 0.8 OUTLIER -83.09 137.16 21.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.897 -175.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 23.2 p -99.34 -8.3 25.05 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.704 -176.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.442 ' HA ' ' HD3' ' A' ' 268' ' ' LYS . 14.0 tppt? -126.51 107.44 10.24 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.052 173.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.728 HG21 HG23 ' A' ' 238' ' ' ILE . 0.9 OUTLIER -105.04 163.26 4.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -170.76 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.514 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 4.3 p30 -143.3 -172.53 3.72 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.225 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 26.0 m -103.03 -5.91 9.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -175.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 5.5 m -100.99 -44.85 5.6 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.481 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . 0.482 ' HA3' ' CD1' ' A' ' 288' ' ' PHE . . . 133.18 -1.81 4.6 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.289 -0.958 . . . . 0.0 113.513 -178.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.9 OUTLIER -95.99 102.08 13.83 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 118.003 0.901 . . . . 0.0 109.274 174.463 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.87 ' HZ2' ' HG ' ' A' ' 293' ' ' LEU . 0.0 OUTLIER -128.24 173.27 10.28 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -173.582 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.517 ' O ' ' HB ' ' A' ' 266' ' ' VAL . 45.1 tt0 -96.34 125.16 40.65 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 171.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.658 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -114.97 165.47 12.07 Favored Glycine 0 N--CA 1.439 -1.132 0 CA-C-N 115.466 -0.788 . . . . 0.0 113.15 -166.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 22.4 tt0 -139.04 118.86 13.19 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 171.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 282' ' ' LYS . 21.8 p -99.93 96.3 7.46 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 119.474 -0.891 . . . . 0.0 108.904 176.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 11.4 m120 41.59 52.69 3.9 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.935 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 115.18 -28.62 7.84 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.548 -0.834 . . . . 0.0 114.691 175.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . 0.641 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 10.0 mptt -91.63 134.21 34.89 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.105 0.952 . . . . 0.0 110.428 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . 0.411 ' N ' ' HD2' ' A' ' 283' ' ' ARG . 3.5 mpt_? -106.27 157.76 17.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.953 0.406 . . . . 0.0 111.301 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . 0.688 ' CA ' HD22 ' A' ' 256' ' ' LEU . . . 175.37 -172.97 45.96 Favored Glycine 0 C--O 1.224 -0.499 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -177.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' HIS . . . . . 0.463 ' H ' ' HA ' ' A' ' 255' ' ' ALA . 12.3 p80 -146.85 143.6 28.69 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 118.674 1.237 . . . . 0.0 111.782 171.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.732 ' CE2' ' HB1' ' A' ' 255' ' ' ALA . 5.8 m-85 -156.3 163.04 26.22 Favored Pre-proline 0 N--CA 1.464 0.264 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.429 -174.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 24.1 Cg_endo -92.57 167.09 2.76 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.178 2.585 . . . . 0.0 112.06 175.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.482 ' CD1' ' HA3' ' A' ' 273' ' ' GLY . 39.7 p90 -85.18 -8.02 58.78 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -172.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 6.3 t -56.33 -13.19 2.01 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -174.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . 0.649 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 0.9 OUTLIER -138.94 33.56 2.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.928 0.394 . . . . 0.0 111.89 -178.259 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.76 HG12 ' HA ' ' A' ' 242' ' ' VAL . 15.5 m -146.74 162.08 9.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.348 176.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -117.79 106.37 12.95 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 176.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . 0.87 ' HG ' ' HZ2' ' A' ' 275' ' ' TRP . 0.0 OUTLIER -104.55 128.66 52.57 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 119.622 -0.831 . . . . 0.0 113.223 -169.363 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.663 ' O ' ' HB ' ' A' ' 238' ' ' ILE . 4.8 mp . . . . . 0 N--CA 1.436 -1.15 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 168.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.43 ' HB3' ' HA ' ' A' ' 267' ' ' THR . 11.3 Cg_exo . . . . . 0 N--CA 1.454 -0.824 0 N-CA-C 110.171 -0.742 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.586 HG23 HG21 ' A' ' 269' ' ' ILE . 0.2 OUTLIER -80.43 158.21 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.115 -171.045 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.711 ' HD1' HD11 ' A' ' 263' ' ' LEU . 83.1 m-85 -99.43 118.33 35.8 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 174.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 293' ' ' LEU . . . -114.78 115.74 27.51 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -175.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -79.93 101.88 8.86 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 176.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.852 HG21 ' HD3' ' A' ' 245' ' ' LYS . 7.6 p -81.95 119.11 30.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.324 -175.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.8 pp -98.71 3.7 10.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.411 -174.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.543 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 8.3 tt0 -177.28 106.0 0.06 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.446 -175.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.852 ' HD3' HG21 ' A' ' 242' ' ' VAL . 0.2 OUTLIER -146.93 166.0 28.09 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.344 0.593 . . . . 0.0 110.903 174.446 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.822 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 5.7 ptt180 -104.7 -178.8 3.76 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.135 -0.938 . . . . 0.0 108.602 -177.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 4.7 m -104.22 76.95 0.28 Allowed Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 121.227 0.537 . . . . 0.0 112.357 176.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 1.012 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 3.3 Cg_exo -83.31 177.43 6.51 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.274 3.316 . . . . 0.0 110.6 174.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -139.49 176.99 8.26 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.054 -178.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.937 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -63.6 -5.06 3.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.634 0.73 . . . . 0.0 110.567 170.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -90.2 -11.01 42.32 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.772 176.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -105.95 60.21 0.66 Allowed 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.557 -173.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . 0.5 ' N ' ' HD2' ' A' ' 253' ' ' LYS . 7.2 mptt 56.28 31.56 18.74 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -170.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . 0.937 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 74.3 p 53.14 53.06 12.5 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 114.174 -1.375 . . . . 0.0 112.547 -177.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.436 ' HA ' ' H ' ' A' ' 285' ' ' HIS . . . -90.07 161.4 15.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.046 0.45 . . . . 0.0 110.709 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.687 ' N ' ' HA3' ' A' ' 284' ' ' GLY . 0.2 OUTLIER -78.89 132.67 36.86 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.745 -173.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.012 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -91.27 100.75 13.5 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 172.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.802 HD11 ' HE2' ' A' ' 245' ' ' LYS . 0.7 OUTLIER -150.26 171.25 17.25 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.493 -174.59 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -143.59 170.31 16.08 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.188 -163.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 2.5 p -53.81 118.74 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 121.528 0.68 . . . . 0.0 111.724 173.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 106.45 -1.67 37.05 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.011 171.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -89.04 176.21 7.08 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.079 -174.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.711 HD11 ' HD1' ' A' ' 239' ' ' TYR . 3.0 tm? -126.7 130.47 50.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.227 0.536 . . . . 0.0 110.132 -178.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.437 HG22 HD12 ' A' ' 258' ' ' LEU . 2.2 t -111.44 145.09 18.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.604 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 238' ' ' ILE . 62.3 tttp -120.68 95.12 4.59 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 170.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.735 ' HB ' ' HA2' ' A' ' 277' ' ' GLY . 1.4 m -84.71 124.42 39.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.723 -173.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . 0.43 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 40.4 p -88.36 -9.49 52.56 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.868 -174.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.503 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 4.4 tppp? -116.92 103.62 10.47 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.586 HG21 HG23 ' A' ' 238' ' ' ILE . 0.7 OUTLIER -102.61 154.41 5.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.85 -172.816 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.536 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 4.2 p30 -144.23 -170.81 3.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.774 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 12.0 p -95.67 -33.87 4.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.916 -178.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 10.8 m -74.07 -43.02 59.22 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -173.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 123.88 -5.7 9.03 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.163 -177.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.705 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.9 OUTLIER -94.53 104.71 16.66 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 173.535 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.588 ' HZ2' HD13 ' A' ' 293' ' ' LEU . 0.0 OUTLIER -129.71 -179.76 5.37 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.598 0.713 . . . . 0.0 112.055 -173.684 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.503 ' HB2' ' HB3' ' A' ' 268' ' ' LYS . 32.2 mt-10 -102.42 123.87 46.98 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 173.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.735 ' HA2' ' HB ' ' A' ' 266' ' ' VAL . . . -109.09 153.39 16.84 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.905 -165.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.589 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 29.7 tt0 -135.42 118.88 16.85 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 174.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 47.9 t -99.3 96.38 7.7 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 12.8 m120 38.4 55.93 1.8 Allowed 'General case' 0 CA--C 1.533 0.323 0 O-C-N 124.362 1.039 . . . . 0.0 112.023 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 115.91 -40.26 2.48 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 120.433 -0.889 . . . . 0.0 114.091 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 0.8 OUTLIER -80.05 136.82 36.66 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.969 0.884 . . . . 0.0 110.241 179.788 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 283' ' ' ARG . 5.6 mpt_? -113.12 131.23 55.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.643 0.735 . . . . 0.0 112.031 178.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . 0.687 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . -147.51 -166.96 12.89 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 114.282 -1.326 . . . . 0.0 111.651 174.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' HIS . . . . . 0.436 ' H ' ' HA ' ' A' ' 255' ' ' ALA . 5.6 m-70 -145.91 139.89 26.58 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 117.684 0.742 . . . . 0.0 109.427 178.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.724 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 10.4 m-85 -167.99 157.2 8.69 Favored Pre-proline 0 N--CA 1.471 0.603 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -172.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.705 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 58.7 Cg_endo -95.34 176.39 0.9 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.709 2.939 . . . . 0.0 113.457 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.494 ' HA ' HG22 ' A' ' 291' ' ' VAL . 24.1 p90 -86.07 -9.74 56.2 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.106 -173.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 11.1 t -70.26 8.26 0.82 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -168.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . 0.543 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 0.9 OUTLIER -155.77 38.21 0.37 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.091 0.472 . . . . 0.0 110.95 177.517 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 242' ' ' VAL . 27.6 m -144.67 157.76 14.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.014 0.435 . . . . 0.0 111.112 178.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -115.88 108.84 16.8 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 170.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . 0.588 HD13 ' HZ2' ' A' ' 275' ' ' TRP . 0.2 OUTLIER -102.98 123.65 46.98 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -165.727 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.468 ' H ' HD12 ' A' ' 294' ' ' LEU . 4.6 mp . . . . . 0 N--CA 1.439 -1.002 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.092 167.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo . . . . . 0 C--O 1.235 0.342 0 CA-C-O 121.006 0.336 . . . . 0.0 112.593 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 1.044 HG12 HG22 ' A' ' 266' ' ' VAL . 1.3 pt -91.75 167.98 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.727 173.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.776 ' HB3' HD11 ' A' ' 263' ' ' LEU . 61.5 m-85 -116.35 119.66 36.39 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 169.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.626 ' HA ' ' HA ' ' A' ' 293' ' ' LEU . . . -113.21 117.66 32.52 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.944 -175.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.495 ' HD3' ' O ' ' A' ' 262' ' ' GLU . 16.3 tpp180 -82.45 102.91 11.62 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.416 175.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.906 HG21 ' HD2' ' A' ' 245' ' ' LYS . 2.6 p -87.26 135.15 25.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.512 -173.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.8 pp -109.61 9.1 8.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.787 -175.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.823 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 58.2 tt0 -176.92 95.24 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.723 0.297 . . . . 0.0 110.26 -173.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.906 ' HD2' HG21 ' A' ' 242' ' ' VAL . 4.3 mttt -146.29 161.72 39.68 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 175.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.878 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 5.8 ptp180 -106.62 -178.07 3.54 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -177.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 32.0 t -103.3 80.37 0.36 Allowed Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 120.955 0.407 . . . . 0.0 111.262 176.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.962 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 3.1 Cg_endo -91.45 177.67 1.87 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 125.161 3.907 . . . . 0.0 111.184 175.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -130.29 174.94 9.35 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 175.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.788 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -72.22 5.12 3.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.417 0.627 . . . . 0.0 110.332 175.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -99.2 -2.62 36.28 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.216 174.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.422 ' C ' ' HD2' ' A' ' 253' ' ' LYS . 35.6 m-20 -105.15 63.72 0.7 Allowed 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.464 -177.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . 0.422 ' HD2' ' C ' ' A' ' 252' ' ' ASP . 7.0 mptt 57.58 25.62 11.83 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -171.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . 0.788 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 44.9 p 56.06 75.86 0.32 Allowed 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.823 -174.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -113.77 150.3 33.62 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.253 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.463 ' O ' ' HE2' ' A' ' 286' ' ' PHE . 0.0 OUTLIER -72.84 132.92 44.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.611 -176.163 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.962 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -95.12 104.27 16.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.371 0.605 . . . . 0.0 111.479 174.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.692 ' HG ' ' HD3' ' A' ' 245' ' ' LYS . 0.4 OUTLIER -163.81 175.5 10.41 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.54 -176.344 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -142.45 -166.42 2.26 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 121.591 -0.693 . . . . 0.0 112.383 -171.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 2.8 p -68.51 122.01 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.295 177.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 104.18 -0.75 43.96 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.284 174.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.495 ' O ' ' HD3' ' A' ' 241' ' ' ARG . 9.4 mt-10 -98.73 -174.72 2.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.842 0.353 . . . . 0.0 111.666 -170.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.776 HD11 ' HB3' ' A' ' 239' ' ' TYR . 50.7 tp -133.74 160.27 38.09 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.508 -177.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.498 ' N ' ' HG ' ' A' ' 263' ' ' LEU . 2.8 p -153.48 136.91 7.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.389 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.485 ' HE2' ' CE1' ' A' ' 239' ' ' TYR . 37.9 ttmt -99.98 102.1 13.38 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 175.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 1.044 HG22 HG12 ' A' ' 238' ' ' ILE . 4.0 m -86.79 115.68 28.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.97 0.89 . . . . 0.0 110.71 -178.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 9.9 t -99.95 4.08 44.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.596 -1.183 . . . . 0.0 110.394 -177.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 0.0 OUTLIER -124.94 107.19 10.6 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 168.128 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.579 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.8 OUTLIER -110.49 158.22 10.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 115.286 -0.87 . . . . 0.0 113.113 -172.098 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.769 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 2.6 p30 -146.34 -172.98 4.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.698 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 11.6 p -93.39 -31.92 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 45.7 m -74.99 -43.44 53.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -173.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . 0.777 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 125.04 -13.51 7.55 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.499 -178.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.569 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.6 OUTLIER -89.23 93.09 9.44 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 173.285 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.769 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -123.05 179.09 4.79 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.183 -176.204 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 268' ' ' LYS . 53.4 tt0 -104.32 125.77 50.85 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.723 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -110.2 169.68 13.69 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.95 -172.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 3.1 tm-20 -152.32 119.45 5.87 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 171.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 44.6 t -115.63 99.55 7.42 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.084 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 43.3 54.33 5.16 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 124.252 0.97 . . . . 0.0 112.313 173.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 117.73 -40.45 2.33 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-N 115.828 -0.624 . . . . 0.0 114.102 176.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 0.0 OUTLIER -93.32 128.79 39.48 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 118.066 0.933 . . . . 0.0 109.934 -178.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . 0.622 ' HD3' ' H ' ' A' ' 283' ' ' ARG . 0.0 OUTLIER -121.2 145.47 47.8 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.266 176.28 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 173.05 157.75 15.61 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.072 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' HIS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 30.5 p80 -98.08 148.35 23.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.04 0.42 . . . . 0.0 112.117 -171.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.463 ' HE2' ' O ' ' A' ' 256' ' ' LEU . 5.3 m-85 -158.55 159.21 29.85 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.515 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 93.6 Cg_endo -89.36 168.28 5.14 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.206 2.604 . . . . 0.0 113.809 -177.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.777 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 19.0 t80 -76.62 -19.99 57.22 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 114.158 -1.383 . . . . 0.0 111.922 -172.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 8.9 t -61.8 -11.47 12.61 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -168.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . 0.823 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 1.0 OUTLIER -137.68 33.91 2.45 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.69 -0.631 . . . . 0.0 112.351 -176.359 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.565 HG13 ' HD2' ' A' ' 290' ' ' HIS . 34.1 m -139.93 153.11 22.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.882 0.372 . . . . 0.0 111.192 177.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -121.06 107.96 13.25 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 169.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . 0.744 HD21 ' CE2' ' A' ' 288' ' ' PHE . 0.2 OUTLIER -101.49 139.96 36.44 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -169.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.512 ' N ' HD12 ' A' ' 294' ' ' LEU . 4.5 mp . . . . . 0 N--CA 1.431 -1.424 0 CA-C-N 113.397 -1.729 . . . . 0.0 107.412 166.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo . . . . . 0 N--CA 1.45 -1.043 0 CA-C-O 120.679 0.2 . . . . 0.0 111.935 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.662 HD13 ' HB ' ' A' ' 266' ' ' VAL . 0.1 OUTLIER -97.08 152.24 4.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.391 -178.641 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.7 ' HB3' HD21 ' A' ' 263' ' ' LEU . 67.3 m-85 -96.65 119.54 35.32 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 174.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 293' ' ' LEU . . . -114.42 116.72 29.35 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.24 0.543 . . . . 0.0 110.352 -174.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -86.19 102.29 13.78 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.592 178.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.74 HG21 ' HD3' ' A' ' 245' ' ' LYS . 3.0 p -79.55 128.53 38.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.534 -175.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.721 HD12 ' HB2' ' A' ' 244' ' ' GLN . 2.8 pp -108.31 3.53 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.88 -175.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.721 ' HB2' HD12 ' A' ' 243' ' ' ILE . 4.0 mt-30 -176.29 95.67 0.05 Allowed 'General case' 0 N--CA 1.463 0.203 0 O-C-N 123.043 0.214 . . . . 0.0 111.061 -175.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.74 ' HD3' HG21 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -146.5 163.17 36.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.183 0.516 . . . . 0.0 111.164 173.663 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.869 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 9.8 ptt180 -101.27 -176.92 3.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.679 -177.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 27.3 t -101.66 82.69 0.4 Allowed Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 120.856 0.36 . . . . 0.0 111.292 175.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.98 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 7.0 Cg_endo -93.02 177.14 1.44 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.656 3.571 . . . . 0.0 110.778 172.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' ASN . . . . . 0.409 ' C ' ' H ' ' A' ' 251' ' ' TYR . 51.8 m-80 -131.04 177.26 7.58 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.026 0.441 . . . . 0.0 110.678 176.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.812 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -64.2 0.25 1.02 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.356 0.598 . . . . 0.0 110.99 173.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.409 ' H ' ' C ' ' A' ' 249' ' ' ASN . 44.4 m-85 -103.81 8.57 37.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.454 0.645 . . . . 0.0 109.696 177.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.74 53.19 0.73 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.162 -0.927 . . . . 0.0 108.727 176.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt 58.01 30.45 19.24 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -167.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . 0.812 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 43.4 p 59.1 71.3 0.59 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.826 -176.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.417 ' HB1' ' CE2' ' A' ' 286' ' ' PHE . . . -111.55 150.75 29.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.65 179.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.667 ' HB3' HD22 ' A' ' 258' ' ' LEU . 0.2 OUTLIER -72.12 133.67 45.32 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.663 -174.543 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.98 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -90.57 98.92 12.06 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 172.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.73 HD21 ' HE2' ' A' ' 245' ' ' LYS . 0.9 OUTLIER -154.94 171.14 20.19 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.108 -173.735 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.454 ' O ' HG13 ' A' ' 242' ' ' VAL . 12.3 pt-20 -142.28 -166.59 2.28 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.177 0.513 . . . . 0.0 111.873 -171.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.575 HG22 ' HA ' ' A' ' 244' ' ' GLN . 48.2 t -68.12 117.61 10.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.124 176.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 107.13 0.86 35.74 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.132 172.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.405 ' HB2' ' CG1' ' A' ' 242' ' ' VAL . 13.4 mt-10 -93.15 179.78 5.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.188 0.518 . . . . 0.0 111.915 -173.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.7 HD21 ' HB3' ' A' ' 239' ' ' TYR . 3.0 tm? -136.89 133.57 35.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.251 -176.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.95 HG12 ' HB2' ' A' ' 279' ' ' CYS . 34.1 m -126.15 154.86 35.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.097 173.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -111.52 96.04 5.86 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.662 ' HB ' HD13 ' A' ' 238' ' ' ILE . 49.2 t -69.88 121.47 19.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.836 -174.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 40.8 p -103.51 -7.19 21.06 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.626 -176.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.596 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 0.0 OUTLIER -126.85 106.77 9.56 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 119.445 -0.902 . . . . 0.0 108.74 171.018 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' ILE . . . . . 0.586 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.7 OUTLIER -107.65 148.66 11.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 114.451 -1.249 . . . . 0.0 113.72 -168.613 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.848 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 0.3 OUTLIER -147.12 154.04 40.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.463 -178.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 35.9 m -70.4 -9.71 12.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -174.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.5 m -89.75 -45.49 9.26 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.867 -178.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . 0.434 ' H ' ' ND2' ' A' ' 270' ' ' ASN . . . 119.68 -7.95 12.03 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.061 -178.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.724 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.0 OUTLIER -93.94 70.75 4.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.484 0.659 . . . . 0.0 109.636 176.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.848 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -112.74 174.83 5.7 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.327 -168.814 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.691 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 32.9 tt0 -94.87 123.82 38.56 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.225 0.536 . . . . 0.0 109.796 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.6 ' HA2' HG22 ' A' ' 266' ' ' VAL . . . -100.96 150.21 18.64 Favored Glycine 0 N--CA 1.436 -1.326 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.299 -175.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.808 ' HG3' ' HG2' ' A' ' 283' ' ' ARG . 32.4 tt0 -127.8 116.85 20.81 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' CYS . . . . . 0.95 ' HB2' HG12 ' A' ' 264' ' ' VAL . 43.7 t -111.17 98.36 7.46 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 24.95 61.56 0.05 Allowed 'General case' 0 C--N 1.343 0.306 0 O-C-N 125.619 1.824 . . . . 0.0 113.301 174.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 118.53 -24.27 8.63 Favored Glycine 0 CA--C 1.523 0.55 0 CA-C-N 115.447 -0.797 . . . . 0.0 114.134 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.35 144.4 31.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 118.003 0.902 . . . . 0.0 110.38 175.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . 0.808 ' HG2' ' HG3' ' A' ' 278' ' ' GLU . 28.7 mtm180 -123.91 129.5 51.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.792 0.33 . . . . 0.0 110.188 171.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . 0.614 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . -165.52 140.57 6.46 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.112 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' HIS . . . . . 0.691 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 20.7 p80 -99.25 148.04 24.54 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 117.434 0.617 . . . . 0.0 111.696 -175.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.654 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 5.7 m-85 -161.2 164.05 19.34 Favored Pre-proline 0 C--O 1.235 0.324 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.041 -177.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.724 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 1.7 Cg_endo -85.72 158.76 10.54 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.518 2.812 . . . . 0.0 112.13 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.709 ' HB2' HD21 ' A' ' 293' ' ' LEU . 1.8 p90 -87.03 -5.95 58.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.891 -174.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.541 HG22 ' HB2' ' A' ' 287' ' ' PRO . 5.6 t -52.8 -32.73 45.48 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . 0.438 ' CD2' ' HD2' ' A' ' 245' ' ' LYS . 0.8 OUTLIER -121.38 43.77 2.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.35 0.595 . . . . 0.0 111.429 -177.322 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.692 HG12 ' HA ' ' A' ' 242' ' ' VAL . 19.8 m -147.46 170.11 3.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.158 173.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -131.71 109.06 9.9 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 173.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' LEU . . . . . 0.709 HD21 ' HB2' ' A' ' 288' ' ' PHE . 0.1 OUTLIER -113.88 133.13 55.62 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.742 0.782 . . . . 0.0 112.883 -166.379 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.456 ' H ' HD12 ' A' ' 294' ' ' LEU . 4.5 mp . . . . . 0 N--CA 1.437 -1.076 0 CA-C-N 114.326 -1.307 . . . . 0.0 108.075 171.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . 0.465 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . . . . . . 0 N--CA 1.446 -0.665 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.545 ' HB2' ' HD3' ' A' ' 265' ' ' LYS . 4.3 Cg_endo -88.05 121.62 1.47 Allowed 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.395 2.73 . . . . 0.0 111.554 176.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.779 ' CD1' ' HB ' ' A' ' 266' ' ' VAL . 0.2 OUTLIER -85.12 161.56 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 C-N-CA 119.219 -0.992 . . . . 0.0 109.852 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.839 ' HB3' HD21 ' A' ' 263' ' ' LEU . 44.4 m-85 -103.46 118.64 37.21 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 172.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.702 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -111.83 115.76 29.55 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.05 -174.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.514 ' HB3' ' O ' ' A' ' 292' ' ' ARG . 21.9 tpp180 -75.48 101.64 4.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 175.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.751 HG21 ' HD3' ' A' ' 245' ' ' LYS . 5.2 p -81.29 119.88 31.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 C-N-CA 120.316 -0.554 . . . . 0.0 109.991 -175.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.8 pp -102.23 9.15 8.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.629 -173.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.88 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 30.5 tt0 -176.9 95.44 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.192 -177.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.751 ' HD3' HG21 ' A' ' 242' ' ' VAL . 0.1 OUTLIER -146.48 164.22 33.22 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.839 0.828 . . . . 0.0 111.189 174.242 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.83 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 2.6 ptm180 -105.24 -175.88 2.92 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.637 -1.62 . . . . 0.0 108.767 -177.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 3.8 m -110.52 70.87 0.64 Allowed Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 121.42 0.628 . . . . 0.0 111.547 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 1.016 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 28.7 Cg_endo -95.29 123.08 0.32 Allowed 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 125.051 3.834 . . . . 0.0 111.913 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.416 ' C ' ' H ' ' A' ' 251' ' ' TYR . 40.7 m-80 -78.55 176.18 9.66 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.873 0.368 . . . . 0.0 111.038 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.705 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -62.9 -2.07 1.09 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.751 0.786 . . . . 0.0 111.349 175.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.416 ' H ' ' C ' ' A' ' 249' ' ' ASN . 12.0 m-85 -92.87 -1.93 56.32 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.998 178.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.38 47.81 1.14 Allowed 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt 59.99 30.22 19.73 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -167.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . 0.705 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 29.4 p 63.79 86.22 0.12 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 113.825 -1.534 . . . . 0.0 111.048 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.685 ' HB3' ' HB2' ' A' ' 248' ' ' PRO . . . -120.6 163.78 17.5 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.951 178.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.515 ' HB3' ' CG ' ' A' ' 258' ' ' LEU . 4.5 mm? -83.15 120.59 25.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.203 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.016 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -88.84 91.19 8.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.65 0.738 . . . . 0.0 110.303 176.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.699 ' CD2' ' HB ' ' A' ' 264' ' ' VAL . 0.2 OUTLIER -148.34 176.28 10.4 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.561 -174.645 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.501 ' HG2' ' N ' ' A' ' 260' ' ' VAL . 15.4 tt0 -142.04 167.11 22.91 Favored 'General case' 0 C--N 1.313 -1.022 0 O-C-N 121.931 -0.481 . . . . 0.0 110.931 -162.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.501 ' N ' ' HG2' ' A' ' 259' ' ' GLU . 1.6 p -57.79 117.73 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 121.41 0.624 . . . . 0.0 111.236 174.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 107.52 -2.65 34.47 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.918 176.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -95.44 -173.33 2.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.941 0.4 . . . . 0.0 111.379 -173.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.839 HD21 ' HB3' ' A' ' 239' ' ' TYR . 3.4 tm? -133.73 122.27 23.11 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.711 -174.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.702 HG13 ' HB3' ' A' ' 240' ' ' ALA . 2.5 p -113.82 125.74 71.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.077 174.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.563 ' HG3' ' CE1' ' A' ' 239' ' ' TYR . 5.2 tmmm? -96.47 96.11 8.47 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.779 ' HB ' ' CD1' ' A' ' 238' ' ' ILE . 96.6 t -71.89 114.94 11.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.084 -177.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . 0.446 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 4.7 t -93.36 -9.28 39.34 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 124.313 1.008 . . . . 0.0 111.266 -178.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.631 ' HA ' ' HE3' ' A' ' 268' ' ' LYS . 0.0 OUTLIER -127.32 103.28 7.31 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 175.399 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.449 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.8 OUTLIER -98.98 160.12 3.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -170.426 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.622 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 3.6 p30 -146.69 -169.62 3.32 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.925 178.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 8.5 p -96.65 -37.0 6.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 5.0 m -73.27 -43.02 61.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.864 0.364 . . . . 0.0 111.767 -172.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . 0.866 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 124.27 -4.79 8.87 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.828 -175.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -90.59 82.19 5.83 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 176.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.622 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -116.87 175.51 5.54 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.246 0.546 . . . . 0.0 112.054 -174.244 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.558 ' O ' HG13 ' A' ' 266' ' ' VAL . 36.0 mt-10 -102.62 124.66 48.57 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.831 177.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.614 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -108.41 153.38 16.83 Favored Glycine 0 N--CA 1.439 -1.128 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.418 -169.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.599 ' HG3' ' HG2' ' A' ' 283' ' ' ARG . 21.8 tt0 -130.74 119.8 22.87 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 173.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . 0.507 ' O ' ' HD2' ' A' ' 282' ' ' LYS . 53.7 t -116.56 96.22 5.41 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.958 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 24.38 61.31 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 O-C-N 124.914 1.384 . . . . 0.0 113.505 -177.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.79 -20.32 11.9 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.84 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . 0.507 ' HD2' ' O ' ' A' ' 279' ' ' CYS . 5.7 mptt -97.93 132.13 43.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.632 0.716 . . . . 0.0 109.749 174.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . 0.599 ' HG2' ' HG3' ' A' ' 278' ' ' GLU . 48.7 mtt180 -123.68 141.5 51.96 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 176.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 175.29 -148.79 9.73 Favored Glycine 0 C--O 1.223 -0.542 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.315 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' HIS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 12.8 p80 -149.17 145.92 27.4 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 117.37 0.585 . . . . 0.0 111.54 -177.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.617 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 4.4 m-85 -162.57 164.07 17.23 Favored Pre-proline 0 N--CA 1.47 0.546 0 C-N-CA 122.543 0.337 . . . . 0.0 111.119 -177.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.511 ' HD3' ' HD1' ' A' ' 286' ' ' PHE . 31.4 Cg_endo -95.39 168.11 1.45 Allowed 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 123.464 2.776 . . . . 0.0 114.144 -175.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.866 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 7.2 t80 -76.28 -17.71 59.33 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.748 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 35.8 p -45.61 -37.98 6.14 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -174.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . 0.88 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 0.8 OUTLIER -132.61 48.39 2.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.141 0.496 . . . . 0.0 112.32 -174.432 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 27.7 m -142.75 151.78 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.773 173.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.514 ' O ' ' HB3' ' A' ' 241' ' ' ARG . 21.2 mmt180 -128.83 109.39 11.24 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 176.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . 0.512 ' HB3' ' HA ' ' A' ' 240' ' ' ALA . 0.2 OUTLIER -116.7 144.07 44.88 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -162.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.554 ' O ' ' HB ' ' A' ' 238' ' ' ILE . 4.5 mp -86.97 171.11 11.02 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 113.461 -1.7 . . . . 0.0 108.8 169.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.415 ' OD1' ' HG2' ' A' ' 297' ' ' GLN . 4.3 t70 -76.35 168.27 20.36 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.778 0.799 . . . . 0.0 111.887 -163.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.638 ' HB3' HG22 ' A' ' 238' ' ' ILE . 6.0 pt20 -100.73 -5.72 26.04 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.594 -175.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.415 ' HG2' ' OD1' ' A' ' 295' ' ' ASP . 17.3 pt20 -89.18 -0.41 57.43 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 174.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 CA--C 1.531 0.224 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.221 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . 0.463 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . . . . . . 0 N--CA 1.443 -0.859 0 N-CA-C 112.088 -0.405 . . . . 0.0 112.088 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.463 ' HD3' ' HA2' ' A' ' 236' ' ' GLY . 5.1 Cg_exo -78.54 142.28 18.27 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.44 2.093 . . . . 0.0 111.612 175.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.934 HG23 ' HB ' ' A' ' 266' ' ' VAL . 0.1 OUTLIER -105.92 142.55 18.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.971 -173.26 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.708 ' HB3' HD11 ' A' ' 263' ' ' LEU . 76.7 m-85 -96.81 117.04 30.21 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 174.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.485 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -114.68 117.19 30.13 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.424 -173.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.59 ' HB3' ' O ' ' A' ' 292' ' ' ARG . 23.8 tpp180 -83.12 103.18 12.35 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.316 -177.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.984 HG21 ' HD3' ' A' ' 245' ' ' LYS . 3.7 p -81.86 128.79 38.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.258 -175.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.601 HD12 ' HB2' ' A' ' 244' ' ' GLN . 2.8 pp -107.33 7.43 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.344 -176.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.601 ' HB2' HD12 ' A' ' 243' ' ' ILE . 13.5 mt-30 -176.35 95.43 0.05 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.522 -173.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.984 ' HD3' HG21 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -146.09 163.32 35.68 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.118 0.485 . . . . 0.0 110.353 173.044 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.857 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 12.6 ptp180 -104.3 -177.08 3.26 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.344 -177.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 6.9 m -104.21 80.23 0.43 Allowed Pre-proline 0 CA--C 1.54 0.57 0 CA-C-O 121.522 0.677 . . . . 0.0 111.828 175.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.922 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 9.1 Cg_endo -92.93 176.67 1.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 125.167 3.911 . . . . 0.0 111.545 176.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -126.85 175.47 8.01 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.602 ' O ' HG22 ' A' ' 254' ' ' THR . . . -68.03 -0.99 5.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.4 175.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -114.93 14.83 17.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.431 0.634 . . . . 0.0 110.011 173.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -104.56 56.54 0.71 Allowed 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 173.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . 0.504 ' HE2' ' HA ' ' A' ' 253' ' ' LYS . 11.1 mmpt? 65.63 22.62 11.67 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.813 -169.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . 0.602 HG22 ' O ' ' A' ' 250' ' ' ALA . 29.1 p 59.26 75.54 0.4 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.488 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.679 ' HB1' ' CE2' ' A' ' 286' ' ' PHE . . . -125.32 159.06 32.67 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.163 -176.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.591 HD21 ' O ' ' A' ' 277' ' ' GLY . 4.6 mm? -78.99 124.84 28.65 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.074 -0.967 . . . . 0.0 112.598 -176.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.922 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -83.03 93.17 7.52 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.338 0.589 . . . . 0.0 110.72 172.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.609 HD11 ' HE2' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -156.97 171.95 19.55 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.992 -1.003 . . . . 0.0 109.486 -177.508 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.413 ' O ' HG13 ' A' ' 242' ' ' VAL . 11.9 pt-20 -141.38 -163.87 1.65 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 118.488 0.586 . . . . 0.0 112.018 -167.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 244' ' ' GLN . 75.3 t -67.08 118.27 10.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.024 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 105.69 -2.18 39.15 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.606 171.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.536 ' O ' ' HD3' ' A' ' 241' ' ' ARG . 7.9 mt-10 -91.85 -179.46 5.32 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.824 0.345 . . . . 0.0 110.92 -172.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.708 HD11 ' HB3' ' A' ' 239' ' ' TYR . 41.1 tp -129.22 161.06 31.03 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.981 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.542 ' N ' ' HG ' ' A' ' 263' ' ' LEU . 2.4 p -151.15 132.31 4.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.944 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -93.19 97.98 10.99 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 177.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.934 ' HB ' HG23 ' A' ' 238' ' ' ILE . 97.8 t -69.8 119.3 15.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.498 -178.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 73.7 p -102.2 -25.57 13.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.751 -175.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.523 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 2.4 tppp? -108.56 106.04 15.94 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 173.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.769 HD13 ' H ' ' A' ' 269' ' ' ILE . 0.1 OUTLIER -109.77 148.07 13.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -167.022 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.772 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 1.9 p30 -135.85 -170.76 2.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.688 176.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.07 -21.25 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 120.54 -0.464 . . . . 0.0 112.082 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.4 m -79.2 -44.26 22.23 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -174.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 126.02 -11.3 7.35 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.411 -177.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.529 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.0 OUTLIER -91.33 107.79 19.45 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 174.196 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.772 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -147.72 -179.87 7.2 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -173.004 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.631 ' HG2' ' HB3' ' A' ' 285' ' ' HIS . 35.0 mt-10 -97.29 126.05 42.27 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.148 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.591 ' O ' HD21 ' A' ' 256' ' ' LEU . . . -110.68 156.42 15.57 Favored Glycine 0 N--CA 1.437 -1.242 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.717 -173.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 33.7 tt0 -135.21 119.69 18.03 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 172.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 45.6 t -109.72 97.1 6.71 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.922 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 34.4 56.52 0.67 Allowed 'General case' 0 N--CA 1.464 0.263 0 O-C-N 124.873 1.358 . . . . 0.0 112.479 176.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.36 -34.63 4.59 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.881 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 49.5 mttt -82.15 129.7 34.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.954 0.877 . . . . 0.0 110.874 178.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -113.07 148.29 35.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.026 0.441 . . . . 0.0 111.502 176.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 166.38 -150.42 17.59 Favored Glycine 0 C--O 1.225 -0.459 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.554 174.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' HIS . . . . . 0.631 ' HB3' ' HG2' ' A' ' 276' ' ' GLU . 30.1 p80 -149.74 157.22 43.01 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.59 0.695 . . . . 0.0 111.68 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.711 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 2.4 m-85 -163.3 158.78 18.0 Favored Pre-proline 0 C--N 1.331 -0.227 0 O-C-N 123.563 0.54 . . . . 0.0 110.479 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.529 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 10.7 Cg_endo -89.09 158.92 5.78 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.187 2.591 . . . . 0.0 111.938 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -83.97 -5.26 59.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.562 -176.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 11.1 t -54.83 -13.06 0.92 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . 0.548 ' NE2' ' HD2' ' A' ' 245' ' ' LYS . 0.6 OUTLIER -137.71 47.0 2.07 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.113 -0.367 . . . . 0.0 111.564 -179.635 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.769 HG12 ' HA ' ' A' ' 242' ' ' VAL . 35.6 m -147.36 170.26 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.39 0.614 . . . . 0.0 111.61 177.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.59 ' O ' ' HB3' ' A' ' 241' ' ' ARG . 16.3 tpp180 -129.35 110.16 11.69 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 171.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . 0.505 ' HB3' HD11 ' A' ' 238' ' ' ILE . 2.9 mt -91.31 140.64 29.59 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -163.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.422 ' N ' HD12 ' A' ' 294' ' ' LEU . 3.9 mp -98.05 125.28 42.95 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 163.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -75.76 156.22 34.8 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 122.157 0.98 . . . . 0.0 111.373 -164.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.45 ' H ' ' HG2' ' A' ' 296' ' ' GLN . 6.4 pt20 -77.59 -18.04 57.23 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.617 -1.629 . . . . 0.0 111.116 -175.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -85.21 -10.24 56.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.21 0.528 . . . . 0.0 109.712 171.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 12.4 m120 . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.636 -179.591 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . 0.545 ' N ' ' HD2' ' A' ' 237' ' ' PRO . . . . . . . . 0 CA--C 1.521 0.451 0 CA-C-O 120.136 -0.258 . . . . 0.0 112.495 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.751 ' HB3' ' HA ' ' A' ' 267' ' ' THR . 4.2 Cg_exo -39.99 147.73 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 124.9 3.733 . . . . 0.0 113.271 173.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.726 HD13 ' HB ' ' A' ' 266' ' ' VAL . 0.1 OUTLIER -84.07 151.55 3.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 120.996 0.427 . . . . 0.0 111.095 -170.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.49 ' HB3' HD11 ' A' ' 263' ' ' LEU . 57.6 m-85 -103.96 119.62 39.32 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 175.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.643 ' HA ' ' HA ' ' A' ' 293' ' ' LEU . . . -113.46 118.33 34.21 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.336 0.589 . . . . 0.0 111.154 -171.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.42 ' HB3' ' O ' ' A' ' 292' ' ' ARG . 20.9 tpp180 -78.0 102.34 7.34 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.637 176.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.647 HG21 ' HB2' ' A' ' 245' ' ' LYS . 3.2 p -80.94 124.96 39.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.609 -176.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.567 HD12 ' HB2' ' A' ' 244' ' ' GLN . 2.8 pp -105.44 8.58 9.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.588 -174.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.797 ' HA ' HG22 ' A' ' 260' ' ' VAL . 17.1 mt-30 -176.17 95.39 0.06 Allowed 'General case' 0 CA--C 1.515 -0.369 0 O-C-N 123.296 0.372 . . . . 0.0 110.347 -173.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.762 ' HG2' ' CD1' ' A' ' 258' ' ' LEU . 0.0 OUTLIER -146.72 163.56 35.55 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.603 0.716 . . . . 0.0 111.663 176.298 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.905 ' HG3' ' HG3' ' A' ' 248' ' ' PRO . 2.4 ptm180 -108.5 -173.3 2.24 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.175 -1.375 . . . . 0.0 109.303 -176.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 37.7 t -108.39 75.67 0.6 Allowed Pre-proline 0 CA--C 1.537 0.443 0 CA-C-O 121.523 0.678 . . . . 0.0 110.175 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.955 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 9.6 Cg_endo -95.0 132.45 0.57 Allowed 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 125.187 3.924 . . . . 0.0 111.768 178.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.41 ' O ' ' HB2' ' A' ' 252' ' ' ASP . 3.6 m-20 -89.53 175.81 7.14 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.772 0.32 . . . . 0.0 110.423 -176.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -71.12 4.02 3.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.608 0.718 . . . . 0.0 110.669 177.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -107.04 8.95 30.63 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.097 176.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 249' ' ' ASN . 0.7 OUTLIER -96.88 51.97 1.16 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.005 175.274 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.93 25.7 14.89 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -166.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 22.4 p 65.61 88.08 0.11 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.819 1.248 . . . . 0.0 110.0 -174.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.748 ' HB3' ' HB2' ' A' ' 248' ' ' PRO . . . -122.0 168.32 12.06 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.066 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.747 ' H ' ' HE2' ' A' ' 286' ' ' PHE . 4.3 mm? -94.86 118.44 31.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.526 -176.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.955 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -85.64 97.26 10.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.54 0.686 . . . . 0.0 110.115 176.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.762 ' CD1' ' HG2' ' A' ' 245' ' ' LYS . 0.2 OUTLIER -156.12 176.42 12.69 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.49 -174.471 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.564 ' HG2' ' N ' ' A' ' 260' ' ' VAL . 24.5 tt0 -142.67 173.79 11.23 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.584 -0.698 . . . . 0.0 111.705 -161.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.797 HG22 ' HA ' ' A' ' 244' ' ' GLN . 69.5 t -56.35 118.2 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 C-N-CA 123.241 0.616 . . . . 0.0 111.443 173.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 104.83 -2.38 41.64 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.805 173.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.442 ' OE2' ' HB3' ' A' ' 259' ' ' GLU . 14.4 mt-10 -97.14 -173.16 2.6 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.023 -174.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.49 HD11 ' HB3' ' A' ' 239' ' ' TYR . 12.4 tp -127.83 157.77 39.55 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.039 0.447 . . . . 0.0 110.685 -176.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.563 HG12 ' HB3' ' A' ' 240' ' ' ALA . 7.7 p -144.09 143.41 23.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 175.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -103.87 95.24 5.88 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.726 ' HB ' HD13 ' A' ' 238' ' ' ILE . 74.8 t -74.39 105.64 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-O 121.94 0.876 . . . . 0.0 110.566 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . 0.751 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 5.3 t -93.93 -9.34 37.4 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 113.264 -1.789 . . . . 0.0 110.678 -174.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.552 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 14.8 tppt? -122.53 106.18 10.78 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 172.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.531 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.7 OUTLIER -106.78 153.21 8.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -166.66 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.802 HD22 ' HB3' ' A' ' 275' ' ' TRP . 2.0 p30 -147.14 177.01 9.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.057 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 9.7 p -89.91 -23.39 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -176.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.63 -1.05 51.02 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -175.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . 0.773 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 78.31 8.7 87.43 Favored Glycine 0 C--O 1.223 -0.532 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.983 177.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.492 ' N ' HD21 ' A' ' 270' ' ' ASN . 19.3 mm-40 -93.29 73.25 4.56 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.802 ' HB3' HD22 ' A' ' 270' ' ' ASN . 0.0 OUTLIER -124.25 -179.41 4.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.507 0.67 . . . . 0.0 112.612 -166.554 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.728 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 32.0 mt-10 -104.32 125.74 50.82 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.584 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.594 ' O ' HD21 ' A' ' 256' ' ' LEU . . . -103.51 156.1 17.82 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.25 -173.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 20.0 tt0 -138.55 118.34 13.19 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 175.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . 0.626 ' SG ' ' HD3' ' A' ' 282' ' ' LYS . 26.6 p -102.48 97.12 7.4 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.419 -0.912 . . . . 0.0 109.635 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 12.0 m120 39.45 56.69 2.21 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.438 -1.256 . . . . 0.0 112.323 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 115.92 -39.87 2.6 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.646 -0.788 . . . . 0.0 114.136 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . 0.626 ' HD3' ' SG ' ' A' ' 279' ' ' CYS . 5.9 mptt -76.58 129.16 36.03 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 118.144 0.972 . . . . 0.0 110.414 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.39 131.06 54.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.606 -176.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -167.78 -151.18 6.88 Favored Glycine 0 C--O 1.224 -0.49 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.228 174.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' HIS . . . . . 0.728 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 16.8 p80 -150.56 147.91 28.03 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 117.122 0.461 . . . . 0.0 111.187 -177.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.747 ' HE2' ' H ' ' A' ' 256' ' ' LEU . 4.5 m-85 -157.84 160.18 30.12 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 120.728 0.299 . . . . 0.0 111.69 -177.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -95.19 155.24 1.69 Allowed 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 123.342 2.694 . . . . 0.0 114.005 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.773 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 20.0 t80 -66.29 -21.39 66.27 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 114.221 -1.354 . . . . 0.0 112.514 -176.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 9.2 t -57.77 -20.73 37.33 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 -168.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . 0.569 ' HB2' ' HB2' ' A' ' 244' ' ' GLN . 1.0 OUTLIER -136.36 37.61 2.71 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.952 -0.468 . . . . 0.0 111.9 -175.181 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.408 HG23 ' CD1' ' A' ' 293' ' ' LEU . 32.8 m -141.05 151.0 19.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.253 175.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.42 ' O ' ' HB3' ' A' ' 241' ' ' ARG . 14.1 mmm180 -121.68 108.06 13.1 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 173.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . 0.643 ' HA ' ' HA ' ' A' ' 240' ' ' ALA . 0.0 OUTLIER -101.21 137.1 40.01 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -167.553 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.538 ' H ' HD12 ' A' ' 294' ' ' LEU . 4.3 mp -77.23 121.36 23.56 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 162.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.687 ' HB3' ' HG2' ' A' ' 297' ' ' GLN . 23.2 t70 -87.76 157.05 19.14 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.807 -161.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -75.58 5.83 5.52 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.99 -1.459 . . . . 0.0 111.214 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.687 ' HG2' ' HB3' ' A' ' 295' ' ' ASP . 0.0 OUTLIER -66.05 -42.14 89.9 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 168.223 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.498 ' N ' ' HG3' ' A' ' 297' ' ' GLN . 55.5 t-20 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.76 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . 0.469 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . . . . . . 0 N--CA 1.448 -0.559 0 N-CA-C 111.864 -0.495 . . . . 0.0 111.864 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.469 ' HD3' ' HA2' ' A' ' 236' ' ' GLY . 9.1 Cg_exo -71.08 127.86 14.09 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 123.054 2.502 . . . . 0.0 111.856 -178.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 1.041 HG23 ' HB ' ' A' ' 266' ' ' VAL . 0.0 OUTLIER -91.79 131.04 39.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.951 -177.469 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.421 ' HB2' ' HB2' ' A' ' 294' ' ' LEU . 47.4 m-85 -97.55 120.22 37.53 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 176.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.732 ' HB2' HD11 ' A' ' 238' ' ' ILE . . . -116.02 118.13 32.05 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.366 -174.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 292' ' ' ARG . 0.0 OUTLIER -78.88 100.94 7.43 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 174.601 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.786 HG21 ' HB2' ' A' ' 245' ' ' LYS . 9.8 p -81.08 115.48 23.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 119.192 -1.003 . . . . 0.0 109.932 -176.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.5 HD12 ' HB2' ' A' ' 244' ' ' GLN . 2.8 pp -97.99 2.97 10.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.113 -174.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.794 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 56.1 tp60 -176.59 93.17 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.032 -174.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.876 ' HG2' HD21 ' A' ' 258' ' ' LEU . 0.5 OUTLIER -147.16 166.21 27.66 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.202 0.525 . . . . 0.0 110.026 173.114 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.807 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 6.2 ptm180 -102.25 -178.59 3.74 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.548 -174.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 43.5 t -107.73 80.6 1.0 Allowed Pre-proline 0 CA--C 1.536 0.415 0 CA-C-O 121.233 0.54 . . . . 0.0 111.011 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.88 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 9.9 Cg_endo -93.96 168.03 2.02 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 124.606 3.537 . . . . 0.0 111.339 174.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -123.3 178.24 5.22 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.02 0.438 . . . . 0.0 110.426 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.712 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -61.83 -2.23 0.81 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.571 174.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -100.99 -2.46 31.66 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.182 0.515 . . . . 0.0 110.543 176.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -105.6 65.45 0.71 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -177.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . 0.678 ' HA ' ' HE3' ' A' ' 253' ' ' LYS . 0.0 OUTLIER 61.2 19.7 10.31 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.587 -171.772 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . 0.712 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 30.5 p 56.63 64.44 1.67 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.723 -175.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.519 ' HB1' ' CE2' ' A' ' 286' ' ' PHE . . . -109.55 154.65 22.44 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.272 -0.877 . . . . 0.0 111.006 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.874 ' HB3' HD22 ' A' ' 258' ' ' LEU . 0.2 OUTLIER -69.03 132.91 47.39 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.606 -175.643 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.88 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -85.52 93.25 8.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.346 0.593 . . . . 0.0 109.546 168.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.876 HD21 ' HG2' ' A' ' 245' ' ' LYS . 0.5 OUTLIER -142.14 160.92 39.26 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.292 -175.013 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.577 ' O ' HG13 ' A' ' 242' ' ' VAL . 37.4 tt0 -142.29 173.66 11.33 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.887 -165.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.551 HG22 ' HA ' ' A' ' 244' ' ' GLN . 47.3 t -56.15 117.79 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-O 121.267 0.556 . . . . 0.0 112.162 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 95.67 0.93 62.21 Favored Glycine 0 CA--C 1.505 -0.591 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.0 172.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -87.41 164.52 16.16 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.51 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.53 ' HG ' ' N ' ' A' ' 264' ' ' VAL . 16.6 tp -121.32 152.56 38.82 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.721 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.723 HG12 ' HB2' ' A' ' 279' ' ' CYS . 15.0 m -141.81 166.34 17.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.401 ' O ' ' HD3' ' A' ' 265' ' ' LYS . 8.2 tmtt? -132.42 97.21 4.04 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 1.041 ' HB ' HG23 ' A' ' 238' ' ' ILE . 46.1 t -68.95 128.24 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.732 -176.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 11.6 p -100.03 -18.86 16.81 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 113.722 -1.581 . . . . 0.0 111.852 -173.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -127.73 106.4 9.11 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 121.459 0.647 . . . . 0.0 109.762 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 1.02 HG21 HE22 ' A' ' 296' ' ' GLN . 0.0 OUTLIER -98.21 154.48 3.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.604 -167.073 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.784 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 0.4 OUTLIER -146.43 -169.65 3.32 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.515 178.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 12.7 p -98.34 -35.04 4.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.961 -177.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 3.5 m -68.84 -44.61 73.06 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -174.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . 0.421 ' HA3' ' CD1' ' A' ' 288' ' ' PHE . . . 121.83 -5.98 10.47 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.316 -176.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.6 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.0 OUTLIER -96.01 70.73 2.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.791 0.805 . . . . 0.0 110.351 176.479 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.784 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -102.32 173.33 6.41 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.615 -172.265 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.744 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 33.3 tt0 -93.39 123.74 36.9 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.524 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -103.08 151.43 17.96 Favored Glycine 0 N--CA 1.437 -1.253 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.27 -171.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -129.12 119.51 24.26 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 173.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . 0.723 ' HB2' HG12 ' A' ' 264' ' ' VAL . 44.7 t -114.04 97.1 6.17 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.566 -177.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 28.84 61.31 0.13 Allowed 'General case' 0 N--CA 1.466 0.375 0 O-C-N 124.967 1.417 . . . . 0.0 112.564 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.58 -38.63 2.96 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 115.724 -0.671 . . . . 0.0 113.268 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -80.61 146.63 31.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.297 0.548 . . . . 0.0 110.52 177.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 39.8 mtt180 -132.4 129.78 39.78 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.012 0.434 . . . . 0.0 110.033 170.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . 0.636 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . -173.81 142.1 6.36 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.006 -177.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' HIS . . . . . 0.744 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 14.7 p80 -91.92 148.03 22.52 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 117.908 0.854 . . . . 0.0 111.681 -175.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.84 ' HD1' ' HD3' ' A' ' 287' ' ' PRO . 3.2 m-85 -165.03 170.12 6.73 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -174.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.84 ' HD3' ' HD1' ' A' ' 286' ' ' PHE . 58.1 Cg_endo -100.84 156.94 0.42 Allowed 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 123.306 2.67 . . . . 0.0 112.856 -174.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.469 ' HA ' HG22 ' A' ' 291' ' ' VAL . 0.7 OUTLIER -87.16 -8.85 56.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.076 -177.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.566 HG22 ' HB2' ' A' ' 287' ' ' PRO . 10.0 t -55.79 -32.65 63.68 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.84 -178.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . 0.794 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 0.5 OUTLIER -119.98 55.13 1.0 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.585 0.707 . . . . 0.0 111.365 175.363 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.469 HG22 ' HA ' ' A' ' 288' ' ' PHE . 10.6 m -147.17 171.96 3.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.811 170.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 241' ' ' ARG . 14.5 tpt180 -122.66 108.88 13.58 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 171.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 6.1 tp -84.62 123.55 30.46 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 115.231 -0.895 . . . . 0.0 113.37 -164.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 239' ' ' TYR . 6.6 mt -88.31 132.96 34.2 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 169.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.464 ' OD2' ' HB2' ' A' ' 297' ' ' GLN . 31.1 t70 -74.72 136.27 41.79 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 122.097 0.951 . . . . 0.0 111.903 -163.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 1.02 HE22 HG21 ' A' ' 269' ' ' ILE . 9.3 pt20 -77.47 -1.95 32.97 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.569 -1.65 . . . . 0.0 112.366 -172.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.498 HE21 ' HB2' ' A' ' 297' ' ' GLN . 7.8 mt-30 -94.25 1.16 56.02 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 171.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 16.6 m120 . . . . . 0 CA--C 1.536 0.431 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.436 173.401 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.28 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.987 ' HB3' ' HA ' ' A' ' 267' ' ' THR . 4.5 Cg_exo -41.67 134.62 3.55 Favored 'Trans proline' 0 C--O 1.238 0.487 0 C-N-CA 124.112 3.208 . . . . 0.0 111.92 169.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 1.077 HG12 HG22 ' A' ' 266' ' ' VAL . 0.8 OUTLIER -78.73 160.77 4.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.016 -167.3 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.682 ' HB3' HD11 ' A' ' 263' ' ' LEU . 86.7 m-85 -108.5 118.75 37.58 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 174.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.596 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -113.77 118.49 34.42 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.165 0.507 . . . . 0.0 111.021 -174.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.415 ' HB3' ' O ' ' A' ' 292' ' ' ARG . 15.1 tpp180 -81.6 103.73 11.52 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 1.07 HG21 ' HD2' ' A' ' 245' ' ' LYS . 5.6 p -86.01 130.74 36.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.986 -175.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.45 HD12 ' HB2' ' A' ' 244' ' ' GLN . 2.8 pp -106.83 8.8 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.704 -174.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.77 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 63.3 tt0 -177.8 94.06 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -173.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 1.07 ' HD2' HG21 ' A' ' 242' ' ' VAL . 11.0 mttt -145.57 161.84 38.85 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 175.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.856 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 13.2 ptt180 -107.59 -176.31 3.03 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.875 -172.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 7.0 p -104.13 78.83 0.34 Allowed Pre-proline 0 CA--C 1.547 0.848 0 CA-C-O 121.812 0.815 . . . . 0.0 111.533 175.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.959 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 1.7 Cg_endo -88.99 177.95 2.81 Favored 'Trans proline' 0 N--CA 1.459 -0.537 1 C-N-CA 125.303 4.002 . . . . 0.0 110.654 174.436 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.422 ' C ' ' H ' ' A' ' 251' ' ' TYR . 27.7 m-80 -130.16 170.65 13.79 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.045 0.45 . . . . 0.0 109.913 177.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.699 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -76.4 14.87 0.68 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.568 0.699 . . . . 0.0 110.544 178.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.422 ' H ' ' C ' ' A' ' 249' ' ' ASN . 37.2 m-85 -110.92 1.89 17.83 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.844 175.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -95.6 49.19 1.17 Allowed 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.72 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt 60.42 33.99 20.63 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -166.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . 0.699 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 71.5 p 59.55 77.63 0.3 Allowed 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 113.728 -1.578 . . . . 0.0 111.864 -178.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.425 ' C ' ' HA3' ' A' ' 284' ' ' GLY . . . -112.44 154.79 25.29 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.714 176.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 1.108 HD12 ' HG ' ' A' ' 258' ' ' LEU . 0.0 OUTLIER -83.73 133.64 34.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.255 -174.46 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.959 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -91.03 101.24 14.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.346 0.593 . . . . 0.0 109.591 171.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 1.108 ' HG ' HD12 ' A' ' 256' ' ' LEU . 0.1 OUTLIER -158.1 169.53 24.32 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.746 -174.864 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.457 ' HG2' ' N ' ' A' ' 260' ' ' VAL . 32.0 tt0 -142.16 173.21 11.73 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 121.902 -0.499 . . . . 0.0 112.048 -160.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.736 HG22 ' HA ' ' A' ' 244' ' ' GLN . 53.9 t -55.11 118.3 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 C-N-CA 123.364 0.665 . . . . 0.0 111.537 175.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 102.73 -1.69 48.84 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.644 -0.582 . . . . 0.0 111.644 172.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -95.94 173.23 7.54 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.711 -173.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.682 HD11 ' HB3' ' A' ' 239' ' ' TYR . 40.1 tp -117.27 157.62 25.75 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.326 0.584 . . . . 0.0 111.059 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.596 HG13 ' HB3' ' A' ' 240' ' ' ALA . 2.6 p -152.31 119.19 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.139 -177.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.453 ' HE3' ' HG2' ' A' ' 237' ' ' PRO . 54.7 tttp -86.9 97.34 10.62 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.572 177.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 1.077 HG22 HG12 ' A' ' 238' ' ' ILE . 7.0 m -77.23 114.4 17.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.892 0.853 . . . . 0.0 109.988 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . 0.987 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 9.7 t -96.93 4.39 51.61 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.06 -174.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.563 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 0.0 OUTLIER -132.48 107.52 8.53 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 169.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.674 HG21 HG23 ' A' ' 238' ' ' ILE . 0.8 OUTLIER -111.12 156.37 12.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 114.961 -1.018 . . . . 0.0 113.355 -170.25 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.766 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 0.1 OUTLIER -146.13 -161.1 1.24 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.938 -1.483 . . . . 0.0 109.195 178.357 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 35.1 m -110.04 -23.3 4.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.888 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 3.0 m -65.62 -44.62 85.94 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -175.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . 0.64 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 124.03 -21.89 6.87 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.127 -177.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.647 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.3 OUTLIER -89.76 102.77 15.47 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 173.057 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.766 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -134.6 174.92 10.02 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.067 -177.071 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 44.4 tt0 -91.14 125.46 35.92 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.629 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -105.03 155.84 16.99 Favored Glycine 0 N--CA 1.437 -1.289 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.549 -175.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 30.8 tt0 -139.27 119.86 14.08 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 176.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . 0.438 ' HB3' HD11 ' A' ' 256' ' ' LEU . 49.0 t -108.5 98.44 7.96 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 46.51 46.17 14.16 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.378 176.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 115.59 -39.34 2.78 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.385 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 55.3 mttt -69.96 130.87 43.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.237 0.518 . . . . 0.0 109.711 177.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 36.1 mtt180 -113.67 129.67 56.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.12 0.486 . . . . 0.0 110.969 176.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . 0.55 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . -170.18 142.82 7.44 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.995 -178.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' HIS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 25.3 p80 -99.56 148.73 23.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 117.265 0.533 . . . . 0.0 111.172 -171.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.65 ' CG ' ' HE2' ' A' ' 245' ' ' LYS . 5.8 m-85 -159.26 158.96 28.83 Favored Pre-proline 0 CA--C 1.533 0.289 0 O-C-N 123.469 0.48 . . . . 0.0 110.796 -176.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.647 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 97.2 Cg_endo -91.58 169.88 3.1 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.919 2.413 . . . . 0.0 113.909 -175.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.64 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 9.8 t80 -75.87 -13.18 60.27 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.554 -175.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 25.4 p -48.24 -29.36 3.72 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -174.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . 0.77 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 1.3 p-80 -136.9 39.84 2.55 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.779 0.323 . . . . 0.0 111.586 -171.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.462 HG23 ' HA ' ' A' ' 242' ' ' VAL . 3.1 p -141.78 150.81 19.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 119.454 -0.899 . . . . 0.0 112.53 -175.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.415 ' O ' ' HB3' ' A' ' 241' ' ' ARG . 30.0 mmm180 -130.39 108.89 10.32 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . 0.59 HD21 ' CE2' ' A' ' 288' ' ' PHE . 0.4 OUTLIER -120.09 145.34 46.98 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -163.799 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.493 ' H ' HD12 ' A' ' 294' ' ' LEU . 4.7 mp -80.12 124.51 28.83 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 113.677 -1.601 . . . . 0.0 107.553 168.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.449 ' OD1' ' HG2' ' A' ' 297' ' ' GLN . 9.1 t70 -83.27 152.74 25.01 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.587 -165.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.586 ' HB3' HG22 ' A' ' 238' ' ' ILE . 7.7 pt20 -75.15 -8.27 56.11 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.266 -1.334 . . . . 0.0 112.047 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.449 ' HG2' ' OD1' ' A' ' 295' ' ' ASP . 1.6 pt20 -78.18 -22.98 47.82 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.16 172.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.233 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . 0.636 ' N ' ' HD2' ' A' ' 237' ' ' PRO . . . . . . . . 0 N--CA 1.46 0.297 0 N-CA-C 112.585 -0.206 . . . . 0.0 112.585 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.681 ' HB3' ' HA ' ' A' ' 267' ' ' THR . 7.6 Cg_exo -38.72 141.79 0.32 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 125.086 3.857 . . . . 0.0 113.438 171.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 1.092 HG12 HG22 ' A' ' 266' ' ' VAL . 0.6 OUTLIER -80.59 160.17 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.987 -171.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.883 ' HD1' HD11 ' A' ' 263' ' ' LEU . 64.5 m-85 -104.23 120.48 41.25 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 173.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.766 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -113.65 116.97 30.3 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.309 -176.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 241' ' ' ARG . 0.0 OUTLIER -81.65 101.03 9.78 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.766 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.75 ' CG2' ' HD3' ' A' ' 245' ' ' LYS . 3.4 p -78.33 122.3 33.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 119.931 -0.708 . . . . 0.0 110.116 -176.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.534 HG21 ' HG2' ' A' ' 292' ' ' ARG . 2.8 pp -110.12 6.46 8.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.516 -174.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.733 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 58.7 tt0 -176.3 94.55 0.05 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.081 -175.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.857 ' HE2' HD21 ' A' ' 258' ' ' LEU . 0.2 OUTLIER -147.07 168.0 22.67 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 122.008 0.909 . . . . 0.0 111.613 178.302 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.854 ' HG3' ' HG3' ' A' ' 248' ' ' PRO . 12.3 ptm180 -108.47 -176.4 3.04 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.787 -1.552 . . . . 0.0 109.717 -173.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 19.0 t -108.28 75.33 0.56 Allowed Pre-proline 0 CA--C 1.54 0.589 0 CA-C-O 121.029 0.442 . . . . 0.0 110.997 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.98 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 5.7 Cg_endo -91.11 177.41 2.03 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 124.861 3.707 . . . . 0.0 110.712 176.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.451 ' C ' ' H ' ' A' ' 251' ' ' TYR . 10.9 m120 -135.18 175.34 9.67 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.781 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -69.46 9.7 0.44 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.393 0.616 . . . . 0.0 111.269 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.451 ' H ' ' C ' ' A' ' 249' ' ' ASN . 18.9 m-85 -103.14 -4.01 25.05 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 176.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -105.28 67.96 0.79 Allowed 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.16 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . 0.457 ' HE2' ' HB2' ' A' ' 253' ' ' LYS . 2.6 mppt? 54.54 28.97 10.49 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -169.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . 0.781 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 78.3 p 55.66 73.48 0.43 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.903 -174.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.589 ' C ' ' HA3' ' A' ' 284' ' ' GLY . . . -108.47 153.08 23.84 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.366 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.727 ' N ' ' HA3' ' A' ' 284' ' ' GLY . 0.2 OUTLIER -79.92 132.58 36.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.341 -173.083 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.98 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -92.22 100.98 13.49 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 173.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.857 HD21 ' HE2' ' A' ' 245' ' ' LYS . 0.6 OUTLIER -154.62 170.67 20.96 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.521 -174.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.489 ' O ' HG13 ' A' ' 242' ' ' VAL . 29.8 tt0 -142.98 169.55 17.36 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.704 0.288 . . . . 0.0 111.584 -165.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.417 ' N ' ' HG2' ' A' ' 259' ' ' GLU . 3.5 p -55.04 118.0 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.703 0.763 . . . . 0.0 112.351 176.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 105.23 -2.71 40.38 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 114.92 -1.037 . . . . 0.0 111.741 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -90.98 -179.9 5.58 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.832 -176.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.883 HD11 ' HD1' ' A' ' 239' ' ' TYR . 3.2 tm? -132.18 130.04 40.55 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.766 HG13 ' HB3' ' A' ' 240' ' ' ALA . 2.4 p -124.05 118.21 53.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.264 178.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 238' ' ' ILE . 78.8 tttt -87.27 97.06 10.58 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 1.092 HG22 HG12 ' A' ' 238' ' ' ILE . 5.0 m -77.11 122.93 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 121.87 0.843 . . . . 0.0 111.049 -175.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . 0.681 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 49.5 p -91.8 -15.42 28.28 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.983 -174.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.596 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 0.0 OUTLIER -119.66 105.46 11.2 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.733 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.579 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.8 OUTLIER -106.46 159.54 6.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -170.235 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.782 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 3.5 p30 -145.59 -168.25 2.92 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.988 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 13.3 p -99.28 -32.27 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 120.616 -0.433 . . . . 0.0 112.004 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 11.7 m -78.62 -26.63 45.35 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -173.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . 0.624 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 105.35 4.25 40.8 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.364 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.804 ' N ' HE21 ' A' ' 274' ' ' GLN . 0.0 OUTLIER -97.07 81.14 3.03 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 176.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.782 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -122.93 168.42 12.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.19 -168.847 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.596 ' HB3' ' HB3' ' A' ' 268' ' ' LYS . 40.8 tt0 -90.42 126.06 35.77 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.111 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.687 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -108.7 159.05 14.36 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.303 -173.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 40.8 tt0 -140.94 120.15 12.94 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 172.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . 0.412 ' HB3' HD11 ' A' ' 256' ' ' LEU . 34.6 t -114.62 96.89 5.97 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.349 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 33.65 57.19 0.55 Allowed 'General case' 0 N--CA 1.465 0.28 0 O-C-N 124.615 1.197 . . . . 0.0 112.527 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.97 -39.27 2.72 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-N 115.705 -0.68 . . . . 0.0 113.351 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 0.2 OUTLIER -77.77 139.85 39.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.492 0.646 . . . . 0.0 109.943 178.621 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 12.4 mtm180 -124.25 129.2 50.35 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 175.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . 0.727 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . 177.72 145.97 6.11 Favored Glycine 0 C--O 1.225 -0.467 0 C-N-CA 120.09 -1.052 . . . . 0.0 113.58 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' HIS . . . . . 0.554 ' CB ' ' HA ' ' A' ' 276' ' ' GLU . 28.5 p80 -104.18 147.71 27.13 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.965 0.383 . . . . 0.0 111.423 -175.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.56 ' CZ ' ' HB1' ' A' ' 255' ' ' ALA . 12.4 m-85 -159.14 167.02 15.18 Favored Pre-proline 0 CA--C 1.535 0.397 0 O-C-N 123.271 0.357 . . . . 0.0 111.494 -175.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.456 ' HD3' ' HD1' ' A' ' 286' ' ' PHE . 1.4 Cg_endo -86.25 153.99 9.46 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 123.514 2.809 . . . . 0.0 113.585 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.738 ' HE1' ' HG ' ' A' ' 293' ' ' LEU . 44.3 t80 -67.44 -23.28 65.51 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 114.374 -1.285 . . . . 0.0 112.477 -177.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.441 HG22 ' HB2' ' A' ' 287' ' ' PRO . 8.9 t -53.1 -29.36 30.27 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -168.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . 0.733 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 0.9 OUTLIER -122.16 53.43 1.23 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.612 0.72 . . . . 0.0 110.956 -179.684 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.518 ' O ' ' HD2' ' A' ' 292' ' ' ARG . 0.5 OUTLIER -147.24 158.74 9.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.129 176.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.534 ' HG2' HG21 ' A' ' 243' ' ' ILE . 21.1 mmm180 -121.69 109.49 14.8 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 173.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . 0.954 HD11 HD12 ' A' ' 238' ' ' ILE . 0.3 OUTLIER -91.07 127.19 36.4 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -161.396 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 239' ' ' TYR . 3.9 mt -91.05 121.67 33.05 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 167.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -79.04 147.43 32.83 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.903 0.858 . . . . 0.0 112.415 -163.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.984 ' HB3' HG22 ' A' ' 238' ' ' ILE . 0.6 OUTLIER -76.72 -6.15 50.98 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.775 -177.603 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -72.43 -30.22 64.41 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 173.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 15.1 m120 . . . . . 0 C--N 1.332 -0.159 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.633 179.171 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . 0.444 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . . . . . . 0 N--CA 1.446 -0.68 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.506 ' HD2' ' HB3' ' A' ' 298' ' ' ASN . 12.4 Cg_exo -69.06 132.22 23.97 Favored 'Trans proline' 0 C--N 1.33 -0.399 0 C-N-CA 122.977 2.451 . . . . 0.0 113.068 -176.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.836 HG23 ' HB ' ' A' ' 266' ' ' VAL . 0.0 OUTLIER -94.33 139.54 18.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 173.612 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.567 ' HB2' ' HB2' ' A' ' 294' ' ' LEU . 0.7 OUTLIER -99.28 143.94 28.96 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 172.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.746 ' HA ' ' HA ' ' A' ' 293' ' ' LEU . . . -136.03 116.97 14.22 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 118.781 -1.168 . . . . 0.0 110.548 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -85.9 102.0 13.35 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 1.051 HG21 ' HD2' ' A' ' 245' ' ' LYS . 4.3 p -83.63 129.82 36.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.151 -173.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.9 pp -102.15 4.49 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.458 -175.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.621 ' H ' HG22 ' A' ' 242' ' ' VAL . 10.1 tt0 -178.47 102.6 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.687 -175.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 1.051 ' HD2' HG21 ' A' ' 242' ' ' VAL . 8.1 mttt -145.72 162.33 37.84 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 175.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.897 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 7.9 ttt-85 -99.41 177.21 5.25 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 123.433 0.693 . . . . 0.0 109.462 -174.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.442 ' N ' ' CG ' ' A' ' 246' ' ' ARG . 9.4 m -100.85 75.94 0.14 Allowed Pre-proline 0 CA--C 1.548 0.883 0 CA-C-O 121.546 0.688 . . . . 0.0 111.787 172.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.897 ' HD3' ' O ' ' A' ' 246' ' ' ARG . 0.9 OUTLIER -90.52 175.49 2.69 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 125.212 3.941 . . . . 0.0 111.04 177.036 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 252' ' ' ASP . 11.5 m120 -128.22 175.73 8.22 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.949 0.404 . . . . 0.0 110.547 176.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.927 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -67.13 -11.22 56.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 122.127 0.965 . . . . 0.0 110.195 174.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -87.45 5.42 38.99 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.814 175.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 249' ' ' ASN . 3.0 m-20 -103.85 49.27 0.83 Allowed 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.168 177.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . 0.551 ' N ' ' HD2' ' A' ' 253' ' ' LYS . 0.0 OUTLIER 58.7 31.13 20.83 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -169.409 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . 0.927 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 30.7 p 61.12 81.94 0.18 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 113.413 -1.721 . . . . 0.0 111.609 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.435 ' HB1' ' CE2' ' A' ' 286' ' ' PHE . . . -118.94 156.76 28.98 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.479 176.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.802 HD12 ' SG ' ' A' ' 279' ' ' CYS . 3.8 mm? -81.16 130.63 35.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.567 -175.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.854 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -89.99 97.76 11.38 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.438 0.637 . . . . 0.0 110.432 172.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.73 HD21 ' HD3' ' A' ' 245' ' ' LYS . 0.4 OUTLIER -159.79 171.89 18.67 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.275 -175.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.446 ' O ' HG13 ' A' ' 242' ' ' VAL . 12.4 pt-20 -143.53 -162.3 1.43 Allowed 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 119.822 -0.751 . . . . 0.0 112.865 -166.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.551 HG22 ' HA ' ' A' ' 244' ' ' GLN . 88.0 t -66.33 117.39 7.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.755 177.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 105.8 -1.27 38.9 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.85 171.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -91.58 -179.89 5.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.91 0.386 . . . . 0.0 111.399 -170.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.501 ' HG ' ' N ' ' A' ' 264' ' ' VAL . 38.2 tp -133.39 157.52 45.35 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.273 0.559 . . . . 0.0 111.314 -177.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.68 HG13 ' HB3' ' A' ' 240' ' ' ALA . 1.8 p -152.72 136.01 7.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.243 -177.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -98.49 96.8 8.24 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.836 ' HB ' HG23 ' A' ' 238' ' ' ILE . 52.0 t -68.63 117.92 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-O 121.205 0.526 . . . . 0.0 110.903 177.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 81.9 p -97.31 -19.2 18.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.422 -176.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.608 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 2.9 tppp? -116.97 107.08 14.13 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.575 HG21 HE21 ' A' ' 296' ' ' GLN . 0.6 OUTLIER -102.67 155.48 5.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -167.631 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.818 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 3.5 p30 -143.41 -178.53 5.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.275 174.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 8.9 p -82.53 -35.94 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -176.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 5.9 m -82.19 -43.33 17.81 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -172.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . 0.555 ' HA3' ' CD2' ' A' ' 288' ' ' PHE . . . 123.41 2.42 8.99 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.518 -178.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 1.0 OUTLIER -93.35 85.17 4.9 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 173.272 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.818 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -131.12 -179.79 5.54 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.89 -168.022 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.696 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 39.2 mt-10 -94.48 124.81 38.73 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.018 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.563 ' O ' HD21 ' A' ' 256' ' ' LEU . . . -106.67 145.34 15.94 Favored Glycine 0 N--CA 1.437 -1.267 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.334 -175.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.579 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 0.4 OUTLIER -124.14 118.73 27.55 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.023 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . 0.802 ' SG ' HD12 ' A' ' 256' ' ' LEU . 29.7 p -111.01 98.76 7.78 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.449 -174.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 4.9 m120 49.09 45.65 22.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.491 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 114.14 -17.08 19.81 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.689 -0.767 . . . . 0.0 114.27 175.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 5.4 mptt -99.93 133.8 43.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.733 0.766 . . . . 0.0 110.352 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.94 134.48 54.43 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.793 0.33 . . . . 0.0 111.375 -174.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -176.22 -146.46 5.99 Favored Glycine 0 C--O 1.225 -0.407 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' HIS . . . . . 0.696 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 24.8 p80 -148.82 151.45 34.77 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 117.562 0.681 . . . . 0.0 111.134 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.656 ' CG ' ' HE2' ' A' ' 245' ' ' LYS . 1.8 m-85 -164.72 153.83 11.45 Favored Pre-proline 0 CA--C 1.535 0.395 0 O-C-N 123.452 0.47 . . . . 0.0 110.829 -177.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.534 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 95.3 Cg_endo -90.77 173.35 3.02 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.057 2.504 . . . . 0.0 114.029 -174.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.555 ' CD2' ' HA3' ' A' ' 273' ' ' GLY . 16.2 t80 -82.92 -20.86 34.55 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 114.369 -1.287 . . . . 0.0 111.926 -170.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 12.9 t -68.62 1.78 2.93 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -167.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . 0.593 ' HD2' HG13 ' A' ' 291' ' ' VAL . 1.2 p-80 -147.25 33.71 0.89 Allowed 'General case' 0 C--N 1.33 -0.239 0 O-C-N 121.706 -0.621 . . . . 0.0 111.682 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.593 HG13 ' HD2' ' A' ' 290' ' ' HIS . 31.8 m -140.25 151.76 21.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.73 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.415 ' HA ' ' HD2' ' A' ' 292' ' ' ARG . 20.8 tpt180 -122.03 108.37 13.3 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 173.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . 0.746 ' HA ' ' HA ' ' A' ' 240' ' ' ALA . 0.0 OUTLIER -94.42 139.54 30.99 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -163.687 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.567 ' HB2' ' HB2' ' A' ' 239' ' ' TYR . 5.0 mt -79.12 165.7 23.05 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 113.948 -1.478 . . . . 0.0 107.21 167.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -71.25 133.66 46.25 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 122.964 1.364 . . . . 0.0 113.125 -157.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.7 ' HA ' ' HA ' ' A' ' 238' ' ' ILE . 58.5 tt0 -72.82 88.11 1.31 Allowed 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 111.895 -2.411 . . . . 0.0 111.245 -176.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.405 HE21 ' HB3' ' A' ' 297' ' ' GLN . 3.0 pt20 175.33 -34.95 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.086 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.506 ' HB3' ' HD2' ' A' ' 237' ' ' PRO . 2.7 t-20 . . . . . 0 N--CA 1.465 0.312 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . 0.419 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . . . . . . 0 N--CA 1.447 -0.593 0 N-CA-C 112.945 -0.062 . . . . 0.0 112.945 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.477 ' HG2' ' HE3' ' A' ' 265' ' ' LYS . 16.7 Cg_exo -72.23 129.53 15.15 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.449 2.766 . . . . 0.0 112.536 177.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.729 HD13 HG22 ' A' ' 266' ' ' VAL . 0.0 OUTLIER -89.69 149.47 4.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.764 174.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.543 ' N ' HG12 ' A' ' 238' ' ' ILE . 20.2 m-85 -95.89 119.35 34.23 Favored 'General case' 0 C--O 1.208 -1.107 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.46 ' HB3' ' CG2' ' A' ' 264' ' ' VAL . . . -113.87 118.22 33.61 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.481 -171.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.31 101.38 8.89 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.067 178.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 1.079 ' HA ' HG12 ' A' ' 291' ' ' VAL . 6.3 p -80.86 117.71 27.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.193 -176.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.568 ' O ' ' HG3' ' A' ' 244' ' ' GLN . 2.8 pp -105.15 0.61 10.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.013 -172.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.574 ' HB2' ' HB2' ' A' ' 290' ' ' HIS . 57.5 mt-30 -172.25 94.08 0.14 Allowed 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -173.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.848 ' HG2' ' CD2' ' A' ' 258' ' ' LEU . 2.5 tptt -146.66 165.54 29.26 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.517 0.675 . . . . 0.0 111.453 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.788 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 2.7 ptm85 -102.23 -178.13 3.61 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.079 -1.418 . . . . 0.0 110.279 -173.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 21.9 t -110.48 72.46 0.72 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.333 0.587 . . . . 0.0 109.71 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 1.071 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 72.1 Cg_endo -95.54 175.82 0.92 Allowed 'Trans proline' 0 N--CA 1.441 -1.612 0 C-N-CA 124.135 3.223 . . . . 0.0 110.541 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -136.3 176.2 8.91 Favored 'General case' 0 C--N 1.314 -0.978 0 O-C-N 121.952 -0.467 . . . . 0.0 110.298 -177.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.775 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -61.55 -7.61 3.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.368 0.604 . . . . 0.0 111.001 172.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -95.51 -2.29 48.9 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.313 176.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -105.41 63.73 0.69 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? 56.94 30.75 18.59 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -169.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . 0.775 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 44.5 p 52.49 62.94 2.44 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.323 -173.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.605 ' HB3' ' HB2' ' A' ' 248' ' ' PRO . . . -96.85 150.8 20.32 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.337 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.755 ' N ' ' HA3' ' A' ' 284' ' ' GLY . 0.4 OUTLIER -74.34 131.09 40.82 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.913 -179.016 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.071 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -90.56 104.5 17.07 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 175.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.848 ' CD2' ' HG2' ' A' ' 245' ' ' LYS . 0.6 OUTLIER -153.8 164.47 38.3 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.427 -175.144 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.558 ' O ' HG13 ' A' ' 242' ' ' VAL . 32.4 tt0 -142.3 174.66 10.42 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 120.578 0.228 . . . . 0.0 111.159 -165.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.505 HG22 ' HA ' ' A' ' 244' ' ' GLN . 88.3 t -57.12 117.7 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.373 0.606 . . . . 0.0 112.234 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 98.71 -2.1 58.5 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.507 170.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -84.38 175.88 9.07 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.33 -176.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.558 ' HG ' ' N ' ' A' ' 264' ' ' VAL . 17.0 tp -130.35 154.72 47.38 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.65 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.7 HG12 ' HB2' ' A' ' 279' ' ' CYS . 17.1 m -145.5 160.37 12.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.778 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.477 ' HE3' ' HG2' ' A' ' 237' ' ' PRO . 56.8 tttp -117.87 97.9 6.07 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 177.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.729 HG22 HD13 ' A' ' 238' ' ' ILE . 4.6 m -80.38 121.66 34.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.49 0.662 . . . . 0.0 110.345 -176.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 38.2 p -99.6 -5.09 29.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.853 -174.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.63 ' O ' ' HB3' ' A' ' 275' ' ' TRP . 1.3 tppp? -119.03 105.47 11.46 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 174.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.78 HD13 ' H ' ' A' ' 269' ' ' ILE . 0.2 OUTLIER -114.95 149.42 17.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.645 -166.736 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -144.14 -168.76 2.96 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.85 -174.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 28.7 m -100.88 -21.52 5.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.8 m -81.54 -45.39 15.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.776 0.322 . . . . 0.0 111.211 -175.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 125.92 -8.37 7.66 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.655 -177.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.9 OUTLIER -90.56 105.04 17.55 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 173.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.63 ' HB3' ' O ' ' A' ' 268' ' ' LYS . 0.0 OUTLIER -115.57 173.46 6.52 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.706 0.765 . . . . 0.0 111.345 -175.464 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 268' ' ' LYS . 29.9 tt0 -96.65 124.28 40.59 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 165.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.517 ' O ' HD23 ' A' ' 256' ' ' LEU . . . -109.66 149.42 17.3 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.784 -167.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.643 ' HG3' ' HG2' ' A' ' 283' ' ' ARG . 31.9 tt0 -127.75 117.61 22.22 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 172.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . 0.7 ' HB2' HG12 ' A' ' 264' ' ' VAL . 53.7 t -101.65 94.84 6.06 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.314 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 36.38 55.13 1.08 Allowed 'General case' 0 CA--C 1.533 0.296 0 O-C-N 124.754 1.284 . . . . 0.0 111.843 175.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.51 -40.4 2.4 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 115.639 -0.71 . . . . 0.0 113.39 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . 0.503 ' HD2' ' HB3' ' A' ' 279' ' ' CYS . 35.3 mttt -76.42 138.83 40.62 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 117.513 0.656 . . . . 0.0 110.381 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . 0.643 ' HG2' ' HG3' ' A' ' 278' ' ' GLU . 23.2 mtt180 -122.33 129.93 52.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.365 0.602 . . . . 0.0 111.726 176.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . 0.755 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . -159.91 -171.09 25.32 Favored Glycine 0 C--O 1.221 -0.709 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.189 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -147.62 139.84 24.38 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 118.409 1.105 . . . . 0.0 111.053 175.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.589 ' CZ ' ' HB1' ' A' ' 255' ' ' ALA . 28.1 m-85 -159.17 168.89 11.46 Favored Pre-proline 0 N--CA 1.472 0.633 0 C-N-CA 122.627 0.371 . . . . 0.0 111.472 -174.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.481 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 17.7 Cg_endo -94.92 168.7 1.59 Allowed 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 123.611 2.874 . . . . 0.0 112.796 -177.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.679 ' HA ' ' CG2' ' A' ' 291' ' ' VAL . 29.4 p90 -87.12 -12.38 47.26 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.31 -174.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 5.2 t -49.91 -33.66 18.01 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . 0.574 ' HB2' ' HB2' ' A' ' 244' ' ' GLN . 1.5 p-80 -125.75 56.97 1.37 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.792 0.806 . . . . 0.0 111.686 177.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 1.079 HG12 ' HA ' ' A' ' 242' ' ' VAL . 0.9 OUTLIER -154.56 170.94 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.573 168.23 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -130.01 107.75 9.58 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 172.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . 0.702 HD22 ' H ' ' A' ' 293' ' ' LEU . 0.0 OUTLIER -94.86 127.05 40.6 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 119.41 -0.916 . . . . 0.0 112.063 -169.266 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 10.4 mt -76.08 123.24 25.47 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 171.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -76.39 148.21 37.52 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.936 0.874 . . . . 0.0 111.834 -164.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -76.86 18.34 0.36 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.654 -1.612 . . . . 0.0 112.122 -176.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -73.64 -28.26 61.69 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 167.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 16.5 m120 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.957 -179.875 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . 0.447 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . . . . . . 0 N--CA 1.449 -0.463 0 N-CA-C 112.232 -0.347 . . . . 0.0 112.232 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.625 ' HA ' ' O ' ' A' ' 266' ' ' VAL . 4.3 Cg_endo -86.78 121.75 1.85 Allowed 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.206 2.604 . . . . 0.0 112.51 -178.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.897 HD11 ' HB2' ' A' ' 240' ' ' ALA . 0.1 OUTLIER -86.38 152.46 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.345 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.795 ' HD1' HD11 ' A' ' 263' ' ' LEU . 59.4 m-85 -100.84 118.04 36.11 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 175.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.897 ' HB2' HD11 ' A' ' 238' ' ' ILE . . . -120.19 117.3 27.54 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.587 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.555 HH11 ' HA2' ' A' ' 261' ' ' GLY . 0.1 OUTLIER -85.76 103.48 14.58 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.7 -175.237 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.737 ' HA ' HG12 ' A' ' 291' ' ' VAL . 2.2 t -66.17 131.79 31.84 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.104 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.081 -175.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.417 HD12 ' CB ' ' A' ' 244' ' ' GLN . 2.9 pp -120.84 2.3 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 O-C-N 123.539 0.524 . . . . 0.0 110.421 176.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.547 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 8.2 tt0 -178.22 95.58 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.072 -172.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.722 ' HB3' ' O ' ' A' ' 258' ' ' LEU . 0.0 OUTLIER -145.75 164.84 30.59 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.37 0.605 . . . . 0.0 110.443 175.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.881 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 12.7 ttm180 -92.87 171.98 8.62 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.778 -176.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.443 ' N ' ' HG2' ' A' ' 246' ' ' ARG . 21.9 t -101.72 75.48 0.16 Allowed Pre-proline 0 CA--C 1.542 0.646 0 CA-C-O 121.02 0.438 . . . . 0.0 110.123 170.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.996 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 1.2 Cg_endo -89.02 178.89 2.53 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 125.226 3.951 . . . . 0.0 111.875 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -127.52 175.36 8.31 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.97 0.414 . . . . 0.0 109.959 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.518 ' O ' HG22 ' A' ' 254' ' ' THR . . . -68.98 -1.23 6.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.125 0.488 . . . . 0.0 110.796 174.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -106.17 1.18 25.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.124 176.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -93.34 55.02 2.19 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp 60.54 22.61 12.33 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.46 -168.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . 0.518 HG22 ' O ' ' A' ' 250' ' ' ALA . 28.6 p 64.65 83.59 0.16 Allowed 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.553 -177.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.64 ' HB1' ' CE2' ' A' ' 286' ' ' PHE . . . -128.67 153.56 47.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.015 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.59 HD21 ' O ' ' A' ' 277' ' ' GLY . 4.2 mm? -72.83 120.48 18.51 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.85 -175.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.996 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -81.04 87.11 6.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.18 0.514 . . . . 0.0 111.007 174.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.722 ' O ' ' HB3' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -157.69 168.47 27.13 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.192 -176.046 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.477 ' O ' ' HB ' ' A' ' 242' ' ' VAL . 12.6 pt-20 -142.56 -164.91 1.92 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -168.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 4.3 p -60.25 122.46 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 121.593 0.711 . . . . 0.0 112.095 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.555 ' HA2' HH11 ' A' ' 241' ' ' ARG . . . 107.57 -1.44 34.41 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.851 172.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -89.68 -177.62 5.32 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -170.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.795 HD11 ' HD1' ' A' ' 239' ' ' TYR . 3.4 tm? -138.78 122.11 17.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.526 177.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.7 HG13 ' HB3' ' A' ' 240' ' ' ALA . 2.1 p -115.11 129.28 71.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.056 178.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 238' ' ' ILE . 75.9 tttt -98.54 95.17 7.11 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.768 ' HB ' HG23 ' A' ' 238' ' ' ILE . 21.0 t -66.14 123.17 18.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.243 -175.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 35.3 p -95.77 -24.46 16.49 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.855 -174.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.568 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 0.0 OUTLIER -119.12 107.34 13.36 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.534 -0.866 . . . . 0.0 109.509 177.007 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.471 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.6 OUTLIER -97.04 155.08 3.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-N 114.334 -1.303 . . . . 0.0 114.166 -167.772 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.893 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 0.3 OUTLIER -146.48 -172.55 3.98 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.772 171.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 60.1 t -93.35 -41.31 12.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.949 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 2.6 p -58.95 -43.7 91.31 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -175.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . 0.517 ' H ' ' ND2' ' A' ' 270' ' ' ASN . . . 115.45 -4.34 21.6 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.319 -0.944 . . . . 0.0 112.673 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.587 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.0 OUTLIER -95.91 71.93 2.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.709 0.766 . . . . 0.0 109.725 176.667 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.893 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -111.98 179.01 4.12 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.633 -168.609 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.63 ' HG2' ' O ' ' A' ' 284' ' ' GLY . 6.1 tt0 -90.2 125.27 35.41 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.59 ' O ' HD21 ' A' ' 256' ' ' LEU . . . -110.26 141.9 16.41 Favored Glycine 0 N--CA 1.436 -1.304 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 -173.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 26.6 tt0 -127.14 118.48 24.44 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 170.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . 0.48 ' O ' ' HD3' ' A' ' 282' ' ' LYS . 13.8 t -106.28 96.88 6.78 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -178.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 28.69 60.33 0.13 Allowed 'General case' 0 N--CA 1.468 0.454 0 O-C-N 125.015 1.447 . . . . 0.0 112.991 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 115.63 -30.53 6.61 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.334 178.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . 0.569 ' HE3' ' O ' ' A' ' 257' ' ' ALA . 6.1 mppt? -85.94 131.59 34.25 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.096 0.448 . . . . 0.0 110.378 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 40.1 mmm-85 -114.42 149.89 35.54 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.793 0.33 . . . . 0.0 111.698 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . 0.63 ' O ' ' HG2' ' A' ' 276' ' ' GLU . . . 159.72 -162.41 32.97 Favored Glycine 0 C--O 1.216 -0.973 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 173.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' HIS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 31.3 p80 -136.94 148.48 46.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 118.087 0.943 . . . . 0.0 111.077 177.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.64 ' CE2' ' HB1' ' A' ' 255' ' ' ALA . 2.4 m-85 -161.24 159.06 24.11 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 120.718 0.294 . . . . 0.0 111.325 -174.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 73.4 Cg_endo -93.14 149.44 2.52 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.251 2.634 . . . . 0.0 112.867 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.636 ' HA ' HG22 ' A' ' 291' ' ' VAL . 0.5 OUTLIER -75.28 -9.1 58.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.251 -174.26 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 8.9 t -63.0 -24.93 68.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.231 -0.441 . . . . 0.0 112.017 -173.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . 0.547 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 1.4 p-80 -121.67 38.07 4.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.48 0.657 . . . . 0.0 111.343 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.737 HG12 ' HA ' ' A' ' 242' ' ' VAL . 27.6 m -144.26 161.56 15.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.423 170.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -117.0 106.85 13.85 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 240' ' ' ALA . 0.2 OUTLIER -102.93 129.04 49.51 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-O 121.753 0.787 . . . . 0.0 113.008 -165.598 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 3.8 mp -93.51 174.08 7.37 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 114.348 -1.296 . . . . 0.0 108.797 168.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.646 ' OD2' ' HA ' ' A' ' 298' ' ' ASN . 12.7 t0 -76.76 156.86 32.07 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.194 -165.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.822 ' HG2' ' HB ' ' A' ' 238' ' ' ILE . 13.8 mt-30 -77.45 -36.41 52.97 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.396 -1.274 . . . . 0.0 109.203 -172.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? 178.76 20.06 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.023 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.646 ' HA ' ' OD2' ' A' ' 295' ' ' ASP . 14.4 m120 . . . . . 0 CA--C 1.535 0.385 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.028 -169.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.953 0 N-CA-C 111.504 -0.639 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 266' ' ' VAL . 3.2 Cg_exo -76.51 131.48 12.62 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.487 2.791 . . . . 0.0 111.659 -177.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.814 HD13 ' HB ' ' A' ' 266' ' ' VAL . 0.1 OUTLIER -93.68 165.96 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.476 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.694 ' HB3' HD11 ' A' ' 263' ' ' LEU . 36.4 m-85 -102.66 123.86 47.14 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 172.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.605 ' HB3' HG22 ' A' ' 264' ' ' VAL . . . -111.72 117.73 33.66 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.287 -168.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 292' ' ' ARG . 0.0 OUTLIER -85.9 103.05 14.27 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.021 176.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.611 HG21 ' HB2' ' A' ' 245' ' ' LYS . 3.5 p -91.57 121.4 42.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.737 -177.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.505 HD12 ' HB2' ' A' ' 244' ' ' GLN . 2.8 pp -100.33 4.7 10.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.864 -172.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.534 ' HB2' ' HB2' ' A' ' 290' ' ' HIS . 16.8 mt-30 -173.78 99.32 0.11 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.932 -174.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.966 ' HG2' HD13 ' A' ' 258' ' ' LEU . 0.1 OUTLIER -146.51 163.11 36.77 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.849 0.357 . . . . 0.0 110.057 176.316 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.848 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 10.5 ptp180 -103.32 -178.21 3.6 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.382 -178.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 2.9 m -105.81 77.45 0.41 Allowed Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.909 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 1.4 Cg_endo -88.82 173.78 4.13 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 124.934 3.756 . . . . 0.0 111.278 174.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -127.53 175.73 8.02 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 122.147 -0.346 . . . . 0.0 110.452 174.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.721 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -66.03 -1.69 3.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.587 0.708 . . . . 0.0 110.55 174.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -100.18 3.97 44.08 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.674 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.453 ' C ' ' HD2' ' A' ' 253' ' ' LYS . 2.2 m-20 -102.73 49.58 0.84 Allowed 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . 0.453 ' HD2' ' C ' ' A' ' 252' ' ' ASP . 0.0 OUTLIER 60.36 30.88 20.17 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -169.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . 0.721 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 32.0 p 59.37 74.65 0.43 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 113.388 -1.733 . . . . 0.0 112.16 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.435 ' HB1' ' CE2' ' A' ' 286' ' ' PHE . . . -115.77 150.46 36.88 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.008 174.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.775 ' HB3' HD11 ' A' ' 258' ' ' LEU . 0.0 OUTLIER -77.38 138.55 39.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.437 -174.497 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.909 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -90.55 94.45 9.71 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.336 0.588 . . . . 0.0 110.381 173.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.966 HD13 ' HG2' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -146.04 166.97 24.52 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.83 -175.467 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.443 ' O ' HG13 ' A' ' 242' ' ' VAL . 12.2 pt-20 -138.68 -166.48 2.02 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.08 0.467 . . . . 0.0 111.491 -169.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 2.3 p -67.09 116.82 6.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.199 175.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 103.2 -1.85 47.18 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 114.801 -1.09 . . . . 0.0 112.66 169.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.433 ' HG3' ' HG2' ' A' ' 259' ' ' GLU . 18.2 mt-10 -80.87 169.83 17.06 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.204 0.526 . . . . 0.0 111.123 -174.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.694 HD11 ' HB3' ' A' ' 239' ' ' TYR . 10.2 tp -132.6 151.0 52.07 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.317 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.706 HG11 HD23 ' A' ' 258' ' ' LEU . 18.4 m -148.12 173.71 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.088 -176.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.452 ' HG3' ' CE1' ' A' ' 239' ' ' TYR . 5.0 ttmm -119.72 95.55 4.82 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 175.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.814 ' HB ' HD13 ' A' ' 238' ' ' ILE . 53.8 t -69.19 115.05 6.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.136 0.493 . . . . 0.0 110.436 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 40.5 p -93.37 -7.97 43.2 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.261 -174.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 3.2 tppp? -129.5 104.82 7.69 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.59 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.8 OUTLIER -107.83 157.62 7.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.629 0.728 . . . . 0.0 112.82 -173.39 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.632 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 4.7 p30 -147.37 -176.81 5.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.359 -173.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 32.0 m -110.73 15.45 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.3 m -109.66 -43.33 4.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.073 0.463 . . . . 0.0 110.382 176.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . 0.785 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 123.73 -9.91 8.56 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.544 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.9 OUTLIER -95.37 90.13 5.7 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.659 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.632 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -115.87 171.36 7.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.112 -173.523 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.664 ' O ' HG13 ' A' ' 266' ' ' VAL . 36.0 mt-10 -96.05 122.81 39.28 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 174.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.598 ' HA2' HG22 ' A' ' 266' ' ' VAL . . . -104.51 134.09 11.83 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.182 -171.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 34.0 tt0 -120.47 119.37 32.8 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 117.542 0.671 . . . . 0.0 109.584 178.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . 0.535 ' HB2' HG12 ' A' ' 264' ' ' VAL . 36.2 t -111.11 98.21 7.36 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.677 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 43.0 57.32 3.71 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 124.141 0.9 . . . . 0.0 112.232 174.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 114.38 -34.3 4.99 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.9 174.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . 0.567 ' HD2' ' H ' ' A' ' 282' ' ' LYS . 4.1 mptt -98.87 138.89 35.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.332 0.566 . . . . 0.0 109.592 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . 0.45 ' H ' ' HD2' ' A' ' 283' ' ' ARG . 0.0 OUTLIER -121.54 129.11 52.68 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.454 0.645 . . . . 0.0 111.094 176.621 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . 0.574 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . -149.94 145.78 14.26 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.714 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -101.55 138.16 38.92 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 117.918 0.859 . . . . 0.0 111.953 -172.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.562 ' CG ' ' HE2' ' A' ' 245' ' ' LYS . 9.5 m-85 -154.44 163.54 23.87 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.635 -175.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 68.3 Cg_endo -96.79 174.67 0.73 Allowed 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 123.69 2.926 . . . . 0.0 115.203 -173.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.785 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 32.4 t80 -82.14 -21.76 36.46 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 113.978 -1.464 . . . . 0.0 112.716 -171.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 9.9 t -58.62 -13.15 5.11 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -171.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . 0.534 ' HB2' ' HB2' ' A' ' 244' ' ' GLN . 1.1 p-80 -141.64 44.28 1.72 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.962 0.41 . . . . 0.0 111.957 -177.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.419 ' O ' ' HD2' ' A' ' 292' ' ' ARG . 12.6 m -135.0 156.96 40.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.496 0.665 . . . . 0.0 112.022 177.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.419 ' HD2' ' O ' ' A' ' 291' ' ' VAL . 22.7 mmm180 -127.53 106.7 9.36 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 166.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . 0.431 HD12 ' CB ' ' A' ' 240' ' ' ALA . 1.8 mm? -92.21 143.46 26.4 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.63 -0.669 . . . . 0.0 112.242 -170.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.459 HD23 ' N ' ' A' ' 294' ' ' LEU . 4.1 mt -94.81 123.58 38.35 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 164.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.586 ' OD2' ' HB2' ' A' ' 297' ' ' GLN . 4.5 p-10 -76.83 155.63 32.86 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.773 0.797 . . . . 0.0 112.215 -166.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.755 ' HB3' HG22 ' A' ' 238' ' ' ILE . 1.7 pm0 -77.58 12.34 1.67 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.273 -1.331 . . . . 0.0 111.579 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.586 ' HB2' ' OD2' ' A' ' 295' ' ' ASP . 29.0 mm-40 -91.36 -30.2 16.68 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 171.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 19.7 m120 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.15 176.07 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 113.721 0.249 . . . . 0.0 113.721 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.676 ' HB2' ' HD3' ' A' ' 265' ' ' LYS . 6.9 Cg_endo -90.82 131.56 1.56 Allowed 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 124.022 3.148 . . . . 0.0 110.788 172.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 1.034 HG12 HG22 ' A' ' 266' ' ' VAL . 2.2 pt -82.38 158.67 3.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.642 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.709 ' HB3' HD21 ' A' ' 263' ' ' LEU . 36.1 m-85 -104.79 117.11 33.25 Favored 'General case' 0 C--O 1.21 -1.025 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 169.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.654 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -113.34 116.54 29.86 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.187 -172.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.417 ' HB3' ' O ' ' A' ' 292' ' ' ARG . 22.7 tpp180 -74.88 101.68 4.48 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.803 -1.09 . . . . 0.0 108.287 175.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.601 HG21 ' HD3' ' A' ' 245' ' ' LYS . 7.6 p -83.59 124.57 39.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.153 -175.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.9 pp -102.36 1.66 10.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.109 -173.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.507 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 52.5 tt0 -177.37 98.51 0.05 OUTLIER 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.94 -176.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.659 ' HE2' HD11 ' A' ' 258' ' ' LEU . 0.0 OUTLIER -146.09 163.29 35.76 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.272 0.558 . . . . 0.0 110.156 173.179 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.771 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 5.7 ptp180 -94.82 -174.35 3.25 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.306 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 2.8 m -108.98 69.31 0.38 Allowed Pre-proline 0 CA--C 1.536 0.426 0 CA-C-O 121.246 0.546 . . . . 0.0 111.615 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.976 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 57.0 Cg_endo -95.86 122.25 0.27 Allowed 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 124.645 3.563 . . . . 0.0 111.442 178.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -79.35 175.66 10.4 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.989 0.423 . . . . 0.0 110.966 -176.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -65.02 -0.53 1.61 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.179 0.514 . . . . 0.0 111.375 177.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -103.67 8.61 37.43 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.087 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -98.12 53.47 1.08 Allowed 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . 0.535 ' N ' ' HD3' ' A' ' 253' ' ' LYS . 0.1 OUTLIER 61.42 28.99 18.26 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -167.399 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 26.5 p 62.09 87.01 0.1 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.197 -1.365 . . . . 0.0 110.942 -176.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.648 ' HB3' ' HB2' ' A' ' 248' ' ' PRO . . . -123.72 165.64 16.91 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.785 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.602 ' H ' ' HE2' ' A' ' 286' ' ' PHE . 4.3 mm? -89.07 114.96 26.24 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.009 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.976 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -85.31 87.14 7.35 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.59 0.709 . . . . 0.0 110.413 177.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.659 HD11 ' HE2' ' A' ' 245' ' ' LYS . 0.4 OUTLIER -151.98 167.2 29.15 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.869 -173.247 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.543 ' O ' HG13 ' A' ' 242' ' ' VAL . 11.1 pt-20 -141.89 -161.89 1.31 Allowed 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.755 -0.591 . . . . 0.0 111.903 -170.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 2.7 p -65.06 119.13 8.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.494 0.664 . . . . 0.0 112.112 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 106.26 -2.67 37.51 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.927 171.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -90.99 -177.78 5.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.782 0.325 . . . . 0.0 111.434 -171.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.709 HD21 ' HB3' ' A' ' 239' ' ' TYR . 3.3 tm? -131.18 120.08 22.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.944 0.402 . . . . 0.0 110.458 -176.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.654 HG13 ' HB3' ' A' ' 240' ' ' ALA . 2.5 p -115.63 116.88 53.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.637 175.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.676 ' HD3' ' HB2' ' A' ' 237' ' ' PRO . 0.0 OUTLIER -89.41 98.64 11.88 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.006 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 1.034 HG22 HG12 ' A' ' 238' ' ' ILE . 6.1 m -79.12 122.89 35.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.533 0.682 . . . . 0.0 110.969 -176.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . 0.516 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 36.4 p -86.47 -19.48 29.5 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.426 -174.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.902 ' HA ' ' HE3' ' A' ' 268' ' ' LYS . 0.1 OUTLIER -123.11 105.95 10.36 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -178.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.462 HG21 ' NE2' ' A' ' 296' ' ' GLN . 0.7 OUTLIER -94.32 157.25 3.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -172.774 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.722 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 3.4 p30 -146.43 179.83 7.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.724 -179.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 10.2 p -93.36 -18.85 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -173.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 33.5 m -94.65 -34.91 12.41 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -176.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . 0.767 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 115.29 -2.81 22.25 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.929 -177.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 1.9 mp0 -89.93 76.79 7.03 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 175.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.722 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -115.1 173.02 6.71 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.532 0.682 . . . . 0.0 111.808 -171.636 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 36.1 mt-10 -96.85 125.55 41.38 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.132 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.658 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -111.25 155.02 16.37 Favored Glycine 0 N--CA 1.437 -1.265 0 CA-C-N 114.669 -1.151 . . . . 0.0 112.509 -169.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.597 ' HG2' ' HG3' ' A' ' 283' ' ' ARG . 6.1 tm-20 -139.47 119.7 13.74 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 174.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . 0.576 ' O ' ' HD3' ' A' ' 282' ' ' LYS . 12.4 t -124.46 99.85 6.39 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.829 -173.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.443 HD22 ' N ' ' A' ' 280' ' ' ASN . 0.9 OUTLIER 51.66 38.01 21.57 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.808 0.693 . . . . 0.0 111.672 170.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 114.93 -26.42 9.35 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.187 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . 0.576 ' HD3' ' O ' ' A' ' 279' ' ' CYS . 0.1 OUTLIER -81.93 137.04 35.25 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 177.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . 0.597 ' HG3' ' HG2' ' A' ' 278' ' ' GLU . 0.1 OUTLIER -128.15 140.07 52.13 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.927 177.783 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 177.48 -145.51 7.2 Favored Glycine 0 C--O 1.222 -0.6 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.103 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' HIS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 13.7 p80 -150.54 140.2 21.66 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.665 0.233 . . . . 0.0 111.252 -178.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.602 ' HE2' ' H ' ' A' ' 256' ' ' LEU . 9.9 m-85 -157.44 159.31 30.9 Favored Pre-proline 0 N--CA 1.469 0.5 0 C-N-CA 122.249 0.22 . . . . 0.0 111.11 -177.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 63.7 Cg_endo -92.86 176.9 1.52 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.246 2.631 . . . . 0.0 114.435 -173.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.767 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 21.2 t80 -80.64 -33.62 35.55 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 113.816 -1.538 . . . . 0.0 112.657 -168.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 6.6 t -55.77 -33.72 64.6 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -168.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . 0.555 ' CD2' ' HD2' ' A' ' 245' ' ' LYS . 1.2 p-80 -115.05 49.27 1.07 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.605 0.717 . . . . 0.0 110.845 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -150.04 155.64 7.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.551 175.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.417 ' O ' ' HB3' ' A' ' 241' ' ' ARG . 29.2 mmm180 -130.83 107.42 9.12 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 175.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . 0.612 ' H ' HD23 ' A' ' 293' ' ' LEU . 0.3 OUTLIER -102.04 136.14 42.4 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -162.735 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 239' ' ' TYR . 0.0 OUTLIER -84.42 143.6 29.32 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 113.96 -1.473 . . . . 0.0 107.373 170.477 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -75.61 152.6 37.63 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.34 -163.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.847 ' HB3' HG22 ' A' ' 238' ' ' ILE . 12.5 pt20 -93.79 -22.8 18.46 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.066 -174.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.44 HE21 ' HB2' ' A' ' 297' ' ' GLN . 0.0 OUTLIER -91.95 -35.04 14.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.191 0.519 . . . . 0.0 109.606 -178.919 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 10.8 m120 . . . . . 0 C--N 1.323 -0.554 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.897 171.925 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . 0.486 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . . . . . . 0 N--CA 1.445 -0.741 0 N-CA-C 112.255 -0.338 . . . . 0.0 112.255 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.486 ' HD3' ' HA2' ' A' ' 236' ' ' GLY . 7.1 Cg_exo -73.17 133.72 19.98 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.072 2.515 . . . . 0.0 112.003 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 1.062 HG22 ' HB3' ' A' ' 296' ' ' GLN . 0.2 OUTLIER -92.8 167.47 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.545 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.7 ' HB3' HD11 ' A' ' 263' ' ' LEU . 72.4 m-85 -106.64 127.73 53.59 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 170.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.513 ' HB3' ' CG1' ' A' ' 264' ' ' VAL . . . -114.39 118.16 33.07 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.528 -176.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.608 ' NH1' ' HA2' ' A' ' 261' ' ' GLY . 0.1 OUTLIER -88.8 100.82 13.45 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.297 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 1.016 HG21 ' HD2' ' A' ' 245' ' ' LYS . 7.2 p -86.56 127.15 40.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.071 -172.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.8 pp -100.29 3.28 10.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.4 -174.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.532 ' H ' HG22 ' A' ' 242' ' ' VAL . 7.2 tp-100 -177.33 106.91 0.06 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -176.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 1.061 ' HD3' ' HB2' ' A' ' 258' ' ' LEU . 14.7 tttt -144.63 157.15 44.33 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 177.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.81 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 16.4 ptt180 -103.92 -175.14 2.71 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 6.8 m -110.51 69.37 0.58 Allowed Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 121.177 0.513 . . . . 0.0 111.987 -174.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 1.017 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 17.8 Cg_endo -94.47 124.51 0.42 Allowed 'Trans proline' 0 N--CA 1.444 -1.433 0 C-N-CA 124.285 3.324 . . . . 0.0 111.175 176.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.417 ' C ' ' H ' ' A' ' 251' ' ' TYR . 7.0 m-20 -81.46 176.92 9.28 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.022 0.439 . . . . 0.0 111.043 -174.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.607 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -67.77 4.86 0.99 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.202 0.525 . . . . 0.0 111.281 177.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.417 ' H ' ' C ' ' A' ' 249' ' ' ASN . 44.8 m-85 -106.5 5.74 29.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.553 0.692 . . . . 0.0 109.572 176.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.423 ' C ' ' HD2' ' A' ' 253' ' ' LYS . 3.7 m-20 -101.17 55.73 0.84 Allowed 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . 0.423 ' HD2' ' C ' ' A' ' 252' ' ' ASP . 0.0 OUTLIER 59.0 27.01 15.78 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -169.568 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . 0.607 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 30.2 p 61.42 85.19 0.12 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.63 -176.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.685 ' HB3' ' HB2' ' A' ' 248' ' ' PRO . . . -118.31 165.63 13.6 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.499 178.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.961 ' HB3' HD13 ' A' ' 258' ' ' LEU . 3.8 mm? -88.35 112.78 23.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.632 178.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.017 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -82.32 81.86 8.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.6 0.714 . . . . 0.0 110.234 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 1.061 ' HB2' ' HD3' ' A' ' 245' ' ' LYS . 6.1 mp -122.83 177.92 5.26 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.382 -171.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -143.71 -169.31 3.05 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.156 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 2.3 p -65.71 121.06 14.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.247 177.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.608 ' HA2' ' NH1' ' A' ' 241' ' ' ARG . . . 103.44 -2.22 46.39 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.486 171.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -88.76 174.99 7.68 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.991 0.424 . . . . 0.0 111.261 -171.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.7 HD11 ' HB3' ' A' ' 239' ' ' TYR . 21.5 tp -130.0 158.85 38.45 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.222 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.823 HG23 ' HB2' ' A' ' 279' ' ' CYS . 8.3 p -151.13 150.71 13.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.427 ' HD3' ' HB2' ' A' ' 237' ' ' PRO . 0.0 OUTLIER -110.34 97.92 7.27 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.22 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.965 HG22 HG12 ' A' ' 238' ' ' ILE . 15.5 m -74.39 113.3 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 121.972 0.891 . . . . 0.0 110.43 -178.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . 0.464 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 61.0 p -92.34 0.52 57.45 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.095 -174.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.65 107.14 6.48 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.375 172.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.605 HG21 HG23 ' A' ' 238' ' ' ILE . 0.8 OUTLIER -104.21 160.86 4.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 114.34 -1.3 . . . . 0.0 113.102 -170.25 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.717 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 3.8 p30 -146.87 171.62 14.92 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.815 -176.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 27.0 m -87.04 5.06 3.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -175.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 4.4 m -111.54 -43.42 3.67 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . 0.439 ' HA2' ' CZ2' ' A' ' 275' ' ' TRP . . . 120.24 -0.4 12.92 Favored Glycine 0 C--O 1.223 -0.543 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.021 -175.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.592 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.2 OUTLIER -98.04 77.64 2.47 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.813 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.717 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -117.87 169.88 9.27 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.461 -167.457 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.595 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 39.9 mt-10 -90.68 126.29 35.93 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.228 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.654 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -111.36 146.37 17.78 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.294 -170.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 4.3 tm-20 -133.7 116.51 15.87 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . 0.823 ' HB2' HG23 ' A' ' 264' ' ' VAL . 10.5 t -115.7 99.0 7.0 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.744 0.783 . . . . 0.0 110.009 -177.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 31.63 55.89 0.29 Allowed 'General case' 0 C--N 1.343 0.301 0 CA-C-N 112.918 -1.947 . . . . 0.0 113.525 175.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.82 -14.41 14.37 Favored Glycine 0 CA--C 1.522 0.495 0 CA-C-N 115.933 -0.576 . . . . 0.0 113.51 176.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 19.0 mttt -108.38 128.64 54.94 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 117.213 0.506 . . . . 0.0 109.699 177.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . 0.491 ' C ' ' HD3' ' A' ' 283' ' ' ARG . 0.2 OUTLIER -123.21 143.95 49.69 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.276 -0.569 . . . . 0.0 111.173 179.637 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 176.63 -145.1 7.24 Favored Glycine 0 C--O 1.224 -0.508 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.243 178.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' HIS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 13.6 p80 -150.15 147.65 28.0 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.852 0.326 . . . . 0.0 110.822 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.64 ' HD1' ' HD2' ' A' ' 287' ' ' PRO . 2.5 m-85 -161.68 153.93 16.57 Favored Pre-proline 0 N--CA 1.467 0.398 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -178.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.64 ' HD2' ' HD1' ' A' ' 286' ' ' PHE . 87.4 Cg_endo -88.32 165.1 6.8 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.399 2.733 . . . . 0.0 112.513 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.608 ' HA ' HG12 ' A' ' 291' ' ' VAL . 9.4 p90 -88.16 -4.77 58.69 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -172.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 5.6 t -56.76 -11.38 1.37 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -177.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -133.47 30.76 3.8 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 122.259 -0.276 . . . . 0.0 111.149 -175.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.709 HG23 ' HA ' ' A' ' 242' ' ' VAL . 9.5 p -147.35 157.6 9.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 C-N-CA 119.759 -0.776 . . . . 0.0 112.005 -170.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.447 ' HA ' ' HD2' ' A' ' 292' ' ' ARG . 25.3 tpt180 -125.98 109.74 12.79 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . 0.561 HD22 ' H ' ' A' ' 293' ' ' LEU . 0.4 OUTLIER -86.42 150.16 24.5 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 119.562 -0.855 . . . . 0.0 113.22 -165.522 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 239' ' ' TYR . 11.3 mt -99.81 122.78 43.28 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 105.153 -2.165 . . . . 0.0 105.153 163.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.522 ' HB3' ' HG3' ' A' ' 297' ' ' GLN . 4.7 t70 -77.87 150.83 34.09 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 122.197 0.998 . . . . 0.0 112.713 -160.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 1.062 ' HB3' HG22 ' A' ' 238' ' ' ILE . 5.5 pt20 -73.95 -9.17 58.37 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 113.512 -1.677 . . . . 0.0 111.433 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.522 ' HG3' ' HB3' ' A' ' 295' ' ' ASP . 0.0 OUTLIER -71.14 -21.85 62.14 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.163 173.01 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.451 HD22 ' C ' ' A' ' 298' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 121.23 0.538 . . . . 0.0 110.105 175.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' A' ' 296' ' ' GLN . . . . . . . . 0 N--CA 1.447 -0.569 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.474 ' HD3' ' HA2' ' A' ' 236' ' ' GLY . 19.7 Cg_exo -67.48 136.12 38.61 Favored 'Trans proline' 0 CA--C 1.52 -0.191 0 C-N-CA 123.242 2.628 . . . . 0.0 113.135 -179.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.942 HG23 ' HB ' ' A' ' 266' ' ' VAL . 0.1 OUTLIER -90.02 151.52 3.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.211 175.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.584 ' HD1' HD11 ' A' ' 263' ' ' LEU . 27.4 m-85 -109.64 117.37 33.76 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.616 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -115.15 117.17 29.78 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.413 0.625 . . . . 0.0 111.447 -171.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 241' ' ' ARG . 4.2 tpp85 -74.89 104.79 5.64 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.847 174.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.787 HG21 ' HD3' ' A' ' 245' ' ' LYS . 7.5 p -84.24 133.46 29.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.23 0.538 . . . . 0.0 110.852 -176.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.636 HD12 ' HB2' ' A' ' 244' ' ' GLN . 2.4 pp -115.19 3.99 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.919 -171.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.636 ' HB2' HD12 ' A' ' 243' ' ' ILE . 5.3 mt-30 -173.94 94.14 0.09 Allowed 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 123.202 0.314 . . . . 0.0 110.5 -175.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.787 ' HD3' HG21 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -147.1 162.99 37.71 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.238 0.542 . . . . 0.0 110.427 173.437 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.855 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 4.5 ptt180 -101.59 -176.42 3.13 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.978 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.4 77.96 0.23 Allowed Pre-proline 0 CA--C 1.542 0.644 0 O-C-N 122.156 -0.34 . . . . 0.0 111.382 175.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 1.032 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 12.7 Cg_endo -94.55 142.23 1.44 Allowed 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.54 3.494 . . . . 0.0 112.214 175.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.406 ' O ' ' HB2' ' A' ' 252' ' ' ASP . 15.1 m120 -96.78 177.06 5.76 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.731 -177.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.764 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -63.95 -7.63 8.93 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 121.823 0.821 . . . . 0.0 110.197 172.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -95.04 6.79 48.08 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.065 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 249' ' ' ASN . 1.1 m-20 -105.04 48.11 0.85 Allowed 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . 0.478 ' N ' ' HD2' ' A' ' 253' ' ' LYS . 0.1 OUTLIER 60.42 32.7 20.66 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -167.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . 0.764 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 23.4 p 57.03 77.55 0.26 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.166 -1.379 . . . . 0.0 111.158 -179.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.62 ' HB3' ' HB2' ' A' ' 248' ' ' PRO . . . -117.77 167.14 11.65 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.024 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.537 ' H ' ' HE2' ' A' ' 286' ' ' PHE . 4.6 mm? -88.55 118.8 28.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.909 -175.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.032 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -83.54 90.64 7.27 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.768 0.794 . . . . 0.0 110.547 175.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.658 ' O ' ' HB3' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -150.72 167.52 27.14 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.04 -176.183 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.457 ' CG ' ' N ' ' A' ' 260' ' ' VAL . 24.7 tt0 -142.93 177.24 8.49 Favored 'General case' 0 C--N 1.313 -1.005 0 O-C-N 122.088 -0.383 . . . . 0.0 110.547 -164.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 243' ' ' ILE . 57.8 t -50.05 118.52 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 122.906 0.482 . . . . 0.0 111.479 174.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 106.1 -2.32 38.01 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.58 170.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -98.23 -173.59 2.62 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.875 0.369 . . . . 0.0 111.725 -172.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.584 HD11 ' HD1' ' A' ' 239' ' ' TYR . 3.3 tm? -129.47 131.14 46.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.525 -173.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.616 HG13 ' HB3' ' A' ' 240' ' ' ALA . 2.4 p -123.39 124.49 69.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.435 174.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -82.68 112.24 19.36 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 175.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.942 ' HB ' HG23 ' A' ' 238' ' ' ILE . 94.8 t -77.06 112.91 15.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 65.8 p -94.65 -32.89 13.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.962 -171.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.579 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 11.9 tppt? -116.16 107.56 15.05 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.571 HG21 ' NE2' ' A' ' 296' ' ' GLN . 0.7 OUTLIER -96.74 140.25 17.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -168.134 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.904 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 0.3 OUTLIER -148.06 149.07 31.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.852 178.118 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 10.9 p -65.37 -17.4 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -173.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 3.9 p -78.26 -30.68 48.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.914 0.388 . . . . 0.0 111.995 -177.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . 0.605 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 94.96 -5.67 68.99 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.464 -177.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.64 ' HG3' ' HB3' ' A' ' 287' ' ' PRO . 1.7 mp0 -92.56 77.41 5.0 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 174.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.904 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -122.76 178.42 5.03 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.489 -0.778 . . . . 0.0 113.042 -167.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 268' ' ' LYS . 40.2 mt-10 -83.33 127.47 33.69 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.525 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.448 ' O ' HD21 ' A' ' 256' ' ' LEU . . . -111.75 156.44 15.57 Favored Glycine 0 N--CA 1.433 -1.528 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.615 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 21.2 tt0 -141.88 119.43 11.68 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . 0.479 ' HB2' HD23 ' A' ' 258' ' ' LEU . 51.6 t -115.2 99.06 7.14 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.061 -176.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 45.18 45.12 9.23 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 124.065 0.853 . . . . 0.0 111.958 176.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 114.86 -33.51 5.31 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.202 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 12.2 mptt -73.32 139.69 46.22 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 117.178 0.489 . . . . 0.0 110.084 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -124.01 142.05 51.51 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.216 0.531 . . . . 0.0 111.921 -176.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 169.49 -145.54 9.41 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.391 175.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' HIS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 7.5 p80 -150.35 147.53 27.72 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.936 0.368 . . . . 0.0 111.191 -177.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.61 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 2.1 m-85 -158.18 150.74 17.93 Favored Pre-proline 0 N--CA 1.466 0.331 0 CA-C-O 120.936 0.398 . . . . 0.0 112.052 -178.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.64 ' HB3' ' HG3' ' A' ' 274' ' ' GLN . 2.4 Cg_endo -81.34 174.32 10.76 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.915 3.076 . . . . 0.0 114.152 -178.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.605 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 24.9 t80 -87.77 -35.67 17.74 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -167.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 4.1 t -65.41 -7.27 13.1 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -164.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . 0.534 ' NE2' ' HD2' ' A' ' 245' ' ' LYS . 1.1 p-80 -120.35 31.82 6.3 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.907 -0.496 . . . . 0.0 110.92 178.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.673 HG23 ' HA ' ' A' ' 242' ' ' VAL . 4.0 p -147.23 154.19 11.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.296 0.569 . . . . 0.0 111.566 -175.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -131.95 110.25 10.63 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 240' ' ' ALA . 0.2 OUTLIER -118.02 135.68 54.01 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -162.18 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.443 ' H ' HD12 ' A' ' 294' ' ' LEU . 5.3 mp -77.93 153.42 32.55 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.864 168.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -76.34 150.49 36.86 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.756 -162.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.571 ' NE2' HG21 ' A' ' 269' ' ' ILE . 2.6 pt20 -77.86 5.41 9.67 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 113.618 -1.628 . . . . 0.0 112.086 -173.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -73.96 -31.78 63.16 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.11 174.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 120.795 0.331 . . . . 0.0 111.156 -175.059 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . 0.412 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . . . . . . 0 N--CA 1.447 -0.611 0 N-CA-C 112.145 -0.382 . . . . 0.0 112.145 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.503 ' HB3' ' HA ' ' A' ' 267' ' ' THR . 6.2 Cg_exo -78.68 131.73 10.49 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.149 2.566 . . . . 0.0 112.116 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 1.069 HG22 ' HB3' ' A' ' 296' ' ' GLN . 0.2 OUTLIER -87.01 163.55 2.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.553 176.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.819 ' HB3' HD11 ' A' ' 263' ' ' LEU . 67.7 m-85 -104.92 123.49 47.84 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 171.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.694 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -112.52 118.62 35.62 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.861 -174.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 292' ' ' ARG . 0.0 OUTLIER -75.89 100.86 4.95 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.7 HG21 ' HB2' ' A' ' 245' ' ' LYS . 3.3 p -82.63 121.01 35.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.111 -176.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.708 HD12 ' HB2' ' A' ' 244' ' ' GLN . 2.8 pp -105.85 10.55 9.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.708 -175.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.708 ' HB2' HD12 ' A' ' 243' ' ' ILE . 1.0 OUTLIER -177.0 94.95 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.272 -176.642 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.7 ' HB2' HG21 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -147.09 164.68 32.31 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.27 0.557 . . . . 0.0 111.202 174.335 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.818 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 3.2 ptm180 -101.06 -177.96 3.61 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.525 -177.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 46.2 t -104.67 81.91 0.6 Allowed Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 121.201 0.524 . . . . 0.0 110.918 174.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.95 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 4.6 Cg_endo -91.03 175.46 2.44 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 124.959 3.773 . . . . 0.0 111.881 174.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -138.55 179.91 6.19 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.146 176.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.751 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -57.25 -12.59 2.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.877 0.37 . . . . 0.0 111.89 176.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -91.34 -5.71 54.16 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 122.081 -0.387 . . . . 0.0 110.486 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -92.06 48.35 1.42 Allowed 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? 59.01 24.5 12.74 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -167.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . 0.751 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 19.3 p 64.98 83.35 0.17 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.405 -1.271 . . . . 0.0 110.885 -177.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.634 ' HB1' ' CE2' ' A' ' 286' ' ' PHE . . . -122.33 159.25 27.84 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.466 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.568 HD22 ' HA3' ' A' ' 284' ' ' GLY . 0.7 OUTLIER -78.27 123.91 27.48 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.251 -174.849 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.95 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -84.28 93.96 8.33 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.561 0.696 . . . . 0.0 111.171 172.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.644 ' O ' ' HB3' ' A' ' 245' ' ' LYS . 0.2 OUTLIER -155.6 167.98 28.64 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.623 -177.133 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.436 ' O ' HG13 ' A' ' 242' ' ' VAL . 12.3 pt-20 -141.78 -165.2 1.94 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.916 -0.49 . . . . 0.0 111.855 -172.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 43.0 t -59.63 118.38 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 96.71 0.18 60.76 Favored Glycine 0 CA--C 1.508 -0.396 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.165 170.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -89.74 -175.93 4.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.72 0.295 . . . . 0.0 110.396 -176.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.819 HD11 ' HB3' ' A' ' 239' ' ' TYR . 44.4 tp -130.0 159.84 35.46 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.01 0.433 . . . . 0.0 111.322 -176.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.694 HG13 ' HB3' ' A' ' 240' ' ' ALA . 2.4 p -152.24 133.82 5.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.019 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.464 ' HE2' ' HG2' ' A' ' 237' ' ' PRO . 86.1 tttt -96.16 96.36 8.77 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.246 0.546 . . . . 0.0 109.833 178.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.869 ' HB ' HD13 ' A' ' 238' ' ' ILE . 50.3 t -76.98 114.72 17.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.043 0.449 . . . . 0.0 111.473 -178.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . 0.503 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 42.0 p -90.8 -10.45 42.79 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.49 -174.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.52 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 13.3 tppt? -127.21 105.94 8.9 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.818 HG21 HG23 ' A' ' 238' ' ' ILE . 0.8 OUTLIER -111.65 140.25 32.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -170.391 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.866 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 0.2 OUTLIER -148.6 140.44 23.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.634 177.766 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 10.6 p -58.68 -15.07 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -172.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.4 m -62.0 -36.11 80.54 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.297 0.481 . . . . 0.0 112.297 -177.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . 0.536 ' CA ' ' HB2' ' A' ' 288' ' ' PHE . . . 89.11 36.43 7.64 Favored Glycine 0 N--CA 1.437 -1.299 0 C-N-CA 119.908 -1.139 . . . . 0.0 110.797 -170.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 1.0 OUTLIER -148.7 96.92 2.65 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 171.163 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.866 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -134.15 173.07 12.0 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -168.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.728 ' O ' HG13 ' A' ' 266' ' ' VAL . 18.4 mm-40 -90.06 123.39 33.89 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.348 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -105.37 162.12 14.48 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -175.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.537 ' HG2' ' HG3' ' A' ' 283' ' ' ARG . 3.5 tm-20 -151.47 120.17 6.54 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 174.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 43.4 t -122.64 97.68 5.57 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.668 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 45.17 49.92 9.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.329 170.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.49 -27.31 8.08 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.684 -0.77 . . . . 0.0 113.4 177.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.85 128.58 41.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 117.311 0.556 . . . . 0.0 110.166 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . 0.537 ' HG3' ' HG2' ' A' ' 278' ' ' GLU . 0.4 OUTLIER -109.0 136.44 48.52 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.185 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . 0.568 ' HA3' HD22 ' A' ' 256' ' ' LEU . . . -161.94 -171.98 28.74 Favored Glycine 0 C--O 1.226 -0.395 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.599 -176.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -147.02 135.79 22.17 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 172.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.688 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 4.4 m-85 -154.81 158.63 32.2 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -173.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 56.9 Cg_endo -94.93 164.68 1.69 Allowed 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.442 2.761 . . . . 0.0 113.938 -176.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.662 ' HA ' HG22 ' A' ' 291' ' ' VAL . 9.1 t80 -74.86 -18.47 60.43 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.131 -174.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 8.9 t -48.31 -24.91 1.35 Allowed 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 -175.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . 0.499 ' NE2' ' HD2' ' A' ' 245' ' ' LYS . 0.8 OUTLIER -137.51 48.19 2.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.807 0.337 . . . . 0.0 111.86 -177.839 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.662 HG22 ' HA ' ' A' ' 288' ' ' PHE . 30.1 m -143.22 155.09 16.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 121.102 0.477 . . . . 0.0 111.208 173.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.478 ' HD2' ' O ' ' A' ' 291' ' ' VAL . 15.9 mmm180 -121.79 110.43 15.9 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 173.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . 0.518 HD22 ' HE2' ' A' ' 288' ' ' PHE . 2.6 tp -94.24 126.92 39.78 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -160.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.535 HD13 ' N ' ' A' ' 294' ' ' LEU . 0.1 OUTLIER -83.41 124.4 30.63 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 163.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -82.76 152.9 25.52 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.932 0.872 . . . . 0.0 112.208 -162.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 1.069 ' HB3' HG22 ' A' ' 238' ' ' ILE . 9.0 pt20 -75.45 -7.98 55.51 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.753 -1.567 . . . . 0.0 111.716 -176.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.495 ' HG3' ' N ' ' A' ' 298' ' ' ASN . 0.2 OUTLIER -65.03 -38.28 90.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.971 0.415 . . . . 0.0 110.02 173.406 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.495 ' N ' ' HG3' ' A' ' 297' ' ' GLN . 13.5 m120 . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.755 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.553 0 N-CA-C 112.774 -0.13 . . . . 0.0 112.774 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.536 ' HA ' ' O ' ' A' ' 266' ' ' VAL . 10.1 Cg_endo -91.29 120.01 0.61 Allowed 'Trans proline' 0 N--CA 1.446 -1.277 0 C-N-CA 123.515 2.81 . . . . 0.0 112.413 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 1.089 HD11 ' HB2' ' A' ' 240' ' ' ALA . 0.1 OUTLIER -92.46 144.6 8.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 171.682 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.798 ' HD1' HD11 ' A' ' 263' ' ' LEU . 46.7 m-85 -96.96 119.53 35.6 Favored 'General case' 0 C--O 1.21 -1.01 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 173.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 1.089 ' HB2' HD11 ' A' ' 238' ' ' ILE . . . -113.94 115.9 28.4 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.107 -173.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.45 ' HB3' ' O ' ' A' ' 292' ' ' ARG . 17.8 tpp180 -84.76 103.4 13.82 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.189 -1.369 . . . . 0.0 108.375 177.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 1.049 HG11 ' HD2' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -89.75 149.47 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.546 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.669 -177.245 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.503 HD12 ' HB2' ' A' ' 244' ' ' GLN . 2.3 pp -124.88 11.23 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-N 113.544 -1.662 . . . . 0.0 110.654 -171.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.808 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 52.9 tt0 -177.23 94.6 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.63 -174.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 1.049 ' HD2' HG11 ' A' ' 242' ' ' VAL . 5.3 mttt -146.93 162.79 37.99 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.966 0.412 . . . . 0.0 110.11 177.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.868 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 10.7 ptm180 -113.37 -177.26 3.09 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.494 -174.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 9.3 m -102.57 81.83 0.4 Allowed Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 121.488 0.661 . . . . 0.0 112.091 174.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.97 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 1.1 Cg_endo -90.84 177.03 2.21 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 125.063 3.842 . . . . 0.0 110.573 171.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -131.36 175.43 9.14 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.105 0.478 . . . . 0.0 110.622 175.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.635 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -66.96 -2.97 5.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.316 0.579 . . . . 0.0 110.883 176.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -95.79 1.35 53.2 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.295 177.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -97.96 51.08 1.03 Allowed 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . 0.709 ' HE2' ' HA ' ' A' ' 253' ' ' LYS . 10.7 mmpt? 62.11 26.7 16.08 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -168.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . 0.635 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 24.4 p 63.83 86.05 0.13 Allowed 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 125.107 1.504 . . . . 0.0 110.699 -175.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.418 ' HB1' ' CE2' ' A' ' 286' ' ' PHE . . . -121.66 156.55 32.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.186 178.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.596 HD21 ' O ' ' A' ' 277' ' ' GLY . 4.3 mm? -78.53 131.23 36.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.841 -178.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.97 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -92.03 99.05 11.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.361 0.6 . . . . 0.0 110.355 171.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.793 HD13 ' CD ' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -153.3 174.4 14.35 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.371 -175.332 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.431 ' CG ' ' N ' ' A' ' 260' ' ' VAL . 32.3 tt0 -142.84 175.73 9.61 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 122.128 -0.357 . . . . 0.0 111.073 -165.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.574 HG22 ' HA ' ' A' ' 244' ' ' GLN . 56.0 t -57.07 118.71 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 123.083 0.553 . . . . 0.0 111.351 175.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 104.53 -1.19 42.71 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -97.79 -179.16 4.34 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.676 -169.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.798 HD11 ' HD1' ' A' ' 239' ' ' TYR . 2.3 tm? -134.16 134.29 41.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.07 0.462 . . . . 0.0 110.613 -170.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.606 HG12 ' HB3' ' A' ' 240' ' ' ALA . 5.4 p -125.54 145.3 33.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.453 173.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -99.79 99.65 10.49 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 175.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.941 ' HB ' HG23 ' A' ' 238' ' ' ILE . 76.0 t -70.06 114.14 7.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.324 -179.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 33.2 p -92.6 -32.3 14.85 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.165 -171.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.36 107.65 15.08 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 121.598 0.713 . . . . 0.0 109.831 175.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.434 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.6 OUTLIER -93.91 154.1 3.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 113.877 -1.511 . . . . 0.0 113.366 -170.024 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.754 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 2.4 p30 -145.89 -178.62 6.21 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.688 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 53.6 t -87.63 -38.81 12.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.5 m -73.33 -28.15 61.91 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -172.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . 0.853 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 102.99 0.66 48.42 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.582 -175.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.426 ' NE2' ' HB3' ' A' ' 287' ' ' PRO . 0.2 OUTLIER -89.96 76.14 7.1 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.9 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.754 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -122.33 175.66 6.29 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.619 0.723 . . . . 0.0 112.709 -170.033 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 284' ' ' GLY . 43.1 tt0 -98.52 127.31 44.4 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.081 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.596 ' O ' HD21 ' A' ' 256' ' ' LEU . . . -112.1 151.59 17.98 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.908 -174.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.624 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 17.2 tt0 -136.23 119.9 17.2 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 174.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 49.5 t -101.2 97.6 8.1 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.258 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 36.89 58.11 1.14 Allowed 'General case' 0 N--CA 1.465 0.282 0 O-C-N 124.542 1.151 . . . . 0.0 112.261 177.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 116.08 -37.51 3.39 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.661 177.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 37.3 mttt -82.13 128.28 33.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 117.808 0.804 . . . . 0.0 110.587 -178.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -110.79 141.85 43.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.344 0.592 . . . . 0.0 112.002 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . 0.492 ' O ' ' HG3' ' A' ' 276' ' ' GLU . . . -176.07 -158.89 20.77 Favored Glycine 0 C--O 1.216 -1.021 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 174.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -149.66 146.67 27.4 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 118.848 1.324 . . . . 0.0 111.842 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.418 ' CE2' ' HB1' ' A' ' 255' ' ' ALA . 4.0 m-85 -154.18 162.74 26.15 Favored Pre-proline 0 C--O 1.238 0.471 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.571 -176.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.426 ' HB3' ' NE2' ' A' ' 274' ' ' GLN . 87.5 Cg_endo -92.92 171.67 2.18 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.151 2.567 . . . . 0.0 114.177 -176.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.853 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 17.9 t80 -79.65 -16.19 56.21 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 114.112 -1.404 . . . . 0.0 111.795 -174.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 67.3 p -55.63 -28.91 57.97 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -168.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . 0.808 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 1.5 p-80 -127.88 35.77 4.43 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.617 -172.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.788 HG23 HG13 ' A' ' 242' ' ' VAL . 5.4 p -139.36 148.27 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 C-N-CA 119.428 -0.909 . . . . 0.0 112.422 -174.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 241' ' ' ARG . 26.1 mmt180 -129.95 110.93 12.06 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.0 178.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . 0.722 HD22 ' H ' ' A' ' 293' ' ' LEU . 0.1 OUTLIER -89.89 138.5 31.44 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.588 0.709 . . . . 0.0 112.779 -163.695 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 239' ' ' TYR . 7.1 mt -81.12 133.63 35.5 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 161.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -73.69 132.6 42.87 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 122.187 0.994 . . . . 0.0 112.952 -160.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.784 ' HB3' ' HA ' ' A' ' 238' ' ' ILE . 15.1 pt20 -80.71 -0.23 37.45 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.579 -1.646 . . . . 0.0 112.656 -176.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.05 10.75 34.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.628 0.728 . . . . 0.0 109.422 169.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 . . . . . 0 CA--C 1.532 0.277 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.789 167.709 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . 0.458 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . . . . . . 0 N--CA 1.445 -0.758 0 N-CA-C 112.556 -0.218 . . . . 0.0 112.556 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.596 ' HA ' ' O ' ' A' ' 266' ' ' VAL . 11.7 Cg_exo -73.09 119.38 6.0 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.124 1.882 . . . . 0.0 111.137 175.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 1.013 HG22 ' HB3' ' A' ' 296' ' ' GLN . 0.2 OUTLIER -88.02 170.72 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.329 -177.634 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.958 ' HB3' HD21 ' A' ' 263' ' ' LEU . 81.9 m-85 -111.02 120.92 43.99 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 173.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.557 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -112.76 118.26 34.49 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.82 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.572 ' HD3' ' O ' ' A' ' 262' ' ' GLU . 0.0 OUTLIER -79.97 103.86 10.15 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.571 -177.737 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.918 ' HA ' HG12 ' A' ' 291' ' ' VAL . 2.2 t -68.88 136.19 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.225 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.2 -177.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.415 ' C ' HD12 ' A' ' 243' ' ' ILE . 2.7 pp -123.01 -1.33 6.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.406 0.622 . . . . 0.0 110.227 172.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 1.07 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 33.4 tt0 -164.37 99.72 0.82 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.713 -178.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.975 ' HG2' ' HB2' ' A' ' 258' ' ' LEU . 5.3 tptt -145.76 165.12 29.74 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.419 0.628 . . . . 0.0 110.454 176.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.835 ' HG3' ' HG3' ' A' ' 248' ' ' PRO . 3.6 ptm180 -113.03 -178.78 3.46 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.466 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 5.9 m -105.67 75.76 0.33 Allowed Pre-proline 0 CA--C 1.537 0.481 0 CA-C-O 121.103 0.478 . . . . 0.0 111.826 176.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.993 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 1.0 OUTLIER -88.28 175.5 4.0 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 124.055 3.17 . . . . 0.0 111.527 175.002 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.454 ' HB3' ' HD1' ' A' ' 251' ' ' TYR . 66.3 m-20 -132.68 179.21 6.29 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.769 176.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.87 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -56.95 -10.92 1.23 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.304 0.573 . . . . 0.0 110.895 171.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.454 ' HD1' ' HB3' ' A' ' 249' ' ' ASN . 34.4 m-85 -83.21 -11.24 58.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.677 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -96.31 45.23 1.07 Allowed 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -175.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 4.1 mmpm? 60.74 28.76 18.48 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 -168.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . 0.87 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 26.8 p 62.17 80.72 0.22 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.906 -178.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.513 ' HB1' ' CE2' ' A' ' 286' ' ' PHE . . . -117.03 156.99 26.57 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.619 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 1.024 ' HB3' HD13 ' A' ' 258' ' ' LEU . 4.5 mm? -79.1 120.32 23.47 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.389 -176.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.993 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -76.3 84.01 3.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.347 0.594 . . . . 0.0 110.867 172.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 1.024 HD13 ' HB3' ' A' ' 256' ' ' LEU . 2.4 mp -119.71 175.39 5.89 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.374 -176.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.554 ' O ' ' HB ' ' A' ' 242' ' ' VAL . 24.9 tt0 -146.17 174.61 11.17 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.403 ' N ' ' CG ' ' A' ' 259' ' ' GLU . 7.2 p -58.28 124.1 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.681 0.753 . . . . 0.0 111.825 173.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 97.9 1.5 58.54 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.192 175.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.572 ' O ' ' HD3' ' A' ' 241' ' ' ARG . 6.6 mt-10 -87.32 -174.21 4.74 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -171.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.958 HD21 ' HB3' ' A' ' 239' ' ' TYR . 3.4 tm? -140.62 131.18 25.47 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.563 -177.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.79 ' HB ' HD21 ' A' ' 258' ' ' LEU . 4.1 p -126.62 125.68 67.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.247 175.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -90.49 95.51 10.2 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.337 0.589 . . . . 0.0 109.45 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.864 ' HB ' HD13 ' A' ' 238' ' ' ILE . 48.4 t -77.84 118.21 24.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.476 -176.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 41.1 p -93.74 -12.72 28.55 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.856 -1.066 . . . . 0.0 111.593 -176.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.562 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 17.4 tppt? -119.65 104.37 10.21 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.356 174.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.534 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.8 OUTLIER -105.99 159.64 5.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -172.31 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.594 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 3.9 p30 -145.2 -166.41 2.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.658 -177.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 9.8 p -103.82 -18.01 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.883 -177.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.4 m -83.62 -45.34 13.58 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.122 -0.361 . . . . 0.0 111.263 -177.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . 0.483 ' HA3' ' CD1' ' A' ' 288' ' ' PHE . . . 124.57 -7.84 8.36 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.249 -175.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.445 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.9 OUTLIER -95.12 103.21 15.06 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 173.849 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.691 ' HZ2' HD13 ' A' ' 293' ' ' LEU . 0.0 OUTLIER -127.35 177.79 6.48 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.726 -174.213 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.736 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 46.5 mt-10 -99.08 125.12 44.52 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.576 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -108.8 154.0 16.63 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.448 -0.797 . . . . 0.0 112.636 -169.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.566 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 0.2 OUTLIER -133.3 117.43 17.34 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 172.044 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . 0.711 ' SG ' ' HD2' ' A' ' 282' ' ' LYS . 27.4 p -109.45 98.16 7.6 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.311 -176.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 9.9 m120 39.65 55.81 2.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.429 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 117.09 -39.94 2.52 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.78 -0.645 . . . . 0.0 114.054 176.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . 0.711 ' HD2' ' SG ' ' A' ' 279' ' ' CYS . 20.1 mttp -86.33 132.55 33.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 117.919 0.86 . . . . 0.0 111.287 -174.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -106.11 150.19 26.04 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.964 0.412 . . . . 0.0 111.833 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 175.52 -147.92 9.12 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.002 171.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' HIS . . . . . 0.736 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 10.2 p80 -147.62 151.38 36.12 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.705 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 0.9 OUTLIER -166.76 154.6 9.01 Favored Pre-proline 0 N--CA 1.469 0.478 0 CA-C-O 120.695 0.283 . . . . 0.0 111.492 -177.54 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.491 ' HD2' ' HD1' ' A' ' 286' ' ' PHE . 9.3 Cg_endo -90.19 163.03 4.7 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 124.049 3.166 . . . . 0.0 112.972 -177.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.542 ' HA ' HG22 ' A' ' 291' ' ' VAL . 18.4 p90 -87.8 -18.77 28.6 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -172.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 7.5 t -66.77 -4.23 8.62 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -169.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . 1.07 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 0.8 OUTLIER -130.59 33.86 4.21 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.245 173.143 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.918 HG12 ' HA ' ' A' ' 242' ' ' VAL . 26.8 m -145.03 167.34 10.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.483 173.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -123.05 109.12 13.68 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . 0.691 HD13 ' HZ2' ' A' ' 275' ' ' TRP . 0.1 OUTLIER -91.99 128.81 37.97 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.635 -0.826 . . . . 0.0 112.862 -165.6 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.451 HD23 ' N ' ' A' ' 294' ' ' LEU . 4.4 mt -84.82 135.57 34.04 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 169.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.527 ' OD1' ' HG2' ' A' ' 297' ' ' GLN . 7.1 t70 -76.29 149.66 37.06 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.665 0.745 . . . . 0.0 111.447 -166.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 1.013 ' HB3' HG22 ' A' ' 238' ' ' ILE . 10.0 pt20 -75.46 2.03 12.55 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.371 -177.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.527 ' HG2' ' OD1' ' A' ' 295' ' ' ASP . 15.9 mm100 -64.07 -23.57 67.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.38 170.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 42.2 t30 . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.234 176.742 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . 0.462 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . . . . . . 0 N--CA 1.447 -0.594 0 N-CA-C 111.73 -0.548 . . . . 0.0 111.73 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.554 ' HG2' ' HE2' ' A' ' 265' ' ' LYS . 1.2 Cg_endo -84.96 148.13 10.64 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 123.383 2.722 . . . . 0.0 113.009 -177.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.991 HG22 ' HB3' ' A' ' 296' ' ' GLN . 0.2 OUTLIER -107.53 163.32 5.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 175.405 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.799 ' HB3' HD21 ' A' ' 263' ' ' LEU . 69.8 m-85 -101.86 120.75 40.89 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 174.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.76 ' HB3' HG13 ' A' ' 264' ' ' VAL . . . -113.93 117.18 30.64 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.461 0.648 . . . . 0.0 110.234 -177.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.508 ' NH1' ' HA2' ' A' ' 261' ' ' GLY . 0.6 OUTLIER -84.17 107.26 16.38 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.682 -176.046 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.76 ' HA ' HG12 ' A' ' 291' ' ' VAL . 3.9 t -69.6 131.74 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.122 -177.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.48 ' O ' HG22 ' A' ' 260' ' ' VAL . 2.8 pp -121.94 -0.52 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.015 175.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.649 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 6.7 tp-100 -178.1 95.69 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.685 -175.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.646 ' HB3' ' O ' ' A' ' 258' ' ' LEU . 0.9 OUTLIER -146.29 162.88 37.14 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.158 0.504 . . . . 0.0 110.261 177.248 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.877 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 12.1 ttt180 -95.43 179.64 5.09 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.35 -174.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.453 ' N ' ' CG ' ' A' ' 246' ' ' ARG . 8.9 m -106.36 69.68 0.23 Allowed Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 121.893 0.854 . . . . 0.0 110.805 173.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.923 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 11.6 Cg_endo -95.62 131.71 0.49 Allowed 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 125.146 3.897 . . . . 0.0 111.376 -178.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -92.39 178.26 5.88 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.58 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.641 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -59.85 -8.13 2.03 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.388 0.613 . . . . 0.0 110.999 174.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -92.14 -8.08 46.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.198 0.523 . . . . 0.0 110.118 177.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -104.67 66.85 0.8 Allowed 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.645 -174.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.97 23.66 13.78 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.179 -172.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 34.8 p 52.81 65.33 1.55 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.888 -177.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.732 ' HB1' ' CE2' ' A' ' 286' ' ' PHE . . . -109.53 158.32 18.12 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.429 -175.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.688 HD22 ' CA ' ' A' ' 284' ' ' GLY . 1.7 mm? -67.37 128.37 36.16 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.869 176.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.923 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -92.6 98.08 11.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.442 0.639 . . . . 0.0 110.311 173.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.646 ' O ' ' HB3' ' A' ' 245' ' ' LYS . 0.2 OUTLIER -160.06 164.48 33.09 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.881 -173.743 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.504 ' O ' ' HG3' ' A' ' 262' ' ' GLU . 12.0 pt-20 -143.47 -167.52 2.59 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.975 -0.453 . . . . 0.0 111.888 -172.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 243' ' ' ILE . 62.8 t -54.49 123.22 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.508 ' HA2' ' NH1' ' A' ' 241' ' ' ARG . . . 102.04 -1.04 51.24 Favored Glycine 0 CA--C 1.509 -0.331 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.699 170.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 259' ' ' GLU . 8.3 mt-10 -86.57 -174.83 5.19 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -168.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.799 HD21 ' HB3' ' A' ' 239' ' ' TYR . 3.4 tm? -140.0 128.28 22.55 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.634 177.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.76 HG13 ' HB3' ' A' ' 240' ' ' ALA . 2.6 p -127.17 115.54 41.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.297 177.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.554 ' HE2' ' HG2' ' A' ' 237' ' ' PRO . 86.9 tttt -89.61 100.75 13.49 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.658 ' HA ' ' HA2' ' A' ' 277' ' ' GLY . 0.8 OUTLIER -83.09 137.16 21.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.897 -175.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 23.2 p -99.34 -8.3 25.05 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.704 -176.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.442 ' HA ' ' HD3' ' A' ' 268' ' ' LYS . 14.0 tppt? -126.51 107.44 10.24 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.052 173.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.728 HG21 HG23 ' A' ' 238' ' ' ILE . 0.9 OUTLIER -105.04 163.26 4.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -170.76 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.514 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 4.3 p30 -143.3 -172.53 3.72 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.225 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 26.0 m -103.03 -5.91 9.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -175.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 5.5 m -100.99 -44.85 5.6 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.481 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . 0.482 ' HA3' ' CD1' ' A' ' 288' ' ' PHE . . . 133.18 -1.81 4.6 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.289 -0.958 . . . . 0.0 113.513 -178.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.9 OUTLIER -95.99 102.08 13.83 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 118.003 0.901 . . . . 0.0 109.274 174.463 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.87 ' HZ2' ' HG ' ' A' ' 293' ' ' LEU . 0.0 OUTLIER -128.24 173.27 10.28 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -173.582 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.517 ' O ' ' HB ' ' A' ' 266' ' ' VAL . 45.1 tt0 -96.34 125.16 40.65 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 171.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.658 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -114.97 165.47 12.07 Favored Glycine 0 N--CA 1.439 -1.132 0 CA-C-N 115.466 -0.788 . . . . 0.0 113.15 -166.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 22.4 tt0 -139.04 118.86 13.19 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 171.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 282' ' ' LYS . 21.8 p -99.93 96.3 7.46 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 119.474 -0.891 . . . . 0.0 108.904 176.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 11.4 m120 41.59 52.69 3.9 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.935 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 115.18 -28.62 7.84 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.548 -0.834 . . . . 0.0 114.691 175.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . 0.641 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 10.0 mptt -91.63 134.21 34.89 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.105 0.952 . . . . 0.0 110.428 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . 0.411 ' N ' ' HD2' ' A' ' 283' ' ' ARG . 3.5 mpt_? -106.27 157.76 17.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.953 0.406 . . . . 0.0 111.301 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . 0.688 ' CA ' HD22 ' A' ' 256' ' ' LEU . . . 175.37 -172.97 45.96 Favored Glycine 0 C--O 1.224 -0.499 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -177.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' HIS . . . . . 0.463 ' H ' ' HA ' ' A' ' 255' ' ' ALA . 12.3 p80 -146.85 143.6 28.69 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 118.674 1.237 . . . . 0.0 111.782 171.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.732 ' CE2' ' HB1' ' A' ' 255' ' ' ALA . 5.8 m-85 -156.3 163.04 26.22 Favored Pre-proline 0 N--CA 1.464 0.264 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.429 -174.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 24.1 Cg_endo -92.57 167.09 2.76 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.178 2.585 . . . . 0.0 112.06 175.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.482 ' CD1' ' HA3' ' A' ' 273' ' ' GLY . 39.7 p90 -85.18 -8.02 58.78 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -172.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 6.3 t -56.33 -13.19 2.01 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -174.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . 0.649 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 0.9 OUTLIER -138.94 33.56 2.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.928 0.394 . . . . 0.0 111.89 -178.259 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.76 HG12 ' HA ' ' A' ' 242' ' ' VAL . 15.5 m -146.74 162.08 9.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.348 176.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -117.79 106.37 12.95 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 176.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . 0.87 ' HG ' ' HZ2' ' A' ' 275' ' ' TRP . 0.0 OUTLIER -104.55 128.66 52.57 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 119.622 -0.831 . . . . 0.0 113.223 -169.363 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.663 ' O ' ' HB ' ' A' ' 238' ' ' ILE . 4.8 mp -84.7 125.0 32.14 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 168.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.553 ' HB3' ' HG2' ' A' ' 297' ' ' GLN . 33.8 t70 -84.72 153.47 23.05 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.497 -164.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.991 ' HB3' HG22 ' A' ' 238' ' ' ILE . 0.0 OUTLIER -76.57 11.89 1.47 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.1 -176.27 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.553 ' HG2' ' HB3' ' A' ' 295' ' ' ASP . 9.3 pt20 -58.45 -35.52 72.26 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 163.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.448 ' N ' ' HG3' ' A' ' 297' ' ' GLN . 7.8 t30 . . . . . 0 N--CA 1.451 -0.4 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.706 174.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.972 0 CA-C-O 120.904 0.169 . . . . 0.0 113.199 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.43 ' HB3' ' HA ' ' A' ' 267' ' ' THR . 11.3 Cg_exo -71.23 120.57 7.09 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.49 2.127 . . . . 0.0 110.171 171.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 1.011 HG22 ' HB3' ' A' ' 296' ' ' GLN . 0.2 OUTLIER -80.43 158.21 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.115 -171.045 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.711 ' HD1' HD11 ' A' ' 263' ' ' LEU . 83.1 m-85 -99.43 118.33 35.8 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 174.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 293' ' ' LEU . . . -114.78 115.74 27.51 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -175.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -79.93 101.88 8.86 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 176.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.852 HG21 ' HD3' ' A' ' 245' ' ' LYS . 7.6 p -81.95 119.11 30.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.324 -175.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.8 pp -98.71 3.7 10.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.411 -174.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.543 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 8.3 tt0 -177.28 106.0 0.06 Allowed 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.446 -175.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.852 ' HD3' HG21 ' A' ' 242' ' ' VAL . 0.2 OUTLIER -146.93 166.0 28.09 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.344 0.593 . . . . 0.0 110.903 174.446 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.822 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 5.7 ptt180 -104.7 -178.8 3.76 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.135 -0.938 . . . . 0.0 108.602 -177.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 4.7 m -104.22 76.95 0.28 Allowed Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 121.227 0.537 . . . . 0.0 112.357 176.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 1.012 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 3.3 Cg_exo -83.31 177.43 6.51 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.274 3.316 . . . . 0.0 110.6 174.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -139.49 176.99 8.26 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.054 -178.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.937 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -63.6 -5.06 3.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.634 0.73 . . . . 0.0 110.567 170.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -90.2 -11.01 42.32 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.772 176.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -105.95 60.21 0.66 Allowed 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.557 -173.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . 0.5 ' N ' ' HD2' ' A' ' 253' ' ' LYS . 7.2 mptt 56.28 31.56 18.74 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -170.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . 0.937 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 74.3 p 53.14 53.06 12.5 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 114.174 -1.375 . . . . 0.0 112.547 -177.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.436 ' HA ' ' H ' ' A' ' 285' ' ' HIS . . . -90.07 161.4 15.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.046 0.45 . . . . 0.0 110.709 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.687 ' N ' ' HA3' ' A' ' 284' ' ' GLY . 0.2 OUTLIER -78.89 132.67 36.86 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.745 -173.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.012 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -91.27 100.75 13.5 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 172.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.802 HD11 ' HE2' ' A' ' 245' ' ' LYS . 0.7 OUTLIER -150.26 171.25 17.25 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.493 -174.59 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -143.59 170.31 16.08 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.188 -163.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 2.5 p -53.81 118.74 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 121.528 0.68 . . . . 0.0 111.724 173.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 106.45 -1.67 37.05 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.011 171.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -89.04 176.21 7.08 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.079 -174.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.711 HD11 ' HD1' ' A' ' 239' ' ' TYR . 3.0 tm? -126.7 130.47 50.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.227 0.536 . . . . 0.0 110.132 -178.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.437 HG22 HD12 ' A' ' 258' ' ' LEU . 2.2 t -111.44 145.09 18.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.604 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 238' ' ' ILE . 62.3 tttp -120.68 95.12 4.59 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 170.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.735 ' HB ' ' HA2' ' A' ' 277' ' ' GLY . 1.4 m -84.71 124.42 39.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.723 -173.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . 0.43 ' HA ' ' HB3' ' A' ' 237' ' ' PRO . 40.4 p -88.36 -9.49 52.56 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.868 -174.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.503 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 4.4 tppp? -116.92 103.62 10.47 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.586 HG21 HG23 ' A' ' 238' ' ' ILE . 0.7 OUTLIER -102.61 154.41 5.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.85 -172.816 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.536 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 4.2 p30 -144.23 -170.81 3.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.774 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 12.0 p -95.67 -33.87 4.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.916 -178.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 10.8 m -74.07 -43.02 59.22 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -173.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 123.88 -5.7 9.03 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.163 -177.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.705 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.9 OUTLIER -94.53 104.71 16.66 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 173.535 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.588 ' HZ2' HD13 ' A' ' 293' ' ' LEU . 0.0 OUTLIER -129.71 -179.76 5.37 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.598 0.713 . . . . 0.0 112.055 -173.684 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.503 ' HB2' ' HB3' ' A' ' 268' ' ' LYS . 32.2 mt-10 -102.42 123.87 46.98 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 173.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.735 ' HA2' ' HB ' ' A' ' 266' ' ' VAL . . . -109.09 153.39 16.84 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.905 -165.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.589 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 29.7 tt0 -135.42 118.88 16.85 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 174.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 47.9 t -99.3 96.38 7.7 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 12.8 m120 38.4 55.93 1.8 Allowed 'General case' 0 CA--C 1.533 0.323 0 O-C-N 124.362 1.039 . . . . 0.0 112.023 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 115.91 -40.26 2.48 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 120.433 -0.889 . . . . 0.0 114.091 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 0.8 OUTLIER -80.05 136.82 36.66 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.969 0.884 . . . . 0.0 110.241 179.788 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 283' ' ' ARG . 5.6 mpt_? -113.12 131.23 55.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.643 0.735 . . . . 0.0 112.031 178.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . 0.687 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . -147.51 -166.96 12.89 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 114.282 -1.326 . . . . 0.0 111.651 174.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' HIS . . . . . 0.436 ' H ' ' HA ' ' A' ' 255' ' ' ALA . 5.6 m-70 -145.91 139.89 26.58 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 117.684 0.742 . . . . 0.0 109.427 178.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.724 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 10.4 m-85 -167.99 157.2 8.69 Favored Pre-proline 0 N--CA 1.471 0.603 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -172.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.705 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 58.7 Cg_endo -95.34 176.39 0.9 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.709 2.939 . . . . 0.0 113.457 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.494 ' HA ' HG22 ' A' ' 291' ' ' VAL . 24.1 p90 -86.07 -9.74 56.2 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.106 -173.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 11.1 t -70.26 8.26 0.82 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -168.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . 0.543 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 0.9 OUTLIER -155.77 38.21 0.37 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.091 0.472 . . . . 0.0 110.95 177.517 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 242' ' ' VAL . 27.6 m -144.67 157.76 14.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.014 0.435 . . . . 0.0 111.112 178.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -115.88 108.84 16.8 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 170.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . 0.588 HD13 ' HZ2' ' A' ' 275' ' ' TRP . 0.2 OUTLIER -102.98 123.65 46.98 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -165.727 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.468 ' H ' HD12 ' A' ' 294' ' ' LEU . 4.6 mp -82.38 125.31 30.89 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.092 167.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -77.63 160.07 28.77 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.922 0.867 . . . . 0.0 111.728 -166.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 1.011 ' HB3' HG22 ' A' ' 238' ' ' ILE . 12.3 pt20 -75.5 -15.42 60.4 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.07 -1.423 . . . . 0.0 111.499 -176.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -84.1 -8.8 59.0 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.116 175.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.462 HD22 ' HA ' ' A' ' 298' ' ' ASN . 1.6 m120 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.748 174.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . 0.459 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . . . . . . 0 N--CA 1.446 -0.687 0 N-CA-C 113.463 0.145 . . . . 0.0 113.463 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.459 ' HD3' ' HA2' ' A' ' 236' ' ' GLY . 26.4 Cg_exo -68.06 145.66 68.07 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.859 3.04 . . . . 0.0 112.593 174.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 1.044 HG12 HG22 ' A' ' 266' ' ' VAL . 1.3 pt -91.75 167.98 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.727 173.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.776 ' HB3' HD11 ' A' ' 263' ' ' LEU . 61.5 m-85 -116.35 119.66 36.39 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 169.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.626 ' HA ' ' HA ' ' A' ' 293' ' ' LEU . . . -113.21 117.66 32.52 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.944 -175.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.495 ' HD3' ' O ' ' A' ' 262' ' ' GLU . 16.3 tpp180 -82.45 102.91 11.62 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.416 175.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.906 HG21 ' HD2' ' A' ' 245' ' ' LYS . 2.6 p -87.26 135.15 25.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.512 -173.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.8 pp -109.61 9.1 8.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.787 -175.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.823 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 58.2 tt0 -176.92 95.24 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.723 0.297 . . . . 0.0 110.26 -173.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.906 ' HD2' HG21 ' A' ' 242' ' ' VAL . 4.3 mttt -146.29 161.72 39.68 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 175.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.878 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 5.8 ptp180 -106.62 -178.07 3.54 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -177.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 32.0 t -103.3 80.37 0.36 Allowed Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 120.955 0.407 . . . . 0.0 111.262 176.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.962 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 3.1 Cg_endo -91.45 177.67 1.87 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 125.161 3.907 . . . . 0.0 111.184 175.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -130.29 174.94 9.35 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 175.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.788 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -72.22 5.12 3.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.417 0.627 . . . . 0.0 110.332 175.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -99.2 -2.62 36.28 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.216 174.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.422 ' C ' ' HD2' ' A' ' 253' ' ' LYS . 35.6 m-20 -105.15 63.72 0.7 Allowed 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.464 -177.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . 0.422 ' HD2' ' C ' ' A' ' 252' ' ' ASP . 7.0 mptt 57.58 25.62 11.83 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -171.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . 0.788 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 44.9 p 56.06 75.86 0.32 Allowed 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.823 -174.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -113.77 150.3 33.62 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.253 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.463 ' O ' ' HE2' ' A' ' 286' ' ' PHE . 0.0 OUTLIER -72.84 132.92 44.16 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.611 -176.163 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.962 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -95.12 104.27 16.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.371 0.605 . . . . 0.0 111.479 174.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.692 ' HG ' ' HD3' ' A' ' 245' ' ' LYS . 0.4 OUTLIER -163.81 175.5 10.41 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.54 -176.344 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -142.45 -166.42 2.26 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 121.591 -0.693 . . . . 0.0 112.383 -171.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 2.8 p -68.51 122.01 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.295 177.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 104.18 -0.75 43.96 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.284 174.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.495 ' O ' ' HD3' ' A' ' 241' ' ' ARG . 9.4 mt-10 -98.73 -174.72 2.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.842 0.353 . . . . 0.0 111.666 -170.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.776 HD11 ' HB3' ' A' ' 239' ' ' TYR . 50.7 tp -133.74 160.27 38.09 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.508 -177.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.498 ' N ' ' HG ' ' A' ' 263' ' ' LEU . 2.8 p -153.48 136.91 7.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.389 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.485 ' HE2' ' CE1' ' A' ' 239' ' ' TYR . 37.9 ttmt -99.98 102.1 13.38 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 175.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 1.044 HG22 HG12 ' A' ' 238' ' ' ILE . 4.0 m -86.79 115.68 28.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.97 0.89 . . . . 0.0 110.71 -178.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 9.9 t -99.95 4.08 44.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.596 -1.183 . . . . 0.0 110.394 -177.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 276' ' ' GLU . 0.0 OUTLIER -124.94 107.19 10.6 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 168.128 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.579 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.8 OUTLIER -110.49 158.22 10.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 115.286 -0.87 . . . . 0.0 113.113 -172.098 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.769 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 2.6 p30 -146.34 -172.98 4.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.698 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 11.6 p -93.39 -31.92 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 45.7 m -74.99 -43.44 53.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -173.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . 0.777 ' HA3' ' HB2' ' A' ' 288' ' ' PHE . . . 125.04 -13.51 7.55 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.499 -178.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.569 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.6 OUTLIER -89.23 93.09 9.44 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 173.285 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.769 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -123.05 179.09 4.79 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.183 -176.204 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 268' ' ' LYS . 53.4 tt0 -104.32 125.77 50.85 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.723 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -110.2 169.68 13.69 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.95 -172.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 282' ' ' LYS . 3.1 tm-20 -152.32 119.45 5.87 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 171.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . . . . . . . . . 44.6 t -115.63 99.55 7.42 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.084 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 43.3 54.33 5.16 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 124.252 0.97 . . . . 0.0 112.313 173.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 117.73 -40.45 2.33 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-N 115.828 -0.624 . . . . 0.0 114.102 176.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 278' ' ' GLU . 0.0 OUTLIER -93.32 128.79 39.48 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 118.066 0.933 . . . . 0.0 109.934 -178.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . 0.622 ' HD3' ' H ' ' A' ' 283' ' ' ARG . 0.0 OUTLIER -121.2 145.47 47.8 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.266 176.28 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 173.05 157.75 15.61 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.072 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' HIS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 30.5 p80 -98.08 148.35 23.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.04 0.42 . . . . 0.0 112.117 -171.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.463 ' HE2' ' O ' ' A' ' 256' ' ' LEU . 5.3 m-85 -158.55 159.21 29.85 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.515 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 93.6 Cg_endo -89.36 168.28 5.14 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.206 2.604 . . . . 0.0 113.809 -177.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.777 ' HB2' ' HA3' ' A' ' 273' ' ' GLY . 19.0 t80 -76.62 -19.99 57.22 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 114.158 -1.383 . . . . 0.0 111.922 -172.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 8.9 t -61.8 -11.47 12.61 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -168.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . 0.823 ' HB2' ' HB3' ' A' ' 244' ' ' GLN . 1.0 OUTLIER -137.68 33.91 2.45 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.69 -0.631 . . . . 0.0 112.351 -176.359 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.565 HG13 ' HD2' ' A' ' 290' ' ' HIS . 34.1 m -139.93 153.11 22.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.882 0.372 . . . . 0.0 111.192 177.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -121.06 107.96 13.25 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 169.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . 0.744 HD21 ' CE2' ' A' ' 288' ' ' PHE . 0.2 OUTLIER -101.49 139.96 36.44 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -169.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.512 ' N ' HD12 ' A' ' 294' ' ' LEU . 4.5 mp -77.0 130.23 37.19 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 113.397 -1.729 . . . . 0.0 107.412 166.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.451 ' HB3' ' HG3' ' A' ' 297' ' ' GLN . 13.7 m-20 -77.13 144.15 38.65 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.486 -164.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.951 ' HB3' HG22 ' A' ' 238' ' ' ILE . 3.1 pt20 -77.15 0.47 21.54 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 113.864 -1.516 . . . . 0.0 111.233 -177.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.451 ' HG3' ' HB3' ' A' ' 295' ' ' ASP . 0.0 OUTLIER -79.01 -16.06 57.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.062 0.458 . . . . 0.0 110.145 175.447 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 48.1 t30 . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.19 175.965 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . 0.417 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . . . . . . 0 N--CA 1.449 -0.458 0 N-CA-C 112.583 -0.207 . . . . 0.0 112.583 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.417 ' HD3' ' HA2' ' A' ' 236' ' ' GLY . 18.9 Cg_endo -89.03 136.45 2.97 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 123.156 2.57 . . . . 0.0 111.935 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.662 HD13 ' HB ' ' A' ' 266' ' ' VAL . 0.1 OUTLIER -97.08 152.24 4.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.391 -178.641 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.7 ' HB3' HD21 ' A' ' 263' ' ' LEU . 67.3 m-85 -96.65 119.54 35.32 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 174.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 293' ' ' LEU . . . -114.42 116.72 29.35 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.24 0.543 . . . . 0.0 110.352 -174.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -86.19 102.29 13.78 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.592 178.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.74 HG21 ' HD3' ' A' ' 245' ' ' LYS . 3.0 p -79.55 128.53 38.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.534 -175.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.721 HD12 ' HB2' ' A' ' 244' ' ' GLN . 2.8 pp -108.31 3.53 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.88 -175.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.721 ' HB2' HD12 ' A' ' 243' ' ' ILE . 4.0 mt-30 -176.29 95.67 0.05 Allowed 'General case' 0 N--CA 1.463 0.203 0 O-C-N 123.043 0.214 . . . . 0.0 111.061 -175.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.74 ' HD3' HG21 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -146.5 163.17 36.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.183 0.516 . . . . 0.0 111.164 173.663 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.869 ' O ' ' HD3' ' A' ' 248' ' ' PRO . 9.8 ptt180 -101.27 -176.92 3.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.679 -177.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 27.3 t -101.66 82.69 0.4 Allowed Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 120.856 0.36 . . . . 0.0 111.292 175.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.98 ' HD2' ' HA ' ' A' ' 257' ' ' ALA . 7.0 Cg_endo -93.02 177.14 1.44 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.656 3.571 . . . . 0.0 110.778 172.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . 0.409 ' C ' ' H ' ' A' ' 251' ' ' TYR . 51.8 m-80 -131.04 177.26 7.58 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.026 0.441 . . . . 0.0 110.678 176.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.812 ' HA ' ' HA ' ' A' ' 254' ' ' THR . . . -64.2 0.25 1.02 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.356 0.598 . . . . 0.0 110.99 173.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.409 ' H ' ' C ' ' A' ' 249' ' ' ASN . 44.4 m-85 -103.81 8.57 37.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.454 0.645 . . . . 0.0 109.696 177.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.74 53.19 0.73 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.162 -0.927 . . . . 0.0 108.727 176.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt 58.01 30.45 19.24 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -167.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . 0.812 ' HA ' ' HA ' ' A' ' 250' ' ' ALA . 43.4 p 59.1 71.3 0.59 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.826 -176.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.417 ' HB1' ' CE2' ' A' ' 286' ' ' PHE . . . -111.55 150.75 29.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.65 179.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.667 ' HB3' HD22 ' A' ' 258' ' ' LEU . 0.2 OUTLIER -72.12 133.67 45.32 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.663 -174.543 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.98 ' HA ' ' HD2' ' A' ' 248' ' ' PRO . . . -90.57 98.92 12.06 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 172.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.73 HD21 ' HE2' ' A' ' 245' ' ' LYS . 0.9 OUTLIER -154.94 171.14 20.19 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.108 -173.735 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.454 ' O ' HG13 ' A' ' 242' ' ' VAL . 12.3 pt-20 -142.28 -166.59 2.28 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.177 0.513 . . . . 0.0 111.873 -171.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.575 HG22 ' HA ' ' A' ' 244' ' ' GLN . 48.2 t -68.12 117.61 10.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.124 176.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 107.13 0.86 35.74 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.132 172.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.405 ' HB2' ' CG1' ' A' ' 242' ' ' VAL . 13.4 mt-10 -93.15 179.78 5.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.188 0.518 . . . . 0.0 111.915 -173.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.7 HD21 ' HB3' ' A' ' 239' ' ' TYR . 3.0 tm? -136.89 133.57 35.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.251 -176.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.95 HG12 ' HB2' ' A' ' 279' ' ' CYS . 34.1 m -126.15 154.86 35.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.097 173.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -111.52 96.04 5.86 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.662 ' HB ' HD13 ' A' ' 238' ' ' ILE . 49.2 t -69.88 121.47 19.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.836 -174.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 40.8 p -103.51 -7.19 21.06 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.626 -176.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.596 ' O ' ' HB2' ' A' ' 275' ' ' TRP . 0.0 OUTLIER -126.85 106.77 9.56 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 119.445 -0.902 . . . . 0.0 108.74 171.018 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.586 ' H ' HD12 ' A' ' 269' ' ' ILE . 0.7 OUTLIER -107.65 148.66 11.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 114.451 -1.249 . . . . 0.0 113.72 -168.613 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.848 ' H ' ' HE3' ' A' ' 275' ' ' TRP . 0.3 OUTLIER -147.12 154.04 40.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.463 -178.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 35.9 m -70.4 -9.71 12.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -174.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 1.5 m -89.75 -45.49 9.26 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.867 -178.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . 0.434 ' H ' ' ND2' ' A' ' 270' ' ' ASN . . . 119.68 -7.95 12.03 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.061 -178.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.724 ' HA ' ' HA ' ' A' ' 287' ' ' PRO . 0.0 OUTLIER -93.94 70.75 4.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.484 0.659 . . . . 0.0 109.636 176.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.848 ' HE3' ' H ' ' A' ' 270' ' ' ASN . 0.0 OUTLIER -112.74 174.83 5.7 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.327 -168.814 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.691 ' HA ' ' HA ' ' A' ' 285' ' ' HIS . 32.9 tt0 -94.87 123.82 38.56 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.225 0.536 . . . . 0.0 109.796 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.6 ' HA2' HG22 ' A' ' 266' ' ' VAL . . . -100.96 150.21 18.64 Favored Glycine 0 N--CA 1.436 -1.326 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.299 -175.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.808 ' HG3' ' HG2' ' A' ' 283' ' ' ARG . 32.4 tt0 -127.8 116.85 20.81 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . 0.95 ' HB2' HG12 ' A' ' 264' ' ' VAL . 43.7 t -111.17 98.36 7.46 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 24.95 61.56 0.05 Allowed 'General case' 0 C--N 1.343 0.306 0 O-C-N 125.619 1.824 . . . . 0.0 113.301 174.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 118.53 -24.27 8.63 Favored Glycine 0 CA--C 1.523 0.55 0 CA-C-N 115.447 -0.797 . . . . 0.0 114.134 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.35 144.4 31.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 118.003 0.902 . . . . 0.0 110.38 175.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . 0.808 ' HG2' ' HG3' ' A' ' 278' ' ' GLU . 28.7 mtm180 -123.91 129.5 51.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.792 0.33 . . . . 0.0 110.188 171.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . 0.614 ' HA3' ' N ' ' A' ' 256' ' ' LEU . . . -165.52 140.57 6.46 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.112 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' HIS . . . . . 0.691 ' HA ' ' HA ' ' A' ' 276' ' ' GLU . 20.7 p80 -99.25 148.04 24.54 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 117.434 0.617 . . . . 0.0 111.696 -175.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.654 ' CG ' ' HE3' ' A' ' 245' ' ' LYS . 5.7 m-85 -161.2 164.05 19.34 Favored Pre-proline 0 C--O 1.235 0.324 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.041 -177.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.724 ' HA ' ' HA ' ' A' ' 274' ' ' GLN . 1.7 Cg_endo -85.72 158.76 10.54 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.518 2.812 . . . . 0.0 112.13 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.709 ' HB2' HD21 ' A' ' 293' ' ' LEU . 1.8 p90 -87.03 -5.95 58.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.891 -174.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.541 HG22 ' HB2' ' A' ' 287' ' ' PRO . 5.6 t -52.8 -32.73 45.48 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . 0.438 ' CD2' ' HD2' ' A' ' 245' ' ' LYS . 0.8 OUTLIER -121.38 43.77 2.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.35 0.595 . . . . 0.0 111.429 -177.322 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.692 HG12 ' HA ' ' A' ' 242' ' ' VAL . 19.8 m -147.46 170.11 3.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.158 173.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -131.71 109.06 9.9 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 173.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . 0.709 HD21 ' HB2' ' A' ' 288' ' ' PHE . 0.1 OUTLIER -113.88 133.13 55.62 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.742 0.782 . . . . 0.0 112.883 -166.379 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.456 ' H ' HD12 ' A' ' 294' ' ' LEU . 4.5 mp -86.41 125.67 33.85 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.326 -1.307 . . . . 0.0 108.075 171.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -75.96 166.75 23.05 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.282 -167.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.428 ' HB3' HG22 ' A' ' 238' ' ' ILE . 1.5 pm0 -76.74 -0.49 23.92 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.731 -176.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.89 -16.21 30.5 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.88 174.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.16 179.349 . . . . . . . . 0 0 . 1 stop_ save_